Clustering O 0 1.109572789204094e-08
of O 0 4.394207220315138e-12
missense O 0 8.159425306075718e-06
mutations O 0 0.0001323838805546984
in O 0 1.6099675759218002e-10
the O 0 2.8627991355278937e-07
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999994039535522
telangiectasia I-Disease 1 1.0
gene O 0 0.10979177057743073
in O 0 1.2719814784789563e-11
a O 0 2.3485362959929645e-11
sporadic B-Disease 0 6.376207693392644e-06
T I-Disease 1 0.9992259740829468
- I-Disease 0 0.012564255855977535
cell I-Disease 0 0.0007102075032889843
leukaemia I-Disease 1 0.9498315453529358
. O 0 7.095223297781672e-10

Ataxia B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999970197677612
telangiectasia I-Disease 1 0.9999998807907104
( O 0 0.0044882954098284245
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999997615814209
T I-Disease 1 1.0
) O 0 2.7341560005639254e-12
is O 0 1.7570216183132766e-14
a O 0 5.262011597392986e-14
recessive B-Disease 0 0.00033808156149461865
multi I-Disease 1 0.9778712391853333
- I-Disease 1 0.9999959468841553
system I-Disease 0 0.1997801661491394
disorder I-Disease 1 0.9416652321815491
caused O 0 1.4233186677869991e-11
by O 0 4.446727308474261e-15
mutations O 0 1.485001122070173e-09
in O 0 1.867844359813419e-14
the O 0 3.278969232093677e-14
ATM O 0 1.7090918618123396e-06
gene O 0 7.181632355468537e-08
at O 0 2.6242454875813337e-09
11q22 O 0 2.27603109692609e-08
- O 0 7.133142077009325e-08
q23 O 0 7.826648662501157e-09
( O 0 2.740545149756274e-13
ref O 0 5.288681848014676e-08
. O 0 1.349616388969261e-14
3 O 0 3.403917501598047e-13
) O 0 6.007217293046985e-14
. O 0 4.872075507790508e-13

The O 0 1.4179001028846727e-10
risk O 0 8.568736689085199e-07
of O 0 2.0172171225074642e-12
cancer B-Disease 0 1.5945081486279378e-06
, O 0 7.0858570747067695e-12
especially O 0 1.3949906334242979e-11
lymphoid B-Disease 0 8.747480251258821e-08
neoplasias I-Disease 0 4.069624083058443e-06
, O 0 8.130710595901855e-14
is O 0 1.4166166612157582e-13
substantially O 0 1.6574530636859208e-10
elevated O 0 1.0269779522786848e-05
in O 0 4.18574863658705e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 0.0004947303095832467
and O 0 1.1815946832083313e-10
has O 0 5.394835619898508e-11
long O 0 1.687359627022822e-11
been O 0 1.683623900017306e-11
associated O 0 1.6551830435765358e-12
with O 0 1.3363309347980135e-09
chromosomal O 1 1.0
instability O 1 0.9999995231628418
. O 0 9.105101561601714e-09

By O 0 7.416177047470107e-12
analysing O 0 4.922424423625671e-08
tumour B-Disease 1 0.9999955892562866
DNA O 0 1.0067334414998186e-06
from O 0 4.053480207738547e-12
patients O 0 2.4225786307563446e-11
with O 0 2.8820319069623734e-13
sporadic B-Disease 0 9.637818720875657e-07
T I-Disease 1 0.9990506768226624
- I-Disease 0 0.01604744791984558
cell I-Disease 0 0.017474548891186714
prolymphocytic I-Disease 1 0.9799228310585022
leukaemia I-Disease 0 0.36140695214271545
( O 0 7.37513106141563e-11
T B-Disease 0 4.8240133764920756e-05
- I-Disease 0 4.597034219955276e-08
PLL I-Disease 0 2.2932880483494955e-07
) O 0 2.7534341451827815e-13
, O 0 4.794264714974464e-16
a O 0 1.3093556000851958e-15
rare O 0 3.664725207325192e-12
clonal B-Disease 0 4.730424336685246e-07
malignancy I-Disease 0 8.16458668850828e-06
with O 0 4.4821210545137324e-13
similarities O 0 4.143831978942192e-12
to O 0 2.5142023269623774e-14
a O 0 2.076032921960458e-12
mature B-Disease 0 5.496123094417271e-07
T I-Disease 0 8.591917139710858e-05
- I-Disease 0 9.770829478839005e-08
cell I-Disease 0 2.3683332983637229e-07
leukaemia I-Disease 0 0.0002225790376542136
seen O 0 4.2282024992346123e-07
in O 0 4.430499023211354e-11
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999997615814209
T I-Disease 1 1.0
, O 0 3.86709241018135e-11
we O 0 3.1435851101033196e-13
demonstrate O 0 2.605772983659319e-15
a O 0 2.978746736626009e-16
high O 0 2.8833624940785563e-13
frequency O 0 3.751141311090188e-14
of O 0 1.612555066961372e-14
ATM O 0 1.1515696314745583e-05
mutations O 0 4.043948251819529e-07
in O 0 1.6578157249758085e-11
T B-Disease 0 0.006491799373179674
- I-Disease 0 3.0619105473306263e-06
PLL I-Disease 0 1.78999180207029e-05
. O 0 1.7099097138206787e-10

In O 0 6.585348585885775e-12
marked O 0 1.0624924551283499e-11
contrast O 0 2.2803620428578364e-13
to O 0 4.8259562409377465e-15
the O 0 2.889279188621717e-14
ATM O 0 1.6704289009794593e-05
mutation O 0 2.8583903599610494e-07
pattern O 0 4.7087075927265687e-07
in O 0 1.0391209004367852e-09
A B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
T I-Disease 1 1.0
, O 0 4.156957330442301e-12
the O 0 4.162946971886396e-16
most O 0 1.620054008462092e-16
frequent O 0 1.8678941653507176e-14
nucleotide O 0 1.5987943607909116e-11
changes O 0 9.524734516722089e-13
in O 0 6.567576682687572e-15
this O 0 3.111527420267268e-13
leukaemia B-Disease 0 2.75549064099323e-06
were O 0 8.387728012149154e-12
missense O 0 3.808815449701797e-07
mutations O 0 1.3686085367226042e-06
. O 0 4.184405599794161e-10

These O 0 9.09307698582218e-12
clustered O 0 4.665160258099377e-09
in O 0 1.8362897736667189e-13
the O 0 3.411416385924043e-14
region O 0 2.900782641434424e-13
corresponding O 0 2.4151389438689663e-13
to O 0 2.5631366061713845e-13
the O 0 2.5995752859359067e-13
kinase O 0 6.885040537696341e-09
domain O 0 4.050889401696622e-09
, O 0 1.8464654718414186e-12
which O 0 1.147223710750182e-14
is O 0 1.819342236814101e-14
highly O 0 2.083122865555783e-14
conserved O 0 7.642500456268853e-13
in O 0 5.6100533696616314e-14
ATM O 0 2.7378177946957294e-07
- O 0 5.5176796465161715e-09
related O 0 3.6794370328330217e-10
proteins O 0 1.8738036122734059e-10
in O 0 8.691672734187708e-14
mouse O 0 2.013311814152985e-06
, O 0 8.587520451686093e-12
yeast O 0 1.5430828170792665e-08
and O 0 4.735547023959619e-12
Drosophila O 0 2.2640656016648109e-10
. O 0 7.757335572511348e-12

The O 0 1.841384336676022e-11
resulting O 0 1.4003712078825004e-10
amino O 0 2.1630799373895115e-09
- O 0 1.4114250745933532e-07
acid O 0 4.5935322212642404e-10
substitutions O 0 9.253663807440304e-11
are O 0 4.1176389148399675e-14
predicted O 0 3.2294670410104587e-12
to O 0 1.1732410561734324e-13
interfere O 0 6.339382352393841e-10
with O 0 1.994043818953628e-11
ATP O 0 9.185305316350423e-07
binding O 0 1.7929220774703936e-08
or O 0 1.8721031669333144e-10
substrate O 0 3.172723666011734e-07
recognition O 0 8.852576449669414e-10
. O 0 1.51548537608015e-10

Two O 0 4.912491420594467e-12
of O 0 5.619349048037979e-14
seventeen O 0 1.0528707905521628e-09
mutated O 0 8.838882195050246e-07
T B-Disease 0 0.001222548307850957
- I-Disease 0 6.99957602989798e-09
PLL I-Disease 0 2.023031520081986e-08
samples O 0 1.6500601995872444e-09
had O 0 5.059071651186686e-12
a O 0 9.917566578089912e-15
previously O 0 3.9469405521685985e-10
reported O 0 1.2559472395423654e-07
A B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999990463256836
T I-Disease 1 0.9999998807907104
allele O 0 1.9059192709391937e-05
. O 0 4.1480746615363273e-10

In O 0 2.895379422329647e-11
contrast O 0 4.971054817781706e-11
, O 0 1.2975231512054458e-13
no O 0 6.811588240066696e-14
mutations O 0 2.6954069531903713e-10
were O 0 3.838219238966323e-12
detected O 0 3.1920620813252754e-08
in O 0 6.128243562836342e-15
the O 0 1.7326301399267865e-15
p53 O 0 1.1742597996397541e-13
gene O 0 2.611579702493927e-11
, O 0 3.137806871565717e-15
suggesting O 0 1.0448909532750905e-12
that O 0 7.290615864925104e-14
this O 0 3.9948843929063504e-13
tumour B-Disease 1 1.0
suppressor O 0 2.8987326459173346e-06
is O 0 1.6214022124927396e-08
not O 0 1.086872258859728e-10
frequently O 0 2.6732988045452544e-10
altered O 0 4.522352714531053e-09
in O 0 5.344777355073549e-13
this O 0 1.5698189276269758e-11
leukaemia B-Disease 0 0.00010642297274898738
. O 0 8.548663860130645e-11

Occasional O 0 4.2649955389606475e-07
missense O 0 4.4478412746684626e-05
mutations O 0 2.2513944713864475e-05
in O 0 6.15604138845538e-12
ATM O 0 6.331330223474652e-05
were O 0 1.2608624366805543e-08
also O 0 4.428809055601057e-11
found O 0 4.668965561394067e-11
in O 0 1.4706712410383904e-12
tumour B-Disease 1 0.9999998807907104
DNA O 0 2.943504568975186e-06
from O 0 1.2326068984935823e-11
patients O 0 3.692511921227215e-11
with O 0 8.055093593008211e-13
B B-Disease 0 1.6154517652466893e-05
- I-Disease 0 2.8390026272973046e-05
cell I-Disease 0 0.10361864417791367
non I-Disease 1 0.9999253749847412
- I-Disease 1 0.9998776912689209
Hodgkins I-Disease 1 0.999993085861206
lymphomas I-Disease 1 0.6009536981582642
( O 0 3.4621111533184035e-11
B B-Disease 0 2.734542704274645e-06
- I-Disease 0 4.380676443815901e-08
NHL I-Disease 0 1.245778946667997e-07
) O 0 8.135286606696102e-14
and O 0 5.456316889734976e-14
a O 0 3.3061129788708454e-13
B B-Disease 0 4.6101129669295915e-07
- I-Disease 0 1.3174718205277713e-08
NHL I-Disease 0 1.9852425481303726e-08
cell O 0 2.074706184629349e-09
line O 0 7.87579992334031e-08
. O 0 2.339906914061718e-11

The O 0 5.282619502423869e-13
evidence O 0 1.4479395330294076e-12
of O 0 1.1879688966009582e-15
a O 0 1.4852834538453194e-14
significant O 0 2.0548649316397966e-13
proportion O 0 3.551067426221799e-11
of O 0 3.880498895304785e-13
loss O 0 1.95820319959239e-08
- O 0 2.6922856832811703e-08
of O 0 7.407895824540489e-11
- O 0 3.885011210513767e-06
function O 0 1.9176953358623905e-09
mutations O 0 5.093623940410907e-07
and O 0 5.269793976192538e-11
a O 0 1.8263220796788104e-12
complete O 0 9.722894711572394e-10
absence O 0 1.1732367299899238e-09
of O 0 1.3753640729834236e-14
the O 0 3.050622024414716e-14
normal O 0 3.538513002033193e-14
copy O 0 1.7309426461609156e-11
of O 0 5.679475173579057e-14
ATM O 0 1.82562615691495e-07
in O 0 2.2494574020322233e-13
the O 0 2.0135335185213904e-13
majority O 0 3.544082778986213e-12
of O 0 7.819116014384786e-12
mutated O 0 0.33387336134910583
tumours B-Disease 1 1.0
establishes O 0 4.649891991448385e-07
somatic O 0 3.4494880196689337e-07
inactivation O 0 1.4612711311201565e-05
of O 0 6.831387635208765e-15
this O 0 1.581740987722106e-16
gene O 0 3.768334169013121e-12
in O 0 6.944762254044925e-16
the O 0 4.844121603645444e-16
pathogenesis O 0 4.512850596688489e-12
of O 0 7.103523227535574e-14
sporadic B-Disease 0 3.2228621194008156e-07
T I-Disease 0 0.13099899888038635
- I-Disease 0 7.741282956885698e-07
PLL I-Disease 0 7.741608101241582e-07
and O 0 2.999184884819317e-12
suggests O 0 1.294483183839068e-12
that O 0 2.56778393713979e-14
ATM O 0 7.598694651278493e-07
acts O 0 3.3472435490011776e-08
as O 0 1.5846499459848395e-11
a O 0 4.389083194111798e-11
tumour B-Disease 1 0.9999996423721313
suppressor O 0 3.297175862826407e-05
. O 0 4.72328343104067e-10

As O 0 1.9076876189849656e-10
constitutional O 0 2.4049902694334158e-12
DNA O 0 1.972929197791018e-08
was O 0 3.598512821056943e-09
not O 0 3.863495826972145e-14
available O 0 1.1989762210406346e-13
, O 0 3.629188471959829e-15
a O 0 1.0390256363623784e-13
putative O 0 1.3212722649313946e-07
hereditary O 0 0.0007584090926684439
predisposition O 0 0.001115001505240798
to O 0 6.011384101611839e-08
T B-Disease 1 0.9326266050338745
- I-Disease 0 3.0243402306950884e-06
PLL I-Disease 0 3.914365152013488e-06
will O 0 2.0683189536074842e-11
require O 0 7.672774091430079e-14
further O 0 5.030390183856414e-15
investigation O 0 6.15846046034263e-12
. O 0 1.1014392929621294e-13
. O 0 1.6512289582534811e-12

Myotonic B-Disease 1 0.9999914169311523
dystrophy I-Disease 1 0.9999948740005493
protein O 0 7.709919009357691e-05
kinase O 0 4.188425009488128e-05
is O 0 3.762152742114999e-11
involved O 0 4.973309524619607e-12
in O 0 1.7179798580710761e-15
the O 0 2.040633130646842e-16
modulation O 0 9.70070174904393e-14
of O 0 5.80234763638025e-15
the O 0 2.8672444735318436e-13
Ca2 O 0 5.563989713408546e-09
+ O 0 1.678531447169007e-08
homeostasis O 0 1.2239064744790085e-05
in O 0 2.0258704436226793e-11
skeletal O 0 0.00013253609358798712
muscle O 0 8.780701250543643e-07
cells O 0 2.1076431711009036e-09
. O 0 4.5616441179952005e-11

Myotonic B-Disease 1 0.9999773502349854
dystrophy I-Disease 1 0.9999966621398926
( O 0 2.9606160296680173e-06
DM B-Disease 1 0.9999997615814209
) O 0 5.903139088658804e-11
, O 0 5.637467590999517e-15
the O 0 2.127086289562181e-15
most O 0 1.977514072631914e-12
prevalent O 0 6.8934396040276624e-06
muscular B-Disease 0 0.015755467116832733
disorder I-Disease 0 0.09040984511375427
in O 0 6.345279336683607e-12
adults O 0 3.2461539234418524e-08
, O 0 8.636268241345169e-13
is O 0 2.332838132737547e-12
caused O 0 6.165712038153082e-12
by O 0 4.043514722812565e-14
( O 0 1.2264240187645492e-13
CTG O 0 1.3287668743089398e-09
) O 0 3.4833216904428185e-14
n O 0 3.124765168838195e-10
- O 0 1.2438213792265174e-09
repeat O 0 1.9000045980988034e-09
expansion O 0 1.7970003957090697e-11
in O 0 5.861454230714365e-16
a O 0 3.39513304572185e-16
gene O 0 1.0685294202185044e-13
encoding O 0 9.052850971028731e-14
a O 0 4.3079643042946703e-13
protein O 0 2.485476713331991e-09
kinase O 0 1.2174247785878833e-05
( O 0 2.789203312758559e-09
DM B-Disease 1 0.9999998807907104
protein O 0 3.2496916446689283e-07
kinase O 0 4.3664701365742076e-07
; O 0 1.6053970219170877e-12
DMPK O 0 2.2606531047131284e-07
) O 0 2.1085626530936187e-14
and O 0 6.183400336658292e-16
involves O 0 4.928525578103138e-14
changes O 0 2.2980017411536324e-13
in O 0 1.6794486469378332e-14
cytoarchitecture O 0 3.3723068781910115e-07
and O 0 2.629603826354021e-11
ion O 0 9.167411829658079e-10
homeostasis O 0 5.823361561851925e-07
. O 0 5.091328400541606e-11

To O 0 1.9948368586326926e-13
obtain O 0 1.8927955448659606e-13
clues O 0 8.234681686536405e-11
to O 0 1.673259377192246e-13
the O 0 3.0683267070782255e-14
normal O 0 2.9300092083475726e-13
biological O 0 3.59568902430496e-11
role O 0 1.93424898493888e-12
of O 0 1.1596353268779466e-15
DMPK O 0 8.721723787630253e-08
in O 0 4.398538079445659e-14
cellular O 0 5.629383181826597e-09
ion O 0 6.374776262418891e-10
homeostasis O 0 1.2345167306193616e-06
, O 0 5.785887177353621e-13
we O 0 3.2282659618437792e-12
have O 0 6.392918150150556e-14
compared O 0 1.2511528271752503e-12
the O 0 4.5554729557811466e-14
resting O 0 6.686562858959633e-09
[ O 0 5.04742818721593e-12
Ca2 O 0 2.984583413745412e-11
+ O 0 9.150444291172732e-11
] O 0 2.336852933382261e-10
i O 0 6.718778866598996e-09
, O 0 9.935813997114375e-16
the O 0 2.6956337164167927e-17
amplitude O 0 2.317038933698115e-15
and O 0 1.4516775910695945e-13
shape O 0 6.621694837415093e-13
of O 0 6.524202666557521e-15
depolarization O 0 2.693021153299391e-11
- O 0 2.9138223567315436e-07
induced O 0 2.270984253982533e-07
Ca2 O 0 9.152072433238345e-10
+ O 0 1.753352601996383e-10
transients O 0 2.6578355516448937e-08
, O 0 4.969056782255614e-14
and O 0 5.667328043489073e-16
the O 0 7.484191216036885e-18
content O 0 3.032175002076233e-14
of O 0 2.1902403249556327e-16
ATP O 0 2.47319914548072e-10
- O 0 2.7799590754384873e-11
driven O 0 2.920833713782045e-11
ion O 0 5.747736314676288e-11
pumps O 0 1.3787267993947694e-09
in O 0 8.006900128814873e-14
cultured O 0 1.1759078155648695e-08
skeletal O 0 3.6813997894569184e-07
muscle O 0 4.3040943031869006e-10
cells O 0 2.3029260790008443e-12
of O 0 1.0559612469910988e-14
wild O 0 1.1816504752459878e-07
- O 0 5.229573434917256e-05
type O 0 0.0011427330318838358
and O 0 5.8751754572483605e-09
DMPK O 0 4.176009679213166e-05
[ O 0 4.965770017406612e-10
- O 0 8.404815332596627e-08
/ O 0 1.2334605514752184e-07
- O 0 1.1030402191636313e-07
] O 0 1.1284085471574556e-10
knockout O 0 6.886264714012214e-08
mice O 0 3.4514985713940405e-07
. O 0 1.45672710005762e-11

In O 0 3.499704415155236e-10
vitro O 0 1.0373171789979097e-05
- O 0 5.581914592767134e-05
differentiated O 0 1.0083013876283076e-05
DMPK O 0 0.00017099810065701604
[ O 0 7.97487853532175e-10
- O 0 2.5532381542348048e-08
/ O 0 1.242274407786681e-07
- O 0 2.3052947994983697e-08
] O 0 2.8318261364318476e-12
myotubes O 0 1.543219718680433e-10
exhibit O 0 1.6803506286064418e-12
a O 0 6.694419188912545e-14
higher O 0 2.4182793354615706e-12
resting O 0 6.846432309970396e-10
[ O 0 7.133237143325255e-12
Ca2 O 0 9.081226742813087e-11
+ O 0 3.723133953914548e-11
] O 0 2.7371051605773467e-11
i O 0 2.370974250265334e-10
than O 0 7.96899015282097e-15
do O 0 3.678098407441932e-13
wild O 0 9.47390360606093e-11
- O 0 2.118085795643765e-08
type O 0 7.258043055458074e-09
myotubes O 0 2.1213486078863752e-08
because O 0 2.3084043899480877e-13
of O 0 1.131882054133143e-16
an O 0 3.2591705992812605e-15
altered O 0 1.1319718079549901e-10
open O 0 2.2812690972373595e-11
probability O 0 5.535163459849911e-14
of O 0 1.731984374713294e-13
voltage O 0 8.484140323616884e-08
- O 0 2.089218469336629e-06
dependent O 0 2.9818485813848383e-07
l O 0 3.747052232938586e-07
- O 0 2.3505015711577926e-09
type O 0 3.775987966747607e-09
Ca2 O 0 2.4622603955748446e-10
+ O 0 1.442081593028277e-10
and O 0 1.1246112548157772e-11
Na O 0 2.4960721489719617e-08
+ O 0 2.1089531510032344e-10
channels O 0 3.0544724527459266e-09
. O 0 6.475938535421832e-11

The O 0 6.464286137625175e-12
mutant O 0 1.1629442298044523e-08
myotubes O 0 1.750694345048487e-08
exhibit O 0 1.3901486732581514e-11
smaller O 0 3.53587211593398e-12
and O 0 2.5278309176771097e-13
slower O 0 1.1291943768920731e-10
Ca2 O 0 1.6190888907363643e-10
+ O 0 3.425910249932329e-11
responses O 0 3.9620290555320015e-12
upon O 0 1.678830482292927e-14
triggering O 0 4.892583300303288e-12
by O 0 2.9199084929174956e-15
acetylcholine O 0 1.2751656619514051e-08
or O 0 5.977002892620931e-09
high O 0 1.6947262793109985e-07
external O 0 5.182631923617009e-08
K O 0 9.838001346906822e-08
+ O 0 9.048173876813337e-10
. O 0 2.5823948882064407e-11

In O 0 2.4555617955668296e-11
addition O 0 4.397535720984669e-12
, O 0 2.3061058135797827e-14
we O 0 1.7558323840553315e-14
observed O 0 2.4937090424299174e-14
that O 0 7.088140579817844e-16
these O 0 1.6973505188714634e-14
Ca2 O 0 2.802298670889769e-10
+ O 0 1.0852487797308186e-09
transients O 0 3.872583249631134e-07
partially O 0 1.6805271840780733e-08
result O 0 1.2737209832865137e-13
from O 0 1.6621277760785484e-15
an O 0 1.2289188103150857e-15
influx O 0 9.140365737512687e-14
of O 0 1.6113890202303582e-15
extracellular O 0 1.9605546353052006e-11
Ca2 O 0 2.4167310513911744e-11
+ O 0 3.6148176466022086e-12
through O 0 7.113434190644807e-14
the O 0 4.998470170755609e-13
l O 0 4.3028016705193295e-08
- O 0 3.3726565984437684e-10
type O 0 2.477665572708787e-10
Ca2 O 0 1.205359284606189e-10
+ O 0 5.391913998620268e-11
channel O 0 2.6045285927978057e-09
. O 0 3.4153409267378976e-11

Neither O 0 2.309875624106894e-09
the O 0 9.538182553893784e-14
content O 0 3.798635885010615e-12
nor O 0 2.131361927226738e-12
the O 0 1.4376233874746906e-15
activity O 0 3.3249154297865235e-12
of O 0 4.863658524452983e-15
Na O 0 4.343444715004807e-08
+ O 0 2.2615408157289352e-10
/ O 0 7.079676844767846e-10
K O 0 9.5815988476744e-10
+ O 0 3.1526552202176816e-11
ATPase O 0 7.835472271011668e-10
and O 0 4.700343846780752e-12
sarcoplasmic O 0 3.591246056089403e-08
reticulum O 0 8.355151237537939e-09
Ca2 O 0 1.1537621524837505e-08
+ O 0 1.6006305614268967e-08
- O 0 7.027067567833001e-07
ATPase O 0 5.037408072894323e-07
are O 0 6.3972906833020815e-12
affected O 0 1.136067368651128e-12
by O 0 3.6630163420710293e-14
DMPK O 0 8.689610695000738e-06
absence O 0 3.275469062646863e-10
. O 0 3.898662209039783e-12

In O 0 1.0562771143862726e-11
conclusion O 0 1.3550396698799871e-12
, O 0 2.44513576866303e-14
our O 0 2.186276316641601e-15
data O 0 4.0138256759102153e-13
suggest O 0 2.51891714951602e-13
that O 0 4.3490266319863927e-14
DMPK O 0 5.734428896175814e-07
is O 0 6.664445471177283e-13
involved O 0 1.1760623941717285e-12
in O 0 2.0418021419931712e-15
modulating O 0 3.1851103785701662e-12
the O 0 1.3923348651256082e-15
initial O 0 2.0907495502128608e-14
events O 0 2.0197175366627046e-14
of O 0 1.7018240386790923e-14
excitation O 0 1.943230243384164e-09
- O 0 4.145358252571896e-05
contraction O 0 2.9366548915277235e-05
coupling O 0 6.951429298851508e-08
in O 0 5.718656884839968e-12
skeletal O 0 3.830606146948412e-06
muscle O 0 1.2808989424684114e-08
. O 0 1.5959502057578956e-13
. O 0 3.0996583338244177e-12

Constitutional O 0 2.5445851292715815e-07
RB1 O 0 0.0015771391335874796
- O 0 6.019937245582696e-06
gene O 0 3.1962895263859536e-06
mutations O 0 1.1769749107770622e-05
in O 0 2.796102542210188e-12
patients O 0 1.0190025906409161e-10
with O 0 1.9200166630206628e-12
isolated O 0 5.070370434623328e-07
unilateral B-Disease 0 0.005308799911290407
retinoblastoma I-Disease 0 0.06792522221803665
. O 0 7.3607204775782975e-09

In O 0 4.496697285361062e-12
most O 0 2.428358892008625e-13
patients O 0 3.233072446914842e-12
with O 0 2.9717821628007235e-13
isolated O 0 1.4087220279179746e-07
unilateral B-Disease 0 0.0002181862946599722
retinoblastoma I-Disease 0 0.0008595685940235853
, O 0 4.8860394896710346e-11
tumor B-Disease 0 2.4304785029016784e-07
development O 0 1.38503997767353e-12
is O 0 3.287268189860332e-13
initiated O 0 1.4212154673606814e-12
by O 0 2.496883552509637e-14
somatic O 0 3.484985189317058e-09
inactivation O 0 4.8556253204878885e-06
of O 0 3.648011661630188e-14
both O 0 2.6845615574283554e-13
alleles O 0 3.0532037401803658e-12
of O 0 1.2708979749392457e-14
the O 0 1.2475783210327829e-12
RB1 O 0 1.0120749720954336e-05
gene O 0 9.26697651948416e-08
. O 0 1.798592247359565e-10

However O 0 3.6069491837764645e-10
, O 0 6.040303755219453e-15
some O 0 3.9139635561000156e-17
of O 0 1.117155724600637e-16
these O 0 2.232373357349826e-13
patients O 0 3.794269586021581e-12
can O 0 5.896898095693326e-13
transmit O 0 1.8284418956682202e-07
retinoblastoma B-Disease 0 0.0001879192132037133
predisposition O 0 7.062351505737752e-05
to O 0 2.725150140270305e-11
their O 0 3.3035508356649146e-11
offspring O 0 1.0216502310811393e-08
. O 0 1.777691535642667e-11

To O 0 1.3961186807326387e-12
determine O 0 7.435974037038606e-13
the O 0 4.2859321641849565e-14
frequency O 0 1.8676084984070584e-11
and O 0 1.2485161559119828e-12
nature O 0 6.811072430883136e-13
of O 0 1.9013375672071592e-14
constitutional O 0 5.005747483188827e-10
RB1 O 0 5.799114296678454e-05
- O 0 5.217176379801458e-08
gene O 0 1.0462076005524068e-07
mutations O 0 5.736589514526713e-07
in O 0 3.076069130317216e-13
patients O 0 1.7579562805458693e-11
with O 0 8.748559602450579e-13
isolated O 0 2.145053343838299e-07
unilateral B-Disease 0 7.924142119009048e-05
retinoblastoma I-Disease 0 0.00038182150456123054
, O 0 1.596097169362376e-12
we O 0 1.2397964497753728e-14
analyzed O 0 3.9795675977651046e-13
DNA O 0 6.03843330893028e-09
from O 0 1.269097023651189e-12
peripheral O 0 5.739232733503741e-07
blood O 0 1.36591026489441e-07
and O 0 1.9065707346221927e-10
from O 0 5.193169679007514e-12
tumor B-Disease 0 2.5699434900161577e-06
tissue O 0 5.561770649364917e-06
. O 0 3.5971245426758003e-10

The O 0 4.717765891490422e-13
analysis O 0 7.32042811785183e-12
of O 0 1.1289918999679571e-10
tumors B-Disease 1 1.0
from O 0 1.6156901372355037e-09
54 O 0 7.875740237750506e-08
( O 0 5.746626265124011e-12
71 O 0 3.2142870587392736e-09
% O 0 1.1724022902677433e-13
) O 0 3.0347653135322315e-15
of O 0 7.134043518691041e-15
76 O 0 7.371057098026768e-10
informative O 0 2.6231708361024175e-08
patients O 0 4.2635395658408015e-08
showed O 0 4.302735945316272e-08
loss O 0 7.97621801940096e-10
of O 0 5.527907233522644e-13
constitutional O 0 2.419211497795004e-08
heterozygosity O 0 3.4971355489687994e-05
( O 0 2.1901311875183183e-09
LOH O 1 0.9999668598175049
) O 0 1.1873505650905614e-11
at O 0 7.007904673228538e-11
intragenic O 0 1.0691786656025215e-07
loci O 0 1.7371631244600394e-08
. O 0 8.220887165455437e-11

Three O 0 3.79759640400934e-10
of O 0 2.0297062641727592e-12
13 O 0 2.9762287079293515e-10
uninformative O 0 3.368832403793931e-05
patients O 0 5.859801532892561e-08
had O 0 6.852154399439314e-10
constitutional O 0 9.930439803795821e-11
deletions O 0 5.301146757119568e-06
. O 0 2.6581892242916183e-09

For O 0 1.0098193115037901e-11
39 O 0 1.224530199461782e-10
randomly O 0 4.724619362406202e-09
selected O 0 1.2493388567236252e-05
tumors B-Disease 1 1.0
, O 0 2.149409539242697e-09
SSCP O 0 0.0011748563265427947
, O 0 1.1976426794735318e-11
hetero O 0 5.734532919632329e-07
- O 0 4.110545515079167e-10
duplex O 0 1.2157414630564745e-08
analysis O 0 2.288135826644666e-12
, O 0 4.443418374265812e-16
sequencing O 0 1.133655994599303e-12
, O 0 6.481267074680969e-14
and O 0 8.462313152730189e-14
Southern O 0 4.5007235412793545e-15
blot O 0 2.711011504175076e-08
analysis O 0 1.2633104198161993e-12
were O 0 2.9127137442415407e-13
used O 0 6.569785405800832e-14
to O 0 3.865832960280209e-14
identify O 0 3.403780035604598e-10
mutations O 0 3.652799307474197e-08
. O 0 2.104527836721548e-11

Mutations O 0 1.0089882380270865e-05
were O 0 3.546789251185345e-11
detected O 0 6.555234932648091e-08
in O 0 1.299547166926096e-12
21 O 0 3.3483388284238913e-10
( O 0 8.973240038382194e-14
91 O 0 3.513849280989412e-11
% O 0 1.5286683119970952e-14
) O 0 1.606982437201386e-14
of O 0 1.11669354319055e-12
23 O 0 7.725493560428731e-06
tumors B-Disease 1 1.0
with O 0 4.146088485867949e-06
LOH O 1 0.9999943971633911
. O 0 3.720723951161631e-09

In O 0 1.0933302874160944e-10
6 O 0 5.470750519265266e-10
( O 0 1.0744848072266958e-13
38 O 0 4.445224570381878e-12
% O 0 8.57031070053806e-15
) O 0 5.252873975364596e-15
of O 0 2.1332561368422875e-13
16 O 0 2.6469795102457283e-06
tumors B-Disease 1 1.0
without O 0 5.563786544371396e-06
LOH O 1 0.9999985694885254
, O 0 4.706749313215797e-12
one O 0 1.1394825241792944e-13
mutation O 0 2.1364923719069395e-10
was O 0 1.2473613253405347e-09
detected O 0 5.151326831764891e-07
, O 0 3.695722981117422e-12
and O 0 1.4576888307527014e-11
in O 0 2.0863764546314584e-13
9 O 0 1.2101075697046326e-09
( O 0 6.062514314349177e-14
56 O 0 9.244432476462894e-12
% O 0 1.531399146219043e-15
) O 0 1.6567092004358443e-15
of O 0 1.5293574241216634e-13
the O 0 4.130300510496454e-07
tumors B-Disease 1 1.0
without O 0 0.0001522876409580931
LOH O 1 0.9999992847442627
, O 0 3.244353743991901e-11
both O 0 4.088574910490056e-13
mutations O 0 1.9185479871453026e-09
were O 0 6.631227685016672e-12
found O 0 4.943691289671648e-11
. O 0 2.4354721364638898e-11

Thus O 0 3.550732374790755e-09
, O 0 1.7503694620026738e-13
a O 0 2.96789502696182e-14
total O 0 9.920358805259877e-13
of O 0 3.3597446656360996e-14
45 O 0 2.0393232241788795e-11
mutations O 0 1.5963864896662017e-08
were O 0 3.120828040437118e-10
identified O 0 6.888248549330456e-08
in O 0 3.4244226898572094e-10
tumors B-Disease 1 1.0
of O 0 3.869734047090567e-11
36 O 0 1.4471589793174644e-07
patients O 0 1.835460117227683e-09
. O 0 2.814488572755458e-11

Thirty O 0 8.622016878234717e-09
- O 0 2.319793850347196e-07
nine O 0 5.904774447174077e-10
of O 0 6.083360133994284e-15
the O 0 9.499179735991334e-15
mutations O 0 7.804328849836395e-10
- O 0 3.986945440459522e-09
including O 0 9.494090930095567e-11
34 O 0 1.314290482001823e-10
small O 0 3.1790288717442605e-12
mutations O 0 5.4914345071210846e-08
, O 0 4.3191372787326765e-13
2 O 0 1.097867388904876e-13
large O 0 3.944701336411338e-12
structural O 0 6.823637704655994e-06
alterations O 0 5.573625685428851e-07
, O 0 1.9954782617959133e-11
and O 0 1.3924812691801236e-11
hypermethylation O 0 9.89827526609588e-07
in O 0 1.0706260877846319e-10
3 O 0 3.825812655122718e-06
tumors O 1 1.0
- O 0 0.0001057717454386875
were O 0 8.080127122944702e-10
not O 0 1.2335164356960804e-12
detected O 0 3.3873055471644875e-09
in O 0 2.1312041402352577e-15
the O 0 6.064985448269496e-15
corresponding O 0 6.542855666979985e-12
peripheral O 0 7.3072565776044485e-09
blood O 0 4.000204611998015e-10
DNA O 0 1.2000505478226842e-07
. O 0 1.3006842825014076e-10

In O 0 3.6807987213727245e-10
6 O 0 9.93457538456255e-10
( O 0 3.711870491963226e-13
17 O 0 1.2412464285571634e-11
% O 0 9.644570188530456e-16
) O 0 9.771848535558439e-17
of O 0 2.327410958016362e-16
the O 0 2.8195109007950192e-12
36 O 0 5.755959264774901e-09
patients O 0 1.63424759835884e-11
, O 0 4.797192272598411e-16
a O 0 2.5141435005241906e-15
mutation O 0 2.1715947096101473e-10
was O 0 5.4887721034901915e-09
detected O 0 1.0974539321750854e-07
in O 0 2.5710772012387147e-14
constitutional O 0 7.642747654364179e-13
DNA O 0 1.3376835283906985e-07
, O 0 7.085573013737578e-12
and O 0 2.332615654451753e-12
1 O 0 1.7887709542752095e-13
of O 0 1.3529515811990748e-14
these O 0 2.9938180840655138e-12
mutations O 0 7.083489794723619e-09
is O 0 2.0111174878212346e-11
known O 0 6.759338228023992e-11
to O 0 6.477195516052525e-12
be O 0 4.4307205127047666e-10
associated O 0 3.891745432860194e-12
with O 0 1.8018328148960983e-11
reduced O 0 4.2756385099096406e-09
expressivity O 0 2.5075038138311356e-05
. O 0 3.1310473658230364e-10

The O 0 6.375571945382852e-12
presence O 0 2.1950302686590817e-11
of O 0 3.274886025068143e-15
a O 0 4.360824039113115e-13
constitutional O 0 2.6818467585565386e-11
mutation O 0 8.596682476991191e-08
was O 0 2.3634730439425766e-07
not O 0 1.9470272616395334e-11
associated O 0 7.285364802753214e-13
with O 0 1.2086450004895888e-13
an O 0 2.1576447226112627e-13
early O 0 3.1846501130639027e-11
age O 0 4.998251146304256e-09
at O 0 7.1117256528197e-10
treatment O 0 9.583348697939087e-11
. O 0 1.1308700286968842e-12

In O 0 1.1373411934467725e-10
1 O 0 8.419644842438956e-11
patient O 0 3.966753592266059e-09
, O 0 2.475375590269002e-13
somatic O 0 6.466000002092187e-08
mosaicism O 0 0.0010329392971470952
was O 0 1.1269281685599708e-07
demonstrated O 0 1.6069717171524056e-12
by O 0 2.912807670136875e-17
molecular O 0 2.0276544386663847e-13
analysis O 0 1.1279441736091605e-13
of O 0 7.257809220086761e-16
DNA O 0 1.9483675117726307e-08
and O 0 5.543516166939266e-12
RNA O 0 1.43521056150675e-10
from O 0 1.0945058878317204e-12
peripheral O 0 7.731632649665698e-07
blood O 0 2.840482693500235e-07
. O 0 1.7134486884895495e-10

In O 0 5.766975785803652e-11
2 O 0 8.973920911925504e-11
patients O 0 3.670056966664781e-11
without O 0 2.7181704695226905e-13
a O 0 5.819114287652916e-12
detectable O 0 3.766635563806631e-05
mutation O 0 9.668709026300348e-06
in O 0 9.289084085262189e-11
peripheral O 0 0.0004999916418455541
blood O 0 3.5553472116589546e-05
, O 0 1.1839087002418758e-11
mosaicism O 0 3.8368986565728846e-07
was O 0 5.702632144277686e-09
suggested O 0 1.8885072672336634e-10
because O 0 5.016531352645959e-13
1 O 0 1.3601497518881366e-14
of O 0 1.401019388054688e-15
the O 0 9.892531238619995e-12
patients O 0 2.9210536212076477e-09
showed O 0 6.486802135441394e-07
multifocal O 1 0.9986316561698914
tumors B-Disease 1 1.0
and O 0 1.327480791957214e-08
the O 0 2.7424536166303914e-13
other O 0 5.345460402442215e-13
later O 0 1.1488902884604357e-10
developed O 0 4.261813568717798e-09
bilateral B-Disease 0 9.346400133836141e-07
retinoblastoma I-Disease 0 1.8233678929391317e-05
. O 0 8.280613417177562e-10

In O 0 1.482995497237294e-11
conclusion O 0 2.367993605020824e-12
, O 0 2.570735237097249e-13
our O 0 1.607179287658328e-13
results O 0 3.59581376447541e-14
emphasize O 0 7.164922951816144e-13
that O 0 1.9020629662231878e-14
the O 0 4.0080379336629446e-15
manifestation O 0 1.6742858835461227e-11
and O 0 1.5975824721285725e-13
transmissibility O 0 1.950894445990059e-10
of O 0 7.0463569739253815e-15
retinoblastoma B-Disease 0 4.611671489129776e-09
depend O 0 2.577964317712622e-12
on O 0 3.556250996808452e-12
the O 0 5.957487649900506e-15
nature O 0 2.192853103960557e-12
of O 0 1.0808376729157156e-14
the O 0 9.430961735298546e-14
first O 0 4.835382441670255e-11
mutation O 0 3.6029800670744905e-11
, O 0 2.1695990002398163e-14
its O 0 1.2333333342779383e-15
time O 0 5.192869246585519e-13
in O 0 1.3705298865468538e-14
development O 0 8.682907637249521e-14
, O 0 1.1087469511299533e-13
and O 0 9.422600503669609e-14
the O 0 9.76585874207193e-15
number O 0 9.891423097263541e-11
and O 0 4.2490927443239457e-10
types O 0 3.89830390190582e-09
of O 0 9.314937872689083e-14
cells O 0 1.223229243590973e-11
that O 0 1.3715669225367044e-12
are O 0 2.8699213144856017e-12
affected O 0 4.357002172244995e-12
. O 0 1.614777173195199e-14
. O 0 8.889860202143662e-12

Hereditary B-Disease 1 0.9999784231185913
deficiency I-Disease 1 0.9999939203262329
of I-Disease 0 3.2861678656015414e-11
the I-Disease 0 2.1148885594179934e-12
fifth I-Disease 0 3.655642899502709e-08
component I-Disease 0 6.70283073489486e-09
of I-Disease 0 1.9735603396745655e-13
complement I-Disease 0 2.874734339464169e-10
in O 0 1.8784955958372346e-13
man O 0 1.904051316614641e-07
. O 0 3.6707151207515665e-11

I O 0 0.0005724666407331824
. O 0 3.2050369025427017e-09

Clinical O 0 7.158100925153121e-05
, O 0 2.5524660163256385e-10
immunochemical O 0 4.609331153915264e-05
, O 0 9.660132416211553e-11
and O 0 1.0529420217675334e-11
family O 0 8.136132392810858e-12
studies O 0 8.284116448376011e-11
. O 0 8.91193507879251e-11

The O 0 6.660610864933636e-12
first O 0 1.4264502079530672e-10
recognized O 0 3.6646169432330566e-10
human O 0 4.934894715091787e-10
kindred O 0 4.663668732973747e-06
with O 0 9.664363460615277e-07
hereditary B-Disease 1 0.9999746084213257
deficiency I-Disease 1 0.9999650716781616
of I-Disease 0 4.850936492772906e-12
the I-Disease 0 1.0527693300454999e-11
fifth I-Disease 0 5.753590812673792e-07
component I-Disease 0 1.6174492145637487e-07
of I-Disease 0 1.2428905127315204e-11
complement I-Disease 0 1.0877942102638372e-08
( O 0 1.104890593080221e-12
C5 O 0 4.115523566383672e-08
) O 0 1.4061663075257136e-13
is O 0 2.970014642209029e-13
described O 0 5.923044693600943e-11
. O 0 1.2711375355078935e-11

The O 0 3.2059077614832177e-11
proband O 0 2.628696051942825e-07
, O 0 1.2721014562913635e-13
a O 0 7.287747811365701e-15
20 O 0 8.806145510064159e-14
- O 0 8.743914620135129e-11
year O 0 1.7283100298137732e-11
- O 0 7.538120350147892e-09
old O 0 1.26590165905327e-07
black O 0 3.964968353642462e-09
female O 0 1.0844257936071244e-08
with O 0 4.905691852741256e-09
systemic B-Disease 1 0.9999998807907104
lupus I-Disease 1 0.9998231530189514
erythematosus I-Disease 1 0.9999983310699463
since O 0 3.0466174028020987e-09
age O 0 4.7463326602326106e-09
11 O 0 3.0820818119892124e-10
, O 0 1.3302356178385155e-12
lacked O 0 4.28630286819498e-09
serum O 0 2.046000190603081e-06
hemolytic O 0 0.0009296869393438101
complement O 0 7.431703030746917e-10
activity O 0 7.92215537614993e-09
, O 0 3.605457946087576e-13
even O 0 3.427673292769051e-12
during O 0 3.990942992748714e-11
remission O 0 1.379330427653258e-07
. O 0 3.594790784489099e-11

C5 O 0 0.0008929363102652133
was O 0 3.0656545391138934e-07
undetectable O 0 5.2262934332247823e-05
in O 0 9.765570513700639e-13
her O 0 1.0828222866965387e-11
serum O 0 3.4077293764589456e-10
by O 0 1.9660488514983143e-14
both O 0 2.891404346852533e-12
immunodiffusion O 0 1.3229988326202147e-05
and O 0 4.2760361917970613e-10
hemolytic O 0 0.0003768108144868165
assays O 0 5.637268259306438e-06
. O 0 1.998187171281529e-10

Other O 0 3.077731429088071e-12
complement O 0 8.38083508841736e-12
components O 0 1.1890991524765582e-09
were O 0 1.7207700108573531e-12
normal O 0 3.769690993821878e-13
during O 0 1.8969121249896165e-13
remission O 0 7.533129675607597e-10
of O 0 3.178883371812713e-12
lupus O 0 0.002062806161120534
, O 0 6.600069882983783e-13
but O 0 2.3657813989080845e-12
C1 O 0 2.02766523216269e-06
, O 0 3.4412726574589714e-12
C4 O 0 1.4961990018491633e-05
, O 0 1.193782156461154e-10
C2 O 0 5.155182589078322e-05
, O 0 6.538663707700287e-12
and O 0 7.549538078022167e-11
C3 O 0 0.1609814465045929
levels O 0 4.321230928638897e-09
fell O 0 1.6115058087962097e-06
during O 0 2.0003990131023386e-10
exacerbations O 0 1.921761577250436e-05
. O 0 3.079118557347549e-11

A O 0 2.315473146552449e-09
younger O 0 9.587196814209165e-09
half O 0 9.154551006140821e-10
- O 0 8.61411137975665e-07
sister O 0 1.0241015843348578e-05
, O 0 4.995575134114638e-12
who O 0 1.8311311356100646e-09
had O 0 2.6221902871270686e-08
no O 0 6.885749748164471e-09
underlying O 0 4.03838157581049e-06
disease O 0 0.0014909334713593125
, O 0 6.690252084967652e-12
was O 0 1.3590699232679526e-08
also O 0 6.66888044786873e-10
found O 0 2.283298827787661e-10
to O 0 1.6323573048815376e-10
lack O 0 3.4958769212778407e-09
immunochemically O 0 2.7848735044244677e-05
detectable O 0 7.237168574647512e-06
C5 O 0 6.591727924387669e-06
. O 0 5.634987476632602e-10

By O 0 9.095011965776223e-10
hemolytic O 0 0.023110460489988327
assay O 0 9.410238817508798e-06
, O 0 7.293050052759043e-10
she O 0 3.801702419536923e-08
exhibited O 0 1.0508694714417288e-07
1 O 0 5.260404264961771e-11
- O 0 4.915172624464503e-08
2 O 0 5.4875212013305585e-11
% O 0 2.1498373827671946e-15
of O 0 5.895607128543251e-16
the O 0 2.5836385982025423e-13
normal O 0 6.843817179635892e-11
serum O 0 2.169452351097334e-08
C5 O 0 2.7189742013433715e-07
level O 0 2.308946145390678e-09
and O 0 7.399387092626997e-13
normal O 0 3.706138111789388e-14
concentrations O 0 2.465301725783353e-13
of O 0 2.5024402580502147e-16
other O 0 1.8185755025902466e-14
complement O 0 9.007939359706452e-12
components O 0 3.007105675578714e-09
. O 0 1.2165677319708745e-11

C5 O 0 4.1369548853253946e-05
levels O 0 3.6320059848549135e-08
of O 0 7.340848984455431e-14
other O 0 1.4839843763547744e-13
family O 0 3.4953849710472884e-12
members O 0 6.392369272800735e-14
were O 0 9.841036405916492e-13
either O 0 1.4287189324408561e-13
normal O 0 4.814579182381429e-13
or O 0 3.41829619080955e-13
approximately O 0 6.963209306029561e-13
half O 0 6.190644441517179e-09
- O 0 5.3725721954833716e-05
normal O 0 1.194995391529119e-08
, O 0 3.0552717474041646e-12
consistent O 0 3.013121141481889e-10
with O 0 3.1446180295130466e-12
autosomal O 0 1.188596115753171e-06
codominant O 0 3.0773861681154813e-07
inheritance O 0 8.405492968321937e-11
of O 0 3.13801366618946e-13
the O 0 1.3680142955940777e-11
gene O 0 1.0158888471778482e-05
determining O 0 0.01466410979628563
C5 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999997615814209
. O 0 1.863610599173171e-09

Normal O 0 7.569910667371005e-05
hemolytic O 1 0.9691036939620972
titers O 0 0.0018348939483985305
were O 0 2.797006515287137e-10
restored O 0 2.0492436914043566e-10
to O 0 1.2007413292824953e-12
both O 0 6.225979287677319e-09
homozygous O 1 0.9999251365661621
C5 B-Disease 1 1.0
- I-Disease 1 0.9999996423721313
deficient I-Disease 1 1.0
( O 0 9.408567080981811e-08
C5D B-Disease 1 0.9999998807907104
) O 0 2.832679620382028e-12
sera O 0 3.4401342885459485e-10
by O 0 8.005975952341947e-16
addition O 0 3.390567516960326e-14
of O 0 2.798531212674796e-15
highly O 0 1.4335354951711121e-11
purified O 0 2.423764078329782e-09
human O 0 2.4239202311981956e-10
C5 O 0 1.303308863498387e-06
. O 0 4.1834778696792085e-11

In O 0 1.0739921105229477e-11
specific O 0 3.19984767849224e-11
C5 O 0 4.634257038560463e-06
titrations O 0 5.62990271646413e-06
, O 0 4.244795053648387e-12
however O 0 9.632556931997785e-14
, O 0 1.5020865546397713e-14
it O 0 3.822640717420639e-13
was O 0 4.728423430577777e-09
noted O 0 1.4404925863242823e-10
that O 0 1.4170274383138587e-13
when O 0 1.014392476267334e-11
limited O 0 4.4736485566368445e-13
amounts O 0 2.7805980174627765e-13
of O 0 8.83309538794036e-14
C5 O 0 1.095866295486303e-07
were O 0 7.436144256779686e-13
assayed O 0 6.023544441013939e-10
in O 0 7.091876948027301e-15
the O 0 6.081666491616249e-15
presence O 0 9.830606381017182e-13
of O 0 1.4470924746711649e-15
low O 0 5.6170647994013834e-11
dilutions O 0 2.3547106486887515e-09
of O 0 5.368112096330868e-13
either O 0 6.545489128484405e-08
C5D B-Disease 1 1.0
serum O 0 1.728639836073853e-05
, O 0 3.235191181247786e-14
curving O 0 5.179281482858844e-12
rather O 0 4.154907686892799e-14
than O 0 6.703983080271641e-16
linear O 0 4.2056967988497035e-14
dose O 0 4.479954601732672e-11
- O 0 1.4212692134307758e-09
response O 0 7.001097293048153e-13
plots O 0 1.0438999664685866e-10
were O 0 3.770694173566014e-11
consistently O 0 1.643253311200965e-10
obtained O 0 3.7916464266278885e-14
, O 0 6.179226581810697e-16
suggesting O 0 1.3443656994918673e-13
some O 0 1.5332287373851124e-15
inhibitory O 0 7.294744669428255e-11
effect O 0 1.741995714343858e-10
. O 0 8.155118941255424e-12

Further O 0 6.895534143680493e-11
studies O 0 9.621952540284084e-12
suggested O 0 2.5203134718099207e-11
that O 0 1.3800211787120403e-13
low O 0 1.9772454784572346e-09
dilutions O 0 2.6230266030324856e-06
of O 0 2.2456936310533138e-09
C5D B-Disease 1 1.0
serum O 0 1.8079022993333638e-05
contain O 0 1.4943532522515568e-11
a O 0 1.5677885964286709e-13
factor O 0 2.941031099212843e-11
( O 0 2.990995648312518e-14
or O 0 1.2776853143200984e-12
factors O 0 8.322370028367165e-13
) O 0 1.1128476620913424e-15
interfering O 0 1.7054390668777564e-12
at O 0 1.3537428556614772e-12
some O 0 1.8228737712810885e-15
step O 0 9.194549982494138e-11
in O 0 4.584463844247051e-14
the O 0 1.3568706705088807e-12
hemolytic O 0 1.1524311958055478e-06
assay O 0 1.0576530762307357e-09
of O 0 1.8312880779945e-13
C5 O 0 6.097280902395141e-07
, O 0 4.912814472184286e-14
rather O 0 2.3479492835257925e-15
than O 0 1.9076098885332246e-15
a O 0 4.591648377705662e-14
true O 0 2.167401848274242e-11
C5 O 0 8.234628126047028e-07
inhibitor O 0 3.8773791288804205e-08
or O 0 2.38167541244394e-10
inactivator O 0 7.115868356777355e-06
. O 0 4.836009717679168e-11

Of O 0 6.273786351540522e-11
clinical O 0 2.383260380156571e-06
interest O 0 2.2647725472779712e-07
are O 0 1.5164678540680043e-11
( O 0 1.433544479141364e-14
a O 0 5.935680278453676e-14
) O 0 6.0093912878094076e-15
the O 0 2.1593222459523114e-15
documentation O 0 5.02380637090738e-10
of O 0 2.0284388058122715e-10
membranous O 1 0.9872271418571472
glomerulonephritis B-Disease 1 1.0
, O 0 9.759374734130688e-06
vasculitis B-Disease 1 0.9999998807907104
, O 0 1.6027232874193942e-08
and O 0 2.1157254650461255e-06
arthritis B-Disease 1 1.0
in O 0 1.2185898991268207e-12
an O 0 1.514007669234374e-12
individual O 0 3.448637153624645e-09
lacking O 0 1.1746927874867197e-08
C5 O 0 3.482226702544722e-07
( O 0 2.1956395035438447e-13
and O 0 6.743244878497714e-14
its O 0 1.6420741651731845e-15
biologic O 0 2.775455906767199e-11
functions O 0 1.2375338384260082e-13
) O 0 5.907500508738062e-14
, O 0 5.192480695631954e-14
and O 0 7.94411324916977e-12
( O 0 1.89422221939968e-13
b O 0 2.158734857538036e-10
) O 0 7.480202484948706e-16
a O 0 3.8791258718379445e-15
remarkable O 0 5.12744230754536e-12
propensity O 0 1.4884079746479983e-07
to O 0 4.756857308052531e-08
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 2.163869127283502e-12
the O 0 1.6342396186308505e-13
proband O 0 5.1418883373344215e-08
, O 0 1.4020680571950363e-14
even O 0 6.323912070003643e-14
during O 0 1.3797684240805796e-13
periods O 0 8.635169836124224e-12
of O 0 5.78982771014952e-13
low O 0 2.0591276950199244e-07
- O 0 3.3673572374937066e-08
dose O 0 2.217993427811038e-10
or O 0 8.620288727625991e-13
alternate O 0 1.9514990751839933e-12
- O 0 7.614154307056253e-10
day O 0 5.36499525360945e-11
corticosteroid O 0 3.330113429456105e-08
therapy O 0 3.6627165189706545e-10
. O 0 1.9915950399268523e-12

Other O 0 4.692485549434577e-13
observations O 0 4.5804302191421176e-12
indicate O 0 1.9577409138271662e-11
that O 0 8.382744910544193e-14
the O 0 2.89644393539068e-12
C5D B-Disease 1 1.0
state O 0 3.714792015663271e-11
is O 0 1.8633225930091146e-13
compatible O 0 6.534997803314679e-12
with O 0 3.880301028408306e-12
normal O 0 3.257522506946997e-12
coagulation O 0 2.3901763901434947e-10
function O 0 7.903703386213934e-11
and O 0 4.965215304880699e-12
the O 0 4.416857030402517e-14
capacity O 0 2.7815490796084807e-12
to O 0 1.0380168540035165e-14
mount O 0 4.4707849866654215e-08
a O 0 3.3037934610291586e-09
neutrophilic O 0 0.01513601653277874
leukocytosis O 0 0.014580384828150272
during O 0 2.862372383560796e-08
pyogenic B-Disease 0 0.12648901343345642
infection I-Disease 0 0.34089311957359314
. O 0 6.283783389460229e-12
. O 0 2.2344161243470495e-11

Susceptibility O 0 0.0003394311643205583
to O 0 1.4941709025606542e-07
ankylosing B-Disease 1 0.9999994039535522
spondylitis I-Disease 1 1.0
in O 0 2.344414724575472e-06
twins O 0 6.52371090836823e-05
: O 0 5.2536679840493525e-14
the O 0 6.872447345568681e-16
role O 0 8.739557688652866e-12
of O 0 4.2759660486429453e-16
genes O 0 4.856009257897531e-12
, O 0 2.1815082834782118e-14
HLA O 0 8.157025055410827e-10
, O 0 2.773971102734002e-13
and O 0 4.536892779863355e-13
the O 0 3.3236076651260715e-13
environment O 0 4.2986489923180216e-09
. O 0 8.852770079503802e-12

OBJECTIVE O 0 1.5396336427997426e-09
To O 0 2.001876854389184e-13
determine O 0 2.3851552243686625e-12
the O 0 2.951991475157352e-14
relative O 0 1.4095612697884174e-12
effects O 0 2.4867354703195232e-11
of O 0 8.311475325428156e-16
genetic O 0 5.338794406561931e-10
and O 0 2.7314036449288537e-12
environmental O 0 5.664375760973395e-13
factors O 0 5.687931272898086e-14
in O 0 1.5144595037134938e-14
susceptibility O 0 1.2369800295175537e-08
to O 0 5.140142889104027e-08
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 0 2.860470431187423e-06
AS B-Disease 1 0.9999960660934448
) O 0 6.8261624651400066e-12
. O 0 3.6175695685564113e-12

METHODS O 0 1.5583722756673524e-07
Twins O 0 4.891046410193667e-05
with O 0 2.2179637293451293e-10
AS B-Disease 1 0.9999983310699463
were O 0 2.600335311658819e-12
identified O 0 1.7588716941241422e-11
from O 0 2.16189601485485e-13
the O 0 1.7651505257454403e-10
Royal O 0 1.429594249202637e-06
National O 0 1.1646216080407612e-05
Hospital O 0 8.788536831616511e-08
for O 0 1.1665203247801514e-09
Rheumatic B-Disease 0 0.011937655508518219
Diseases I-Disease 0 1.2438036378625839e-07
database O 0 2.0964689984026563e-09
. O 0 4.9551703018568816e-11

Clinical O 0 4.749672007164918e-05
and O 0 7.473837104754466e-10
radiographic O 0 7.895464477769565e-06
examinations O 0 5.477633294503903e-06
were O 0 9.66544511094014e-10
performed O 0 5.498304589401926e-10
to O 0 1.3406886278238828e-13
establish O 0 2.4784030383528943e-10
diagnoses O 0 6.799507536925375e-05
, O 0 4.379750728755738e-11
and O 0 1.6316018536244314e-09
disease O 0 1.2307983524806332e-05
severity O 0 4.57700544131967e-09
was O 0 1.1131608967929196e-09
assessed O 0 5.612098563645418e-10
using O 0 4.295316879954214e-11
a O 0 2.4647355337248378e-11
combination O 0 8.22621970542059e-11
of O 0 1.795018398243614e-13
validated O 0 1.347043632193845e-08
scoring O 0 8.414210661555899e-09
systems O 0 5.792593071873853e-08
. O 0 8.004209794965078e-11

HLA O 0 1.8158897319153766e-06
typing O 0 2.2457896875494043e-07
for O 0 1.3156768209621195e-11
HLA O 0 1.335641428568124e-07
- O 0 1.048538589287773e-08
B27 O 0 1.206579058887769e-09
, O 0 4.2156873830559785e-14
HLA O 0 1.6925208456974872e-10
- O 0 9.587407256983482e-11
B60 O 0 1.2361156542795015e-10
, O 0 5.543359265944249e-15
and O 0 5.940331421070344e-15
HLA O 0 1.5575505329934458e-09
- O 0 2.759292527798607e-08
DR1 O 0 7.241567800519988e-05
was O 0 6.675787700416436e-11
performed O 0 4.742595205442512e-13
by O 0 1.9716347532057927e-16
polymerase O 0 1.113110905531789e-11
chain O 0 8.555861574777168e-10
reaction O 0 3.5825761302878123e-13
with O 0 9.114693905298951e-16
sequence O 0 3.810796621837864e-13
- O 0 2.12162856727538e-11
specific O 0 3.092759067509915e-13
primers O 0 6.621533543693658e-08
, O 0 3.7004752560798604e-13
and O 0 3.1971465270152696e-14
zygosity O 0 1.3212911875726263e-09
was O 0 3.901352981991457e-13
assessed O 0 2.5853999930519622e-12
using O 0 1.2148211039550438e-12
microsatellite O 0 5.5814093684602994e-06
markers O 0 6.654921890003607e-05
. O 0 1.1004461786257025e-09

Genetic O 0 1.3107003269396955e-06
and O 0 2.0035739560497756e-12
environmental O 0 2.151304172781296e-13
variance O 0 8.344905577098091e-14
components O 0 3.101987333664624e-09
were O 0 3.767047871555684e-12
assessed O 0 3.662898040435181e-10
with O 0 1.741930926758839e-12
the O 0 4.986300543470545e-13
program O 0 1.1776753183756483e-10
Mx O 0 6.651553197123405e-10
, O 0 1.607869042469145e-17
using O 0 5.871678712481113e-17
data O 0 2.0574505640857943e-12
from O 0 1.8804017926630535e-14
this O 0 6.706313903184248e-15
and O 0 1.0690007906655197e-12
previous O 0 1.4063977846895392e-12
studies O 0 1.6237748992620205e-13
of O 0 2.6630742966729515e-14
twins O 0 2.5191454255946155e-07
with O 0 6.583204120724773e-11
AS B-Disease 1 0.9999992847442627
. O 0 3.723285013634836e-10

RESULTS O 0 1.6698831473149767e-07
Six O 0 1.7861663259566285e-09
of O 0 1.4241651477911454e-12
8 O 0 4.515302354235473e-09
monozygotic O 0 4.812801307707559e-06
( O 0 2.7880838263105723e-11
MZ O 1 0.9985938668251038
) O 0 2.3205654064994974e-10
twin O 0 1.8614075088407844e-05
pairs O 0 6.857213179500832e-07
were O 0 7.98559796066911e-09
disease O 0 5.330227850208757e-07
concordant O 0 6.730271451260705e-09
, O 0 3.797518397831434e-13
compared O 0 1.636412186312164e-11
with O 0 5.454821165075396e-13
4 O 0 1.3116478389529895e-11
of O 0 1.5513804162755468e-13
15 O 0 1.4568278527971046e-10
B27 O 0 1.0047661369583238e-08
- O 0 5.593723173547005e-08
positive O 0 2.2031529933741467e-09
dizygotic O 0 9.344683604695092e-08
( O 0 2.1026852134453655e-12
DZ O 0 9.869127097772434e-05
) O 0 1.9179523420842504e-12
twin O 0 3.2373861813539406e-08
pairs O 0 1.8449298755385257e-09
( O 0 4.392648571271973e-12
27 O 0 1.6281501147297206e-10
% O 0 2.5403431189673607e-14
) O 0 8.565506329661233e-15
and O 0 3.856305194876314e-13
4 O 0 1.2694601229587543e-12
of O 0 2.949246478544526e-13
32 O 0 4.335126391197264e-08
DZ O 1 0.9997729659080505
twin O 0 0.00093131820904091
pairs O 0 5.8748646836193075e-08
overall O 0 1.3919381558480381e-07
( O 0 3.0149348729385794e-12
12 O 0 2.041712979239385e-11
. O 0 1.2104022889232804e-14
5 O 0 3.3075590877285066e-12
% O 0 1.7871671820928782e-14
) O 0 1.5301305957959171e-13
. O 0 2.2063457831567046e-12

Nonsignificant O 0 2.1405532606877387e-05
increases O 0 6.157274157203574e-08
in O 0 5.261660248126465e-14
similarity O 0 1.8720940596350655e-12
with O 0 7.039537003447269e-14
regard O 0 4.881826280028756e-12
to O 0 4.225779014904729e-12
age O 0 1.678793069004314e-07
at O 0 3.2847887609932513e-07
disease O 0 4.109246583539061e-05
onset O 0 1.0890667923035835e-08
and O 0 4.233566275324563e-11
all O 0 1.3184117426262576e-12
of O 0 9.48118621509281e-15
the O 0 2.621624922358179e-12
disease O 0 1.5906592807368725e-06
severity O 0 1.4557001437598416e-10
scores O 0 4.064149711213716e-11
assessed O 0 1.2797316983892415e-08
were O 0 1.9796218830858692e-10
noted O 0 7.682952607446225e-10
in O 0 1.3352110216080515e-11
disease O 0 0.0006211639265529811
- O 0 1.576350405230187e-05
concordant O 0 0.0006316279177553952
MZ O 1 0.999721109867096
twins O 0 7.13979679858312e-05
compared O 0 3.4333433318600726e-10
with O 0 1.2511390361236163e-11
concordant O 0 2.163254248443991e-05
DZ O 1 0.9977668523788452
twins O 0 0.0005544949672184885
. O 0 1.5966772348718905e-10

HLA O 0 0.00018894784443546087
- O 0 9.9249227787368e-06
B27 O 0 1.1915022213315751e-07
and O 0 4.713846500636887e-12
B60 O 0 1.1968075142032575e-10
were O 0 2.016623494712974e-13
associated O 0 8.859619038837502e-14
with O 0 3.8219189098243067e-13
the O 0 6.309749597810388e-12
disease O 0 4.580379481922137e-06
in O 0 5.551226253848462e-13
probands O 0 2.859030473700841e-06
, O 0 5.970029158530732e-13
and O 0 3.583361905812321e-13
the O 0 1.8350608305042065e-13
rate O 0 4.435874814134877e-07
of O 0 2.5295585938389653e-12
disease O 0 2.9951041824460845e-07
concordance O 0 1.3062956272236192e-10
was O 0 1.1234149895067436e-11
significantly O 0 1.624073965589279e-11
increased O 0 1.1043944231348135e-10
among O 0 3.3462829729380417e-10
DZ O 1 0.9995040893554688
twin O 0 2.0694937120424584e-05
pairs O 0 7.190767981057888e-10
in O 0 2.8024544490579117e-13
which O 0 1.1515041307627594e-12
the O 0 4.552185451506263e-12
co O 0 0.002332147443667054
- O 0 1.1958273944401299e-06
twin O 0 2.207357510997099e-06
was O 0 2.414810851281146e-10
positive O 0 1.7400481012661007e-12
for O 0 5.281324541513447e-15
both O 0 2.28056207815866e-13
B27 O 0 3.401216530640738e-10
and O 0 6.40621670294772e-12
DR1 O 0 1.0706071407184936e-05
. O 0 6.156655046885007e-11

Additive O 0 2.150734035311075e-09
genetic O 0 8.184460398297233e-08
effects O 0 1.1907770769425952e-08
were O 0 4.972794637007893e-13
estimated O 0 1.2768026924365322e-13
to O 0 1.663340960193077e-13
contribute O 0 1.8950733343681136e-11
97 O 0 4.5152487304633837e-10
% O 0 5.988524292340619e-14
of O 0 7.686535475735117e-16
the O 0 1.975966082651357e-14
population O 0 2.0524314737449707e-14
variance O 0 1.2926827143433517e-11
. O 0 1.600695270775887e-11

CONCLUSION O 0 6.817737485675934e-10
Susceptibility O 0 3.575117091259017e-08
to O 0 1.9174969945190412e-10
AS B-Disease 1 0.9999995231628418
is O 0 9.615312018818045e-12
largely O 0 3.0197141309825856e-14
genetically O 0 1.9871954082262278e-10
determined O 0 2.822817812830891e-10
, O 0 3.4038849755328726e-13
and O 0 3.319812415421286e-13
the O 0 1.2671945774872604e-14
environmental O 0 2.95605831479584e-11
trigger O 0 5.070072361945677e-09
for O 0 1.3102519286559144e-12
the O 0 9.715080302730161e-12
disease O 0 5.656875146087259e-07
is O 0 2.9467682634287673e-12
probably O 0 2.837526220933473e-11
ubiquitous O 0 3.947877758037066e-08
. O 0 1.0082532725386173e-10

HLA O 0 8.716305455891415e-05
- O 0 9.831592251430266e-07
B27 O 0 1.977694452648393e-09
accounts O 0 1.0625993357785135e-12
for O 0 1.8898797525296503e-14
a O 0 1.7973574966681158e-14
minority O 0 4.269265605101602e-13
of O 0 4.528067670640855e-16
the O 0 8.254132783085816e-15
overall O 0 4.845094811467554e-11
genetic O 0 2.489878581091176e-10
susceptibility O 0 2.6125376861863003e-10
to O 0 9.862750199873815e-11
AS B-Disease 1 0.9999996423721313
. O 0 6.364825888560688e-10

Cell O 0 2.186265010095667e-05
cycle O 0 3.1181323720375076e-05
- O 0 4.470088970265351e-05
dependent O 0 5.1390742328294436e-08
colocalization O 0 1.1357628864061553e-06
of O 0 1.1935100260526688e-12
BARD1 O 0 0.00014290690887719393
and O 0 4.303452039167155e-11
BRCA1 O 0 3.4298130913157365e-07
proteins O 0 4.071239439323859e-12
in O 0 3.214865905700414e-15
discrete O 0 8.743964580171237e-11
nuclear O 0 0.0003874896210618317
domains O 0 2.948320116047398e-06
. O 0 1.4240389423214594e-10

Germ O 0 0.022542409598827362
- O 0 0.0006338024395518005
line O 0 3.637545944457088e-07
mutations O 0 2.65935700127784e-08
of O 0 2.8018279496088046e-14
the O 0 1.4331512864472484e-13
BRCA1 O 0 2.8495603601186303e-06
gene O 0 3.555598482307687e-09
predispose O 0 4.930268193703569e-09
women O 0 3.953138857926142e-11
to O 0 4.31542923954014e-14
early O 0 1.5848289347530908e-10
- O 1 0.7472208738327026
onset O 1 0.9977005124092102
breast B-Disease 1 0.9999994039535522
and I-Disease 1 0.9999773502349854
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.999998927116394
by O 0 2.4185043074123613e-13
compromising O 0 9.470736728189877e-08
the O 0 2.8585348064297245e-13
genes O 0 4.914288975754744e-09
presumptive O 0 4.547622665995732e-06
function O 0 2.3052058040207157e-09
as O 0 7.459032523582376e-12
a O 0 3.619729949805306e-12
tumor B-Disease 0 5.230288024904439e-07
suppressor O 0 1.990734745049849e-06
. O 0 1.339829913682422e-09

Although O 0 9.336457301722945e-11
the O 0 7.816245887288728e-14
biochemical O 0 3.251219016231488e-10
properties O 0 4.4093721729421276e-11
of O 0 1.8945448508611573e-12
BRCA1 O 0 0.025906670838594437
polypeptides O 0 1.178659431388951e-06
are O 0 5.462135604927809e-11
not O 0 1.434152818204082e-12
understood O 0 3.818818525291867e-11
, O 0 3.7692718819195767e-14
their O 0 9.915341253130885e-14
expression O 0 1.9717148053155498e-11
pattern O 0 1.2801613102908505e-08
and O 0 3.153894159724224e-11
subcellular O 0 5.438146044589587e-10
localization O 0 7.518789479910026e-10
suggest O 0 4.992491489663742e-11
a O 0 7.34385382367142e-12
role O 0 1.9552100383180004e-08
in O 0 1.528036594825033e-13
cell O 0 7.425883463696437e-09
- O 0 1.5138366507017054e-06
cycle O 0 1.3989371154821129e-06
regulation O 0 4.234840744743451e-08
. O 0 2.47258463703659e-11

When O 0 7.191965245567644e-09
resting O 0 8.569556086968078e-08
cells O 0 2.5823188032347844e-09
are O 0 1.6187045193821747e-12
induced O 0 4.2659509258413664e-10
to O 0 5.3688261789867214e-14
proliferate O 0 5.134425578035007e-07
, O 0 1.0046178705548289e-13
the O 0 3.0483868738735015e-15
steady O 0 1.0990470755700699e-09
- O 0 2.8603663881909824e-10
state O 0 1.9209459055976458e-13
levels O 0 1.6080684689650376e-13
of O 0 8.180245569701231e-16
BRCA1 O 0 2.3334834509114444e-08
increase O 0 4.55110667034464e-13
in O 0 1.9255733397621202e-15
late O 0 4.006419423107331e-14
G1 O 0 9.999807204508215e-09
and O 0 4.722576062848871e-12
reach O 0 3.063309561525049e-14
a O 0 1.3579308643795092e-14
maximum O 0 5.7177374813977e-13
during O 0 8.347460743463042e-12
S O 0 7.450074122061778e-07
phase O 0 3.6813815884606527e-10
. O 0 1.9332316997244803e-11

Moreover O 0 6.208926262019077e-09
, O 0 1.2324370040131538e-12
in O 0 8.073562977016502e-14
S O 0 2.96273555022708e-07
phase O 0 4.1456860166988463e-10
cells O 0 7.213090125191002e-10
, O 0 7.878289492134483e-13
BRCA1 O 0 1.0378220167694963e-06
polypeptides O 0 4.672732245580846e-08
are O 0 8.232070407288017e-12
hyperphosphorylated O 0 1.0464012234479014e-07
and O 0 5.930262249147222e-13
accumulate O 0 3.043764129628812e-10
into O 0 3.5843122090165047e-13
discrete O 0 4.051924573644783e-09
subnuclear O 0 0.00030738094937987626
foci O 0 1.6219423741858918e-06
termed O 0 9.110889465091532e-08
" O 0 1.3371135310080717e-09
BRCA1 O 0 5.687661086994922e-06
nuclear O 0 6.553877938131336e-07
dots O 0 3.024978241228382e-07
. O 0 2.668688325879742e-10

" O 0 2.1139246797474698e-08
BRCA1 O 0 0.00019856798462569714
associates O 0 1.0300442454536096e-06
in O 0 6.719640469055044e-12
vivo O 0 1.7362046946800547e-06
with O 0 3.490508012835014e-12
a O 0 1.352034586718509e-12
structurally O 0 3.710525886546634e-09
related O 0 5.631828892127544e-10
protein O 0 8.37859772673255e-08
termed O 0 3.5097056638733193e-07
BARD1 O 0 0.0006565843359567225
. O 0 1.848680236671285e-10

Here O 0 1.7710455324504437e-10
we O 0 1.0141231387636451e-12
show O 0 1.283579254170164e-12
that O 0 1.03590795372309e-15
the O 0 1.5020083734987397e-15
steady O 0 4.247269758117511e-10
- O 0 4.3583858744256077e-10
state O 0 6.306665259470101e-13
levels O 0 1.7806089719005214e-12
of O 0 2.8357445464212297e-16
BARD1 O 0 3.8251650735787734e-09
, O 0 5.916646897557456e-17
unlike O 0 9.509108444440812e-16
those O 0 4.283690406786753e-15
of O 0 4.11660002893016e-15
BRCA1 O 0 1.7841655335359974e-06
, O 0 1.0995611973013686e-12
remain O 0 1.5224604346317228e-12
relatively O 0 2.899973487800571e-14
constant O 0 1.9363316505760508e-11
during O 0 2.6199016914252304e-11
cell O 0 6.964926768660007e-08
cycle O 0 3.962709797633579e-06
progression O 0 4.622576170731918e-07
. O 0 1.5406316500321537e-10

However O 0 2.301067558718728e-09
, O 0 1.2556088981041658e-12
immunostaining O 0 5.242102929514658e-08
revealed O 0 2.5808674308791524e-08
that O 0 6.097146659084229e-12
BARD1 O 0 8.312756835948676e-05
resides O 0 8.235600645889463e-09
within O 0 1.218943349035051e-12
BRCA1 O 0 1.3296202268975321e-05
nuclear O 0 8.694233315509337e-07
dots O 0 7.60618945605529e-09
during O 0 1.457822230988004e-11
S O 0 7.064980422910594e-08
phase O 0 3.671168837676708e-12
of O 0 2.0736405011178606e-14
the O 0 9.387387649986353e-14
cell O 0 1.8181429695118823e-09
cycle O 0 6.317227274621473e-08
, O 0 2.316104664827623e-13
but O 0 1.6623822883033747e-14
not O 0 4.064699779153047e-15
during O 0 2.9843213251496857e-15
the O 0 4.909139958555802e-15
G1 O 0 1.9139108076160483e-08
phase O 0 3.0430619135657366e-10
. O 0 2.0941691089571002e-11

Nevertheless O 0 3.930065020085749e-07
, O 0 1.9665094205811862e-11
BARD1 O 0 5.453086941997753e-07
polypeptides O 0 3.107038404337459e-09
are O 0 4.878807861180556e-13
found O 0 6.20846310559614e-13
exclusively O 0 2.7969772765229495e-12
in O 0 1.6927887382307306e-14
the O 0 1.9488002113736067e-14
nuclear O 0 1.5373271544660838e-09
fractions O 0 2.7354689151846967e-13
of O 0 2.582931469687186e-15
both O 0 5.760733415901415e-14
G1 O 0 3.126704228861854e-09
- O 0 8.702178533326332e-09
and O 0 1.9352988656073933e-10
S O 0 2.7491861942507967e-07
- O 0 6.18195661328258e-10
phase O 0 7.853602490559553e-11
cells O 0 9.016350166479725e-11
. O 0 3.2410495728191213e-12

Therefore O 0 1.9385425209517138e-10
, O 0 8.962822888383681e-14
progression O 0 2.7124866588956742e-11
to O 0 3.37627061725021e-12
S O 0 1.7525975636090152e-05
phase O 0 8.62480864505244e-10
is O 0 1.6413542400228742e-11
accompanied O 0 5.981631748079586e-13
by O 0 8.031027481152585e-16
the O 0 1.5430214970465561e-15
aggregation O 0 1.2526195358741887e-11
of O 0 6.187276168842515e-14
nuclear O 0 1.5399200492538512e-07
BARD1 O 0 2.278693678192667e-08
polypeptides O 0 1.2951167915886685e-10
into O 0 5.1244212866119465e-12
BRCA1 O 0 7.687660399824381e-06
nuclear O 0 1.091335803948823e-07
dots O 0 1.0545277717710633e-07
. O 0 1.117252887428144e-10

This O 0 7.606686114325356e-12
cell O 0 2.9312463567521263e-08
cycle O 0 5.892415629205061e-06
- O 0 1.341548249911284e-05
dependent O 0 4.280144949575515e-08
colocalization O 0 1.0701922974476474e-06
of O 0 8.672071307586071e-13
BARD1 O 0 0.00017482081602793187
and O 0 2.07892262432674e-11
BRCA1 O 0 6.184657763697032e-07
indicates O 0 1.2525240393468362e-11
a O 0 4.6680144965378575e-14
role O 0 1.218465606189767e-10
for O 0 5.50463374968807e-13
BARD1 O 0 4.961068498232635e-06
in O 0 3.411654205670578e-12
BRCA1 O 0 0.0030026123858988285
- O 0 0.00013682807912118733
mediated O 0 1.0137296158063691e-05
tumor B-Disease 0 7.1566205406270456e-06
suppression O 0 8.26510682117032e-09
. O 0 7.802360840747369e-11

Ethnic O 0 8.226835879199257e-10
differences O 0 6.171039679259138e-09
in O 0 6.325121090951236e-13
the O 0 2.8940860125059586e-12
HFE O 0 0.001084988471120596
codon O 0 2.680291800061241e-06
282 O 0 4.057201863361115e-07
( O 0 1.1657946830112564e-10
Cys O 0 0.00018127646762877703
/ O 0 3.866641236527357e-06
Tyr O 0 7.766157636979187e-07
) O 0 4.155656721516188e-12
polymorphism O 0 1.415761285983308e-08
. O 0 1.5954533527651193e-10

Recent O 0 3.781694679627634e-10
studies O 0 4.727174554575164e-11
have O 0 9.422682252513415e-12
shown O 0 2.499319862181437e-09
that O 0 3.097407557106635e-07
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 0 1.6167372450581752e-05
HH B-Disease 1 0.9772951602935791
) O 0 1.7137942107114945e-11
is O 0 2.923128102419459e-12
likely O 0 2.0834907150241166e-12
to O 0 5.2523754117718424e-14
be O 0 2.192753964513905e-11
caused O 0 8.981566033440525e-13
by O 0 6.772565008670217e-15
homozygosity O 0 3.35153664821064e-08
for O 0 1.3997708699607647e-13
a O 0 1.525934543653018e-12
Cys282Tyr O 0 1.991037379411864e-07
mutation O 0 1.3944972954149648e-09
in O 0 2.486817074151288e-14
the O 0 5.841036882685627e-14
HFE O 0 1.9256337964179693e-06
gene O 0 1.794434290047775e-08
located O 0 5.707221362172277e-10
4 O 0 1.8256455236453917e-09
. O 0 2.922650316206088e-11

5 O 0 3.6414447013299878e-09
Mb O 0 1.6173689232346078e-07
telomeric O 0 1.8692489902605303e-06
to O 0 7.053202466522634e-11
HLA O 0 1.9407179934205487e-06
- O 0 2.0566196212712384e-07
A O 0 3.665484027415289e-10
. O 0 1.3316426954179672e-11

Population O 0 4.906042239127828e-11
studies O 0 5.388035503872679e-12
of O 0 7.630098199855155e-15
this O 0 2.471146202297431e-15
polymorphism O 0 1.6321060058999137e-09
are O 0 3.1823274484338304e-13
facilitated O 0 4.263341524431141e-13
by O 0 2.1736374839257354e-14
the O 0 2.0364127254596763e-14
fact O 0 6.63741587733635e-12
that O 0 3.338907655133644e-13
the O 0 1.4572488181430199e-12
Cys282Tyr O 0 1.7347878156215302e-06
mutation O 0 3.915218815819799e-09
creates O 0 6.250400891305574e-11
a O 0 4.774927848949506e-12
Rsal O 0 3.056700847992033e-07
restriction O 0 3.5516720120476464e-10
site O 0 1.0868810296216225e-09
. O 0 7.717698702336406e-11

We O 0 1.5952055676393684e-08
have O 0 4.729552686988381e-12
studied O 0 2.1903001981571357e-11
the O 0 6.783509301153123e-13
codon O 0 2.3126229820036315e-08
282 O 0 5.803981739660458e-09
( O 0 6.4790495017674754e-12
Cys O 0 5.279783727019094e-05
/ O 0 6.330012070066005e-07
Tyr O 0 3.400720416379954e-08
) O 0 9.444264218328585e-14
polymorphism O 0 3.7780230333073206e-11
in O 0 2.3846147987135894e-15
different O 0 1.5126573775907392e-15
ethnic O 0 1.0712189192326263e-13
groups O 0 1.5261178822403854e-12
. O 0 1.360405971900791e-11

In O 0 4.1435889441832074e-11
agreement O 0 3.823590749574279e-12
with O 0 5.8785653550400864e-15
previous O 0 1.1299251465035631e-13
observations O 0 6.821581060439952e-12
the O 0 4.954995289942199e-13
Tyr O 0 5.972412253640869e-08
allele O 0 3.0484426094545825e-09
appeared O 0 1.037619656862887e-09
to O 0 4.886814626461726e-14
be O 0 2.086282101937398e-12
rare O 0 4.7806693499741204e-12
or O 0 1.9027137643234937e-09
absent O 0 3.255094327414554e-08
in O 0 8.878671994665133e-13
Asiatic O 0 8.288102981701684e-10
( O 0 1.5782053398513685e-13
Indian O 0 3.985236186193619e-12
, O 0 4.96354064959321e-15
Chinese O 0 1.1581587366926455e-15
) O 0 1.1225479469307697e-14
populations O 0 4.908136830988896e-12
. O 0 1.5416000724230439e-12

The O 0 3.5278981125319575e-11
highest O 0 8.456828015646067e-10
allele O 0 8.663982864476338e-10
frequency O 0 3.480725152549269e-10
( O 0 2.1474638473711893e-12
7 O 0 1.563072588028902e-11
. O 0 1.3734084433148028e-14
5 O 0 8.189516230959482e-13
% O 0 1.9784089256712385e-15
) O 0 4.290509869045098e-15
was O 0 6.369506918429968e-12
found O 0 2.520659549143378e-11
in O 0 2.8205222445815137e-12
Swedes O 0 1.3305500488058897e-06
. O 0 2.3463423912128967e-11

Saamis O 0 6.18904668954201e-05
( O 0 1.0553572599159011e-10
2 O 0 2.9185334704529e-11
% O 0 6.490783930300503e-13
) O 0 1.5443774189181914e-13
and O 0 2.4151999844512773e-12
Mordvinians O 0 7.59814540174375e-08
( O 0 2.9810003207217384e-14
1 O 0 9.34146626697073e-14
. O 0 8.282077247048682e-15
8 O 0 4.834974434708705e-12
% O 0 5.505759685173867e-16
) O 0 5.133185361181367e-16
had O 0 6.008159464734875e-13
significantly O 0 2.4987905624870854e-13
lower O 0 6.404393616994686e-13
frequencies O 0 2.0273229709572016e-12
of O 0 9.242501647918969e-14
the O 0 2.7777738876438862e-12
Tyr O 0 1.0687404028431047e-07
allele O 0 2.8707360932855863e-09
. O 0 3.632734738023835e-11

Comparisons O 0 2.5534105385638384e-10
with O 0 5.799521019672627e-13
allele O 0 8.110462995647438e-11
frequencies O 0 6.054477232064759e-12
based O 0 8.67816018698675e-13
on O 0 2.1678979791883712e-11
prevalence O 0 1.3516041619254793e-08
estimates O 0 1.6135720147178456e-12
of O 0 7.385311437922704e-14
HH B-Disease 0 0.06406388431787491
showed O 0 6.200094730957062e-07
some O 0 4.0356864443140406e-14
disagreements O 0 7.033404414436006e-10
with O 0 6.4479722424034755e-15
the O 0 9.378053389259258e-16
RFLP O 0 3.898140032987385e-09
data O 0 1.1758757301194578e-09
, O 0 8.385223667761038e-14
particularly O 0 2.1375815614094185e-13
in O 0 2.5394518709002598e-14
Finns O 0 1.1543260569624181e-07
. O 0 3.765462247562468e-11

The O 0 7.157745923747072e-11
newly O 0 4.3007666761241126e-08
described O 0 5.250603285489319e-10
HFE O 0 1.0902298527071252e-05
marker O 0 1.2325634202170477e-07
provides O 0 3.932641701436673e-13
a O 0 3.720785344326488e-14
new O 0 1.8517618807691733e-13
approach O 0 7.947363199391905e-14
to O 0 1.9022897540008592e-16
the O 0 1.4156367679743536e-16
screening O 0 9.119461262530049e-12
of O 0 5.136615738738628e-15
HH B-Disease 0 2.9776365408906713e-06
as O 0 4.295390779174291e-11
well O 0 3.4381346511111466e-13
as O 0 1.6393407898523948e-13
studies O 0 6.14212177416063e-15
of O 0 9.906483363733326e-16
the O 0 2.1881141917898944e-13
relationship O 0 1.7522494566435398e-10
between O 0 6.486337752716412e-14
the O 0 1.4852225352357529e-12
HFE O 0 8.179076394299045e-05
Tyr O 0 5.343965199244849e-07
allele O 0 8.146925978280706e-08
and O 0 2.4704457923796497e-10
different O 0 1.009852097777486e-11
disorders O 0 1.5144001736189239e-05
including O 0 6.962794785181359e-10
cancer B-Disease 0 1.973173493752256e-05

Autosomal B-Disease 1 0.9999476671218872
dominant I-Disease 1 0.9998706579208374
neurohypophyseal I-Disease 1 0.9999580383300781
diabetes I-Disease 1 0.9999977350234985
insipidus I-Disease 1 0.9999263286590576
associated O 0 5.552951733989175e-06
with O 0 3.977583540315521e-11
a O 0 4.231465438458981e-12
missense O 0 1.7925225392900757e-06
mutation O 0 9.556037383617877e-08
encoding O 0 1.5472178205300224e-08
Gly23 O 0 0.04156791791319847
- O 0 0.0011949017643928528
- O 0 5.690460602636449e-05
> O 0 5.509900447009386e-08
Val O 0 0.00026160303968936205
in O 0 2.5156836683248862e-11
neurophysin O 0 4.054647433804348e-06
II O 0 1.8848746776711778e-06
. O 0 4.76981509844876e-11

Autosomal B-Disease 1 0.9999691247940063
dominant I-Disease 1 0.9999127388000488
neurohypophyseal I-Disease 1 0.9999532699584961
diabetes I-Disease 1 0.9999932050704956
insipidus I-Disease 1 0.9997332692146301
( O 0 3.9410466001754685e-08
ADNDI B-Disease 0 0.0038246505428105593
) O 0 2.2690231638033964e-11
is O 0 1.2204845467600478e-10
an O 0 8.035380005821935e-08
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 6.232839950826019e-05
by O 0 3.127583955708779e-11
progressive O 0 1.6493679755313906e-09
degeneration O 0 9.207406606037694e-07
of O 0 1.6081604906244273e-13
the O 0 7.162650870638429e-14
magnocellular O 0 1.1421025236657556e-09
neurons O 0 5.234571456846915e-11
of O 0 3.680017225058665e-15
the O 0 1.3243364196079133e-13
hypothalamus O 0 5.914569389808833e-10
leading O 0 1.1778893416192204e-09
to O 0 1.7644116419648914e-12
decreased O 0 1.9832694420074404e-07
ability O 0 1.243218306079541e-10
to O 0 4.800189922198744e-14
produce O 0 8.197447581848039e-11
the O 0 2.9116389854699776e-11
hormone O 0 1.3335005633052788e-07
arginine O 0 2.5085946653291558e-09
vasopressin O 0 4.14069167842257e-10
( O 0 3.270632191725714e-13
AVP O 0 7.204241825320423e-08
) O 0 1.5179834386008784e-12
. O 0 4.850501510861305e-12

Affected O 0 1.0199101296848312e-07
individuals O 0 9.803091671756192e-11
are O 0 2.2595939876135507e-12
not O 0 2.0476476417230494e-12
symptomatic O 0 3.5430471889696946e-09
at O 0 5.62358493105819e-10
birth O 0 2.1891301216214742e-08
, O 0 1.3330454795568158e-11
but O 0 1.4887864552282082e-10
usually O 0 6.872644320310428e-08
develop O 0 8.880434324964881e-05
diabetes B-Disease 1 0.5104421377182007
insipidus I-Disease 0 0.0015456746332347393
at O 0 9.328990699941642e-07
1 O 0 1.5620139848238068e-08
- O 0 0.00018327638099435717
6 O 0 8.536407136716662e-08
yr O 0 0.0002330778370378539
of O 0 8.258459888166314e-12
age O 0 3.378942459164591e-09
. O 0 6.887919488246519e-12

The O 0 2.018017480551193e-12
genetic O 0 8.62694748970938e-10
locus O 0 7.722672279442122e-08
of O 0 2.2016216974507508e-11
the O 0 4.6173172923991146e-11
disease O 0 1.0979541002598125e-05
is O 0 1.9556984070384642e-12
the O 0 6.883621277153917e-13
AVP O 0 0.007002734113484621
- O 0 1.076867829397088e-05
neurophysin O 0 2.767511068668682e-05
II O 0 1.218766556121409e-06
( O 0 1.6319408389746382e-13
NPII O 0 2.8611479852003185e-09
) O 0 1.3573448869865987e-15
gene O 0 3.5423120599981095e-12
, O 0 9.052742550811482e-15
and O 0 7.348413327487591e-14
mutations O 0 4.237026007825051e-10
that O 0 6.75881919875998e-12
cause O 0 1.037308433593509e-10
ADNDI B-Disease 0 0.0033912656363099813
have O 0 7.489962539075634e-10
been O 0 9.958721347569366e-11
found O 0 1.915537728436334e-10
in O 0 5.3346304424665286e-14
both O 0 2.1621475497588666e-13
the O 0 1.9251630793541176e-14
signal O 0 7.942538120253584e-12
peptide O 0 4.256313454898547e-13
of O 0 2.9769758554310964e-15
the O 0 1.6273343349942904e-13
prepro O 0 1.0321101626686868e-06
- O 0 3.405601489703258e-08
AVP O 0 1.6713596778572537e-05
- O 0 3.1808486511408773e-08
NPII O 0 3.948563858102716e-07
precursor O 0 1.1397190829987025e-10
and O 0 5.893660125905198e-13
within O 0 6.023739856529306e-14
NPII O 0 4.450111816822755e-07
itself O 0 5.269200700763754e-11
. O 0 1.061694308857053e-11

An O 0 1.786423439731344e-11
affected O 0 2.4632855755157834e-09
girl O 0 7.104162068571895e-05
who O 0 4.858128566098685e-09
presented O 0 2.36509553261377e-12
at O 0 2.0239702275270943e-11
9 O 0 8.57483615362975e-12
months O 0 2.1723671039114434e-12
of O 0 2.5519693237947838e-14
age O 0 4.994315627726564e-09
and O 0 2.0893575064517833e-11
her O 0 3.0318789145944436e-11
similarly O 0 3.157818798116274e-11
affected O 0 1.9858227909286263e-11
younger O 0 1.7418089540144344e-11
brother O 0 3.29993921077687e-09
and O 0 7.643252003530776e-11
father O 0 3.074648591283591e-10
were O 0 3.338832899393851e-12
all O 0 8.30229372121398e-14
found O 0 1.2394129125792297e-11
to O 0 1.1204869497516423e-12
have O 0 3.984582629124045e-12
a O 0 2.0523296603847108e-14
novel O 0 1.0347514511899192e-10
missense O 0 3.554082184109575e-07
mutation O 0 1.6526815471706868e-08
( O 0 4.834990914581727e-13
G1758 O 0 9.218822372147883e-10
- O 0 1.5170256162377882e-08
- O 0 4.744380177612584e-08
> O 0 2.7776284050595734e-10
T O 0 7.100617693822642e-08
) O 0 5.984156482244807e-16
encoding O 0 5.990097571336849e-15
the O 0 1.2635544110447877e-15
amino O 0 1.406714371723905e-12
acid O 0 2.235489137553115e-12
substitution O 0 6.175335850316932e-13
Gly23 O 0 2.5005090265040053e-07
- O 0 1.1755341802199837e-06
- O 0 1.3266082987684058e-06
> O 0 2.548235400468002e-09
Val O 0 3.1527997634839267e-05
within O 0 1.6366939747936016e-10
NPII O 0 4.292361336410977e-05
. O 0 6.724631268495429e-11

The O 0 2.8035229693301744e-10
mutation O 0 3.647136281870189e-07
was O 0 5.976418249176163e-10
confirmed O 0 5.339074234805841e-12
by O 0 4.12669412056259e-15
restriction O 0 2.505090969731616e-12
endonuclease O 0 1.8912485799660317e-08
analysis O 0 1.0408540696005275e-10
. O 0 3.177539481535874e-11

A O 0 4.664366115569862e-10
T1 O 0 6.833261068095453e-07
- O 0 3.1349317586304437e-10
weighted O 0 3.04766073488949e-11
magnetic O 0 1.744877137742351e-12
resonance O 0 4.753555188363734e-12
imaging O 0 2.063076749436732e-07
of O 0 2.3903984694428893e-11
the O 0 2.3966415518827944e-09
fathers O 0 0.00011708022793754935
pituitary O 0 0.000670185312628746
gland O 0 6.805076395721699e-07
demonstrates O 0 3.125969205708401e-10
an O 0 1.1124800082876196e-12
attenuated O 0 1.5294526747311465e-05
posterior O 0 0.00024293595924973488
pituitary O 0 0.01434927899390459
bright O 0 1.1406145006276347e-07
spot O 0 1.8570757447378128e-06
. O 0 8.22479639950302e-10

This O 0 2.6854298298961687e-11
mutation O 0 5.986760243104072e-08
may O 0 3.727482558724127e-11
be O 0 6.336147905619028e-16
valuable O 0 3.2481694200656164e-14
for O 0 2.728213078492586e-15
developing O 0 1.7132059659807908e-11
models O 0 1.4230602474185616e-08
of O 0 6.609572264504315e-12
dominantly B-Disease 0 0.011923098005354404
inherited I-Disease 1 0.9859458804130554
neurodegeneration I-Disease 1 1.0
, O 0 5.92321747205915e-10
as O 0 1.104703026104381e-12
the O 0 1.2408421119487582e-14
early O 0 2.772480812637812e-12
age O 0 6.044859612863718e-10
of O 0 4.877291062341249e-13
onset O 0 2.7551168457762287e-08
of O 0 3.6463478070292155e-11
symptoms O 0 7.815150127044035e-08
suggests O 0 7.200676551332927e-14
that O 0 1.3271830601744097e-14
this O 0 2.158520486916088e-14
mutation O 0 6.39310684391603e-08
may O 0 1.0193068611386025e-08
be O 0 1.4835190367823436e-11
particularly O 0 4.377591496761146e-13
deleterious O 0 9.880845447396425e-11
to O 0 4.646535096248204e-14
the O 0 8.104992642744141e-14
magnocellular O 0 7.733886420169256e-09
neuron O 0 2.356095407662906e-08
. O 0 1.790922553486507e-12
. O 0 1.8834737589012995e-11

Frequent O 0 2.9345758889576246e-07
inactivation O 0 1.0784896403492894e-05
of O 0 2.0053870022906928e-11
PTEN O 0 0.0010643318528309464
/ O 0 2.9414612072287127e-05
MMAC1 O 0 0.004890039563179016
in O 0 5.107613221255747e-10
primary O 0 0.0002598597202450037
prostate B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999994039535522
. O 0 6.272658481520921e-08

Sporadic B-Disease 1 0.7333644032478333
prostate I-Disease 1 0.9999850988388062
carcinoma I-Disease 1 1.0
is O 0 4.767221071233507e-07
the O 0 1.905532806198429e-12
most O 0 3.9460179915296045e-12
common O 0 9.376294185514666e-10
male B-Disease 0 3.6708029949039656e-09
cancer I-Disease 0 2.8796860451762996e-09
in O 0 1.9690145510158769e-13
the O 0 3.098371559318025e-11
Western O 0 8.964790576548864e-10
world O 0 1.0662136418204682e-07
, O 0 9.893748689239479e-14
yet O 0 4.585609371604918e-14
many O 0 1.233041081441356e-16
of O 0 2.1633611902123956e-16
the O 0 9.927409100937007e-15
major O 0 4.513659845190032e-12
genetic O 0 6.01817554124473e-12
events O 0 1.4097649100614645e-13
involved O 0 4.960222788064073e-10
in O 0 7.657627787080457e-14
the O 0 6.548492352759575e-14
progression O 0 9.874571299528512e-11
of O 0 5.41041786838916e-14
this O 0 8.567769432289707e-13
often O 0 4.317441071322037e-09
fatal O 0 0.00028087536338716745
cancer B-Disease 0 4.942773375660181e-05
remain O 0 7.263925017042538e-10
to O 0 1.61236605664139e-12
be O 0 6.894709247973196e-10
elucidated O 0 9.900531949824654e-07
. O 0 1.7227816395681828e-10

Numerous O 0 3.2761455770469183e-09
cytogenetic O 0 0.0001333403924945742
and O 0 1.5058625457697872e-09
allelotype O 0 1.36218886837014e-06
studies O 0 2.0861648519776566e-10
have O 0 9.833067519948724e-12
reported O 0 8.695980741046938e-11
frequent O 0 2.338471360996408e-10
loss O 0 6.821938569601116e-10
of O 0 4.5650840692270517e-14
heterozygosity O 0 1.1517880693645566e-07
on O 0 1.819676520575797e-09
chromosomal O 1 0.8854441046714783
arm O 0 0.014766830950975418
10q O 0 2.701470691590657e-07
in O 0 1.459920379032198e-11
sporadic B-Disease 0 0.0002017784136114642
prostate I-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999988079071045
. O 0 6.904793181661262e-09

Deletion O 0 1.0164441846427508e-05
mapping O 0 3.095587771895225e-06
studies O 0 1.3357941952563124e-07
have O 0 2.402874565987645e-10
unambiguously O 0 2.54327488846684e-07
identified O 0 9.626702990317426e-09
a O 0 1.1122662686713358e-11
region O 0 2.015045422187889e-11
of O 0 2.9584014816889936e-13
chromosome O 0 0.0001638432586332783
10q23 O 0 1.7007257824275257e-08
to O 0 7.716395881637861e-13
be O 0 1.1068078962020445e-12
the O 0 1.8227206700758723e-15
minimal O 0 2.649104893781562e-12
area O 0 4.11527149163371e-12
of O 0 1.0533391650233148e-12
loss O 0 5.587218865343857e-08
. O 0 6.944912006590087e-11

A O 0 2.359060724543838e-10
new O 0 1.038576950135317e-11
tumor B-Disease 0 1.4424893501896463e-09
suppressor O 0 1.2023588791265638e-09
gene O 0 1.536745202201928e-07
, O 0 1.5193572094895913e-11
PTEN O 0 0.0002513389044906944
/ O 0 1.1996574357908685e-05
MMAC1 O 0 0.0019611872266978025
, O 0 2.4451057498153794e-12
was O 0 6.386115247725144e-11
isolated O 0 3.4737679399654553e-10
recently O 0 2.1262462013282857e-08
at O 0 3.158613648412967e-11
this O 0 2.0000782307476664e-14
region O 0 6.524408834376882e-13
of O 0 3.432969308673518e-14
chromosome O 0 2.134536998710246e-06
10q23 O 0 7.669395118981015e-10
and O 0 5.037077525915645e-13
found O 0 1.2162237363055883e-12
to O 0 6.934166782435192e-14
be O 0 2.3471112206574496e-12
inactivated O 0 2.755854988656381e-10
by O 0 1.3043901870692727e-15
mutation O 0 1.3131404297261895e-10
in O 0 3.347479411719423e-12
three O 0 2.434283487673383e-06
prostate B-Disease 1 1.0
cancer I-Disease 1 0.9999991655349731
cell O 0 1.8173416265199194e-06
lines O 0 5.362016395338287e-07
. O 0 1.829482398907345e-10

We O 0 2.5016772653430053e-08
screened O 0 8.751327186473645e-06
80 O 0 6.406950348036844e-08
prostate B-Disease 1 0.998397171497345
tumors I-Disease 1 1.0
by O 0 3.920249541655707e-12
microsatellite O 0 1.1072060033257003e-06
analysis O 0 1.9175317333974817e-08
and O 0 3.190585851076122e-10
found O 0 1.4375063639437968e-10
chromosome O 0 1.1948061910516117e-05
10q23 O 0 2.3253028391678754e-09
to O 0 1.8217286674396954e-13
be O 0 1.9040131071183103e-13
deleted O 0 1.4287137029000974e-09
in O 0 3.1561171319645365e-13
23 O 0 1.6996013971204427e-11
cases O 0 1.2523472710246342e-11
. O 0 1.6065341765236774e-11

We O 0 9.663573763418754e-08
then O 0 3.524259703513444e-11
proceeded O 0 7.678546383796392e-13
with O 0 2.237617789371322e-16
sequence O 0 8.271495899713345e-16
analysis O 0 5.9582376975752995e-15
of O 0 4.108941739356238e-16
the O 0 8.908280234624314e-15
entire O 0 1.9967243136687074e-10
PTEN O 0 3.772254058276303e-05
/ O 0 1.4495540767711645e-07
MMAC1 O 0 4.349656137492275e-06
coding O 0 1.3832084277964896e-07
region O 0 3.826386776872859e-11
and O 0 8.026961934764001e-14
tested O 0 2.3863133691293115e-10
for O 0 1.4175666001957745e-15
homozygous O 0 2.2650591124939723e-10
deletion O 0 5.973455063923439e-10
with O 0 2.00860183520446e-12
new O 0 3.620180544228191e-11
intragenic O 0 5.060134071754874e-07
markers O 0 4.2873924144259945e-07
in O 0 1.5573036837943782e-13
these O 0 3.423227074527378e-14
23 O 0 3.1817708190384764e-12
cases O 0 1.3964782021730349e-12
with O 0 2.9811457122330687e-12
10q23 O 0 2.3411425686958864e-08
loss O 0 2.982479263557991e-10
of O 0 1.2668188980463624e-12
heterozygosity O 0 1.5473025314349798e-06
. O 0 3.1280866785721173e-10

The O 0 7.032665872179142e-14
identification O 0 9.853038523965907e-13
of O 0 1.5332675314940966e-14
the O 0 2.4872925984478766e-13
second O 0 1.972905616653975e-09
mutational O 0 5.247975423117168e-07
event O 0 3.195299302927168e-10
in O 0 3.9122695426156706e-13
10 O 0 3.731855536398543e-12
( O 0 5.439535472983974e-14
43 O 0 1.2167263030438136e-10
% O 0 3.1838167085379565e-12
) O 0 5.504012245971523e-10
tumors B-Disease 1 1.0
establishes O 0 1.05900144262705e-05
PTEN O 0 0.0011024677660316229
/ O 0 3.2123143682838418e-06
MMAC1 O 0 9.720582602312788e-05
as O 0 1.6588175060991417e-12
a O 0 2.1821115403432463e-14
main O 0 9.60256830648265e-13
inactivation O 0 3.7215777126675675e-08
target O 0 3.067003248591327e-11
of O 0 1.1064311122301832e-14
10q O 0 8.565103071234148e-10
loss O 0 2.2030677282458555e-10
in O 0 2.612037105706455e-12
sporadic B-Disease 0 0.008659237064421177
prostate I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
. O 0 5.352954537962695e-11
. O 0 2.5009482332305488e-11

Risk O 0 3.6467229165282333e-06
reversals O 0 2.584703562291679e-09
in O 0 1.7623623643336223e-13
predictive O 0 5.373347100601222e-09
testing O 0 6.384504303014182e-08
for O 0 4.277382059658663e-10
Huntington B-Disease 1 0.9999960660934448
disease I-Disease 1 0.9999995231628418
. O 0 3.6155747284993822e-09

The O 0 1.185077833391543e-13
first O 0 1.4322057266275695e-13
predictive O 0 1.2770391411009996e-09
testing O 0 2.7398934676625686e-08
for O 0 1.5679285647607344e-10
Huntington B-Disease 1 0.9999994039535522
disease I-Disease 1 1.0
( O 0 1.6441584205217907e-11
HD B-Disease 0 1.0455634765094146e-05
) O 0 4.540686836945751e-12
was O 0 1.2301971073769291e-11
based O 0 4.551987245796606e-15
on O 0 7.785638859959462e-14
analysis O 0 2.615159675725849e-14
of O 0 6.349964601175522e-16
linked O 0 1.755948858539469e-11
polymorphic O 0 7.439808318021601e-12
DNA O 0 1.4983904117471525e-09
markers O 0 8.965204578714747e-09
to O 0 2.301114587234792e-14
estimate O 0 3.3146684182139285e-13
the O 0 3.3932847986551176e-14
likelihood O 0 8.980512861134216e-11
of O 0 4.7344848988538704e-14
inheriting O 0 3.7098466521001683e-09
the O 0 1.3561455560959224e-13
mutation O 0 6.444468569899442e-11
for O 0 4.703913040332575e-12
HD B-Disease 0 5.876663271919824e-05
. O 0 5.075991293956861e-10

Limits O 0 6.952072806321041e-10
to O 0 7.720691084069434e-14
accuracy O 0 5.896001568916898e-12
included O 0 3.9757114294507526e-14
recombination O 0 9.200697929229174e-13
between O 0 3.287768210349755e-14
the O 0 7.321264693330317e-16
DNA O 0 3.1266089717263412e-09
markers O 0 6.6746970333042555e-06
and O 0 7.855494033037758e-10
the O 0 2.714110186596841e-12
mutation O 0 5.418101522991492e-07
, O 0 5.270748767993716e-11
pedigree O 0 2.5358376660733484e-06
structure O 0 7.624243458792535e-09
, O 0 5.773451920536299e-13
and O 0 7.71103304499825e-15
whether O 0 1.9495799475532016e-15
DNA O 0 1.627516003910312e-11
samples O 0 8.965879427780266e-11
were O 0 1.9096139600160988e-13
available O 0 6.959660441268473e-14
from O 0 5.0375553202605325e-14
family O 0 1.540501580465925e-11
members O 0 1.1975848914977383e-12
. O 0 6.447317939944908e-12

With O 0 3.5451845452338926e-12
direct O 0 4.752123174134315e-12
tests O 0 1.939276650375632e-08
for O 0 1.2507363038056357e-14
the O 0 1.3810341115323439e-14
HD B-Disease 0 5.017017247155309e-05
mutation O 0 8.22436447833752e-08
, O 0 1.6617626328804813e-12
we O 0 1.6909993370839427e-12
have O 0 1.2563024114119279e-14
assessed O 0 1.15850081264246e-12
the O 0 1.918285891800418e-15
accuracy O 0 4.517996810005087e-10
of O 0 6.245802757365998e-14
results O 0 1.6573050711735787e-13
obtained O 0 3.34607829725192e-14
by O 0 2.51460407468926e-15
linkage O 0 1.8954429692463748e-10
approaches O 0 6.526477708962419e-12
when O 0 6.560813090722428e-12
requested O 0 7.55493215730263e-13
to O 0 4.237722911297481e-13
do O 0 5.4434356328014744e-11
so O 0 1.1595032320898223e-14
by O 0 5.129388006599707e-16
the O 0 4.4891170723196025e-14
test O 0 7.043933436534644e-09
individuals O 0 2.8359448036446855e-12
. O 0 1.4394611804607882e-12

For O 0 1.6686301645973955e-11
six O 0 8.770772996768983e-11
such O 0 2.5865824781513835e-13
individuals O 0 3.9754598918362305e-11
, O 0 1.3410576902433968e-12
there O 0 4.708327369477849e-13
was O 0 3.138329873753065e-10
significant O 0 2.925409480630803e-12
disparity O 0 2.757769290706591e-10
between O 0 4.4178194631185053e-13
the O 0 4.379430845746768e-12
tests O 0 4.826056283491198e-07
. O 0 1.5326207317145624e-11

Three O 0 1.0963623758852847e-10
went O 0 1.3208269200593037e-10
from O 0 1.6921558352125422e-14
a O 0 1.2267983395645998e-13
decreased O 0 1.3481277205684705e-09
risk O 0 1.8519237532377275e-10
to O 0 5.789678564588167e-15
an O 0 7.820201192339227e-13
increased O 0 5.805932801195013e-08
risk O 0 5.979001116429572e-07
, O 0 2.666257243200826e-13
while O 0 7.529541768726278e-13
in O 0 1.6987996175436701e-16
another O 0 2.2898317695641858e-14
three O 0 8.206450384691533e-13
the O 0 5.7204020166568e-12
risk O 0 1.518470895689461e-07
was O 0 4.346151882828053e-09
decreased O 0 4.560476796200419e-08
. O 0 1.1789466972111917e-11

Knowledge O 0 1.2337977861598404e-10
of O 0 6.655753151309923e-14
the O 0 7.903777933244809e-15
potential O 0 3.4017385262818944e-12
reasons O 0 1.1084165574585473e-14
for O 0 6.354762513426126e-16
these O 0 2.664942893706242e-15
changes O 0 7.932420454000166e-13
in O 0 1.9666038274853553e-14
results O 0 8.341046603410618e-12
and O 0 2.0909282985592803e-11
impact O 0 5.567484841206838e-12
of O 0 1.4361379034434434e-15
these O 0 1.421881818015891e-13
risk O 0 1.1661416277064518e-10
reversals O 0 3.4418503203764717e-12
on O 0 9.382402840762971e-12
both O 0 5.406937050866922e-12
patients O 0 7.0609354951498e-13
and O 0 3.5202164127461424e-14
the O 0 2.3349679530377046e-14
counseling O 0 7.118076683632069e-10
team O 0 1.0407185530025842e-11
can O 0 1.0114568145709601e-13
assist O 0 3.67455008478193e-13
in O 0 4.762641375163435e-15
the O 0 3.811025269911646e-15
development O 0 3.706221036314924e-15
of O 0 3.4405305706233325e-16
strategies O 0 6.65508338541787e-13
for O 0 3.700993572480944e-15
the O 0 3.6354396598138605e-14
prevention O 0 2.1639383618321517e-09
and O 0 2.2233374863400712e-11
, O 0 6.727478291920818e-15
where O 0 5.1743978974607904e-14
necessary O 0 2.9831462278716303e-13
, O 0 1.782475974817805e-14
management O 0 1.350827544439881e-13
of O 0 1.5079035375231725e-16
a O 0 7.621640406470231e-13
risk O 0 1.1651728470951639e-09
reversal O 0 1.8863955536518873e-12
in O 0 6.079181402828123e-16
any O 0 1.6261296169740695e-14
predictive O 0 2.717324421031009e-10
testing O 0 4.6556467014902125e-10
program O 0 1.4177958937086621e-12
. O 0 4.3111821316393125e-15
. O 0 3.382398527929098e-13

A O 0 3.388647973334713e-10
novel O 0 5.135061820205067e-10
common O 0 2.686845190780218e-10
missense O 0 3.327168371924927e-07
mutation O 0 3.5583070712164044e-08
G301C O 0 2.3944528582120483e-09
in O 0 1.5535835150900373e-13
the O 0 2.579640331640959e-13
N O 0 2.062385465251282e-05
- O 0 1.8371637224845472e-06
acetylgalactosamine O 0 0.00032135870424099267
- O 0 3.7346833892115683e-07
6 O 0 6.806515351343023e-09
- O 0 2.228550322058709e-08
sulfate O 0 1.7973689203643062e-09
sulfatase O 0 3.705046935920109e-08
gene O 0 8.780620119885896e-10
in O 0 8.190577664886345e-13
mucopolysaccharidosis B-Disease 0 9.097377073885582e-07
IVA I-Disease 0 0.0010008829412981868
. O 0 4.681255383331973e-10

Mucopolysaccharidosis B-Disease 1 0.617885947227478
IVA I-Disease 1 0.9994657635688782
( O 0 0.00018777181685436517
MPS B-Disease 1 0.999997615814209
IVA I-Disease 1 0.9999996423721313
) O 0 4.069475423307267e-09
is O 0 7.32181815177313e-10
an O 0 2.892390771336295e-09
autosomal B-Disease 1 0.9999994039535522
recessive I-Disease 1 0.9999997615814209
lysosomal I-Disease 1 0.9999988079071045
storage I-Disease 1 0.9999973773956299
disorder I-Disease 1 0.9999986886978149
caused O 0 1.8505447840766465e-08
by O 0 1.9102989047385666e-13
a O 0 1.4351291266478938e-09
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 2.656119768573717e-10
N O 0 0.0010755755938589573
- O 0 1.954630351974629e-05
acetylgalactosamine O 0 0.10822247713804245
- O 0 3.8754380511818454e-05
6 O 0 8.294592817037483e-07
- O 0 2.3169926862465218e-05
sulfate O 0 5.708719072572421e-06
sulfatase O 0 2.1374284187913872e-05
( O 0 4.059917332877028e-12
GALNS O 0 3.473195064884749e-08
) O 0 4.258229782238415e-13
. O 0 1.1847529251055033e-12

In O 0 1.9329478989638105e-11
previous O 0 5.467994113050878e-11
studies O 0 8.172905407999309e-11
, O 0 2.3499242916141805e-12
we O 0 1.6055511087298413e-11
have O 0 1.139443492901085e-13
found O 0 2.3014242421515174e-12
two O 0 1.558930285208704e-12
common O 0 7.92655611286941e-12
mutations O 0 8.320351629897971e-10
in O 0 8.770759861659663e-14
Caucasians O 0 8.286842323457222e-09
and O 0 8.730498962661315e-11
Japanese O 0 1.3432670087354381e-08
, O 0 1.4722168525504314e-13
respectively O 0 2.437210155914471e-11
. O 0 1.875082727975652e-11

To O 0 2.1512520497618537e-12
characterize O 0 2.4624857708488435e-10
the O 0 1.781001968082993e-13
mutational O 0 1.4076888099623375e-08
spectrum O 0 4.910648623845937e-11
in O 0 1.598715734449363e-14
various O 0 2.3881651373120058e-15
ethnic O 0 2.8193359512219615e-14
groups O 0 6.65938522858775e-14
, O 0 7.467747394854923e-15
mutations O 0 1.0129675744041666e-11
in O 0 6.849728863132136e-16
the O 0 1.2556316460209972e-14
GALNS O 0 1.7327991486126848e-07
gene O 0 1.0689942264718866e-09
in O 0 2.8058523386664813e-12
Colombian O 0 1.0636193792379345e-06
MPS B-Disease 1 0.999997615814209
IVA I-Disease 1 0.9999998807907104
patients O 0 1.6813306729090982e-06
were O 0 2.6295625833033798e-12
investigated O 0 2.0405440892545812e-08
, O 0 8.780991884137224e-13
and O 0 1.0613516359184172e-12
genetic O 0 6.983330025356338e-10
backgrounds O 0 2.960289652298442e-11
were O 0 3.160008333561587e-13
extensively O 0 9.054189689661207e-12
analyzed O 0 9.661754729606287e-11
to O 0 7.140825880906296e-14
identify O 0 8.671385831604539e-11
racial O 0 4.853326421305759e-11
origin O 0 4.245434732930153e-12
, O 0 5.231736268165865e-15
based O 0 2.5889487917444805e-15
on O 0 7.057862053041347e-14
mitochondrial O 0 5.614726565628114e-12
DNA O 0 6.629872650876223e-09
( O 0 6.587867187532459e-14
mtDNA O 0 1.0542683913372652e-11
) O 0 1.2819050833855206e-13
lineages O 0 1.4565026962287675e-10
. O 0 4.773719267103793e-11

Three O 0 1.4521837898850976e-10
novel O 0 1.3291243661228691e-09
missense O 0 3.102288246736862e-05
mutations O 0 5.668778976541944e-05
never O 0 1.3133200127413147e-07
identified O 0 8.140646379217742e-09
previously O 0 9.356575958463509e-09
in O 0 4.254065090643355e-13
other O 0 1.0579385457953894e-11
populations O 0 1.5910963657717048e-09
and O 0 5.2362489344481844e-11
found O 0 1.0797484017999182e-09
in O 0 5.721654161745804e-13
16 O 0 2.245019101176915e-11
out O 0 1.5501701311482208e-10
of O 0 9.132928788235795e-13
19 O 0 1.300214247379472e-08
Colombian O 0 1.0007563560066046e-06
MPS B-Disease 1 0.9999797344207764
IVA I-Disease 1 0.9999963045120239
unrelated O 0 3.0999483868754396e-08
alleles O 0 9.180219362470154e-10
account O 0 2.7006698960496678e-11
for O 0 7.65667130392389e-12
84 O 0 5.018005122536806e-09
. O 0 4.003583922718157e-11

2 O 0 9.231865938374995e-09
% O 0 4.522535991535737e-12
of O 0 6.79842365400047e-15
the O 0 8.934046129846843e-14
alleles O 0 1.0657831561733389e-10
in O 0 4.4127224931803793e-14
this O 0 5.229461561186014e-15
study O 0 2.4606287059997234e-12
. O 0 2.0078902082665273e-11

The O 0 5.21185733459717e-11
G301C O 0 1.555648232454132e-08
and O 0 2.1364657005334964e-12
S162F O 0 1.2929718407050927e-10
mutations O 0 1.1217754503078936e-10
account O 0 1.0915829871949168e-12
for O 0 1.6941953482479954e-12
68 O 0 1.6662156099300773e-08
. O 0 3.834613529485331e-11

4 O 0 7.700976567548423e-08
% O 0 1.4721909802339894e-10
and O 0 2.325101049194256e-11
10 O 0 4.446448070849485e-11
. O 0 1.1459089753473872e-11

5 O 0 7.082490149912246e-09
% O 0 6.968421499553568e-12
of O 0 8.8680724276511e-14
mutations O 0 8.831352715787943e-08
, O 0 2.1487431625666353e-11
respectively O 0 9.309823467695821e-10
, O 0 2.0460301747120269e-13
whereas O 0 1.1817152074586335e-12
the O 0 8.126001499290936e-13
remaining O 0 3.6672407333071533e-09
F69V O 0 0.0005243418854661286
is O 0 4.853881879762767e-11
limited O 0 8.823063807339437e-13
to O 0 5.897750143075628e-14
a O 0 8.722118621969088e-13
single O 0 1.0975226061304966e-08
allele O 0 8.210537139063945e-09
. O 0 7.943207896987659e-11

The O 0 4.302128531891158e-12
skewed O 0 6.091668947050266e-09
prevalence O 0 1.9816125131910667e-06
of O 0 1.9406852969257316e-13
G301C O 0 3.028441386554448e-10
in O 0 3.3001809699719983e-15
only O 0 2.224186546745388e-14
Colombian O 0 1.9815257767952232e-10
patients O 0 5.385723551160071e-12
and O 0 2.791697774372822e-14
haplotype O 0 9.223104918687497e-12
analysis O 0 1.7172740551622823e-13
by O 0 4.7679679418522435e-15
restriction O 0 4.4113215684482565e-12
fragment O 0 2.549984390309845e-10
length O 0 1.4261081204836046e-09
polymorphisms O 0 1.1197184335287602e-07
in O 0 2.6823351482671565e-13
the O 0 1.3471174046056356e-13
GALNS O 0 2.0240331650711596e-06
gene O 0 2.270930554715278e-09
suggest O 0 2.7025917961887025e-11
that O 0 1.884298245864377e-13
G301C O 0 2.0872704606378356e-11
originated O 0 8.108057953336301e-13
from O 0 1.4481452942729546e-14
a O 0 4.2528727393041643e-13
common O 0 8.319898589514985e-12
ancestor O 0 3.1394672972417936e-10
. O 0 1.631937085466717e-10

Investigation O 0 1.927556336767111e-09
of O 0 9.605445779048427e-13
the O 0 1.056243783300985e-13
genetic O 0 6.466659985271406e-10
background O 0 1.5118413465575742e-11
by O 0 3.7264103207226146e-14
means O 0 3.7883232792065846e-13
of O 0 1.4425676246669324e-15
mtDNA O 0 3.7783904477395325e-11
lineages O 0 5.803842476059806e-11
indicate O 0 6.221773651837736e-10
that O 0 2.8864783827020624e-12
all O 0 1.1900673502207582e-10
our O 0 1.8389363365400868e-09
patients O 0 1.4468905674275279e-12
are O 0 1.741669040265174e-15
probably O 0 2.0900487829149383e-13
of O 0 8.999682712929578e-15
native O 0 3.953940230783104e-10
American O 0 3.631008951288095e-07
descent O 0 2.6321218683733605e-05

Low O 0 7.344609542769831e-08
frequency O 0 4.478573067956404e-10
of O 0 3.07715615141535e-12
BRCA1 O 0 0.0001675470994086936
germline O 0 9.845591648627305e-07
mutations O 0 7.547391305706697e-06
in O 0 2.5139761800074822e-11
45 O 0 3.2477896638738457e-07
German O 1 0.9999871253967285
breast B-Disease 1 0.9999994039535522
/ I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 7.736331326668733e-07
. O 0 3.135230686179824e-10

In O 0 4.204409823765909e-12
this O 0 1.373732539296246e-15
study O 0 6.9283868837130124e-15
we O 0 3.451643810180316e-13
investigated O 0 6.1448472976621815e-09
45 O 0 2.677465538170054e-08
German O 1 0.9999502897262573
breast B-Disease 1 0.9999990463256836
/ I-Disease 1 0.9999997615814209
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.4247861224170322e-10
for O 0 1.1785273549159286e-13
germline O 0 4.595858982270329e-08
mutations O 0 9.118991073364668e-08
in O 0 6.44351312215595e-14
the O 0 5.884785931123404e-13
BRCA1 O 0 7.136468775570393e-05
gene O 0 4.3578549480116635e-07
. O 0 3.655311608952161e-10

We O 0 4.452730406612204e-10
identified O 0 1.072981148375618e-10
four O 0 1.4067410430973482e-12
germline O 0 2.924065256593167e-08
mutations O 0 4.860633453063201e-06
in O 0 1.5535139147315746e-11
three O 0 2.3047894259775603e-08
breast B-Disease 1 0.9398202300071716
cancer I-Disease 0 0.001274824608117342
families O 0 3.2547806116944855e-10
and O 0 2.514663199892908e-10
in O 0 2.8076900179807573e-11
one O 0 0.040251798927783966
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 3.547200577713738e-08
. O 0 3.740303016310301e-14
among O 0 3.872622437572221e-14
these O 0 3.561263629370086e-14
were O 0 3.6864601649089224e-11
one O 0 3.919503610561037e-11
frameshift O 0 1.7838898429545225e-06
mutation O 0 1.1334516329952748e-06
, O 0 2.864131674884529e-11
one O 0 4.997876557055747e-10
nonsense O 0 0.0016258382238447666
mutation O 0 4.3671047933457885e-06
, O 0 5.614469392872801e-12
one O 0 1.8334689506644547e-13
novel O 0 9.638672499034939e-11
splice O 0 0.00014858521171845496
site O 0 2.358693336645956e-06
mutation O 0 8.480837277602404e-05
, O 0 7.372501914515439e-11
and O 0 3.6096089225251538e-12
one O 0 4.072388693626694e-12
missense O 0 2.4380900867981836e-05
mutation O 0 5.487777343660127e-06
. O 0 6.460865176194375e-10

The O 0 1.439943164704971e-10
missense O 0 2.088332075800281e-05
mutation O 0 9.780815162230283e-05
was O 0 5.718673037335975e-07
also O 0 8.442511967299282e-11
found O 0 1.7134215921088547e-11
in O 0 1.501637491652455e-13
2 O 0 2.9276450708159985e-10
. O 0 5.250309909055062e-11

8 O 0 1.1687212086997079e-08
% O 0 2.3317348486068257e-12
of O 0 6.751542074435839e-15
the O 0 3.033442908754319e-13
general O 0 3.80598981150615e-12
population O 0 1.6699681459723947e-14
, O 0 2.4125213579520664e-15
suggesting O 0 6.7946750656466826e-12
that O 0 2.1630838938600794e-13
it O 0 1.1668574093071094e-11
is O 0 3.013138349938771e-10
not O 0 9.001215883763791e-10
disease O 0 1.0534743921652989e-07
associated O 0 5.944171804078691e-12
. O 0 1.8799420353765584e-11

The O 0 1.2415873884563666e-11
average O 0 5.784621848192728e-08
age O 0 2.853253100454367e-08
of O 0 2.2046094116934256e-11
disease O 0 0.00014947621093597263
onset O 0 4.889346882919199e-08
in O 0 3.675097064777949e-13
those O 0 5.923923244305351e-12
families O 0 9.46648792340965e-13
harbouring O 0 1.6278014527415507e-06
causative O 0 1.0377219041401986e-05
mutations O 0 1.0679762141307947e-07
was O 0 1.7180507017044988e-09
between O 0 1.446179460906638e-11
32 O 0 1.2265744864237149e-08
. O 0 7.15463382983117e-11

3 O 0 1.5260278374285008e-08
and O 0 5.230689145707679e-11
37 O 0 1.6326228147178767e-09
. O 0 3.207210538813676e-11

4 O 0 6.0183800165702905e-09
years O 0 2.4897173211968493e-10
, O 0 5.675663525316413e-14
whereas O 0 1.3823524844334273e-13
the O 0 1.8962057333929243e-14
family O 0 4.839347238910774e-12
harbouring O 0 2.51307960752456e-06
the O 0 4.205265692960869e-13
missense O 0 5.712552137993043e-07
mutation O 0 5.071192390460055e-07
had O 0 1.3647111218872965e-09
an O 0 3.847017309203081e-14
average O 0 5.663568813929487e-08
age O 0 1.2315513053806626e-08
of O 0 1.9171038454640632e-12
onset O 0 3.123618341760448e-08
of O 0 2.0005724507554667e-12
51 O 0 9.33460029273192e-08
. O 0 8.791507799532639e-11

2 O 0 1.3634838147424944e-08
years O 0 1.8939982915355813e-09
. O 0 1.182528103216285e-10

These O 0 2.8441678266016845e-12
findings O 0 4.5613655214049587e-11
show O 0 5.229118027472168e-09
that O 0 2.150923753344025e-12
BRCA1 O 0 3.210214345017448e-05
is O 0 9.82956563366777e-11
implicated O 0 1.0176579223752924e-07
in O 0 4.467333926015064e-15
a O 0 1.825267486390029e-15
small O 0 2.4182629707850296e-14
fraction O 0 2.2184966363969494e-10
of O 0 5.620207161882718e-07
breast B-Disease 1 0.9999998807907104
/ I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 3.9796191342311715e-10
suggesting O 0 2.468156790058629e-10
the O 0 3.5168475933083226e-14
involvement O 0 8.051539296394239e-11
of O 0 4.65061152701016e-15
another O 0 5.794523389758555e-13
susceptibility O 0 1.53807133695949e-10
gene O 0 1.124900528282069e-08
( O 0 7.130628726370603e-11
s O 0 1.8137436654797057e-06
) O 0 3.928397052099797e-10

Paternal O 0 0.0005221765022724867
transmission O 1 0.8340309262275696
of O 0 4.227374574838905e-06
congenital B-Disease 1 0.9999982118606567
myotonic I-Disease 1 0.9999997615814209
dystrophy I-Disease 1 0.9999996423721313
. O 0 1.749313440768674e-07

We O 0 8.452703426087282e-09
report O 0 5.306070253313644e-12
a O 0 6.469851950464001e-15
rare O 0 9.099869431117638e-14
case O 0 2.4956779698381837e-11
of O 0 6.629979204531011e-11
paternally O 1 0.9848854541778564
transmitted O 1 0.999988317489624
congenital B-Disease 1 0.9999994039535522
myotonic I-Disease 1 0.9999998807907104
dystrophy I-Disease 1 0.9999997615814209
( O 0 2.0126074105064617e-06
DM B-Disease 1 0.9999994039535522
) O 0 1.4105370205186318e-09
. O 0 4.2005884881568534e-11

The O 0 3.396670097965959e-11
proband O 0 5.970863981019647e-07
is O 0 2.517434394624929e-12
a O 0 6.91529353311765e-14
23 O 0 2.9799233827038085e-12
year O 0 2.5618574102381775e-12
old O 0 6.794273758714553e-06
, O 0 1.7335676227858698e-09
mentally B-Disease 1 0.9999998807907104
retarded I-Disease 1 0.9999998807907104
male O 0 9.531187970424071e-05
who O 0 3.5861207834386732e-06
suffers O 0 0.01634754054248333
severe O 0 0.0008357533370144665
muscular B-Disease 0 0.006594768259674311
weakness I-Disease 0 0.005935512948781252
. O 0 4.3103379199216363e-10

He O 0 1.5187170276931283e-07
presented O 0 2.4541033649683186e-09
with O 0 2.6773122385748138e-08
respiratory O 0 0.005602960009127855
and O 0 1.0712278175617485e-08
feeding O 0 0.00023078337835613638
difficulties O 0 1.1398830110920244e-06
at O 0 5.518245305147218e-10
birth O 0 2.0840470682514933e-08
. O 0 1.6600187890958296e-10

His O 0 1.4998494890505754e-08
two O 0 5.461183061328256e-09
sibs O 1 0.959977388381958
suffer O 0 3.8669029891025275e-05
from O 0 1.208955852094462e-10
childhood O 0 2.3090955437510274e-05
onset O 0 0.15019895136356354
DM B-Disease 1 0.999998927116394
. O 0 1.210847067056875e-08

Their O 0 3.013424232367612e-11
late O 0 1.2167371277183037e-11
father O 0 4.721409929686615e-10
had O 0 1.0804971500855132e-11
the O 0 1.0056961943186605e-15
adult O 0 2.9606005147453374e-11
type O 0 3.14455270711278e-08
of O 0 1.2018493145138365e-10
DM B-Disease 1 1.0
, O 0 1.0438522268785277e-10
with O 0 8.325577098393377e-13
onset O 0 1.3255572195447485e-09
around O 0 4.806601297535629e-11
30 O 0 3.400674490269817e-12
years O 0 2.966726473860315e-12
. O 0 1.6438378436234302e-12

Only O 0 7.66590697170999e-12
six O 0 3.5021231791290686e-13
other O 0 1.5809033515466102e-15
cases O 0 5.051172696259043e-13
of O 0 4.213294481098667e-13
paternal O 0 3.3723004889907315e-05
transmission O 1 0.9863412976264954
of O 0 5.26399560385471e-07
congenital B-Disease 1 0.9999996423721313
DM I-Disease 1 1.0
have O 0 2.1936006078249193e-07
been O 0 1.4187820362998593e-10
reported O 0 2.8221880388201726e-10
recently O 0 1.0573208086839259e-08
. O 0 2.3303621185521983e-11

We O 0 5.484227516561191e-10
review O 0 5.709871811476752e-12
the O 0 7.79181542421084e-15
sex O 0 2.407313758057139e-11
related O 0 3.4299752708216724e-12
effects O 0 3.2110238079585685e-11
on O 0 1.2867297505270159e-11
transmission O 0 6.370412393152947e-07
of O 0 2.520333941546937e-10
congenital B-Disease 1 0.9998822212219238
DM I-Disease 1 0.9999997615814209
. O 0 4.799762809426511e-09

Decreased O 0 7.2489110607421026e-06
fertility O 0 2.168894468468352e-07
of O 0 9.09239643211851e-13
males O 0 1.039311192663206e-09
with O 0 4.2031048780311053e-11
adult O 0 8.997866643767338e-06
onset O 0 0.06603088974952698
DM B-Disease 1 1.0
and O 0 6.50932179269148e-08
contraction O 0 9.822757363053825e-08
of O 0 2.122296106487221e-15
the O 0 1.0699992934325338e-14
repeat O 0 3.909336743213032e-10
upon O 0 5.591063636373184e-13
male O 0 1.916494220266518e-11
transmission O 0 2.53183973786264e-10
contribute O 0 1.5127742808429545e-13
to O 0 2.3410594751811786e-14
the O 0 2.2625297631511526e-13
almost O 0 1.5885960949479916e-11
absent O 0 4.5371592594101173e-10
occurrence O 0 1.4121191715954495e-10
of O 0 6.795733680647897e-13
paternal O 0 2.211799483120558e-06
transmission O 0 0.0005006106221117079
of O 0 3.0359224467702006e-08
congenital B-Disease 1 0.9999822378158569
DM I-Disease 1 0.9999994039535522
. O 0 7.441582283718162e-08

Also O 0 1.5672245723408196e-08
the O 0 9.871110547877981e-14
fathers O 0 3.305782036999716e-11
of O 0 1.8406921681177668e-15
the O 0 6.341486309593275e-14
reported O 0 2.301383750236141e-09
congenitally O 0 1.7532527181174373e-06
affected O 0 4.90713292222722e-09
children O 0 8.99561605760546e-11
showed O 0 1.734212662363177e-09
, O 0 1.691809610495352e-15
on O 0 5.231641942576859e-13
average O 0 3.733902909086595e-10
, O 0 7.684193959031551e-15
shorter O 0 1.5498618013976007e-11
CTG O 0 4.7862052099389985e-09
repeat O 0 9.771324860352593e-10
lengths O 0 6.5918053238078755e-09
and O 0 1.6002077440901985e-10
hence O 0 2.0413079213077445e-11
less O 0 2.2734331778240247e-11
severe O 0 6.578569013981905e-07
clinical O 0 6.573513928742614e-07
symptoms O 0 7.471734164710142e-08
than O 0 8.538852743909982e-15
the O 0 4.2907271160554095e-13
mothers O 0 3.2952220951898425e-09
of O 0 5.9218275628211e-14
children O 0 1.1146396028394179e-09
with O 0 1.3067380955078534e-08
congenital B-Disease 1 0.9999393224716187
DM I-Disease 1 0.9999997615814209
. O 0 1.5282823895290676e-08

We O 0 8.815137508833004e-10
conclude O 0 3.1009847467622365e-11
that O 0 1.6609188525397445e-13
paternal O 0 2.4924183605889993e-08
transmission O 0 0.0010135638294741511
of O 0 1.4425231675829764e-08
congenital B-Disease 1 0.9999991655349731
DM I-Disease 1 1.0
is O 0 1.0283446272296715e-07
rare O 0 5.620818255280824e-10
and O 0 3.408538425467289e-12
preferentially O 0 5.560910065760538e-10
occurs O 0 4.120709329313854e-11
with O 0 1.1531255822167658e-13
onset O 0 2.9817925906172604e-09
of O 0 9.954391477773328e-11
DM B-Disease 1 1.0
past O 0 2.603495090625074e-07
30 O 0 1.3150176780829526e-10
years O 0 3.265497681287366e-12
in O 0 3.5544077446950095e-15
the O 0 1.9406326114764123e-14
father O 0 2.4252150288006646e-10
. O 0 5.701117204194583e-14
. O 0 6.667153266103065e-13

The O 0 7.200522816885879e-11
RB1 O 0 1.3716994544665795e-05
gene O 0 1.5144445342230028e-07
mutation O 0 5.246804235525815e-08
in O 0 7.25026592582334e-13
a O 0 6.979305328114194e-11
child O 0 0.00439390679821372
with O 0 2.012613094848348e-06
ectopic B-Disease 1 0.9999873638153076
intracranial I-Disease 1 0.999994158744812
retinoblastoma I-Disease 1 0.9997896552085876
. O 0 9.489303920418024e-07

The O 0 6.074189762284021e-11
RB1 O 0 1.1844765140267555e-05
gene O 0 2.4966942646642565e-07
mutation O 0 9.414831936283008e-08
was O 0 2.1877838429773533e-10
investigated O 0 6.342663727565423e-09
in O 0 5.491934489641748e-13
a O 0 1.36943775763676e-10
child O 0 0.2552499771118164
with O 0 6.228909796845983e-07
ectopic B-Disease 1 0.9999858140945435
intracranial I-Disease 1 0.9986771941184998
retinoblastoma I-Disease 0 2.0515744836302474e-06
using O 0 9.977005333006161e-12
DNA O 0 1.475779853876702e-08
obtained O 0 4.4377973518194835e-11
from O 0 4.579336584410731e-13
both O 0 2.1222266565618098e-12
the O 0 6.350603636712249e-13
pineal B-Disease 0 3.943291631003376e-07
and I-Disease 0 1.7610966907000147e-08
retinal I-Disease 0 1.8323063386560534e-06
tumours I-Disease 1 1.0
of O 0 2.0307538983743711e-10
the O 0 5.095178168268433e-10
patient O 0 7.505541930186155e-07
. O 0 3.764952585805226e-11

A O 0 6.249846418171501e-09
nonsense O 0 7.265351769092376e-07
mutation O 0 3.399916082003074e-08
in O 0 7.6948793474238e-13
exon O 0 1.7242915362203348e-07
17 O 0 5.9077853720168605e-09
( O 0 1.4802583800637564e-13
codon O 0 8.253582539641258e-11
556 O 0 1.9883773447193498e-11
) O 0 1.674037461657594e-14
of O 0 8.197614509680273e-16
the O 0 7.601239109715843e-14
RB1 O 0 1.1735124871847802e-06
gene O 0 2.4182980951081845e-08
was O 0 7.032358029235297e-10
found O 0 6.357151350472323e-12
to O 0 1.0163456854546046e-13
be O 0 1.849910502560448e-11
present O 0 3.425750080745388e-13
homozygously O 0 8.17371201833339e-08
in O 0 2.534709333428583e-14
both O 0 3.5275580199944923e-13
the O 0 1.1260998101884911e-13
retinal B-Disease 0 2.721287084561652e-10
and I-Disease 0 8.693780140234253e-10
the I-Disease 0 1.608635447070128e-10
pineal I-Disease 0 0.0005473230266943574
tumours I-Disease 1 0.9999996423721313
. O 0 9.550585211570706e-09

The O 0 3.6742861357630385e-12
same O 0 2.5439190684539703e-12
mutation O 0 5.261151958535493e-09
was O 0 8.102010728983089e-10
present O 0 1.0831150429671532e-12
heterozygously O 0 7.12695396032359e-08
in O 0 1.3574018499523015e-15
the O 0 4.017938504736706e-17
DNA O 0 1.5463429148265817e-10
from O 0 2.9291488939237054e-13
the O 0 1.0407709985721728e-13
constitutional O 0 5.031568911517681e-12
cells O 0 1.3121576308144922e-12
of O 0 1.1001726398928054e-14
the O 0 1.9855718631778263e-12
patient O 0 2.949100741389543e-09
, O 0 9.251809692976346e-15
proving O 0 8.77694358164538e-12
it O 0 3.3118120875905155e-13
to O 0 7.849876483426513e-14
be O 0 7.718372815879171e-12
of O 0 4.979151382107812e-14
germline O 0 5.135299296910034e-09
origin O 0 8.774370813258159e-11
. O 0 1.1208130951123607e-10

The O 0 1.7327584679593944e-12
initial O 0 4.828495676206801e-12
mutation O 0 5.527402091587419e-09
was O 0 2.3245090297052684e-09
shown O 0 4.943417897251834e-11
to O 0 2.1306089217128926e-13
have O 0 3.084713474238443e-12
occurred O 0 7.162491086343259e-13
in O 0 3.990265064847181e-15
the O 0 3.3679846021469895e-13
paternally O 0 2.2817040701283986e-07
derived O 0 9.859232874553925e-11
RB1 O 0 1.3914996998209972e-05
allele O 0 8.218641056600973e-08
. O 0 2.978483015780853e-10

The O 0 2.148989146355529e-11
mutation O 0 5.4048957309760226e-08
is O 0 1.4083156862909618e-10
in O 0 2.4794805829819397e-14
an O 0 5.549180499874254e-14
area O 0 1.2208850597161813e-10
of O 0 8.734933078496238e-14
the O 0 1.9002907700096244e-13
gene O 0 7.278705416169373e-11
that O 0 8.690541945203124e-15
encodes O 0 3.3392578524353567e-13
the O 0 6.887834080220381e-14
protein O 0 6.253802475875148e-10
- O 0 6.633998594907098e-08
binding O 0 9.08757780138103e-09
region O 0 5.695524780968686e-12
known O 0 3.972852255507142e-11
as O 0 1.6068039260241918e-11
the O 0 4.049691625877122e-13
pocket O 0 2.494780892448034e-05
region O 0 6.29987395583953e-09
and O 0 6.602849933479149e-10
has O 0 2.4423803257622723e-11
been O 0 1.746815149125669e-12
detected O 0 3.782488211534485e-10
in O 0 1.056500595220263e-15
other O 0 5.461936953340008e-15
cases O 0 3.992583715896336e-13
of O 0 1.532714927199308e-14
retinoblastoma B-Disease 0 5.3426706614345676e-08
. O 0 8.273716997977965e-13
. O 0 2.2244954142602857e-11

Low O 0 3.709737575263716e-05
levels O 0 6.7840666417851025e-09
of O 0 5.1673170408349234e-14
beta O 0 7.046637145319279e-12
hexosaminidase O 0 8.874901169519944e-08
A O 0 1.685641730364562e-11
in O 0 1.6662623429468393e-13
healthy O 0 1.8125302370108898e-09
individuals O 0 1.3187167503814212e-11
with O 0 4.288949750907989e-10
apparent O 0 3.9235939652826346e-07
deficiency O 0 0.0009836273966357112
of O 0 1.4105656611284809e-14
this O 0 6.789774363406831e-13
enzyme O 0 4.0039344639808405e-07
. O 0 5.66923487321791e-11

Appreciable O 0 3.1984818633645773e-06
beta O 0 3.808894888379655e-08
hexosaminidase O 0 3.195592580595985e-05
A O 0 2.1313650844234644e-09
( O 0 6.013319182873733e-13
hex O 0 1.8277543034628252e-08
A O 0 9.980660395370045e-12
) O 0 1.389815047986645e-14
activity O 0 1.3027958703157316e-12
has O 0 9.117764865600869e-14
been O 0 3.996345490859046e-14
detected O 0 6.773680505389734e-10
in O 0 1.8671745261587304e-14
cultured O 0 4.4889080896837186e-08
skin O 0 1.0328207281418145e-05
fibroblasts O 0 3.940430985949206e-07
and O 0 1.6706994898640914e-08
melanoma B-Disease 1 0.5778495073318481
tissue O 0 4.1289618820883334e-05
from O 0 5.622574281161086e-11
healthy O 0 1.360958368223919e-08
individuals O 0 9.769818417812437e-13
previously O 0 4.732664482531845e-09
reported O 0 2.4691252065167646e-07
as O 0 1.480505744666516e-07
having O 0 0.002085066167637706
deficiency B-Disease 0 0.0022787947673350573
of I-Disease 0 9.432989193361094e-15
hex I-Disease 0 5.468340305014863e-07
A I-Disease 0 1.926679649155716e-11
activity O 0 1.0750783076274306e-11
indistinguishable O 0 1.1173284519827575e-12
from O 0 2.561824255674556e-15
that O 0 5.41149910594633e-15
of O 0 5.045248073487496e-14
patients O 0 2.433476753438413e-10
with O 0 1.286050235194125e-07
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 0.6960774660110474
( O 0 6.328648109038548e-12
TSD B-Disease 0 5.189239686842484e-07
) O 0 2.456235085115943e-12
. O 0 1.836259226270509e-12

Identification O 0 2.892589279213098e-09
and O 0 3.640683934880151e-11
quantitation O 0 1.1947952316404553e-07
of O 0 2.5814283436537133e-12
hex O 0 4.308051302359672e-06
A O 0 4.6656362800989726e-11
, O 0 6.7169136734861884e-15
amounting O 0 1.6530124708272198e-12
to O 0 1.7331939377619732e-13
3 O 0 2.3674529350814488e-11
. O 0 1.6645740341658666e-11

5 O 0 1.0781214854205246e-07
% O 0 1.2747685129710362e-09
- O 0 2.3649213289900217e-06
6 O 0 8.785163707614174e-09
. O 0 2.2260106952165515e-11

9 O 0 8.331344503176297e-09
% O 0 1.620486947753741e-12
of O 0 1.891383405417616e-14
total O 0 3.4002401588795195e-12
beta O 0 2.6045558071396968e-11
hexosaminidase O 0 1.1685472145472886e-06
activity O 0 3.186453412240553e-08
, O 0 2.2713677726854398e-13
has O 0 5.300291997835382e-13
been O 0 3.567899285478876e-14
obtained O 0 2.1166255597185324e-14
by O 0 6.24401585666047e-14
cellulose O 0 7.219349754450377e-06
acetate O 0 1.31567094285856e-06
gel O 0 4.608250037563266e-06
electrophoresis O 0 1.3733706616392283e-08
, O 0 1.1123167274404433e-12
DEAE O 0 7.884637653887694e-08
- O 0 1.11912125400071e-10
cellulose O 0 8.752971325520775e-08
ion O 0 4.5280296179228685e-10
- O 0 1.2507927138472041e-08
exchange O 0 7.209455255008379e-11
chromatography O 0 4.736545045069818e-10
, O 0 4.068293147025184e-14
radial O 0 9.877288986714916e-10
immunodiffusion O 0 1.7564296683758585e-07
, O 0 3.4694255389607076e-13
and O 0 2.0113236163382675e-12
radioimmunoassay O 0 1.149932586486102e-06
. O 0 1.8667891885093546e-11

Previous O 0 8.573949550338966e-09
family O 0 2.957300238026761e-10
studies O 0 4.8123783603915005e-12
suggested O 0 4.153876201340445e-11
that O 0 6.431344308022516e-14
these O 0 5.3210030375979225e-14
individuals O 0 1.6476304695589583e-11
may O 0 7.028010118315109e-11
be O 0 5.692945707945832e-14
compound O 0 3.036225852443182e-14
heterozygotes O 0 1.9418832861162194e-11
for O 0 6.8324824252930915e-15
the O 0 2.8771971106620817e-14
common O 0 7.404900997931563e-11
mutant O 0 9.815453694272946e-08
TSD B-Disease 0 1.3887694194636424e-06
gene O 0 1.5664151931105152e-07
and O 0 2.0684452414765353e-11
a O 0 5.191542725227483e-13
rare O 0 1.9085100166904567e-10
( O 0 3.007680476202479e-12
allelic O 0 1.056382870068262e-09
) O 0 5.06226408448357e-13
mutant O 0 5.587301288301205e-09
gene O 0 4.48714487788493e-08
. O 0 1.3749576477373182e-10

Thus O 0 4.932626529452477e-10
, O 0 1.040562696229784e-13
the O 0 4.5434694824790164e-15
postulated O 0 4.2672773648000373e-10
rate O 0 3.478604782003458e-08
mutant O 0 3.229947864724636e-08
gene O 0 4.4715783076298976e-08
appears O 0 3.4369337931217103e-10
to O 0 8.988600133847703e-15
code O 0 5.981949283790852e-14
for O 0 1.558797782150699e-14
the O 0 1.2322947024780151e-14
expression O 0 4.755647915397065e-13
of O 0 5.933514499910841e-15
low O 0 8.376524474051905e-11
amounts O 0 3.3836437341241976e-13
of O 0 5.567874720308064e-13
hex O 0 7.634995199623518e-06
A O 0 3.998442688057935e-10
. O 0 2.2510562858180094e-11

Heterozygotes O 0 1.5325609581395838e-07
for O 0 3.2761406434933527e-12
the O 0 9.799768012049362e-14
rare O 0 1.3532142420502602e-11
mutant O 0 6.0850456975458656e-06
may O 0 6.5001013460630475e-09
be O 0 1.462599979280485e-13
indistinguishable O 0 1.2722428362546556e-12
from O 0 7.705505307984469e-15
heterozygotes O 0 5.0542518087448585e-11
for O 0 3.063671752813295e-14
the O 0 1.1611881161471826e-13
common O 0 1.1778325537115109e-10
TSD B-Disease 0 1.9251490357419243e-06
mutant O 0 5.342375288819312e-07
. O 0 2.2168768210040213e-10

However O 0 9.964991332100936e-11
, O 0 4.437714369695707e-14
direct O 0 1.3626587651218575e-13
visualization O 0 7.4792172455318e-09
and O 0 6.602006163980434e-10
quantitation O 0 1.6206251984840492e-06
of O 0 1.831903986143635e-12
hex O 0 9.190045489049226e-07
A O 0 2.2671530451601196e-12
by O 0 2.9665014460053497e-15
the O 0 1.7224224400003065e-15
methods O 0 1.6108298722672387e-11
described O 0 3.766132128379951e-10
may O 0 2.0373014039676285e-11
prevent O 0 7.291095678596538e-12
false O 0 1.7747966429837447e-09
- O 0 7.485826927222661e-07
positive O 0 1.761357837359867e-09
prenatal O 0 1.2515461378370674e-07
diagnosis O 0 5.4380033809309225e-09
of O 0 4.365349295693162e-14
TSD B-Disease 0 1.3776256082564942e-06
in O 0 2.812501750590335e-12
fetuses O 0 1.2236042721269769e-06
having O 0 2.2060279991631404e-10
the O 0 1.1464193852041282e-13
incomplete O 0 3.0999132150100195e-08
hex B-Disease 0 0.02061566337943077
A I-Disease 0 5.21458957791765e-07
deficiency I-Disease 0 0.010088381357491016
of O 0 3.228268889189645e-14
the O 0 1.9876255589329483e-12
type O 0 1.995924139919225e-05
described O 0 4.261862418530882e-09
in O 0 4.407952681247801e-14
the O 0 8.323925858484682e-13
four O 0 4.1441068354686195e-09
healthy O 0 1.7397171347965923e-07
individuals O 0 7.374994503983601e-10

The O 0 4.891242272320184e-11
tumor B-Disease 0 5.743416409131896e-08
suppressor O 0 8.259846140390437e-08
gene O 0 1.4120570085651707e-05
Smad4 O 0 0.0003537728334777057
/ O 0 5.958854671916924e-06
Dpc4 O 0 2.2209710550669115e-06
is O 0 1.4297964938750352e-12
required O 0 3.608937354146989e-14
for O 0 7.651229977823255e-15
gastrulation O 0 1.8802273071827358e-09
and O 0 2.0593526883772029e-10
later O 0 8.88588161385151e-11
for O 0 8.885384615575642e-12
anterior O 0 6.48820048354537e-07
development O 0 3.238594559629854e-13
of O 0 4.3018507931758855e-15
the O 0 1.962131357998581e-13
mouse O 0 3.652033626622142e-07
embryo O 0 4.5327956854634976e-07
. O 0 5.872035635512418e-10

Mutations O 0 8.669107046443969e-06
in O 0 5.87875321339526e-12
the O 0 1.639104000097924e-12
SMAD4 O 0 0.00035925148404203355
/ O 0 2.3950472041178728e-06
DPC4 O 0 5.626628080790397e-06
tumor B-Disease 0 8.105693005688863e-09
suppressor O 0 3.4259906023237363e-10
gene O 0 4.471703896058443e-09
, O 0 3.509510255106027e-14
a O 0 2.5208672904111426e-14
key O 0 7.688699676933197e-10
signal O 0 7.390874717794205e-11
transducer O 0 1.04568051995102e-08
in O 0 1.0184432778451852e-13
most O 0 6.893462580273568e-13
TGFbeta O 0 1.883446088868368e-06
- O 0 2.2926750276042185e-08
related O 0 1.8706050042283096e-09
pathways O 0 4.27304023276065e-08
, O 0 3.009588360317929e-14
are O 0 4.082957680210232e-16
involved O 0 1.1157519136037464e-13
in O 0 6.926827496057117e-15
50 O 0 1.9516591034246522e-12
% O 0 4.972699769317801e-13
of O 0 5.4569290058870124e-11
pancreatic B-Disease 1 0.9817065596580505
cancers I-Disease 1 0.9805659055709839
. O 0 8.906437365396869e-09

Homozygous O 0 0.24747751653194427
Smad4 O 0 0.009792652912437916
mutant O 0 0.005348068196326494
mice O 0 0.09917616099119186
die O 0 4.083300518686883e-05
before O 0 1.3029941570152914e-09
day O 0 2.4980700841226167e-10
7 O 0 3.566938411303511e-11
. O 0 1.4858146180421472e-12

5 O 0 1.0610313738723676e-09
of O 0 5.206062577561843e-12
embryogenesis O 0 9.981307158568598e-08
. O 0 1.0021758978240314e-09

Mutant O 0 1.2994330518267816e-06
embryos O 0 1.3115931096763234e-06
have O 0 3.7793440599287464e-10
reduced O 0 5.579308542946748e-11
size O 0 7.541715696390838e-09
, O 0 1.7355750170366946e-10
fail O 0 3.8573009675246794e-08
to O 0 1.588165146268472e-12
gastrulate O 0 3.585647573345341e-05
or O 0 1.75066586227679e-10
express O 0 7.7758971137043e-12
a O 0 6.211655555833683e-15
mesodermal O 0 9.599227662748788e-11
marker O 0 2.185132075283036e-07
, O 0 1.5917497354911436e-12
and O 0 2.8876788113474383e-12
show O 0 2.7111667577628396e-08
abnormal O 0 4.879006354485682e-08
visceral O 0 2.7634043942015296e-09
endoderm O 0 3.242342643261509e-07
development O 0 1.0685859835879441e-10
. O 0 5.0897751291412163e-11

Growth B-Disease 1 0.9999995231628418
retardation I-Disease 1 0.9999998807907104
of O 0 1.221989315292049e-10
the O 0 6.445059069770664e-11
Smad4 O 0 0.002188486745581031
- O 0 3.122423731838353e-05
deficient O 0 3.2582458970864536e-06
embryos O 0 3.346385113456307e-10
results O 0 1.1857566794767904e-12
from O 0 6.033122271079452e-14
reduced O 0 6.85469649791548e-12
cell O 0 6.635666682797137e-09
proliferation O 0 2.4193582248699386e-06
rather O 0 5.2190412771655967e-14
than O 0 1.4398934993008032e-14
increased O 0 2.6796061029787932e-12
apoptosis O 0 2.1682755591001523e-10
. O 0 6.154213250120222e-11

Aggregation O 0 2.4089986894182402e-08
of O 0 2.882166727502522e-11
mutant O 0 7.398723937512841e-06
Smad4 O 0 6.320321699604392e-05
ES O 0 1.8504714205391792e-07
cells O 0 1.4570258333179709e-09
with O 0 9.504118412412277e-13
wild O 0 9.894645103258881e-08
- O 0 3.1948613468557596e-05
type O 0 4.915158115181839e-06
tetraploid O 0 9.588935654392117e-07
morulae O 0 1.6093067642941605e-06
rescues O 0 1.4181726726292254e-07
the O 0 6.304672929557942e-12
gastrulation B-Disease 0 7.726605417701649e-07
defect I-Disease 0 4.124164843233302e-05
. O 0 5.271291736441697e-11

These O 0 7.674743653096616e-12
results O 0 4.957911858838315e-11
indicate O 0 1.799309451433473e-10
that O 0 2.1376069317402546e-12
Smad4 O 0 8.917905915950541e-07
is O 0 3.4349790373200406e-11
initially O 0 2.2650277486935266e-11
required O 0 4.3593665325801154e-14
for O 0 2.287268266700968e-15
the O 0 1.3950357355570469e-15
differentiation O 0 9.91202259159607e-12
of O 0 4.0279194910008975e-14
the O 0 2.753780818827434e-13
visceral O 0 2.0350811313907258e-10
endoderm O 0 4.176531831490138e-08
and O 0 5.833004652205931e-12
that O 0 4.387149128546762e-15
the O 0 1.1820702226837503e-14
gastrulation B-Disease 0 1.1224829066236452e-08
defect I-Disease 0 3.886950139531109e-07
in O 0 1.4152710138537732e-14
the O 0 8.952537197898583e-14
epiblast O 0 4.020679114091763e-07
is O 0 1.4607295373281204e-09
secondary O 0 6.309448252750371e-08
and O 0 1.456640408292742e-08
non O 0 5.589303327724338e-06
- O 0 3.6662120237451745e-06
cell O 0 5.711675044040021e-07
autonomous O 0 4.954249011035472e-09
. O 0 6.243290329166484e-10

Rescued O 0 1.307049160459428e-06
embryos O 0 6.092379771871492e-05
show O 0 0.15282052755355835
severe O 1 0.7121567726135254
anterior O 0 0.22837765514850616
truncations O 0 0.0001500531507190317
, O 0 2.7710880812215066e-10
indicating O 0 2.8903612836472803e-09
a O 0 2.7645706904277922e-12
second O 0 2.394122955440281e-10
important O 0 2.117585794214616e-11
role O 0 3.0058211475392227e-09
for O 0 1.9958503166134234e-12
Smad4 O 0 1.0930873486358905e-06
in O 0 1.610202422785978e-12
anterior O 0 3.5083946841041325e-06
patterning O 0 1.5995325952644635e-07
during O 0 6.61319402017746e-11
embryogenesis O 0 6.595568180500777e-08
. O 0 6.887440617830975e-10

Prevalence O 0 0.00012856711691711098
of O 0 3.4525412043184822e-12
p16 O 0 1.461477161512903e-08
and O 0 1.9681228868861922e-11
CDK4 O 0 1.5357841220975388e-06
germline O 0 2.9764510145469103e-07
mutations O 0 1.357944938717992e-06
in O 0 5.884317772625325e-12
48 O 0 8.062922773888204e-08
melanoma B-Disease 1 0.9999533891677856
- O 1 0.9548370242118835
prone O 1 0.99763023853302
families O 0 1.2113344993736064e-08
in O 0 5.579116682530305e-11
France O 0 3.326037131046178e-06
. O 0 1.195144538890247e-10

The O 0 2.61714689031578e-07
French O 0 0.003073472762480378
Familial B-Disease 1 0.7837785482406616
Melanoma I-Disease 1 0.9999178647994995
Study O 0 1.2713218211501953e-07
Group O 0 2.5700837014142053e-09
. O 0 4.921375112987292e-11

Germline O 0 4.972757596988231e-05
mutations O 0 2.3430520741385408e-05
in O 0 1.924570312145102e-12
the O 0 3.090033789824101e-14
p16 O 0 3.32024185922819e-10
and O 0 5.763816507409203e-12
CDK4 O 0 3.4693357520154677e-07
genes O 0 5.523808521701312e-09
have O 0 1.645965828911411e-11
been O 0 2.212799041223512e-11
reported O 0 4.981115866997676e-11
in O 0 4.2012670071179766e-16
a O 0 3.4780485715329816e-15
subset O 0 1.9239685799393724e-12
of O 0 1.7525050421268729e-12
melanoma B-Disease 0 0.0022718016989529133
pedigrees O 0 3.0888796231920423e-07
, O 0 2.0844536166575445e-11
but O 0 8.335337628451178e-12
their O 0 2.0611986076279898e-11
prevalence O 0 6.317664428934222e-06
is O 0 2.0172422066089268e-10
not O 0 4.147991412156715e-12
well O 0 3.777985303071718e-12
known O 0 1.4242616808157749e-10
. O 0 2.6678980205585567e-11

We O 0 1.3677352653229669e-11
searched O 0 1.0311828647913135e-11
for O 0 5.931183465239997e-15
such O 0 7.000996665534019e-15
germline O 0 4.992248836543922e-09
mutations O 0 4.683260783622245e-07
in O 0 1.556931319979249e-11
48 O 0 3.4985216643690364e-06
French O 0 0.01805475726723671
melanoma B-Disease 1 0.9999983310699463
- O 1 0.9968570470809937
prone O 0 0.3489297926425934
families O 0 1.6577399175599083e-11
selected O 0 2.9735868715269342e-12
according O 0 6.012644317843338e-16
to O 0 8.295832215079145e-15
two O 0 2.246542795542039e-12
major O 0 4.4672456844807584e-09
criteria O 0 8.217743818761392e-09
families O 0 2.8484593156408167e-14
with O 0 2.0093352844216192e-14
at O 0 4.745085400992277e-12
least O 0 1.640641324239609e-14
three O 0 6.206157983357219e-12
affected O 0 1.5773049533152061e-10
members O 0 1.3901040556282482e-14
( O 0 1.9561328061913977e-14
n O 0 1.2979917585198564e-08
= O 0 2.00033145603129e-09
20 O 0 9.517946326920157e-12
) O 0 7.148375316158584e-14
or O 0 1.7268592155186835e-12
families O 0 8.364442222619922e-14
with O 0 1.317011278680058e-13
two O 0 1.779061793716341e-11
affected O 0 7.779628052873022e-10
members O 0 1.2051868529571515e-14
, O 0 6.412035175550317e-16
one O 0 1.9321441978504455e-15
of O 0 2.4981479185900036e-16
them O 0 1.3121970144584078e-13
affected O 0 1.902859814162383e-12
before O 0 3.132332717856179e-13
the O 0 2.1759231176306064e-14
age O 0 6.6983467383874284e-12
of O 0 2.006033211180043e-15
50 O 0 1.347202107900361e-13
( O 0 1.440385286629979e-14
n O 0 1.8458882422578426e-08
= O 0 8.110425220309025e-09
28 O 0 5.500622179965831e-10
) O 0 8.089023699996145e-14
, O 0 9.26678608251675e-15
and O 0 8.219820325425491e-15
one O 0 6.4019686124886736e-15
additional O 0 3.8391249272511085e-13
minor O 0 4.031363298739876e-10
criterion O 0 1.1720139525550621e-08
. O 0 7.882866581709891e-11

Sixteen O 0 1.7467044477470495e-09
different O 0 2.6752855573214385e-12
p16 O 0 2.285103661847643e-09
germline O 0 6.081826597892359e-08
mutations O 0 1.5942282516334672e-06
were O 0 4.163481712171624e-11
found O 0 2.155994410779627e-10
in O 0 9.89071563366195e-13
21 O 0 9.47954825747388e-10
families O 0 5.177767394524968e-13
, O 0 1.2759354492831564e-14
while O 0 2.6567912366631807e-12
one O 0 2.661234080325592e-12
germline O 0 2.6537527730852162e-08
mutation O 0 1.4947808324450307e-07
, O 0 5.1563545100385966e-12
Arg24His O 0 7.862291795390774e-08
, O 0 5.6074539949530974e-14
was O 0 7.799380932760336e-12
detected O 0 8.648797233945515e-09
in O 0 1.536256371951778e-14
the O 0 2.0217382184616745e-13
CDK4 O 0 3.94245216739364e-06
gene O 0 2.799436460421134e-09
. O 0 2.5333310102459983e-11

The O 0 4.787464912350825e-13
frequency O 0 1.4430485886091082e-12
of O 0 7.053053616406374e-15
p16 O 0 7.199506268928957e-11
gene O 0 3.0240257520297575e-10
mutation O 0 9.42531608316699e-10
in O 0 6.575602150456217e-14
our O 0 9.787985309414604e-13
sample O 0 1.4617983906672904e-11
( O 0 1.0354152431280017e-13
44 O 0 7.461693589394525e-12
% O 0 4.340737652267857e-15
) O 0 3.5420617630327453e-16
is O 0 1.448985212143452e-14
among O 0 9.370411076844304e-14
the O 0 2.9424141075040655e-13
highest O 0 7.523228759964695e-07
rates O 0 8.959514161688276e-06
yet O 0 6.470879942988006e-10
reported O 0 4.167378886421602e-09
and O 0 9.074798204555812e-12
the O 0 2.2705880957981511e-13
CDK4 O 0 9.369529834657442e-06
mutation O 0 2.266395737748894e-09
is O 0 3.3680248260475887e-12
the O 0 3.217075857011448e-14
second O 0 8.072748580723044e-10
mutation O 0 1.2333190468893918e-08
detected O 0 2.489539951966435e-07
in O 0 8.688486196240137e-15
this O 0 2.7232947816843538e-15
gene O 0 8.986052457693461e-10
worldwide O 0 9.207422380086427e-09
. O 0 6.578271261048485e-11

In O 0 3.081751173694691e-11
summary O 0 1.1589262882694129e-10
, O 0 5.394408335822332e-13
our O 0 1.7095678171707984e-13
results O 0 4.675668625062426e-14
show O 0 3.834160072768711e-11
frequent O 0 4.581094618233417e-12
involvement O 0 1.829743301318132e-11
of O 0 1.5831361303955726e-15
the O 0 2.7464344512539204e-15
p16 O 0 3.349039448541369e-11
gene O 0 3.0592633981640915e-10
in O 0 1.2820933279877184e-13
familial B-Disease 0 8.469457384308043e-07
melanoma I-Disease 1 0.7253994941711426
and O 0 4.765224881353447e-10
confirm O 0 2.657782049997337e-10
the O 0 1.115180322218412e-12
role O 0 3.381134705549016e-09
of O 0 6.525446957957037e-15
the O 0 5.707275472534301e-14
CDK4 O 0 2.920354233992839e-07
gene O 0 6.142488739868668e-10
as O 0 2.432532257221065e-12
a O 0 6.837472862203375e-12
melanoma B-Disease 0 0.03912857919931412
- O 0 2.782547596780205e-07
predisposing O 0 3.557852323865518e-08
gene O 0 8.725846711854501e-09
. O 0 1.1069768149005177e-12
. O 0 3.1142781495990812e-12

Progression O 0 9.352331886702814e-08
of O 0 4.6499978346992155e-12
somatic O 0 1.1784701570149991e-07
CTG O 0 5.911281732551288e-06
repeat O 0 1.1489806439612948e-07
length O 0 7.922452693875925e-10
heterogeneity O 0 6.711961542116285e-10
in O 0 1.0390712406162586e-13
the O 0 1.6065356781436863e-13
blood O 0 9.960786684359846e-08
cells O 0 4.060398239857932e-08
of O 0 5.060024843572819e-09
myotonic B-Disease 1 0.9999997615814209
dystrophy I-Disease 1 0.9999992847442627
patients O 0 2.2170657757669687e-05
. O 0 1.275417271795476e-10

The O 0 1.962222268350744e-12
genetic O 0 3.42045525236756e-09
basis O 0 2.1515260684168425e-09
of O 0 2.977123081393529e-08
myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 0.9999998807907104
( O 0 5.405590854934417e-07
DM B-Disease 1 1.0
) O 0 5.046468798397541e-11
is O 0 4.850875696136084e-14
the O 0 1.9754592393115438e-16
expansion O 0 8.573164422299995e-13
of O 0 7.76297734048862e-15
an O 0 4.793570922145829e-12
unstable O 0 2.8254285666662327e-07
CTG O 0 1.759475765084062e-07
repeat O 0 1.0453235610441425e-08
in O 0 4.017116771604795e-14
the O 0 1.5118679217080745e-14
34 O 0 5.530293670924502e-12
UTR O 0 6.544780689621277e-11
of O 0 2.1812792457692742e-14
the O 0 4.647428969439815e-11
DM B-Disease 1 1.0
protein O 0 1.3319902514297155e-08
kinase O 0 1.6217702736298634e-08
gene O 0 4.503621919837997e-09
on O 0 5.325420660007296e-10
chromosome O 0 9.721067726786714e-06
19 O 0 3.017033289864912e-09
. O 0 1.3545802500514181e-11

One O 0 2.33081692835313e-10
of O 0 1.1341550257542438e-13
the O 0 4.908168665875186e-14
principal O 0 6.927131784850715e-11
features O 0 1.281019127580274e-11
of O 0 1.2490205538676774e-13
the O 0 1.0459433319454092e-09
DM B-Disease 1 1.0
mutation O 0 2.2497242753161117e-06
is O 0 1.5431071351268422e-11
an O 0 9.358480109562459e-14
extraordinarily O 0 1.584126430032029e-08
high O 0 1.957160122856294e-07
level O 0 1.1719484271921488e-09
of O 0 6.170894551642617e-14
somatic O 0 9.579976811835422e-09
mosaicism O 0 6.772277743039012e-07
, O 0 1.306683060364744e-12
due O 0 1.7049015465456924e-13
to O 0 4.313534765650311e-15
an O 0 9.556136264243786e-14
extremely O 0 2.103461432811926e-10
high O 0 3.110169011222297e-09
degree O 0 1.2962226778046038e-12
of O 0 5.975064193419755e-13
somatic O 0 3.5695277347258525e-06
instability O 0 2.807919941005821e-07
both O 0 3.996885114543325e-11
within O 0 8.728975116507887e-13
and O 0 3.3904955232255674e-11
between O 0 2.2736042107167342e-13
different O 0 7.961340462749045e-13
tissues O 0 1.3783200358830072e-08
. O 0 1.5522907612086634e-11

This O 0 2.4548968760584877e-11
instability O 0 1.079744293974727e-09
appears O 0 8.32161249630925e-12
to O 0 3.200805794050703e-15
be O 0 5.6583660113906486e-15
biased O 0 1.8266423530005627e-12
towards O 0 1.6028682287699825e-14
further O 0 3.664371933599815e-14
expansion O 0 8.308254800283577e-13
and O 0 1.1233667397995625e-13
continuous O 0 2.0580341901152432e-13
throughout O 0 4.66913664578638e-14
the O 0 3.118429722347854e-14
life O 0 6.456815334135446e-13
of O 0 1.2135177396307528e-15
an O 0 8.802283039824679e-14
individual O 0 3.2570734304071536e-13
, O 0 1.5431048027369186e-14
features O 0 3.6136961478749896e-11
that O 0 4.3854347236971236e-11
could O 0 1.876559529989663e-08
be O 0 8.681749208427902e-10
associated O 0 2.654761133147332e-11
with O 0 1.0397641948822756e-11
the O 0 6.317769658120698e-12
progressive O 0 4.3821737905069824e-11
nature O 0 1.331113330671485e-09
of O 0 1.8123582062185006e-12
the O 0 6.061115498390279e-10
disease O 0 2.3572436475660652e-05
. O 0 4.614552837067798e-11

Although O 0 3.3279497213545284e-11
increasing O 0 3.0133191948611415e-12
measured O 0 1.9159578090732765e-10
allele O 0 1.2357436185439497e-09
size O 0 6.90690127314042e-09
between O 0 3.0450822419147983e-10
patients O 0 1.6607069053264922e-09
clearly O 0 3.923143927775374e-12
correlates O 0 5.437142164450848e-13
with O 0 3.628353043363952e-14
an O 0 7.771485278224022e-14
increased O 0 1.0232332758874918e-09
severity O 0 9.617163243547111e-08
of O 0 1.3905000484371044e-09
symptoms O 0 7.333729172387393e-06
and O 0 4.469126078324864e-14
an O 0 1.267857041955308e-14
earlier O 0 3.026310591014436e-10
age O 0 1.6252849732723007e-08
of O 0 6.772472339877655e-12
onset O 0 8.440491860994825e-09
, O 0 5.405887089154297e-15
this O 0 2.0771999069392796e-17
correlation O 0 1.3061105148814978e-11
is O 0 2.4975731552356883e-11
not O 0 6.651542923223619e-13
precise O 0 9.722055105410021e-11
and O 0 3.048698404839456e-09
measured O 0 1.81352589834205e-07
allele O 0 1.5968485422845902e-09
length O 0 3.922030202829774e-07
cannot O 0 1.851885542691889e-07
be O 0 4.8912051492377984e-11
used O 0 9.630293090756581e-11
as O 0 4.775401428458448e-12
an O 0 5.098879150389028e-15
accurate O 0 2.022136591506296e-08
predictor O 0 4.6911565732443705e-05
of O 0 1.9726853831003588e-11
age O 0 6.271032049198766e-08
of O 0 4.473977091579151e-11
onset O 0 7.704398399255297e-07
. O 0 1.059853732554572e-10

In O 0 8.505542624381857e-12
order O 0 2.280884086203888e-13
to O 0 4.796899516836017e-16
further O 0 3.689758527468563e-15
characterize O 0 3.640939546384336e-12
the O 0 4.097183746790134e-14
dynamics O 0 1.7026066667646944e-10
of O 0 8.288821885804598e-12
DM B-Disease 1 0.9999988079071045
CTG O 0 1.0224378002021695e-06
repeat O 0 2.201843329885378e-08
somatic O 0 2.353325072590451e-07
instability O 0 4.5998760356269486e-08
, O 0 2.639243803972263e-13
we O 0 1.7169833263497303e-12
have O 0 3.781008709249911e-14
studied O 0 1.0847173853578695e-12
repeat O 0 9.098563569231999e-11
length O 0 4.829907307435377e-11
changes O 0 6.789528791614763e-13
over O 0 7.334610349629678e-13
time O 0 3.6180665668322787e-12
in O 0 2.665424738562683e-12
111 O 0 1.4391872582564247e-07
myotonic B-Disease 1 0.9999990463256836
dystrophy I-Disease 1 0.9999994039535522
patients O 0 7.933041779040195e-09
with O 0 1.4233163868966787e-14
varying O 0 3.2718052984763435e-13
clinical O 0 4.866644687240296e-08
severity O 0 1.7897447079917583e-08
and O 0 2.190764063214612e-11
CTG O 0 2.874159861221415e-07
repeat O 0 3.979175389190459e-08
size O 0 2.170436275150678e-09
over O 0 6.07034755795155e-10
time O 0 7.968944948366641e-11
intervals O 0 1.2339960164808872e-09
of O 0 2.386772996311546e-14
1 O 0 3.946808591753781e-12
- O 0 1.9892594238513084e-09
7 O 0 9.542049442257117e-12
years O 0 1.076955690425263e-12
. O 0 1.2048110989773542e-12

We O 0 2.3082428413090383e-08
have O 0 3.919544268142505e-13
found O 0 5.476356334014297e-14
a O 0 2.555216763411262e-15
direct O 0 2.5637529751064425e-13
progression O 0 6.644376715492228e-10
of O 0 4.11300767749756e-14
the O 0 1.2575154472956908e-14
size O 0 7.026706473622912e-12
heterogeneity O 0 1.3371554731522739e-11
over O 0 2.6337989948721496e-12
time O 0 1.721520875071908e-13
related O 0 5.373141710209028e-13
to O 0 2.317693054891632e-15
initial O 0 7.219999066925692e-14
CTG O 0 9.898581954104202e-10
repeat O 0 5.975255290557868e-10
size O 0 3.7785222173347677e-10
and O 0 1.9227147651790233e-11
the O 0 3.630394731580014e-14
time O 0 6.412915771331074e-12
interval O 0 2.292707551587725e-10
and O 0 9.410859678343764e-13
always O 0 3.1902217955022405e-13
biased O 0 1.2180764209779316e-12
towards O 0 2.8289834870845985e-14
further O 0 1.5660401849002664e-13
expansion O 0 8.452034211403614e-11
. O 0 1.0678478934433855e-11

Attempts O 0 3.1107488807080586e-10
to O 0 1.451013246188404e-13
mathematically O 0 1.3880793216236587e-11
model O 0 1.2956906658700973e-09
the O 0 1.1773141326849174e-13
dynamics O 0 7.835927817723132e-08
have O 0 1.8356772768512997e-09
proved O 0 5.957184745497557e-10
only O 0 3.702439830416404e-12
partially O 0 2.0318019267051568e-08
successful O 0 5.652617610096833e-11
suggesting O 0 1.4623798838542257e-09
that O 0 1.2290514472042963e-13
individual O 0 3.483262059323332e-14
specific O 0 4.0211510878886136e-13
genetic O 0 3.2716371833885205e-09
and O 0 7.35209740310161e-11
/ O 0 7.014514524783522e-10
or O 0 2.749396196821685e-11
environmental O 0 1.1706610680839447e-10
factors O 0 4.188651855918657e-11
also O 0 5.211809872562867e-10
play O 0 4.905258976783955e-10
a O 0 1.4058827886576086e-12
role O 0 1.368681279423356e-09
in O 0 2.8664831603188515e-14
somatic O 0 7.765988963015502e-10
mosaicism O 0 1.0310333209417877e-07
. O 0 5.459932094116493e-13
. O 0 1.2093449505701237e-11

Aspartylglucosaminuria B-Disease 1 0.9999761581420898
among O 0 1.377025142801358e-07
Palestinian O 0 1.615405125221514e-07
Arabs O 0 7.941765289842806e-08
. O 0 3.1288685531372096e-10

Aspartylglucosaminuria B-Disease 1 0.9999953508377075
( O 0 2.5092167561524548e-06
AGU B-Disease 1 0.9999933242797852
) O 0 5.111703768601039e-11
is O 0 6.98422548094102e-13
a O 0 8.969667998799669e-13
rare O 0 1.3451847635792546e-08
disorder B-Disease 1 0.8914278745651245
of I-Disease 0 4.3469436383780646e-11
glycoprotein I-Disease 0 0.0018619461916387081
metabolism I-Disease 0 0.01523221842944622
caused O 0 1.7469318436269532e-08
by O 0 2.6315393007042553e-12
the O 0 5.664948954375859e-09
deficiency B-Disease 0 0.3553580343723297
of I-Disease 0 8.761268078215367e-13
the I-Disease 0 6.204421698630114e-11
lysosomal I-Disease 0 0.0064704809337854385
enzyme I-Disease 0 0.0007956771878525615
aspartylglucosaminidase I-Disease 0 2.9173525035730563e-05
( O 0 2.3054002283584563e-12
AGA O 0 2.8487043279845636e-10
) O 0 2.0705915280971876e-12
. O 0 1.6617087480325088e-12

AGU B-Disease 1 0.9999579191207886
is O 0 1.6666548674493242e-07
inherited O 0 0.00044486502883955836
as O 0 4.651938390054511e-09
an O 0 7.459936002263134e-10
autosomal O 1 0.999971866607666
recessive O 1 0.9999899864196777
trait O 1 0.9846485257148743
and O 0 4.860021718400276e-08
occurs O 0 1.1854775494590797e-10
with O 0 3.566654147046412e-14
a O 0 1.4715915118423961e-12
high O 0 5.5661473652435234e-08
frequency O 0 4.610440473840072e-09
in O 0 2.6936491925866335e-10
Finland O 0 1.5967236777214566e-06
because O 0 1.9845127277595687e-11
of O 0 1.1825844563860283e-14
a O 0 5.964588089928113e-13
founder O 0 2.2473949368162494e-09
effect O 0 3.456512853716731e-09
. O 0 3.276054774681292e-11

While O 0 7.811090108056362e-10
very O 0 9.838709708054338e-13
few O 0 7.304705885308183e-13
patients O 0 8.060707483437124e-12
with O 0 4.426762775788795e-12
AGU B-Disease 1 0.9999998807907104
have O 0 3.2133290472913245e-10
been O 0 8.053163171040101e-12
reported O 0 6.36552616173347e-11
from O 0 2.100175935937365e-12
non O 0 4.881440418103011e-06
- O 0 1.5002464124336257e-06
Finnish O 0 1.7449977463002142e-07
origin O 0 4.3255968251720844e-11
, O 0 1.3730910505826976e-11
we O 0 7.615116537351696e-09
diagnosed O 0 1.4701234249514528e-05
the O 0 3.084656141627562e-11
disorder O 0 2.1578724044957198e-05
in O 0 1.3271836700381318e-13
8 O 0 6.637444760482225e-11
patients O 0 9.502300882995376e-14
originating O 0 2.784768367237924e-14
from O 0 2.6157282042400462e-14
3 O 0 7.580697679830661e-13
unrelated O 0 1.0805925598766919e-10
families O 0 9.542377304994076e-12
, O 0 1.4616015646048974e-13
all O 0 4.0422851697863305e-12
Palestinian O 0 2.3789559211451206e-10
Arabs O 0 3.474223339572369e-11
from O 0 5.771667865861474e-13
the O 0 1.7695952125515446e-12
region O 0 9.810868263626649e-12
of O 0 1.1692936115886843e-13
Jerusalem O 0 5.0366868009632526e-08
. O 0 1.304318736350396e-10

The O 0 1.0602580619023527e-10
clinical O 0 2.869878699129913e-07
diagnosis O 0 0.00022872792033012956
of O 0 7.580077010516106e-09
AGU B-Disease 1 1.0
is O 0 1.5766545402584597e-07
often O 0 1.199813165486674e-10
difficult O 0 5.871831493253765e-11
, O 0 1.1672035408506753e-13
in O 0 2.385106077822997e-15
particular O 0 2.4304253813493826e-13
early O 0 1.4640409110727726e-12
in O 0 1.4731044075538824e-13
the O 0 4.610448307851289e-13
course O 0 8.385608318839388e-10
of O 0 7.469549609916137e-13
the O 0 4.4098766305289416e-11
disease O 0 3.8781995499448385e-06
, O 0 5.525195576126622e-14
and O 0 7.170524211289747e-14
most O 0 4.469311324430429e-15
of O 0 1.849463067231643e-14
the O 0 6.392488621775883e-11
patients O 0 1.1148649781134168e-09
are O 0 2.963204681627474e-11
diagnosed O 0 1.423725990434832e-07
after O 0 5.551176272128311e-12
the O 0 1.489049682168453e-11
age O 0 9.260276101485942e-09
of O 0 2.239345997046352e-13
5 O 0 2.718769480380967e-11
years O 0 1.094001365192776e-11
. O 0 1.006285419574704e-11

However O 0 1.6733417429470876e-10
, O 0 1.415606455841545e-13
since O 0 2.9515761579626543e-13
these O 0 2.6490565790222506e-14
patients O 0 2.2656908901103057e-13
excrete O 0 8.066932538630667e-13
early O 0 6.5147273324930605e-15
large O 0 2.5536588157113772e-14
amounts O 0 1.0379070649810251e-12
of O 0 7.931875642408492e-13
aspartylglucosamine O 0 1.765905471984297e-05
in O 0 2.0387999014742642e-13
urine O 0 1.0231279157224549e-09
, O 0 4.9056391713848e-15
biochemical O 0 7.745390266655772e-12
screening O 0 9.236347797703104e-11
is O 0 6.48871689885866e-13
easy O 0 1.3869142379691057e-12
by O 0 7.440226277959094e-14
urine O 0 4.453089452738368e-09
chromatography O 0 4.258530861278587e-09
. O 0 3.0250997019865e-13
. O 0 3.0747858686258622e-12

Detection O 0 1.1681190459356117e-09
of O 0 5.046771377539838e-13
heterozygous O 0 3.0259562322498823e-07
carriers O 0 1.0328225386047052e-07
of O 0 1.6085240778229704e-11
the O 0 1.568270363350166e-06
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 1.4550187721340535e-08
ATM O 0 2.5765348254935816e-07
) O 0 8.452259718679227e-15
gene O 0 2.4384446827181716e-13
by O 0 2.184034008671982e-15
G2 O 0 1.4723959551599108e-10
phase O 0 3.0221446872813473e-11
chromosomal O 0 2.6392353902338073e-05
radiosensitivity O 0 3.976557763962774e-06
of O 0 9.46067963553121e-12
peripheral O 0 0.00031751059577800333
blood O 0 0.0002646465436555445
lymphocytes O 0 0.0002991399960592389
. O 0 2.737978732625379e-10

In O 0 4.55618328487617e-06
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999988079071045
telangiectasia I-Disease 1 1.0
( O 0 0.00150702940300107
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
) O 0 8.697594311435353e-10
patients O 0 7.633956661257102e-11
, O 0 2.4229432513350833e-15
mutations O 0 3.183581176458006e-11
in O 0 8.386035294731097e-15
a O 0 3.851936537747555e-14
single O 0 2.2953329514852072e-10
gene O 0 1.3489815930967097e-09
, O 0 9.054473208529312e-14
ATM O 0 5.741357611555031e-08
, O 0 1.760690118007835e-12
result O 0 3.6371093636855534e-11
in O 0 3.703773066021654e-09
an O 1 0.9726217985153198
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 5.2774161929391994e-08
embraces O 0 3.5935449060886526e-10
a O 0 2.0576692205589303e-13
variety O 0 4.235276625935702e-12
of O 0 2.376166619152617e-14
clinical O 0 1.2047669528669758e-09
features O 0 2.3626748557603605e-08
and O 0 4.36088276600799e-09
manifests O 0 1.557925699557927e-08
extreme O 0 2.2203805460918602e-10
radiosensitivity O 0 2.7473301997815724e-06
and O 0 6.015768438949465e-11
a O 0 8.266639109355545e-12
strong O 0 7.90035675768408e-11
pre O 0 1.1566202573476403e-07
- O 0 1.4140118764771614e-06
disposition O 0 3.4300225593142386e-07
to O 0 2.8838934712505093e-11
malignancy B-Disease 0 1.7380671124556102e-05
. O 0 3.2378134895427735e-11

Heterozygotes O 0 1.36613181211942e-07
for O 0 1.0425040821923637e-12
the O 0 2.968546564704848e-14
ATM O 0 8.541591682842409e-07
gene O 0 6.762609814359166e-07
have O 0 4.865647329488354e-10
no O 0 4.523260672267826e-12
clinical O 0 4.6902826067452e-10
expression O 0 7.55538253488508e-12
of O 0 3.14320444672056e-11
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
but O 0 3.8172592553564755e-07
may O 0 1.053582465715408e-08
be O 0 5.860332219498332e-10
cancer B-Disease 0 1.0289407548214058e-08
prone O 0 2.559860057260721e-08
with O 0 8.504982606854714e-14
a O 0 1.4106291005080984e-12
moderate O 0 1.1478760303385016e-10
increase O 0 4.220652438657879e-10
in O 0 1.620310764900712e-12
in O 0 5.512748244007604e-12
vitro O 0 1.4915441397533868e-06
radiosensitivity O 0 2.1295989427017048e-05
. O 0 4.5799874309748745e-11

We O 0 2.9246676191974075e-08
performed O 0 3.311413088180615e-10
a O 0 4.734930438184126e-13
blind O 0 5.051112861309548e-10
chromosomal O 0 6.158871457273563e-08
analysis O 0 2.6569987529589945e-12
on O 0 6.112364954458105e-12
G2 O 0 1.1489176721113381e-08
- O 0 6.658919193824886e-09
phase O 0 3.4882619015519367e-10
lymphocytes O 0 9.74679625898034e-09
from O 0 1.6101332303585826e-14
7 O 0 3.156719135220809e-13
unrelated O 0 3.55489304659784e-09
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
patients O 0 3.113806599230884e-07
, O 0 1.5791079381599626e-14
13 O 0 7.249021261729327e-13
obligate O 0 1.6214785318879876e-06
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999997615814209
T I-Disease 1 1.0
heterozygotes O 0 8.185323167708702e-06
( O 0 1.4284627896776064e-13
parents O 0 2.8519398756650383e-13
of O 0 7.854810746805801e-16
the O 0 6.934550996580066e-14
patients O 0 1.0010243502167615e-12
) O 0 3.846751425560938e-15
, O 0 1.1239233590305212e-14
and O 0 3.4447924113917283e-12
14 O 0 2.011616220820578e-11
normal O 0 6.973354185757508e-12
controls O 0 1.5490299043463551e-09
following O 0 2.9036625534550886e-12
X O 0 8.393647590310138e-07
- O 0 1.3599994741486654e-10
irradiation O 0 2.1804672650782564e-11
with O 0 3.519580460409344e-13
1 O 0 2.893069085078276e-13
Gy O 0 1.7668694285433162e-09
in O 0 2.4676797199607928e-15
order O 0 2.8679142224832376e-15
to O 0 1.6683404451093035e-15
evaluate O 0 2.863513029124909e-12
this O 0 2.4355355078267617e-16
cytogenetic O 0 3.2044648184959e-11
method O 0 4.461361022365523e-13
as O 0 1.2515483712328274e-13
a O 0 4.54990153304311e-16
tool O 0 2.1244377784723767e-12
for O 0 9.111669997677254e-16
detection O 0 9.167572300253224e-13
of O 0 1.0184841387145607e-13
ATM O 0 0.0006282664253376424
carriers O 0 2.870715889002895e-06
. O 0 6.709833383355956e-11

Both O 0 2.669216030426469e-07
A B-Disease 1 0.9999939203262329
- I-Disease 1 0.9999974966049194
T I-Disease 1 1.0
homozygotes O 0 0.0013899547047913074
and O 0 3.433143309569675e-12
heterozygotes O 0 4.318155277793778e-10
showed O 0 5.046911152883915e-11
significantly O 0 5.446650075402459e-13
increased O 0 3.812730296412492e-13
levels O 0 1.0838280143157797e-12
of O 0 2.985484174331324e-14
radiation O 0 1.943020322414668e-07
- O 0 6.168189429445192e-05
induced O 0 0.00011049247405026108
chromatid O 0 0.0019527690019458532
damage O 0 3.269231285685237e-07
relative O 0 6.913348365999994e-12
to O 0 2.6753184967386913e-14
that O 0 2.6387842716577188e-14
of O 0 2.4052586433524238e-14
normal O 0 3.160114184219687e-11
controls O 0 1.9313256771624765e-08
. O 0 5.99960012226397e-11

These O 0 4.399541061322898e-12
results O 0 1.9036874941008586e-12
show O 0 1.313912034728304e-10
that O 0 1.1750388327820029e-14
the O 0 8.549412703663401e-15
G2 O 0 2.7669502244975774e-08
- O 0 6.413478814693008e-08
phase O 0 2.519498831787814e-09
chromosomal O 0 0.0003745348658412695
radiosensitivity O 0 2.200308472311008e-06
assay O 0 3.5137992515643646e-09
can O 0 6.4130753658908635e-12
be O 0 3.4086958431524044e-15
used O 0 6.9187463782238376e-15
for O 0 1.5940373914871762e-16
the O 0 1.6143414329773518e-16
detection O 0 4.932210195818243e-11
of O 0 1.0019231971858389e-10
A B-Disease 1 1.0
- I-Disease 1 0.9999996423721313
T I-Disease 1 0.9999998807907104
heterozygotes O 0 0.0005479112733155489
. O 0 1.5669479602742342e-10

In O 0 5.7129249247944713e-11
combination O 0 3.1666863575807724e-10
with O 0 2.5377632937792494e-13
molecular O 0 9.061105338270536e-11
genetic O 0 1.4309125440092885e-08
analyses O 0 4.9961190740077654e-08
, O 0 2.1202846336304537e-12
this O 0 1.5230927684437706e-13
test O 0 5.294018137647072e-06
may O 0 1.0738902128659689e-10
be O 0 2.1437702551726015e-14
of O 0 3.0494202540691517e-16
value O 0 1.1684209155760072e-11
in O 0 2.2482295769532014e-14
studies O 0 1.7618113185794565e-13
of O 0 7.616724227244367e-14
familial B-Disease 0 1.2408054317347705e-06
and I-Disease 0 2.1009645134739685e-09
sporadic I-Disease 0 6.918017447787861e-07
cancers I-Disease 0 0.05284690111875534
aimed O 0 4.772406470010537e-08
at O 0 5.98495086823192e-10
determination O 0 1.866718238319187e-11
of O 0 2.18140180084883e-16
the O 0 1.5869151678897476e-15
potential O 0 9.911696029901718e-13
involvement O 0 4.308459838897605e-12
of O 0 9.155964696269323e-14
ATM O 0 0.0008561429567635059
mutations O 0 2.4541839593439363e-05
in O 0 2.4992601738160758e-11
tumor B-Disease 0 0.0002248957462143153
risk O 0 2.565521128872206e-07
or O 0 1.2049082218079654e-11
development O 0 1.7264772510933168e-12
. O 0 2.51442421571324e-13
. O 0 5.521124356311358e-12

Ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999982118606567
telangiectasia I-Disease 1 0.9999997615814209
: O 0 5.947852210752558e-10
identification O 0 3.712268773631289e-12
and O 0 7.778677604385748e-14
detection O 0 1.7118698819595934e-11
of O 0 5.0596262883605483e-14
founder O 0 1.0958826734963623e-08
- O 0 8.547502147848718e-06
effect O 0 4.5436223672368214e-09
mutations O 0 3.150940486307263e-08
in O 0 1.2086075108113433e-14
the O 0 1.992655808085819e-15
ATM O 0 1.7730686252548367e-08
gene O 0 4.660533070577344e-10
in O 0 1.318201800428083e-14
ethnic O 0 3.032558199781571e-13
populations O 0 1.8391528577854643e-10
. O 0 5.76949208894173e-12

To O 0 9.139637831279135e-13
facilitate O 0 1.0196275247731368e-12
the O 0 1.1220642064145928e-14
evaluation O 0 6.801699503101999e-13
of O 0 4.796880987990295e-16
ATM O 0 9.980428039568778e-09
heterozygotes O 0 8.811539831121706e-10
for O 0 1.5222323862572676e-14
susceptibility O 0 4.683503931901534e-11
to O 0 1.4495249076561245e-13
other O 0 2.5806025719110615e-11
diseases O 0 3.410194722164306e-07
, O 0 1.2609403403146188e-14
such O 0 2.280640411765622e-13
as O 0 1.2649525871211154e-08
breast B-Disease 0 0.00042350226431153715
cancer I-Disease 0 1.0298584811607725e-06
, O 0 1.6931163502459379e-12
we O 0 8.966803688448266e-11
have O 0 3.973045308545975e-13
attempted O 0 4.5476056947935106e-11
to O 0 1.5152122178480054e-12
define O 0 8.079911739677925e-10
the O 0 4.879794485157518e-13
most O 0 2.0286525822914292e-13
common O 0 3.223182354697429e-13
mutations O 0 1.9923330346616197e-11
and O 0 2.730105367037411e-13
their O 0 1.5452142874700786e-13
frequencies O 0 6.749335312861149e-09
in O 0 1.2893904965949332e-07
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
telangiectasia I-Disease 1 1.0
( O 0 0.002535282401368022
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.4100621711921058e-11
homozygotes O 0 2.214131100686245e-09
from O 0 2.074451450461562e-14
10 O 0 4.100678265917326e-14
ethnic O 0 1.5260588745371478e-13
populations O 0 2.1080119594341085e-10
. O 0 7.788736669511742e-12

Both O 0 3.3977327895673426e-11
genomic O 0 1.4774527379302071e-08
mutations O 0 2.4073389795375988e-05
and O 0 8.410929591695648e-11
their O 0 3.0339755230715526e-13
effects O 0 2.4081405272657896e-11
on O 0 1.8140693211921716e-13
cDNA O 0 5.694601474398597e-12
were O 0 9.498596353907374e-12
characterized O 0 5.0913381149930714e-11
. O 0 1.0325132242250401e-11

Protein O 0 1.0937572625380199e-07
- O 0 5.882410292201712e-08
truncation O 0 1.1305919755955074e-08
testing O 0 5.457728491364833e-08
of O 0 4.581795182243432e-15
the O 0 7.8548705685077e-16
entire O 0 2.1235090237863713e-13
ATM O 0 9.826122138179016e-10
cDNA O 0 8.343450062786584e-12
detected O 0 2.4566897849354064e-08
92 O 0 1.5426222799153066e-10
( O 0 3.1248736779600217e-13
66 O 0 6.172034411333627e-11
% O 0 2.7870584055141208e-14
) O 0 1.53691788350776e-15
truncating O 0 1.3644371743559702e-10
mutations O 0 3.660169056729501e-09
in O 0 3.1669823285108284e-14
140 O 0 9.229699253140988e-13
mutant O 0 4.305839240714704e-08
alleles O 0 3.8738455998554855e-08
screened O 0 1.4666911738459021e-05
. O 0 2.7286362058731584e-10

The O 0 2.0427100982933766e-11
haplotyping O 0 4.527578312263358e-06
of O 0 8.148339641911306e-12
patients O 0 1.3223652173266487e-09
with O 0 9.271675224450937e-13
identical O 0 3.518065838647999e-08
mutations O 0 2.2021196855348535e-05
indicates O 0 1.313184725404426e-07
that O 0 6.044222761181217e-11
almost O 0 2.0236690795316647e-11
all O 0 3.5615337068417574e-11
of O 0 5.857034963367008e-14
these O 0 1.2108190968959653e-12
represent O 0 5.569736078597787e-12
common O 0 6.952258213566154e-10
ancestry O 0 1.0486929369335485e-07
and O 0 1.0431406849420455e-08
that O 0 2.2051350329066466e-11
very O 0 6.424853270931008e-12
few O 0 9.010723590885394e-12
spontaneously O 0 4.5531975412238523e-10
recurring O 0 8.630754564364906e-07
ATM O 0 0.0002237109438283369
mutations O 0 3.211972216377035e-05
exist O 0 3.0248248350517315e-08
. O 0 2.288330080979506e-10

Assays O 0 1.8330459283788514e-07
requiring O 0 6.777079453179624e-10
minimal O 0 5.444274371602109e-12
amounts O 0 7.282888891567071e-14
of O 0 4.045747787535147e-16
genomic O 0 2.84442972647847e-11
DNA O 0 1.0755485391200637e-06
were O 0 5.96095534044494e-11
designed O 0 3.273131765624271e-11
to O 0 4.443098619328224e-15
allow O 0 1.9101385783423103e-13
rapid O 0 5.549797275385127e-13
screening O 0 5.310099582267469e-12
for O 0 1.630166745407273e-14
common O 0 2.3884044156492756e-13
ethnic O 0 2.336220951935919e-13
mutations O 0 9.717226134853263e-09
. O 0 3.7165638622216335e-11

These O 0 3.5252863996027006e-12
rapid O 0 1.6703825822528273e-10
assays O 0 1.1614147865657287e-08
detected O 0 5.920715651086539e-08
mutations O 0 6.704968313897552e-08
in O 0 5.618644655439042e-13
76 O 0 7.61572671592603e-09
% O 0 2.0732393666428317e-12
of O 0 1.9078603714223208e-12
Costa O 0 5.019769560021814e-07
Rican O 0 6.5927983072811e-09
patients O 0 1.7548382191812095e-10
( O 0 5.338159605241264e-15
3 O 0 2.651833559599165e-13
) O 0 1.2375331777403093e-14
, O 0 1.9203799690042673e-15
50 O 0 3.3425634493339934e-14
% O 0 5.5427278028820706e-14
of O 0 8.078686157542148e-12
Norwegian O 1 0.6644313335418701
patients O 0 9.272952894434638e-08
( O 0 1.6201059591103295e-13
1 O 0 3.4062295627308725e-13
) O 0 2.6327615285895618e-14
, O 0 1.311935958904064e-14
25 O 0 4.3323713215005777e-13
% O 0 6.2023030415465745e-15
of O 0 3.1373433581963206e-13
Polish O 0 1.461009287595516e-05
patients O 0 2.4416363375578953e-10
( O 0 5.200694628231363e-15
4 O 0 1.1503055452610766e-12
) O 0 2.952469879365961e-14
, O 0 3.292028786074444e-14
and O 0 6.947770483933802e-12
14 O 0 2.5540427411874234e-11
% O 0 2.2014672596275438e-14
of O 0 8.435807391168892e-13
Italian O 0 1.0127730092790443e-05
patients O 0 2.4544499765966066e-09
( O 0 3.896264482382804e-14
1 O 0 4.732907859031354e-13
) O 0 1.0145366941298126e-13
, O 0 1.2557465883919396e-14
as O 0 2.7800729925607504e-13
well O 0 8.792354322904872e-13
as O 0 3.404763450343129e-12
in O 0 2.5012306950015356e-14
patients O 0 1.0798373913795123e-12
of O 0 5.038016444997018e-14
Amish O 0 2.769370075839106e-05
/ O 0 8.11626796348719e-06
Mennonite O 0 1.620924990675121e-06
and O 0 2.7188730200577993e-07
Irish O 0 8.803014679870103e-06
English O 0 1.4852227891992698e-08
backgrounds O 0 1.3993953551505456e-08
. O 0 1.5712996181971306e-10

Additional O 0 2.0075772988459306e-10
mutations O 0 3.286922662937286e-07
were O 0 1.8958543068769984e-11
observed O 0 3.685925523133626e-11
in O 0 6.237302612333712e-14
Japanese O 0 1.576505814782081e-09
, O 0 1.3347626709754438e-15
Utah O 0 5.073367873270444e-14
Mormon O 0 1.2362456707198238e-13
, O 0 1.1308652853123796e-13
and O 0 1.1327654309348234e-12
African O 0 3.3766954076613898e-12
American O 0 4.441161327584098e-10
patients O 0 2.1407049743960016e-11
. O 0 1.1981561576224209e-12

These O 0 1.7384589861418887e-12
assays O 0 8.613201818441496e-10
should O 0 6.301191935852851e-14
facilitate O 0 2.203281773607152e-14
screening O 0 4.9744691005271235e-11
for O 0 1.4893735550414178e-11
A B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999994039535522
T I-Disease 1 1.0
heterozygotes O 0 2.0622596821340267e-06
in O 0 7.861608228559164e-14
the O 0 1.6818174592781246e-14
populations O 0 1.5869841248419836e-12
studied O 0 4.351370826161105e-12
. O 0 3.1231202519965695e-14
. O 0 2.1204342535302567e-12

The O 0 1.5176622625290292e-08
von B-Disease 1 0.9989964365959167
Hippel I-Disease 1 0.999148964881897
- I-Disease 1 0.9992689490318298
Lindau I-Disease 1 0.9957489967346191
tumor I-Disease 0 0.003971211612224579
suppressor O 0 9.006837444758276e-07
gene O 0 1.8345290300203487e-05
is O 0 2.3604831977941387e-10
required O 0 2.1110838771543072e-12
for O 0 2.2361266619830636e-14
cell O 0 2.3987820618742717e-09
cycle O 0 3.1416186629940057e-07
exit O 0 1.0081349977042464e-08
upon O 0 1.217146383680756e-10
serum O 0 2.035694251389941e-06
withdrawal O 0 1.7391258211318927e-08
. O 0 1.7922354572652566e-11

The O 0 2.829219844513453e-11
inactivation O 0 1.959071823876002e-06
of O 0 7.267032028218656e-13
the O 0 2.2077538408549202e-10
von B-Disease 1 0.9999673366546631
Hippel I-Disease 1 0.9999610185623169
- I-Disease 1 0.9999895095825195
Lindau I-Disease 1 0.9998643398284912
( I-Disease 0 9.290705982323288e-09
VHL I-Disease 0 6.226744881132618e-05
) I-Disease 0 2.2871409627311934e-12
tumor I-Disease 0 5.86827653137334e-09
suppressor O 0 2.0237996167793426e-08
gene O 0 7.523889280491858e-07
predisposes O 0 4.704695129476022e-06
affected O 0 3.255795988366117e-08
individuals O 0 7.474327580470064e-12
to O 0 6.198311720655159e-13
the O 0 6.155871368207499e-10
human O 0 0.002136825118213892
VHL B-Disease 1 0.999993085861206
cancer I-Disease 1 0.9999914169311523
syndrome I-Disease 1 0.999998927116394
and O 0 6.276288516682271e-11
is O 0 3.752433259951449e-12
associated O 0 9.904991757347936e-12
with O 0 4.1484726764906554e-09
sporadic B-Disease 1 0.7808698415756226
renal I-Disease 1 0.9999821186065674
cell I-Disease 1 0.9999856948852539
carcinomas I-Disease 1 1.0
( O 0 4.432586138136685e-06
RCC B-Disease 0 0.022290242835879326
) O 0 3.4827059014475026e-09
and O 0 3.9382266336929206e-09
brain B-Disease 0 4.920753781334497e-05
hemangioblastomas I-Disease 0 0.0048911720514297485
. O 0 5.143628856174587e-10

VHL O 0 0.05295475944876671
- O 0 4.6881919843144715e-05
negative O 0 2.7590434115154494e-07
786 O 0 7.111134436854627e-07
- O 0 1.3586686691269279e-05
0 O 0 1.6933184021628023e-10
RCC B-Disease 0 2.2702566582211148e-07
cells O 0 2.271650600960129e-08
are O 0 3.491588615456287e-11
tumorigenic O 0 3.351512714289129e-05
in O 0 4.737843797841812e-11
nude O 1 0.9996614456176758
mice O 0 0.4033673107624054
which O 0 5.059344609925631e-11
is O 0 1.9966298579754405e-13
suppressed O 0 5.216754762546461e-13
by O 0 1.8704983575591392e-16
the O 0 1.0587034102787162e-15
reintroduction O 0 1.0681540374424259e-10
of O 0 1.5286203292746992e-12
VHL B-Disease 0 7.909270607342478e-06
. O 0 2.096035324472556e-11

Remarkably O 0 7.618723429914098e-08
, O 0 3.171844026577525e-13
this O 0 3.558000805517703e-16
occurs O 0 4.230444391063043e-14
without O 0 1.932001345743891e-14
affecting O 0 1.791292288111368e-11
the O 0 4.652071371354094e-13
growth O 0 5.441561370389536e-06
rate O 0 2.2171088858158328e-06
and O 0 1.2807649905910434e-11
cell O 0 1.6228483834535012e-10
cycle O 0 1.2162981732899425e-08
profile O 0 2.9776436871742362e-09
of O 0 3.308111231237372e-14
these O 0 3.809123088021997e-14
cells O 0 8.825150354420386e-13
in O 0 1.8209912405558158e-14
culture O 0 9.615312018818045e-12
. O 0 1.8104450230649327e-11

The O 0 1.483227429766032e-11
786 O 0 8.607786483594282e-09
- O 0 5.945543648522289e-07
0 O 0 1.2849147960902751e-11
cell O 0 4.303374101510826e-09
line O 0 3.731912912030566e-08
, O 0 2.593244900501307e-14
like O 0 9.681225005692129e-13
many O 0 1.7770175250991088e-14
cancer B-Disease 0 2.527429654453073e-10
cells O 0 6.052064231709675e-12
, O 0 2.57620341075418e-13
fails O 0 1.8979283422648763e-10
to O 0 3.6842913702511693e-13
exit O 0 1.6692119686467777e-08
the O 0 4.353247363281243e-12
cell O 0 3.1816480561275284e-09
cycle O 0 3.050043773100697e-08
upon O 0 3.3623014095152115e-11
serum O 0 3.012233946719789e-07
withdrawal O 0 4.173392298412182e-09
. O 0 4.710485040221313e-12

Here O 0 2.7410995695476004e-09
, O 0 7.820584728857743e-14
it O 0 4.275348402805719e-15
is O 0 2.0917535807168887e-15
shown O 0 8.546054218027538e-15
that O 0 4.858572713644541e-17
reintroduction O 0 1.8361637351641674e-13
of O 0 3.7256693363003565e-15
the O 0 1.3284651970060096e-13
wild O 0 5.236946662989794e-07
- O 0 8.17550881038187e-06
type O 0 2.852693228305725e-07
VHL B-Disease 0 2.566588079844223e-07
gene O 0 2.773858920335215e-10
restores O 0 4.987487645102817e-10
the O 0 7.761574992741146e-14
ability O 0 8.961417025110663e-11
of O 0 3.909482113040319e-12
VHL O 0 0.02090887911617756
- O 0 0.00010875028237933293
negative O 0 6.398995992640266e-06
RCC B-Disease 0 0.00011967797036049888
cancer I-Disease 0 3.684241107748676e-07
cells O 0 4.881139936685486e-11
to O 0 5.636610224250306e-14
exit O 0 8.961593134237944e-10
the O 0 2.1609406972156187e-12
cell O 0 6.622519066468158e-08
cycle O 0 1.456195377613767e-06
and O 0 1.1861311932648277e-10
enter O 0 4.171048575973835e-11
G0 O 0 2.3638607160592073e-07
/ O 0 3.2266151972493162e-09
quiescence O 0 2.617628069856437e-08
in O 0 4.978615176370882e-12
low O 0 9.278769752540938e-09
serum O 0 9.210218365751643e-08
. O 0 1.842072848423637e-11

Both O 0 3.642167012429809e-09
VHL O 0 0.0005120216519571841
- O 0 2.313254663022235e-05
positive O 0 1.4156458405523153e-07
and O 0 4.69760619292714e-10
VHL O 0 0.00033535476541146636
- O 0 3.7039592371002072e-06
negative O 0 1.0479671175289695e-07
RCC B-Disease 0 2.1330677100195317e-06
cells O 0 9.198522832321032e-09
exit O 0 3.868454001576538e-09
the O 0 2.786677410094446e-13
cell O 0 1.5814509701783663e-09
cycle O 0 4.132030717585167e-09
by O 0 7.274100755332719e-14
contact O 0 1.035488850220645e-08
inhibition O 0 8.023220487984872e-08
. O 0 3.1760365171162874e-11

The O 0 2.6767071892308536e-10
cyclin O 0 7.739811553619802e-05
- O 0 1.3246627531771082e-05
dependent O 0 9.00477843401859e-08
kinase O 0 9.093153039430035e-07
inhibitor O 0 1.0451106646769404e-07
, O 0 4.3253676465168645e-14
p27 O 0 2.8069296886812367e-11
, O 0 8.207563970436958e-16
accumulates O 0 8.067671422411216e-13
upon O 0 9.638953047189092e-14
serum O 0 2.7793273460474666e-08
withdrawal O 0 3.483248689484242e-10
, O 0 3.5062367692264207e-15
only O 0 2.00341037365887e-15
in O 0 7.289857241041719e-16
the O 0 1.6346075697431378e-13
presence O 0 3.487024835546748e-10
of O 0 6.382905814138196e-13
VHL B-Disease 0 2.972081801999593e-06
, O 0 2.6791240124827975e-13
as O 0 1.44681521537654e-13
a O 0 1.3386495145879806e-13
result O 0 1.0542497864279854e-12
of O 0 3.486698302583753e-14
the O 0 1.978464917937184e-12
stabilization O 0 4.520315510792017e-10
of O 0 5.1788187318191e-15
the O 0 1.8315116946925752e-13
protein O 0 1.936354965259568e-10
. O 0 7.886894262676414e-12

We O 0 2.9010080448976794e-10
propose O 0 1.9464183736994656e-11
that O 0 2.613090374235707e-14
the O 0 7.236387968608936e-15
loss O 0 1.0477373309225602e-11
of O 0 1.3951534731367152e-14
wild O 0 9.932629154718597e-07
- O 0 0.000564436602871865
type O 0 2.4100198061205447e-05
VHL B-Disease 0 1.9887856979039498e-05
gene O 0 2.574731361448812e-08
results O 0 1.2790074555013575e-11
in O 0 1.0432643289908753e-15
a O 0 6.577982058928117e-15
specific O 0 4.619667062083499e-12
cellular O 0 1.9468577647785423e-06
defect O 0 2.753967009994085e-06
in O 0 3.0558530966090514e-13
serum O 0 1.041647465171991e-06
- O 0 2.0304983081587125e-06
dependent O 0 4.368465340576222e-07
growth O 0 4.823479571314238e-07
control O 0 3.6138647629968546e-09
, O 0 3.3533443491613746e-13
which O 0 5.566780760316026e-13
may O 0 1.9998790817821188e-11
initiate O 0 6.681994957347115e-10
tumor B-Disease 0 5.389936745814339e-07
formation O 0 1.1811222000446264e-09
. O 0 7.59193402588565e-11

This O 0 7.575729106534812e-12
is O 0 4.553798202237835e-13
corrected O 0 1.8578426297377604e-10
by O 0 2.5456129979761744e-16
the O 0 8.840395520220447e-17
reintroduction O 0 2.0509542415086957e-12
of O 0 8.032689910366514e-14
wild O 0 9.403988201484026e-07
- O 0 0.005844084080308676
type O 0 0.00014422135427594185
VHL B-Disease 0 0.0002788315759971738
, O 0 6.846996385666271e-13
implicating O 0 1.9519501393006067e-07
VHL B-Disease 0 1.059362057276303e-05
as O 0 9.622204292028536e-13
the O 0 1.8603446030434874e-15
first O 0 3.4026321799225656e-13
tumor B-Disease 0 5.996603213986873e-11
suppressor O 0 6.918576128667198e-11
involved O 0 2.0253385080160058e-10
in O 0 9.823703130259695e-14
the O 0 2.8672059843547204e-13
regulation O 0 4.2437875436007744e-10
of O 0 4.723922398001609e-14
cell O 0 2.379760388748764e-09
cycle O 0 6.354059678415069e-07
exit O 0 2.0904933251131297e-07
, O 0 8.615592614336087e-12
which O 0 1.036549969121725e-12
is O 0 9.935645188530184e-12
consistent O 0 1.233223662078231e-10
with O 0 8.172990821446457e-13
its O 0 6.81265753445931e-13
gatekeeper O 0 1.1920221822947497e-06
function O 0 3.764694112007305e-11
in O 0 2.585171660074437e-13
the O 0 1.4457078763296938e-11
kidney O 0 1.879551092542897e-07
. O 0 1.3002116744376124e-12
. O 0 2.530129578071083e-11

Piebaldism B-Disease 1 0.9999996423721313
with O 0 0.3103308081626892
deafness B-Disease 1 1.0
: O 0 7.473943339220135e-12
molecular O 0 2.484478768549625e-11
evidence O 0 1.0022060265013621e-10
for O 0 2.2186056811146493e-11
an O 0 2.2757042916765613e-09
expanded O 1 0.9653970003128052
syndrome O 1 0.9999921321868896
. O 0 4.791025354222711e-10

In O 0 1.4596084757512173e-11
a O 0 2.573205364064801e-11
South O 0 1.8860459860547962e-09
African O 0 1.759502613052355e-11
girl O 0 5.168413697020924e-09
of O 0 2.0386356787264505e-14
Xhosa O 0 2.094586504242102e-09
stock O 0 3.7419609633104756e-09
with O 0 1.015652839608805e-11
severe O 0 3.0174028609053494e-08
piebaldism B-Disease 0 1.463749686081428e-05
and O 0 6.0816152114284705e-09
profound O 0 3.491314828352188e-07
congenital O 1 0.9999887943267822
sensorineural B-Disease 1 0.9999724626541138
deafness I-Disease 1 1.0
we O 0 5.428070835478138e-06
identified O 0 3.309962082198581e-09
a O 0 8.394856804063572e-14
novel O 0 3.20338963688549e-11
missense O 0 1.3954816324712738e-07
substitution O 0 1.4270943801686364e-11
at O 0 1.5979743570038174e-11
a O 0 3.188261490211751e-14
highly O 0 1.9750929949706453e-13
conserved O 0 3.708418988557227e-12
residue O 0 5.662521118665609e-08
in O 0 2.4297580549122177e-13
the O 0 2.5492219554897055e-13
intracellular O 0 8.038810506150185e-09
kinase O 0 7.252769940180315e-09
domain O 0 1.3315443192496446e-10
of O 0 4.2459997106822356e-13
the O 0 1.6650685821448241e-12
KIT O 0 2.576490942374221e-06
proto O 0 1.0400533483334584e-06
- O 0 7.50650173131362e-08
oncogene O 0 5.991718410314206e-08
, O 0 2.8829679529079888e-12
R796G O 0 3.6675626979842946e-09
. O 0 3.825217486513877e-12

Though O 0 1.2948901950693426e-09
auditory B-Disease 0 1.4252881896936742e-07
anomalies I-Disease 0 6.991651844145963e-06
have O 0 9.783216597947231e-11
been O 0 1.682147476866902e-11
observed O 0 2.6274180747742903e-11
in O 0 6.944503972523483e-14
mice O 0 1.7460899925936246e-07
with O 0 3.628808364908309e-11
dominant O 0 1.174346493826306e-06
white O 0 6.516066974882051e-08
spotting O 0 1.0484191989235114e-05
( O 0 6.902416138654388e-11
W O 0 0.008909543976187706
) O 0 1.471976186773194e-12
due O 0 1.2875171848808487e-12
to O 0 1.6458802636759584e-12
KIT O 0 0.0004893549485132098
mutations O 0 0.00012295025226194412
, O 0 1.4327286024240493e-08
deafness B-Disease 1 1.0
is O 0 1.143423933314125e-08
not O 0 6.863448177851783e-12
typical O 0 2.6886380274926402e-11
in O 0 8.582064095832842e-13
human O 0 3.397877257338422e-10
piebaldism B-Disease 0 5.172280907572713e-06
. O 0 3.88708093490564e-11

Thus O 0 9.639670173200443e-10
, O 0 1.890421548684032e-13
the O 0 1.3149873950965476e-14
occurrence O 0 7.692414705218198e-09
of O 0 2.339034743670254e-09
sensorineural B-Disease 1 0.9999890327453613
deafness I-Disease 1 1.0
in O 0 1.9600844558542718e-10
this O 0 1.2865689145557385e-13
patient O 0 1.161426857465564e-10
extends O 0 1.1758180150020503e-12
considerably O 0 1.9091260690384804e-13
the O 0 1.0260952887873858e-15
phenotypic O 0 3.496450240447757e-09
range O 0 2.1810142580847014e-09
of O 0 7.011989188072942e-13
piebaldism B-Disease 0 1.5859864106460009e-06
due O 0 1.1889233521300557e-11
to O 0 7.288919766151522e-14
KIT O 0 1.4313798146758927e-07
gene O 0 4.076000426067594e-09
mutation O 0 8.214934843486787e-10
in O 0 1.7200332141659863e-14
humans O 0 4.695632424556173e-11
and O 0 4.065374772932451e-11
tightens O 0 3.548020458765677e-06
the O 0 4.374960070325888e-14
clinical O 0 1.2861905984706823e-10
similarity O 0 4.911376427080283e-12
between O 0 9.693604426097568e-13
piebaldism B-Disease 0 6.593303965019004e-07
and O 0 3.980890703886297e-12
the O 0 4.1986732863543656e-15
various O 0 2.8911272789873543e-13
forms O 0 7.799868306790358e-09
of O 0 2.5734581754477404e-07
Waardenburg B-Disease 1 0.999954342842102
syndrome I-Disease 1 0.9999630451202393
. O 0 2.317400611684395e-12
. O 0 1.6294790169957274e-11

Cycloheximide O 0 1.912542870741163e-07
facilitates O 0 5.141213496595576e-11
the O 0 1.3548109032215927e-14
identification O 0 3.7589999472495417e-13
of O 0 5.2186004812198455e-15
aberrant O 0 1.4875410903059105e-09
transcripts O 0 3.6894742816429016e-09
resulting O 0 1.1236470781605945e-10
from O 0 1.0452298748742095e-12
a O 0 1.2528579519319183e-12
novel O 0 3.122048453096937e-10
splice O 0 0.0001822548219934106
- O 0 2.99297425954137e-07
site O 0 1.949838956960548e-09
mutation O 0 3.0316517296569145e-08
in O 0 5.547256989694993e-13
COL17A1 O 0 1.3559416629504994e-06
in O 0 2.6474805895205893e-14
a O 0 1.2602684737808567e-12
patient O 0 1.8942043489289517e-09
with O 0 4.981552323424232e-11
generalized O 0 1.0445050975249615e-05
atrophic B-Disease 1 0.9974900484085083
benign I-Disease 1 0.7598456740379333
epidermolysis I-Disease 1 0.9360604882240295
bullosa I-Disease 0 0.47998547554016113
. O 0 6.834148535972417e-08

Patients O 0 2.746256313912454e-06
with O 0 9.108604981378221e-10
generalized O 0 9.759182285051793e-05
atrophic B-Disease 1 0.9997078776359558
benign I-Disease 1 0.9983966946601868
epidermolysis I-Disease 1 0.9911326766014099
bullosa I-Disease 1 0.8256527781486511
often O 0 1.6909193618630525e-06
show O 0 2.0552391788442037e-07
decreased O 0 9.128057598672967e-08
expression O 0 1.7450851874656337e-10
of O 0 7.278812969024884e-12
type O 0 0.04050946235656738
XVII O 0 0.008094453252851963
collagen O 0 0.053572043776512146
, O 0 1.5401498132394664e-10
a O 0 1.528530774175252e-11
transmembrane O 0 8.947817775606381e-08
hemidesmosomal O 0 4.620178373215822e-08
protein O 0 6.321867942332693e-12
encoded O 0 4.559745810095439e-12
by O 0 1.2670895149086148e-12
COL17A1 O 0 3.65806081390474e-05
. O 0 4.855993385177726e-11

This O 0 7.770722433575461e-12
report O 0 4.273202885290983e-12
documents O 0 1.612495185120133e-12
a O 0 2.8024224650938234e-13
novel O 0 1.18027476680993e-10
splice O 0 0.000372559909010306
- O 0 3.593624455788813e-07
site O 0 1.0282122930860282e-09
mutation O 0 4.273903897455966e-08
in O 0 2.2815977622839267e-13
COL17A1 O 0 4.994680580239219e-07
in O 0 8.640328985056941e-15
a O 0 1.9061061594122936e-13
patient O 0 2.4488466809913234e-10
with O 0 8.974292663166406e-12
generalized O 0 2.1660225684172474e-06
atrophic B-Disease 1 0.9994378685951233
benign I-Disease 1 0.6449212431907654
epidermolysis I-Disease 0 0.01251823827624321
bullosa I-Disease 0 0.000620872771833092
, O 0 3.6356406774018524e-10
and O 0 4.4231144354783813e-13
applies O 0 2.778864107138429e-13
a O 0 5.3350247363034755e-15
new O 0 8.237857553224093e-14
methodology O 0 1.4978851492486456e-12
to O 0 6.079257784024142e-14
define O 0 5.494572019593136e-10
and O 0 2.027996694187184e-11
characterize O 0 8.056547096124689e-11
the O 0 2.394749708863747e-13
resulting O 0 8.434009567126477e-12
mRNA O 0 5.055910204387892e-11
splice O 0 4.542932401818689e-06
variants O 0 2.87661407583073e-07
. O 0 3.0630761815864105e-10

Mutational O 0 4.769717634189874e-06
analysis O 0 5.812752501554996e-10
of O 0 3.3315236420278227e-12
COL17A1 O 0 1.834189606597647e-05
identified O 0 4.169032674639084e-09
a O 0 1.0543246831140607e-11
maternally O 0 9.84862617769977e-06
inherited O 0 8.23015216155909e-05
G O 0 0.0006121554761193693
- O 0 5.394030040406506e-07
to O 0 7.850460836955619e-10
- O 0 4.3654032197082415e-05
T O 0 2.0463907276280224e-05
transversion O 0 4.3258921778033255e-08
at O 0 6.503340834601579e-12
the O 0 8.710388774190239e-15
- O 0 8.358681108378008e-11
1 O 0 1.0831413484223631e-13
position O 0 2.0992378029025677e-13
of O 0 3.548796733754601e-16
exon O 0 4.89671470038644e-10
32 O 0 2.752766348201874e-10
. O 0 6.027400367009106e-12

This O 0 1.296160878280772e-12
acceptor O 0 9.792178179424127e-11
splice O 0 6.011688356011291e-07
- O 0 4.931634478566593e-08
site O 0 4.679381326866405e-10
mutation O 0 2.3935957216281167e-08
led O 0 3.399521983360465e-11
to O 0 1.0606568927188156e-13
the O 0 4.893884979879047e-14
formation O 0 6.834265792177163e-12
of O 0 1.2843003231537663e-14
aberrant O 0 1.3489944716837954e-09
transcripts O 0 1.6126053825615827e-09
present O 0 7.425574911901212e-12
at O 0 1.237061286740726e-10
extremely O 0 2.783717145682374e-10
low O 0 1.0722624921299939e-07
levels O 0 4.51240955712251e-09
. O 0 1.742536497040259e-11

Based O 0 2.0395098804248946e-11
on O 0 2.9057676403931865e-12
our O 0 1.0413965832256969e-13
recent O 0 2.0595919514678797e-14
finding O 0 1.696765422392818e-13
that O 0 1.129259446369657e-13
cycloheximide O 0 4.829242357118346e-07
stabilized O 0 1.1186746462499286e-07
mutant O 0 8.33856184101478e-09
COL17A1 O 0 2.843412403308321e-07
transcripts O 0 8.825837283232829e-10
in O 0 1.805250285195903e-13
keratinocytes O 0 9.014823887376622e-10
homozygous O 0 1.5013455367807182e-07
for O 0 7.269291505546116e-13
a O 0 5.1045300798746585e-12
frameshift O 0 4.106344476895174e-06
mutation O 0 1.3405036725089303e-06
, O 0 1.2612809017695237e-12
the O 0 1.5768574055004259e-13
effects O 0 2.4505638407390506e-08
of O 0 4.4172551358877266e-13
the O 0 1.0040499681673865e-11
splice O 0 0.015525054186582565
- O 0 5.165313154975593e-07
site O 0 8.400624640358956e-10
mutation O 0 4.750949633702817e-10
on O 0 2.650827148932555e-13
splicing O 0 1.4350565007148486e-11
of O 0 1.9389565026803855e-14
COL17A1 O 0 3.3497582485608746e-09
transcripts O 0 6.1690882437182015e-12
were O 0 7.529792558241301e-15
determined O 0 6.474172242011472e-15
using O 0 6.346677605120407e-14
reverse O 0 1.1942428157496465e-09
transcriptase O 0 9.016448387910714e-08
polymerase O 0 3.5789360364191225e-09
chain O 0 7.948581348671269e-09
reaction O 0 3.2921137604197126e-12
of O 0 5.167646367244816e-16
total O 0 4.315116514976014e-14
RNA O 0 1.909543183298279e-11
from O 0 5.639771690022638e-14
keratinocytes O 0 5.4759259626724344e-11
incubated O 0 1.9620884778026593e-11
for O 0 8.202095822191016e-14
2 O 0 3.8181176970075725e-12
. O 0 3.0793286757285765e-12

5 O 0 1.88331039652212e-09
h O 0 9.916750087768378e-08
in O 0 2.1225411022968849e-13
the O 0 9.484139818979886e-14
presence O 0 4.571329426106274e-11
or O 0 2.084461596385534e-11
absence O 0 1.0494092574087066e-11
of O 0 6.0566159157176766e-15
10 O 0 2.246131449237798e-12
microg O 0 6.661078355563177e-09
cycloheximide O 0 4.168412282012923e-09
per O 0 9.527282608667864e-12
ml O 0 1.5489811744373583e-07
. O 0 4.8718570844208386e-11

Using O 0 1.8288639699881593e-11
this O 0 9.799468501199213e-14
approach O 0 5.180568127260976e-11
, O 0 3.084323161456348e-13
an O 0 5.344267780052481e-13
abnormally O 0 4.3793022541649407e-07
spliced O 0 0.0034539205953478813
transcript O 0 2.5531622668495402e-05
was O 0 1.1090462948004642e-07
identified O 0 1.168446561727876e-09
that O 0 4.299144099392934e-15
contains O 0 5.860965280945563e-15
an O 0 1.8241536380643898e-15
extra O 0 1.0224338736763983e-12
264 O 0 4.437702375709174e-12
bases O 0 2.2592806098176155e-11
upstream O 0 4.167181790609709e-12
from O 0 2.905127852691203e-14
exon O 0 1.5146627285744785e-09
32 O 0 3.7613079317821985e-10
, O 0 1.9823835430729346e-14
resulting O 0 1.7655419227297076e-13
in O 0 1.9589629126747637e-14
a O 0 1.2442852304062058e-11
premature O 0 1.915433500698782e-08
termination O 0 2.629445994273283e-09
codon O 0 7.855677885970636e-09
27 O 0 4.1700625591500895e-11
bp O 0 6.409388575434605e-10
downstream O 0 2.2818708034222368e-10
from O 0 4.535445708776266e-14
the O 0 2.593566603614674e-14
cryptic O 0 6.718105932668195e-11
splice O 0 1.07139371152698e-07
site O 0 5.325849983250919e-09
. O 0 1.556228340637844e-10

Three O 0 2.1260695981517586e-10
other O 0 8.447464732927457e-13
splice O 0 1.5866504554651328e-06
variants O 0 3.8904175880816183e-07
, O 0 6.624018824771816e-13
including O 0 4.625895952642227e-14
one O 0 1.529595982480928e-14
derived O 0 1.7166771002223753e-14
from O 0 9.037387537543656e-15
the O 0 2.763396074264451e-15
skipping O 0 3.0274940887586865e-10
of O 0 1.612450543095681e-14
exon O 0 1.2369840707293633e-09
32 O 0 2.3835853291132025e-09
, O 0 1.9344028874372643e-13
were O 0 1.7048276852726918e-12
also O 0 2.848050788262224e-11
identified O 0 1.0436874697816734e-09
. O 0 8.104865389935156e-11

These O 0 6.036304702611295e-12
results O 0 2.7385400804685878e-12
indicate O 0 2.7630734072275898e-12
the O 0 5.278705939157011e-15
usefulness O 0 9.96454915108691e-12
of O 0 6.917347503311447e-15
cycloheximide O 0 1.9270572693130816e-08
treatment O 0 7.461067354219697e-12
in O 0 6.04989365049003e-16
evaluating O 0 4.542046426470048e-12
the O 0 8.182123124107939e-15
abnormal O 0 1.8214247818337803e-11
processing O 0 5.248657758416542e-11
of O 0 4.9641280669421306e-15
mRNA O 0 2.0095828213301248e-12
due O 0 4.341886659237071e-12
to O 0 1.1442217074005e-13
splice O 0 0.0002726925304159522
- O 0 1.2053694717906183e-06
site O 0 9.595758854175074e-09
mutations O 0 5.992461069581623e-07
, O 0 1.4095451151760474e-12
because O 0 1.8713372865186706e-12
( O 0 7.918357403146128e-14
i O 0 5.317181805963855e-09
) O 0 3.571819353958769e-15
aberrant O 0 3.766975880531431e-12
splicing O 0 5.4599481186246024e-11
often O 0 2.1359767253537054e-12
generates O 0 4.312175616583147e-12
a O 0 1.4688637459125964e-11
premature O 0 3.15199848444081e-08
termination O 0 6.506576610831871e-09
codon O 0 1.0417210205559968e-08
, O 0 7.618035434246717e-13
( O 0 2.2756336338957198e-14
ii O 0 8.49210840536685e-11
) O 0 1.0009660235280136e-14
transcripts O 0 4.379073839655412e-11
with O 0 6.1296787957909604e-12
premature O 0 1.4780328072561133e-09
termination O 0 4.6898596117728175e-11
codons O 0 5.188580676218635e-10
can O 0 2.7334273733359282e-11
occur O 0 2.311004469388034e-12
at O 0 3.6323537927485106e-11
low O 0 1.0924020443781046e-07
or O 0 1.6137606451138709e-07
undetectable O 0 0.38147208094596863
levels O 0 1.2031119211997066e-08
due O 0 4.372636801253105e-12
to O 0 7.678839118382963e-13
nonsense O 0 2.7397661597206024e-06
- O 0 2.143775823526539e-09
mediated O 0 2.1589077747741214e-10
mRNA O 0 2.156616085800117e-13
decay O 0 3.781375212952298e-11
, O 0 1.48361927127319e-13
and O 0 1.2534069648070106e-13
( O 0 1.9458722725848327e-15
iii O 0 4.567703854041483e-11
) O 0 1.0569935091032587e-13
the O 0 6.646821358287716e-14
levels O 0 5.4273353172762384e-11
of O 0 8.237488056276677e-16
these O 0 3.7984413249307625e-15
transcripts O 0 3.689977143284118e-11
can O 0 2.3421126149614224e-11
be O 0 7.670437093647287e-13
increased O 0 1.4765363140056137e-13
by O 0 8.325175808064286e-14
cycloheximide O 0 2.7227804366702912e-06
. O 0 1.9926447644702527e-11

A O 0 8.385880323480421e-10
deletion O 0 1.1778897714975756e-06
mutation O 0 2.7294515803077957e-06
in O 0 9.73988684843663e-12
COL17A1 O 0 7.03040641383268e-05
in O 0 1.0750736238740455e-12
five O 0 6.86848078412794e-11
Austrian O 0 2.733213023020653e-06
families O 0 2.6361723567958073e-11
with O 0 1.9684844032585858e-10
generalized O 0 0.00011329529661452398
atrophic B-Disease 1 0.9998241066932678
benign I-Disease 1 0.9973006844520569
epidermolysis I-Disease 1 0.9558560252189636
bullosa I-Disease 0 0.0063397265039384365
represents O 0 1.882990652291028e-09
propagation O 0 4.473576023511505e-11
of O 0 2.4356509647702196e-13
an O 0 2.661775693520857e-13
ancestral O 0 1.559560836028595e-08
allele O 0 2.928935600721161e-06
. O 0 1.3950745003654674e-09

Patients O 0 6.13239717495162e-06
with O 0 1.6451890960667015e-09
generalized O 0 0.00033902269206009805
atrophic B-Disease 1 0.9998574256896973
benign I-Disease 1 0.9995536208152771
epidermolysis I-Disease 1 0.9958603978157043
bullosa I-Disease 1 0.864529013633728
, O 0 3.1691638202602235e-10
a O 0 1.9194381327414245e-12
usually O 0 4.851010218520635e-12
nonlethal O 0 5.648140177783034e-09
form O 0 7.372491506174583e-10
of O 0 1.24648083521528e-10
junctional B-Disease 0 0.0009071800159290433
epidermolysis I-Disease 0 0.016901882365345955
bullosa I-Disease 0 0.001500914804637432
, O 0 3.5688935140498756e-10
have O 0 4.487187097584888e-12
generalized O 0 4.739003078846338e-10
blistering B-Disease 0 5.007060281059239e-06
, O 0 1.9172080589768825e-10
nail B-Disease 1 0.9999246597290039
dystrophy I-Disease 1 0.9948334693908691
, O 0 6.064121982340964e-10
patchy B-Disease 0 0.0003077870642300695
alopecia I-Disease 1 0.99992835521698
, O 0 4.00380217868701e-09
and O 0 6.954213915832952e-08
dental B-Disease 1 0.9398785829544067
abnormalities I-Disease 1 0.9998571872711182
. O 0 1.444196207067705e-09

Skin B-Disease 1 0.9975519776344299
fragility I-Disease 0 0.00014982953143771738
in O 0 2.931915506817345e-13
most O 0 1.4115937897198581e-14
cases O 0 1.446803007260078e-11
is O 0 2.5205922418725102e-11
due O 0 2.368029817373385e-12
to O 0 1.5367171239937666e-13
mutations O 0 1.88988469318474e-09
in O 0 4.911612447728838e-15
the O 0 7.134914268560819e-15
gene O 0 1.1257562659849896e-09
encoding O 0 5.71405367466582e-09
type O 0 0.020669547840952873
XVII O 0 0.0005500202532857656
collagen O 0 7.274888048414141e-05
( O 0 1.1026306256933793e-10
COL17A1 O 0 7.651322448509745e-06
) O 0 3.8792281019384145e-12
. O 0 1.2042734431200186e-12

Recently O 0 1.1806489055743441e-05
, O 0 1.0235387190582479e-11
we O 0 4.0979298947252385e-12
reported O 0 1.4048274696309981e-11
five O 0 1.3104899977689488e-11
Austrian O 0 9.581165159033844e-07
families O 0 9.256342220487213e-12
with O 0 4.66734498272281e-11
generalized O 0 6.9303200689319056e-06
atrophic B-Disease 1 0.9995262622833252
benign I-Disease 1 0.6996812224388123
epidermolysis I-Disease 0 0.02613225020468235
bullosa I-Disease 0 0.0052155195735394955
who O 0 1.5486903066630475e-06
share O 0 2.6796340146795217e-10
the O 0 3.166826609973805e-13
same O 0 2.19095627057575e-11
COL17A1 O 0 4.6063392801443115e-05
mutation O 0 9.474367601569611e-08
. O 0 8.578734944642008e-11

Affected O 0 1.378687244368848e-07
individuals O 0 6.336031005416132e-11
in O 0 1.6642740516877724e-13
three O 0 6.2468810506366435e-12
families O 0 5.692470691869012e-13
are O 0 4.3989490598316666e-14
homozygous O 0 8.899475822943259e-09
for O 0 1.331393112077861e-12
4003delTC O 0 5.7275105547205385e-08
, O 0 1.9485621951154282e-14
whereas O 0 1.9639211047348115e-13
those O 0 1.1139747978228254e-12
in O 0 1.81228729939642e-14
two O 0 2.045235291889269e-12
others O 0 9.49276421358114e-12
are O 0 9.893917418202572e-14
compound O 0 1.0449387665908971e-12
heterozygotes O 0 1.3287017708307758e-08
. O 0 1.892746896714481e-11

To O 0 4.668055005041527e-12
determine O 0 1.624476594908053e-11
if O 0 1.7048276852726918e-12
the O 0 7.507048876574576e-15
occurrence O 0 2.553099121005431e-10
of O 0 6.787521391292406e-13
4003delTC O 0 5.108787703989037e-08
in O 0 6.960759212407651e-15
these O 0 1.7402742946384013e-15
unrelated O 0 3.0839484611855372e-12
families O 0 9.630750210721292e-15
signifies O 0 7.348722325106749e-14
propagation O 0 1.2192193598031115e-13
of O 0 5.724107711262139e-14
an O 0 4.1016894199684406e-13
ancestral O 0 9.069776041314981e-09
allele O 0 4.528803287939809e-07
or O 0 5.797940350049657e-09
a O 0 1.3698793488448047e-10
mutational O 0 5.201638941798592e-06
hot O 0 1.9144713405694347e-06
spot O 0 1.189557906400296e-06
, O 0 7.72859207187615e-13
haplotypes O 0 1.296317914123435e-10
were O 0 1.862215026279812e-12
determined O 0 2.1058237618942766e-12
for O 0 1.2192054007001407e-13
polymorphisms O 0 6.986346789972231e-08
both O 0 3.287806138452254e-10
within O 0 4.4365702084325775e-11
and O 0 5.1120303545815204e-09
flanking O 0 0.0002496349043212831
COL17A1 O 0 0.13554319739341736
. O 0 3.3214769823430856e-10

Five O 0 4.531557351583615e-09
intragenic O 0 1.482800598751055e-06
polymorphisms O 0 4.724721236470941e-07
were O 0 5.0162009962440024e-11
chosen O 0 3.545710545917874e-13
based O 0 2.7825026896292904e-13
on O 0 1.5830012300988017e-10
their O 0 8.17346277465214e-12
informativeness O 0 2.759972176136216e-06
. O 0 1.188465298396224e-11

One O 0 2.5192273614416116e-11
of O 0 3.6549275162379297e-14
these O 0 2.5672941826896875e-14
, O 0 1.6005922512407102e-14
not O 0 5.599640963047624e-14
previously O 0 3.2323992371630084e-09
reported O 0 2.0893127228305275e-08
, O 0 1.8125656140940971e-12
was O 0 8.960927000423169e-10
2988 O 0 7.052160633236326e-09
A O 0 5.276461906289498e-11
or O 0 7.525418066478551e-10
C O 0 2.7555847381677268e-08
that O 0 4.548917598395756e-14
introduces O 0 4.106317716412455e-12
a O 0 2.938587686986821e-14
new O 0 9.440302137014508e-14
restriction O 0 6.236589071778945e-14
site O 0 4.383741091483484e-13
for O 0 4.901304514158544e-13
Eco0109 O 0 2.669198861937616e-09
I O 0 2.3380417246698926e-07
. O 0 7.529344335510668e-12

All O 0 3.9718672795174825e-11
the O 0 4.748161499396053e-13
4003delTC O 0 1.0383605975050614e-08
alleles O 0 7.830899817484749e-10
showed O 0 6.734842461497692e-09
the O 0 6.539676264437962e-15
same O 0 3.778413400299524e-14
haplotype O 0 2.5645574205923616e-11
for O 0 2.3985560716408005e-14
these O 0 6.1269344734163605e-15
five O 0 3.319001974297353e-13
polymorphic O 0 3.144490667850164e-09
markers O 0 2.3141117253544508e-06
. O 0 2.3433294193964116e-10

Fourteen O 0 4.4921604214209765e-09
microsatellite O 0 2.1263967653339932e-07
polymorphisms O 0 6.765054081370181e-07
were O 0 3.561010861186098e-11
selected O 0 3.0307440584964596e-12
based O 0 1.115917999824044e-13
on O 0 1.414224293228017e-10
their O 0 1.061929277151874e-11
high O 0 6.972579846831195e-09
heterozygosity O 0 2.496775675098206e-09
and O 0 4.176412254225381e-12
their O 0 1.107541741830623e-14
location O 0 1.0121289657077925e-12
within O 0 7.103932784906231e-13
10q23 O 0 5.179387585485529e-09
- O 0 1.6690338000557858e-08
q25 O 0 1.2866703258396228e-08
near O 0 1.7030298282705303e-09
COL17A1 O 0 1.4108994946582243e-05
. O 0 8.262528855551565e-11

Three O 0 1.5488674787178525e-09
families O 0 1.068781174673461e-11
shared O 0 2.5940156272996617e-11
microsatellite O 0 1.28276769828517e-06
polymorphisms O 0 3.695856867125258e-05
covering O 0 1.8921504306490533e-05
at O 0 8.297015341440783e-08
most O 0 1.1093784745008772e-11
19 O 0 2.9838506665491593e-10
cM O 0 1.5416523613254185e-09
, O 0 1.891466414646447e-14
whereas O 0 1.371846158806228e-13
the O 0 1.9687817185993356e-13
others O 0 2.2368211449741437e-11
shared O 0 3.466188100431644e-11
smaller O 0 6.725776602323208e-10
regions O 0 3.3648175912226463e-10
consistent O 0 3.949389704160922e-09
with O 0 8.722305863684277e-12
cross O 0 2.908477654273156e-07
- O 0 7.467582690878771e-06
over O 0 1.3636502593783462e-08
events O 0 6.41066921769351e-11
during O 0 1.7438299068639473e-11
passage O 0 2.2487366786380636e-13
of O 0 2.856820631973048e-15
this O 0 8.632648513807713e-16
mutation O 0 3.3349676644388315e-13
through O 0 7.662971548538094e-15
several O 0 1.366036596990236e-13
generations O 0 3.532006631612461e-10
. O 0 2.0422970606337465e-11

These O 0 1.638954770510903e-11
results O 0 4.7860909679897645e-11
indicate O 0 2.744618976535662e-10
that O 0 9.41495752887489e-12
4003delTC O 0 2.3205757315736264e-06
occurs O 0 2.1887855417013213e-10
on O 0 2.1936898911972813e-12
a O 0 1.2835369431803828e-13
single O 0 6.810442487736879e-11
ancestral O 0 1.0686553031380441e-10
allele O 0 2.0555002144817536e-09
. O 0 1.4225959819869072e-12
. O 0 1.261707405220136e-11

The O 0 1.652723929934652e-10
haptoglobin O 0 8.225586043408839e-07
- O 0 2.963729350824451e-08
gene O 0 2.425470713163236e-09
deletion O 0 1.4178015206312011e-08
responsible O 0 3.915054502812154e-09
for O 0 7.092387874912953e-12
anhaptoglobinemia B-Disease 0 1.1544922926987056e-05
. O 0 6.162082649696643e-11

We O 0 1.5136929931713894e-08
have O 0 4.398095657196649e-13
found O 0 8.602938917886063e-14
an O 0 3.3389805846704024e-15
allelic O 0 4.991084767702603e-10
deletion O 0 1.1138266131638375e-07
of O 0 4.019680855532615e-12
the O 0 3.691537960731628e-12
haptoglobin O 0 5.794947099957426e-08
( O 0 1.1581378488601662e-13
Hp O 0 9.741353557135568e-12
) O 0 8.538326630570618e-16
gene O 0 1.4891058221569442e-12
from O 0 5.2783061396059067e-14
an O 0 2.2544989760155988e-14
individual O 0 1.1475099516433662e-11
with O 0 3.9544101326782766e-09
anhaptoglobinemia B-Disease 0 0.0003874240501318127
. O 0 1.67161284814199e-10

The O 0 8.305121347584876e-12
Hp O 0 8.948087604210286e-09
gene O 0 7.505926546969022e-09
cluster O 0 2.6938251629360366e-09
consists O 0 1.5693272419417537e-12
of O 0 2.4532313707597078e-14
coding O 0 3.105387236246315e-08
regions O 0 3.968762471440179e-11
of O 0 1.2412878884482392e-13
the O 0 3.7763691371033026e-13
alpha O 0 3.169704733060885e-12
chain O 0 6.496744475725791e-08
and O 0 7.349149934443577e-12
beta O 0 8.769136946532724e-14
chain O 0 2.5912674783690193e-10
of O 0 1.377437948451481e-14
the O 0 1.8900466857828951e-13
haptoglobin O 0 1.007600225477745e-09
gene O 0 1.1598418059310944e-10
( O 0 4.8132706520031925e-15
Hp O 0 4.975615405800049e-12
) O 0 6.34287451189053e-15
and O 0 1.8431347146761166e-14
of O 0 8.279292837992821e-16
the O 0 2.1186260482520397e-13
alpha O 0 2.5180489204162937e-12
chain O 0 6.316059142363883e-08
and O 0 3.2769297692025745e-11
beta O 0 1.814858349323198e-13
chain O 0 1.8042960181485768e-10
of O 0 2.2322147250194643e-14
the O 0 9.525478279412414e-13
haptoglobin O 0 2.5442059126135064e-08
- O 0 3.4425759465328554e-10
related O 0 1.7949253194871062e-10
gene O 0 1.0099826752707486e-08
( O 0 2.1282976737316966e-13
Hpr O 0 3.024683281616092e-10
) O 0 6.714662598725565e-14
, O 0 4.439727004681678e-15
in O 0 5.016532513081096e-16
tandem O 0 5.090712296151878e-09
from O 0 8.943564205193821e-13
the O 0 6.3913761436107386e-12
5 O 0 1.6274587233411353e-09
side O 0 2.3271276461400703e-08
. O 0 7.855339989593091e-11

Southern O 0 5.198112162929647e-09
blot O 0 9.682660675025545e-06
and O 0 4.25988931629373e-12
PCR O 0 1.7551538000759592e-09
analyses O 0 6.973743110760822e-11
have O 0 1.950616968296459e-12
indicated O 0 2.0121218059776513e-12
that O 0 1.3244310924804279e-15
the O 0 2.9825686022235797e-15
individual O 0 9.69144144276346e-13
with O 0 7.249329175146313e-12
anhaptoglobinemia B-Disease 0 9.304636705564917e-07
was O 0 8.429194009451635e-10
homozygous O 0 1.0598507849124417e-08
for O 0 5.513036926388555e-14
the O 0 1.902556447618258e-14
gene O 0 7.141779945207816e-10
deletion O 0 1.1489576223766562e-07
and O 0 1.826254009129613e-10
that O 0 1.1208583025482458e-13
the O 0 6.342850371451533e-15
gene O 0 5.994238994055934e-10
deletion O 0 5.3702660096632826e-08
was O 0 6.447598455139314e-09
included O 0 7.869072581045966e-12
at O 0 7.2453206628741995e-12
least O 0 8.401917162492115e-15
from O 0 9.861883479170361e-15
the O 0 2.908298805232544e-14
promoter O 0 1.7872124891127328e-09
region O 0 2.328818019502188e-13
of O 0 2.4851182225206275e-15
Hp O 0 1.3367813800346795e-10
to O 0 1.3503038409092526e-14
Hpr O 0 1.132920077195898e-10
alpha O 0 1.5113379840149543e-13
but O 0 1.6228213434513195e-13
not O 0 1.0075923114524071e-13
to O 0 3.111207038525299e-13
Hpr O 0 3.1874442640855705e-08
beta O 0 1.4335847613178299e-11
( O 0 2.6018968338377413e-13
Hpdel O 0 6.88827173078721e-09
) O 0 4.78544721210783e-13
. O 0 1.6823774361476862e-12

In O 0 1.1103522615241168e-11
addition O 0 7.920148044349151e-12
, O 0 6.480278417824933e-14
we O 0 1.4056621535155078e-13
found O 0 8.156078351757856e-13
seven O 0 4.576648955645357e-12
individuals O 0 3.5777346254865783e-13
with O 0 9.981607554387928e-13
hypohaptoglobinemia B-Disease 0 8.29505950150633e-07
in O 0 2.968485375044738e-13
three O 0 3.9821836800291166e-11
families O 0 4.202173331524506e-12
, O 0 8.190620897447973e-14
and O 0 4.314542429925683e-13
the O 0 1.507292757946775e-14
genotypes O 0 3.68459873723026e-10
of O 0 4.578285585929778e-14
six O 0 7.039605010028538e-10
of O 0 1.9944869323815229e-13
the O 0 4.626968513193885e-12
seven O 0 7.288461500998267e-10
individuals O 0 1.2239737869068623e-11
were O 0 1.0683953721724038e-12
found O 0 5.389834412117267e-12
to O 0 5.303469902823155e-12
be O 0 5.071203901252375e-09
Hp2 O 0 3.090570089625544e-06
/ O 0 5.3892076579131754e-08
Hpdel O 0 4.0374123955189134e-07
. O 0 1.791791194583059e-11

The O 0 8.898719955352519e-11
phenotypes O 0 2.496375088867353e-07
and O 0 5.712260525703172e-11
genotypes O 0 1.0143843987009404e-08
in O 0 9.269936706267357e-14
one O 0 2.92851192514737e-13
of O 0 2.6918753650553764e-15
these O 0 4.849136568088781e-14
three O 0 1.3555055515535042e-11
families O 0 2.094895220836057e-12
showed O 0 5.5688631483974405e-09
the O 0 3.3063588217134565e-13
father O 0 4.0912664367454e-09
to O 0 5.707846955499418e-12
be O 0 2.5994850716415385e-10
hypohaptoglobinemic B-Disease 0 2.300243906461219e-08
( O 0 4.103525990685995e-14
Hp2 O 0 8.435240839155256e-10
) O 0 3.5408762239560326e-14
and O 0 4.3387884431089763e-13
Hp2 O 0 3.2062551724720834e-08
/ O 0 2.624495731851084e-09
Hpdel O 0 4.4955225320109093e-08
, O 0 2.3685782203847552e-14
the O 0 2.9853686813889656e-15
mother O 0 1.8897396147909973e-10
to O 0 5.178920036959592e-14
be O 0 1.1285263522287092e-11
Hp2 O 0 1.3430005552095281e-08
- O 0 7.071849217332726e-10
1 O 0 2.489686191584073e-12
and O 0 2.1262052448539626e-12
Hp1 O 0 1.3401703746751537e-08
/ O 0 1.0059807847850877e-10
Hp2 O 0 6.035136834725563e-10
, O 0 5.575209504706023e-16
one O 0 2.3871892494776504e-16
of O 0 9.624534947652135e-17
the O 0 1.0239335760026981e-14
two O 0 9.5477976653352e-13
children O 0 2.321466152990781e-12
to O 0 2.6643243478965094e-14
be O 0 1.0900356138543454e-11
hypohaptoglobinemic B-Disease 0 7.878124819171717e-09
( O 0 2.4119796803822972e-14
Hp2 O 0 1.2884697753179353e-09
) O 0 3.727057453894317e-14
and O 0 7.222027338139869e-13
Hp2 O 0 1.8097434661967782e-08
/ O 0 1.60440161156572e-09
Hpdel O 0 3.507981816142092e-08
, O 0 6.597625007084829e-14
and O 0 7.931081193266604e-15
the O 0 2.53269151036581e-16
other O 0 3.009628679086218e-14
child O 0 3.0503388703806422e-09
to O 0 2.1262598818671923e-14
be O 0 9.985630378128718e-12
Hp1 O 0 3.0264867945106744e-08
and O 0 1.910679774119739e-11
Hp1 O 0 5.8800772251288436e-08
/ O 0 1.9470294265744315e-09
Hpdel O 0 5.326926899584805e-09
, O 0 1.623736219502484e-15
showing O 0 1.1333447201555824e-12
an O 0 1.4956733082071064e-15
anomalous O 0 1.2415991845760033e-11
inheritance O 0 1.2246779146352083e-09
of O 0 4.492190300298127e-11
Hp O 0 1.6241310731857084e-06
phenotypes O 0 2.5816994764227275e-08
in O 0 1.8394377546745305e-13
the O 0 1.6335515839321912e-12
child O 0 5.7115939853247255e-06
with O 0 1.0011399348419658e-10
Hp1 O 0 5.65903519600397e-06
. O 0 3.666334943974725e-11

The O 0 1.1380464626231657e-10
Hp2 O 0 1.5393899275295553e-06
/ O 0 1.7588450873518013e-07
Hpdel O 0 8.924209851102205e-07
individuals O 0 2.2984872338760454e-10
had O 0 3.4648017788185825e-10
an O 0 2.770291049510043e-13
extremely O 0 5.001369984825033e-09
low O 0 3.6426141036827175e-07
level O 0 8.166722853530928e-10
of O 0 2.7461529822055478e-14
Hp O 0 7.894607745306814e-10
( O 0 1.088135285272785e-14
mean O 0 1.3260457185429453e-12
+ O 0 4.1247803783672765e-12
/ O 0 9.258117605881466e-10
- O 0 8.665639761318289e-09
SD O 0 4.434810307429871e-06
= O 0 2.8367591609068654e-10
0 O 0 6.346656056602229e-13
. O 0 3.030473397588494e-15
049 O 0 3.1186855875553476e-10
+ O 0 5.699415332044433e-12
/ O 0 1.446290448514631e-10
- O 0 2.453175718120093e-10
0 O 0 2.593716257395795e-13
. O 0 1.025680454401468e-15
043 O 0 6.373751526567162e-11
mg O 0 6.170115113279806e-11
/ O 0 1.0781626459677174e-11
ml O 0 5.233154187767042e-11
; O 0 1.32016937326126e-14
n O 0 9.095249553503493e-11
= O 0 2.5171378870147976e-11
6 O 0 5.204709276410147e-13
) O 0 5.094890472240408e-16
, O 0 7.291133216767419e-17
compared O 0 3.684535383502614e-14
with O 0 4.32640929375408e-13
the O 0 6.258043562523685e-12
level O 0 1.10031441735714e-08
( O 0 2.6053466296253186e-14
1 O 0 3.910133799861146e-14
. O 0 2.3078998717137146e-15
64 O 0 1.962589162365913e-12
+ O 0 3.2365401591433196e-12
/ O 0 9.55666171198466e-11
- O 0 2.266342530310439e-10
1 O 0 1.1579308475603844e-12
. O 0 1.2284366368098612e-14
07 O 0 3.040525123343407e-11
mg O 0 2.8281460506818235e-11
/ O 0 8.064471399699125e-13
ml O 0 2.7866028711950874e-13
) O 0 1.6353276337750877e-17
obtained O 0 1.652719039979566e-16
from O 0 2.0298270019431268e-15
52 O 0 9.399527163556076e-12
healthy O 0 1.320076409294657e-10
volunteers O 0 2.303483792598371e-12
having O 0 7.425068893063269e-11
phenotype O 0 1.3347692950915757e-09
Hp2 O 0 7.485085262715074e-08
, O 0 3.2706181648601076e-14
whereas O 0 8.846583540592437e-14
the O 0 1.0845300589393866e-14
serum O 0 2.8926445683197244e-09
Hp O 0 4.153666299799852e-09
level O 0 9.424844238381525e-11
of O 0 1.0216588690228467e-14
an O 0 5.438967418808227e-13
individual O 0 8.061342565701679e-11
with O 0 4.880632786807837e-09
Hp1 O 0 4.5714830775978044e-05
/ O 0 3.3608770877435745e-07
Hpdel O 0 1.9965204955951776e-06
was O 0 2.305883040065737e-09
0 O 0 4.557661192894358e-11
. O 0 5.945781193783528e-12

50 O 0 4.237448170130165e-09
mg O 0 1.4054062091872765e-07
/ O 0 6.956150855330634e-08
ml O 0 1.752091662865496e-07
, O 0 7.911447647175607e-13
which O 0 9.08252507626989e-15
was O 0 1.0233800569123264e-12
approximately O 0 4.610006292178094e-14
half O 0 3.1541692001313404e-12
the O 0 1.3636104235787566e-13
level O 0 8.462079127691258e-12
of O 0 1.960438486420528e-15
Hp O 0 1.5718361334737807e-10
in O 0 1.7427133683616675e-14
control O 0 4.0168243731208975e-11
sera O 0 1.663364201931472e-08
from O 0 3.623926449181601e-14
the O 0 1.288172314043573e-13
Hp1 O 0 7.618548636401101e-08
phenotype O 0 7.672346785669859e-11
( O 0 4.445251777080144e-15
1 O 0 2.1972805451758552e-14
. O 0 4.0033013254218985e-15
26 O 0 2.7771912373963925e-12
+ O 0 1.783035416362544e-12
/ O 0 8.678698731889867e-11
- O 0 1.9304105536299687e-10
0 O 0 1.0252355334052637e-13
. O 0 8.923513275147735e-16
33 O 0 3.4007895783304265e-13
mg O 0 1.687375586478801e-11
/ O 0 2.8156845344878834e-12
ml O 0 2.1455490162303192e-11
; O 0 1.260613300893684e-14
n O 0 2.457667125366214e-10
= O 0 8.429688197475471e-11
9 O 0 5.4151522675682795e-12
) O 0 1.5658264827228389e-15
, O 0 4.277056802085882e-17
showing O 0 4.2502451753391457e-13
a O 0 2.4401089669342547e-14
gene O 0 6.802306495856669e-10
- O 0 4.735502301400629e-08
dosage O 0 8.274242446759672e-08
effect O 0 1.0478102829836189e-09
. O 0 5.793498493444904e-12

The O 0 5.860817907377136e-12
other O 0 2.042848312386325e-13
allele O 0 2.572161650338245e-10
( O 0 2.356372746665364e-13
Hp2 O 0 1.7630988891070842e-09
) O 0 4.775084712675074e-15
of O 0 3.214447153787115e-16
individuals O 0 6.448323320619453e-13
with O 0 8.705818184406855e-12
Hp2 O 0 2.6640457235771464e-06
/ O 0 4.4579184788062776e-08
Hpdel O 0 2.1326064469917583e-08
was O 0 1.5888689669507627e-11
found O 0 7.970974141152665e-13
to O 0 4.122284924436975e-13
have O 0 9.915714777042339e-11
, O 0 3.931371965167421e-14
in O 0 5.758511563777472e-15
all O 0 1.4769574452344614e-11
exons O 0 2.081668242226442e-07
, O 0 3.287219671813113e-12
no O 0 1.3344184698199646e-12
mutation O 0 4.426290063641591e-12
, O 0 8.938191429681366e-17
by O 0 8.466282904986394e-18
DNA O 0 4.59192449689394e-12
sequencing O 0 2.9653448585520437e-09
. O 0 1.8219538377994837e-10

On O 0 1.04868148886883e-10
the O 0 1.735889332125408e-14
basis O 0 2.1011045279930446e-13
of O 0 7.242214708253099e-15
the O 0 1.3835869841320736e-13
present O 0 6.786459957365543e-13
study O 0 1.597853793722237e-13
, O 0 4.0936115547416784e-15
the O 0 3.7358859300727827e-16
mechanism O 0 1.2945628943827892e-11
of O 0 7.966287948312639e-14
anhaptoglobinemia B-Disease 0 1.3448432127916021e-06
and O 0 1.9349214938624293e-11
the O 0 4.941135357588913e-15
mechanism O 0 5.384593378815472e-12
of O 0 2.2017264093577562e-15
anomalous O 0 8.502233639351431e-12
inheritance O 0 1.0322498411596825e-10
of O 0 3.731990844829669e-12
Hp O 0 2.8775110649803537e-07
phenotypes O 0 7.489140330108057e-08
were O 0 1.6169586503078648e-11
well O 0 1.6508612185606175e-11
explained O 0 9.533240863390802e-09
. O 0 2.5586015944822904e-11

However O 0 3.697265604785116e-09
, O 0 2.348157746804441e-13
the O 0 7.298041802773683e-15
mechanism O 0 3.164269887778737e-11
of O 0 2.3738351779059585e-13
hypohaptoglobinemia B-Disease 0 3.627210753620602e-05
remains O 0 1.2121757819727463e-08
unknown O 0 2.8084549796858482e-08

ATM O 0 0.00025376948178745806
mutations O 0 0.0010217454982921481
and O 0 2.29268817264483e-08
phenotypes O 0 0.0002297720784554258
in O 0 1.0645879910953226e-07
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
telangiectasia I-Disease 1 1.0
families O 0 0.0010843462077900767
in O 0 9.302790482390577e-11
the O 0 5.86373061217671e-10
British O 0 0.001022909302264452
Isles O 0 1.116834141612344e-06
: O 0 2.7110562059173837e-13
expression O 0 3.303495579301194e-14
of O 0 2.3337054716056457e-16
mutant O 0 1.1454506093633299e-10
ATM O 0 7.420619851927768e-08
and O 0 2.121653026876391e-11
the O 0 7.107022761097814e-13
risk O 0 8.380323635037712e-08
of O 0 2.8121718842477605e-10
leukemia B-Disease 1 0.9910504817962646
, O 0 1.0484534413990332e-06
lymphoma B-Disease 1 1.0
, O 0 3.247832225383718e-08
and O 0 3.92028397300237e-07
breast B-Disease 1 0.9119918942451477
cancer I-Disease 0 0.0003552958369255066
. O 0 2.2770807461824916e-09

We O 0 1.4319238850202254e-10
report O 0 1.2137417806923345e-12
the O 0 1.0747644255080786e-15
spectrum O 0 2.299264294583492e-13
of O 0 1.643735874409108e-14
59 O 0 4.30432182951801e-11
ATM O 0 3.704669552462292e-06
mutations O 0 1.744966175465379e-05
observed O 0 8.506421181664336e-06
in O 0 1.395765139022842e-07
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
telangiectasia I-Disease 1 1.0
( O 0 0.0028849684167653322
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.5692748489559705e-10
patients O 0 2.2536899429992374e-11
in O 0 4.730809029972671e-15
the O 0 7.337114856648119e-13
British O 0 4.966398591932375e-06
Isles O 0 1.662521026446484e-05
. O 0 3.633519596313306e-10

Of O 0 5.009861622773393e-11
51 O 0 3.232906209404973e-08
ATM O 0 6.989216490183026e-05
mutations O 0 7.731168807367794e-06
identified O 0 1.966790534879692e-07
in O 0 6.6347887470522e-14
families O 0 1.3108055087326584e-14
native O 0 6.091793194017148e-14
to O 0 1.0075039489753496e-13
the O 0 1.4198703324197481e-10
British O 0 0.0036721774376928806
Isles O 0 2.201933284595725e-06
, O 0 1.3746003467429713e-11
11 O 0 1.6652918627402258e-11
were O 0 5.562429314896755e-13
founder O 0 2.5928087801774247e-11
mutations O 0 3.23132809398885e-08
, O 0 4.204450156086725e-12
and O 0 2.0742439883758568e-12
2 O 0 4.0652932951391885e-13
of O 0 1.3214995538016281e-14
these O 0 1.244757010139541e-12
11 O 0 1.620911217747878e-11
conferred O 0 9.375135216760366e-13
a O 0 1.0996654704453074e-13
milder O 0 8.05980948648255e-10
clinical O 0 1.615351297168388e-09
phenotype O 0 3.4180666630412304e-10
with O 0 1.2823386016241889e-12
respect O 0 3.985182843446733e-12
to O 0 1.0668681649922407e-12
both O 0 4.794446617495396e-09
cerebellar B-Disease 0 1.358089593850309e-05
degeneration I-Disease 0 2.4779979867162183e-05
and O 0 2.648916863634554e-09
cellular O 0 8.531976618542103e-07
features O 0 9.034038725985738e-07
. O 0 1.0116673054838543e-09

We O 0 1.3612562188569655e-09
report O 0 7.176688930632391e-12
, O 0 5.917352687760755e-15
in O 0 1.200588311086508e-15
two O 0 6.807845259748646e-11
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
families O 0 1.1818191758550256e-08
, O 0 5.382493563810438e-14
an O 0 1.1002481952317004e-14
ATM O 0 8.805935976852197e-06
mutation O 0 4.476988735291343e-08
( O 0 3.613761037375013e-13
7271T O 0 7.088270526089957e-10
- O 0 1.98217033897663e-08
- O 0 1.367599011814491e-08
> O 0 2.7837636709659996e-11
G O 0 7.152760161943661e-08
) O 0 1.6232168400750514e-14
that O 0 2.858539007713143e-14
may O 0 1.4144042707886495e-11
be O 0 3.7137114672521065e-13
associated O 0 2.2624593916538947e-14
with O 0 1.4112734418592066e-14
an O 0 3.0365748977800866e-13
increased O 0 4.233635220174392e-09
risk O 0 2.1801967875489936e-07
of O 0 1.3471957924227063e-11
breast B-Disease 0 0.001167873851954937
cancer I-Disease 0 5.37193500349531e-07
in O 0 2.6793744631846417e-13
both O 0 2.2264353555234706e-11
homozygotes O 0 7.235790917548002e-07
and O 0 1.0325762814233919e-11
heterozygotes O 0 4.118246188511421e-09
( O 0 4.958228380820551e-13
relative O 0 5.970262478838251e-11
risk O 0 3.4442743412910204e-07
12 O 0 1.146720635114562e-10
. O 0 1.0469231682746702e-13
7 O 0 1.2298927154485995e-10
; O 0 7.32100144396064e-12
P O 0 0.00019497536413837224
= O 0 4.048523738475751e-10
. O 0 9.51702417909114e-15
0025 O 0 2.0649143506190626e-10
) O 0 2.6131703341459277e-14
, O 0 3.0837187356858465e-16
although O 0 1.5208734912999875e-15
there O 0 4.4893034195679984e-15
is O 0 9.402452808579629e-15
a O 0 1.3024696880921394e-13
less O 0 2.0303356218498436e-10
severe O 0 0.014660995453596115
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
phenotype O 0 1.289271949644899e-05
in O 0 3.932319151290359e-13
terms O 0 9.520084373604298e-13
of O 0 1.1142664422779933e-15
the O 0 1.5078482082722666e-13
degree O 0 1.8716023522658e-11
of O 0 3.9518721628439835e-11
cerebellar B-Disease 0 4.499277929426171e-05
degeneration I-Disease 0 0.00013932179717812687
. O 0 6.103703098503388e-10

This O 0 3.981315711137912e-12
mutation O 0 2.4054711555976382e-09
( O 0 4.719187822639637e-13
7271T O 0 1.4337611098369507e-09
- O 0 4.027424793662249e-08
- O 0 9.167559511524814e-08
> O 0 2.5270441295077717e-10
G O 0 4.450549226930889e-07
) O 0 1.1876929967942138e-14
also O 0 2.4491673913820764e-15
allows O 0 8.426917445809444e-16
expression O 0 2.4046486102238113e-14
of O 0 2.0760138027327724e-15
full O 0 8.672824264310819e-11
- O 0 2.202061821776624e-08
length O 0 5.256595714264733e-10
ATM O 0 4.380108293844387e-07
protein O 0 7.00162872124821e-10
at O 0 9.240889303763211e-12
a O 0 3.734438431234055e-13
level O 0 2.3474928598221645e-11
comparable O 0 4.960617333571449e-11
with O 0 6.067838289117167e-13
that O 0 9.75479245990396e-13
in O 0 2.4952517265960927e-13
unaffected O 0 3.499859957400986e-09
individuals O 0 1.067725682174503e-11
. O 0 1.5191342975229283e-11

In O 0 1.2590581355276242e-11
addition O 0 5.582413871441094e-12
, O 0 8.2137435416553e-14
we O 0 2.7374851517547594e-12
have O 0 1.6688831306482799e-13
studied O 0 5.626996646412863e-10
18 O 0 1.1914659125977778e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 6.800813707741327e-07
, O 0 1.2413393202887965e-14
in O 0 5.719714384298791e-16
15 O 0 1.4256620244155332e-13
families O 0 1.1872355990026964e-14
, O 0 1.03442428234235e-13
who O 0 6.621809767182185e-09
developed O 0 2.440820480842376e-06
leukemia B-Disease 1 0.9232954382896423
, O 0 3.6769299072147987e-07
lymphoma B-Disease 1 1.0
, O 0 3.023552797021267e-10
preleukemic O 0 0.00016453150601591915
T O 0 0.011654048226773739
- O 0 9.93844764707319e-07
cell O 0 3.608651604736224e-05
proliferation O 1 0.980622410774231
, O 0 2.418130806702834e-09
or O 0 0.005662941373884678
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 2.1204200895130754e-10
mostly O 0 8.141546790040033e-13
in O 0 2.2938240391325027e-13
childhood O 0 5.440371708687053e-08
. O 0 8.257030476022109e-11

A O 0 2.315133196262309e-09
wide O 0 4.2509165631976487e-10
variety O 0 7.151550185380273e-11
of O 0 1.0809578330096131e-13
ATM O 0 0.00012920286098960787
mutation O 0 7.220791076179012e-07
types O 0 4.163135258750117e-07
, O 0 2.0584464579913309e-13
including O 0 3.4692667033424385e-13
missense O 0 2.7427620352682425e-06
mutations O 0 1.6937850887188688e-05
and O 0 4.061627922880007e-09
in O 0 9.498754864264991e-13
- O 0 9.629349051465397e-07
frame O 0 9.796646736504044e-06
deletions O 0 1.4468432709691115e-06
, O 0 2.16702576022465e-11
were O 0 2.381073420029689e-12
seen O 0 4.921199558971523e-10
in O 0 8.697439334492615e-15
these O 0 2.651602245065665e-12
patients O 0 1.67942239975849e-11
. O 0 2.5907114994949687e-12

We O 0 2.217784000890788e-08
also O 0 1.112646086376401e-11
show O 0 1.1593883492144741e-10
that O 0 1.0181306210436947e-13
25 O 0 1.9496303714245516e-13
% O 0 1.9114696059156257e-16
of O 0 5.526907980284439e-16
all O 0 2.104947327552509e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 7.800541368396807e-08
carried O 0 1.2636203194915652e-10
in O 0 1.1148541942049284e-13
- O 0 2.7828159776532857e-09
frame O 0 1.0392189864205648e-07
deletions O 0 1.4117480873210297e-07
or O 0 1.1071537020512778e-09
missense O 0 1.4777269825572148e-06
mutations O 0 1.4286032978816365e-07
, O 0 3.542396139876586e-14
many O 0 4.312413611665502e-16
of O 0 4.8735942209242756e-15
which O 0 3.0618438340290766e-10
were O 0 2.539595200801159e-08
also O 0 6.165582533412817e-08
associated O 0 1.6773287619953337e-11
with O 0 1.2644682176321531e-11
expression O 0 3.2538728655939764e-11
of O 0 2.1805857629546982e-13
mutant O 0 2.8800505447179603e-07
ATM O 0 9.106560355576221e-06
protein O 0 4.161329343332909e-07
. O 0 1.446285036177386e-10

The O 0 2.370498242143526e-11
DMPK O 0 3.8835375448798004e-07
gene O 0 6.833157328856032e-08
of O 0 3.3962962997513557e-10
severely O 1 0.7002313733100891
affected O 0 6.670608854619786e-05
myotonic B-Disease 1 0.9999997615814209
dystrophy I-Disease 1 1.0
patients O 0 3.849613858619705e-05
is O 0 1.997408835552328e-11
hypermethylated O 0 3.726372099777109e-08
proximal O 0 3.821817085025714e-09
to O 0 1.1237595055890726e-12
the O 0 2.6690252113471813e-13
largely O 0 1.9319932806349804e-11
expanded O 0 3.9675103202796436e-09
CTG O 0 2.1022958662797464e-06
repeat O 0 2.3067558174716396e-07
. O 0 1.0555103319154213e-10

Using O 0 6.274277625228919e-11
methylation O 0 1.7407618457809804e-08
- O 0 1.2162271332272212e-06
sensitive O 0 2.8743685106746852e-05
restriction O 0 1.972205954103856e-09
enzymes O 0 3.451916086305573e-08
, O 0 5.932092246889106e-14
we O 0 4.327975152741692e-14
characterized O 0 1.509090670080617e-14
the O 0 1.654699773587161e-16
methylation O 0 1.9063479961278773e-11
pattern O 0 5.020928028898197e-08
on O 0 2.3745281296783105e-09
the O 0 1.293732915935708e-12
5 O 0 1.169160948610859e-11
side O 0 7.31688321042867e-12
of O 0 3.169712061589945e-15
the O 0 2.2114370068233163e-14
CTG O 0 6.7111969315192255e-09
repeat O 0 3.9395620099469397e-10
in O 0 3.988743370157439e-15
the O 0 5.058620097922505e-15
DMPK O 0 2.7242277322869768e-09
gene O 0 2.4767937267106133e-12
of O 0 2.2893185628893563e-16
normal O 0 8.797986211089848e-14
individuals O 0 1.4882616894505013e-13
and O 0 1.2336594419626312e-13
of O 0 1.68064780842192e-13
patients O 0 4.1917305737548816e-10
affected O 0 2.2638206864655785e-09
with O 0 3.038996396753646e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 1.8367742223024397e-12
showing O 0 1.5829801358613338e-10
expansions O 0 1.1576145597658183e-09
of O 0 7.52792942457052e-14
the O 0 1.3769560578552609e-12
repetitive O 0 4.967877771377971e-07
sequence O 0 2.9237345877675125e-09
. O 0 8.960340802666167e-11

The O 0 2.623380679356302e-12
gene O 0 3.285323679769192e-10
segment O 0 1.1619303297294437e-09
analyzed O 0 7.236871518712107e-11
corresponds O 0 5.390242831075642e-13
to O 0 3.679457590390414e-14
the O 0 3.5867173082482565e-14
genomic O 0 1.2814708405528563e-08
SacI O 0 3.6707319850393105e-06
- O 0 2.865295414267166e-07
HindIII O 0 6.192926349513073e-08
fragment O 0 5.731285446231027e-10
carrying O 0 6.952125541914711e-10
exons O 0 1.3825570022163447e-07
11 O 0 5.639783084987471e-10
- O 0 1.4813467785756984e-08
15 O 0 1.33464392315652e-10
. O 0 4.901325872941342e-12

There O 0 8.794510258924859e-11
is O 0 1.3504160897154227e-12
constitutive O 0 6.348455094951078e-11
methylation O 0 5.105781908376628e-10
in O 0 9.379534909176312e-13
intron O 0 2.839669832610525e-07
12 O 0 7.725829004323614e-11
at O 0 5.527169433944268e-13
restriction O 0 4.839416695612449e-14
sites O 0 1.2478782113536924e-12
of O 0 6.063878376207435e-14
SacII O 0 8.951296877057757e-07
and O 0 8.019383768154142e-11
HhaI O 0 2.8641634841619634e-08
, O 0 8.314682086287342e-15
localized O 0 1.1455149979619494e-12
1 O 0 1.1765021465728887e-12
, O 0 2.1352008228452297e-14
159 O 0 5.0232287079898796e-11
- O 0 2.460440295948274e-09
1 O 0 1.3189148124342909e-12
, O 0 6.285424925759481e-16
232 O 0 4.222801782186557e-14
bp O 0 9.53255356594962e-12
upstream O 0 1.2919525475482696e-12
of O 0 1.1085681340044585e-15
the O 0 1.8828673361659214e-14
CTG O 0 4.986120405447991e-09
repeat O 0 4.4181294733824927e-10
, O 0 2.01752173080189e-15
whereas O 0 1.7642171632002018e-15
most O 0 2.968969276497175e-15
, O 0 1.0826615889610383e-14
if O 0 1.1968885084423508e-12
not O 0 2.700271863748105e-12
all O 0 4.503649623371908e-12
, O 0 1.2028214287486492e-14
of O 0 2.731990785880336e-17
the O 0 4.567239238682222e-16
other O 0 1.6981073004581878e-15
sites O 0 5.834495647033533e-12
of O 0 9.639577141064629e-14
SacII O 0 1.9894729419434043e-08
, O 0 6.750979305745683e-14
HhaI O 0 1.41367484385313e-09
, O 0 2.5706064203266307e-14
and O 0 3.528971006475784e-13
HpaII O 0 9.034433645638273e-09
in O 0 4.718372892241083e-15
this O 0 7.832255318211603e-15
region O 0 9.929313231002435e-13
are O 0 1.0075788266878868e-13
unmethylated O 0 5.32359534233251e-09
, O 0 2.4996484374560646e-13
in O 0 4.753747105700791e-15
normal O 0 2.6757855913633888e-12
individuals O 0 7.391435553893988e-12
and O 0 2.9734281443288824e-12
most O 0 5.1287446850762676e-15
of O 0 3.7155782092832424e-15
the O 0 2.180915387520188e-12
patients O 0 5.898343619081814e-11
. O 0 1.0573469183539075e-12

In O 0 1.8977707860051707e-12
a O 0 2.9312151122139196e-14
number O 0 8.017139063081283e-14
of O 0 1.018744414998593e-13
young O 0 2.3702448004314647e-07
and O 0 3.3287022027650437e-09
severely O 0 9.000206046039239e-05
affected O 0 5.941400704756461e-10
patients O 0 9.906919902491484e-12
, O 0 3.0976160899547425e-14
however O 0 2.3375447627885237e-13
, O 0 7.832224825025502e-15
complete O 0 6.993339826504019e-14
methylation O 0 5.072768316516374e-10
of O 0 6.111514072593138e-12
these O 0 3.603191096185343e-12
restriction O 0 3.7040238931584923e-11
sites O 0 9.614368190469236e-10
was O 0 5.780030676305614e-09
found O 0 2.904228940669995e-11
in O 0 5.913696893560406e-15
the O 0 5.3553461578509376e-14
mutated O 0 9.967662251142428e-09
allele O 0 8.607803358984256e-09
. O 0 1.0520492116361524e-10

In O 0 4.937242888830573e-12
most O 0 4.127766718383698e-14
of O 0 2.6146246897163633e-15
these O 0 2.6593042546686763e-13
patients O 0 3.598644385954808e-12
, O 0 2.3155545084580518e-15
the O 0 1.1469612152398279e-14
onset O 0 5.76843373067959e-09
of O 0 4.4683124388045226e-12
the O 0 1.723874554215854e-08
disease O 1 0.505294144153595
was O 0 1.9458240785752423e-05
congenital O 1 0.9990457892417908
. O 0 1.1062608606948743e-09

Preliminary O 0 4.849465895517824e-08
in O 0 4.9050877942713456e-11
vivo O 0 5.256711688161886e-07
footprinting O 0 1.2971473779543885e-06
data O 0 5.077540610187725e-10
gave O 0 1.2997430822586642e-12
evidence O 0 5.06849553646993e-13
for O 0 2.9276042107597745e-15
protein O 0 7.709055290829048e-13
- O 0 3.422951505571703e-11
DNA O 0 2.80494294457867e-08
contact O 0 1.5844187828406575e-07
in O 0 3.518553720952e-13
normal O 0 3.1487113263950484e-12
genes O 0 1.3163500844903808e-10
at O 0 1.6541810976544724e-10
an O 0 4.471345169121399e-13
Sp1 O 0 3.5436579537417856e-07
consensus O 0 2.498199672303081e-13
binding O 0 1.651313959703804e-12
site O 0 4.2765456974291904e-12
upstream O 0 7.682451202972729e-11
of O 0 2.1340444534656382e-14
the O 0 6.042266161151652e-14
CTG O 0 2.0518152510362597e-08
repeat O 0 3.741782439448116e-09
and O 0 5.4718873881845834e-14
for O 0 4.076605793373662e-17
a O 0 3.362805768592094e-16
significant O 0 1.2471582672298441e-14
reduction O 0 4.07872433744183e-12
of O 0 2.5329537729421037e-15
this O 0 1.4838196115058745e-14
interaction O 0 6.952911011694207e-13
in O 0 3.0376681801457667e-14
cells O 0 3.237213015011564e-12
with O 0 4.3321317128204584e-13
a O 0 6.556872666346747e-12
hypermethylated O 0 5.106574008095777e-06
DMPK O 0 1.2312398212088738e-06
gene O 0 3.3858456038871054e-09
. O 0 3.6394238317472016e-13
. O 0 7.692829012695412e-12

The O 0 2.1239050795873737e-10
hemochromatosis B-Disease 1 0.999988317489624
gene O 0 8.661793799547013e-06
product O 0 1.3036031987212482e-07
complexes O 0 4.4478415395232673e-10
with O 0 3.075535160747267e-13
the O 0 1.7298780409426978e-13
transferrin O 0 1.0447918441514048e-07
receptor O 0 1.4569627282412512e-08
and O 0 5.814582149099579e-10
lowers O 0 1.297464109484281e-06
its O 0 1.5011443151892456e-14
affinity O 0 2.0573316271074726e-13
for O 0 5.082353114071623e-15
ligand O 0 1.944050172578149e-12
binding O 0 3.44817480124604e-10
. O 0 2.4296401696100034e-11

We O 0 5.6314020113745755e-09
recently O 0 3.4248357483335212e-09
reported O 0 3.324815769922829e-11
the O 0 1.825072457053924e-15
positional O 0 4.909627565607977e-11
cloning O 0 3.378475277315829e-11
of O 0 1.1423190088207533e-15
a O 0 3.2974396325415045e-14
candidate O 0 6.959017563590297e-12
gene O 0 5.296586280678639e-08
for O 0 7.187915116446675e-07
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 0.738457441329956
HFE O 1 0.9151618480682373
. O 0 3.1559068691677794e-09

The O 0 9.993875301969601e-13
gene O 0 2.5075233001103925e-09
product O 0 4.946990372900473e-08
, O 0 1.0177229610268401e-13
a O 0 1.1316442168106747e-13
member O 0 2.369430172899367e-12
of O 0 6.773365878321846e-15
the O 0 4.311548134575821e-13
major O 0 6.200922553212251e-10
histocompatibility O 0 1.337958077662904e-09
complex O 0 1.5722581223065468e-11
class O 0 3.798859005144095e-09
I O 0 4.306063146941597e-06
- O 0 1.7757251669081597e-08
like O 0 1.1376434239096511e-09
family O 0 2.1897657298541873e-11
, O 0 1.1198193149944847e-14
was O 0 1.4504162844722335e-12
found O 0 1.4741170523829839e-12
to O 0 7.69617063221123e-13
have O 0 1.0996938602791939e-11
a O 0 1.9878482269541226e-13
mutation O 0 3.8977815419727335e-10
, O 0 1.0472192774405031e-12
Cys O 0 8.09096661669173e-07
- O 0 3.25700710845922e-08
282 O 0 1.525308221062005e-06
- O 0 1.505498312326381e-05
- O 0 7.193455644483038e-07
> O 0 2.16053910873093e-10
Tyr O 0 1.3846860547062079e-08
( O 0 6.926949384098227e-14
C282Y O 0 7.47112094412472e-12
) O 0 2.2434906393715504e-15
, O 0 3.0133647084824963e-16
in O 0 1.4082147741229358e-16
85 O 0 1.6761436260216006e-13
% O 0 5.651032400133321e-15
of O 0 1.6115496388529812e-14
patient O 0 1.585921394209322e-09
chromosomes O 0 4.0795182343345004e-08
. O 0 1.421637252363439e-10

This O 0 2.2725649487242983e-12
mutation O 0 1.5714800571942078e-09
eliminates O 0 3.2625766532845546e-09
the O 0 4.70772563727212e-13
ability O 0 1.1667466992548725e-10
of O 0 2.8009568609258483e-14
HFE O 0 1.6401288576162187e-06
to O 0 1.7400049500196357e-12
associate O 0 4.91751195319523e-10
with O 0 6.265404167704602e-11
beta2 O 0 4.695247480412945e-05
- O 0 9.637644780013943e-07
microglobulin O 0 8.164352948369924e-06
( O 0 5.24785184925769e-13
beta2m O 0 5.64317570450612e-09
) O 0 4.214562184488846e-14
and O 0 2.471241832317176e-14
prevents O 0 2.6090903743059002e-11
cell O 0 5.56641275295533e-08
- O 0 0.00012080596934538335
surface O 0 5.748299372498877e-06
expression O 0 3.3235906471418275e-08
. O 0 6.97047142228513e-11

A O 0 2.1198347521789174e-09
second O 0 4.914368217923126e-11
mutation O 0 3.3100822083298453e-09
that O 0 4.479576432014909e-12
has O 0 1.1577155206721201e-10
no O 0 9.289664523737251e-12
effect O 0 1.5298964872734189e-10
on O 0 9.253302124534457e-09
beta2m O 0 0.00018373497005086392
association O 0 4.408691120505459e-11
, O 0 4.63310149251793e-14
H63D O 0 1.784101186785847e-07
, O 0 9.192395922143909e-14
was O 0 1.261707405220136e-11
found O 0 6.514119799128082e-11
in O 0 1.0364485555610162e-13
eight O 0 4.325357780277095e-11
out O 0 6.529173868230487e-10
of O 0 2.1156860985360737e-13
nine O 0 7.78990372207744e-10
patients O 0 1.6540143820548137e-13
heterozygous O 0 1.3007251525865016e-12
for O 0 6.283270073941666e-15
the O 0 2.2043674665576246e-13
C282Y O 0 4.348672533183162e-09
mutant O 0 9.872927364540374e-08
. O 0 7.400495494191972e-11

In O 0 3.336859434599493e-12
this O 0 4.710172342762241e-15
report O 0 1.4981852564099896e-12
, O 0 3.619054569778879e-15
we O 0 5.804963443527961e-14
demonstrate O 0 8.905770137188421e-14
in O 0 1.8120167147214197e-15
cultured O 0 4.2396270522049306e-11
293 O 0 1.1904867716627798e-11
cells O 0 1.2354454265173231e-11
overexpressing O 0 7.281076364051842e-08
wild O 0 4.986931685380114e-07
- O 0 0.00014037084474693984
type O 0 0.00011622338206507266
or O 0 5.510419898158148e-10
mutant O 0 5.117618684380432e-07
HFE O 0 5.374251372813887e-07
proteins O 0 4.531587605161036e-11
that O 0 3.893315452473643e-14
both O 0 1.536567063636831e-14
the O 0 1.0358926647783921e-14
wild O 0 1.0046361609283849e-07
- O 0 2.9926062779850326e-05
type O 0 0.00019319842976983637
and O 0 2.7764130550167465e-08
H63D O 0 0.00023416618932969868
HFE O 0 4.2476909584365785e-05
proteins O 0 7.698480430917698e-08
form O 0 1.0380353243633067e-09
stable O 0 7.647371624841526e-09
complexes O 0 4.6158932232032157e-10
with O 0 1.6774622055987232e-12
the O 0 2.0769054878688742e-11
transferrin O 0 2.554271759436233e-06
receptor O 0 1.5167832145834836e-07
( O 0 6.376827538234764e-11
TfR O 0 4.379642177809728e-06
) O 0 1.3218689380936621e-12
. O 0 3.5119043090281465e-12

The O 0 4.4886788730380545e-11
C282Y O 0 9.626134556128818e-09
mutation O 0 9.453642313417276e-09
nearly O 0 1.4792016569953326e-11
completely O 0 7.56317619643454e-10
prevents O 0 6.883635883525585e-09
the O 0 1.986677966234196e-12
association O 0 1.622234985232396e-11
of O 0 1.824168630547556e-14
the O 0 9.644768707642304e-13
mutant O 0 9.155447742159595e-07
HFE O 0 8.134028576023411e-06
protein O 0 2.047745262245826e-08
with O 0 6.923720277662859e-12
the O 0 3.003319468120047e-11
TfR O 0 6.456178380176425e-05
. O 0 1.3278838965902207e-11

Studies O 0 3.0566522646324756e-09
on O 0 8.955369085184017e-11
cell O 0 4.1403481532142905e-08
- O 0 8.107565463433275e-07
associated O 0 7.672932428315349e-11
transferrin O 0 5.050960982799779e-09
at O 0 1.0449398291090262e-10
37 O 0 1.4674587933694028e-10
degrees O 0 2.7860847309768566e-11
C O 0 8.39806535424259e-09
suggest O 0 4.7767588495784e-12
that O 0 4.3784993127926955e-14
the O 0 3.765485305832171e-14
overexpressed O 0 8.600476917308697e-07
wild O 0 4.17724777435069e-06
- O 0 8.20536442915909e-05
type O 0 3.921274128515506e-06
HFE O 0 1.8757989892037585e-05
protein O 0 1.179258912742398e-08
decreases O 0 3.52900347833085e-10
the O 0 2.8660659965923287e-15
affinity O 0 1.4105832387562023e-12
of O 0 2.4819363009026194e-14
the O 0 7.530518634883687e-13
TfR O 0 2.793286455471389e-07
for O 0 5.921491053571815e-13
transferrin O 0 3.828809269634803e-08
. O 0 3.0379396914748114e-11

The O 0 7.463007295482882e-11
overexpressed O 0 1.9138981315336423e-06
H63D O 0 2.126079380104784e-06
protein O 0 6.42400532768761e-09
does O 0 8.24539950206038e-11
not O 0 1.5242263018151042e-13
have O 0 5.854499285536108e-14
this O 0 7.98752016321246e-16
effect O 0 3.032918317533162e-12
, O 0 3.690800377993686e-15
providing O 0 3.917164003916767e-15
the O 0 8.470426351936346e-16
first O 0 3.509317673695139e-13
direct O 0 6.606565609249687e-14
evidence O 0 1.981465130862503e-10
for O 0 2.127641379051637e-12
a O 0 2.8664421097140957e-12
functional O 0 6.235242877572489e-11
consequence O 0 5.410557852442155e-12
of O 0 2.923387511341753e-14
the O 0 1.836739961513789e-11
H63D O 0 0.0012296998174861073
mutation O 0 1.3701844636671012e-07
. O 0 9.740207251862643e-11

Addition O 0 6.551953979361258e-10
of O 0 9.733196236830222e-13
soluble O 0 1.0868899558147405e-08
wild O 0 1.9915425752969895e-07
- O 0 0.0002899153041653335
type O 0 0.0002074876392725855
HFE O 1 0.8325467109680176
/ O 0 0.0004701617581304163
beta2m O 0 4.2690437112469226e-05
heterodimers O 0 1.6640613864637999e-07
to O 0 1.0402416775190382e-12
cultured O 0 4.8697343935089066e-09
cells O 0 1.0371690173371917e-08
also O 0 2.2316830328161785e-10
decreased O 0 8.733301304353347e-10
the O 0 1.8056557090457767e-14
apparent O 0 3.2226062096629704e-12
affinity O 0 5.867350008625927e-12
of O 0 1.5960992835566123e-13
the O 0 2.0126745322451844e-12
TfR O 0 2.813988508876264e-08
for O 0 9.74226273350203e-16
its O 0 1.4120769796646193e-16
ligand O 0 4.1106549587832664e-14
under O 0 1.2978646748897787e-13
steady O 0 1.6497486710065346e-09
- O 0 5.9932014906394215e-09
state O 0 8.07041933281738e-11
conditions O 0 9.185294885805106e-11
, O 0 3.24987007164129e-16
both O 0 2.492295556199187e-15
in O 0 6.659022571431383e-16
293 O 0 2.693307382672927e-12
cells O 0 1.5762808809952067e-12
and O 0 1.7377695419804051e-12
in O 0 7.965558822351643e-14
HeLa O 0 6.112341566222312e-08
cells O 0 9.923004640199906e-10
. O 0 4.645532222791182e-11

Furthermore O 0 4.940519104934538e-09
, O 0 1.636267727214702e-12
at O 0 2.531722401166725e-11
4 O 0 6.260172241701056e-11
degrees O 0 2.3994672915250703e-10
C O 0 2.8552890398714226e-06
, O 0 3.6089549317747105e-12
the O 0 4.574482611284514e-13
added O 0 2.6637925198969015e-09
soluble O 0 1.043107353965178e-11
complex O 0 1.0057547920579515e-13
of O 0 1.4979558121252373e-13
HFE O 0 5.621395757771097e-05
/ O 0 1.5973938616298256e-07
beta2m O 0 6.080735914792967e-08
inhibited O 0 3.238858903298336e-10
binding O 0 6.753432882367072e-12
of O 0 1.8096276159420416e-14
transferrin O 0 6.535129104534576e-10
to O 0 4.605368278572108e-13
HeLa O 0 3.135969350864798e-08
cell O 0 1.7186029310778395e-07
TfR O 0 5.876999239262659e-06
in O 0 4.694533065237316e-14
a O 0 7.464351402600156e-13
concentration O 0 2.508395766653848e-07
- O 0 3.6019250728713814e-06
dependent O 0 2.0345398255017244e-08
manner O 0 4.055667357505399e-09
. O 0 2.262717790912916e-11

Scatchard O 0 1.7842408794876974e-07
plots O 0 5.188988794202487e-09
of O 0 1.2842030498901036e-13
these O 0 5.60906657627808e-15
data O 0 4.808380082987895e-11
indicate O 0 1.104388108741361e-10
that O 0 3.476833621354758e-12
the O 0 1.592542937800534e-11
added O 0 3.0742737067157577e-07
heterodimer O 0 2.9120419409167653e-09
substantially O 0 3.6202947306662736e-09
reduced O 0 9.567806269483725e-11
the O 0 3.248088782529038e-14
affinity O 0 9.932007473401061e-12
of O 0 2.2071568476968867e-13
TfR O 0 1.0623283230870584e-07
for O 0 1.3081937334617766e-13
transferrin O 0 8.152331254507317e-09
. O 0 1.4404149747959671e-11

These O 0 4.1223049279670576e-11
results O 0 3.1671800598820354e-11
establish O 0 7.321755181310952e-12
a O 0 2.8206229669633376e-13
molecular O 0 4.5645709434438686e-10
link O 0 2.0282068362575956e-06
between O 0 2.0661485855555384e-09
HFE O 0 0.0036988474894315004
and O 0 1.7033081889383794e-10
a O 0 3.024159427652412e-13
key O 0 2.549468969270663e-10
protein O 0 1.6426405591643545e-12
involved O 0 1.919450015597235e-11
in O 0 4.2365023707018057e-13
iron O 0 2.334881719434634e-05
transport O 0 3.297072126429157e-08
, O 0 2.305825615080831e-13
the O 0 1.790784995335873e-13
TfR O 0 1.3409307939582504e-06
, O 0 3.909671658685124e-14
and O 0 2.092700436496977e-14
raise O 0 8.693501105626333e-13
the O 0 2.7153176371453496e-15
possibility O 0 2.762752049703665e-12
that O 0 9.926883940509709e-14
alterations O 0 1.3953878330585923e-10
in O 0 3.2924370559550206e-14
this O 0 5.589557205217151e-14
regulatory O 0 8.175938148724526e-09
mechanism O 0 4.804739006658565e-08
may O 0 4.309386625322986e-09
play O 0 1.1457084586607991e-10
a O 0 1.8608435647417265e-13
role O 0 6.530391505332744e-11
in O 0 6.20329290542456e-16
the O 0 2.9817965316921574e-14
pathogenesis O 0 2.163368817420519e-09
of O 0 2.425304179709542e-09
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 5.560703897344865e-08
. O 0 9.38287225693557e-11

Genomic O 0 7.63126024594385e-08
organization O 0 1.3481013527716357e-10
of O 0 2.8815811499091626e-13
the O 0 5.6936894435311025e-12
UBE3A O 0 3.3341293601552024e-05
/ O 0 1.950301538045096e-07
E6 O 0 2.6566351607471006e-06
- O 0 1.5348557269589946e-07
AP O 0 5.768909261405497e-08
gene O 0 1.7666192120291413e-10
and O 0 1.171664490689367e-13
related O 0 1.1138558608445037e-12
pseudogenes O 0 1.4794831137976416e-08
. O 0 3.0369720627199115e-11

The O 0 4.6144470189357634e-11
UBE3A O 0 3.7239567518554395e-07
gene O 0 1.3128855780308868e-09
encodes O 0 1.6559931204085387e-10
the O 0 2.137456227638279e-12
E6 O 0 1.3322592167241964e-06
- O 0 8.783933935774257e-07
AP O 0 5.228941404311627e-07
ubiquitin O 0 2.997449788377793e-10
- O 0 4.087986546497113e-11
protein O 0 1.2130192141544816e-13
ligase O 0 2.385377052133153e-13
and O 0 1.6697429029710609e-13
has O 0 1.3624327089688942e-13
recently O 0 1.6793648069390876e-11
been O 0 7.772556469970437e-13
shown O 0 1.5398125211962127e-13
to O 0 7.64451893578216e-15
be O 0 1.5142597245554335e-11
mutated O 0 1.3369849511946086e-05
in O 0 5.183020675758598e-06
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 1.1025801995856455e-06
who O 0 8.201517798234192e-10
lack O 0 5.877027163536663e-12
15q11 O 0 1.4742795872990655e-09
- O 0 1.4527282488074889e-08
q13 O 0 1.9406384055287162e-08
deletions O 0 2.766470856840897e-07
or O 0 2.980304714128579e-08
chromosome O 0 0.05532800778746605
15 O 0 1.35071431373035e-07
paternal O 0 4.0880659071262926e-05
uniparental B-Disease 0 0.21514250338077545
disomy I-Disease 0 0.03349674865603447
. O 0 4.790004393129266e-09

Previous O 0 6.184527889807612e-10
UBE3A O 0 9.440275050565106e-08
cDNA O 0 4.9881130476103763e-11
analysis O 0 1.7597787116407915e-10
has O 0 5.713458872680377e-11
shown O 0 8.77135007421731e-13
a O 0 7.048632782048064e-14
coding O 0 2.1597572619214134e-09
region O 0 3.434911643312999e-12
of O 0 6.714915099247142e-15
approximately O 0 7.1313324169486325e-12
2 O 0 7.504658700030475e-11
. O 0 1.3200555232240063e-11

6 O 0 5.065706076834431e-08
kb O 0 6.468300125561655e-05
and O 0 5.444643069729693e-10
a O 0 1.846096712998513e-11
3 O 0 1.4470673548316881e-08
- O 0 0.0013607601867988706
untranslated O 0 0.20208145678043365
region O 0 1.0530801120012256e-08
( O 0 9.287357124673767e-13
UTR O 0 1.3506956664244285e-10
) O 0 7.179800238501718e-15
of O 0 3.4800242758824523e-16
< O 0 5.826933553720881e-12
50 O 0 1.4676553429602418e-13
bp O 0 1.1209119188393402e-09
, O 0 8.754359948548104e-15
whereas O 0 4.586930065376277e-14
Northern O 0 1.5949330547135147e-14
analysis O 0 9.177894989137458e-13
has O 0 3.205596205146932e-11
indicated O 0 5.754542892547065e-13
mRNA O 0 1.2398721745208573e-14
sizes O 0 2.1539792519065237e-11
of O 0 1.5715309912775477e-13
5 O 0 3.808716675379742e-10
- O 0 2.2964832169236615e-07
8 O 0 4.858664026663462e-10
kb O 0 1.1078017223553616e-06
. O 0 2.97166076468347e-11

We O 0 1.0882952872215412e-10
have O 0 9.553945498229008e-15
analyzed O 0 9.08246053235931e-14
additional O 0 3.066874214980274e-15
cDNA O 0 5.678416179107082e-13
clones O 0 1.9867767875325626e-08
and O 0 4.755550120361107e-12
provide O 0 7.126644685896775e-15
evidence O 0 1.3131885173451457e-13
for O 0 1.0565213051758233e-14
an O 0 9.137990487721997e-15
additional O 0 4.777861266347383e-12
0 O 0 8.810829843497459e-11
. O 0 1.6673608674300233e-11

5 O 0 8.419038799445389e-10
kb O 0 1.6758175434006262e-06
of O 0 7.658483222594548e-12
5 O 0 1.854504882992103e-09
- O 0 6.047862370905932e-06
UTR O 0 5.690785656042863e-07
and O 0 5.070783029581527e-11
> O 0 3.1724386572590246e-12
2 O 0 6.833818450360796e-13
kb O 0 2.5127860681095626e-08
of O 0 3.0236403658623345e-13
3 O 0 6.295762244867831e-10
- O 0 5.932737394687138e-07
UTR O 0 2.21412861378667e-07
. O 0 8.101541659755185e-11

We O 0 7.053132122791794e-08
have O 0 3.9955417446835284e-12
established O 0 2.048903412113067e-14
the O 0 6.263547652918678e-16
genomic O 0 5.5278077254472535e-11
organization O 0 6.205530880820653e-12
of O 0 4.5210305632667133e-14
UBE3A O 0 4.348677521193167e-06
and O 0 8.621670001193737e-13
the O 0 2.9775183403291434e-17
sequence O 0 1.0560766128785148e-13
of O 0 4.559671528694097e-14
intron O 0 7.301978826035338e-07
- O 0 4.5740577547803696e-07
exon O 0 1.6930883361965243e-07
borders O 0 8.844716070655068e-09
. O 0 1.9273410992171058e-11

We O 0 7.08475567989808e-07
have O 0 1.5957454801984738e-10
also O 0 2.929625075517861e-12
mapped O 0 5.697286198369511e-08
two O 0 7.185286979120853e-13
highly O 0 2.4854478284513926e-13
homologous O 0 1.3070470270340473e-12
processed O 0 7.241072741415167e-10
pseudogenes O 0 2.5987922924741724e-09
, O 0 2.6191546219182793e-13
UBE3AP1 O 0 5.855845941482585e-08
and O 0 4.689123655338134e-12
UBE3AP2 O 0 8.177345733884067e-08
, O 0 5.670899134394697e-15
to O 0 2.195972302788821e-15
chromosomes O 0 6.106882777245914e-10
2 O 0 1.557870776824899e-10
and O 0 5.883470932666057e-10
21 O 0 4.413935050795459e-10
, O 0 5.841716541922504e-14
respectively O 0 6.317604772654306e-11
, O 0 2.7534970289087857e-13
and O 0 2.3256676532495968e-12
determined O 0 2.3599599704993146e-11
their O 0 4.4055511734357455e-13
genomic O 0 9.500255027106164e-10
organization O 0 3.4977626350851665e-10
. O 0 1.3337474354113699e-11

These O 0 1.8853185679290618e-10
results O 0 8.473074686321524e-09
will O 0 1.0143625939207368e-09
form O 0 2.4739043279209394e-12
the O 0 4.042527760022424e-14
basis O 0 5.133803104850898e-12
for O 0 8.89626236176208e-14
studies O 0 2.972285706947207e-14
of O 0 6.443497367343131e-15
mutation O 0 1.7460383139322744e-09
and O 0 2.6538437246370616e-12
imprinting O 0 1.120463632986457e-08
of O 0 1.3026623182921249e-11
UBE3A O 0 0.000981532852165401
. O 0 3.4626479461508097e-10

Mutation O 0 1.0983319498336641e-06
spectrum O 0 1.1327634830138322e-08
and O 0 3.5872652071056166e-10
genotype O 0 4.737038068469701e-07
- O 0 1.7076548601835384e-06
phenotype O 0 3.574203688572197e-08
analyses O 0 3.5186547009402602e-09
in O 0 4.297904480227155e-12
Cowden B-Disease 0 0.0008652550750412047
disease I-Disease 0 0.06900590658187866
and O 0 1.4288369598602912e-08
Bannayan B-Disease 1 0.9827398061752319
- I-Disease 1 0.9999463558197021
Zonana I-Disease 1 0.9999594688415527
syndrome I-Disease 1 0.9999985694885254
, O 0 7.379179732536212e-12
two O 0 7.280288177868854e-11
hamartoma B-Disease 0 0.11083236336708069
syndromes I-Disease 0 0.0015474993269890547
with O 0 2.99867179698321e-11
germline O 0 6.311666948022321e-05
PTEN O 0 0.48208126425743103
mutation O 0 0.0006269188597798347
. O 0 3.515676194609796e-09

The O 0 6.800144003449304e-09
tumour B-Disease 1 0.9999933242797852
suppressor O 0 2.3303327907342464e-05
gene O 0 6.352231139317155e-05
PTEN O 0 0.03254329413175583
, O 0 6.174126748054176e-12
which O 0 1.791911583037039e-14
maps O 0 3.6213149146036017e-10
to O 0 9.591613614468031e-11
10q23 O 0 1.162058310910652e-06
. O 0 6.549052272708522e-11

3 O 0 1.1384160281124878e-09
and O 0 3.8868176255660303e-13
encodes O 0 3.714209495520038e-12
a O 0 1.3322155878459085e-13
403 O 0 3.2315945058813966e-11
amino O 0 8.948800034325188e-10
acid O 0 6.341707603496616e-09
dual O 0 6.305598958533665e-07
specificity O 0 2.2248502773436485e-06
phosphatase O 1 0.9970605969429016
( O 0 4.336924985803847e-10
protein O 0 7.641965993343547e-08
tyrosine O 0 3.4823938221961726e-06
phosphatase O 0 0.02073742263019085
; O 0 2.6821943971411244e-11
PTPase O 0 1.907104234533108e-07
) O 0 7.184396307036156e-13
, O 0 4.3061524499985165e-15
was O 0 6.060346235264857e-12
shown O 0 3.130412595808707e-11
recently O 0 2.4171635359948596e-08
to O 0 7.771581989057808e-12
play O 0 7.473698104831783e-09
a O 0 1.5526184938413623e-12
broad O 0 6.255496676210726e-10
role O 0 1.805412375155413e-09
in O 0 2.4148245252389455e-14
human O 0 3.6987923140996415e-11
malignancy B-Disease 0 3.2821333206811687e-07
. O 0 8.614704435916387e-12

Somatic O 0 1.564275771670509e-05
PTEN O 0 0.0003159036859869957
deletions O 0 3.3191184911629534e-07
and O 0 1.7568073384932603e-10
mutations O 0 4.5488793176673425e-08
were O 0 9.719009451403249e-12
observed O 0 5.010291834195435e-11
in O 0 5.687391204690917e-13
sporadic B-Disease 0 7.386752258753404e-06
breast I-Disease 1 0.9998462200164795
, I-Disease 0 5.261014024426913e-08
brain I-Disease 0 0.042463164776563644
, I-Disease 0 1.2338272625811442e-08
prostate I-Disease 1 0.9576146006584167
and I-Disease 0 1.6907188182813115e-05
kidney I-Disease 0 0.0011874291813001037
cancer I-Disease 0 1.8505330444895662e-05
cell O 0 2.6268058718414977e-05
lines O 0 0.0005390666192397475
and O 0 8.280649055336653e-09
in O 0 1.4616769166558852e-13
several O 0 4.291637791670189e-12
primary O 0 7.730696779617574e-06
tumours B-Disease 1 1.0
such O 0 5.217750231878426e-09
as O 0 6.214544896465668e-07
endometrial B-Disease 1 0.9997673630714417
carcinomas I-Disease 1 1.0
, O 1 0.5626472234725952
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 0.9999758005142212
thyroid B-Disease 1 0.9999983310699463
tumours I-Disease 1 0.9999998807907104
. O 0 7.169848004195956e-08

In O 0 1.0412029745332507e-11
addition O 0 1.5393061825186294e-11
, O 0 3.4208790314349535e-13
PTEN O 0 6.954054697416723e-06
was O 0 6.715213940466924e-10
identified O 0 3.928337100056467e-10
as O 0 4.0577946818637356e-13
the O 0 3.308853740318935e-15
susceptibility O 0 9.359239078188253e-12
gene O 0 1.335525023904438e-10
for O 0 1.0390683972960613e-11
two O 0 9.003009893149283e-08
hamartoma B-Disease 1 0.9994357228279114
syndromes I-Disease 1 0.9998362064361572
Cowden B-Disease 1 0.9900297522544861
disease I-Disease 1 0.997538685798645
( O 0 2.2788423925668155e-11
CD B-Disease 0 1.0871822269109543e-06
; O 0 4.923274010693035e-10
MIM O 0 0.0008621631423011422
158350 O 0 4.815064471586084e-07
) O 0 3.671932116006138e-12
and O 0 1.4838782980142184e-11
Bannayan B-Disease 0 3.498162914183922e-05
- I-Disease 0 2.400917401246261e-05
Zonana I-Disease 0 8.596629049861804e-05
( I-Disease 0 1.2942567156892792e-11
BZS I-Disease 0 1.0111588721883891e-07
) I-Disease 0 6.629665891787206e-14
or I-Disease 0 4.963149032380376e-13
Ruvalcaba I-Disease 0 1.639461260083408e-07
- I-Disease 0 5.633195087284548e-06
Riley I-Disease 0 0.0015564946224913
- I-Disease 1 0.9997629523277283
Smith I-Disease 1 0.9998258948326111
syndrome I-Disease 1 0.9999172687530518
( O 0 7.733462308034955e-12
MIM O 0 6.177900104376022e-06
153480 O 0 1.601589438848805e-08
) O 0 1.1111822182871545e-12
. O 0 7.83330865450349e-13

Constitutive O 0 6.128694440832305e-09
DNA O 0 1.7198187762801354e-08
from O 0 2.2649746661551617e-12
37 O 0 7.683974984074027e-11
CD B-Disease 0 9.120922328520464e-08
families O 0 4.852421797707507e-10
and O 0 1.1172017477800722e-10
seven O 0 8.363210818318478e-11
BZS B-Disease 0 4.918117156194057e-06
families O 0 1.3722386399926678e-13
was O 0 1.4168660819255385e-12
screened O 0 4.890183813444082e-09
for O 0 3.2006272632223443e-12
germline O 0 3.273493121014326e-07
PTEN O 0 0.00011856288620037958
mutations O 0 4.372013790998608e-06
. O 0 1.6644796652087734e-10

PTEN O 0 0.006614621262997389
mutations O 0 9.579471225151792e-05
were O 0 7.325390988244251e-11
identified O 0 2.7904364929831615e-10
in O 0 3.610768978192132e-14
30 O 0 1.0443650068012178e-12
of O 0 4.3708810984650903e-14
37 O 0 7.490165820911443e-09
( O 0 1.870659226479998e-12
81 O 0 1.757950313097112e-10
% O 0 3.6709689650062105e-14
) O 0 3.575923228588216e-15
CD B-Disease 0 3.666219772213708e-09
families O 0 1.7336319879657225e-11
, O 0 2.1955754678530323e-14
including O 0 2.5583598824499565e-13
missense O 0 1.1643711559372605e-06
and O 0 7.165426030297795e-10
nonsense O 0 9.930640771926846e-07
point O 0 6.651109107913555e-10
mutations O 0 4.215802817952863e-09
, O 0 2.6779836012039322e-14
deletions O 0 3.1532820798929606e-10
, O 0 5.986928075692177e-13
insertions O 0 1.8020484660041802e-08
, O 0 4.152044159877466e-12
a O 0 4.6114006710396005e-12
deletion O 0 1.0729825589805841e-05
/ O 0 1.3345415936782956e-05
insertion O 0 1.7007000252533544e-08
and O 0 6.080867059887751e-11
splice O 0 4.231218099448597e-06
site O 0 5.973141270487758e-08
mutations O 0 7.136868589441292e-06
. O 0 2.629399475928551e-10

These O 0 7.0755393731525285e-12
mutations O 0 7.27698079572292e-08
were O 0 4.577085238599565e-12
scattered O 0 7.81626846579897e-12
over O 0 1.795178727892477e-10
the O 0 2.637829733288799e-13
entire O 0 7.550401970313203e-11
length O 0 5.2489207424955e-10
of O 0 6.130374528325044e-14
PTEN O 0 1.3823213294017478e-06
, O 0 3.032209561020481e-14
with O 0 5.405144664776028e-15
the O 0 2.2861441269250195e-14
exception O 0 3.038965259993809e-11
of O 0 1.180964370349133e-13
the O 0 6.7020789959459925e-12
first O 0 5.466541779242107e-07
, O 0 7.566389875757196e-11
fourth O 0 4.994594249296824e-08
and O 0 1.394387522113405e-10
last O 0 1.3166313872492452e-10
exons O 0 6.340966365314671e-07
. O 0 7.332407597759882e-11

A O 0 1.9037482701378394e-09
hot O 0 7.855078365537338e-09
spot O 0 1.0228824898206312e-08
for O 0 6.632214742674503e-12
PTEN O 0 7.60556067689322e-05
mutation O 0 1.7017099196436902e-07
in O 0 2.0703298559028582e-13
CD B-Disease 0 3.760204094760411e-07
was O 0 3.3232737450816785e-08
identified O 0 6.188421997066484e-10
in O 0 6.9212010797049806e-15
exon O 0 1.2390950487883856e-09
5 O 0 2.205160359869396e-11
that O 0 2.0033503190229097e-14
contains O 0 1.857294157879552e-13
the O 0 7.562818101804203e-13
PTPase O 0 3.3679552302601223e-07
core O 0 2.918502994830874e-09
motif O 0 2.2225245255302895e-10
, O 0 2.1057171306106126e-14
with O 0 1.3526058223500056e-14
13 O 0 9.011784374290954e-13
of O 0 5.149761266563541e-15
30 O 0 1.6426665583324507e-11
( O 0 2.7478307173048333e-13
43 O 0 2.584298053331935e-10
% O 0 3.902296034593612e-14
) O 0 1.2201701881677223e-14
CD B-Disease 0 7.998555595634116e-09
mutations O 0 1.6150262638348067e-07
identified O 0 3.2595348642416866e-09
in O 0 3.611083989745216e-15
this O 0 4.565987429865298e-15
exon O 0 6.185005219094819e-08
. O 0 2.9537264301104926e-10

Seven O 0 9.782400445246253e-10
of O 0 5.217471420182473e-13
30 O 0 4.77737190085481e-11
( O 0 1.8551697992478383e-13
23 O 0 2.6201202665832035e-12
% O 0 2.4888180624342343e-15
) O 0 2.425458515671955e-15
were O 0 1.684213071740867e-13
within O 0 2.749977801830522e-15
the O 0 2.002029591370233e-13
core O 0 6.242126371347467e-09
motif O 0 2.1961915619428396e-10
, O 0 3.9655555044131735e-14
the O 0 4.6890359061129306e-15
majority O 0 1.0609604693271116e-13
( O 0 1.1291145698543587e-14
five O 0 2.417841100943452e-12
of O 0 3.9137303017551875e-14
seven O 0 4.742337425533982e-11
) O 0 5.638714847014349e-15
of O 0 9.57871761204617e-16
which O 0 9.621512787882924e-12
were O 0 4.38239132483087e-11
missense O 0 3.1544618650514167e-07
mutations O 0 2.5925069735421857e-07
, O 0 5.100741877483994e-13
possibly O 0 7.517519592936672e-12
pointing O 0 2.0357398966552864e-07
to O 0 8.128981862642881e-12
the O 0 2.4922613885841605e-12
functional O 0 5.828492549708741e-11
significance O 0 1.6452086004301036e-12
of O 0 3.559722029406083e-14
this O 0 2.4370357619950267e-13
region O 0 3.948685128873919e-11
. O 0 2.86945207178535e-11

Germline O 0 0.0008748743566684425
PTEN O 0 0.0031826638150960207
mutations O 0 0.00033806354622356594
were O 0 1.1107558206546742e-09
identified O 0 4.23387769288297e-09
in O 0 3.892916262786261e-13
four O 0 6.935976792910026e-11
of O 0 2.5692267324045615e-12
seven O 0 1.434443532843943e-07
( O 0 9.730421329789962e-11
57 O 0 1.749165789988183e-08
% O 0 3.002172512325818e-12
) O 0 2.6320915932909195e-12
BZS B-Disease 0 4.4309172153589316e-06
families O 0 8.870212724054749e-12
studied O 0 1.9164776432489816e-09
. O 0 2.891985088904203e-11

Interestingly O 0 2.5281554627554215e-08
, O 0 7.243551678609572e-12
none O 0 1.2278945221710913e-12
of O 0 7.042081045728523e-16
these O 0 5.789427504022601e-14
mutations O 0 1.3319850999948812e-08
was O 0 1.5938431019435484e-08
observed O 0 1.137001270912208e-09
in O 0 2.8352672857070993e-13
the O 0 6.5135201919586105e-12
PTPase O 0 3.4329029858781723e-06
core O 0 5.228602617535216e-08
motif O 0 3.0930028316333846e-08
. O 0 3.4277795879500417e-11

It O 0 4.156223976092832e-10
is O 0 1.3800487662363192e-11
also O 0 7.190359418984826e-13
worthy O 0 4.2606180085738576e-13
of O 0 2.020395501833687e-14
note O 0 3.4876165844188733e-10
that O 0 4.3815401610733384e-14
a O 0 2.25216641668545e-13
single O 0 2.5303359407757853e-08
nonsense O 0 1.6010479839678737e-06
point O 0 7.368442522803775e-10
mutation O 0 6.109631689454886e-10
, O 0 2.887649700519107e-13
R233X O 0 4.8653660961184286e-11
, O 0 2.5005295211277985e-14
was O 0 9.666541005148854e-12
observed O 0 5.170851594127335e-12
in O 0 2.161877320837704e-15
the O 0 1.1463525797155783e-15
germline O 0 1.0180597684317227e-11
DNA O 0 3.760729061497159e-09
from O 0 2.508637557668142e-13
two O 0 2.0327116996999434e-13
unrelated O 0 3.567013351357673e-11
CD B-Disease 0 3.346699941175757e-06
families O 0 1.602477928130952e-09
and O 0 1.0477697875987957e-10
one O 0 7.02701785648685e-11
BZS B-Disease 0 7.308870408451185e-05
family O 0 2.704955148757904e-10
. O 0 2.8331456972119362e-11

Genotype O 0 7.385222852462903e-05
- O 0 0.00010121532250195742
phenotype O 0 2.2037777398509206e-06
studies O 0 2.1367381197734403e-09
were O 0 3.5464259307005364e-10
not O 0 1.7869985005636302e-12
performed O 0 5.237620337439353e-10
on O 0 4.103610506955846e-11
this O 0 1.3533695919585448e-14
small O 0 5.466426790390333e-12
group O 0 1.600429684611715e-11
of O 0 8.770313034839328e-13
BZS B-Disease 0 3.8811482227174565e-05
families O 0 2.3956885086828805e-11
. O 0 2.790439103741993e-12

However O 0 8.516618660303621e-11
, O 0 3.6671146262830245e-13
genotype O 0 3.127479830666857e-09
- O 0 1.2079870259640302e-07
phenotype O 0 3.410137061621299e-09
analysis O 0 1.0814125636637861e-11
inthe O 0 2.853115006473672e-07
group O 0 8.586690386502838e-11
of O 0 1.0159264888490085e-14
CD B-Disease 0 1.1820326051292795e-07
families O 0 4.211962809780312e-12
revealed O 0 3.066848330846028e-09
two O 0 7.589261792791124e-13
possible O 0 7.639370906697973e-12
associations O 0 3.1473765651005015e-13
worthy O 0 1.0745570015388561e-12
of O 0 1.1270017308707275e-14
follow O 0 9.475312201523423e-11
- O 0 2.3774839874590725e-08
up O 0 5.027930516376955e-09
in O 0 5.413233405905833e-15
independent O 0 5.318185670490083e-13
analyses O 0 8.446478516610512e-10
. O 0 8.866559396414342e-12

The O 0 3.27395575927536e-11
first O 0 5.765394828216586e-10
was O 0 2.243488950171013e-09
an O 0 5.346398237321415e-13
association O 0 1.3490145112093899e-10
noted O 0 3.165969486573772e-09
in O 0 1.1153264320136816e-13
the O 0 1.5163166946011164e-12
group O 0 5.083553369922278e-12
of O 0 9.181317917039949e-15
CD B-Disease 0 9.064951882464811e-07
families O 0 2.1475723976926986e-10
with O 0 3.037357254598305e-09
breast B-Disease 0 0.1317128688097
disease I-Disease 0 0.0012940302258357406
. O 0 1.1612540096184176e-10

A O 0 2.8771754423395635e-10
correlation O 0 7.444415084378875e-10
was O 0 2.369423546255689e-10
observed O 0 3.954780947168501e-12
between O 0 7.23346553553432e-14
the O 0 6.344465426112722e-13
presence O 0 8.001405094049119e-10
/ O 0 2.3277936023191614e-08
absence O 0 7.585420486178052e-11
of O 0 2.926052022883931e-15
a O 0 1.2084750517990517e-12
PTEN O 0 3.515982098178938e-05
mutation O 0 8.775789694936975e-08
and O 0 6.0901032480908945e-12
the O 0 1.7309135217800573e-14
type O 0 2.596856916170509e-07
of O 0 5.5587622178887575e-12
breast O 0 4.0415499825030565e-05
involvement O 0 8.713060850595866e-08
( O 0 1.4735893061335048e-11
unaffected O 0 1.0594428800914102e-07
versus O 0 3.2361023727389693e-07
benign O 0 0.01862766593694687
versus O 0 2.7768486688728444e-05
malignant O 1 0.7284753918647766
) O 0 4.335684589129585e-10
. O 0 4.99780772322822e-11

Specifically O 0 4.586618196356085e-09
and O 0 1.0944975394749923e-12
more O 0 1.0069322271469413e-15
directly O 0 1.7783009223157342e-12
, O 0 2.1213686189625047e-12
an O 0 1.07939724866557e-11
association O 0 2.5277973048076774e-09
was O 0 2.550467343098717e-06
also O 0 9.967586755976754e-09
observed O 0 4.6064824177349806e-10
between O 0 2.6746104788387404e-13
the O 0 1.4480381954271038e-13
presence O 0 1.2386017775659064e-12
of O 0 3.9725998750948376e-16
a O 0 1.8148903603923405e-12
PTEN O 0 0.004372004419565201
mutation O 0 0.00027885177405551076
and O 0 1.7784118426789064e-06
malignant B-Disease 1 0.9999858140945435
breast I-Disease 1 0.9999351501464844
disease I-Disease 1 0.9908985495567322
. O 0 2.6754731763389827e-09

Secondly O 0 5.702025373466313e-05
, O 0 1.446320060244366e-11
there O 0 9.369629638128485e-13
appeared O 0 6.05145877852209e-10
to O 0 7.376446458859376e-13
be O 0 2.1717438958290813e-10
an O 0 7.395020706901789e-11
interdependent O 1 0.6466125249862671
association O 0 1.99904495734593e-10
between O 0 4.925521253883181e-13
mutations O 0 6.627014936810838e-09
upstream O 0 3.76659556877712e-08
and O 0 2.3582330532789797e-10
within O 0 4.2284941824052846e-13
the O 0 3.815344307850355e-12
PTPase O 0 1.5386824543384137e-06
core O 0 1.3648316254943893e-08
motif O 0 1.0615987200424115e-08
, O 0 1.131853603355236e-13
the O 0 4.2201587005779445e-15
core O 0 4.1523173788249323e-10
motif O 0 6.772033021157364e-12
containing O 0 2.821727660556883e-12
the O 0 5.096508813389432e-14
majority O 0 3.1064988905912805e-13
of O 0 4.425661090856278e-14
missense O 0 7.37078210022446e-07
mutations O 0 4.1082302004724625e-07
, O 0 7.872641883018006e-13
and O 0 1.304182591999395e-13
the O 0 4.028024946602831e-15
involvement O 0 1.4764097722164138e-09
of O 0 1.1404921061372586e-12
all O 0 4.723553215235654e-10
major O 0 2.0321111460219754e-09
organ O 0 7.268640800361936e-09
systems O 0 1.6686254600273287e-09
( O 0 4.85776674961913e-13
central O 0 5.90696545496594e-12
nervous O 0 6.63074715134826e-08
system O 0 1.2830152218423763e-10
, O 0 1.0431152469569938e-11
thyroid O 0 0.0008139662677422166
, O 0 1.2203535924848463e-11
breast O 0 0.05803900212049484
, O 0 2.317736061741016e-06
skin O 1 0.9999982118606567
and O 1 0.7733603715896606
gastrointestinal O 1 0.9233033657073975
tract O 0 0.0648014023900032
) O 0 1.3556440414674853e-09
. O 0 2.2684011613538502e-10

However O 0 5.5956458216988025e-11
, O 0 8.845060236540095e-15
these O 0 1.0294547935097638e-16
observations O 0 2.426970950597518e-12
would O 0 4.383494608961591e-11
need O 0 1.5749044863372363e-12
to O 0 1.101335785535975e-14
be O 0 6.10779656018412e-12
confirmed O 0 4.171953581211252e-12
by O 0 7.389193029930967e-16
studying O 0 3.505518087181664e-13
a O 0 2.2211934711229703e-14
larger O 0 1.525858026084695e-13
number O 0 4.531928489166087e-13
of O 0 7.630126998975362e-15
CD B-Disease 0 6.566032766386343e-07
families O 0 3.0853283816689725e-10
. O 0 1.6537575128761084e-11

Molecular O 0 0.00011442302638897672
defects O 1 0.9996210336685181
leading O 0 2.040509095024845e-08
to O 0 3.3535186346606016e-12
human O 0 5.062110286502275e-09
complement B-Disease 0 5.916818554396741e-05
component I-Disease 1 0.9979411959648132
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 6.902675913494916e-12
an O 0 1.7104370003684366e-11
African O 0 1.4254337710184473e-09
- O 0 2.5508043677291425e-08
American O 0 8.605073875678215e-10
family O 0 5.067650118983913e-11
. O 0 1.397211599890591e-11

Complement B-Disease 0 0.036467887461185455
component I-Disease 1 0.9985336065292358
C6 I-Disease 1 0.9999995231628418
deficiency I-Disease 1 1.0
( O 0 3.260304248797752e-10
C6D B-Disease 0 1.3848884009348694e-05
) O 0 5.55628199699898e-12
was O 0 1.7990290368530282e-09
diagnosed O 0 1.1074636859120801e-05
in O 0 5.850938359025851e-14
a O 0 1.5888771418351433e-12
16 O 0 6.986471123848759e-11
- O 0 3.0390319150086498e-09
year O 0 2.3159932305283348e-10
- O 0 5.73908032208692e-08
old O 0 3.221861788915703e-06
African O 0 7.306664301376387e-11
- O 0 2.0768588238073704e-10
American O 0 6.737945618118246e-11
male O 0 2.5502569500623906e-10
with O 0 5.699223037947121e-11
meningococcal B-Disease 1 0.9999978542327881
meningitis I-Disease 1 0.9999977350234985
. O 0 3.1402697109328415e-10

The O 0 1.4897549860393156e-10
patients O 0 5.550199855264282e-09
father O 0 7.578414340514428e-09
and O 0 2.088115513831923e-10
two O 0 4.0595866945825065e-11
brothers O 0 2.272332494612783e-06
also O 0 2.560162748466155e-08
had O 0 1.0339258338376567e-08
C6D B-Disease 0 9.017237061925698e-06
, O 0 1.0351427018068932e-13
but O 0 2.8596296473360275e-14
gave O 0 6.591103531017328e-12
no O 0 2.45203284759965e-11
history O 0 1.1907122510201873e-10
of O 0 2.4804849285686714e-09
meningitis B-Disease 1 1.0
or O 0 4.293388311538138e-09
other O 0 2.0795067057211014e-10
neisserial B-Disease 0 0.0018482112791389227
infection I-Disease 0 0.0008489583851769567
. O 0 4.471350026347132e-11

By O 0 1.29207015637893e-13
using O 0 4.580952587748821e-13
exon O 0 1.5293838417917982e-09
- O 0 1.9767365522227465e-09
specific O 0 2.7497197227499548e-12
polymerase O 0 5.081842724408148e-10
chain O 0 1.5342930481665462e-08
reaction O 0 9.99921391346692e-13
( O 0 5.217263969108197e-16
PCR O 0 5.861313517874223e-11
) O 0 2.377221683391717e-15
/ O 0 3.157538249962122e-13
single O 0 7.652350107745232e-12
- O 0 1.5830192712229518e-10
strand O 0 1.184768283479798e-09
conformation O 0 6.828044241125042e-10
polymorphism O 0 8.278860375021679e-10
as O 0 1.7167041713953696e-13
a O 0 2.117201838584197e-15
screening O 0 1.12291374115836e-11
step O 0 3.0132101241225895e-12
and O 0 2.1437026142978073e-16
nucleotide O 0 8.098466762105315e-15
sequencing O 0 2.471931351017559e-13
of O 0 1.0821578584673062e-14
target O 0 7.244250199711644e-10
exons O 0 2.2535942889589933e-08
, O 0 5.893277402538311e-13
we O 0 1.0940884699953135e-12
determined O 0 6.950975168715234e-13
that O 0 1.1499189187663683e-13
the O 0 7.715115438872155e-13
proband O 0 5.037267783336574e-06
was O 0 1.6203925701230304e-10
a O 0 1.8882368474251558e-14
compound O 0 7.183885647812915e-14
heterozygote O 0 3.7009520448272326e-11
for O 0 1.8480349696825722e-14
two O 0 1.0363483075176427e-12
C6 O 0 2.2973865725361975e-06
gene O 0 9.234581455075386e-08
mutations O 0 7.403809831885155e-07
. O 0 1.2185352726845622e-10

The O 0 2.8839814217307413e-11
first O 0 9.328661454421905e-11
, O 0 7.388777496742868e-14
1195delC O 0 1.1911074904169539e-10
located O 0 4.952793817430967e-13
in O 0 5.574233616871668e-15
exon O 0 5.1859809779841726e-09
7 O 0 3.908779522276973e-09
, O 0 9.044048604640864e-14
is O 0 8.134134472481246e-15
a O 0 6.351103331093987e-16
novel O 0 4.004910986177279e-12
mutation O 0 1.423059448057984e-09
, O 0 2.369108327484465e-13
while O 0 1.6375853581149236e-12
the O 0 5.177271033217877e-14
second O 0 5.371543654320021e-09
, O 0 1.4635216866523693e-12
1936delG O 0 2.8472427193726446e-10
in O 0 4.783252227868974e-15
exon O 0 8.399374529233228e-10
12 O 0 3.390031311223396e-10
, O 0 3.084451503888516e-14
has O 0 9.045330131608742e-13
been O 0 9.665800061384178e-13
described O 0 3.4071278784408854e-12
before O 0 5.296780028474224e-11
to O 0 1.4375268553648568e-12
cause O 0 8.805180543025592e-12
C6D B-Disease 0 8.84647249677073e-07
in O 0 2.0382352015489887e-14
an O 0 6.367738909947296e-14
unrelated O 0 3.210710275425299e-08
African O 0 1.3526815223485755e-09
- O 0 1.1490338458486349e-08
American O 0 3.7832528776426955e-10
individual O 0 1.2253402285888892e-11
. O 0 1.5552632098847496e-11

Both O 0 1.7637346028109846e-09
mutations O 0 8.299585374516028e-07
result O 0 1.5309649381567425e-10
in O 0 5.1965285373378745e-12
premature O 0 6.579296751851871e-08
termination O 0 2.824064715412078e-08
codons O 0 1.3682953294846811e-06
and O 0 1.4682209892313836e-09
C6 O 0 4.253564475220628e-05
null O 0 8.967138001025887e-07
alleles O 0 1.4211931897989416e-07
. O 0 5.106892131401253e-10

Allele O 0 5.7526477803548914e-08
- O 0 1.5012567855521297e-09
specific O 0 1.2998819685569596e-12
PCR O 0 3.151235006271236e-08
indicated O 0 4.933790875849553e-11
that O 0 3.757426295558815e-15
the O 0 1.9651266020253438e-14
probands O 0 2.2640133465756662e-06
two O 0 1.9833179543127244e-10
brothers O 0 3.5512600788933923e-06
also O 0 2.2991373249681146e-09
inherited O 0 1.4953476679124833e-08
the O 0 2.369185034788168e-13
1195delC O 0 1.2633371682113648e-08
mutation O 0 4.736798175919432e-10
from O 0 3.2756639740082194e-13
their O 0 1.8188165817195623e-12
heterozygous O 0 2.0848908377502084e-07
mother O 0 5.0793669714721545e-08
and O 0 9.421167188397583e-13
the O 0 5.212197250951782e-14
1936delG O 0 1.8902388987385166e-08
mutation O 0 1.2627944245835465e-09
from O 0 1.3065036249051976e-12
their O 0 3.397212632733071e-12
homozygous O 0 6.870887432341988e-07
father O 0 4.205418679958939e-09
. O 0 6.648523962274333e-13
. O 0 7.759288871145298e-12

PAX6 O 0 0.0015472620725631714
mutations O 0 0.00010843910422408953
reviewed O 0 1.8957831571242423e-06
. O 0 3.969129913627967e-09

Mutations O 0 0.00013621911057271063
in O 0 1.9465521208794634e-11
PAX6 O 0 2.0843490347033367e-06
are O 0 8.130699347304315e-13
responsible O 0 6.076504317081843e-12
for O 0 3.909554429325224e-13
human O 0 1.5958445231945007e-08
aniridia B-Disease 1 1.0
and O 0 5.20033722750668e-07
have O 0 4.5614897969947776e-10
also O 0 2.43942852029555e-11
been O 0 4.704254347176473e-12
found O 0 1.6775655517498045e-11
in O 0 5.397608900635509e-13
patients O 0 7.695180603839447e-11
with O 0 7.856254535809626e-11
Peters B-Disease 1 1.0
anomaly I-Disease 1 0.9999998807907104
, O 0 2.8450186650985643e-09
with O 0 9.330132400009461e-08
congenital B-Disease 1 0.9999986886978149
cataracts I-Disease 1 0.9999959468841553
, O 0 1.4030140604859298e-08
with O 0 3.2840237196296584e-08
autosomal B-Disease 1 0.9999213218688965
dominant I-Disease 1 0.9135808348655701
keratitis I-Disease 1 0.9994381070137024
, O 0 9.977058290644436e-09
and O 0 1.7317501876945585e-09
with O 0 1.570357355262786e-08
isolated B-Disease 0 0.08776696026325226
foveal I-Disease 1 0.9999998807907104
hypoplasia I-Disease 1 0.9999995231628418
. O 0 7.545950353460285e-08

No O 0 1.3530136733219678e-10
locus O 0 1.6423862270187328e-09
other O 0 3.240874636798591e-13
than O 0 1.891517948130958e-13
chromosome O 0 2.4342898541362956e-07
11p13 O 0 5.458516749712317e-09
has O 0 2.2649876765812316e-12
been O 0 2.2458616997372838e-12
implicated O 0 5.262449462861696e-07
in O 0 3.6127190128354414e-10
aniridia B-Disease 1 1.0
, O 0 1.7714306410621106e-10
and O 0 3.0731034036945992e-12
PAX6 O 0 9.881467804007116e-07
is O 0 1.1044850450891985e-10
clearly O 0 1.1118447135194387e-10
the O 0 8.294759193741563e-14
major O 0 5.187692497798935e-09
, O 0 2.7260897532410677e-12
if O 0 4.632993641506822e-11
not O 0 1.2425841605656629e-12
only O 0 7.485534409120906e-14
, O 0 4.776906680544618e-15
gene O 0 7.023316390269985e-12
responsible O 0 3.266748649366491e-09
. O 0 8.99616561800265e-11

Twenty O 0 1.0956275886542244e-08
- O 0 1.576507173695063e-07
eight O 0 1.4077605747786492e-09
percent O 0 1.1344970518578634e-09
of O 0 2.2750682394034275e-15
identified O 0 2.1188474585986938e-10
PAX6 O 0 1.0744284736574627e-05
mutations O 0 1.29775855839398e-06
are O 0 1.5348829152106447e-10
C O 0 6.105226930230856e-06
- O 0 0.00014267624646890908
T O 0 0.0028492657002061605
changes O 0 1.3480723481951173e-11
at O 0 3.2308654449725305e-12
CpG O 0 1.004648697566779e-09
dinucleotides O 0 1.958628992326794e-08
, O 0 2.1161048038625604e-14
20 O 0 2.1142731798174177e-14
% O 0 3.8436690197263203e-16
are O 0 1.1180424622172938e-16
splicing O 0 2.6865466448700026e-11
errors O 0 2.5976098640967393e-06
, O 0 8.882156213871686e-14
and O 0 1.1894976851916338e-14
more O 0 1.3776415169384858e-16
than O 0 1.3441401854399904e-13
30 O 0 1.21780285508577e-11
% O 0 2.0448041114615352e-14
are O 0 3.5053824941474673e-14
deletion O 0 3.4541780546959444e-10
or O 0 1.880892490369046e-11
insertion O 0 5.740803943332651e-10
events O 0 1.091728263347136e-09
. O 0 7.192482720519422e-10

There O 0 3.226704320402618e-11
is O 0 6.209138563549599e-13
a O 0 5.178814191722503e-13
noticeably O 0 9.227060004945997e-09
elevated O 0 1.3891987009628792e-06
level O 0 2.629004791643297e-09
of O 0 5.4219985028440207e-14
mutation O 0 4.115733087672879e-09
in O 0 3.101975328077128e-13
the O 0 2.8934550610516807e-13
paired O 0 5.3566062696575045e-09
domain O 0 9.594509631227766e-10
compared O 0 2.9696070047435796e-09
with O 0 1.4301592679219488e-12
the O 0 2.860956643032514e-13
rest O 0 2.1185663900274987e-12
of O 0 3.3423176297847884e-16
the O 0 4.0363410313756787e-14
gene O 0 6.435481036959345e-10
. O 0 1.9717449895040318e-11

Increased O 0 7.095284360048026e-08
mutation O 0 2.1688985896162194e-07
in O 0 7.690843946937809e-13
the O 0 6.515103669231526e-14
homeodomain O 0 1.0634977343215724e-08
is O 0 1.5024920326997537e-12
accounted O 0 2.4318019820057657e-10
for O 0 8.262637840909196e-15
by O 0 4.869431477504994e-15
the O 0 2.3466444716221946e-13
hypermutable O 0 4.7531571567560604e-07
CpG O 0 3.922252300725404e-09
dinucleotide O 0 1.027918195006805e-09
in O 0 6.578763955041728e-14
codon O 0 3.3494756968011075e-10
240 O 0 2.3276124083704275e-11
. O 0 1.8807624728445216e-12

Very O 0 1.1955360312843055e-11
nearly O 0 1.249321501285705e-12
all O 0 4.813404449327541e-13
mutations O 0 7.172868077276462e-09
appear O 0 1.169018909452646e-10
to O 0 2.9993908832320892e-12
cause O 0 3.1791352883558943e-10
loss O 0 2.454440428678595e-09
of O 0 1.0462105763968041e-13
function O 0 9.191914590589434e-12
of O 0 1.1668762473198563e-13
the O 0 1.764017968156062e-12
mutant O 0 4.015593901840475e-07
allele O 0 4.88233398154847e-10
, O 0 6.96788275949406e-14
and O 0 1.604402798360523e-15
more O 0 1.4571782415579096e-17
than O 0 1.559400679026731e-15
80 O 0 1.624338684391713e-13
% O 0 7.282746081812164e-15
of O 0 2.743085198277182e-14
exonic O 0 4.069923306815326e-06
substitutions O 0 9.1297263082879e-09
result O 0 1.2909881497158437e-10
in O 0 2.4931931519311945e-12
nonsense O 0 1.5327290157074458e-06
codons O 0 2.2149396272652666e-07
. O 0 4.968087746748395e-11

In O 0 2.9463636391779957e-12
a O 0 6.343797015473385e-14
gene O 0 6.849419642573906e-11
with O 0 3.2950392089316216e-13
such O 0 1.3687777311328225e-13
extraordinarily O 0 3.4813909532971365e-09
high O 0 1.481028910621518e-10
sequence O 0 3.0530931515587723e-12
conservation O 0 2.5982629676263302e-12
throughout O 0 5.207881702788816e-15
evolution O 0 1.31865005026377e-13
, O 0 5.0224449301078736e-14
there O 0 2.103806224281607e-14
are O 0 3.338714870434849e-14
presumed O 0 1.2225488676964602e-10
undiscovered O 0 1.0890223165915813e-05
missense O 0 1.0650561307556927e-05
mutations O 0 6.0447200667113066e-06
, O 0 2.5501752402498634e-13
these O 0 7.518799764651835e-15
are O 0 2.349496092742421e-14
hypothesized O 0 3.022973147845387e-12
to O 0 5.020781425162102e-13
exist O 0 8.234968262854636e-10
in O 0 2.194568745478298e-12
as O 0 3.8223570975048915e-09
- O 0 2.145279722753912e-06
yet O 0 3.872822340600379e-10
unidentified O 0 9.63993240787886e-09
phenotypes O 0 1.4007351945011237e-09
. O 0 1.2850484565340992e-13
. O 0 4.395297060338921e-12

Genetic O 0 8.498362149111927e-06
heterogeneity O 0 9.887501164485002e-07
and O 0 5.419280579843644e-10
penetrance O 0 1.2799885951153556e-07
analysis O 0 1.765533552688936e-11
of O 0 8.119324440211684e-13
the O 0 5.7690546784172625e-11
BRCA1 O 1 0.9617253541946411
and O 0 1.3898410600177158e-07
BRCA2 O 0 0.03400237113237381
genes O 0 1.977134843400563e-06
in O 0 3.5482661253638526e-10
breast B-Disease 1 0.9908547401428223
cancer I-Disease 0 0.0176575668156147
families O 0 8.186096245310637e-09
. O 0 1.9281730379017148e-10

The O 0 5.319306183082517e-06
Breast B-Disease 1 0.9999996423721313
Cancer I-Disease 1 0.9999990463256836
Linkage O 0 0.027878182008862495
Consortium O 0 4.449973403097829e-06
. O 0 4.5226614120430497e-10

The O 0 6.070245760041171e-13
contribution O 0 5.1415443083624446e-12
of O 0 1.6784342741615194e-13
BRCA1 O 0 0.0027701882645487785
and O 0 8.929609407459793e-08
BRCA2 O 1 0.9998206496238708
to O 0 0.013090162537992
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 0.00010782291064970195
assessed O 0 7.289997938642045e-08
by O 0 8.51151072366052e-13
linkage O 0 5.478714683704311e-06
and O 0 1.1288929513408874e-10
mutation O 0 4.218187604765333e-11
analysis O 0 3.949368609923454e-12
in O 0 9.133168667966457e-14
237 O 0 3.006450366438429e-10
families O 0 2.3377020805237514e-12
, O 0 1.203606289477575e-14
each O 0 1.2851440018505494e-13
with O 0 2.66369695398061e-12
at O 0 9.2891555558694e-11
least O 0 3.39326548630392e-14
four O 0 1.259062992753357e-11
cases O 0 3.787167912605582e-09
of O 0 3.752739896611956e-09
breast B-Disease 1 0.9092038869857788
cancer I-Disease 0 1.1820591225841781e-06
, O 0 1.2650838560859974e-14
collected O 0 5.9542704967940896e-12
by O 0 1.5540482789511145e-10
the O 0 1.2179195437056478e-05
Breast B-Disease 1 1.0
Cancer I-Disease 1 0.9999997615814209
Linkage O 0 0.00020674018014688045
Consortium O 0 1.1651049902638988e-07
. O 0 1.5556851640230462e-10

Families O 0 4.439325795857485e-09
were O 0 1.748889574826329e-11
included O 0 1.809118610127114e-12
without O 0 3.6024541639687047e-13
regard O 0 5.022648963404208e-13
to O 0 4.141628581972104e-15
the O 0 1.1914464369527228e-13
occurrence O 0 1.4419597960113606e-07
of O 0 1.1930111343261274e-09
ovarian B-Disease 1 0.7974438667297363
or I-Disease 0 3.016216165718788e-09
other I-Disease 0 6.09645445237561e-10
cancers I-Disease 0 9.315409261034802e-05
. O 0 9.077936319323854e-11

Overall O 0 0.00018365283904131502
, O 0 1.7256371886986699e-09
disease O 0 0.0001501201477367431
was O 0 2.1716373144187173e-09
linked O 0 9.254026736016385e-07
to O 0 9.655692911891833e-11
BRCA1 O 0 0.024106377735733986
in O 0 2.2518013116038654e-13
an O 0 4.3093567756379795e-15
estimated O 0 2.4186080221921813e-11
52 O 0 1.868758658929437e-08
% O 0 1.1027600273910698e-12
of O 0 3.2295945973960516e-13
families O 0 2.9293643899475086e-11
, O 0 1.9858435371371969e-13
to O 0 2.275977529272305e-13
BRCA2 O 0 8.999077181215398e-06
in O 0 6.913819560264156e-13
32 O 0 1.0245138765130335e-10
% O 0 1.2099913932405674e-14
of O 0 1.0182000099827337e-14
families O 0 2.845524163519464e-12
, O 0 2.0398889825565258e-13
and O 0 5.568649924861391e-13
to O 0 2.2450155951381397e-14
neither O 0 6.67780891347447e-12
gene O 0 4.874108894270535e-10
in O 0 6.774393329286865e-13
16 O 0 5.8000139413483254e-11
% O 0 5.060453500736837e-15
( O 0 6.31012483001789e-15
95 O 0 1.7981113126230852e-11
% O 0 7.193439593988771e-11
confidence O 0 2.852588295354508e-05
interval O 0 2.5026125172189495e-08
[ O 0 4.5608289367393695e-10
CI O 0 3.349171038280474e-06
] O 0 2.9540741380840174e-11
6 O 0 1.789960367426513e-11
% O 0 3.2629058959940394e-13
- O 0 7.349304098624998e-08
28 O 0 2.2183412884402287e-09
% O 0 4.824391771084168e-15
) O 0 3.929568748489747e-16
, O 0 4.04872550539144e-17
suggesting O 0 2.3238220158913747e-13
other O 0 1.9263714565566706e-14
predisposition O 0 1.0454845877916341e-09
genes O 0 1.09190112507207e-09
. O 0 2.0497470040736765e-11

The O 0 5.005134154356661e-11
majority O 0 3.642531762326762e-11
( O 0 1.6934619938985263e-12
81 O 0 1.858511608499036e-11
% O 0 9.440513387031554e-15
) O 0 6.566946913691288e-16
of O 0 2.4635145201459645e-14
the O 0 1.5214337167890335e-07
breast B-Disease 1 0.9999998807907104
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 4.2573939929013704e-09
were O 0 2.9188901295995606e-11
due O 0 4.734894117411348e-13
to O 0 2.9241805374682905e-13
BRCA1 O 0 3.063431358896196e-05
, O 0 2.999675703142801e-13
with O 0 7.008615557487982e-14
most O 0 1.356979415986781e-12
others O 0 1.3283810162967313e-10
( O 0 2.3366007479569406e-12
14 O 0 1.1839815239333973e-10
% O 0 7.301271539401563e-15
) O 0 2.2381151565300378e-14
due O 0 2.0596649386028787e-12
to O 0 1.6228011989749547e-11
BRCA2 O 0 0.0017739892937242985
. O 0 7.41717409713516e-10

Conversely O 0 4.4929684861472197e-08
, O 0 4.008592503074171e-13
the O 0 1.8041812364428438e-15
majority O 0 4.742772946836164e-14
of O 0 2.1396892504327303e-14
families O 0 4.898709042577831e-12
with O 0 9.684447688229625e-11
male B-Disease 0 1.6976783854261157e-06
and I-Disease 0 4.2910819786357024e-08
female I-Disease 0 1.4840703443042003e-05
breast I-Disease 0 5.487582166097127e-05
cancer I-Disease 0 5.553492428589379e-06
were O 0 7.09500680429187e-10
due O 0 7.7312385660111e-11
to O 0 7.252956568670754e-11
BRCA2 O 0 0.054952219128608704
( O 0 1.3925456621155519e-10
76 O 0 1.927373460830495e-08
% O 0 1.625839762299519e-12
) O 0 1.794902984922353e-12
. O 0 8.99070574933436e-12

The O 0 1.1844778630143438e-11
largest O 0 1.779891789510657e-09
proportion O 0 1.0784229065308182e-09
( O 0 2.8190110835935034e-12
67 O 0 7.847018035356257e-10
% O 0 4.290299466061e-14
) O 0 1.8025163931850155e-15
of O 0 2.524426480503858e-15
families O 0 6.932610410216589e-13
due O 0 6.843444539349208e-13
to O 0 3.2630101149278695e-14
other O 0 4.3401621272615154e-13
genes O 0 9.796138900064477e-11
was O 0 1.050139197822375e-09
found O 0 4.991141944188371e-10
in O 0 4.266465381940615e-13
families O 0 3.181344348113929e-13
with O 0 1.4085210862241349e-12
four O 0 3.071528795195455e-11
or O 0 4.1162313141329676e-11
five O 0 1.988775637229434e-11
cases O 0 2.5968385775065883e-10
of O 0 3.649452962051214e-10
female O 0 0.006287335883826017
breast B-Disease 0 0.0006230493891052902
cancer I-Disease 0 1.4629086990680662e-06
only O 0 3.136008119852818e-10
. O 0 1.6458348572889747e-10

These O 0 2.0585258758004654e-12
estimates O 0 1.2841675639529981e-11
were O 0 6.573552466249133e-12
not O 0 1.5681234793746973e-13
substantially O 0 4.80667484981101e-11
affected O 0 1.2046869578286046e-12
either O 0 2.6160114944092554e-15
by O 0 1.9492676041539016e-15
changing O 0 5.6952782767627497e-11
the O 0 1.760235972822835e-13
assumed O 0 4.756571247988006e-10
penetrance O 0 8.92509355310267e-09
model O 0 1.8207493290844923e-09
for O 0 1.9585056233034637e-12
BRCA1 O 0 3.323285000078613e-06
or O 0 5.415327474639353e-12
by O 0 1.2921359708389316e-14
including O 0 2.5352873012779442e-12
or O 0 2.613738947498945e-10
excluding O 0 1.1196484592801426e-06
BRCA1 O 0 0.00020588132611010224
mutation O 0 2.6038396327976443e-08
data O 0 1.729838743358414e-07
. O 0 4.46300191248028e-10

Among O 0 4.5871584308798674e-10
those O 0 1.4280882032480235e-11
families O 0 6.724358483228832e-12
with O 0 1.3742340598810188e-10
disease O 0 8.044253627303988e-05
due O 0 9.630991837372704e-11
to O 0 4.653023192441319e-12
BRCA1 O 0 0.005357212387025356
that O 0 2.3048002395498202e-10
were O 0 2.99616755017329e-11
tested O 0 8.850820631955969e-10
by O 0 9.830810631365709e-17
one O 0 1.847094085484762e-14
of O 0 6.208145874816735e-16
the O 0 2.3316777806090374e-15
standard O 0 6.351621160451126e-13
screening O 0 5.019833290362263e-13
methods O 0 5.393345411117481e-14
, O 0 1.2176261670622914e-15
mutations O 0 1.5642169634219605e-12
were O 0 1.7237256001896573e-13
detected O 0 3.035145024199437e-09
in O 0 1.1436974278874676e-14
the O 0 1.0533286347097146e-13
coding O 0 4.115623397638046e-09
sequence O 0 1.267891569511903e-09
or O 0 9.20925766201286e-11
splice O 0 2.1918086190453323e-07
sites O 0 7.953342873179281e-09
in O 0 2.3938394533773097e-14
an O 0 4.641891322818177e-15
estimated O 0 3.836135228918458e-11
63 O 0 2.468262927379783e-08
% O 0 5.691319811262918e-13
( O 0 4.004586104996294e-14
95 O 0 1.977190633439818e-11
% O 0 2.4451523705087963e-12
CI O 0 0.00015587515372317284
51 O 0 1.9005675255812093e-08
% O 0 1.1622284731838128e-11
- O 0 7.112666935427114e-07
77 O 0 5.8423439419641454e-09
% O 0 4.0091966747347885e-13
) O 0 1.2036529271116508e-13
. O 0 9.28976622190103e-13

The O 0 3.488863928660657e-12
estimated O 0 3.034445958394194e-12
sensitivity O 0 3.662406836135723e-11
was O 0 7.02565089438778e-11
identical O 0 1.1155483004357536e-12
for O 0 1.0931981917809371e-15
direct O 0 3.4531419912354425e-15
sequencing O 0 1.1319718079549901e-10
and O 0 1.1045771936002424e-11
other O 0 1.4355800687202054e-14
techniques O 0 1.347104094939766e-10
. O 0 1.5602368355627227e-11

The O 0 9.642828202593989e-11
penetrance O 0 5.087607405585004e-06
of O 0 3.752733800793662e-12
BRCA2 O 0 0.00011329982226016
was O 0 3.862765315942873e-11
estimated O 0 3.1756182105729122e-15
by O 0 3.790174918640271e-16
maximizing O 0 2.485910262362001e-11
the O 0 1.2515968079648832e-12
LOD O 0 2.687546111701522e-05
score O 0 3.1999014993289165e-08
in O 0 5.020170910918775e-12
BRCA2 O 0 0.010184019804000854
- O 0 5.24865345141734e-06
mutation O 0 3.292853989478317e-06
families O 0 6.461429308268762e-11
, O 0 1.9511248085940514e-14
over O 0 2.3206060011972396e-13
all O 0 1.4014491607136637e-12
possible O 0 1.4844332360541834e-11
penetrance O 0 6.112954338277632e-07
functions O 0 3.4932823300692917e-10
. O 0 4.9246051680995606e-11

The O 0 2.516127497326215e-13
estimated O 0 3.032328077870461e-12
cumulative O 0 6.143288988624818e-09
risk O 0 1.9546454495866783e-05
of O 0 2.499404572198216e-10
breast B-Disease 1 0.995724081993103
cancer I-Disease 0 0.19975262880325317
reached O 0 1.3174023479223251e-05
28 O 0 9.87368053984028e-08
% O 0 6.220387703190222e-13
( O 0 4.1634593315282784e-14
95 O 0 2.2722452391876757e-11
% O 0 1.143441851619853e-11
CI O 0 6.234617467271164e-05
9 O 0 5.739194675058457e-10
% O 0 2.2682982608098617e-13
- O 0 7.749804353807122e-09
44 O 0 2.673798682462092e-10
% O 0 4.430607847971538e-15
) O 0 1.6933445930144544e-17
by O 0 9.291625191346084e-17
age O 0 4.3603586453305754e-13
50 O 0 3.901968402249614e-14
years O 0 1.1076483697261552e-12
and O 0 2.985020217116663e-12
84 O 0 3.0839367518020744e-12
% O 0 1.3148312445727213e-15
( O 0 1.3134074880675052e-15
95 O 0 5.036376589211133e-13
% O 0 2.982218692913069e-13
CI O 0 6.469469099101843e-06
43 O 0 4.0149647495546503e-10
% O 0 1.4946252785766334e-13
- O 0 2.661679543436435e-09
95 O 0 7.443190508382713e-11
% O 0 4.978685852800001e-14
) O 0 4.4860310136554e-16
by O 0 1.3306853720047168e-15
age O 0 8.688416305857594e-12
70 O 0 4.777294011770739e-13
years O 0 1.2100410734169897e-12
. O 0 4.651663169236153e-13

The O 0 3.550578497879542e-08
corresponding O 0 0.3769528865814209
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 1 0.9997566342353821
were O 0 3.71400266097055e-09
0 O 0 3.185405272887465e-10
. O 0 2.781094105008819e-11

4 O 0 3.271875925747736e-08
% O 0 2.479640451302778e-11
( O 0 3.344108572955057e-13
95 O 0 1.9664945019592928e-11
% O 0 2.236394576471401e-11
CI O 0 0.00010305355681339279
0 O 0 8.989304439710466e-11
% O 0 6.520875419496752e-13
- O 0 4.495040339946854e-09
1 O 0 3.699672512791352e-12
% O 0 9.262363511740898e-16
) O 0 1.6004889370439468e-17
by O 0 5.591820350197272e-17
age O 0 8.525711603715735e-13
50 O 0 6.542874152627026e-14
years O 0 3.0988011635868506e-12
and O 0 8.625786716842665e-12
27 O 0 2.4586866830683674e-12
% O 0 3.136261777590807e-16
( O 0 2.0087125616806656e-16
95 O 0 2.0148319861482133e-13
% O 0 1.5774047920722595e-13
CI O 0 1.4246496675696108e-06
0 O 0 4.5176046063744035e-12
% O 0 2.40738039312266e-13
- O 0 2.7381588552088942e-08
47 O 0 1.5259230323749762e-08
% O 0 4.721814302402483e-14
) O 0 2.8940802348942254e-16
by O 0 5.911799751516793e-16
age O 0 7.037960058492443e-12
70 O 0 7.754106601601252e-13
years O 0 8.680478211231524e-13
. O 0 1.0953579623190768e-12

The O 0 2.484914704559138e-11
lifetime O 0 2.899607238759927e-07
risk O 0 6.86298226355575e-05
of O 0 7.1192413075849e-11
breast B-Disease 1 0.8226731419563293
cancer I-Disease 0 6.012781159370206e-05
appears O 0 1.8262759082787738e-09
similar O 0 7.667511374084834e-13
to O 0 3.2055253091668734e-13
the O 0 1.3126588357947888e-11
risk O 0 2.4754771743573656e-07
in O 0 4.925521253883181e-13
BRCA1 O 0 2.290209158672951e-05
carriers O 0 8.314948729548632e-08
, O 0 1.347014540924521e-13
but O 0 2.0199534861604918e-13
there O 0 1.9318550123319234e-13
was O 0 2.147830663323802e-10
some O 0 1.8064951186965057e-15
suggestion O 0 2.4712159402140443e-12
of O 0 2.7089136445476334e-15
a O 0 2.284813657715823e-11
lower O 0 1.786045515927981e-07
risk O 0 1.3912004988014814e-06
in O 0 2.5245072959173553e-12
BRCA2 O 0 1.7004660548991524e-05
carriers O 0 1.3249049635177812e-09
< O 0 1.852692825543567e-11
50 O 0 4.106096159698508e-13
years O 0 1.3283695974794507e-12
of O 0 1.5263732931671686e-13
age O 0 1.0162920283107724e-08
. O 0 2.2025077942022797e-11

Eye B-Disease 1 0.9948347806930542
movement I-Disease 0 2.1803110428209038e-07
abnormalities I-Disease 0 0.08239523321390152
correlate O 0 1.5739106018486382e-08
with O 0 7.864504047994103e-10
genotype O 0 0.00021217383618932217
in O 0 1.2346512257011e-08
autosomal O 1 0.9999905824661255
dominant O 1 0.9999213218688965
cerebellar B-Disease 1 0.9996557235717773
ataxia I-Disease 1 0.9999549388885498
type I-Disease 1 0.9999866485595703
I I-Disease 1 0.9978131055831909
. O 0 9.047172455645125e-10

We O 0 4.046302404248081e-09
compared O 0 1.3635663709266055e-09
horizontal O 0 4.359711965662427e-05
eye O 1 0.9312777519226074
movements O 0 3.3657912013040914e-07
( O 0 2.188437799033327e-11
visually O 0 6.284464060257733e-09
guided O 0 1.0035040531874984e-06
saccades O 0 1.1029873348888941e-05
, O 0 1.0638145746255656e-11
antisaccades O 0 9.740016082560032e-08
, O 0 2.625451668136075e-13
and O 0 5.281689866823598e-14
smooth O 0 2.316406181451791e-12
pursuit O 0 1.9363252667936592e-10
) O 0 2.3317068761907755e-13
in O 0 1.0437783721107402e-14
control O 0 3.998814127048611e-11
subjects O 0 3.366938061688529e-09
( O 0 6.629732570220814e-13
n O 0 5.0334790557826636e-08
= O 0 6.336388302941032e-09
14 O 0 1.0261214100637517e-10
) O 0 1.0341875196929334e-13
and O 0 1.227613496967983e-12
patients O 0 1.4894459092733986e-13
with O 0 4.3591563837059016e-15
three O 0 1.0991816181207814e-12
forms O 0 2.560472667223479e-10
of O 0 1.6314213313606274e-09
autosomal O 1 0.9998350143432617
dominant O 1 0.9149206280708313
cerebellar B-Disease 0 0.0983848050236702
ataxias I-Disease 1 0.8186718821525574
type I-Disease 1 0.9987351298332214
I I-Disease 1 0.5649570226669312
spinocerebellar B-Disease 1 0.8847457766532898
ataxias I-Disease 0 0.000438475253758952
1 I-Disease 0 1.045997288784406e-09
and I-Disease 0 1.7357231971160125e-11
2 I-Disease 0 2.2908606435445567e-12
( O 0 5.805761009751095e-14
SCA1 B-Disease 0 1.7391067785865744e-07
, O 0 2.5665269063647467e-13
n O 0 4.452596957804644e-09
= O 0 8.541056195632279e-10
11 O 0 9.05351574959079e-12
; O 0 2.7075718173042405e-14
SCA2 B-Disease 0 3.79854228071963e-08
, O 0 1.8324866634961828e-13
n O 0 1.655299231018148e-09
= O 0 1.0671765554581825e-10
10 O 0 1.0889212708614648e-12
) O 0 7.995088423772001e-14
and O 0 2.6819386989007654e-11
SCA3 B-Disease 1 0.9999996423721313
/ O 0 2.51950098117959e-07
Machado B-Disease 0 7.667317163395637e-07
- I-Disease 0 3.98267644641237e-07
Joseph I-Disease 0 1.1190837767571793e-06
disease I-Disease 0 8.888966112863272e-05
( O 0 5.578646052051273e-12
MJD B-Disease 1 0.9999986886978149
) O 0 2.1675413200417104e-12
( O 0 6.328835025493085e-14
n O 0 2.3281042871303725e-08
= O 0 5.78137626661146e-09
16 O 0 7.735118101592775e-11
) O 0 1.3701705785587603e-12
. O 0 1.8828153012379056e-12

In O 0 1.421826961722772e-10
SCA1 B-Disease 0 3.754023225610581e-07
, O 0 5.5408460344864505e-14
saccade O 0 2.9437813298116566e-11
amplitude O 0 1.947984742262099e-12
was O 0 1.376884023462921e-10
significantly O 0 7.913568411677119e-11
increased O 0 2.32317706738705e-11
, O 0 3.24324781982889e-14
resulting O 0 7.358459544817841e-13
in O 0 1.2720584134651158e-12
hypermetria B-Disease 0 5.076637171441689e-05
. O 0 8.313779525925824e-11

The O 0 9.544707038622313e-12
smooth O 0 3.438454798665447e-10
pursuit O 0 7.411111280219984e-09
gain O 0 7.117458977745628e-08
was O 0 2.4166842749195894e-08
decreased O 0 6.811907127257655e-08
. O 0 1.2987499964367544e-11

In O 0 2.0506825404442708e-10
SCA2 B-Disease 0 1.365010803056066e-06
, O 0 1.544088750089767e-13
saccade O 0 2.7272833991176526e-10
velocity O 0 3.4162092599210325e-10
was O 0 3.9167480370139174e-10
markedly O 0 3.0048121768544434e-09
decreased O 0 6.406314412288339e-08
. O 0 2.659652012515501e-11

The O 0 1.835299924188294e-12
percentage O 0 1.1459537763158778e-09
of O 0 3.694358932811691e-14
errors O 0 1.3088786943171726e-07
in O 0 1.0971807501165137e-13
antisaccades O 0 5.8585271744959755e-08
was O 0 2.5867194497486423e-10
greatly O 0 1.1496168600411139e-12
increased O 0 1.8672592985713443e-11
and O 0 6.87377195093819e-12
was O 0 2.3182339381477846e-10
significantly O 0 8.430986811469587e-12
correlated O 0 1.9746515533825004e-10
with O 0 1.15550950752219e-10
age O 0 5.0684409558243715e-08
at O 0 8.877643864479978e-08
disease O 0 4.839896791963838e-05
onset O 0 1.4501114264930948e-07
. O 0 2.6655176330048214e-11

In O 0 1.1754058663882017e-11
addition O 0 2.3785814897564483e-12
, O 0 1.0018708876497417e-15
a O 0 8.644347097600479e-16
correlation O 0 2.6165607874828467e-11
between O 0 5.1420742663843555e-12
smooth O 0 1.427144957766302e-09
pursuit O 0 1.5783177431671902e-08
gain O 0 4.231752654959564e-07
and O 0 4.0553227442785555e-11
the O 0 1.7033341290174572e-14
number O 0 3.650911604285989e-12
of O 0 3.296384703827676e-13
trinucleotide O 0 9.023636948768399e-07
repeats O 0 4.0304223603016e-07
was O 0 1.7614174008251382e-10
found O 0 1.5133588826543587e-11
. O 0 3.591650197740104e-12

In O 0 4.338731152131459e-09
SCA3 B-Disease 1 0.9999955892562866
, O 0 1.0549009443749924e-09
gaze B-Disease 0 0.0024707817938178778
- I-Disease 0 9.838531696004793e-05
evoked I-Disease 0 5.839550567543483e-07
nystagmus I-Disease 0 0.00038245011819526553
was O 0 1.0048926135652891e-08
often O 0 2.567003250589228e-12
present O 0 1.0628947537654615e-13
as O 0 4.0613871857622663e-13
was O 0 1.5073983727909024e-11
saccade O 0 5.748484466217008e-10
hypometria O 0 1.0130764849236584e-06
and O 0 1.01812135111512e-12
smooth O 0 1.7323099552046806e-11
pursuit O 0 7.350896003011087e-10
gain O 0 1.304355023989956e-08
was O 0 1.2071874166963426e-08
markedly O 0 4.815507548272535e-09
decreased O 0 1.7336942548240586e-08
. O 0 1.2249197316183125e-11

Three O 0 4.899199934627063e-10
major O 0 4.018642363323721e-10
criteria O 0 8.949085222864639e-11
, O 0 5.054222302860361e-15
saccade O 0 1.3743958228451536e-11
amplitude O 0 2.4114659379591286e-13
, O 0 3.348509070052303e-15
saccade O 0 1.6056734067348977e-11
velocity O 0 4.347971982454624e-11
, O 0 6.574524046920951e-14
and O 0 8.536120893248497e-14
presence O 0 4.232385275582118e-12
of O 0 2.74262627582636e-13
gaze B-Disease 1 0.9207218885421753
- I-Disease 0 4.812228144146502e-05
evoked I-Disease 0 1.7006294683596934e-07
nystagmus I-Disease 0 2.930284836111241e-06
, O 0 4.3417665431888866e-14
permitted O 0 1.8011574219947701e-13
the O 0 1.593259868181156e-15
correct O 0 2.831049804308261e-11
assignment O 0 2.081633615480527e-10
of O 0 4.3484608986809215e-15
90 O 0 8.551863508792987e-14
% O 0 9.967818078235194e-16
of O 0 4.3070540106917503e-16
the O 0 4.949176918983555e-13
SCA1 B-Disease 0 4.818302841158584e-06
, O 0 1.5460241864929253e-14
90 O 0 2.274044388328434e-15
% O 0 1.9817843254962673e-16
of O 0 3.3464257395789717e-16
the O 0 2.631206613267628e-13
SCA2 B-Disease 0 2.569419848441612e-05
, O 0 6.683349078155654e-13
and O 0 5.361726687636015e-13
93 O 0 2.4622812469510258e-12
% O 0 1.378751527146083e-15
of O 0 7.307370176621794e-16
the O 0 1.504769182522625e-12
patients O 0 3.760058236990105e-11
with O 0 6.5692403773687236e-12
SCA3 B-Disease 1 1.0
to O 0 2.4765103162627256e-12
their O 0 1.6760414399668438e-13
genetically O 0 1.1204374095186154e-09
confirmed O 0 3.12035203231531e-10
patient O 0 6.427874899017638e-10
group O 0 3.177598375397883e-12
and O 0 1.058310383772465e-10
, O 0 3.2740338760418874e-13
therefore O 0 1.348011871397936e-13
, O 0 3.5317319273080183e-13
may O 0 2.10558775276537e-11
help O 0 1.914250008505647e-12
orient O 0 7.569038729116073e-09
diagnoses O 0 2.567212220583315e-07
of O 0 9.899699332863166e-13
SCA1 B-Disease 0 1.4307262972579338e-05
, O 0 6.097212578576316e-13
SCA2 B-Disease 0 5.644986345032521e-07
, O 0 7.572330349564504e-13
and O 0 1.568352392400385e-11
SCA3 B-Disease 1 1.0
at O 0 1.7009619268648635e-09
early O 0 2.1533126844108796e-12
clinical O 0 1.131635674056497e-09
stages O 0 1.0709794856511579e-10
of O 0 2.3588460828713465e-13
the O 0 2.1463686383782488e-10
diseases O 0 2.6642719603842124e-06
. O 0 1.3583304945240238e-13
. O 0 7.34278870345717e-12

Genetic O 0 3.6847998785560776e-07
basis O 0 2.1419148399370869e-10
and O 0 3.225638072618109e-12
molecular O 0 9.49248946113812e-09
mechanism O 0 1.6120384316309355e-05
for O 0 7.216685389721533e-06
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 0.9999910593032837
fibrillation I-Disease 1 0.9999986886978149
. O 0 1.2796971304851468e-06

Ventricular B-Disease 1 0.6987685561180115
fibrillation I-Disease 0 0.0010122783714905381
causes O 0 3.6416740734068753e-09
more O 0 1.5372939873121647e-14
than O 0 1.1234175956577157e-14
300 O 0 2.4711240947375077e-14
, O 0 2.108127151103788e-15
000 O 0 3.263788368799807e-14
sudden O 0 1.5089164726728166e-12
deaths O 0 3.288889646735349e-11
each O 0 1.4097018691261454e-11
year O 0 2.19413570645699e-10
in O 0 4.294229021309902e-14
the O 0 1.1415432401434833e-12
USA O 0 1.113420512410812e-05
alone O 0 2.6762081439812846e-09
. O 0 6.590600894890164e-12

In O 0 3.259059341842452e-11
approximately O 0 5.1079609292292716e-11
5 O 0 4.794572516786388e-10
- O 0 3.1225999919115566e-07
12 O 0 2.3132031012895737e-10
% O 0 4.767512661643094e-15
of O 0 3.223569500105697e-17
these O 0 1.4462316774385177e-15
cases O 0 7.62364618048933e-13
, O 0 5.377278127844309e-15
there O 0 5.887017219194379e-14
are O 0 3.5990546480568764e-13
no O 0 2.8063622606322447e-11
demonstrable O 0 4.737331619253382e-05
cardiac O 0 7.294250281120185e-06
or O 0 3.4137445936721633e-07
non O 1 0.8617687821388245
- O 1 0.7096827030181885
cardiac O 0 0.00017258421576116234
causes O 0 1.2280479411153067e-10
to O 0 4.412023860405484e-14
account O 0 1.0088952243081373e-11
for O 0 3.7149371578081014e-13
the O 0 1.0134343315709379e-13
episode O 0 1.2592707321346097e-07
, O 0 4.765609022856776e-13
which O 0 3.197530741160144e-14
is O 0 1.9589379760247966e-13
therefore O 0 3.647081551691467e-13
classified O 0 1.6400119420723058e-05
as O 0 0.0007459706394001842
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 0.9999635219573975
fibrillation I-Disease 1 0.999998927116394
( O 0 3.5126222996950673e-07
IVF B-Disease 1 0.9999983310699463
) O 0 2.5917925583485157e-09
. O 0 5.5816712363210286e-11

A O 0 4.0809616796977366e-10
distinct O 0 8.326422884508133e-12
group O 0 2.835988171731585e-12
of O 0 2.807151754970205e-13
IVF B-Disease 1 1.0
patients O 0 4.4936712129128864e-07
has O 0 2.68614679110879e-11
been O 0 2.7460930664829908e-12
found O 0 5.022538981935831e-11
to O 0 1.0536210792722045e-11
present O 0 7.913689148431047e-11
with O 0 2.1536546851441685e-11
a O 0 5.6390492969571326e-11
characteristic O 0 1.6624538190512794e-08
electrocardiographic O 0 1.6629472156637348e-05
pattern O 0 8.319404969370225e-07
. O 0 4.85125606353165e-10

Because O 0 3.416007199330551e-10
of O 0 1.3740477837833904e-14
the O 0 1.2030227896560352e-15
small O 0 6.0023383832708e-14
size O 0 4.270986342369554e-12
of O 0 1.3439522796509715e-14
most O 0 7.073830995789343e-14
pedigrees O 0 1.8074373941967536e-10
and O 0 2.2049909641219667e-12
the O 0 7.040987123852968e-14
high O 0 4.224866678725903e-09
incidence O 0 2.3528177450771182e-07
of O 0 1.770950053270326e-11
sudden B-Disease 0 2.7539188707237372e-08
death I-Disease 0 6.590334056255642e-09
, O 0 2.5352582446597216e-12
however O 0 4.566634139520527e-14
, O 0 2.117523869922831e-16
molecular O 0 1.545273105437936e-13
genetic O 0 1.462089060932925e-10
studies O 0 5.741871388076358e-12
of O 0 1.3437254781090147e-12
IVF B-Disease 1 1.0
have O 0 1.1392773302532078e-07
not O 0 2.714079178414708e-12
yet O 0 3.2359904686418695e-12
been O 0 2.6295186514313507e-11
done O 0 6.987886935760912e-10
. O 0 1.0241812606337497e-11

Because O 0 8.093105918760557e-08
IVF B-Disease 1 0.9999979734420776
causes O 0 0.024630917236208916
cardiac O 1 0.9458072781562805
rhythm O 0 0.000522876565810293
disturbance O 0 3.1861820843914757e-06
, O 0 7.777209188068387e-14
we O 0 3.362488374758846e-14
investigated O 0 1.2349507701181484e-11
whether O 0 1.3337162320728457e-12
malfunction O 0 3.907273615766371e-09
of O 0 4.214865591690552e-15
ion O 0 1.7802226706664648e-11
channels O 0 2.400525431767164e-07
could O 0 5.073669058219821e-07
cause O 0 1.2399485882497174e-09
the O 0 2.8587994818640716e-11
disorder O 0 2.3902819634713524e-07
by O 0 5.151349982735235e-16
studying O 0 4.519974672323457e-12
mutations O 0 4.92025398202145e-09
in O 0 6.30084363590494e-14
the O 0 8.943342485849548e-13
cardiac O 0 4.053989144381376e-09
sodium O 0 5.288118901103367e-11
channel O 0 7.994315431858467e-09
gene O 0 1.6741644515150256e-07
SCN5A O 0 0.0002259170141769573
. O 0 1.0338577216550959e-10

We O 0 1.5187141855221853e-07
have O 0 3.881694965457427e-11
now O 0 3.724609596439388e-12
identified O 0 2.7700033239375088e-11
a O 0 4.512727810792455e-13
missense O 0 1.6739359125494957e-06
mutation O 0 5.261571800474485e-07
, O 0 2.770465606059813e-13
a O 0 4.707626432773337e-13
splice O 0 0.3099633455276489
- O 0 0.22351692616939545
donor O 0 5.627957762044389e-07
mutation O 0 2.958211553050205e-06
, O 0 2.246458401244933e-11
and O 0 1.9292896273614968e-12
a O 0 5.332812099897999e-13
frameshift O 0 3.6944692283213953e-07
mutation O 0 3.385976299341564e-08
in O 0 8.686733515665679e-14
the O 0 9.503624287272167e-14
coding O 0 3.614583832245444e-08
region O 0 2.3718188871257873e-11
of O 0 1.6370036565443308e-13
SCN5A O 0 1.3976721675135195e-05
in O 0 1.3383074488025615e-13
three O 0 2.3052958847413763e-11
IVF B-Disease 1 0.9999958276748657
families O 0 4.880472137536174e-10
. O 0 1.059002451703206e-11

We O 0 5.767781252608017e-10
show O 0 5.372921205171188e-11
that O 0 3.843832126508226e-15
sodium O 0 2.8000716437333317e-13
channels O 0 1.2486478864759398e-11
with O 0 1.0664505303153993e-13
the O 0 3.0193976794734914e-14
missense O 0 1.097677895245397e-07
mutation O 0 2.5114719193197743e-09
recover O 0 6.906225591407633e-10
from O 0 1.7816875565505007e-14
inactivation O 0 7.926537648472731e-09
more O 0 2.0280226629467975e-16
rapidly O 0 4.817629043092631e-13
than O 0 2.6391050006831967e-15
normal O 0 9.236549242466752e-13
and O 0 1.398389325342475e-12
that O 0 1.3725815189297164e-13
the O 0 9.530984942246468e-13
frameshift O 0 2.095971922244644e-06
mutation O 0 9.834605663172624e-08
causes O 0 4.9970264037746404e-11
the O 0 5.937774821525646e-14
sodium O 0 1.662048797201887e-11
channel O 0 1.0166274044820511e-08
to O 0 7.953881303590649e-11
be O 0 1.0939007921706434e-08
non O 0 6.469479103543563e-07
- O 0 1.4650640878244303e-07
functional O 0 2.1461978860770614e-09
. O 0 1.1526253042293266e-11

Our O 0 1.808748706366714e-09
results O 0 1.1595713104994854e-11
indicate O 0 3.0135434078704115e-12
that O 0 3.082046269131493e-14
mutations O 0 3.4000766646613556e-09
in O 0 4.640231883630552e-13
cardiac O 0 8.49213410702987e-09
ion O 0 1.383106962293823e-09
- O 0 1.524956246612419e-06
channel O 0 7.198225659976742e-08
genes O 0 2.287170453030285e-09
contribute O 0 2.598499486330258e-13
to O 0 5.401867070786628e-15
the O 0 3.561073216363543e-14
risk O 0 8.350363456255394e-11
of O 0 2.4815750837022628e-15
developing O 0 1.9974137621669996e-10
IVF B-Disease 1 0.9997331500053406
. O 0 2.0635095466115666e-13
. O 0 9.548362534667065e-13

Molecular O 0 1.8546119306961373e-08
heterogeneity O 0 5.3687706724758755e-08
in O 0 3.251304434015445e-11
mucopolysaccharidosis B-Disease 0 9.145202056970447e-06
IVA I-Disease 0 0.3629186451435089
in O 0 5.149167758844442e-09
Australia O 0 1.4874992302793544e-05
and O 0 4.668593844847635e-10
Northern O 0 9.821432556123e-11
Ireland O 0 1.465458154825683e-07
: O 0 1.5480727864978366e-13
nine O 0 1.8957292604194348e-13
novel O 0 1.257370401373803e-12
mutations O 0 8.347453284152095e-10
including O 0 7.369640379721598e-13
T312S O 0 1.660788451207651e-10
, O 0 3.690068118010785e-15
a O 0 5.798984068546703e-15
common O 0 1.620412788325143e-12
allele O 0 1.0396715433014236e-10
that O 0 7.046207367578106e-12
confers O 0 3.324184927322449e-09
a O 0 2.5881272680550182e-09
mild O 0 1.649183832341805e-05
phenotype O 0 8.446533001915668e-07
. O 0 2.776558705175347e-10

Mucopolysaccharidosis B-Disease 1 0.5181729197502136
IVA I-Disease 1 0.9995120763778687
( O 0 0.00011652721877908334
MPS B-Disease 1 0.9999985694885254
IVA I-Disease 1 0.9999997615814209
) O 0 1.5358860849801204e-08
is O 0 5.436580075013353e-10
an O 0 2.5649025126028846e-09
autosomal B-Disease 1 0.9999996423721313
recessive I-Disease 1 0.9999997615814209
lysosomal I-Disease 1 0.9999992847442627
storage I-Disease 1 0.9999978542327881
disorder I-Disease 1 0.9999992847442627
caused O 0 1.1606042349399104e-08
by O 0 3.429960308831692e-13
a O 0 2.9445030857999654e-09
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 1.2796522175229086e-10
N O 0 0.00015833049837965518
- O 0 1.1906260624527931e-05
acetylgalactosamine O 0 0.028922583907842636
- O 0 6.053615834389348e-06
6 O 0 1.346484168607276e-07
- O 0 4.119747245567851e-06
sulfate O 0 4.091332073130616e-07
sulfatase O 0 4.393840754346456e-06
( O 0 1.5604741891023233e-12
GALNS O 0 3.556237615498503e-08
) O 0 4.3799550574971646e-13
. O 0 1.6005693949036615e-12

Previous O 0 4.5391240766079477e-10
studies O 0 7.687489533836356e-12
of O 0 2.3820885653000508e-14
patients O 0 1.6437312665498749e-12
from O 0 5.4918969322008664e-15
a O 0 3.072688631311493e-11
British O 0 0.009999734349548817
- O 0 0.06627427041530609
Irish O 0 3.2615618692943826e-05
population O 0 4.292300889718881e-12
showed O 0 2.3553126116127032e-09
that O 0 8.619495362686275e-14
the O 0 9.223336680454393e-15
I113F O 0 6.962791454512285e-11
mutation O 0 2.2447450148677106e-11
is O 0 9.920638258369835e-14
the O 0 1.6663305418045875e-15
most O 0 1.786689963730395e-14
common O 0 5.418352398700588e-13
single O 0 4.142431286879855e-09
mutation O 0 3.384496494618361e-06
among O 0 6.728407697664807e-06
MPS B-Disease 1 0.9999998807907104
IVA I-Disease 1 1.0
patients O 0 0.004394478630274534
and O 0 2.296769302523316e-10
produces O 0 1.0317824816752363e-08
a O 0 2.3785624581051934e-09
severe O 0 1.718945895845536e-05
clinical O 0 1.1734742884073057e-06
phenotype O 0 4.341013948305772e-07
. O 0 1.7564655285795538e-10

We O 0 2.5637445943971215e-08
studied O 0 1.3996455106024541e-09
mutations O 0 2.9047763305811714e-08
in O 0 6.470916332065521e-14
the O 0 4.918906671954118e-15
GALNS O 0 1.3678442378761702e-08
gene O 0 1.067086974337883e-10
from O 0 3.479863695376312e-13
23 O 0 7.421076253510961e-11
additional O 0 2.9707685200719425e-09
MPS B-Disease 1 0.9999996423721313
IVA I-Disease 1 1.0
patients O 0 1.5500703511861502e-06
( O 0 8.764472166685605e-14
15 O 0 3.6690035775180374e-13
from O 0 1.8714290371275172e-13
Australia O 0 1.0090064783696562e-08
, O 0 1.5662207765597858e-15
8 O 0 5.437844795221254e-14
from O 0 1.6134134501501196e-14
Northern O 0 1.6222836875939839e-12
Ireland O 0 1.0376201231565574e-08
) O 0 6.159029991743836e-14
, O 0 4.616618612529187e-16
with O 0 8.563410981907963e-16
various O 0 4.4043496063780885e-13
clinical O 0 6.758406811968598e-08
phenotypes O 0 9.863158823009144e-08
( O 0 9.702529751853817e-11
severe O 0 1.3567268979386427e-06
, O 0 7.266713272779945e-13
16 O 0 1.280645294671201e-11
cases O 0 1.2103948919539587e-11
; O 0 7.172494071111882e-14
intermediate O 0 9.051103616597445e-11
, O 0 1.3145825573934733e-12
4 O 0 1.0891170777738157e-11
cases O 0 2.2947386213445498e-09
; O 0 4.6180417823116215e-10
mild O 0 2.869960837870167e-07
, O 0 5.846758082024561e-13
3 O 0 3.301911261771595e-12
cases O 0 1.6739547248345588e-10
) O 0 1.3382628338831637e-11
. O 0 1.9883015373034496e-11

We O 0 6.047538469999836e-09
found O 0 1.109408676036594e-10
two O 0 4.748786541948491e-13
common O 0 1.977664993574324e-12
mutations O 0 1.820072093039471e-09
that O 0 3.122162901478265e-13
together O 0 5.919529623421571e-12
accounted O 0 5.13128782131389e-07
for O 0 3.113988580882854e-11
32 O 0 1.9590091770993467e-09
% O 0 3.986083517296471e-14
of O 0 5.990577415501469e-15
the O 0 1.4389452086469023e-12
44 O 0 5.57841446646723e-11
unrelated O 0 1.0092994148780399e-11
alleles O 0 5.4862548531930955e-11
in O 0 4.423956182940045e-14
these O 0 6.919334354614504e-13
patients O 0 2.7227758242487354e-11
. O 0 1.1891404744571177e-12

One O 0 1.8711393545700616e-10
is O 0 1.2232152790669915e-11
the O 0 1.5161423548917807e-13
T312S O 0 4.859206370610991e-08
mutation O 0 6.590889967128533e-08
, O 0 4.033902931740302e-13
a O 0 1.2680407634015674e-14
novel O 0 3.0421897639909545e-11
mutation O 0 2.794683151563504e-09
found O 0 1.0246208395625622e-11
exclusively O 0 2.5436295431058298e-11
in O 0 5.242779409393716e-13
milder O 0 1.5893137472744456e-08
patients O 0 2.3243305891096355e-10
. O 0 9.56365889259736e-12

The O 0 4.698371899869436e-12
other O 0 1.0649890257868888e-13
is O 0 1.7035721791569536e-13
the O 0 4.9212711644263784e-15
previously O 0 9.603883244224676e-10
described O 0 3.2837368241223075e-11
I113F O 0 9.39350958129026e-11
that O 0 1.3949627043763346e-13
produces O 0 7.279538777327232e-11
a O 0 7.654631095643794e-11
severe O 0 6.047743568160513e-07
phenotype O 0 5.746331410705352e-08
. O 0 1.0303419228918642e-10

The O 0 2.8857917791502707e-11
I113F O 0 6.101937177760419e-09
and O 0 1.084326313634254e-12
T312S O 0 1.321527332009964e-10
mutations O 0 2.0399078259902836e-10
accounted O 0 4.428120536914548e-09
for O 0 1.6147973800131887e-12
8 O 0 1.0732764677001683e-09
( O 0 5.349519655376e-13
18 O 0 1.0707425224243394e-10
% O 0 2.638200496550471e-14
) O 0 4.840505641169439e-14
and O 0 1.8176765648192372e-11
6 O 0 2.4854751590197566e-10
( O 0 5.713244005493834e-14
14 O 0 2.154894535380536e-12
% O 0 4.664058280926941e-16
) O 0 1.682637170118874e-16
of O 0 3.688659078703027e-16
44 O 0 1.8767060388363843e-12
unrelated O 0 1.5995600677332078e-11
alleles O 0 1.3887209437957182e-10
, O 0 1.5340120666784696e-12
respectively O 0 2.7109983702366947e-10
. O 0 8.99458632575012e-11

The O 0 4.925072502603989e-12
relatively O 0 1.2043199770772617e-11
high O 0 1.5300870570555958e-09
residual O 0 3.9712066524089096e-08
GALNS O 0 3.990427558164811e-06
activity O 0 1.3683445487799872e-09
seen O 0 2.022589734584912e-10
when O 0 1.5151710452705053e-13
the O 0 8.849409538966009e-16
T312S O 0 1.3739338442994575e-12
mutant O 0 1.868027867807376e-12
cDNA O 0 4.3258479480792755e-13
is O 0 1.455009479870914e-13
overexpressed O 0 4.785392970774183e-09
in O 0 2.1921817456465632e-14
mutant O 0 6.3364362645756955e-09
cells O 0 1.3392382688937055e-11
provides O 0 2.5321520562575275e-15
an O 0 1.9349608735676416e-16
explanation O 0 1.1931832949517267e-14
for O 0 1.049699064649412e-12
the O 0 1.2947116989625584e-10
mild O 0 5.179163622415217e-07
phenotype O 0 3.993581909611521e-09
in O 0 1.687048802523003e-13
patients O 0 2.671430568076949e-12
with O 0 3.232302925952591e-15
this O 0 4.8647738127346324e-14
mutation O 0 5.300517358364232e-08
. O 0 3.4514252567063863e-10

The O 0 6.82626318752183e-13
distribution O 0 1.6652369587422111e-12
and O 0 1.0836207690705091e-13
relative O 0 1.454997790816242e-14
frequencies O 0 3.7533456296321224e-14
of O 0 1.8001595240092804e-15
the O 0 3.954822241718746e-14
I113F O 0 2.163726836590385e-10
and O 0 1.4119338565075218e-13
T312S O 0 1.5781589576824295e-11
mutations O 0 2.830068401848962e-10
in O 0 3.25005931997753e-14
Australia O 0 1.6100650326866806e-11
corresponded O 0 1.4774151953916848e-13
to O 0 2.0213657780747667e-15
those O 0 2.7197872182497737e-14
observed O 0 3.985716964804986e-11
in O 0 1.2699922764900645e-13
Northern O 0 1.7399227891790048e-11
Ireland O 0 1.8484429631371313e-07
and O 0 4.3436615415615165e-11
are O 0 1.4749818391408126e-14
unique O 0 8.656622722588562e-16
to O 0 2.5224243063747855e-15
these O 0 1.6621571469459945e-14
two O 0 8.055881482726956e-12
populations O 0 1.4690431163200124e-11
, O 0 5.790429459295908e-15
suggesting O 0 8.066506664017314e-12
that O 0 4.710842176416929e-13
both O 0 1.7158801506392263e-12
mutations O 0 4.773023309923019e-09
were O 0 3.058229364194531e-11
probably O 0 1.2855130154809657e-11
introduced O 0 4.0684931118528667e-11
to O 0 2.9575003470533323e-12
Australia O 0 8.542755836060678e-09
by O 0 1.2788377399142875e-13
Irish O 0 5.794093205224726e-09
migrants O 0 2.5734299673868533e-12
during O 0 8.769505575271369e-14
the O 0 5.6037649970612155e-14
19th O 0 1.4125824121524744e-10
century O 0 8.922587113602276e-10
. O 0 1.0991644261437727e-09

Haplotype O 0 2.6402480557408126e-07
analysis O 0 1.7121680462306443e-10
using O 0 3.8262282231471545e-10
6 O 0 4.247067142415517e-10
RFLPs O 0 1.1690551859899756e-09
provides O 0 2.2612344126055756e-14
additional O 0 7.431939924042695e-15
data O 0 5.438599570695146e-11
that O 0 3.069346805797263e-13
the O 0 2.2038797111052777e-13
I113F O 0 2.2347508288333984e-09
mutation O 0 1.4858615726698332e-10
originated O 0 1.6311574486949088e-12
from O 0 1.6670053941294886e-14
a O 0 1.231106687947514e-13
common O 0 1.025973576929129e-12
ancestor O 0 1.4003176396215622e-10
. O 0 1.7683317310446256e-10

The O 0 5.525085597368751e-12
other O 0 3.5309643121698986e-13
9 O 0 2.7265368782170007e-12
novel O 0 2.1348038354435106e-12
mutations O 0 1.6391533685933268e-09
identified O 0 3.2554900997183722e-09
in O 0 6.623409367625607e-14
these O 0 9.44351259517251e-13
23 O 0 6.381198902616347e-10
patients O 0 6.371839687824288e-12
were O 0 2.581407310131567e-13
each O 0 1.655808194549191e-12
limited O 0 5.961754423466914e-10
to O 0 8.252948671683136e-12
a O 0 7.435428661661803e-11
single O 0 2.616700101043534e-07
family O 0 3.762745226509878e-09
. O 0 9.580095744476935e-11

These O 0 1.4887017400072589e-13
data O 0 4.829913812648412e-12
provide O 0 2.1505768425301476e-14
further O 0 1.379567008116052e-15
evidence O 0 1.4578986076100447e-13
for O 0 9.522653560058592e-15
extensive O 0 9.683445885422248e-12
allelic O 0 9.918770693673196e-09
heterogeneity O 0 7.698333348571396e-08
in O 0 4.899332939345413e-09
MPS B-Disease 1 0.9999992847442627
IVA I-Disease 1 0.9999998807907104
in O 0 4.0260271561010086e-08
British O 0 0.03327275812625885
- O 0 0.4368884563446045
Irish O 0 7.207019370980561e-05
patients O 0 1.245179181985634e-09
and O 0 4.316530297668276e-15
provide O 0 1.5360320458636097e-16
evidence O 0 1.961584140833337e-14
for O 0 8.578421888040966e-15
their O 0 1.2485530763840878e-14
transmission O 0 1.1393175292084834e-09
to O 0 6.769369136419567e-13
Australia O 0 3.5002453713239845e-10
by O 0 9.332917332840682e-14
British O 0 4.894898779639334e-07
- O 0 6.529067491101159e-07
Irish O 0 3.114403313020375e-08
migrants O 0 2.998626000283444e-11
. O 0 7.262109479305029e-14
. O 0 1.4048266673213905e-12

Identification O 0 1.1454774906383136e-09
of O 0 3.4169683141987983e-12
constitutional O 0 3.046581042998042e-10
WT1 O 0 4.1475963371340185e-05
mutations O 0 2.334393002456636e-06
, O 0 4.668604370282325e-13
in O 0 9.311469611583256e-15
patients O 0 2.23880050782832e-12
with O 0 1.3581394038911232e-12
isolated O 0 3.989704509876901e-06
diffuse B-Disease 1 0.6190345883369446
mesangial I-Disease 1 0.9999998807907104
sclerosis I-Disease 1 1.0
, O 0 8.460437211921246e-11
and O 0 3.8253593543681463e-14
analysis O 0 3.8366285517489607e-13
of O 0 1.7539898570020918e-12
genotype O 0 1.2670867590713897e-06
/ O 0 5.797417998110177e-06
phenotype O 0 2.0447869175654887e-08
correlations O 0 7.377526922702771e-10
by O 0 2.0996251002473702e-14
use O 0 6.3458361829193954e-12
of O 0 2.6633282371505383e-14
a O 0 1.9836213292594163e-13
computerized O 0 4.5091599076840794e-07
mutation O 0 1.676346172985177e-08
database O 0 1.2182941588889662e-07
. O 0 2.4260479736248897e-10

Constitutional O 0 5.7222115934507656e-09
mutations O 0 5.943650904782771e-08
of O 0 9.677785780875733e-14
the O 0 4.0646244779240365e-14
WT1 O 0 1.3172412138828804e-07
gene O 0 1.507287850088801e-09
, O 0 1.9657002127372245e-14
encoding O 0 1.0821054339041347e-12
a O 0 2.5708898551690673e-11
zinc O 0 0.000920501712244004
- O 0 6.915550443409302e-07
finger O 0 4.582128531183116e-05
transcription O 0 3.230847767099476e-08
factor O 0 7.672848467699112e-10
involved O 0 4.0646638832519955e-10
in O 0 8.838496774743465e-12
renal O 0 3.96087380067911e-05
and O 0 1.3751950689311343e-08
gonadal O 0 0.1114177256822586
development O 0 1.6271753389140997e-10
, O 0 8.179911012862889e-14
are O 0 3.797050496831371e-15
found O 0 3.9144642388633244e-13
in O 0 8.380471135300584e-15
most O 0 2.380628463458101e-12
patients O 0 1.2286868571187437e-11
with O 0 1.5437201517087829e-10
Denys B-Disease 1 0.9999957084655762
- I-Disease 1 0.9999997615814209
Drash I-Disease 1 0.9999982118606567
syndrome I-Disease 1 0.9999992847442627
( O 0 2.926550668469474e-10
DDS B-Disease 1 0.9999994039535522
) O 0 4.0414695895441e-11
, O 0 4.650971448250107e-13
or O 0 7.751368436004213e-10
diffuse B-Disease 0 0.046870555728673935
mesangial I-Disease 1 0.9999998807907104
sclerosis I-Disease 1 1.0
( O 0 3.715598495546146e-08
DMS B-Disease 1 0.6945427656173706
) O 0 4.763884599301438e-12
associated O 0 8.00011532714473e-12
with O 0 3.8659073164915014e-10
pseudohermaphroditism B-Disease 1 1.0
and O 0 2.6740265184344025e-06
/ O 0 3.979235407314263e-05
or O 0 1.2804014204448322e-06
Wilms B-Disease 1 0.9989023208618164
tumor I-Disease 0 0.24486136436462402
( O 0 1.2579175034943546e-08
WT B-Disease 1 0.9999969005584717
) O 0 1.5615893300680028e-10
. O 0 1.092675082359218e-11

Most O 0 1.0916049314468879e-10
mutations O 0 1.0131265298696235e-05
in O 0 1.4510106449705518e-09
DDS B-Disease 1 1.0
patients O 0 0.0012756024952977896
lie O 0 4.5288592787073867e-07
in O 0 6.605094617952167e-13
exon O 0 9.768295683443284e-08
8 O 0 6.25998419767626e-10
or O 0 4.559884587973517e-12
exon O 0 1.2188480447150596e-08
9 O 0 1.0997348587338251e-09
, O 0 7.252226298876466e-14
encoding O 0 8.805554896351708e-11
zinc O 0 0.015143906697630882
finger O 1 0.8975545167922974
2 O 0 7.186579153994899e-08
or O 0 4.7526945934350806e-08
zinc O 0 0.00427310261875391
finger O 0 0.18063169717788696
3 O 0 1.2576512276041285e-08
, O 0 1.25413459999002e-12
respectively O 0 4.998055788685285e-11
, O 0 1.0541627249935348e-13
with O 0 2.5315508153309074e-13
a O 0 9.974778815424745e-12
hot O 0 2.8228771498106653e-06
spot O 0 1.3160701200831681e-05
( O 0 5.460382580119161e-12
R394W O 0 3.9925496936321636e-11
) O 0 5.837804012035841e-15
in O 0 1.7739214079186575e-15
exon O 0 1.7234332849724865e-09
9 O 0 3.4667866355420074e-09
. O 0 9.679493317982235e-12

We O 0 1.2296300089253975e-10
analyzed O 0 1.6274415842731926e-11
a O 0 1.6100419879695044e-13
series O 0 1.2044078234740851e-10
of O 0 3.9135085146482784e-13
24 O 0 4.086600779995564e-10
patients O 0 2.094523556331329e-12
, O 0 2.7353931650282238e-15
10 O 0 6.82784788452219e-14
with O 0 2.6099352713748747e-12
isolated B-Disease 0 1.7867893120637746e-06
DMS I-Disease 1 0.9984084963798523
( O 0 1.664307407167609e-11
IDMS B-Disease 0 5.944709755567601e-06
) O 0 3.08587682316952e-13
, O 0 7.3713194700736e-15
10 O 0 1.1541729215153868e-13
with O 0 1.8766425913252505e-11
DDS B-Disease 1 1.0
, O 0 4.116665619502413e-10
and O 0 6.997299961675196e-11
4 O 0 1.7642250160765371e-10
with O 0 1.3392601472261845e-09
urogenital B-Disease 1 0.7883082628250122
abnormalities I-Disease 1 0.999976634979248
and O 0 1.1373423092209123e-08
/ O 0 3.224223110009916e-05
or O 0 1.0145691703655757e-05
WT B-Disease 1 0.9999992847442627
. O 0 1.900577251134905e-09

We O 0 7.734874962750382e-09
report O 0 2.433365453580194e-10
WT1 O 0 2.076539885820239e-06
heterozygous O 0 3.0091671305854106e-06
mutations O 0 5.320818672771566e-06
in O 0 1.6506218267209327e-11
16 O 0 2.2610848748882972e-09
patients O 0 8.458727468463323e-11
, O 0 1.56378578977049e-14
4 O 0 1.3960574233098932e-12
of O 0 3.856305194876314e-13
whom O 0 5.981988948633443e-08
presented O 0 2.1011568041018336e-09
with O 0 1.8197181539392204e-09
IDMS B-Disease 0 0.24430015683174133
. O 0 4.940940989683895e-10

One O 0 1.6311164641180653e-09
male O 0 9.466221939646857e-08
and O 0 3.0456848848503526e-11
two O 0 5.277408371417991e-11
female O 0 1.6919435665840865e-06
IDMS B-Disease 1 0.7326434254646301
patients O 0 3.687210892167059e-08
with O 0 3.049439867286452e-11
WT1 O 1 0.68411785364151
mutations O 1 0.6694633960723877
underwent O 0 1.1324499610054772e-05
normal O 0 4.4661319975602964e-07
puberty O 0 0.0006754841888323426
. O 0 6.667621454958805e-10

Two O 0 2.9536377788019763e-09
mutations O 0 3.427633419050835e-05
associated O 0 2.195007509087077e-09
with O 0 1.5870040004362096e-10
IDMS B-Disease 0 0.16341297328472137
are O 0 1.1736400696779614e-12
different O 0 3.409840396422382e-15
from O 0 9.688385889990853e-14
those O 0 2.4997974610446727e-12
described O 0 4.2098788344269167e-10
in O 0 5.908568079249221e-11
DDS B-Disease 1 1.0
patients O 0 9.016909530146222e-07
. O 0 3.049573440994102e-11

No O 0 3.154258187976211e-09
WT1 O 0 1.0961754924210254e-05
mutations O 0 2.8274926080484875e-06
were O 0 1.513465741620479e-11
detected O 0 1.2670341220655246e-08
in O 0 1.3957284391013115e-14
the O 0 1.0548062667455407e-13
six O 0 2.2858839265893494e-09
other O 0 4.808958092850091e-11
IDMS B-Disease 1 0.7127013206481934
patients O 0 1.5010391818393032e-09
, O 0 6.477157715513188e-16
suggesting O 0 4.904044835149501e-13
genetic O 0 3.118721669803648e-10
heterogeneity O 0 2.7137919689224077e-10
of O 0 1.6225652548981784e-12
this O 0 1.5643589201808084e-10
disease O 0 0.0002549704513512552
. O 0 2.8942104268736557e-10

We O 0 9.795507738274978e-10
analyzed O 0 1.0577100972852804e-08
genotype O 0 9.805758054426406e-07
/ O 0 5.435887032945175e-06
phenotype O 0 1.2804206050986977e-07
correlations O 0 4.91929910140243e-08
, O 0 2.7486186070235785e-12
on O 0 2.6130833608029036e-12
the O 0 7.295814953155351e-15
basis O 0 1.3553136477689742e-12
of O 0 5.54609052368267e-14
the O 0 6.2594404486027155e-12
constitution O 0 9.33339516784315e-11
of O 0 2.0651453112283157e-15
a O 0 6.337749200229989e-14
WT1 O 0 1.2062897347675516e-08
mutation O 0 2.113381344925891e-11
database O 0 1.8890621011902198e-10
of O 0 3.0771018328865085e-13
84 O 0 3.787702596014242e-09
germ O 0 0.0006987192900851369
- O 0 2.209998456237372e-05
line O 0 5.399588758336904e-07
mutations O 0 1.798059123814255e-08
, O 0 2.94739322974824e-15
to O 0 7.485993808027761e-17
compare O 0 1.5188754117281822e-12
the O 0 6.226886478774736e-15
distribution O 0 1.0725591421956171e-11
and O 0 2.9219925090639975e-11
type O 0 1.1076886963223842e-08
of O 0 2.4711537070093437e-13
mutations O 0 1.598134402591711e-09
, O 0 3.902755549967498e-15
according O 0 3.5142557889567547e-16
to O 0 4.871812317713137e-14
the O 0 3.975958451363226e-12
different O 0 1.8894843467620603e-09
symptoms O 0 5.250418055879891e-08
. O 0 6.984198375886708e-13

This O 0 4.952503251248741e-12
demonstrated O 0 2.9870265982889777e-11
( O 0 2.9351761770884596e-14
1 O 0 1.5163158272393784e-13
) O 0 1.1880781426753303e-14
the O 0 6.762797109425775e-14
association O 0 4.370902511457997e-12
between O 0 4.2758746304945305e-13
mutations O 0 2.0909143305658517e-09
in O 0 1.2108140824609176e-13
exons O 0 1.423218236595858e-07
8 O 0 4.853164981000191e-09
and O 0 1.7262419271801832e-10
9 O 0 3.0168549880471573e-09
and O 0 3.2993399678993285e-10
DMS B-Disease 0 0.002434787340462208
; O 0 1.2741412471536234e-13
( O 0 3.795110367865685e-15
2 O 0 5.1038729178328607e-14
) O 0 7.965980644759375e-15
among O 0 4.0591878816553795e-13
patients O 0 2.1691335793522226e-12
with O 0 8.105614703740605e-13
DMS B-Disease 0 0.0045845406129956245
, O 0 8.257942737282566e-15
a O 0 1.4174584976158811e-15
higher O 0 7.604313500501197e-14
frequency O 0 1.289426058330781e-13
of O 0 1.3218021139703873e-14
exon O 0 5.610345965578745e-09
8 O 0 8.442592458468567e-11
mutations O 0 5.743542308422889e-10
among O 0 1.7379749982920911e-12
46 O 0 1.7199448809623874e-10
, O 0 3.800853728974651e-12
XY O 0 0.013967500068247318
patients O 0 1.668180038549849e-09
with O 0 4.163590913014437e-12
female O 0 2.1031534291893195e-09
phenotype O 0 1.7211712957654335e-11
than O 0 4.4484344186761574e-14
among O 0 1.041447310334842e-11
46 O 0 3.936484471722679e-09
, O 0 2.049438049822605e-11
XY O 0 0.08881062269210815
patients O 0 1.4207326426429745e-09
with O 0 8.621965988386826e-13
sexual O 0 5.366948130358651e-08
ambiguity O 0 1.6127630786400005e-08
or O 0 1.4826555982949685e-08
male O 0 1.2595698706263647e-07
phenotype O 0 3.142212490203633e-09
; O 0 1.2945549580228866e-12
and O 0 1.0563743629843358e-10
( O 0 2.4891436026068525e-13
3 O 0 2.8137143223000427e-12
) O 0 2.5273366739523868e-15
statistically O 0 1.101194114193349e-12
significant O 0 2.1239990831683347e-13
evidence O 0 1.157755891156853e-09
that O 0 5.178614759238087e-10
mutations O 0 1.1956329615259165e-07
in O 0 1.4749466838853698e-12
exons O 0 4.92659466999612e-07
8 O 0 2.51641574244843e-09
and O 0 7.389198281027021e-11
9 O 0 1.5231242656010835e-10
preferentially O 0 1.3294716438849719e-09
affect O 0 1.6068445185535296e-10
amino O 0 5.720449114399173e-11
acids O 0 3.2231856073039467e-11
with O 0 4.0705654823127834e-15
different O 0 4.740799360069062e-15
functions O 0 1.927038823651417e-12
. O 0 6.058586791979348e-13
. O 0 2.096567017217943e-11

The O 0 7.426177450753357e-10
185delAG O 0 2.5361461666761898e-05
BRCA1 O 0 0.00030498087289743125
mutation O 0 7.337424001718773e-09
originated O 0 1.0822957981215797e-11
before O 0 1.3036651565125762e-13
the O 0 2.8216088900205355e-16
dispersion O 0 2.520985156739819e-12
of O 0 1.216777143587611e-14
Jews O 0 1.7358878006898393e-12
in O 0 1.3355177966127563e-13
the O 0 3.2117938950776415e-12
diaspora O 0 1.5940056219410081e-10
and O 0 4.811407869342865e-11
is O 0 1.7481516451436918e-12
not O 0 3.6848817183340876e-13
limited O 0 2.0182254305278757e-12
to O 0 3.2520841488498098e-12
Ashkenazim O 0 1.0181031029787846e-05
. O 0 4.744427073433144e-11

The O 0 1.4183437757608885e-10
185delAG O 0 3.030279458471341e-07
mutation O 0 4.1657276739215376e-08
in O 0 6.049233379837315e-13
BRCA1 O 0 1.54234076035209e-05
is O 0 7.214967772534164e-12
detected O 0 1.0644499326417645e-07
in O 0 4.133764728089795e-13
Ashkenazi O 0 2.240734930936128e-09
Jews O 0 9.786267933173387e-13
both O 0 2.374986492192921e-12
in O 0 1.8749109903515304e-11
familial B-Disease 1 0.9996169805526733
breast I-Disease 1 0.9999998807907104
and I-Disease 1 0.9999996423721313
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 9.264785916229812e-08
in O 0 2.4488101975882193e-13
the O 0 2.843363565430135e-13
general O 0 6.945597742780141e-12
population O 0 2.2231740374415582e-13
. O 0 7.552270440969178e-12

All O 0 2.283417677162447e-09
tested O 0 3.227133129257709e-05
Ashkenazi O 0 1.0522714433136571e-07
mutation O 0 6.0188392048132755e-09
carriers O 0 3.0228337610793687e-09
share O 0 2.5885790039259504e-11
the O 0 3.681282776985158e-14
same O 0 3.3196286431530497e-13
allelic O 0 9.787888277656975e-10
pattern O 0 1.3155559308586362e-08
at O 0 8.539456641809551e-11
the O 0 8.960947218625281e-13
BRCA1 O 0 1.7265028873225674e-05
locus O 0 5.889269800718466e-07
. O 0 9.138762524507626e-10

Our O 0 2.2775313579526113e-10
previous O 0 2.5808376703101432e-12
study O 0 3.2014926191863136e-13
showed O 0 2.333899740136758e-10
that O 0 8.485780708753637e-14
this O 0 2.2271804355194352e-13
Ashkenazi O 0 3.2637521485412435e-07
mutation O 0 8.693389474956348e-08
also O 0 3.1917803955394675e-09
occurs O 0 4.416459212230883e-11
in O 0 8.988622156704332e-14
Iraqi O 0 1.4330932274209118e-10
Jews O 0 6.335142371631519e-13
with O 0 5.2879697690945415e-14
a O 0 1.1819130472500577e-13
similar O 0 1.0426373306393621e-12
allelic O 0 4.9041037897268325e-08
pattern O 0 8.369515853701159e-07
. O 0 2.5879384746296807e-10

We O 0 1.0532830607701271e-08
extended O 0 3.7211158633587704e-12
our O 0 2.954002331374134e-14
analysis O 0 3.1472413362904723e-15
to O 0 1.830259686822909e-15
other O 0 1.8780514795223302e-13
non O 0 1.887133649347561e-08
- O 0 3.655447500250375e-08
Ashkenazi O 0 5.521888502002525e-10
subsets O 0 6.873300106152724e-12
354 O 0 2.3309045665831363e-11
of O 0 1.0377977096394028e-13
Moroccan O 0 4.983997659024908e-10
origin O 0 1.129453952239401e-12
, O 0 6.079465815315988e-14
200 O 0 4.832480173400794e-14
Yemenites O 0 2.463529824581201e-09
and O 0 7.118608545512994e-13
150 O 0 3.9388349352964536e-13
Iranian O 0 2.3924555045407025e-11
Jews O 0 2.2536510851933755e-11
. O 0 6.192146621841754e-12

Heteroduplex O 0 2.089330337184947e-06
analysis O 0 9.033133269165106e-11
complemented O 0 7.691919150232263e-12
by O 0 2.626178536754267e-16
direct O 0 3.487971827207862e-16
DNA O 0 3.973502082921243e-12
sequencing O 0 2.9030770842819464e-11
of O 0 4.513267675711717e-14
abnormally O 0 7.110111388541895e-10
migrating O 0 5.210216980078286e-11
bands O 0 8.647997595812029e-11
were O 0 3.4197325960577674e-12
employed O 0 3.9117756256423775e-10
. O 0 6.616572307410751e-12

Four O 0 6.509766503626224e-09
of O 0 4.326494457834729e-12
Moroccan O 0 2.493293393968088e-08
origin O 0 4.104644055202833e-11
( O 0 6.602650826255385e-13
1 O 0 5.348489121211053e-13
. O 0 6.840567354774634e-15
1 O 0 1.5457603729993052e-12
% O 0 1.3479982172268264e-14
) O 0 1.5235366475894498e-14
and O 0 4.207729000296756e-13
none O 0 7.793904410746677e-13
of O 0 1.3972299744069092e-15
the O 0 1.2321215011809605e-13
Yemenites O 0 3.895501698991666e-09
or O 0 6.9245924098904066e-12
Iranians O 0 1.5827165966708634e-11
was O 0 3.109412727297922e-11
a O 0 9.564342997063144e-14
carrier O 0 1.2032252971749813e-10
of O 0 7.495403020582776e-15
the O 0 3.0609046655812044e-13
185delAG O 0 2.7328849228069885e-07
mutation O 0 9.25948206997873e-09
. O 0 2.398756540622493e-11

BRCA1 O 0 0.33261969685554504
allelic O 0 1.3816701311952784e-06
patterns O 0 4.041900751872163e-07
were O 0 1.0654518239894273e-10
determined O 0 4.975340018448238e-12
for O 0 1.595396313973027e-13
four O 0 5.9821032676043995e-12
of O 0 1.5172814786805662e-14
these O 0 1.724771448710291e-13
individuals O 0 1.0484924560516529e-12
and O 0 1.5700158187414992e-12
for O 0 3.0188908149578544e-14
12 O 0 3.21039744267948e-12
additional O 0 9.66093784832145e-12
non O 0 7.4794211286643986e-06
- O 0 3.326986188767478e-05
Ashkenazi O 0 4.168637701695843e-07
185delAG O 0 5.926124480026829e-09
mutation O 0 1.2405666716119867e-08
carriers O 0 5.9882907521569e-08
who O 0 6.130485274979947e-08
had O 0 7.952138730615843e-06
breast B-Disease 1 0.9999440908432007
/ I-Disease 1 0.9999973773956299
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999983310699463
. O 0 3.5132696751816184e-09

Six O 0 2.224640184067539e-06
non O 0 6.100815153331496e-05
- O 0 0.0016533100279048085
Ashkenazi O 0 4.8955425882013515e-06
individuals O 0 3.61132547477272e-11
shared O 0 1.1763283402910218e-10
the O 0 1.2514917487743693e-12
common O 0 7.220633535531817e-10
Ashkenazi O 0 1.6496205290650323e-08
haplotype O 0 7.073590047035339e-10
, O 0 4.2670107356333753e-13
four O 0 5.051396367167227e-12
had O 0 1.6062194629906656e-10
a O 0 1.6647397504021728e-14
closely O 0 2.843664886897912e-11
related O 0 3.584044172555423e-10
pattern O 0 3.981969243227468e-08
, O 0 3.4273139881690895e-12
and O 0 1.0853692077039678e-12
the O 0 1.9576529253998581e-13
rest O 0 9.608683848583155e-10
( O 0 4.206182711158357e-12
n O 0 8.863970606398652e-07
= O 0 5.4478480393527207e-08
6 O 0 3.880223642394043e-10
) O 0 2.5031205949134494e-14
displayed O 0 4.2087208718122326e-11
a O 0 1.981002384701669e-12
distinct O 0 3.357970568274027e-10
BRCA1 O 0 0.00023548805620521307
allelic O 0 1.2214276239319588e-06
pattern O 0 7.49961327528581e-06
. O 0 1.4070760112616654e-09

We O 0 6.488639625601422e-10
conclude O 0 3.7607607999978754e-11
that O 0 1.2162533892350058e-13
the O 0 2.492735293353754e-13
185delAG O 0 6.487664904852863e-06
BRCA1 O 0 0.0012904917821288109
mutation O 0 3.765719469583928e-08
occurs O 0 7.178937305729605e-11
in O 0 1.4278130518795913e-15
some O 0 3.610768978192132e-14
non O 0 2.1593646124529187e-06
- O 0 5.8181030908599496e-05
Ashkenazi O 0 5.178559149499051e-06
populations O 0 4.459334568274187e-10
at O 0 5.29355830003464e-11
rates O 0 3.378543000920331e-09
comparable O 0 1.3381913632759534e-11
with O 0 6.143788819704121e-14
that O 0 9.8030016450288e-14
of O 0 5.789551780696622e-13
Ashkenazim O 0 2.398662945779506e-05
. O 0 3.4204059723430547e-11

The O 0 2.5631392841507505e-11
majority O 0 6.350280110783979e-12
of O 0 1.392216962374515e-13
Jewish O 0 6.683754660841146e-10
185delAG O 0 3.391037921574025e-07
mutation O 0 4.2454357185306435e-07
carriers O 0 9.644055865010159e-08
have O 0 1.5656019232770935e-12
a O 0 4.4025248941217954e-14
common O 0 3.212455475243292e-12
allelic O 0 5.5373289287175e-10
pattern O 0 2.6182872758795384e-08
, O 0 1.3731183345303682e-13
supporting O 0 1.2546608717245444e-12
the O 0 2.798776640471263e-15
founder O 0 1.7038663882584792e-11
effect O 0 8.800601219993709e-11
notion O 0 2.6566760943924628e-11
, O 0 1.0442069707820509e-13
but O 0 7.79966657259894e-15
dating O 0 9.942967976739325e-11
the O 0 1.597193406178976e-12
mutations O 0 1.0248686344027647e-08
origin O 0 2.4586209804167147e-12
to O 0 3.046041880099687e-13
an O 0 9.571605796366081e-14
earlier O 0 2.6289758130876306e-12
date O 0 9.22891190552333e-12
than O 0 2.2498951486593644e-13
currently O 0 6.952639852730869e-11
estimated O 0 1.9438027576423877e-11
. O 0 3.164439196789992e-11

However O 0 4.879839310412137e-10
, O 0 4.846085555412771e-14
the O 0 3.157449247975189e-16
different O 0 2.5581036634537415e-15
allelic O 0 6.590230028358235e-10
pattern O 0 2.8105446858717187e-08
at O 0 1.8703899540284397e-10
the O 0 2.893388924719159e-13
BRCA1 O 0 2.2603242086915998e-06
locus O 0 2.2886293749024844e-08
even O 0 7.881713059987305e-10
in O 0 1.4528514093278995e-14
some O 0 6.106890285752535e-15
Jewish O 0 2.0339235504152064e-11
mutation O 0 2.4336138437774935e-08
carriers O 0 1.0057443233790764e-07
, O 0 1.9094029471682789e-13
might O 0 8.003946463941425e-12
suggest O 0 1.4576610751770858e-11
that O 0 3.287395095724621e-12
the O 0 5.485391329530798e-13
mutation O 0 4.745128734384707e-09
arose O 0 1.5242531629239275e-12
independently O 0 1.1505913409537438e-11
. O 0 1.6739656535924574e-12
. O 0 4.791214994193105e-11

Crystal O 0 3.550454130163416e-05
structure O 0 2.227610984562034e-08
of O 0 3.3301323938000893e-12
the O 0 2.629966244782622e-10
hemochromatosis B-Disease 1 1.0
protein O 0 6.577500607818365e-05
HFE O 0 0.00015263335080817342
and O 0 4.981236343543083e-12
characterization O 0 2.136035098798672e-11
of O 0 2.4922002649926207e-15
its O 0 3.1146595786996252e-15
interaction O 0 9.955838237152292e-14
with O 0 3.80104015753821e-13
transferrin O 0 1.3394012121636933e-08
receptor O 0 2.9771782816823134e-09
. O 0 2.999403850290072e-11

HFE O 0 0.004617956932634115
is O 0 1.2585655184693678e-08
an O 0 8.194504103054001e-12
MHC O 0 1.201921975280129e-07
- O 0 1.1134821065184042e-08
related O 0 4.3241885072653474e-10
protein O 0 3.032909756672808e-10
that O 0 3.311463110016247e-14
is O 0 7.017788670196862e-15
mutated O 0 6.685357128999314e-11
in O 0 3.0767554302923994e-13
the O 0 1.8979247340400462e-10
iron B-Disease 1 0.9999145269393921
- I-Disease 1 0.9999697208404541
overload I-Disease 1 0.9997252821922302
disease I-Disease 1 0.9999817609786987
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 4.5611263885803055e-06

HFE O 0 5.899088500882499e-05
binds O 0 4.056690272591368e-08
to O 0 1.70051576986463e-11
transferrin O 0 2.4681435206730384e-07
receptor O 0 3.8920575207157526e-08
( O 0 3.1772830894061244e-12
TfR O 0 5.162801244296134e-07
) O 0 7.864742928090362e-14
and O 0 4.2069483747325664e-14
reduces O 0 6.574956724902936e-12
its O 0 7.780825171720216e-15
affinity O 0 9.314179202218886e-13
for O 0 5.836317757204612e-13
iron O 0 4.753732810058864e-06
- O 0 4.343585402466488e-08
loaded O 0 1.4306606033187563e-07
transferrin O 0 3.868187992139838e-09
, O 0 7.929511810621931e-14
implicating O 0 1.0609878131617734e-07
HFE O 0 0.0004142254765611142
in O 0 5.593522520164207e-11
iron O 0 4.019288462586701e-05
metabolism O 0 1.48502440424636e-05
. O 0 1.0891840207527537e-10

The O 0 9.18350742673546e-11
2 O 0 1.1302679903124613e-09
. O 0 5.8025143717665983e-11

6 O 0 9.743246209836798e-07
A O 0 1.096179502724226e-08
crystal O 0 3.324426870676689e-05
structure O 0 1.2677350724743519e-08
of O 0 4.2566869625469683e-13
HFE O 0 7.562240170955192e-06
reveals O 0 1.822823669783702e-09
the O 0 7.092255571754724e-15
locations O 0 8.821486943699774e-12
of O 0 1.491158585498198e-11
hemochromatosis B-Disease 1 1.0
mutations O 1 0.5448693633079529
and O 0 5.961526827746866e-10
a O 0 9.486990186491351e-12
patch O 0 0.00022426106443163007
of O 0 1.2524660128465648e-12
histidines O 0 1.3053178236077656e-06
that O 0 9.575597259559032e-12
could O 0 8.089590802784485e-11
be O 0 2.6770465184899894e-12
involved O 0 5.790772722447102e-11
in O 0 9.334351867840152e-12
pH O 0 5.765620016973116e-07
- O 0 6.908956518003606e-09
dependent O 0 3.3253247377906803e-10
interactions O 0 1.6391744905863703e-10
. O 0 1.020375103855109e-11

We O 0 1.182152775669465e-08
also O 0 1.3256569453279354e-11
demonstrate O 0 6.5500977038113195e-12
that O 0 9.145414460454138e-12
soluble O 0 2.9880366128054447e-06
TfR O 0 0.00033115199767053127
and O 0 6.619857439993382e-11
HFE O 0 5.677684021065943e-05
bind O 0 3.0190557254172745e-07
tightly O 0 4.9416151171044476e-08
at O 0 7.011384250965591e-10
the O 0 9.896541187459987e-14
basic O 0 2.748567519417211e-11
pH O 0 3.58375482067963e-11
of O 0 2.5636804754389046e-16
the O 0 2.226277871092159e-15
cell O 0 2.975870938559666e-10
surface O 0 3.7460544888290315e-08
, O 0 2.148438978805123e-12
but O 0 2.025923699633392e-12
not O 0 3.0689678229278705e-12
at O 0 2.79880507658703e-10
the O 0 6.050739770335767e-11
acidic O 0 5.729094141315727e-07
pH O 0 1.3174812352190202e-09
of O 0 4.453502725019348e-14
intracellular O 0 7.657548195538766e-08
vesicles O 0 5.746133879824811e-08
. O 0 2.8677682450961584e-10

TfR O 1 0.9089023470878601
HFE O 0 0.002689019776880741
stoichiometry O 0 1.1373767847544514e-06
( O 0 1.8868509532588007e-10
2 O 0 1.73650469004194e-11
1 O 0 4.130785611570348e-13
) O 0 9.385502832272123e-15
differs O 0 3.1985018474935123e-13
from O 0 3.346604894247096e-12
TfR O 0 1.385377072438132e-05
transferrin O 0 1.7839023591648129e-09
stoichiometry O 0 9.417314844606395e-11
( O 0 3.8599112513020006e-13
2 O 0 2.5838519691900874e-12
2 O 0 1.4377078087074446e-12
) O 0 1.0478675930701998e-14
, O 0 1.5974948740987498e-16
implying O 0 3.329678045327182e-14
a O 0 5.38335018940582e-16
different O 0 1.0798639741321333e-16
mode O 0 1.375811465621768e-12
of O 0 2.219705742454413e-15
binding O 0 3.312585969417192e-11
for O 0 6.682724577704302e-13
HFE O 0 3.354537966515636e-06
and O 0 1.9208462598285792e-10
transferrin O 0 9.976221626573079e-09
to O 0 2.3300644400037207e-11
TfR O 0 1.8112330508301966e-05
, O 0 1.0384867878826531e-13
consistent O 0 2.697461394876588e-12
with O 0 6.461653857380706e-14
our O 0 5.47118069165603e-13
demonstration O 0 2.3969658181043074e-13
that O 0 2.154888240231672e-14
HFE O 0 1.2754665590364311e-07
, O 0 1.5523876671988401e-12
transferrin O 0 8.659973183000602e-09
, O 0 6.879074393451035e-11
and O 0 2.173362112500854e-08
TfR O 0 0.001354773761704564
form O 0 1.800898145887242e-11
a O 0 7.85941277336999e-12
ternary O 0 1.3912143437266877e-08
complex O 0 2.5100879152972766e-09
. O 0 1.368270774460001e-10

Identification O 0 1.7276449715275533e-10
of O 0 7.12202784811447e-14
three O 0 2.451927549884658e-13
novel O 0 6.37479652398909e-11
mutations O 0 4.8817803133260895e-08
and O 0 3.770541604636302e-12
a O 0 1.1810296935300252e-13
high O 0 1.3149850652816042e-10
frequency O 0 4.368793955072947e-12
of O 0 5.049467246241723e-13
the O 0 1.4373931732369893e-11
Arg778Leu O 0 2.922768999269465e-06
mutation O 0 5.80777168579516e-08
in O 0 1.6935459111466766e-12
Korean O 0 4.1096875236235064e-08
patients O 0 2.8427375037276548e-11
with O 0 5.745724534177155e-13
Wilson B-Disease 0 2.1802059109177208e-06
disease I-Disease 0 1.0225840014754795e-05
. O 0 2.65484214473366e-11

Four O 0 3.934712999864587e-09
mutations O 0 1.604023736945237e-06
- O 0 7.464948339475086e-06
- O 0 1.2395965995892766e-06
R778L O 0 6.221373194392754e-09
, O 0 2.280900145948568e-14
A874V O 0 1.8738303009940838e-12
, O 0 9.740553844530945e-16
L1083F O 0 8.593268241083307e-13
, O 0 5.324408872375537e-16
and O 0 5.332583163833015e-15
2304delC O 0 4.92344331970429e-10
- O 0 5.920088863575756e-10
- O 0 5.305366701513492e-10
in O 0 2.7253488365814454e-14
the O 0 5.166505837381338e-15
copper O 0 1.5319880919406614e-09
- O 0 6.107423594636785e-12
transporting O 0 2.6716423517925136e-10
enzyme O 0 1.8197181539392204e-09
, O 0 1.3075925433571334e-13
P O 0 7.998846740520094e-07
- O 0 6.307920585868487e-08
type O 0 1.317580284876385e-07
ATPase O 0 3.704827733486127e-08
( O 0 4.82685451937831e-13
ATP7B O 0 1.7988925904433017e-08
) O 0 1.0380920705292326e-14
, O 0 1.7218435459204174e-16
were O 0 6.174400082198123e-15
identified O 0 4.408177989301265e-11
in O 0 7.499185192098856e-13
Korean O 0 4.599880298883363e-07
Patients O 0 1.606764200856592e-11
with O 0 8.409942122040992e-13
Wilson B-Disease 0 3.469723651505774e-06
disease I-Disease 0 8.528075341018848e-06
. O 0 2.0814103912636384e-11

Arg778Leu O 0 1.1788666597567499e-05
, O 0 2.7532043485323232e-12
the O 0 5.9851640279355665e-15
most O 0 2.2018241993115167e-14
frequently O 0 3.346281238214566e-11
reported O 0 7.027044918173075e-11
mutation O 0 1.556882289754924e-09
of O 0 1.7946761969329234e-13
this O 0 1.4471658192540676e-13
enzyme O 0 3.707010032272251e-09
, O 0 2.425146672022094e-13
was O 0 4.490682825597503e-11
found O 0 6.672465358015245e-11
in O 0 7.472424371976483e-14
six O 0 1.8648036240187515e-11
of O 0 1.5045810666694352e-14
eight O 0 5.879721015622508e-11
unrelated O 0 3.101756851364712e-09
patients O 0 1.241311081701113e-10
studied O 0 4.87152262973467e-11
, O 0 6.1531675073093e-15
an O 0 4.797777784123201e-16
allele O 0 7.817848798885585e-12
frequency O 0 2.4250934593794682e-11
of O 0 1.6047579931566247e-11
37 O 0 9.491785846194034e-08
. O 0 9.22310977591323e-11

5 O 0 1.532864928321942e-07
% O 0 8.609649104762696e-11
, O 0 1.1735388051950513e-13
which O 0 3.311973150905436e-15
is O 0 1.5456320102383465e-14
considerably O 0 3.721033694386623e-14
higher O 0 5.5987227793328e-14
than O 0 8.824602696798009e-15
those O 0 3.4654093153006424e-14
in O 0 2.643599145743091e-15
other O 0 4.2835315372871663e-13
Asian O 0 8.412806562496655e-11
populations O 0 5.4456578135742006e-11
. O 0 2.3744337659253878e-12

The O 0 3.5973474633160807e-12
novel O 0 2.3049836345157004e-11
single O 0 6.496875259998092e-10
nucleotide O 0 4.834188604974088e-09
deletion O 0 2.9467076956279925e-07
, O 0 7.585793104780691e-12
2304delC O 0 3.272437609780354e-08
, O 0 1.5625761589591752e-13
was O 0 1.630551596520924e-11
found O 0 4.434979813949802e-11
in O 0 1.2568543211396999e-13
one O 0 9.784691112901811e-11
patient O 0 6.386401629754346e-09
. O 0 1.793548642936571e-11

Since O 0 2.3726978715110647e-10
a O 0 6.305799524035371e-13
mutation O 0 1.1379248932019692e-10
at O 0 6.58326388194852e-12
cDNA O 0 2.546955979454424e-10
nucleotide O 0 1.980375152754732e-08
2302 O 0 1.253080768037762e-07
( O 0 1.755826387062065e-13
2302insC O 0 2.0213943019431468e-10
) O 0 6.883224188108245e-14
had O 0 1.326365146187003e-11
been O 0 1.9179021218396208e-11
previously O 0 2.4494737349556317e-09
described O 0 2.549449540367732e-10
, O 0 6.868378072235129e-14
this O 0 3.0653652257847403e-15
region O 0 2.8322513063137877e-13
of O 0 1.3146012327758944e-14
the O 0 3.8782272207028845e-13
ATP7B O 0 2.973008804474375e-06
gene O 0 1.5726264734894357e-08
may O 0 3.157427444500094e-11
be O 0 4.9309887499137534e-14
susceptible O 0 1.2358273258905594e-11
to O 0 6.1967452348631654e-15
gene O 0 5.790270929395547e-09
rearrangements O 0 3.7504128158616368e-06
causing O 0 1.0072701570607023e-06
Wilson B-Disease 0 0.0001014266163110733
disease I-Disease 0 0.0005083307041786611
. O 0 2.034056673094753e-10

Disruption O 0 1.4337625486859906e-07
of O 0 2.7717392725619405e-13
splicing O 0 4.578550427680739e-09
regulated O 0 5.600338859323983e-09
by O 0 5.2762929116968726e-14
a O 0 1.5677743391701027e-12
CUG O 0 3.268911314080469e-05
- O 0 2.5975250395049443e-08
binding O 0 1.7462646884069954e-09
protein O 0 1.0068014866249086e-08
in O 0 5.6192508979258093e-11
myotonic B-Disease 1 0.9999896287918091
dystrophy I-Disease 1 0.999991774559021
. O 0 1.4700703987458041e-09

Myotonic B-Disease 1 0.9999561309814453
dystrophy I-Disease 1 0.9999973773956299
( O 0 5.596865594270639e-05
DM B-Disease 1 1.0
) O 0 1.0120035476290923e-08
is O 0 1.1883610415153179e-11
caused O 0 1.3219951392265394e-12
by O 0 2.1961565324548488e-15
a O 0 1.1643283722145154e-13
CTG O 0 1.5667559694065858e-07
expansion O 0 2.548185551454196e-10
in O 0 7.484520680089632e-14
the O 0 9.353482615173658e-14
3 O 0 3.089272240797136e-11
untranslated O 0 3.636053946820539e-08
region O 0 6.169978807382681e-13
of O 0 2.0297738506256865e-14
the O 0 2.805420479257137e-11
DM B-Disease 1 0.999998927116394
gene O 0 1.5277250042800006e-07
. O 0 3.8546839331576876e-11

One O 0 2.1004094297172315e-11
model O 0 1.6224841470346973e-09
of O 0 3.5507610306878545e-12
DM B-Disease 1 0.9999994039535522
pathogenesis O 0 2.178180835699095e-07
suggests O 0 3.8951800118702806e-10
that O 0 8.409328192560822e-14
RNAs O 0 8.175118915154655e-11
from O 0 1.522958462899654e-14
the O 0 5.3530864433542526e-15
expanded O 0 6.156135497203952e-12
allele O 0 5.65572068345066e-12
create O 0 1.3321747947391688e-13
a O 0 1.4987932227782108e-13
gain O 0 7.237482835265041e-10
- O 0 1.5083763571510644e-07
of O 0 1.0489615426267918e-10
- O 0 4.1826106667031127e-07
function O 0 1.6135882560663894e-11
mutation O 0 2.290005511607074e-11
by O 0 1.1957623408695266e-14
the O 0 5.08425597358763e-14
inappropriate O 0 3.835654016626222e-10
binding O 0 6.659341047349221e-12
of O 0 5.115084796494134e-16
proteins O 0 2.1115659947553572e-13
to O 0 3.5551555053808456e-14
the O 0 9.384402976930772e-13
CUG O 0 1.2270596926100552e-05
repeats O 0 7.522181988406373e-08
. O 0 1.90420387791157e-11

Data O 0 4.163400646461923e-08
presented O 0 8.029183429236753e-10
here O 0 1.7259108638784104e-12
indicate O 0 3.823248141687774e-12
that O 0 6.354693162603569e-15
the O 0 1.1103505030837183e-14
conserved O 0 8.75588490600876e-10
heterogeneous O 0 5.2720434240427494e-08
nuclear O 0 3.762998630918446e-06
ribonucleoprotein O 0 3.125215286559069e-08
, O 0 4.806770758335188e-13
CUG O 0 9.4385438842437e-07
- O 0 4.153127175499094e-09
binding O 0 1.3534033616036112e-10
protein O 0 4.570022138494778e-11
( O 0 3.6413383972585395e-14
CUG O 0 2.409568367056636e-08
- O 0 1.0618735890588482e-09
BP O 0 5.0956010966274334e-08
) O 0 3.721253922952909e-14
, O 0 2.2537839955048215e-15
may O 0 1.8061595242428036e-13
mediate O 0 7.701655285741182e-11
the O 0 1.3481359041264684e-12
trans O 0 4.832084528061387e-07
- O 0 4.741322300105821e-06
dominant O 0 1.2359285506136075e-07
effect O 0 2.1884169823516153e-11
of O 0 8.326517042384616e-16
the O 0 2.40718174695587e-14
RNA O 0 3.1576455339354936e-10
. O 0 7.743573143814686e-12

CUG O 0 0.000877498765476048
- O 0 3.062391624553129e-05
BP O 0 2.5986655600718223e-05
was O 0 9.809413697992042e-11
found O 0 2.7314961273741667e-13
to O 0 1.1525702250648985e-15
bind O 0 3.0089715441494747e-12
to O 0 1.642372659583797e-14
the O 0 5.946232547147934e-13
human O 0 2.094938222896303e-09
cardiac O 0 8.712562049595363e-08
troponin O 0 4.7902267397148535e-06
T O 0 2.54240217145707e-06
( O 0 1.253940256750602e-13
cTNT O 0 3.12810888303261e-11
) O 0 1.121700405763747e-14
pre O 0 3.7434583211037875e-10
- O 0 1.5684855636521888e-09
messenger O 0 7.251522160522939e-10
RNA O 0 6.659140600051572e-11
and O 0 3.8288850443077976e-14
regulate O 0 4.739357777755471e-13
its O 0 4.880885480534241e-16
alternative O 0 2.741887324283175e-14
splicing O 0 4.48248715922972e-10
. O 0 1.3642803900482114e-11

Splicing O 0 2.0078319451499738e-08
of O 0 1.220618918440497e-11
cTNT O 0 6.336378532978415e-08
was O 0 7.14980796789888e-10
disrupted O 0 1.0870790134731578e-07
in O 0 5.335503566739064e-11
DM B-Disease 1 0.9999998807907104
striated O 1 0.8918877243995667
muscle O 0 0.0006321188411675394
and O 0 8.539342150060136e-11
in O 0 1.0987010726128815e-13
normal O 0 8.381506426402563e-12
cells O 0 3.675128951163842e-11
expressing O 0 2.61920937412799e-13
transcripts O 0 6.494650737348673e-12
that O 0 1.0172881959556734e-13
contain O 0 2.70488825782067e-10
CUG O 0 0.0002253817510791123
repeats O 0 2.418174972262932e-06
. O 0 7.098901327884377e-11

Altered O 0 1.1146815950269229e-06
expression O 0 3.4998581810441465e-10
of O 0 8.513064656424235e-14
genes O 0 9.027350533763467e-10
regulated O 0 6.653815720625289e-09
posttranscriptionally O 0 5.428451999023309e-08
by O 0 5.395571142652322e-13
CUG O 0 8.908908057492226e-05
- O 0 5.907596118959191e-07
BP O 0 2.3354084532911656e-06
therefore O 0 8.317359821707893e-12
may O 0 2.670467796547782e-12
contribute O 0 1.073131045289076e-13
to O 0 1.102837764686837e-12
DM B-Disease 1 0.9999985694885254
pathogenesis O 0 8.827256259280603e-09
. O 0 2.1621228841594425e-13
. O 0 1.1770408866323967e-12

Identification O 0 4.345666881899746e-11
of O 0 1.2869542129027856e-13
a O 0 6.982400768684727e-13
novel O 0 2.152338751670868e-09
nonsense O 0 1.5277310012606904e-05
mutation O 0 6.057445745000223e-08
and O 0 2.847439352447051e-13
a O 0 7.842539992257164e-15
missense O 0 1.9342361046170709e-10
substitution O 0 1.9628875890138897e-13
in O 0 3.0168514137307503e-15
the O 0 5.8664680304874005e-15
vasopressin O 0 5.870623986936607e-10
- O 0 1.0082681001222227e-07
neurophysin O 0 1.1633811709543807e-06
II O 0 2.7568937355226808e-08
gene O 0 2.1940280703347526e-09
in O 0 1.3892115539523853e-13
two O 0 5.176456485678216e-12
Spanish O 0 3.1562201741053286e-09
kindreds O 0 2.3654496544622816e-05
with O 0 1.4619789823200335e-08
familial B-Disease 1 0.9731721878051758
neurohypophyseal I-Disease 1 0.9997451901435852
diabetes I-Disease 1 0.9999158382415771
insipidus I-Disease 1 0.9922426342964172
. O 0 2.368680362963005e-08

Familial B-Disease 1 0.999704897403717
neurohypophyseal I-Disease 1 0.9997909665107727
diabetes I-Disease 1 0.999982476234436
insipidus I-Disease 1 0.9996522665023804
( O 0 7.954535249155015e-06
FNDI B-Disease 1 0.9999998807907104
) O 0 6.514843109428625e-10
is O 0 3.302668902249728e-11
an O 0 6.860519791151987e-11
autosomal B-Disease 1 0.9999985694885254
dominant I-Disease 1 0.9999990463256836
disease I-Disease 1 0.9999995231628418
caused O 0 1.1361658835085109e-05
by O 0 1.8501592480291151e-09
deficiency O 1 0.6639615297317505
in O 0 2.941140441001938e-13
the O 0 3.020496353034474e-11
antidiuretic O 0 0.00054839818039909
hormone O 0 5.248636512078519e-07
arginine O 0 4.76712758157305e-09
vasopressin O 0 1.4595932240624165e-09
( O 0 1.20414434174633e-13
AVP O 0 1.5255818830439694e-09
) O 0 3.193620466498704e-16
encoded O 0 2.736384617092985e-15
by O 0 3.5364605988503486e-15
the O 0 3.463937578614129e-13
AVP O 0 0.00023664765467401594
- O 0 3.795840711973142e-06
neurophysin O 0 2.442088043608237e-05
II O 0 2.8053498226654483e-06
( O 0 3.064633399482708e-12
AVP O 0 1.2113445109207532e-06
- O 0 3.018899619178228e-08
NPII O 0 2.5006571036101377e-07
) O 0 6.216728436154789e-15
gene O 0 2.1585597892448405e-12
on O 0 2.734750360194882e-12
chromosome O 0 3.932869674372341e-07
20p13 O 0 5.570958805378723e-08
. O 0 3.244527216339499e-11

In O 0 3.4926456258382865e-12
this O 0 2.2129421843705872e-15
study O 0 3.97352811732591e-14
, O 0 4.225587334736897e-15
we O 0 6.01083590250095e-15
analyzed O 0 3.8403351679261455e-12
two O 0 7.056518997600181e-13
families O 0 2.7564555455869555e-13
with O 0 3.0712340223087997e-12
FNDI B-Disease 1 0.9999996423721313
using O 0 9.317767911409813e-13
direct O 0 7.157997610439393e-13
automated O 0 5.8264117086537226e-08
fluorescent O 0 6.931421214773081e-09
, O 0 1.0164431145723296e-12
solid O 0 2.3875154631092244e-10
phase O 0 4.87071459553956e-11
, O 0 1.0648732194423402e-13
single O 0 2.5361787323041618e-11
- O 0 1.3605001847327713e-10
stranded O 0 5.080439649703117e-13
DNA O 0 5.680951585887439e-13
sequencing O 0 6.1300409193165706e-12
of O 0 8.154239815923864e-14
PCR O 0 2.0711019033115008e-07
- O 0 3.3364062623775226e-09
amplified O 0 3.4086689026935346e-08
AVP O 0 1.4374386410054285e-06
- O 0 4.026301514414854e-09
NPII O 0 1.462434227050835e-07
DNA O 0 2.1131265626195272e-08
. O 0 4.3048311443305565e-11

In O 0 5.254244522107099e-12
one O 0 2.2446741730977604e-13
of O 0 2.2314898765748515e-15
the O 0 3.7320156459543646e-14
families O 0 1.3233270815954379e-12
, O 0 1.7690575837992634e-13
affected O 0 1.459446972995604e-11
individuals O 0 3.8340828450479647e-13
presented O 0 3.5322324492409463e-12
a O 0 6.720713395524935e-13
novel O 0 4.059157454605611e-09
nonsense O 0 1.5937098396534566e-06
mutation O 0 5.675263592408442e-10
in O 0 4.5370959830674015e-15
exon O 0 6.448649253476546e-11
3 O 0 2.7197380632337786e-12
of O 0 3.627541416393893e-15
the O 0 6.221132414557448e-14
gene O 0 3.202303699989528e-10
, O 0 8.257616460191283e-14
consisting O 0 7.146327190492123e-15
in O 0 1.1130811255474294e-15
a O 0 5.922067307026491e-13
G O 0 6.642012522206642e-07
to O 0 1.4746773246976375e-11
T O 0 1.3800035958411172e-05
transition O 0 1.0934527588934984e-11
at O 0 1.5208128159582834e-11
nucleotide O 0 1.0014455237294939e-10
2101 O 0 1.918162712000182e-10
, O 0 1.1651742870782793e-14
which O 0 5.641917584467036e-16
produces O 0 9.704624528029254e-14
a O 0 3.1810515457647223e-14
stop O 0 1.9068082668383113e-09
signal O 0 7.576116622942664e-09
in O 0 1.041762704746818e-12
codon O 0 2.0065309058736602e-07
82 O 0 1.7673952301677787e-09
( O 0 2.2425601143866852e-13
Glu O 0 4.1494079283665997e-08
) O 0 3.5715760860963175e-14
of O 0 4.221738925244342e-14
NPII O 0 5.408540528151207e-05
. O 0 2.948152486026423e-11

The O 0 1.0388687132767416e-10
premature O 0 1.9536368967010276e-08
termination O 0 3.6329188546346813e-09
eliminates O 0 3.776751800188549e-09
part O 0 8.10697949743533e-12
of O 0 4.036471474449556e-14
the O 0 8.117992497842785e-13
C O 0 3.198449149977023e-08
- O 0 2.687860212180482e-10
terminal O 0 1.9170598268558603e-12
domain O 0 5.30104985515395e-13
of O 0 4.253438286262387e-14
NPII O 0 8.092534642401006e-08
, O 0 8.664221137521025e-16
including O 0 1.1654486463438509e-16
a O 0 1.8288558355919536e-16
cysteine O 0 1.5425051372915805e-13
residue O 0 4.563012745428807e-10
in O 0 1.3741113281950934e-13
position O 0 1.236243440949636e-09
85 O 0 3.105173453435417e-12
, O 0 4.126365725888939e-14
which O 0 4.742432033015553e-13
could O 0 2.0544721479609507e-10
be O 0 1.7078944161696974e-11
involved O 0 8.64819535428829e-11
in O 0 3.8681801902210045e-13
the O 0 1.1067825258712083e-12
correct O 0 1.1076590311631662e-08
folding O 0 3.466478233349335e-07
of O 0 4.1956358092648527e-13
the O 0 9.099132038115076e-12
prohormone O 0 7.233539236040087e-06
. O 0 6.717337103223642e-11

In O 0 3.140387949684964e-11
the O 0 4.736050419028304e-13
second O 0 1.3287561329011766e-10
family O 0 5.105698849816598e-12
, O 0 9.886475386727996e-16
a O 0 2.618216427050077e-16
G279A O 0 2.530348977222707e-13
substitution O 0 1.5374523824733012e-14
at O 0 3.798036538049665e-11
position O 0 6.128141882832949e-10
- O 0 2.4953650257231175e-10
1 O 0 8.222175924051806e-14
of O 0 2.926396924112141e-16
the O 0 4.122807509884113e-15
signal O 0 3.588116999700408e-12
peptide O 0 2.1075274771881203e-12
was O 0 3.2671920724425263e-12
observed O 0 7.542622125836229e-13
in O 0 1.3261246289793444e-15
all O 0 3.918415884731491e-13
affected O 0 7.534027221534068e-12
individuals O 0 7.14453507206364e-13
. O 0 4.966200194134185e-12

This O 0 3.378771915030221e-11
missense O 0 2.3370212147710845e-06
mutation O 0 6.537930403283099e-06
, O 0 7.176446242818102e-11
which O 0 8.625034020326439e-11
replaces O 0 0.0001520425867056474
Ala O 0 2.6434551614329393e-07
with O 0 1.3952674952910638e-11
Thr O 0 0.0001335963315796107
, O 0 1.0121984630670489e-12
is O 0 9.486763588237301e-14
frequent O 0 5.255870738629653e-11
among O 0 4.555467114641942e-09
FNDI B-Disease 1 1.0
patients O 0 2.7736164156522136e-06
and O 0 4.435163607902082e-12
is O 0 9.130887100019733e-14
thought O 0 2.0418404380467825e-12
to O 0 1.759017465106233e-13
reduce O 0 2.0100983377790982e-10
the O 0 1.1290009996767908e-13
efficiency O 0 2.3582634109398093e-11
of O 0 9.768163942237883e-16
cleavage O 0 1.6911244626882649e-09
by O 0 2.959754701525527e-14
signal O 0 7.259655376845586e-11
peptidases O 0 2.720613734297217e-09
. O 0 1.4115164386711149e-13
. O 0 2.175526902722935e-12

Genetic O 0 2.8924648631800665e-07
heterogeneity O 0 4.82134581147875e-08
of O 0 6.107511163477852e-10
Saethre B-Disease 1 0.9996782541275024
- I-Disease 1 0.9999966621398926
Chotzen I-Disease 1 0.9999908208847046
syndrome I-Disease 1 0.9999996423721313
, O 0 1.3505371950980893e-12
due O 0 1.5915544435748247e-13
to O 0 2.194185486786588e-14
TWIST O 0 8.411487328885414e-08
and O 0 7.95937926678647e-10
FGFR O 0 4.011805503978394e-05
mutations O 0 6.902044447087974e-08
. O 0 2.2859995146840006e-11

Thirty O 0 2.4536648268735917e-08
- O 0 9.98632231130614e-07
two O 0 5.297899272060924e-12
unrelated O 0 6.869322888292118e-10
patients O 0 2.1375552369806705e-11
with O 0 9.699291269780162e-15
features O 0 2.6616883697094806e-10
of O 0 3.0491853486580567e-10
Saethre B-Disease 1 0.9999780654907227
- I-Disease 1 0.999994158744812
Chotzen I-Disease 1 0.9999845027923584
syndrome I-Disease 1 0.9999990463256836
, O 0 2.6013856325134144e-13
a O 0 5.840126017335467e-13
common O 0 8.743522350584954e-09
autosomal B-Disease 1 0.9916757345199585
dominant I-Disease 1 0.7297366261482239
condition I-Disease 0 1.0930081089099986e-06
of O 0 2.1149793028030217e-10
craniosynostosis B-Disease 1 0.999186098575592
and O 0 1.237853695101876e-07
limb B-Disease 0 0.007591176778078079
anomalies I-Disease 0 0.00019956902542617172
, O 0 1.631842013946616e-12
were O 0 5.298987702621882e-13
screened O 0 1.6226644916628175e-08
for O 0 1.4542834167810548e-12
mutations O 0 3.038939100363791e-09
in O 0 4.074787653563644e-13
TWIST O 0 1.7947479591384763e-07
, O 0 1.5072516151848347e-11
FGFR2 O 0 5.997223070153268e-06
, O 0 1.3009980462733162e-12
and O 0 8.23731621107937e-12
FGFR3 O 0 2.7444511943031102e-05
. O 0 2.1674226649559536e-11

Nine O 0 2.318805591983164e-09
novel O 0 1.3990316682921389e-09
and O 0 8.798407002963415e-10
three O 0 8.418874625215622e-11
recurrent O 0 1.633557076274883e-06
TWIST O 0 1.5842314269320923e-06
mutations O 0 3.163419387419708e-05
were O 0 8.149167451954042e-11
found O 0 1.3856120417710116e-10
in O 0 1.980615785312015e-13
12 O 0 7.427972820162054e-11
families O 0 9.49890426732436e-12
. O 0 3.143510104997027e-11

Seven O 0 4.969523903497475e-09
families O 0 1.4363491299129727e-11
were O 0 6.69800857572983e-14
found O 0 6.256667818387018e-13
to O 0 4.9424955230956136e-14
have O 0 1.2767066050189957e-11
the O 0 2.429887888122373e-13
FGFR3 O 0 2.5383626052644104e-05
P250R O 0 4.90621321347362e-10
mutation O 0 1.2912843017076625e-09
, O 0 4.018505905638292e-13
and O 0 2.8981445064982236e-13
one O 0 5.85339665192669e-13
individual O 0 1.3509880063614088e-12
was O 0 1.1872481664454426e-08
found O 0 2.321947745187458e-09
to O 0 5.281214354724284e-11
have O 0 3.2039471076217296e-10
an O 0 1.8437556169315084e-12
FGFR2 O 0 4.304539834265597e-05
VV269 O 0 4.412826548616522e-09
- O 0 1.4959224137189864e-10
270 O 0 3.097840040044986e-11
deletion O 0 3.31029269773353e-07
. O 0 3.2318303588851904e-10

To O 0 1.5272484665818098e-11
date O 0 1.536593491335836e-10
, O 0 1.587445791679555e-14
our O 0 6.8192026427460386e-15
detection O 0 6.003486011270376e-13
rate O 0 1.217213690951624e-10
for O 0 8.089297630451287e-15
TWIST O 0 1.0454272114657215e-08
or O 0 5.157519966658697e-10
FGFR O 0 9.949430932465475e-06
mutations O 0 1.7722165068789764e-08
is O 0 5.9954220407720804e-12
68 O 0 2.2631718721299876e-10
% O 0 1.1290375915001122e-13
in O 0 3.7965767682446305e-13
our O 0 6.051164405107556e-07
Saethre B-Disease 1 0.8798858523368835
- I-Disease 1 0.9997826218605042
Chotzen I-Disease 1 0.9999186992645264
syndrome I-Disease 1 0.9999984502792358
patients O 0 2.1591970433831875e-09
, O 0 2.4068220967664658e-15
including O 0 3.522231334721071e-14
our O 0 3.594461533973359e-11
five O 0 1.3274787519224063e-11
patients O 0 5.864706506888973e-13
elsewhere O 0 1.4442677468470139e-13
reported O 0 4.142946836288575e-12
with O 0 1.0009250372977618e-12
TWIST O 0 3.955924057663651e-06
mutations O 0 2.2166810595081188e-05
. O 0 5.982782047553314e-10

More O 0 2.2286507491905971e-13
than O 0 4.898442355948454e-14
35 O 0 4.146929381918657e-13
different O 0 2.9349395160829968e-15
TWIST O 0 8.861805511628518e-09
mutations O 0 1.2682473879976897e-06
are O 0 1.4497255826362299e-11
now O 0 9.882409474082365e-11
known O 0 3.4122284858773e-11
in O 0 6.396771811247384e-14
the O 0 1.8151249275323578e-13
literature O 0 4.4624380579616485e-11
. O 0 3.493293848633172e-11

The O 0 3.7246945978897106e-12
most O 0 6.842788868085398e-14
common O 0 8.75960884231565e-14
phenotypic O 0 6.685564324371285e-10
features O 0 2.3100660939689988e-08
, O 0 4.429617696949384e-12
present O 0 3.3256112707408247e-13
in O 0 2.184750810303596e-15
more O 0 1.2699136167754177e-15
than O 0 2.308526464336446e-14
a O 0 6.276927762283169e-13
third O 0 3.056257114053551e-08
of O 0 5.835745081617105e-11
our O 0 1.6256446855322793e-08
patients O 0 1.3056965448079993e-12
with O 0 2.8436211057977475e-15
TWIST O 0 1.9114153815280588e-08
mutations O 0 3.556344154276303e-06
, O 0 3.933926535221177e-12
are O 0 4.331231282916209e-13
coronal B-Disease 0 5.352432026484166e-07
synostosis I-Disease 0 4.024650115752593e-05
, O 0 3.9072751110980075e-12
brachycephaly B-Disease 0 5.116465217724908e-06
, O 0 2.728823556008564e-10
low B-Disease 0 0.00015062569582369179
frontal I-Disease 1 0.9999961853027344
hairline I-Disease 1 0.9999996423721313
, O 0 3.0782490512137883e-07
facial B-Disease 0 0.3850598931312561
asymmetry I-Disease 0 2.647629844432231e-05
, O 0 1.4679192972266719e-08
ptosis B-Disease 1 0.9997851252555847
, O 0 6.762878701493946e-09
hypertelorism B-Disease 0 0.03920770436525345
, O 0 6.757437276405653e-09
broad B-Disease 0 9.639634299674071e-06
great I-Disease 0 7.750022632535547e-06
toes I-Disease 1 0.9999233484268188
, O 0 2.3716514863103555e-11
and O 0 9.973733644530469e-12
clinodactyly B-Disease 0 1.7209398492923356e-06
. O 0 2.769522458589968e-11

Significant O 0 2.871913373780899e-09
intra O 0 2.9842389267287217e-05
- O 0 0.00016639982641208917
and O 0 9.022736446873125e-10
interfamilial O 0 1.7277149026995176e-06
phenotypic O 0 1.685477855062345e-07
variability O 0 2.0280661772176245e-07
is O 0 7.366313288514892e-12
present O 0 5.710324113518059e-14
for O 0 7.389507808549991e-15
either O 0 1.6191676905502606e-12
TWIST O 0 3.7729739688074915e-07
mutations O 0 1.2936252460349351e-06
or O 0 4.473529546800137e-09
FGFR O 0 0.0007053255685605109
mutations O 0 4.307401923142606e-06
. O 0 9.618177782000359e-11

The O 0 8.907954235359838e-12
overlap O 0 3.233471934649401e-09
in O 0 2.9106589100741376e-13
clinical O 0 2.7160290683170274e-10
features O 0 2.2857620241012455e-09
and O 0 6.365866167534762e-11
the O 0 1.3361148125390354e-12
presence O 0 1.2833927254263244e-09
, O 0 7.882990050653294e-14
in O 0 1.3649257259854062e-15
the O 0 1.728392921135618e-14
same O 0 3.996629416302966e-13
genes O 0 5.761992011993344e-12
, O 0 5.216809430052876e-15
of O 0 8.324004530904823e-17
mutations O 0 1.696128914402406e-12
for O 0 2.7039167854335435e-15
more O 0 8.987258857175726e-16
than O 0 4.5083464142881696e-14
one O 0 2.5081806423465913e-11
craniosynostotic B-Disease 0 1.0908380318142008e-05
condition I-Disease 0 3.0170144160734935e-10
- O 0 1.5068961356501376e-10
such O 0 6.626853579771996e-12
as O 0 2.7804272773046534e-10
Saethre B-Disease 0 6.03670230248099e-07
- I-Disease 0 2.9836375148306615e-08
Chotzen I-Disease 0 1.5294114064090536e-07
, I-Disease 0 1.287656504860013e-13
Crouzon I-Disease 0 2.5328743546992882e-09
, I-Disease 0 1.1568883058563767e-13
and I-Disease 0 1.7197897619891656e-11
Pfeiffer I-Disease 0 0.009553888812661171
syndromes I-Disease 0 2.8201675377204083e-05
- O 0 2.953440603192803e-09
support O 0 4.875486949926233e-13
the O 0 1.6323188867196567e-15
hypothesis O 0 7.034225090428448e-13
that O 0 1.3516291764211624e-13
TWIST O 0 6.266940300037049e-09
and O 0 6.039002631297308e-11
FGFRs O 0 5.534818381391915e-09
are O 0 1.7428463525343864e-14
components O 0 5.209879055945166e-11
of O 0 4.087245255110115e-15
the O 0 3.973512870732859e-14
same O 0 3.7235046589003534e-14
molecular O 0 1.9597199297366474e-12
pathway O 0 6.915933103979199e-12
involved O 0 1.4980766193523065e-12
in O 0 2.0860481785424205e-15
the O 0 9.089214095454358e-15
modulation O 0 2.156145401110976e-11
of O 0 5.2231517722045595e-11
craniofacial O 0 0.004027803894132376
and O 0 7.800046830652718e-09
limb O 0 3.305766995254089e-06
development O 0 7.104370477323263e-12
in O 0 1.907945610041869e-14
humans O 0 1.0034335341801981e-11
. O 0 3.615112495383016e-13
. O 0 1.0412209289212271e-11

Mutation O 0 6.013448228259222e-08
analysis O 0 2.274089111464761e-10
of O 0 2.682989108659939e-10
UBE3A O 1 0.9968730807304382
in O 0 7.389357779175043e-05
Angelman B-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
patients O 0 0.0003359244728926569
. O 0 3.784133284501223e-10

Angelman B-Disease 1 0.9999997615814209
syndrome I-Disease 1 1.0
( O 0 3.3867134334286675e-05
AS B-Disease 1 0.9999997615814209
) O 0 1.4359079897330318e-11
is O 0 1.2162260131301506e-12
caused O 0 2.10096935508719e-12
by O 0 1.2299190799928278e-13
chromosome O 0 0.00010149840090889484
15q11 O 0 2.2307153813017067e-07
- O 0 2.971119794636934e-09
q13 O 0 3.91282756195821e-10
deletions O 0 1.3235108564657594e-09
of O 0 2.7091039914856063e-12
maternal O 0 3.829721961778887e-08
origin O 0 1.7329974261182102e-11
, O 0 3.5401220258197974e-13
by O 0 5.144916068698657e-13
paternal O 0 3.7665097352146404e-06
uniparental B-Disease 0 0.43564364314079285
disomy I-Disease 0 0.03328372910618782
( O 0 2.0542147982638426e-09
UPD B-Disease 1 0.9999949932098389
) O 0 2.6272225714385478e-11
15 O 0 9.938483412977317e-13
, O 0 3.3587929500044765e-16
by O 0 4.368078605255805e-15
imprinting O 0 6.980742909945548e-05
defects O 1 0.9999924898147583
, O 0 2.650166110867991e-12
and O 0 4.966043716655641e-14
by O 0 9.04287122884418e-15
mutations O 0 1.0446155052079575e-09
in O 0 1.2027762141299247e-13
the O 0 2.0326197322506623e-12
UBE3A O 0 2.3614309611730278e-05
gene O 0 8.304345300302884e-08
. O 0 8.283673746944942e-11

UBE3A O 0 7.796540012350306e-05
encodes O 0 1.8426518977321393e-08
a O 0 1.1930508664326211e-11
ubiquitin O 0 4.711648848854111e-10
- O 0 1.938236682264005e-09
protein O 0 8.124161066103142e-12
ligase O 0 9.997235678183003e-12
and O 0 2.161171632278358e-12
shows O 0 5.118613866095245e-10
brain O 0 1.60869603860192e-06
- O 0 6.749968406438711e-08
specific O 0 7.057697481993586e-11
imprinting O 0 1.1292576346022543e-05
. O 0 5.155159632508344e-10

Here O 0 8.664557266113704e-11
we O 0 1.1098181835339505e-12
describe O 0 6.3355809314102896e-12
UBE3A O 0 9.422859079677437e-07
coding O 0 5.154900009074481e-07
- O 0 1.35565721848252e-06
region O 0 2.3413757044288275e-11
mutations O 0 1.238527946867407e-09
detected O 0 1.054305531766886e-09
by O 0 6.458853227643904e-15
SSCP O 0 1.255558768065157e-08
analysis O 0 2.550740868523249e-12
in O 0 2.5122381930829663e-13
13 O 0 8.455344202573656e-10
AS B-Disease 1 0.9999991655349731
individuals O 0 5.993858187558487e-11
or O 0 3.941937332108125e-10
families O 0 9.789451888009282e-11
. O 0 3.6354311921948934e-11

Two O 0 5.15705034231928e-09
identical O 0 2.527683591324603e-07
de O 0 1.3169690191716654e-06
novo O 0 2.5307107875960355e-07
5 O 0 2.2219523443389733e-10
- O 0 3.7016687493007794e-09
bp O 0 1.6274369629698526e-09
duplications O 0 8.149187435968486e-10
in O 0 4.651909012078764e-14
exon O 0 1.1749723416443203e-09
16 O 0 1.8448294974993118e-11
were O 0 4.4305765924557844e-14
found O 0 1.2690921447414127e-12
. O 0 6.745811374775368e-12

Among O 0 6.194501162015698e-11
the O 0 5.240527453718828e-14
other O 0 6.693640596227429e-14
11 O 0 2.304287836929486e-12
unique O 0 1.4550706017683879e-13
mutations O 0 1.3602525328337833e-08
, O 0 1.6845190606989968e-12
8 O 0 3.360961162157672e-11
were O 0 1.659778813955376e-13
small O 0 6.375164339576106e-14
deletions O 0 1.2038166019578966e-08
or O 0 2.03603733872626e-09
insertions O 0 1.158695226877171e-06
predicted O 0 7.839752811378276e-07
to O 0 9.618562890612026e-11
cause O 0 3.0544957674294437e-09
frameshifts O 0 7.450590783264488e-05
, O 0 4.613811502990339e-12
1 O 0 9.358627154482102e-13
was O 0 3.0359988828498885e-11
a O 0 1.5408525421301694e-13
mutation O 0 1.0251158949481365e-10
to O 0 2.9966388528576693e-13
a O 0 1.7951222106016296e-12
stop O 0 3.4515326152728676e-09
codon O 0 2.7300639526828263e-09
, O 0 6.602282333042012e-14
1 O 0 2.0571030298556676e-14
was O 0 3.771720782919097e-12
a O 0 2.948160921119325e-13
missense O 0 2.032558370501647e-07
mutation O 0 3.9498934256698703e-07
, O 0 3.6143851800396476e-11
and O 0 1.26338817879601e-11
1 O 0 4.921973419114156e-12
was O 0 2.8063009693823915e-09
predicted O 0 6.850677802816563e-10
to O 0 2.4195940390159265e-12
cause O 0 2.4275635755049985e-12
insertion O 0 9.512905740916011e-11
of O 0 2.8418795094964366e-12
an O 0 8.170781759520018e-12
isoleucine O 0 7.457669198629446e-06
in O 0 2.100198948128476e-13
the O 0 1.8094377111552672e-14
hect O 0 3.1021234470074432e-09
domain O 0 3.862829760920006e-12
of O 0 3.6436169158866535e-14
the O 0 1.545830249829322e-13
UBE3A O 0 1.8753719643882505e-07
protein O 0 2.0256860078227135e-10
, O 0 2.6818733459043134e-14
which O 0 3.140680854355751e-15
functions O 0 1.1428562902895262e-13
in O 0 6.458659426505572e-14
E2 O 0 3.0240517645552245e-08
binding O 0 4.1446582277337995e-10
and O 0 2.0447701962623271e-13
ubiquitin O 0 1.4124469822907049e-11
transfer O 0 1.590840653653558e-10
. O 0 1.0660860388922444e-10

Eight O 0 7.025118264891717e-10
of O 0 3.7321718388298383e-14
the O 0 7.316945037057557e-14
cases O 0 4.3120648718364407e-10
were O 0 5.280552106690095e-10
familial O 0 1.139316736953333e-06
, O 0 1.2065415333495366e-10
and O 0 4.7264893388021534e-11
five O 0 4.938809083920859e-11
were O 0 6.582463046855835e-11
sporadic O 0 6.24022433726168e-08
. O 0 1.5097673111696963e-10

In O 0 2.675638877125408e-11
two O 0 1.4620430517295335e-12
familial O 0 1.3595997643278679e-06
cases O 0 5.393094681949151e-08
and O 0 1.074718022908705e-10
one O 0 1.4059578154479446e-12
sporadic O 0 3.380475066538935e-10
case O 0 1.0369213265803978e-09
, O 0 3.123252795712156e-13
mosaicism O 0 3.7036617328567445e-08
for O 0 1.8773613306294346e-12
UBE3A O 0 3.063553958781995e-05
mutations O 0 8.863750622367661e-07
was O 0 8.665503870020075e-10
detected O 0 7.788187872392882e-08
in O 0 1.435843631492073e-13
the O 0 1.4521261797184604e-13
mother O 0 3.757912736546132e-08
of O 0 1.7214947186944968e-13
three O 0 7.386823597244074e-09
AS B-Disease 1 1.0
sons O 0 9.44609894304449e-07
, O 0 1.3991675114517765e-13
in O 0 3.3372869422923675e-15
the O 0 2.6281984401299585e-12
maternal O 0 3.9655976280528193e-08
grandfather O 0 1.8030736725904717e-07
of O 0 4.864089816689066e-13
two O 0 1.5006383913274135e-09
AS B-Disease 1 1.0
first O 0 2.6026329535966397e-08
cousins O 0 1.0533271961321589e-06
, O 0 2.5775464661953462e-12
and O 0 3.363447758156224e-12
in O 0 3.2047904911444713e-14
the O 0 1.580462540354266e-12
mother O 0 4.264825008704065e-07
of O 0 1.1765867685524511e-13
an O 0 1.8969774639998604e-09
AS B-Disease 1 1.0
daughter O 0 0.3347611725330353
. O 0 8.568959430910184e-10

The O 0 1.5807397708497706e-12
frequencies O 0 1.5641999848159394e-11
with O 0 7.864672454949151e-13
which O 0 2.58880346630172e-13
we O 0 6.677067210768273e-13
detected O 0 4.643745110666231e-10
mutations O 0 1.8302023230276632e-09
were O 0 2.935818949056923e-11
5 O 0 2.7782825953032164e-12
( O 0 3.1848943648398256e-14
14 O 0 1.13898560721859e-12
% O 0 2.942459845165635e-16
) O 0 6.972870513003966e-17
of O 0 2.990758987307055e-16
35 O 0 1.4008719314770324e-12
in O 0 2.8718772778852037e-15
sporadic O 0 7.673082169645795e-10
cases O 0 3.700915129911664e-08
and O 0 2.1283874662714197e-09
8 O 0 1.0757147256290622e-10
( O 0 2.8427442149391025e-14
80 O 0 1.3983084167553533e-13
% O 0 6.971707113250913e-15
) O 0 5.946974700475659e-15
of O 0 1.9610005351326787e-14
10 O 0 3.077157972875e-11
in O 0 2.106822000387011e-14
familial O 0 1.2346652589201312e-08
cases O 0 7.214658870324797e-10
. O 0 7.17445471521555e-13
. O 0 8.777579357799326e-12

The O 0 4.881107518173167e-09
hemochromatosis B-Disease 1 0.9999779462814331
845 O 0 3.0714727472513914e-05
G O 0 0.00036735882167704403
- O 0 1.9892515012998047e-07
- O 0 9.254025989946513e-09
> O 0 8.34822488915421e-12
A O 0 1.944020465438623e-12
and O 0 2.99206433284141e-13
187 O 0 3.879272771067921e-12
C O 0 3.046489727154267e-09
- O 0 5.2602491251718675e-09
- O 0 6.864611101775608e-09
> O 0 7.119213552009285e-11
G O 0 1.060484109416393e-07
mutations O 0 2.9355082808990574e-09
: O 0 2.9961303620387736e-13
prevalence O 0 2.6516378426322262e-08
in O 0 9.320114124911072e-13
non O 0 2.725259093949717e-07
- O 0 9.599210670785396e-07
Caucasian O 0 8.034351139940554e-07
populations O 0 4.6740225023711446e-09
. O 0 1.1549514816744377e-11

Hemochromatosis B-Disease 1 0.5748417377471924
, O 0 3.00397751118453e-08
the O 0 2.3644379609777388e-07
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 0 4.046088974973827e-07
iron I-Disease 1 0.7540677189826965
metabolism I-Disease 0 0.0002006537397392094
, O 0 2.3989612379926584e-12
leads O 0 9.898557667975538e-11
, O 0 4.649640590083381e-13
if O 0 4.6372284484563764e-11
untreated O 0 1.1385725883883424e-05
, O 0 2.964796106102313e-13
to O 0 7.313906967044981e-13
progressive O 0 2.049871028475536e-08
iron B-Disease 1 0.9712037444114685
overload I-Disease 0 0.0037600977811962366
and O 0 3.295153039317711e-09
premature B-Disease 0 6.99984337160231e-09
death I-Disease 0 9.728584604573598e-11
. O 0 3.4541567522916594e-11

The O 0 4.35821961852767e-10
hemochromatosis B-Disease 1 0.9999933242797852
gene O 0 4.5068187318975106e-05
, O 0 2.2070284835806753e-11
HFE O 0 5.125583356857533e-06
, O 0 8.911217250218151e-12
recently O 0 2.2345901129483536e-08
has O 0 1.8094725717787696e-10
been O 0 2.8212286673490183e-11
identified O 0 1.822420436781158e-09
, O 0 3.5788334643883923e-13
and O 0 4.024248789020676e-14
characterization O 0 3.59701136064261e-12
of O 0 2.476657633926978e-15
this O 0 4.615265265637712e-15
gene O 0 7.1563333037261145e-09
has O 0 6.604100377671784e-09
shown O 0 6.154694115467763e-11
that O 0 2.6462049240207064e-13
it O 0 3.6315118663934887e-13
contains O 0 1.1228424873915843e-12
two O 0 1.5832300748197525e-11
mutations O 0 5.272586633964238e-08
that O 0 4.254386079538541e-11
result O 0 2.7603093422090552e-11
in O 0 5.671013246673351e-13
amino O 0 3.0515009963316686e-10
acid O 0 1.917448491650653e-11
substitutions O 0 5.6041560281272496e-12
- O 0 1.2590437373227736e-11
cDNA O 0 1.7294048137994622e-11
nucleotides O 0 1.275845401549347e-10
845 O 0 1.3375549556826627e-09
G O 0 5.261973115011642e-07
- O 0 1.5521569807219748e-08
- O 0 5.434581673569028e-09
> O 0 7.411906158272252e-12
A O 0 5.756280001267822e-12
( O 0 7.07928156810163e-15
C282Y O 0 8.235238120775368e-13
) O 0 3.754487302990079e-16
and O 0 1.1412867932954055e-15
187 O 0 1.4749496112312355e-12
C O 0 1.2197689969184466e-08
- O 0 1.2209822841668938e-07
- O 0 1.291625437715993e-07
> O 0 2.6170413058856923e-10
G O 0 1.4098604594892095e-07
( O 0 3.2297734907545117e-13
H63D O 0 1.1679702538458514e-08
) O 0 1.9580936535829735e-13
. O 0 4.664563548785472e-13

Although O 0 1.2666069437727856e-07
hemochromatosis B-Disease 1 0.9999991655349731
is O 0 3.0563622743784435e-08
common O 0 4.704400063948455e-11
in O 0 9.978974433886775e-14
Caucasians O 0 5.315579976183926e-09
, O 0 2.5558336913880653e-13
affecting O 0 3.374353921281603e-11
> O 0 7.932847954916777e-12
= O 0 1.2900823465056277e-10
1 O 0 3.2043153395423796e-13
/ O 0 1.2572966973101174e-11
300 O 0 1.9693326288282298e-14
individuals O 0 1.1589642819661433e-13
of O 0 1.3776909571928259e-13
northern O 0 6.685488274094098e-10
European O 0 7.885250674632971e-09
origin O 0 4.184864260681209e-12
, O 0 9.58337467542314e-13
it O 0 5.1447617867295126e-12
has O 0 2.121476050387372e-10
not O 0 1.259280982442157e-12
been O 0 2.9840199755604147e-11
recognized O 0 1.7019229992323859e-12
in O 0 8.47783333742273e-15
other O 0 5.180622640946209e-13
populations O 0 1.7489638903800397e-10
. O 0 9.928218837329528e-12

The O 0 2.6344217606000253e-12
present O 0 2.542103897176795e-13
study O 0 1.3932256261487645e-14
used O 0 4.596794407792093e-13
PCR O 0 1.3828012015437707e-06
and O 0 2.875401999835603e-11
restriction O 0 6.414521691588959e-11
- O 0 5.676866199344488e-10
enzyme O 0 3.886994059953963e-10
digestion O 0 4.514899738794487e-12
to O 0 1.807507561296491e-16
analyze O 0 1.8442963356599812e-13
the O 0 6.652243131479796e-16
frequency O 0 1.3432757544359995e-14
of O 0 4.845415446472375e-16
the O 0 7.733332881400615e-15
845 O 0 1.9521478183959218e-11
G O 0 2.0149590884699364e-09
- O 0 4.712141093987654e-11
- O 0 1.9118026606257388e-11
> O 0 1.35503384229331e-13
A O 0 3.259870400961623e-13
and O 0 8.574500972528126e-14
187 O 0 9.697968339841823e-13
C O 0 2.7753407905173333e-10
- O 0 3.9033759557938197e-10
- O 0 6.189437296022504e-10
> O 0 6.735602960800113e-12
G O 0 1.113135983388247e-08
mutations O 0 3.5731962527707495e-11
in O 0 6.306271465382593e-16
HLA O 0 2.160743979573443e-11
- O 0 8.964092489127662e-13
typed O 0 4.06087793600185e-12
samples O 0 6.770211995188458e-12
from O 0 7.203630324626592e-14
non O 0 1.3093951700682283e-08
- O 0 1.907679205714885e-07
Caucasian O 0 1.4922200364253513e-07
populations O 0 9.286945656938883e-10
, O 0 3.4338078712913e-14
comprising O 0 4.962637831056049e-13
Australian O 0 8.380576232980275e-09
Aboriginal O 0 2.936440673950713e-11
, O 0 2.1938339681134775e-14
Chinese O 0 2.629478047721178e-15
, O 0 4.55209397194796e-14
and O 0 1.875092312322857e-12
Pacific O 0 1.7876547464545922e-10
Islanders O 0 4.145118470688658e-09
. O 0 7.661551081061813e-12

Results O 0 5.550888193539549e-09
showed O 0 3.7418041998193985e-09
that O 0 3.7980235682811767e-14
the O 0 1.1034299897947665e-14
845 O 0 1.6721491968851865e-09
G O 0 1.7596129282537731e-06
- O 0 2.2326174686781997e-08
- O 0 4.129320885226662e-09
> O 0 3.1279282549506737e-12
A O 0 1.4181664740112176e-12
mutation O 0 3.0168648135209253e-10
was O 0 1.87200671630805e-10
present O 0 8.067114006969286e-14
in O 0 9.751855381629686e-16
these O 0 5.175244252781687e-15
populations O 0 1.471430941500651e-13
( O 0 2.968390170659049e-16
allele O 0 2.5245639454808677e-13
frequency O 0 2.4376505588369346e-12
0 O 0 8.604063642114745e-12
. O 0 7.120995145545178e-14
32 O 0 6.754853620893897e-11
% O 0 9.923849868492644e-15
) O 0 2.219131284709585e-14
, O 0 3.294673222935772e-14
and O 0 3.357275395188264e-12
, O 0 2.4565607184621856e-14
furthermore O 0 2.7947894107489824e-13
, O 0 1.1345374441892701e-14
it O 0 3.703428622797711e-12
was O 0 1.4501016210033413e-07
always O 0 1.1728480409090025e-08
seen O 0 1.4530294745185302e-09
in O 0 3.313881304377363e-15
conjunction O 0 3.617429977526704e-13
with O 0 2.5223655629458275e-12
HLA O 0 5.4696709383961206e-08
haplotypes O 0 3.872226095325004e-09
common O 0 6.017684961445724e-11
in O 0 2.6816583689423003e-14
Caucasians O 0 3.77990416744467e-11
, O 0 1.6124527877329911e-15
suggesting O 0 3.5545061360421626e-13
that O 0 4.183559423366623e-14
845 O 0 4.1410705420297234e-10
G O 0 7.203491350082913e-06
- O 0 1.6450413795610075e-06
- O 0 5.442685164780414e-07
> O 0 1.3214468408406788e-10
A O 0 8.270369389329346e-10
may O 0 1.4484334842634894e-09
have O 0 2.8742806745807314e-13
been O 0 1.0198331572676758e-13
introduced O 0 7.539108226595204e-14
into O 0 7.119226371344722e-15
these O 0 1.501556650827969e-14
populations O 0 4.256362243996309e-13
by O 0 5.566183500444258e-14
Caucasian O 0 7.0507883975778896e-09
admixture O 0 1.030293805825977e-08
. O 0 9.797558597757217e-11

187 O 0 2.925265789599507e-07
C O 0 1.8441747670294717e-05
- O 0 6.029803785168042e-07
- O 0 3.245627908654569e-07
> O 0 1.0733747224378476e-09
G O 0 1.7865525023808004e-06
was O 0 9.470615264239868e-11
present O 0 2.1365409983743755e-14
at O 0 1.5696676543188598e-13
an O 0 2.8803569776597257e-16
allele O 0 1.7461087914102946e-12
frequency O 0 1.218585237057479e-12
of O 0 2.8623650216545726e-13
2 O 0 2.1710562514432041e-10
. O 0 1.2660247850071471e-11

68 O 0 3.868031853926368e-06
% O 0 5.754471552044116e-11
in O 0 4.069822210901568e-14
the O 0 1.8432929404306637e-14
two O 0 9.984919792024871e-13
populations O 0 4.680983031746244e-12
analyzed O 0 4.613587012425313e-10
( O 0 1.3907923207198691e-12
Australian O 0 2.1023970475653186e-07
Aboriginal O 0 2.711215696393765e-10
and O 0 9.992774836764529e-12
Chinese O 0 7.18004960500139e-14
) O 0 7.7304746534234e-14
. O 0 3.712323417420782e-13

In O 0 4.173051661171545e-12
the O 0 2.6619926355993077e-14
Australian O 0 2.226054340859207e-10
Aboriginal O 0 3.1463202811339575e-13
samples O 0 1.0313946962117737e-12
, O 0 2.3775300033845176e-15
187 O 0 3.0815595301186827e-13
C O 0 6.530095353340926e-10
- O 0 8.000752949044454e-09
- O 0 1.2656308001623984e-08
> O 0 3.46916419202703e-11
G O 0 6.092217574860115e-08
was O 0 5.031472634364764e-12
found O 0 5.986194612922491e-14
to O 0 7.638747253279569e-15
be O 0 5.778188799827888e-13
associated O 0 3.9821624323770413e-14
with O 0 2.1705562152328495e-13
HLA O 0 1.3680268473592605e-08
haplotypes O 0 1.8649903843481752e-09
common O 0 1.4817860827243123e-10
in O 0 5.137422198807709e-14
Caucasians O 0 5.446512685303162e-10
, O 0 2.0580723743605055e-14
suggesting O 0 4.109835735621736e-12
that O 0 1.848025449032245e-13
it O 0 6.186925429439716e-13
was O 0 3.658483585522454e-11
introduced O 0 7.807473743036419e-13
by O 0 1.0500483640962007e-14
recent O 0 1.1377723416194918e-11
admixture O 0 1.0539160655298474e-08
. O 0 1.2529882686962424e-10

In O 0 4.1412403020690824e-12
the O 0 3.644796748078884e-15
Chinese O 0 3.8705064645666847e-16
samples O 0 3.563573657623838e-14
analyzed O 0 1.285568765156675e-12
, O 0 1.3226791107081508e-15
187 O 0 5.320356243239399e-13
C O 0 9.330159977949393e-10
- O 0 1.1314370551573916e-09
- O 0 2.1243398151682413e-09
> O 0 7.393113031495258e-12
G O 0 1.0996435406696037e-07
was O 0 3.12392500756431e-10
present O 0 1.1249561395268448e-12
in O 0 4.2368902440290124e-13
association O 0 1.2573537046603467e-12
with O 0 2.1051720479683955e-13
a O 0 2.9094708955436366e-13
wide O 0 3.56046914173902e-10
variety O 0 9.550248092349278e-11
of O 0 2.178386594373083e-13
HLA O 0 2.556356726302056e-08
haplotypes O 0 9.740696027549234e-10
, O 0 2.163627587368263e-14
showing O 0 2.5014729870820318e-11
this O 0 2.1044552632774405e-15
mutation O 0 4.685844767760017e-11
to O 0 3.238637927716753e-13
be O 0 5.01725397339392e-11
widespread O 0 1.2095872047035439e-11
and O 0 5.757424745289619e-11
likely O 0 2.988780447091277e-12
to O 0 1.3089760234457075e-15
predate O 0 3.6681239642955e-12
the O 0 7.601129673059058e-16
more O 0 5.59050003759074e-16
genetically O 0 3.914511076397176e-12
restricted O 0 8.294843761511017e-13
845 O 0 7.343996938358188e-11
G O 0 8.786614671407733e-07
- O 0 1.0936362571101199e-07
- O 0 5.134166158882181e-08
> O 0 4.9390446593688964e-11
A O 0 4.284467225446065e-11
mutation O 0 2.993875725110229e-08
. O 0 5.765468658047723e-11

Genotype O 0 0.0017546260496601462
- O 0 0.0019662478007376194
phenotype O 0 8.567691111238673e-05
correlations O 0 7.753877434879541e-05
in O 0 3.1099926189881444e-08
attenuated B-Disease 1 0.9898033142089844
adenomatous I-Disease 1 0.9999920129776001
polyposis I-Disease 1 0.9999067783355713
coli I-Disease 1 0.9999983310699463
. O 0 2.4256877395600895e-07

Germ O 0 0.05113065242767334
- O 0 0.0006101900362409651
line O 0 2.910958585289336e-07
mutations O 0 2.9000487344887915e-08
of O 0 2.7314947382401332e-14
the O 0 2.7987245902966543e-14
tumor B-Disease 0 4.333867487105181e-09
suppressor O 0 6.161325227793668e-09
APC O 0 1.527120474520416e-07
are O 0 1.5434308345274594e-11
implicated O 0 5.609633262793068e-06
in O 0 4.968936373472843e-09
attenuated B-Disease 1 0.9997665286064148
adenomatous I-Disease 1 0.9999996423721313
polyposis I-Disease 1 0.9999932050704956
coli I-Disease 1 1.0
( O 0 5.7632182688394096e-06
AAPC B-Disease 1 0.9999957084655762
) O 0 6.268595365011009e-11
, O 0 2.5554372460874324e-14
a O 0 3.079561887615878e-13
variant O 0 0.0002108253538608551
of O 0 7.265743624884635e-05
familial B-Disease 1 1.0
adenomatous I-Disease 1 0.9999970197677612
polyposis I-Disease 1 0.9999994039535522
( O 0 6.673913333088421e-08
FAP B-Disease 0 7.110849651326134e-07
) O 0 3.5594558550622324e-11
. O 0 1.616157034589616e-11

AAPC B-Disease 1 0.9999896287918091
is O 0 7.120961953432925e-08
recognized O 0 2.0941531495011212e-11
by O 0 1.535140321340476e-14
the O 0 9.705285721947881e-15
occurrence O 0 6.572405397697878e-10
of O 0 4.552764957567457e-13
< O 0 1.2593867282362226e-08
100 O 0 1.2323524362437e-12
colonic B-Disease 0 1.398624647208635e-07
adenomas I-Disease 0 1.1172069207532331e-05
and O 0 1.7535282037170474e-12
a O 0 1.448046462468669e-13
later O 0 2.1099347269348812e-10
onset O 0 6.165045761008514e-06
of O 0 1.576412068970967e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 5.610278908108057e-10
age O 0 1.2593789344705897e-09
> O 0 2.399383469686711e-11
40 O 0 2.1824561255434638e-11
years O 0 1.4739603634850162e-11
) O 0 8.950168080626431e-13
. O 0 2.468728563589928e-12

The O 0 7.645565604230686e-12
aim O 0 5.0273504109688005e-11
of O 0 3.5106531990134046e-15
this O 0 1.7840796887666211e-16
study O 0 8.41927456164725e-15
was O 0 2.85949606007585e-12
to O 0 3.554240032171453e-14
assess O 0 5.800971258906884e-09
genotype O 0 2.964504801639123e-07
- O 0 2.422867737550405e-06
phenotype O 0 2.705381803025375e-07
correlations O 0 4.6307965817504737e-07
in O 0 2.2778179342708427e-10
AAPC B-Disease 1 0.9999802112579346
families O 0 2.163587753400975e-09
. O 0 3.7682572340269616e-11

By O 0 4.076554198373383e-12
protein O 0 1.652485259739933e-09
- O 0 1.084163514519787e-07
truncation O 0 2.777396275632782e-06
test O 0 4.136197458137758e-05
( O 0 9.27280171050815e-14
PTT O 0 4.4667147758303827e-10
) O 0 1.7206033308669595e-15
assay O 0 1.2453862810804517e-12
, O 0 2.9826351472494984e-16
the O 0 9.302158178394089e-17
entire O 0 7.710496195516281e-13
coding O 0 5.34178168365429e-09
region O 0 1.1515985647719829e-12
of O 0 1.4362750169017802e-15
the O 0 5.166880225944024e-15
APC B-Disease 0 8.774939802558279e-11
gene O 0 2.7685296763446665e-11
was O 0 1.0634089095407084e-11
screened O 0 3.808537485383567e-09
in O 0 1.9762034212831778e-14
affected O 0 3.1787135857525017e-12
individuals O 0 9.503515867054918e-14
from O 0 1.6365142747887251e-12
11 O 0 7.172037186364832e-08
AAPC B-Disease 1 0.999998927116394
kindreds O 0 1.3900128578825388e-05
, O 0 2.7888429413036597e-12
and O 0 4.723943133368158e-13
their O 0 1.098066340003527e-13
phenotypic O 0 1.1208403094542518e-07
differences O 0 4.246234919236258e-09
were O 0 5.108848066814886e-11
examined O 0 5.2345697554301296e-08
. O 0 2.716447206063677e-11

Five O 0 1.3885594063456352e-10
novel O 0 7.534552426413654e-10
germ O 0 0.0017151508945971727
- O 0 0.00025009806267917156
line O 0 7.167283797571145e-07
APC B-Disease 0 1.425445930181013e-07
mutations O 0 3.03433047577073e-08
were O 0 1.2924996359645058e-12
identified O 0 3.363500797326502e-11
in O 0 7.9647388944587e-14
seven O 0 4.007734699662535e-10
kindreds O 0 3.864197788061574e-05
. O 0 2.351513983533948e-10

Mutations O 0 4.144907506997697e-05
were O 0 5.394303337347139e-10
located O 0 3.5214175325704034e-11
in O 0 1.5459742115490373e-14
three O 0 3.002176686504182e-13
different O 0 6.419224282986843e-14
regions O 0 5.984599209425678e-13
of O 0 7.081090830476965e-15
the O 0 2.5727171586685527e-13
APC B-Disease 0 3.168282969312486e-09
gene O 0 1.5754438031923002e-10
( O 0 2.4802042879320738e-14
1 O 0 7.109676752490787e-14
) O 0 3.148382077912187e-15
at O 0 2.80322054631299e-12
the O 0 4.211856286916865e-13
5 O 0 1.6783175543766404e-11
end O 0 2.4629449521529345e-11
spanning O 0 5.316641571440073e-10
exons O 0 3.6078097309655277e-07
4 O 0 2.417485100991712e-09
and O 0 1.3594106396119798e-10
5 O 0 3.1282565513685023e-12
, O 0 3.8548028972410636e-14
( O 0 5.006362823758125e-16
2 O 0 1.725329880591757e-14
) O 0 7.661009079078425e-16
within O 0 4.329671643268012e-16
exon O 0 5.670762193155099e-10
9 O 0 6.1963389974550864e-09
, O 0 3.602412693235607e-13
and O 0 1.3795849228628865e-12
( O 0 4.460352680463794e-15
3 O 0 1.228254694132791e-13
) O 0 6.656358864570505e-15
at O 0 2.3021792805444363e-12
the O 0 4.545604005506097e-14
3 O 0 3.4148179076098906e-12
distal O 0 2.8027261067542497e-10
end O 0 1.694882290070865e-10
of O 0 6.288905384139749e-15
the O 0 3.6137383368920264e-14
gene O 0 1.5546233744778704e-10
. O 0 8.938402101810183e-12

Variability O 0 1.6943739922226086e-07
in O 0 4.421511984667448e-13
the O 0 3.7109905941376184e-14
number O 0 6.712649880391552e-11
of O 0 8.130129458550073e-08
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 0 6.474518158938736e-06
most O 0 1.301777479215116e-12
apparent O 0 1.437401499909674e-11
in O 0 7.938651634935984e-14
individuals O 0 3.5512012167698837e-12
with O 0 8.488040131870989e-12
mutations O 0 7.197773044254063e-08
in O 0 1.302185356072405e-11
region O 0 9.59274812362132e-11
1 O 0 1.7451384781708157e-10
, O 0 1.1038574221355901e-10
and O 0 1.9010502683158848e-07
upper O 0 0.003036123001947999
- O 1 0.999984622001648
gastrointestinal O 1 0.5315118432044983
manifestations O 0 5.824622348882258e-07
were O 0 1.9701511255743043e-11
more O 0 1.4095282829373196e-13
severe O 0 5.957801363365434e-09
in O 0 7.383703091762457e-15
them O 0 3.633100330996397e-12
. O 0 4.4957648714927245e-11

In O 0 2.2029154542191343e-11
individuals O 0 5.3609217759431615e-12
with O 0 7.884332835043917e-13
mutations O 0 4.4617806338465016e-08
in O 0 3.1875778058743087e-12
either O 0 4.889269877850211e-09
region O 0 6.316233647218894e-10
2 O 0 1.4147994997770752e-09
or O 0 1.866243870551898e-08
region O 0 1.1997169924171658e-10
3 O 0 1.1722781599610155e-11
, O 0 2.942955412379338e-15
the O 0 7.116751764589318e-16
average O 0 3.3489647166540237e-10
number O 0 3.8887031615642e-12
of O 0 3.5383938075568555e-13
adenomas B-Disease 0 1.7827520650826045e-06
tended O 0 2.3871067345027086e-09
to O 0 8.943491563648265e-14
be O 0 3.2995440147481903e-12
lower O 0 1.7314633884643604e-12
than O 0 9.590958805144947e-14
those O 0 2.4328279733636105e-13
in O 0 4.0020337406163325e-15
individuals O 0 7.53008292113562e-14
with O 0 1.545273105437936e-13
mutations O 0 6.159362797575341e-09
in O 0 6.775883239912295e-12
region O 0 3.957650179797767e-11
1 O 0 7.087266190586305e-11
, O 0 4.452420637041099e-12
although O 0 4.7096611333063976e-11
age O 0 1.4240423285016846e-09
at O 0 3.345429488987861e-09
diagnosis O 0 2.2174080527292972e-07
was O 0 4.967152800183783e-10
similar O 0 8.502753189032486e-12
. O 0 7.34909702537756e-11

In O 0 1.0965008900853945e-09
all O 0 4.708713863266212e-09
AAPC B-Disease 1 0.9999942779541016
kindreds O 0 2.7513429813552648e-05
, O 0 1.584176718841604e-13
a O 0 2.533090314653201e-14
predominance O 0 4.805760234205536e-10
of O 0 3.1229224067841344e-11
right O 1 0.5162311792373657
- O 1 0.9999948740005493
sided O 1 0.9999995231628418
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 0 0.0059028249233961105
rectal B-Disease 1 0.9999220371246338
polyp I-Disease 1 0.9886794686317444
sparing O 0 1.1868270810566628e-08
was O 0 8.252987737655815e-10
observed O 0 8.332993739479377e-10
. O 0 2.4193555145379797e-11

No O 0 2.1622707208734937e-05
desmoid B-Disease 1 0.9991783499717712
tumors I-Disease 1 1.0
were O 0 1.195966703448903e-08
found O 0 1.7208440228344557e-10
in O 0 1.5156219378489877e-13
these O 0 6.123298916527187e-12
kindreds O 0 9.652292646933347e-06
. O 0 1.4753788468713225e-10

Our O 0 1.0797437249854269e-10
data O 0 2.3634330603705678e-11
suggest O 0 1.4513966417606383e-11
that O 0 1.6642430706106937e-12
, O 0 1.8573270092053784e-12
in O 0 5.786530109241905e-12
AAPC B-Disease 1 1.0
families O 0 2.745421445737861e-09
, O 0 1.0577956662449674e-14
the O 0 1.4410762114050544e-16
location O 0 1.277475738040157e-12
of O 0 1.0268520788444396e-13
the O 0 1.1957618922808777e-11
APC B-Disease 0 4.865921255259309e-06
mutation O 0 5.639201958729245e-07
may O 0 2.0420809487831093e-09
partially O 0 1.792264892053197e-09
predict O 0 1.7587107117855716e-11
specific O 0 1.9899784944876764e-11
phenotypic O 0 1.425787331754691e-06
expression O 0 5.7368254147149855e-08
. O 0 2.554175482227805e-10

This O 0 6.917833059866263e-12
should O 0 1.1021401673250164e-11
help O 0 1.5681713197955582e-13
in O 0 5.137318881963968e-16
the O 0 5.543948694996419e-16
design O 0 3.075503046678918e-11
of O 0 2.629330401408142e-13
tailored O 0 7.432206672319808e-08
clinical O 0 2.2621584605531098e-07
- O 0 5.617608280772401e-07
management O 0 5.426624150040027e-10
protocols O 0 2.4711042240221914e-11
in O 0 8.073935920329222e-17
this O 0 5.665506839934415e-18
subset O 0 2.226100502393004e-14
of O 0 3.1087616882878935e-14
FAP B-Disease 0 5.16727061139477e-09
patients O 0 8.559443952227408e-12
. O 0 1.3968256855811847e-14
. O 0 3.469155952090519e-12

Wilms B-Disease 1 0.9979766011238098
' I-Disease 0 0.00017545121954753995
tumor I-Disease 0 2.1975190975354053e-05
1 O 0 8.942674378786819e-10
and O 0 7.096707943521352e-11
Dax O 0 0.24841541051864624
- O 0 1.2318736253291718e-07
1 O 0 1.8923996484426775e-12
modulate O 0 1.430157936521681e-10
the O 0 5.744782362489265e-13
orphan O 0 1.3871384396679787e-07
nuclear O 0 4.252153473771614e-08
receptor O 0 1.5830307550923628e-11
SF O 0 7.521765041929029e-07
- O 0 2.8707469734712276e-09
1 O 0 2.932653848496808e-13
in O 0 3.6061953920296967e-16
sex O 0 2.0222145138970582e-11
- O 0 7.950445857218824e-13
specific O 0 3.426244883511856e-14
gene O 0 2.340415708457222e-11
expression O 0 1.602424269664393e-11
. O 0 2.178969461461011e-12

Products O 0 1.855256357430335e-07
of O 0 1.6171337272746777e-12
steroidogenic O 0 1.9415067527006613e-06
factor O 0 4.998232050468232e-09
1 O 0 1.734935285713224e-11
( O 0 2.2566769687735327e-13
SF O 0 9.35414936975576e-05
- O 0 1.5047700117065688e-06
1 O 0 2.1764007263058716e-10
) O 0 1.3464808695101693e-12
and O 0 6.249971373772922e-11
Wilms B-Disease 0 0.0016397630097344518
tumor I-Disease 0 3.2312655093846843e-06
1 O 0 2.996293491097646e-11
( O 0 7.501785244433748e-14
WT1 O 0 1.7104952121371753e-08
) O 0 1.2880832569994987e-14
genes O 0 7.720635654233365e-13
are O 0 2.1590586069474785e-15
essential O 0 1.532273453627199e-14
for O 0 2.316111009104398e-15
mammalian O 0 3.4816927119152297e-11
gonadogenesis O 0 1.751896938628761e-08
prior O 0 5.214310754009244e-12
to O 0 1.5318280498222148e-12
sexual O 0 1.1035217184485191e-08
differentiation O 0 3.475711718436969e-09
. O 0 2.1334534833217234e-11

In O 0 8.59108062467584e-11
males O 0 6.360990068010608e-10
, O 0 1.3434845683862884e-12
SF O 0 0.0007366043282672763
- O 0 8.462791811325587e-06
1 O 0 3.826241060100877e-11
participates O 0 1.3180685709546225e-10
in O 0 9.915789502966572e-15
sexual O 0 2.2942277418114276e-12
development O 0 5.789189614819365e-16
by O 0 1.4804087157063999e-16
regulating O 0 2.4391041963944815e-10
expression O 0 1.8523951903631763e-12
of O 0 2.770193090149693e-15
the O 0 1.9203315153315526e-12
polypeptide O 0 0.0004136217467021197
hormone O 0 1.2967024304089136e-05
Mullerian O 0 7.267839237101725e-07
inhibiting O 0 1.6094817567591235e-07
substance O 0 3.4685913874454855e-07
( O 0 4.026464491685422e-12
MIS O 0 0.0010430703405290842
) O 0 2.8057146883586626e-11
. O 0 4.950114103341452e-12

Here O 0 4.4569453683251936e-10
, O 0 1.570473081007745e-13
we O 0 8.339925023368236e-14
show O 0 4.126865515985401e-12
that O 0 2.0614402112401065e-13
WT1 O 0 1.6552105535083683e-06
- O 0 1.2874428989562148e-07
KTS O 0 2.7282155770080863e-06
isoforms O 0 1.1038742836477766e-10
associate O 0 4.6313791690621997e-10
and O 0 1.3031289372231192e-12
synergize O 0 5.792383035441162e-07
with O 0 8.059282408101609e-11
SF O 0 0.00843367911875248
- O 0 1.7554026499055908e-06
1 O 0 1.904407360975302e-11
to O 0 2.661014312545229e-13
promote O 0 1.6159605598087268e-10
MIS O 0 0.020223010331392288
expression O 0 3.790029179384646e-09
. O 0 2.5469210074291482e-11

In O 0 9.734747036249658e-11
contrast O 0 1.6948110970194108e-10
, O 0 1.7377827692469094e-12
WT1 O 0 7.093711701600114e-06
missense O 0 3.3327018172712997e-05
mutations O 0 8.80622974364087e-06
, O 0 5.326021741691722e-13
associated O 0 1.231783663784014e-12
with O 0 7.026213638683387e-11
male B-Disease 0 1.918599082273431e-05
pseudohermaphroditism I-Disease 1 1.0
in O 0 5.6610204524076835e-08
Denys B-Disease 1 0.999992847442627
- I-Disease 1 0.9999978542327881
Drash I-Disease 1 0.9999915361404419
syndrome I-Disease 1 0.9999992847442627
, O 0 8.658027420005432e-12
fail O 0 2.633480100655561e-10
to O 0 7.983156778863798e-14
synergize O 0 8.386266927118413e-06
with O 0 1.0905191194510166e-09
SF O 1 0.7129549980163574
- O 0 1.960600638994947e-05
1 O 0 3.484073030080026e-10
. O 0 1.2478788835590393e-11

Additionally O 0 5.624124277403553e-09
, O 0 3.1755121535775865e-13
the O 0 2.609051551736609e-14
X O 0 0.00031929093529470265
- O 0 7.799750960657548e-07
linked O 0 2.5908780116878916e-06
, O 0 1.7363381782722898e-12
candidate O 0 5.575090085765955e-13
dosage O 0 2.517537844859419e-10
- O 0 5.4050833253604935e-11
sensitive O 0 1.2812165550712962e-08
sex O 0 1.999816312547864e-09
- O 0 1.238550408066974e-11
reversal O 0 2.055787181112767e-12
gene O 0 2.9891467773213165e-11
, O 0 4.5197718723070934e-14
Dax O 0 2.315768870175816e-05
- O 0 4.888859539420309e-09
1 O 0 9.11100730451031e-13
, O 0 6.075660604503742e-15
antagonizes O 0 8.998602557541702e-11
synergy O 0 2.675889024250644e-11
between O 0 1.0901098817031607e-12
SF O 0 5.96082245465368e-05
- O 0 2.2530662135977764e-07
1 O 0 1.3045769325925605e-11
and O 0 2.970977684788739e-13
WT1 O 0 4.489882243774446e-09
, O 0 7.59241116293297e-15
most O 0 4.2357364835108983e-16
likely O 0 2.0019637260882545e-14
through O 0 1.0122856871318253e-15
a O 0 3.679036784422218e-14
direct O 0 1.1749168261562803e-12
interaction O 0 2.1789374124447924e-11
with O 0 3.5662309910700074e-11
SF O 0 0.10901394486427307
- O 0 5.766159574704943e-06
1 O 0 2.745529914527367e-10
. O 0 9.844345824627787e-12

We O 0 1.3635507167819583e-09
propose O 0 2.512395569365111e-10
that O 0 4.801374142021642e-13
WT1 O 0 5.50695801848633e-07
and O 0 5.734672459123402e-11
Dax O 0 0.01722630113363266
- O 0 6.886684644769048e-08
1 O 0 1.711699358641905e-12
functionally O 0 2.5567527262015943e-11
oppose O 0 1.1785189794541462e-12
each O 0 3.441702557172889e-14
other O 0 9.72752541901099e-15
in O 0 4.8870171520394145e-15
testis O 0 2.89166107725336e-10
development O 0 3.426512884736367e-14
by O 0 2.360532423825376e-14
modulating O 0 2.9337577700516704e-08
SF O 0 0.07427570223808289
- O 0 1.970484390767524e-06
1 O 0 6.835185195619431e-10
- O 0 1.6485927289977553e-07
mediated O 0 2.3609088017906288e-08
transactivation O 0 4.087178808731551e-07
. O 0 5.23234016877594e-13
. O 0 1.1624274676505508e-12

A O 0 1.9621491931243185e-10
mouse O 0 1.359954637791816e-07
model O 0 2.3162579054769594e-06
for O 0 7.352261377491232e-07
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 0.9999998807907104
imprinting O 1 0.9046342372894287
- O 0 0.29962801933288574
centre O 0 9.542792440697667e-07
mutations O 0 5.884020538360346e-06
. O 0 1.7572766852769206e-10

Imprinting O 0 4.164799065620173e-07
in O 0 9.137063501640785e-12
the O 0 3.0021883416775363e-13
15q11 O 0 3.65164121163275e-09
- O 0 1.3165021961469847e-08
q13 O 0 1.0262862781829085e-09
region O 0 2.7325903584167477e-13
involves O 0 5.997923512024439e-13
an O 0 1.9138721301672178e-14
imprinting O 0 6.499607252408168e-08
centre O 0 8.434827059033978e-09
( O 0 4.184525040926493e-14
IC O 0 9.625485963837832e-10
) O 0 1.6120231302704964e-14
, O 0 3.9527216000095552e-16
mapping O 0 5.937829394841998e-11
in O 0 1.4465861776676026e-13
part O 0 3.913450726672485e-12
to O 0 7.798662974081716e-13
the O 0 1.1485467253918163e-13
promoter O 0 3.6645417811342895e-09
and O 0 2.403376326079454e-12
first O 0 1.9176439678813412e-13
exon O 0 5.787043622085264e-10
of O 0 5.789333856059953e-12
SNRPN O 0 5.0405058573232964e-05
. O 0 1.1520105702711447e-10

Deletion O 0 8.45763224788243e-07
of O 0 7.954180716862602e-12
this O 0 7.286476652081098e-13
IC O 0 8.001693458936643e-06
abolishes O 0 6.213715408875942e-08
local O 0 2.489975890404561e-12
paternally O 0 2.2268367150246604e-09
derived O 0 1.4460132310295526e-12
gene O 0 3.8032235138985016e-09
expression O 0 4.191594848990121e-10
and O 0 3.1703108888114784e-11
results O 0 6.511915007223479e-09
in O 0 4.096491920790868e-06
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 3.6216229659657984e-07
PWS B-Disease 1 0.9999892711639404
) O 0 2.1767203317590855e-10
. O 0 2.104347252007699e-11

We O 0 4.8637868843570686e-08
have O 0 1.7360466363081084e-12
created O 0 2.759448756734645e-13
two O 0 2.6497084555784575e-14
deletion O 0 5.471830988312831e-08
mutations O 0 2.496025217624265e-07
in O 0 6.813888781551439e-14
mice O 0 1.7520615358534997e-07
to O 0 3.4941733534354924e-11
understand O 0 2.0311128423600167e-07
PWS B-Disease 1 1.0
and O 0 9.064358708066322e-10
the O 0 1.631725286030221e-14
mechanism O 0 2.0910080958391752e-11
of O 0 1.0969290966278845e-14
this O 0 2.2151657136197656e-13
IC O 0 3.0953572149883257e-06
. O 0 4.2785386344945664e-11

Mice O 0 0.00014132130309008062
harbouring O 0 6.761411441402743e-06
an O 0 5.601345342415298e-12
intragenic O 0 1.2419206996128196e-06
deletion O 0 5.064989636593964e-06
in O 0 3.827145891865946e-11
Snrpn O 0 2.1964127881801687e-05
are O 0 4.035461895202097e-11
phenotypically O 0 2.2559327739202217e-09
normal O 0 1.7559956960733203e-11
, O 0 5.087008407149733e-15
suggesting O 0 3.6224718970995218e-12
that O 0 5.128072310322737e-14
mutations O 0 9.953921020766643e-10
of O 0 7.458715719707576e-13
SNRPN O 0 0.0013374810805544257
are O 0 4.8677303507438374e-12
not O 0 2.181667390147024e-13
sufficient O 0 1.177516959806335e-12
to O 0 2.552005915618105e-12
induce O 0 1.4010089444127516e-07
PWS B-Disease 1 0.9999791383743286
. O 0 7.178763139492617e-10

Mice O 0 0.0010070325806736946
with O 0 4.065535668534848e-12
a O 0 8.253852923400043e-14
larger O 0 1.9090458380777164e-13
deletion O 0 3.821598593134468e-09
involving O 0 5.2889816970491665e-09
both O 0 3.470952969486518e-10
Snrpn O 0 4.891333446721546e-06
and O 0 7.70629567103942e-12
the O 0 4.820533620712719e-13
putative O 0 8.770433851168491e-06
PWS O 1 0.9999995231628418
- O 0 0.00027833969215862453
IC O 0 0.0005297462921589613
lack O 0 5.525238599979332e-10
expression O 0 1.1344216581735123e-12
of O 0 2.682097004954036e-15
the O 0 2.0763170913498663e-13
imprinted O 0 1.653921458455443e-06
genes O 0 2.534045151492137e-08
Zfp127 O 0 7.33260065999275e-08
( O 0 4.547529141988617e-14
mouse O 0 9.03694563625379e-10
homologue O 0 1.920122061349616e-09
of O 0 3.01324438491124e-12
ZNF127 O 0 2.4766324713709764e-05
) O 0 9.123440935024374e-13
, O 0 1.4086621239861163e-14
Ndn O 0 4.492829219771011e-09
and O 0 1.2144348027209872e-11
Ipw O 0 1.5215643145438662e-07
, O 0 3.889747139836086e-13
and O 0 7.118646492589031e-14
manifest O 0 3.266606603269384e-12
several O 0 4.6290201489648797e-14
phenotypes O 0 4.802427788774821e-09
common O 0 1.179242592463936e-09
to O 0 1.6952590442542714e-08
PWS B-Disease 1 0.9999997615814209
infants O 1 0.8530587553977966
. O 0 1.8217312380830464e-10

These O 0 1.4759759170077102e-13
data O 0 7.396484466570818e-12
demonstrate O 0 1.0959431062315672e-12
that O 0 2.706518447131035e-14
both O 0 3.644953533877421e-13
the O 0 4.3085969362623155e-13
position O 0 2.6687863030616654e-09
of O 0 1.65320523689129e-15
the O 0 2.139771073815435e-14
IC O 0 1.1042717318332507e-07
and O 0 2.5150777727828144e-12
its O 0 1.1820070340258851e-14
role O 0 1.350572015335061e-10
in O 0 2.604977831480084e-15
the O 0 2.5004483753714515e-14
coordinate O 0 1.2227446832824285e-10
expression O 0 2.912970645946311e-12
of O 0 3.1819116653710117e-15
genes O 0 1.9278263013733365e-11
is O 0 1.9357010162509083e-14
conserved O 0 1.5582198075250742e-12
between O 0 9.42853759476614e-13
mouse O 0 2.071369453915395e-05
and O 0 2.3476072197325948e-09
human O 0 3.373994972299954e-10
, O 0 1.3467115064173113e-13
and O 0 5.220119583988769e-13
indicate O 0 1.9574001707683975e-12
that O 0 2.9643776040637337e-13
the O 0 1.7312445422558442e-13
mouse O 0 9.037795507538249e-07
is O 0 6.945809812725079e-12
a O 0 8.946046892643542e-15
suitable O 0 3.3233812837124566e-12
model O 0 3.6615026566266806e-09
system O 0 3.168122708618881e-11
in O 0 1.4622255229551628e-14
which O 0 7.19990744541682e-14
to O 0 7.97215212681307e-15
investigate O 0 1.5036001610457816e-10
the O 0 4.581640175214084e-14
molecular O 0 4.118885787995907e-11
mechanisms O 0 4.803824352195285e-11
of O 0 7.265984993851896e-15
imprinting O 0 6.160925547504803e-09
in O 0 3.253273843893678e-13
this O 0 1.3299349008134495e-14
region O 0 1.0035147626069607e-13
of O 0 6.480247268188298e-16
the O 0 7.419956948937888e-15
genome O 0 3.957167232782055e-11
. O 0 4.394808627260216e-13
. O 0 2.9253478979474057e-12

Mutations O 0 6.143660584712052e-07
of O 0 1.0860334577174682e-13
the O 0 6.2466812152355954e-15
ATM O 0 3.363075862239384e-08
gene O 0 5.845253614467083e-09
detected O 0 5.366336608858546e-06
in O 0 1.4535693482198297e-10
Japanese O 1 0.6675549149513245
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
telangiectasia I-Disease 1 1.0
patients O 0 0.03704749420285225
: O 0 3.6280432325931644e-13
possible O 0 3.2850615673887806e-13
preponderance O 0 1.277745687033871e-09
of O 0 1.5925777949003794e-13
the O 0 4.4640167755870264e-13
two O 0 3.275959364890113e-12
founder O 0 3.033628681592404e-09
mutations O 0 1.4181888730036007e-07
4612del165 O 0 9.960098523720262e-09
and O 0 9.516712938528737e-12
7883del5 O 0 5.9428653109705465e-09
. O 0 9.489595741152268e-12

The O 0 1.7148798006627608e-11
ATM O 0 6.745316204614937e-05
( O 0 1.0183235588101525e-08
A O 1 0.9999998807907104
- O 1 0.9999998807907104
T O 1 1.0
, O 0 9.117773376587923e-12
mutated O 0 5.03962982456585e-11
) O 0 3.813424490734744e-15
gene O 0 1.4798669017643262e-12
on O 0 2.092874267986544e-12
human O 0 8.581479277181003e-12
chromosome O 0 4.6166331912900205e-07
11q22 O 0 1.6337614283656876e-07
. O 0 4.2267408323359845e-11

3 O 0 6.373638683498939e-08
has O 0 7.49533601851482e-10
recently O 0 1.7660741757907772e-09
been O 0 3.2833219650030276e-12
identified O 0 2.1057927970802304e-11
as O 0 1.5888937097995916e-14
the O 0 1.6864799203725504e-16
gene O 0 6.191520386666927e-12
responsible O 0 4.429989361454112e-12
for O 0 5.3720117004947554e-14
the O 0 9.501441300407976e-12
human O 0 1.1895433090103325e-05
recessive B-Disease 1 0.9999970197677612
disease I-Disease 1 0.9999994039535522
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999996423721313
telangiectasia I-Disease 1 1.0
( O 0 0.043307989835739136
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
) O 0 4.342852188976565e-10
. O 0 7.73830218653293e-12

In O 0 3.3997943349461934e-11
order O 0 1.309487457704095e-12
to O 0 1.2748504847810184e-14
define O 0 1.1505342685513842e-11
the O 0 4.8658691957420216e-14
types O 0 7.482427122340596e-09
of O 0 1.1051588463817374e-11
disease O 0 2.9503697078325786e-05
- O 0 5.837802419250693e-08
causing O 0 3.409805326981541e-09
ATM O 0 7.150658348109573e-06
mutations O 0 3.1615106763638323e-06
in O 0 3.1667919155042856e-12
Japanese O 0 4.434703441802412e-05
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 5.721809657188714e-07
as O 0 7.109083829427709e-13
well O 0 1.0362760318903194e-14
as O 0 1.1086111209265316e-14
to O 0 5.632005181401792e-16
look O 0 5.645589464670087e-12
for O 0 3.607559062135217e-15
possible O 0 2.6939122590649567e-13
mutational O 0 1.8857437833474933e-09
hotspots O 0 1.4673476878002134e-09
, O 0 1.9969496976163237e-13
reverse O 0 1.42004985548283e-09
- O 0 1.8252739764079706e-08
transcribed O 0 4.1445513687676794e-08
RNA O 0 4.4816320099450024e-10
derived O 0 2.813660762712722e-12
from O 0 3.658477600726462e-14
ten O 0 9.631643356142194e-13
patients O 0 1.9985043080063963e-13
belonging O 0 2.0632133561305707e-14
to O 0 3.3151836175337665e-15
eight O 0 8.519376176741034e-12
unrelated O 0 6.0198490636764745e-09
Japanese O 0 0.006330883130431175
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
families O 0 1.562501905638669e-09
was O 0 1.0831265051525207e-10
analyzed O 0 1.7978377120364541e-10
for O 0 5.537264779185459e-14
mutations O 0 1.5792029142702724e-12
by O 0 1.974449681917535e-16
the O 0 1.0781151819682982e-15
restriction O 0 5.768267807848559e-13
endonuclease O 0 1.7645118699505247e-09
fingerprinting O 0 1.947415562142396e-09
method O 0 1.2631576340460526e-10
. O 0 2.5837597686373392e-11

As O 0 1.0193917931999863e-09
has O 0 1.0390584226360744e-11
been O 0 2.5422879404955745e-13
reported O 0 8.022159867816792e-13
by O 0 2.259810423166299e-15
others O 0 5.2577135353781834e-12
, O 0 2.4376108973662124e-14
mutations O 0 1.2640685720377576e-10
that O 0 5.248432439521056e-13
lead O 0 1.0579350590012027e-10
to O 0 8.70981143653339e-14
exon O 0 6.248180284273985e-08
skipping O 0 2.903145059462986e-06
or O 0 2.564409662397793e-08
premature O 0 4.163857036942886e-10
protein O 0 1.183935761928101e-11
truncation O 0 2.601008741720534e-09
were O 0 3.2962907958733467e-09
also O 0 1.525439219385305e-09
predominant O 0 3.867074216401534e-09
in O 0 2.5089533315508783e-13
our O 0 1.9665104267208022e-10
mutants O 0 2.157015455139799e-09
. O 0 4.5285953806373236e-12

Six O 0 3.2294289464829262e-09
different O 0 5.846523894355304e-13
mutations O 0 1.1048801873414504e-08
were O 0 1.756685769072064e-11
identified O 0 9.807622491919687e-10
on O 0 9.62596335973842e-10
12 O 0 1.0021066615406582e-10
of O 0 6.5549618210041134e-15
the O 0 1.1235644576182424e-12
16 O 0 2.002657935318286e-11
alleles O 0 2.6859521551347854e-11
examined O 0 6.09725105960024e-08
. O 0 5.3462404642212746e-11

Four O 0 5.706350947320971e-10
were O 0 4.287315673919684e-13
deletions O 0 9.878037277033513e-11
involving O 0 8.732385370358031e-10
a O 0 5.433602179305552e-11
loss O 0 2.9732625250744604e-09
of O 0 1.1516348042295982e-14
a O 0 1.938509980791911e-13
single O 0 2.4682134114328846e-10
exon O 0 2.4730884007340137e-08
exon O 0 1.6715958395252528e-07
7 O 0 1.6372631028716e-09
, O 0 6.744608262729615e-14
exon O 0 5.372124967095715e-10
16 O 0 2.744910722329852e-11
, O 0 4.561704407767507e-15
exon O 0 2.7473529007338016e-10
33 O 0 1.1629563284598632e-10
or O 0 2.2165784832606228e-12
exon O 0 1.49509098434919e-08
35 O 0 2.7161599636116307e-09
. O 0 8.464424300358431e-11

The O 0 1.1105513210429852e-11
others O 0 1.409295857096593e-11
were O 0 1.1727980240607006e-13
minute O 0 3.242822406001461e-13
deletions O 0 1.48620249440512e-09
, O 0 3.2639516089894016e-13
4649delA O 0 3.6007352655076375e-10
in O 0 3.333648088750963e-15
exon O 0 6.38444963563245e-10
33 O 0 4.616861615236445e-10
and O 0 2.520964665318759e-13
7883del5 O 0 1.4340687491676274e-11
in O 0 8.00891250969096e-15
exon O 0 4.667706221539447e-09
55 O 0 2.4171162849029315e-09
. O 0 2.6806295030934457e-11

The O 0 3.727724379176678e-11
mutations O 0 3.8307302219209305e-08
4612del165 O 0 7.0586194667043856e-09
and O 0 1.533786769467027e-12
7883del5 O 0 6.267208974009009e-11
were O 0 1.931070321009587e-13
found O 0 2.0029385593665905e-13
in O 0 1.2248418025119344e-16
more O 0 2.6039121250660953e-17
than O 0 6.086235599091975e-16
two O 0 4.838121751642686e-15
unrelated O 0 2.823898753723242e-11
families O 0 5.554774305457921e-13
; O 0 7.058467851005223e-14
44 O 0 1.3220467776076106e-10
% O 0 8.615385558826197e-14
( O 0 7.148634169427265e-14
7 O 0 6.541408040239283e-12
of O 0 3.675389460551341e-14
16 O 0 9.230918980585034e-12
) O 0 4.0379614371675117e-16
of O 0 9.045759981771232e-17
the O 0 1.1011718846606813e-14
mutant O 0 2.3693628392607025e-08
alleles O 0 2.2345025829650922e-10
had O 0 4.911215434333371e-09
one O 0 4.269078309176305e-13
of O 0 3.1703769824535395e-15
the O 0 6.429848109024486e-14
two O 0 8.276751679858751e-12
mutations O 0 1.5254633112249394e-08
. O 0 6.375356492727136e-11

The O 0 2.7229732357803016e-11
4612del165 O 0 7.341665497762051e-09
mutations O 0 7.1687376035356465e-09
in O 0 1.3951269610054662e-14
three O 0 4.198555633477992e-14
different O 0 1.4061172981993855e-14
families O 0 1.210703222788781e-13
were O 0 9.99216009413273e-13
all O 0 1.30662184359958e-14
ascribed O 0 2.2777496577232326e-13
to O 0 3.744721817789537e-14
the O 0 2.9697140471567074e-13
same O 0 8.409489771210588e-10
T O 0 0.0002570792566984892
- O 0 1.5773457207046704e-08
- O 0 3.5811467680169073e-10
> O 0 1.415066523159647e-13
A O 0 1.667060180220517e-13
substitution O 0 8.813202988580682e-14
at O 0 1.295164930165127e-12
the O 0 2.0438284565612403e-15
splice O 0 1.096520385601707e-08
donor O 0 4.912500961573585e-12
site O 0 1.2465537282957406e-11
in O 0 1.8990551861088056e-13
intron O 0 7.48022443985974e-07
33 O 0 2.943684407341607e-08
. O 0 4.520330290636032e-11

Microsatellite O 0 3.5907269193558022e-06
genotyping O 0 6.865012665002723e-07
around O 0 1.3823625577558118e-10
the O 0 1.5665690045098962e-13
ATM O 0 7.403131689898146e-07
locus O 0 8.533444088243414e-06
also O 0 8.356812486454146e-08
indicated O 0 2.0832553460081726e-09
that O 0 2.7057560835971883e-13
a O 0 1.393003876311305e-12
common O 0 6.246980016610948e-11
haplotype O 0 4.6632475658725525e-09
was O 0 2.4352422300921717e-09
shared O 0 4.2286391944458546e-13
by O 0 2.0395913860008375e-15
the O 0 6.812416638289111e-15
mutant O 0 1.3374126694998267e-08
alleles O 0 9.077035650895127e-11
in O 0 5.5511703496739437e-14
both O 0 8.071723844871315e-12
mutations O 0 4.497478300891089e-08
. O 0 6.673712277249777e-11

This O 0 6.049695249962794e-13
suggests O 0 4.035045908512558e-11
that O 0 2.575823635061949e-14
these O 0 7.373878356607255e-15
two O 0 9.193401248608346e-13
founder O 0 9.856103488914414e-09
mutations O 0 7.513035598094575e-06
may O 0 4.4850398950302406e-08
be O 0 2.003880741896502e-11
predominant O 0 7.086945474910067e-10
among O 0 1.117870010967914e-12
Japanese O 0 3.1898797492324604e-10
ATM O 0 2.327674195612417e-07
mutant O 0 5.167766516933625e-07
alleles O 0 3.178307750317799e-08
. O 0 1.0855213949945153e-10

W474C O 0 3.598312616759358e-07
amino O 0 3.1294846714047253e-09
acid O 0 1.0786938703377658e-10
substitution O 0 6.768206871690663e-13
affects O 0 2.3809099223420782e-12
early O 0 1.8033555910775077e-15
processing O 0 1.002583541361013e-12
of O 0 1.812797017354298e-16
the O 0 3.002487217252975e-16
alpha O 0 6.39774488269719e-15
- O 0 7.733723600758524e-13
subunit O 0 2.0107767650912566e-14
of O 0 5.594556901891614e-15
beta O 0 7.993811775713899e-13
- O 0 4.165549016832415e-10
hexosaminidase O 0 1.8608339757975045e-08
A O 0 1.0858916196787582e-11
and O 0 2.0848262352601843e-12
is O 0 2.52613414127717e-13
associated O 0 4.495391418054412e-13
with O 0 1.6525591658989036e-11
subacute O 0 0.002035475568845868
G B-Disease 0 4.455482849152759e-05
( I-Disease 0 1.1215989074997434e-12
M2 I-Disease 0 3.757923650482553e-06
) I-Disease 0 1.1390055565385637e-11
gangliosidosis I-Disease 0 4.09924069799672e-07
. O 0 3.728172284778175e-11

Mutations O 0 0.00011039758828701451
in O 0 2.8302075960606743e-11
the O 0 5.166876041601265e-13
HEXA O 0 9.208774827129673e-06
gene O 0 1.5506261830111612e-09
, O 0 2.751131884221156e-15
encoding O 0 6.605213744665869e-15
the O 0 2.502030929378454e-15
alpha O 0 2.960612915307685e-14
- O 0 2.0831687069788885e-12
subunit O 0 1.3962935625430606e-13
of O 0 6.776574608532634e-14
beta O 0 1.8953337163618578e-11
- O 0 8.465934620005555e-09
hexosaminidase O 0 1.1136864941363456e-07
A O 0 5.881983268507529e-12
( O 0 2.0997080671245538e-15
Hex O 0 1.261440951694226e-10
A O 0 5.504791501104167e-13
) O 0 2.155717485487034e-15
, O 0 1.6564871454547656e-16
that O 0 3.204371432181729e-16
abolish O 0 6.659877510584167e-11
Hex O 0 3.64297498833821e-08
A O 0 1.3236761513268913e-11
enzyme O 0 3.7513353845497477e-07
activity O 0 6.21171807324572e-07
cause O 0 2.5122715669567697e-05
Tay B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
Sachs I-Disease 1 1.0
disease I-Disease 1 0.6939248442649841
( O 0 7.417841839905959e-13
TSD B-Disease 0 4.868343950192866e-08
) O 0 1.0715806361824218e-13
, O 0 5.882782308567992e-15
the O 0 1.6291853391532662e-13
fatal O 0 0.0004304577596485615
infantile B-Disease 0 0.008061984553933144
form I-Disease 0 2.4319664504446337e-08
of I-Disease 0 9.347915497226467e-11
G I-Disease 0 0.00013498388580046594
( I-Disease 0 6.458034519478406e-13
M2 I-Disease 0 6.52916924082092e-06
) I-Disease 0 9.871383224724362e-12
gangliosidosis I-Disease 0 3.583795091799402e-07
, I-Disease 0 1.0792237329498855e-12
Type I-Disease 0 2.557233091948774e-09
1 I-Disease 0 1.2233979107545423e-10
. O 0 2.940251514482739e-11

Less O 0 2.326298300658891e-07
severe O 0 6.982341437833384e-05
, O 0 4.763666457824334e-12
subacute O 0 8.26875984785147e-05
( O 0 4.6417234639273275e-11
juvenile O 0 0.007424123119562864
- O 1 0.6604886651039124
onset O 0 0.06981520354747772
) O 0 1.4708669837659727e-09
and O 0 9.087005814478744e-09
chronic O 0 0.000640538171865046
( O 0 2.0792892960804638e-13
adult O 0 3.2356334145333676e-07
- O 0 0.0021328215952962637
onset O 0 4.721622190118069e-06
) O 0 4.719547777760902e-13
variants O 0 1.1709827552053298e-10
are O 0 3.4240907093203987e-13
characterized O 0 3.8158712301061826e-14
by O 0 1.788631696764725e-16
a O 0 5.0168633217986466e-14
broad O 0 7.541420959933376e-11
spectrum O 0 4.8725169732311e-11
of O 0 5.6351325515568984e-12
clinical O 0 5.533977187610617e-08
manifestations O 0 1.8424259895510886e-09
and O 0 3.0356962603395043e-12
are O 0 1.1747883481988408e-13
associated O 0 3.4977839309842385e-13
with O 0 2.5205922418725102e-11
residual O 0 0.00023725852952338755
levels O 0 1.5694686794631707e-07
of O 0 9.996467629364014e-13
Hex O 0 1.546347812109161e-05
A O 0 8.299963494273754e-11
enzyme O 0 5.343190778717144e-08
activity O 0 1.0047526366463444e-08
. O 0 1.8491696021638582e-11

We O 0 7.678235824926105e-10
identified O 0 9.873478423738646e-11
a O 0 1.468650071348443e-12
1422 O 0 2.2322177528621978e-07
G O 0 0.00019477432942949235
- O 0 4.6768882384640165e-06
- O 0 4.850881396123441e-06
> O 0 7.055981132708666e-09
C O 0 1.3635428786074044e-07
( O 0 9.694481816705652e-15
amino O 0 2.708461981169169e-13
acid O 0 3.025624997939069e-13
W474C O 0 1.1839617827802407e-13
) O 0 2.970778803570306e-17
substitution O 0 1.7219353960556353e-16
in O 0 4.109271023414483e-16
the O 0 5.417261471086501e-15
first O 0 4.56087223543733e-10
position O 0 3.512302948482926e-10
of O 0 1.7871662503566362e-15
exon O 0 3.87378268351668e-10
13 O 0 6.9501032533281215e-12
of O 0 1.3811158502117539e-14
HEXA O 0 1.2401108506310266e-05
of O 0 3.975273886111519e-13
a O 0 3.8934251656019825e-11
non O 0 7.769387480038858e-07
- O 0 2.5146425741695566e-07
Jewish O 0 4.331776715105207e-09
proband O 0 0.00022111365979071707
who O 0 5.943945780018112e-08
manifested O 0 8.273383089729691e-10
a O 0 4.4859013964386463e-13
subacute O 0 3.1415543162438553e-06
variant O 0 3.196979605490924e-07
of O 0 2.310785417181105e-11
G B-Disease 0 2.9651582735823467e-05
( I-Disease 0 1.4554321289828032e-12
M2 I-Disease 0 6.042149834684096e-06
) I-Disease 0 1.77177439386611e-11
gangliosidosis I-Disease 0 4.035267011204269e-06
. O 0 9.598879330274812e-11

On O 0 1.2505201318901982e-09
the O 0 3.8138524456610146e-12
second O 0 1.646668579269317e-08
maternally O 0 0.00016127937124110758
inherited O 0 4.002309651696123e-05
allele O 0 2.977033091156045e-07
, O 0 6.689690468242304e-12
we O 0 4.085521417701576e-12
identified O 0 4.154597152417061e-11
the O 0 1.1805331885661463e-11
common O 0 3.808484905221121e-07
infantile O 1 0.7392470836639404
disease O 1 0.9904376864433289
- O 0 1.905960175463406e-06
causing O 0 2.805982148856856e-07
4 O 0 8.579998378444031e-10
- O 0 6.103231697807132e-08
bp O 0 2.2248849873562904e-08
insertion O 0 1.1352503381800716e-09
, O 0 3.21039744267948e-12
+ O 0 4.086739280317886e-11
TATC O 0 1.220404755031268e-07
1278 O 0 5.696881189010128e-09
, O 0 3.197866166207257e-14
in O 0 1.1044990936049672e-15
exon O 0 1.4757285393685038e-09
11 O 0 3.772106238475459e-10
. O 0 3.724609596439388e-12

Pulse O 0 8.571942800017496e-08
- O 0 4.858925706230366e-09
chase O 0 1.636201618637756e-09
analysis O 0 5.554922841155552e-13
using O 0 8.033766794174335e-13
proband O 0 5.195475605290767e-09
fibroblasts O 0 2.692760459055421e-10
revealed O 0 2.5818851501213658e-09
that O 0 2.93941168063791e-14
the O 0 5.918188285763222e-15
W474C O 0 1.3882116810248757e-11
- O 0 3.99483831431402e-13
containing O 0 2.0551746068853127e-13
alpha O 0 1.9921057872415195e-14
- O 0 3.741839195263441e-13
subunit O 0 3.777130653604202e-14
precursor O 0 8.533866321935868e-12
was O 0 1.1291814705494119e-10
normally O 0 3.8781664376185895e-14
synthesized O 0 2.762028886854617e-13
, O 0 3.0719676358503508e-15
but O 0 4.440676105099076e-15
not O 0 3.968678430186405e-15
phosphorylated O 0 3.4876331423544515e-12
or O 0 5.544295491460849e-13
secreted O 0 1.1081609241347934e-10
, O 0 4.059822953077913e-13
and O 0 1.2886742454393252e-12
the O 0 2.6388562016955996e-13
mature O 0 1.974362451306888e-09
lysosomal O 0 2.759875439295456e-09
alpha O 0 6.826952740103531e-13
- O 0 8.171409382473627e-11
subunit O 0 2.595172340913443e-12
was O 0 1.3958064704056028e-09
not O 0 2.0448530022032507e-12
detected O 0 7.731615347950083e-09
. O 0 3.654046249607079e-12

When O 0 3.6329098063170306e-10
the O 0 3.0353356546969357e-13
W474C O 0 1.8009403690566472e-10
- O 0 5.963522210772343e-12
containing O 0 9.212551511580958e-13
alpha O 0 1.2955621005259627e-13
- O 0 5.0830589737316245e-12
subunit O 0 6.921656715667968e-13
was O 0 1.3265327725164866e-10
transiently O 0 2.0903041519915178e-09
co O 0 8.988665456399758e-08
- O 0 2.598737669501361e-09
expressed O 0 1.9445461408619524e-13
with O 0 5.511748737506547e-16
the O 0 3.035539766343818e-16
beta O 0 4.379284342928211e-14
- O 0 1.953755950426239e-12
subunit O 0 5.1647549355760686e-14
to O 0 8.49194981911508e-14
produce O 0 5.521324283191964e-12
Hex O 0 1.1684091916208672e-08
A O 0 2.5998396144255587e-12
( O 0 3.443617952776515e-15
alphabeta O 0 1.1436626645711101e-10
) O 0 4.8963849129195734e-15
in O 0 2.430200629627158e-15
COS O 0 3.0399951356230304e-05
- O 0 1.4820929372660885e-08
7 O 0 1.8379841051907597e-11
cells O 0 3.408388805567486e-12
, O 0 9.528498087394647e-16
the O 0 1.516897968631829e-16
mature O 0 3.2468144384005526e-13
alpha O 0 7.396976733320642e-16
- O 0 2.429039770972946e-13
subunit O 0 5.163937379375379e-14
was O 0 2.4770336892743217e-09
present O 0 1.019598359734697e-12
, O 0 5.0193807037178864e-14
but O 0 9.974859039609246e-15
its O 0 5.305009700301046e-15
level O 0 2.9220356603104625e-12
was O 0 2.8795772190337576e-12
much O 0 1.2128519082067399e-14
lower O 0 6.671440201493073e-13
than O 0 3.67834687608668e-15
that O 0 3.3616401983171127e-15
from O 0 3.3593585033154464e-15
normal O 0 8.076659051845306e-14
alpha O 0 1.4499472721649434e-14
- O 0 2.8632619279017613e-12
subunit O 0 2.294344727225839e-13
transfections O 0 4.728008651255777e-09
, O 0 6.546836763336695e-16
although O 0 2.4705029469484404e-17
higher O 0 1.0198398445927944e-15
than O 0 3.2134680895792075e-15
in O 0 3.934550625708582e-15
those O 0 1.7822321309729494e-13
cells O 0 4.2728581090001327e-13
transfected O 0 1.1996437176975405e-10
with O 0 3.5609376910919824e-14
an O 0 2.4716849999551795e-14
alpha O 0 7.890154458609078e-13
- O 0 4.3006007643953126e-09
subunit O 0 9.6978300390127e-11
associated O 0 2.3830579731765056e-09
with O 0 4.8256212359376605e-09
infantile O 0 0.00637733144685626
TSD B-Disease 0 0.0006234670290723443
. O 0 4.140975895516874e-10

Furthermore O 0 4.846079093567823e-09
, O 0 3.0707288925166387e-13
the O 0 2.086430190401632e-15
precursor O 0 6.1263823875057355e-12
level O 0 1.478657890574553e-10
of O 0 4.690950624090199e-15
the O 0 1.3232045464211563e-14
W474C O 0 3.639529649879236e-12
alpha O 0 3.9592276600774155e-15
- O 0 1.04318178986533e-13
subunit O 0 1.298874287340929e-14
was O 0 2.6562489187365035e-12
found O 0 1.940204182211691e-13
to O 0 7.206718098532513e-15
accumulate O 0 2.247351055251201e-10
in O 0 6.728963670072946e-16
comparison O 0 2.1030681197713695e-14
to O 0 2.9353873847538575e-15
the O 0 2.7283483920059097e-15
normal O 0 1.8176469173108306e-13
alpha O 0 3.16186387781716e-14
- O 0 3.4941984201897203e-12
subunit O 0 8.513491018928565e-13
precursor O 0 1.0188334897964779e-10
levels O 0 1.9291452879599547e-09
. O 0 4.718397981356981e-12

We O 0 7.98261012846524e-10
conclude O 0 3.339261506196678e-11
that O 0 9.240985797756562e-14
the O 0 4.325713913585702e-14
1422 O 0 3.846309937216574e-08
G O 0 3.911808380507864e-05
- O 0 1.4730597968082293e-06
- O 0 5.119078423376777e-07
> O 0 4.652895013723679e-10
C O 0 1.8855145000884477e-08
mutation O 0 2.8477969982176887e-10
is O 0 1.182350983612579e-12
the O 0 1.2589794590417251e-14
cause O 0 1.165989180207383e-12
of O 0 1.7026049623988793e-12
Hex B-Disease 1 0.6655496954917908
A I-Disease 0 0.0013602620456367731
enzyme I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 7.432882434543764e-13
the O 0 1.7816382050228619e-12
proband O 0 1.5860932762734592e-05
. O 0 5.099103431160934e-11

The O 0 1.7565977969077884e-12
resulting O 0 8.389759373339523e-12
W474C O 0 3.886126698215975e-10
substitution O 0 8.778735550996064e-12
clearly O 0 2.4766719924906866e-11
interferes O 0 9.695310526636192e-12
with O 0 4.692955127559876e-15
alpha O 0 7.441812093042944e-15
- O 0 7.079693276935972e-13
subunit O 0 2.4174283045188052e-14
processing O 0 1.1301597158119847e-10
, O 0 2.549511149478557e-15
but O 0 8.973482925079819e-17
because O 0 9.617708391492858e-17
the O 0 6.043339865409548e-17
base O 0 7.929213383973954e-13
substitution O 0 5.728367270547291e-14
falls O 0 1.869554182576394e-07
at O 0 2.7753341291791855e-11
the O 0 1.452935130064406e-13
first O 0 1.3638602469612238e-09
position O 0 4.0016850944013527e-10
of O 0 7.204134648043387e-15
exon O 0 2.488104389186674e-09
13 O 0 3.929594150076099e-11
, O 0 1.3190311515625633e-15
aberrant O 0 2.4839754819011572e-12
splicing O 0 2.416406408300986e-09
may O 0 5.448876905234101e-08
also O 0 3.589213995458529e-11
contribute O 0 1.3603145302895636e-12
to O 0 4.338757651767278e-12
Hex B-Disease 0 0.01147247850894928
A I-Disease 0 6.113356221248978e-07
deficiency I-Disease 0 5.201204839977436e-05
in O 0 2.9341557988485497e-15
this O 0 6.809974218785703e-15
proband O 0 8.196786893677199e-08
. O 0 1.690114926266792e-13
. O 0 2.7120506361499874e-12

Two O 0 1.3899663364735915e-10
frequent O 0 1.0819465323663735e-08
missense O 0 0.0014719842001795769
mutations O 1 0.9136680364608765
in O 0 5.005364982935134e-06
Pendred B-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
. O 0 1.4387668834103806e-08

Pendred B-Disease 1 0.9999983310699463
syndrome I-Disease 1 1.0
is O 0 0.0008021673420444131
an O 0 0.003988569136708975
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 0.2677976191043854
by O 0 1.9812385065876015e-10
early O 0 4.134114206522099e-08
childhood O 1 0.9772487878799438
deafness B-Disease 1 1.0
and O 0 0.023115387186408043
goiter B-Disease 1 0.9999995231628418
. O 0 1.0004766792803821e-08

A O 0 2.739749538349656e-10
century O 0 6.608349284453752e-12
after O 0 2.5046130534139843e-12
its O 0 1.1281501381406149e-14
recognition O 0 3.053918608882794e-13
as O 0 1.0942267925084792e-11
a O 0 7.240700261590405e-10
syndrome O 1 0.5157004594802856
by O 0 3.852196068642594e-13
Vaughan O 0 8.07450032880297e-06
Pendred O 0 3.5982511690235697e-06
, O 0 5.171638399643907e-13
the O 0 2.20962937075124e-13
disease O 0 4.6947982923484233e-07
gene O 0 8.921859695476542e-09
( O 0 1.8875402543055975e-12
PDS O 0 1.862112242179137e-08
) O 0 6.835366826588377e-14
was O 0 7.873547300252248e-12
mapped O 0 4.189257651887601e-07
to O 0 1.0519528997887662e-10
chromosome O 0 0.00013530490105040371
7q22 O 0 1.052554921443516e-06
- O 0 1.4334206355215429e-07
q31 O 0 1.1086719098329922e-07
. O 0 2.926672446057488e-11

1 O 0 4.7642846112694315e-08
and O 0 2.8409827268482957e-10
, O 0 4.770465164387339e-13
recently O 0 1.3097416484697533e-09
, O 0 2.3255219686648667e-15
found O 0 3.562676480326106e-14
to O 0 1.373680235011753e-15
encode O 0 3.143850414374927e-12
a O 0 5.3967468514881656e-12
putative O 0 4.4057639314587504e-08
sulfate O 0 3.7318491763471684e-07
transporter O 0 4.569010343402624e-06
. O 0 1.3116184527373065e-10

We O 0 1.5852236856517266e-08
performed O 0 7.071319918505736e-11
mutation O 0 1.0941766590000235e-11
analysis O 0 3.6329115713981674e-13
of O 0 4.295406566513175e-15
the O 0 2.604502137776906e-14
PDS B-Disease 0 2.5936238046142535e-08
gene O 0 1.7556492926118494e-09
in O 0 2.5839541010347356e-13
patients O 0 3.906291522887129e-12
from O 0 1.0548164311409078e-13
14 O 0 8.2087441011236e-11
Pendred B-Disease 0 2.0458635674458492e-08
families O 0 5.5634025218718325e-14
originating O 0 8.227639489849503e-13
from O 0 1.6488368830003264e-12
seven O 0 7.382034983294261e-09
countries O 0 9.062642997159642e-11
and O 0 5.906263434059256e-13
identified O 0 8.273310855844151e-12
all O 0 3.5505240240929492e-12
mutations O 0 3.652692814881675e-09
. O 0 1.1632663582394898e-11

The O 0 1.2237379512503033e-11
mutations O 0 3.7748883130461763e-08
include O 0 2.3537652729666014e-11
three O 0 1.3014703030556074e-11
single O 0 2.530804366074335e-08
base O 0 5.6930140601707535e-09
deletions O 0 3.290632477614963e-08
, O 0 4.021966353712214e-12
one O 0 4.551298032028084e-13
splice O 0 5.673397390637547e-05
site O 0 8.166736620296433e-07
mutation O 0 2.5785391699173488e-05
and O 0 2.985765190643974e-09
10 O 0 6.457930024073022e-11
missense O 0 4.844496743316995e-06
mutations O 0 5.4115876082505565e-06
. O 0 2.1423685048205243e-10

One O 0 2.4357578176648076e-09
missense O 0 1.0700151506171096e-05
mutation O 0 1.144261432273197e-06
( O 0 3.6249395412440988e-12
L236P O 0 2.7830482363100373e-10
) O 0 9.473238166135545e-14
was O 0 4.211448897950554e-12
found O 0 3.822285370158607e-12
in O 0 6.571135068098987e-15
a O 0 1.8373022829705488e-13
homozygous O 0 6.154375000733125e-07
state O 0 7.868893037166202e-12
in O 0 2.2989209413079928e-14
two O 0 8.950049360488543e-13
consanguineous O 0 5.478017328641727e-07
families O 0 4.5355823263815154e-11
and O 0 4.299019473741339e-12
in O 0 2.0541614114847956e-15
a O 0 4.2891620702194266e-14
heterozygous O 0 3.6666745195645944e-09
state O 0 2.9502591233736275e-13
in O 0 2.8351723756653594e-15
five O 0 1.9925714724033927e-12
additional O 0 8.041163568339726e-11
non O 0 8.439578778052237e-06
- O 0 8.259251444542315e-06
consanguineous O 0 0.00021435586677398533
families O 0 1.0421264740045899e-08
. O 0 3.9057125589270214e-11

Another O 0 2.381140618012978e-09
missense O 0 6.35505493846722e-05
mutation O 0 3.688618562591728e-06
( O 0 6.826370631957124e-12
T416P O 0 3.15837439535116e-10
) O 0 3.379714314400567e-14
was O 0 3.3976321105536056e-13
found O 0 8.756372363305509e-13
in O 0 2.8802595159312322e-15
a O 0 1.233348818040214e-13
homozygous O 0 3.351975408349972e-07
state O 0 8.789709411705093e-12
in O 0 3.051809225793588e-14
one O 0 1.0677277638426741e-11
family O 0 1.297792290300137e-10
and O 0 4.731333033691776e-11
in O 0 3.915281473191494e-15
a O 0 1.3444863169835564e-13
heterozygous O 0 1.1102141428409595e-08
state O 0 1.347518884670107e-12
in O 0 1.693237496286186e-14
four O 0 8.613061652784637e-12
families O 0 9.13131376067966e-12
. O 0 9.248895052604844e-12

Pendred B-Disease 0 0.0002898829698096961
patients O 0 1.0214212124992628e-06
in O 0 3.813735785507255e-12
three O 0 6.134971974880443e-10
non O 0 2.554003913246561e-06
- O 0 8.699029422132298e-06
consanguineous O 0 0.00012333199265412986
families O 0 5.885266718408388e-10
were O 0 5.76608162258796e-12
shown O 0 1.4879643741097515e-12
to O 0 4.9353708748663735e-15
be O 0 1.4767051784939783e-13
compound O 0 5.164784412322633e-14
heterozygotes O 0 1.5686636017919753e-11
for O 0 2.2642036018988808e-14
L236P O 0 1.0958563917418118e-10
and O 0 1.2277868608953635e-12
T416P O 0 2.4172175372427773e-09
. O 0 7.1150286183596645e-12

In O 0 8.963588898902586e-11
total O 0 5.029901495312572e-11
, O 0 8.929685604234378e-14
one O 0 2.1243475186415173e-13
or O 0 4.256642607836092e-11
both O 0 2.7311015862035992e-12
of O 0 1.3506670486370352e-14
these O 0 1.9224267902399894e-13
mutations O 0 1.7479108160856072e-09
were O 0 2.441122651242189e-11
found O 0 2.1288774909589137e-10
in O 0 3.8907635793727913e-13
nine O 0 5.070756037284241e-10
of O 0 1.4687894184326616e-13
the O 0 2.7263029073881784e-12
14 O 0 2.954480063377396e-11
families O 0 3.474781226642243e-14
analyzed O 0 7.815352254247898e-10
. O 0 6.633749105589004e-11

The O 0 1.3133037138259723e-13
identification O 0 1.8799877019720634e-12
of O 0 1.620472961545716e-14
two O 0 9.478015160907516e-13
frequent O 0 3.9382400118803673e-10
PDS B-Disease 0 7.245275810419116e-06
mutations O 0 7.435842235281598e-07
will O 0 3.201707995947878e-12
facilitate O 0 2.2153095059328914e-13
the O 0 7.74609055283898e-14
molecular O 0 5.49736611787921e-08
diagnosis O 0 0.00034653162583708763
of O 0 2.9857778827135917e-06
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 4.376197626498879e-09

Insertional O 0 3.4052442060783505e-05
mutation O 0 1.112208991571606e-07
by O 0 5.168808089872634e-13
transposable O 0 5.122564772364058e-08
element O 0 3.608588983183836e-09
, O 0 8.072258139701916e-13
L1 O 0 1.081338837138901e-06
, O 0 2.3249831964181067e-13
in O 0 6.711893309207812e-15
the O 0 1.1906791741803091e-12
DMD B-Disease 1 0.9999996423721313
gene O 0 2.259934035464539e-06
results O 0 2.3151376371544075e-09
in O 0 2.4505321383205825e-11
X B-Disease 1 0.9999934434890747
- I-Disease 1 0.9999961853027344
linked I-Disease 1 0.999990701675415
dilated I-Disease 1 0.9999594688415527
cardiomyopathy I-Disease 1 0.9999979734420776
. O 0 2.9819404723241405e-09

X B-Disease 1 0.9999768733978271
- I-Disease 1 0.9999966621398926
linked I-Disease 1 0.9999954700469971
dilated I-Disease 1 0.9999924898147583
cardiomyopathy I-Disease 1 0.9999998807907104
( O 0 8.085434544113923e-09
XLDCM B-Disease 0 0.00013110692088957876
) O 0 9.741831907134069e-13
is O 0 1.2979585939029703e-13
a O 0 3.05689067808812e-13
clinical O 0 1.4205165044245405e-08
phenotype O 0 4.997355418367988e-09
of O 0 1.05326684873841e-12
dystrophinopathy B-Disease 0 0.0014097775565460324
which O 0 5.2042776338412366e-11
is O 0 2.9024664616184026e-12
characterized O 0 2.6220200056298326e-12
by O 0 2.750295108842893e-13
preferential O 0 1.0127267842108267e-06
myocardial B-Disease 0 1.6854271962074563e-05
involvement I-Disease 0 4.863580205238804e-09
without O 0 6.800898386116749e-12
any O 0 2.2361119032809906e-12
overt O 0 8.024582598409324e-08
clinical O 0 9.1996122364435e-07
signs O 0 1.482145989939454e-06
of O 0 1.2577897612331412e-09
skeletal B-Disease 1 0.9999998807907104
myopathy I-Disease 1 1.0
. O 0 2.6628495675140584e-07

To O 0 8.521553254703385e-12
date O 0 5.773435549083494e-11
, O 0 4.923035957571983e-15
several O 0 7.905432082711678e-16
mutations O 0 1.0004800321539165e-09
in O 0 1.747468164094157e-12
the O 0 9.670373835035662e-09
Duchenne B-Disease 1 0.999811589717865
muscular I-Disease 0 0.02503533475100994
dystrophy I-Disease 0 9.88002066151239e-05
gene O 0 7.3021219577640295e-06
, O 0 6.481156722415449e-10
DMD O 1 0.9999998807907104
, O 0 5.4794783294065397e-11
have O 0 2.0214192732875835e-12
been O 0 1.546519162731741e-11
identified O 0 4.0509511300967915e-09
in O 0 6.927181050997433e-12
patients O 0 3.2666097604661104e-10
with O 0 6.217475839731534e-11
XLDCM B-Disease 0 0.07735387235879898
, O 0 2.4120833368862504e-12
but O 0 1.105270931202329e-14
a O 0 1.7995346254524435e-15
pathogenic O 0 1.8066851834031006e-11
correlation O 0 2.7120196279678543e-12
of O 0 3.468299052903495e-14
these O 0 6.013364719364978e-13
cardiospecific O 0 3.1982909831640427e-07
mutations O 0 1.1762413976157404e-07
in O 0 5.187873134554488e-12
DMD O 1 0.9999996423721313
with O 0 1.561271445460477e-09
the O 0 6.129156210343822e-11
XLDCM B-Disease 1 0.7410580515861511
phenotype O 0 2.9804647056153044e-05
has O 0 2.2219165174419686e-08
remained O 0 1.1456734866355234e-10
to O 0 1.1268689838672338e-13
be O 0 7.994642448050371e-11
elucidated O 0 1.391830579677844e-07
. O 0 4.3175272385065355e-11

We O 0 5.936260816241656e-09
report O 0 1.0175704896753235e-11
here O 0 1.0571980209732085e-15
the O 0 2.3546740038254975e-17
identification O 0 6.734620050215592e-14
of O 0 6.49220133829378e-15
a O 0 3.1369379750040283e-12
unique O 0 4.72367769899229e-11
de O 0 1.7734346613451635e-07
novo O 0 3.265404302510433e-08
L1 O 0 3.4322866326874646e-07
insertion O 0 1.794507736851969e-10
in O 0 1.0954054368217045e-13
the O 0 3.02340854988533e-14
muscle O 0 7.77490710701656e-11
exon O 0 3.2726338305977265e-10
1 O 0 1.436787494535352e-11
in O 0 2.4540718849414e-12
DMD O 1 0.9999997615814209
in O 0 2.770790541450907e-11
three O 0 2.9449731542285917e-10
XLDCM B-Disease 0 0.000607203459367156
patients O 0 2.24033083751074e-11
from O 0 1.0731994262589079e-15
two O 0 2.283246257805873e-14
unrelated O 0 9.342625562069884e-10
Japanese O 0 8.732943257427905e-08
families O 0 1.1723519724449183e-11
. O 0 9.570885750598279e-12

The O 0 1.9392655883909704e-12
insertion O 0 5.331071140091126e-10
was O 0 2.5331257091920634e-09
a O 0 7.428233917729232e-13
5 O 0 2.13390936865121e-11
- O 0 2.668787679738216e-08
truncated O 0 1.9049180011165845e-09
form O 0 1.0513451220717229e-10
of O 0 6.846222400840388e-14
human O 0 3.679489438829231e-12
L1 O 0 1.378830116749441e-08
inversely O 0 5.895577082082326e-11
integrated O 0 1.9863097833194843e-09
in O 0 2.1003752665067765e-13
the O 0 2.4105186163109193e-13
5 O 0 1.3645595764444352e-10
- O 0 4.786828640135354e-07
untranslated O 0 1.6979965948848985e-05
region O 0 1.1086302015295146e-10
in O 0 3.967703918780589e-14
the O 0 4.030609328828198e-14
muscle O 0 2.042258029355537e-11
exon O 0 2.8233925614129518e-11
1 O 0 4.780869710535596e-12
, O 0 1.648904638859843e-14
which O 0 2.5768360088405072e-14
affected O 0 4.152025945280968e-13
the O 0 2.36055821597862e-15
transcription O 0 1.3857998082400513e-10
or O 0 8.055441036436406e-11
the O 0 9.863949067268063e-12
stability O 0 3.6869838293540624e-09
of O 0 8.416629616566154e-14
the O 0 5.30684211852428e-11
muscle O 0 4.745040982356841e-08
form O 0 3.1529282223247135e-13
of O 0 8.138168890409019e-15
dystrophin O 0 1.2061689147468968e-10
transcripts O 0 8.504476983750564e-11
but O 0 1.2957331605237266e-12
not O 0 2.5593834031821007e-14
that O 0 2.7190713060027544e-14
of O 0 3.148287972551747e-14
the O 0 4.0973228282448204e-11
brain O 0 1.4926717994967476e-05
or O 0 1.5394698849036104e-08
Purkinje O 0 9.496966413280461e-06
cell O 0 4.759233706863597e-05
form O 0 3.393011240859778e-07
, O 0 1.322078357901546e-08
probably O 0 1.269817062166112e-06
due O 0 6.868654534031293e-10
to O 0 1.3999263987624078e-12
its O 0 5.05916313074499e-14
unique O 0 9.930324588341456e-15
site O 0 7.424498515984368e-12
of O 0 4.0596524622862895e-13
integration O 0 3.254670533081594e-09
. O 0 1.4979146395477372e-11

We O 0 5.4646367292354725e-11
speculate O 0 2.5233038315058964e-12
that O 0 9.17637484451801e-16
this O 0 3.20419858452093e-17
insertion O 0 2.164181648559721e-13
of O 0 2.720715735766554e-14
an O 0 3.142661640902905e-13
L1 O 0 1.2294339285290334e-05
sequence O 0 1.1398463506395728e-08
in O 0 7.362748605244107e-11
DMD O 1 0.9999998807907104
is O 0 6.65522983944733e-11
responsible O 0 5.733882119107747e-12
for O 0 1.1070643540615505e-14
some O 0 5.497867985083417e-16
of O 0 5.720194546100766e-16
the O 0 1.8070199403106245e-14
population O 0 7.329373551492619e-15
of O 0 8.49774623497973e-15
Japanese O 0 5.3246541398266345e-08
patients O 0 8.179462424214023e-13
with O 0 4.335708902363303e-14
XLDCM B-Disease 0 4.497701695527212e-07
. O 0 1.0119276971269978e-13
. O 0 3.3912241504535645e-12

Severe O 0 0.0013518569758161902
early O 0 4.516562412959502e-08
- O 1 0.9912354946136475
onset O 1 0.999920129776001
obesity B-Disease 1 1.0
, O 0 1.0637497325660661e-05
adrenal B-Disease 1 0.9999997615814209
insufficiency I-Disease 1 0.9999998807907104
and O 0 1.328306922232514e-07
red O 0 1.6218125438172137e-06
hair O 1 0.9997472167015076
pigmentation O 0 0.0007472606375813484
caused O 0 2.3921249425740143e-09
by O 0 4.950886163708479e-13
POMC O 0 4.9861766456160694e-05
mutations O 0 3.8761376686125004e-07
in O 0 3.349017027240442e-13
humans O 0 2.875968629911796e-10
. O 0 5.262652466586637e-11

Sequential O 0 4.357024963042022e-09
cleavage O 0 3.2562547858105972e-06
of O 0 1.0071605008321605e-12
the O 0 1.7648978388766154e-14
precursor O 0 7.366720081170008e-12
protein O 0 5.406127212559397e-10
pre O 0 1.4114816622168291e-06
- O 0 6.483720790129155e-05
pro O 0 2.0127492916799383e-06
- O 0 6.299639153439784e-06
opiomelanocortin O 0 1.9134893136651954e-06
( O 0 8.339176923869221e-14
POMC O 0 1.1571973379531642e-09
) O 0 3.710748427417998e-15
generates O 0 2.013249186501656e-13
the O 0 9.920392280001952e-14
melanocortin O 0 4.349264486336324e-07
peptides O 0 3.8387394596384183e-08
adrenocorticotrophin O 0 5.642370410896547e-07
( O 0 1.637085649333625e-12
ACTH O 0 3.696308681355731e-08
) O 0 1.1164672159870437e-13
, O 0 5.237349724913909e-14
melanocyte O 0 2.619908855194808e-06
- O 0 8.426592103205621e-05
stimulating O 0 0.0007720727007836103
hormones O 0 6.964944623177871e-05
( O 0 9.267267536043969e-14
MSH O 0 3.0860243249719588e-09
) O 0 2.2903766658591545e-15
alpha O 0 1.0274466239756116e-15
, O 0 3.68028006997011e-17
beta O 0 2.8471146402491386e-16
and O 0 3.9525106358661297e-16
gamma O 0 3.4961795235271967e-15
as O 0 2.58296368235017e-13
well O 0 1.2161930804891613e-13
as O 0 1.181757464238306e-13
the O 0 5.949882649286878e-14
opioid O 0 3.1550009133018975e-11
- O 0 4.422545316074e-11
receptor O 0 1.7157861936789587e-11
ligand O 0 9.958981556090762e-12
beta O 0 6.370919763964977e-11
- O 0 8.166512799334669e-08
endorphin O 0 1.0444374311191496e-05
. O 0 1.6927112489462104e-10

While O 0 1.1220022827496123e-10
a O 0 1.0956791978702571e-13
few O 0 3.7257140596399715e-14
cases O 0 3.209026360612155e-12
of O 0 3.1502449954201595e-11
isolated O 0 0.03112759254872799
ACTH B-Disease 1 0.9998233914375305
deficiency I-Disease 1 0.9945735335350037
have O 0 5.383720812907056e-12
been O 0 3.724405506222439e-11
reported O 0 5.303940620038361e-10
( O 0 1.0266979324005665e-12
OMIM O 0 4.995937160856556e-06
201400 O 0 3.231580691931413e-08
) O 0 3.0347683459101826e-13
, O 0 9.63413156624673e-15
an O 0 3.8502932938298817e-13
inherited O 0 0.042244069278240204
POMC O 1 0.999171257019043
defect O 1 0.9933777451515198
has O 0 2.449638714097091e-08
not O 0 3.2530894211041383e-12
been O 0 5.361330303321754e-12
described O 0 1.1485253937140727e-12
so O 0 3.338334383234942e-13
far O 0 3.1154009493689072e-12
. O 0 7.24214264946621e-12

Recent O 0 7.465715268217821e-10
studies O 0 1.352685238126261e-11
in O 0 5.855088142841039e-15
animal O 0 2.2113083933406052e-12
models O 0 6.575301969569125e-10
elucidated O 0 1.1678827904759714e-09
a O 0 6.34118625664204e-13
central O 0 2.867928063001596e-13
role O 0 2.2626012174953303e-11
of O 0 3.7078473395736524e-15
alpha O 0 6.095980924908373e-13
- O 0 2.3752120270614796e-09
MSH O 0 4.479995823203353e-07
in O 0 1.2420023776799072e-14
the O 0 1.8388113314583886e-15
regulation O 0 1.187467767345407e-12
of O 0 3.782779526917353e-16
food O 0 1.0150476921662321e-13
intake O 0 3.214093199894281e-15
by O 0 2.112278816920306e-17
activation O 0 5.897300199174046e-14
of O 0 1.2614310265009632e-14
the O 0 7.342760947881555e-12
brain O 0 8.409864449276938e-07
melanocortin O 0 3.048090206902998e-07
- O 0 1.6787524259598285e-08
4 O 0 4.5413151017470454e-10
- O 0 2.9671454626623017e-08
receptor O 0 3.107890333975405e-10
( O 0 3.746524032850751e-13
MC4 O 0 1.1712411662756494e-07
- O 0 4.764248373589908e-08
R O 0 2.63954063939309e-07
; O 0 9.702773930446093e-14
refs O 0 4.340204196040531e-09
3 O 0 5.020946765993406e-12
- O 0 1.6488449494644897e-10
5 O 0 1.9155675851957599e-13
) O 0 9.246578258675426e-17
and O 0 4.2491828006763153e-17
the O 0 1.7172706267964283e-17
linkage O 0 2.1581667009051841e-10
of O 0 6.693031003555949e-13
human O 0 1.2739822352614283e-07
obesity B-Disease 1 1.0
to O 0 1.4029422588934803e-11
chromosome O 0 3.258814558648737e-06
2 O 0 1.6425912713335933e-11
in O 0 4.210237403666755e-15
close O 0 1.6590138551125788e-12
proximity O 0 9.685694087047114e-13
to O 0 2.8316517425124033e-13
the O 0 1.9499389624678953e-13
POMC O 0 5.5610641425118956e-08
locus O 0 1.7465245916170602e-09
, O 0 3.6280987979545043e-13
led O 0 4.1276587725048997e-13
to O 0 1.3397830987812911e-14
the O 0 1.3379758184630525e-13
proposal O 0 1.849176541057762e-11
of O 0 1.2458269855466445e-14
an O 0 1.971571126843652e-12
association O 0 6.825706666546694e-12
of O 0 7.646156250469202e-14
POMC O 0 1.1523341527208686e-05
with O 0 1.1012119688347255e-10
human O 0 1.1980988574578078e-06
obesity B-Disease 1 0.9999996423721313
. O 0 5.476819442407077e-09

The O 0 1.2781977733189454e-11
dual O 0 7.162139326055694e-08
role O 0 1.149002559763801e-09
of O 0 2.1742344727469602e-14
alpha O 0 4.997929153871539e-12
- O 0 5.540437886253358e-09
MSH O 0 1.5427083326358115e-06
in O 0 9.571605796366081e-14
regulating O 0 4.691069754869659e-10
food O 0 4.957455453091786e-12
intake O 0 8.618381616004589e-13
and O 0 1.07011770863856e-14
influencing O 0 6.46724895858597e-11
hair O 0 2.4558508812333457e-05
pigmentation O 0 1.3509107610332194e-08
predicts O 0 5.406831427023917e-09
that O 0 6.73754021324191e-13
the O 0 2.6332351555323485e-13
phenotype O 0 1.0659062077422732e-08
associated O 0 2.2117144921063314e-11
with O 0 2.4505449752743047e-12
a O 0 1.354431150568658e-10
defect O 0 1.0390419447503518e-05
in O 0 7.388330940973076e-13
POMC O 0 9.271002454624977e-06
function O 0 4.37341052261786e-09
would O 0 1.1128763466317082e-09
include O 0 8.586539479438215e-08
obesity B-Disease 1 1.0
, O 0 3.940521867140667e-11
alteration O 0 2.235672980077652e-08
in O 0 7.655989037180788e-11
pigmentation O 0 0.047769587486982346
and O 0 2.5347582777612843e-05
ACTH B-Disease 1 0.9973459243774414
deficiency I-Disease 1 0.7252935171127319
. O 0 8.406967483276517e-11

The O 0 5.940453857988803e-12
observation O 0 9.301623915547452e-10
of O 0 4.536079357183448e-13
these O 0 4.31347735307952e-11
symptoms O 0 1.290004991716387e-08
in O 0 6.293822198640323e-16
two O 0 3.156868416307433e-14
probands O 0 9.255050059664427e-09
prompted O 0 2.0432778732870638e-12
us O 0 3.2960090819850185e-12
to O 0 2.0590637734857074e-16
search O 0 5.062235353125999e-13
for O 0 6.523338726832639e-13
mutations O 0 9.674963052930252e-10
within O 0 2.0731036516358908e-13
their O 0 4.990203996552145e-12
POMC O 0 1.1557286825336632e-06
genes O 0 3.346910082413501e-09
. O 0 1.5835017325160905e-11

Patient O 0 0.0001006912425509654
1 O 0 5.536684444251705e-10
was O 0 3.8082881292922366e-10
found O 0 2.3029621612491447e-11
to O 0 2.1563324314067406e-13
be O 0 1.169262928667203e-12
a O 0 1.3990574479906103e-14
compound O 0 6.088389476821901e-14
heterozygote O 0 1.2126363281572683e-11
for O 0 8.021601910273776e-15
two O 0 2.381939860195831e-13
mutations O 0 3.194897402192254e-10
in O 0 2.285424826546211e-14
exon O 0 2.754857897357965e-09
3 O 0 1.9694532116254493e-10
( O 0 1.5503954186018437e-13
G7013T O 0 5.744086803427528e-11
, O 0 1.7617096068631502e-14
C7133delta O 0 2.6505428407652687e-10
) O 0 7.08992919576509e-15
which O 0 7.830372363969856e-15
interfere O 0 1.6601248370787247e-12
with O 0 2.7486786650476706e-14
appropriate O 0 3.481010306936351e-14
synthesis O 0 3.9836382348217014e-13
of O 0 1.2930612526898533e-13
ACTH O 0 2.9345363827815163e-07
and O 0 1.773105533925401e-12
alpha O 0 1.7905126166450902e-12
- O 0 9.419357382967064e-08
MSH O 0 5.5733133194735274e-05
. O 0 3.0811870416203035e-11

Patient O 0 6.491701060440391e-05
2 O 0 6.993406964639348e-10
was O 0 1.1484695833230418e-10
homozygous O 0 2.4232107875832298e-08
for O 0 2.020427553560411e-13
a O 0 1.0725954629683954e-12
mutation O 0 1.9373238568931583e-09
in O 0 3.565112072743959e-13
exon O 0 5.5704383328247786e-08
2 O 0 5.387989499006096e-10
( O 0 3.4836955369044187e-13
C3804A O 0 1.7210081970642221e-10
) O 0 5.2129331531763565e-14
which O 0 1.1673459779110856e-13
abolishes O 0 3.242243096224229e-08
POMC O 0 1.0787159226310905e-05
translation O 0 8.257337924533203e-09
. O 0 2.3233910628750465e-10

These O 0 3.0899660000832663e-12
findings O 0 3.50075766986091e-11
represent O 0 3.685240047152094e-13
the O 0 3.950871341239573e-14
first O 0 6.360498933100089e-12
examples O 0 2.1044103959422245e-12
of O 0 1.2619853079209875e-13
a O 0 3.904613965488579e-09
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
within O 0 1.483543648171659e-12
the O 0 9.362782359308153e-14
POMC O 0 4.870805270229539e-08
gene O 0 1.3379274355074244e-09
and O 0 2.642059205963665e-13
define O 0 1.024415708511528e-11
a O 0 3.2027908103415825e-11
new O 0 3.572575337784656e-07
monogenic B-Disease 1 0.999478280544281
endocrine I-Disease 1 0.999749481678009
disorder I-Disease 0 0.00041155118378810585
resulting O 0 2.472767433522871e-12
in O 0 1.83201490002588e-13
early O 0 1.0131546268610236e-08
- O 1 0.9999635219573975
onset O 1 0.999988317489624
obesity B-Disease 1 1.0
, O 0 1.4670365089841653e-05
adrenal B-Disease 1 0.9999998807907104
insufficiency I-Disease 1 0.9999998807907104
and O 0 5.005177605710287e-09
red O 0 2.256071596207221e-08
hair O 0 0.06794856488704681
pigmentation O 0 7.751174280201667e-07
. O 0 1.1546270667003866e-12
. O 0 1.227138789888782e-11

A O 0 2.332429573925765e-07
European O 0 1.3257921693821118e-07
multicenter O 0 0.00010662409476935863
study O 0 3.6344326872495003e-06
of O 0 9.566554217599332e-05
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 8.487720942751409e-11
classification O 0 4.794774022265358e-10
of O 0 1.5421720500554022e-14
105 O 0 2.1495959526274255e-11
mutations O 0 2.1717294629297612e-08
and O 0 1.1023167621748708e-11
a O 0 3.488988611910493e-13
general O 0 7.208856450148515e-13
system O 0 4.955562327678409e-13
for O 0 3.298288698367832e-14
genotype O 0 6.889801923426475e-11
- O 0 1.1899221885602884e-10
based O 0 1.5393787590120556e-12
prediction O 0 7.122775702583795e-10
of O 0 1.1015049549562006e-12
metabolic O 0 0.000153596221935004
phenotype O 0 3.9442575427983684e-08
. O 0 4.128639097267239e-11

Phenylketonuria B-Disease 0 0.011905549094080925
( O 0 1.5764937133511125e-09
PKU B-Disease 0 1.8481657662050566e-06
) O 0 7.751423114488176e-11
and O 0 2.069587834441222e-09
mild B-Disease 0 0.0001405932125635445
hyperphenylalaninemia I-Disease 1 1.0
( O 0 4.962754474036046e-07
MHP B-Disease 1 0.9999998807907104
) O 0 4.1475051171246946e-10
are O 0 1.2140394245463426e-10
allelic B-Disease 0 0.00016566335398238152
disorders I-Disease 1 0.9965638518333435
caused O 0 1.3231314655026694e-10
by O 0 4.375418823370121e-14
mutations O 0 4.194734160023472e-08
in O 0 3.422693443770608e-13
the O 0 7.247669912141541e-12
gene O 0 2.1181493139010854e-05
encoding O 0 6.564536306541413e-05
phenylalanine O 1 0.9998071789741516
hydroxylase O 1 0.9996718168258667
( O 0 1.0417786633354353e-08
PAH O 0 7.498768536606804e-05
) O 0 2.273441677969057e-11
. O 0 1.2168694003833469e-11

Previous O 0 5.160051497199447e-09
studies O 0 1.5136250586245126e-10
have O 0 1.794813971923992e-12
suggested O 0 8.161992674608765e-13
that O 0 9.95691549365461e-15
the O 0 4.232461684730224e-14
highly O 0 3.3035540969450494e-09
variable O 0 1.2703876564046368e-06
metabolic O 1 0.5839739441871643
phenotypes O 0 9.429854981135577e-05
of O 0 2.8865779100328837e-08
PAH B-Disease 1 0.9998517036437988
deficiency I-Disease 1 0.9984943866729736
correlate O 0 3.9777000893082004e-07
with O 0 9.17966413993554e-09
PAH O 0 0.0030042100697755814
genotypes O 0 1.545002123748418e-05
. O 0 3.2714356223984e-10

We O 0 8.408255203207204e-10
identified O 0 1.6718869344511944e-10
both O 0 7.406701120482584e-13
causative O 0 5.60024136575521e-06
mutations O 0 3.4603812082423246e-07
in O 0 6.832332551283404e-13
686 O 0 8.846761545555637e-08
patients O 0 4.7649093559698485e-09
from O 0 3.2193624936033283e-12
seven O 0 3.916355950650541e-08
European O 0 2.490532722276839e-07
centers O 0 3.2006932659811582e-09
. O 0 2.083312862499742e-11

On O 0 2.100907364743776e-10
the O 0 7.304113334939601e-15
basis O 0 3.12451446822775e-14
of O 0 2.974624597848637e-16
the O 0 2.00264613818221e-15
phenotypic O 0 4.054002133990764e-10
characteristics O 0 2.5981999537960654e-11
of O 0 2.2673237324633867e-14
297 O 0 1.4289834870950813e-09
functionally O 0 1.393067705635076e-08
hemizygous O 0 2.8472893518483033e-06
patients O 0 8.679298946212555e-10
, O 0 2.188846638120044e-15
105 O 0 4.327909084171806e-14
of O 0 3.1284486398062148e-15
the O 0 4.622070955140334e-13
mutations O 0 7.152446812597191e-08
were O 0 3.466903708559954e-10
assigned O 0 6.45753950312411e-10
to O 0 1.7577631787179387e-13
one O 0 1.1592258186352011e-12
of O 0 1.1280942339660961e-14
four O 0 1.0793719433868643e-12
arbitrary O 0 2.633077089697622e-11
phenotype O 0 5.36165600806271e-09
categories O 0 2.547790245444048e-07
. O 0 1.5372676742675395e-10

We O 0 2.629511275387131e-09
proposed O 0 3.9287548908584213e-11
and O 0 9.547656935893212e-12
tested O 0 9.270986645049106e-09
a O 0 1.889785138949442e-15
simple O 0 7.161965112764332e-15
model O 0 9.67314423006016e-12
for O 0 2.344217468118427e-15
correlation O 0 2.252456554607818e-11
between O 0 4.2803136252392293e-13
genotype O 0 3.3622388206921983e-10
and O 0 1.6016473087035465e-12
phenotypic O 0 4.317597390723904e-09
outcome O 0 1.1605637562084326e-09
. O 0 1.7447988887031585e-10

The O 0 4.738085358085842e-12
observed O 0 3.6202634640103426e-11
phenotype O 0 1.1262524246546946e-09
matched O 0 6.060467683255411e-10
the O 0 5.10873570010173e-13
predicted O 0 5.4511715141813966e-09
phenotype O 0 4.9779981026176756e-08
in O 0 4.1603838429882245e-12
79 O 0 5.166068461903706e-09
% O 0 5.1163974858041417e-14
of O 0 2.1204023525753972e-15
the O 0 2.9933656464989356e-13
cases O 0 2.1089471502477863e-08
, O 0 8.000897860904743e-11
and O 0 6.79133554948308e-11
in O 0 4.481417542829061e-14
only O 0 6.346716229822802e-13
5 O 0 1.7030230307565897e-13
of O 0 1.5173616927006712e-15
184 O 0 2.591073536284405e-11
patients O 0 1.0920667148361929e-11
was O 0 1.3135512122453008e-10
the O 0 1.9759144136415746e-13
observed O 0 2.744116323061263e-10
phenotype O 0 1.4022200067742574e-11
more O 0 1.2736637492702678e-15
than O 0 2.3316433487197315e-14
one O 0 1.3387165724923489e-12
category O 0 2.5804564041109757e-10
away O 0 3.1319176418964645e-11
from O 0 8.952605638160721e-14
that O 0 8.676206996773017e-13
expected O 0 2.3599868587131922e-11
. O 0 1.2916130838480644e-11

Among O 0 1.3825472711115339e-10
the O 0 1.0419846273789987e-13
seven O 0 3.176150098135877e-12
contributing O 0 8.653904676192425e-11
centers O 0 8.598485638777742e-12
, O 0 3.7518549363482496e-15
the O 0 1.1725263213022098e-15
proportion O 0 9.209393664333376e-12
of O 0 1.3423716314681002e-14
patients O 0 9.79446558579955e-13
for O 0 1.3321487061243933e-14
whom O 0 9.208163745388909e-12
the O 0 1.5703436882547224e-14
observed O 0 1.244433028846359e-10
phenotype O 0 1.8685893110603757e-10
did O 0 1.026834034467683e-10
not O 0 1.743640301588023e-11
match O 0 8.384904437441776e-10
the O 0 2.0723774259157057e-12
predicted O 0 1.8585568639650774e-08
phenotype O 0 4.9555537451340115e-09
was O 0 4.5780090829339315e-09
4 O 0 1.1912028308191935e-10
% O 0 2.8365075045722055e-12
- O 0 9.302497687713185e-07
23 O 0 1.360999934973961e-08
% O 0 4.605491335518686e-13
( O 0 1.9552758121366837e-13
P O 0 6.004577812745993e-07
< O 0 1.8640994997598526e-11
. O 0 7.294336457145919e-16
0001 O 0 1.7779075737675565e-12
) O 0 3.5482554267617463e-16
, O 0 1.652629936083982e-17
suggesting O 0 5.042573821066425e-14
that O 0 1.899981806271784e-14
differences O 0 3.9009735112310873e-13
in O 0 7.300763584331007e-17
methods O 0 2.103019838893376e-14
used O 0 7.414895249451686e-14
for O 0 1.2451142920248248e-14
mutation O 0 2.909286700436553e-10
detection O 0 1.446578856700853e-08
or O 0 2.77033080919864e-07
phenotype O 0 3.6231854210200254e-06
classification O 0 2.417321866232669e-06
may O 0 2.3121544678872397e-09
account O 0 1.5000237380338732e-12
for O 0 1.1562750540025646e-13
a O 0 1.2317971892061158e-13
considerable O 0 9.571464714558386e-13
proportion O 0 4.2491898888386004e-10
of O 0 2.7518515244295827e-11
genotype O 0 2.9390750569291413e-05
- O 0 0.00014434447803068906
phenotype O 0 1.7110031649281154e-06
inconsistencies O 0 8.813361205284309e-07
. O 0 1.1197148069852503e-10

Our O 0 1.571026919666707e-10
data O 0 1.43934461571682e-10
indicate O 0 2.472292336130888e-11
that O 0 6.166708311529379e-13
the O 0 2.0755669752348105e-11
PAH O 0 0.049289461225271225
- O 0 3.2440918857901124e-06
mutation O 0 1.9283557151084096e-07
genotype O 0 1.4660334279881226e-08
is O 0 1.8250091108479305e-12
the O 0 2.538312526882908e-15
main O 0 5.215869511472626e-13
determinant O 0 2.2844773184260703e-08
of O 0 1.1609649873400851e-12
metabolic O 0 1.6577238056925125e-05
phenotype O 0 5.4154698503339205e-09
in O 0 1.5106866495598337e-13
most O 0 4.455642452216857e-11
patients O 0 1.3315253788448445e-08
with O 0 1.1896129592514626e-07
PAH B-Disease 1 0.9996358156204224
deficiency I-Disease 1 0.9974989295005798
. O 0 1.2983865371740677e-10

In O 0 6.253405432365966e-11
the O 0 6.351063880534469e-13
present O 0 7.127085922299659e-13
study O 0 3.892381751115226e-13
, O 0 1.4160675636373712e-14
the O 0 1.804380712701922e-15
classification O 0 6.659801182751224e-11
of O 0 1.217132812722163e-13
105 O 0 1.113475200931191e-09
PAH O 0 1.2870308410128928e-06
mutations O 0 8.064768053372973e-08
may O 0 1.2872697699450875e-11
allow O 0 2.237978445412351e-14
the O 0 7.239507590953674e-15
prediction O 0 2.4872666426478673e-11
of O 0 1.0809119577051898e-14
the O 0 9.791832058722583e-13
biochemical O 0 6.866787316539558e-08
phenotype O 0 1.8025142489719315e-10
in O 0 4.764476895560135e-15
> O 0 7.583590331226853e-13
10 O 0 6.7894409712387915e-12
, O 0 5.084682878193046e-14
000 O 0 7.930968165190122e-13
genotypes O 0 4.9843515981251585e-09
, O 0 3.3232416384726404e-12
which O 0 3.093376249596602e-11
may O 0 7.581779093435159e-10
be O 0 3.7139239708779137e-13
useful O 0 2.9585820013507125e-13
for O 0 2.3233951112859585e-14
the O 0 1.9979936487831557e-13
management O 0 7.776241456314281e-11
of O 0 4.5256742689341045e-13
hyperphenylalaninemia B-Disease 1 0.9999998807907104
in O 0 5.7697367716880166e-11
newborns O 0 9.8342650289851e-07
. O 0 1.7647245427118707e-12

Somatic O 0 5.8687059208750725e-05
instability O 0 2.2638555492449086e-06
of O 0 2.476159468439709e-13
the O 0 2.7628824250149064e-13
CTG O 0 4.682461280935968e-07
repeat O 0 1.7650639838606708e-09
in O 0 6.023621017806806e-15
mice O 0 1.4536019089794738e-11
transgenic O 0 3.0136385054113646e-10
for O 0 4.724393619370826e-13
the O 0 1.0596945543284164e-09
myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 0.9999998807907104
region O 0 4.707010248239385e-08
is O 0 7.072172847344405e-10
age O 0 1.4683050331143477e-09
dependent O 0 3.536826942429627e-10
but O 0 7.921378939075574e-14
not O 0 1.4999335662944403e-14
correlated O 0 2.4180809264640057e-12
to O 0 4.504177995748142e-14
the O 0 2.414761370462398e-13
relative O 0 1.680800464087806e-11
intertissue O 0 4.0169422277358535e-07
transcription O 0 7.766868748149136e-07
levels O 0 1.3530039666420635e-07
and O 0 1.1378256115079921e-09
proliferative O 0 8.647647337056696e-05
capacities O 0 1.5512607376422238e-07
. O 0 1.261351266490518e-11

A O 0 4.3562358165161186e-09
( O 0 4.07386494330475e-12
CTG O 0 4.113145379847083e-08
) O 0 1.8591202795986694e-12
nexpansion O 0 1.0738462563608664e-08
in O 0 9.98956370098017e-14
the O 0 2.418070626543367e-13
3 O 0 2.696148637681972e-09
- O 0 3.2993371860357e-05
untranslated O 0 0.0010096171172335744
region O 0 6.631917792709885e-10
( O 0 8.505809988637592e-14
UTR O 0 1.4013537726065284e-11
) O 0 1.3682360366223945e-15
of O 0 8.566155368657066e-16
the O 0 8.383233343622898e-12
DM O 1 1.0
protein O 0 2.345523313351805e-07
kinase O 0 2.55071967103504e-07
gene O 0 3.369393652974395e-08
( O 0 1.4621349920737603e-12
DMPK O 0 2.070808768905863e-08
) O 0 3.952256155405039e-15
is O 0 3.641461132332597e-15
responsible O 0 3.189129862968265e-11
for O 0 1.0193101918076763e-09
causing O 0 0.010926526039838791
myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 0.9999996423721313
( O 0 6.478227305706241e-07
DM B-Disease 1 0.9999994039535522
) O 0 1.735360743992942e-09
. O 0 5.479519962769963e-11

Major O 0 9.574328942107968e-06
instability O 0 8.594355676905252e-06
, O 0 1.842873076363105e-12
with O 0 2.3513160277328915e-14
very O 0 1.4777181155494466e-15
large O 0 6.686134613765335e-15
expansions O 0 5.58152524199329e-10
between O 0 2.5519124031807283e-13
generations O 0 2.0557422431011219e-10
and O 0 5.352324139451525e-10
high O 0 1.0899998237334785e-08
levels O 0 5.141154862942088e-11
of O 0 5.2124133290566265e-15
somatic O 0 4.664101549423094e-09
mosaicism O 0 2.982556850383844e-07
, O 0 1.405549532014841e-13
is O 0 5.861863051166358e-14
observed O 0 3.7527481122623385e-12
in O 0 5.475941423395414e-13
patients O 0 1.0390212995536885e-10
. O 0 4.5746071861141324e-12

There O 0 2.762934048217147e-10
is O 0 1.6376227630898743e-12
a O 0 3.0487897227432156e-14
good O 0 5.9091737579508585e-12
correlation O 0 1.5309699688548228e-11
between O 0 5.120402799679846e-13
repeat O 0 5.977105477228406e-09
size O 0 4.854588397940063e-10
( O 0 4.585102168276102e-14
at O 0 2.5838619438500743e-12
least O 0 6.926325629035869e-15
in O 0 5.65996351552917e-15
leucocytes O 0 1.4712605356237418e-08
) O 0 1.2396120507027555e-14
, O 0 1.556084968554704e-15
clinical O 0 2.0626066826734402e-11
severity O 0 8.441550236604201e-10
and O 0 8.60196774921107e-11
age O 0 1.0108032189037885e-09
of O 0 5.8850138304200605e-12
onset O 0 3.8205627106435713e-07
. O 0 5.716325676696776e-11

The O 0 3.550554572573361e-10
trinucleotide O 0 2.4820164981065318e-05
repeat O 0 1.081313143913576e-06
instability O 0 1.8440159621491148e-08
mechanisms O 0 7.275096497449951e-11
involved O 0 3.31331906355814e-11
in O 0 9.117234744948632e-12
DM B-Disease 1 1.0
and O 0 2.2536017496577188e-09
other O 0 4.7093891286653644e-12
human O 0 3.471751242045684e-08
genetic B-Disease 1 1.0
diseases I-Disease 1 1.0
are O 0 2.390234364602062e-11
unknown O 0 1.637526746145479e-11
. O 0 1.8804477072698056e-11

We O 0 2.9466264983568635e-09
studied O 0 2.1090014457048056e-10
somatic O 0 9.204932638340324e-08
instability O 0 7.315233307991775e-09
by O 0 2.4148290992168607e-14
measuring O 0 4.69288238491572e-07
the O 0 2.8038072623186305e-13
CTG O 0 3.118564677606628e-07
repeat O 0 6.412240960429472e-09
length O 0 4.2511599795957977e-10
at O 0 9.972477704733862e-12
several O 0 1.464897064870803e-14
ages O 0 1.4112621661566127e-11
in O 0 1.3749541725644235e-15
various O 0 8.154888473754871e-15
tissues O 0 5.027868399398727e-11
of O 0 1.1104390180267064e-15
transgenic O 0 1.1538373456687623e-07
mice O 0 1.1883905415288609e-07
carrying O 0 3.021177752415838e-10
a O 0 2.071986245771873e-12
( O 0 2.4719503245555774e-13
CTG O 0 2.646615193668822e-08
) O 0 3.473318908962103e-13
55expansion O 0 2.8693674103408284e-09
surrounded O 0 3.6857266370871056e-12
by O 0 6.1968871128818305e-15
45 O 0 1.9417071574732991e-13
kb O 0 4.961739019648803e-09
of O 0 2.880326727995597e-14
the O 0 9.585441164763897e-13
human O 0 1.163552187932737e-08
DM B-Disease 1 1.0
region O 0 2.422208961183614e-11
, O 0 1.9335219763484934e-16
using O 0 5.264109528596746e-14
small O 0 1.4429894779066643e-10
- O 0 1.7289976312895305e-05
pool O 0 3.8092657916877215e-08
PCR O 0 1.882065703284752e-07
. O 0 1.44545686184272e-11

These O 0 7.402425894476039e-12
mice O 0 3.845683522740728e-07
have O 0 6.277745684402092e-12
been O 0 1.5181397805541508e-12
shown O 0 1.047690796965317e-12
to O 0 3.839567739135274e-15
reproduce O 0 1.9396604322707844e-09
the O 0 2.5421426574044614e-13
intergenerational O 0 7.779072319635816e-08
and O 0 3.9784768361694756e-12
somatic O 0 1.2595061660292117e-09
instability O 0 4.0203673723482325e-10
of O 0 1.5638923888669021e-15
the O 0 5.919941051040975e-14
55 O 0 1.8164842893741984e-11
CTG O 0 8.894520675539752e-09
repeat O 0 5.741943032155916e-10
suggesting O 0 9.439848208669943e-11
that O 0 2.414381018787763e-15
surrounding O 0 8.070988166263438e-15
sequences O 0 3.5910061816496475e-12
and O 0 3.3892131722640384e-12
the O 0 2.0278301217699747e-15
chromatin O 0 2.9556069397473905e-11
environment O 0 3.515632229778021e-11
are O 0 3.8949022839970295e-15
involved O 0 8.499084682561664e-13
in O 0 3.405034229835707e-13
instability O 0 1.1745359351778006e-08
mechanisms O 0 6.681577513489856e-09
. O 0 1.2888476397243664e-10

As O 0 1.2901979484780668e-10
observed O 0 6.214437818508056e-12
in O 0 1.294782504106804e-15
some O 0 7.110778064728807e-17
of O 0 4.856443815445626e-16
the O 0 5.358281635232942e-13
tissues O 0 1.3054157932401722e-07
of O 0 9.098980596755624e-11
DM B-Disease 1 1.0
patients O 0 2.331122686882736e-06
, O 0 5.694498827557917e-14
there O 0 2.4963121440834193e-14
is O 0 9.838929394519538e-14
a O 0 1.6689850456524935e-13
tendency O 0 9.43279274134845e-11
for O 0 4.1983173122879525e-13
repeat O 0 5.157670290856231e-09
length O 0 9.680242163412345e-10
and O 0 1.7223066505964169e-12
somatic O 0 7.056916162540006e-11
mosaicism O 0 3.2446789699491774e-09
to O 0 5.195762982183882e-13
increase O 0 4.025882752167753e-11
with O 0 6.6864504384700485e-12
the O 0 9.352493605951917e-12
age O 0 3.2763767254806453e-09
of O 0 1.1973279965692314e-14
the O 0 2.4482637596932866e-13
mouse O 0 5.684921688953182e-07
. O 0 8.818496627371886e-11

Furthermore O 0 3.9060540757418494e-07
, O 0 2.6205112732546887e-11
we O 0 1.969368678550465e-12
observed O 0 4.71016834476673e-13
no O 0 1.1197850948634156e-14
correlation O 0 3.3133175023070116e-12
between O 0 3.943991942929881e-13
the O 0 2.1057705275676075e-13
somatic O 0 5.168545271772018e-07
mutation O 0 2.1152627596165985e-05
rate O 0 0.00017881829990074039
and O 0 9.794130839679838e-09
tissue O 0 0.00013739262067247182
proliferation O 0 0.48418334126472473
capacity O 0 1.3867688331004047e-08
. O 0 1.6610853317833296e-11

The O 0 8.450788679947863e-12
somatic O 0 1.516974208470856e-07
mutation O 0 3.6179610560793662e-06
rates O 0 4.945848559145816e-06
in O 0 5.140989901581544e-14
different O 0 6.980279933710073e-14
tissues O 0 9.769167697015746e-09
were O 0 1.129685060774488e-11
also O 0 6.660776097344723e-12
not O 0 7.172548958846864e-14
correlated O 0 1.7488828094047726e-11
to O 0 9.944589639612755e-13
the O 0 5.036602385155575e-11
relative O 0 4.597706659836831e-09
inter O 0 3.8305001908156555e-06
- O 0 8.691483344591688e-06
tissue O 0 1.042192798195174e-05
difference O 0 4.756045002274334e-10
in O 0 1.190632539934365e-14
transcriptional O 0 2.693483283633391e-11
levels O 0 3.5807419529465534e-11
of O 0 1.6845712904445904e-15
the O 0 1.7667064236255928e-14
three O 0 1.9301940146036756e-13
genes O 0 2.934597009840445e-12
( O 0 1.8438767155379114e-14
DMAHP O 0 9.737062356407478e-08
, O 0 6.793634665241965e-13
DMPK O 0 4.109486326342449e-06
and O 0 5.875595843196635e-11
59 O 0 1.181072045719489e-10
) O 0 3.737241923942218e-15
surrounding O 0 5.956467822232012e-14
the O 0 2.564726046556248e-13
repeat O 0 8.062860956670193e-08
. O 0 1.1672975953891385e-12
. O 0 4.2808794703530495e-12

A O 0 2.6390312157786866e-10
novel O 0 6.203915714486641e-10
missense O 0 1.1538275430211797e-05
mutation O 0 2.679141744010849e-06
in O 0 9.91069422709434e-13
patients O 0 8.881386945325254e-12
from O 0 8.747649753539956e-15
a O 0 2.9888827957763597e-12
retinoblastoma B-Disease 0 3.914636545232497e-05
pedigree O 0 0.010323728434741497
showing O 0 0.013503026217222214
only O 0 3.3479846450745754e-08
mild O 0 2.3371254087578563e-07
expression O 0 6.7209350064489914e-12
of O 0 4.388205632741872e-14
the O 0 9.96975765832353e-12
tumor B-Disease 0 9.083801160159055e-06
phenotype O 0 3.263486902937984e-08
. O 0 3.297872044893957e-11

We O 0 2.8288518194585777e-08
have O 0 5.052203772525077e-13
used O 0 4.233640754592802e-14
single O 0 2.1499567751104287e-11
strand O 0 2.409769495059777e-09
conformation O 0 1.2367852575412286e-10
polymorphism O 0 7.431245896416527e-11
analysis O 0 4.900970688309636e-12
to O 0 2.988163102374264e-13
study O 0 1.4182395492376432e-12
the O 0 4.228607210481766e-13
27 O 0 2.6252841914264913e-11
exons O 0 1.3238282692284997e-10
of O 0 3.153562743175831e-15
the O 0 3.7659806506997254e-14
RB1 O 0 1.3133038123669394e-07
gene O 0 4.2907442043826904e-09
in O 0 4.9987056459149456e-14
individuals O 0 5.029656704146068e-13
from O 0 4.329213514910578e-14
a O 0 9.470446996062698e-12
family O 0 2.700739631933402e-09
showing O 0 0.00023103348212316632
mild O 0 2.7199828878110566e-07
expression O 0 4.172398971463709e-12
of O 0 1.0148380515117867e-14
the O 0 3.741320187683472e-12
retinoblastoma B-Disease 0 2.214791857113596e-05
phenotype O 0 4.846858132623311e-07
. O 0 9.517007321102611e-11

In O 0 1.988012402268091e-12
this O 0 9.64722415451244e-15
family O 0 4.607362668468395e-13
affected O 0 1.7503303494093014e-12
individuals O 0 2.437101952537657e-12
developed O 0 9.245205205843376e-07
unilateral B-Disease 1 0.9999710321426392
tumors I-Disease 1 1.0
and O 0 4.2508904698479455e-06
, O 0 3.065522011583277e-12
as O 0 4.288502062146926e-13
a O 0 7.393401619008519e-14
result O 0 2.7353748606462336e-13
of O 0 1.881277116510746e-14
linkage O 0 9.161022518355821e-08
analysis O 0 1.2365877211095722e-09
, O 0 8.590158966093053e-12
unaffected O 0 2.0067667527712274e-09
mutation O 0 3.8140491653848585e-08
carriers O 0 3.430110666613473e-07
were O 0 2.6326765767414884e-10
also O 0 7.492473308445824e-11
identified O 0 7.661466600028533e-11
within O 0 2.6337826776294537e-13
the O 0 1.2809115747247635e-11
pedigree O 0 7.889533299021423e-05
. O 0 5.388513524273719e-10

A O 0 7.615345021250164e-10
single O 0 3.1048330573213434e-10
band O 0 2.4345015586790808e-11
shift O 0 1.056518371053694e-12
using O 0 7.406687025854342e-13
SSCP O 0 2.5595483066354063e-07
was O 0 1.3453315718392478e-11
identified O 0 8.360622090475278e-12
in O 0 4.271647715859165e-15
exon O 0 4.05367961420211e-09
21 O 0 4.271332731953237e-10
which O 0 6.913236259495359e-14
resulted O 0 4.1303757831491483e-13
in O 0 1.1161686029918187e-14
a O 0 3.241703238308913e-13
missense O 0 1.2962998141574644e-07
mutation O 0 1.1973217972638395e-09
converting O 0 1.0254919136087892e-09
a O 0 2.9675728541178614e-10
cys O 0 0.0005628867074847221
- O 0 1.7235219274880365e-05
- O 0 4.1641044390416937e-07
> O 0 1.2610296140636024e-10
arg O 0 2.7197954111102263e-08
at O 0 1.0201727483616363e-11
nucleotide O 0 6.228114135531371e-10
position O 0 2.2793404941268136e-09
28 O 0 8.117063336580965e-13
in O 0 2.9326549094055743e-16
the O 0 9.736620858798607e-15
exon O 0 3.943580750842557e-08
. O 0 1.2597459186913795e-10

The O 0 8.020362846083984e-11
mutation O 0 9.89198412071346e-08
destroyed O 0 2.139487698116227e-08
an O 0 1.645507514969058e-11
NdeI O 0 3.196808756911196e-05
restriction O 0 8.964790576548864e-10
enzyme O 0 9.669617107022077e-09
site O 0 6.46399656023533e-10
. O 0 5.128168029111535e-11

Analysis O 0 4.345468082589399e-11
of O 0 1.4616099671717342e-13
all O 0 4.716506048565994e-13
family O 0 6.394481840733823e-13
members O 0 4.614490654007448e-15
demonstrated O 0 8.562570005246281e-14
that O 0 1.793661510754419e-15
the O 0 4.694147834652905e-14
missense O 0 6.138078333606245e-06
mutation O 0 6.740525350323878e-06
co O 0 0.00012113322736695409
- O 0 2.3032474416595505e-07
segregated O 0 3.889437749649005e-08
with O 0 9.156433250501195e-11
patients O 0 1.3500627282780897e-09
with O 0 1.4717707053080176e-09
tumors B-Disease 1 1.0
or O 0 1.5980162061168812e-05
who O 0 0.0011014725314453244
, O 0 1.052741227525189e-11
as O 0 2.8422912894815466e-12
a O 0 2.539564424638291e-13
result O 0 8.991524430394804e-13
of O 0 1.1214950002740379e-14
linkage O 0 5.419799720129959e-09
analysis O 0 1.089492052130936e-09
had O 0 7.184166861406993e-08
been O 0 1.4972326156659221e-10
predicted O 0 1.963503665214361e-11
to O 0 4.5181167699281585e-14
carry O 0 1.692950224452261e-10
the O 0 1.832749880678608e-12
predisposing O 0 8.909721316285868e-08
mutation O 0 2.15314450713322e-08
. O 0 4.545923013021813e-11

These O 0 4.3270446362271564e-13
observations O 0 7.73428803640952e-12
point O 0 7.967972115441313e-11
to O 0 2.297518424153929e-14
another O 0 1.5070123968174975e-12
region O 0 1.230353709538723e-12
of O 0 4.317781788847844e-15
the O 0 1.4596960792867542e-13
RB1 O 0 4.991889568373153e-07
gene O 0 8.944772145191848e-10
where O 0 3.4809058847146135e-13
mutations O 0 1.3037516899405688e-10
only O 0 1.2470782056756696e-13
modify O 0 1.777671898572919e-10
the O 0 4.843583758899761e-13
function O 0 3.03814070255759e-12
of O 0 2.69716025772318e-14
the O 0 3.128344480164691e-13
gene O 0 3.0851783350271944e-08
and O 0 2.147818173314775e-10
raise O 0 1.4068867598693302e-11
important O 0 1.242491081809155e-13
questions O 0 3.7079519142613204e-12
for O 0 1.3739691791258852e-14
genetic O 0 1.6806472880048773e-10
counseling O 0 3.2797389803995713e-10
in O 0 5.94187649386943e-14
families O 0 8.822891012618198e-14
with O 0 2.0190637627526958e-13
these O 0 1.5886983568969004e-12
distinctive O 0 5.037565919963072e-10
phenotypes O 0 1.7036404509340741e-09
. O 0 3.3875699012413107e-13
. O 0 1.5547944876015407e-11

Maternal B-Disease 0 0.19624316692352295
disomy I-Disease 1 0.9948847889900208
and O 0 0.012527896091341972
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 0 2.0954464616806945e-06
with O 0 5.938958092671642e-12
gamete O 0 3.6654506097022477e-09
complementation O 0 6.716129973938223e-06
in O 0 9.802721785343027e-14
a O 0 5.987667772624355e-14
case O 0 1.7411685981905123e-10
of O 0 7.440570512148859e-13
familial O 0 4.064369818479463e-07
translocation O 0 6.018640874572156e-07
( O 0 2.0025434435688716e-11
3 O 0 4.965672317780445e-11
; O 0 5.846523894355304e-13
15 O 0 4.210452732994474e-12
) O 0 1.6760501813468595e-14
( O 0 4.471372579107572e-16
p25 O 0 2.7284134695472473e-13
; O 0 3.1825672688721865e-15
q11 O 0 8.72082527719753e-12
. O 0 1.8595926495445624e-15
2 O 0 1.6502016495899968e-13
) O 0 5.1198140779001866e-14
. O 0 3.704337997369883e-13

Maternal B-Disease 0 0.2177504152059555
uniparental I-Disease 1 0.9867240786552429
disomy I-Disease 1 0.9659264087677002
( I-Disease 0 7.635044596554508e-08
UPD I-Disease 1 0.9999961853027344
) I-Disease 0 5.682019438291164e-11
for I-Disease 0 6.585244502477217e-13
chromosome I-Disease 0 5.7362591178389266e-05
15 I-Disease 0 7.831856274620463e-10
is O 0 4.08662578603447e-13
responsible O 0 5.524769010334385e-12
for O 0 1.022640088929605e-13
an O 0 2.0943296196677258e-14
estimated O 0 2.7566421367808402e-11
30 O 0 1.0074299901241535e-11
% O 0 8.405663800976058e-16
of O 0 3.2660779412078825e-15
cases O 0 1.10773088479732e-08
of O 0 1.8628443285706453e-05
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 2.010813737740591e-08
PWS B-Disease 1 0.9999934434890747
) O 0 1.2923111192275627e-10
. O 0 1.3154409853055604e-11

We O 0 1.8741763696539238e-09
report O 0 2.439297028256071e-12
on O 0 2.6635721826393476e-14
an O 0 4.619047016284296e-17
unusual O 0 5.356661345908139e-15
case O 0 1.3146584515455473e-11
of O 0 9.736055277959066e-13
maternal B-Disease 0 3.0469681178146857e-07
disomy I-Disease 0 6.310540811682586e-06
15 I-Disease 0 1.323189613433584e-10
in O 0 6.777766824346554e-13
PWS B-Disease 1 0.9999998807907104
that O 0 7.964538056848269e-11
is O 0 1.3516891599063552e-12
most O 0 2.2773270221638706e-14
consistent O 0 3.246799010203638e-11
with O 0 2.72292388289741e-13
adjacent O 0 2.8647614835897173e-10
- O 0 3.7244183204165893e-07
1 O 0 9.371748516118217e-11
segregation O 0 2.7890903475658035e-10
of O 0 1.303451433159325e-13
a O 0 3.554848776454733e-11
paternal O 0 8.909710800253379e-07
t O 0 2.316697418791591e-06
( O 0 1.678664802648444e-13
3 O 0 1.188800360235609e-12
; O 0 8.913481016920455e-15
15 O 0 1.023754377712377e-13
) O 0 1.7230861961935987e-15
( O 0 2.2057099258993544e-16
p25 O 0 1.0240981375636907e-13
; O 0 1.0889444981989444e-15
q11 O 0 2.317351822586633e-12
. O 0 5.258544649188227e-16
2 O 0 4.1500762109616604e-14
) O 0 1.4028002748262903e-15
with O 0 1.3756185216807788e-14
simultaneous O 0 3.359290068338794e-10
maternal O 0 2.168981438899209e-07
meiotic O 0 1.1899935543624451e-06
nondisjunction O 0 1.1028663720935583e-05
for O 0 1.3065690890323722e-11
chromosome O 0 5.492521268024575e-06
15 O 0 6.613273817457355e-10
. O 0 2.8220356607100427e-11

The O 0 3.7336442965107963e-11
patient O 0 1.2998696341526284e-08
( O 0 1.3098222593349584e-12
J O 0 9.208797564497218e-05
. O 0 3.998926623866028e-12
B O 0 1.5778880424477393e-07
. O 0 6.309595010909382e-15
) O 0 8.972392370160229e-16
, O 0 9.268190833720212e-17
a O 0 2.855186281901321e-15
17 O 0 2.5169206996356053e-12
- O 0 2.990264286184541e-11
year O 0 2.0025892402686374e-11
- O 0 1.057294980455481e-07
old O 0 3.470418732831604e-06
white O 0 1.584184587954951e-07
male O 0 2.93477486756899e-09
with O 0 7.604742356670524e-12
PWS B-Disease 1 0.9999985694885254
, O 0 9.973951189696378e-14
was O 0 1.2754110918430928e-12
found O 0 2.05230841002213e-12
to O 0 7.355007445100648e-13
have O 0 2.7388141754514095e-10
47 O 0 4.4442968749613954e-10
chromosomes O 0 5.806417568976485e-09
with O 0 4.046190119066928e-11
a O 0 5.760558696721318e-10
supernumerary O 1 0.8755310773849487
, O 0 1.2473382327016225e-08
paternal O 0 1.4421125342778396e-05
der O 1 0.9771533012390137
( O 0 5.133553582226114e-10
15 O 0 2.550401556611348e-11
) O 0 3.643768026564444e-15
consisting O 0 1.2349299913835127e-14
of O 0 1.2877785792483713e-14
the O 0 3.391549541209571e-11
short O 0 4.291861387173412e-06
arm O 1 0.9217379689216614
and O 0 2.632807027946882e-10
the O 0 1.4021302294133647e-13
proximal O 0 6.59848709005928e-08
long O 0 9.640034477342851e-07
arm O 0 0.0006467272178269923
of O 0 2.4011860208505986e-12
chromosome O 0 1.9291725038783625e-05
15 O 0 1.2790160042186471e-09
, O 0 7.539112021302807e-13
and O 0 9.133595789412308e-12
distal O 0 5.621159652946517e-05
chromosome O 1 0.9994612336158752
arm O 1 0.9988176226615906
3p O 0 0.01031986903399229
. O 0 6.221278603391056e-09

The O 0 1.2546867989016164e-09
t O 0 9.445600881008431e-06
( O 0 5.167733645519701e-13
3 O 0 3.6555152893406884e-13
; O 0 1.813773461054025e-15
15 O 0 5.440023025148413e-14
) O 0 1.0181956477630554e-15
was O 0 8.054498908116603e-12
present O 0 1.8801507320974874e-14
in O 0 4.1683041905799835e-15
the O 0 1.4874437266739968e-14
balanced O 0 9.105820958366095e-11
state O 0 1.907576527293564e-12
in O 0 4.902068673402239e-14
the O 0 6.042225747515673e-12
patients O 0 6.095567800512569e-11
father O 0 4.5885584221139197e-10
and O 0 2.6550346990394935e-11
a O 0 1.554373470213921e-11
sister O 0 1.5602530766045675e-05
. O 0 2.9534560908039964e-10

Fluorescent O 0 4.498693861876291e-09
in O 0 4.817561890320572e-14
situ O 0 5.9432870951059424e-12
hybridization O 0 1.9965431218016416e-12
analysis O 0 3.1468740373935544e-12
demonstrated O 0 6.7664810386725005e-12
that O 0 5.094905549426869e-14
the O 0 4.977162345459751e-12
PWS B-Disease 1 0.9999998807907104
critical O 0 2.338835685122831e-07
region O 0 1.305811622026587e-11
resided O 0 4.058450797650437e-10
on O 0 1.3013021216146115e-10
the O 0 3.3346307486137317e-13
derivative O 0 1.3614465110833862e-08
chromosome O 0 2.2839471967017744e-06
3 O 0 2.2753864070690355e-10
and O 0 3.148254877280432e-12
that O 0 2.9921212534554653e-13
there O 0 1.3080396141229578e-12
was O 0 3.670312942460896e-09
no O 0 1.976232111983167e-12
deletion O 0 2.4267790554866053e-10
of O 0 1.067672209323356e-12
the O 0 1.5521471885548976e-09
PWS B-Disease 1 1.0
region O 0 4.2141284906094256e-10
on O 0 9.71779115510607e-11
the O 0 1.8430409650695145e-13
normal O 0 4.15337469278354e-12
pair O 0 2.0602328176799745e-10
of O 0 4.715352796267648e-14
15s O 0 6.921268419501914e-11
present O 0 4.680516499551424e-13
in O 0 3.697441658401246e-13
J O 0 0.0006643987726420164
. O 0 2.8302629684340275e-10

B O 0 0.001642925082705915
. O 0 6.906743177381713e-09

Methylation O 0 1.3291159839390332e-10
analysis O 0 3.9896319754817444e-12
at O 0 1.3572072068632202e-12
exon O 0 2.291630947504064e-11
alpha O 0 2.925541753295846e-13
of O 0 1.5959789498209607e-15
the O 0 1.3782632126519909e-14
small O 0 2.5542521223109738e-11
nuclear O 0 1.5168314348557033e-05
ribonucleoprotein O 0 6.425748324545566e-07
- O 0 5.342619857628961e-08
associated O 0 7.822954090075385e-11
polypeptide O 0 1.603959418616796e-07
N O 0 1.006175807560794e-06
( O 0 3.8664544114129507e-13
SNRPN O 0 3.6516689672083658e-09
) O 0 3.6708057417572746e-15
gene O 0 1.7576979802202963e-11
showed O 0 5.391638802088039e-10
a O 0 9.68683480325784e-14
pattern O 0 3.542844684290003e-09
characteristic O 0 8.863372813472381e-10
of O 0 7.332134573968807e-13
only O 0 1.7909107530300616e-10
the O 0 1.824930900840016e-10
maternal O 0 1.8235742800243315e-06
chromosome O 0 0.0001138556472142227
15 O 0 3.4619760391763066e-09
in O 0 5.4242075241128784e-12
J O 0 0.00515189440920949
. O 0 5.811422454371495e-10

B O 0 0.002608784707263112
. O 0 1.2453556408331679e-08

Maternal B-Disease 0 0.022127676755189896
disomy I-Disease 0 0.001434196368791163
was O 0 1.0715056397714307e-08
confirmed O 0 5.233001965782025e-12
by O 0 1.7133331412015574e-15
polymerase O 0 1.975358591976839e-11
chain O 0 6.851343936631338e-10
reaction O 0 2.683184620669299e-13
analysis O 0 1.424093116109311e-14
of O 0 8.640456569394622e-16
microsatellite O 0 8.745207225047125e-09
repeats O 0 2.3309123520220965e-08
at O 0 2.66462177843374e-12
the O 0 5.494851806637363e-15
gamma O 0 3.9992339301297974e-11
- O 0 9.211270821651851e-07
aminobutyric O 0 1.0155875315831508e-05
acid O 0 1.1900504581774385e-08
receptor O 0 2.3270188553858873e-10
beta3 O 0 1.7839363319893664e-09
subunit O 0 1.6126038004937726e-11
( O 0 1.201011620884096e-12
GABRB3 O 0 4.5242789070698564e-08
) O 0 1.73060418534772e-13
locus O 0 4.346948134781314e-09
. O 0 1.764743212673281e-10

A O 0 1.021283946300855e-08
niece O 0 2.311757270945236e-05
( O 0 8.271769380563398e-11
B O 0 8.0331562912761e-07
. O 0 7.814829648200919e-14
B O 0 1.1140807165688216e-09
. O 0 2.7760099300962844e-16
) O 0 1.8764015154570116e-16
with O 0 1.5129400748368853e-15
45 O 0 6.91073107485056e-14
chromosomes O 0 2.948557370485716e-11
and O 0 1.6242961836665515e-12
the O 0 5.843418146410243e-15
derivative O 0 1.0791842974811061e-09
3 O 0 1.4783074070434665e-11
but O 0 2.7097291424582615e-12
without O 0 2.7625148262683252e-12
the O 0 9.255596506232977e-13
der O 0 0.0002797564084175974
( O 0 8.887431264016643e-13
15 O 0 3.1511127257868865e-13
) O 0 2.229277850033097e-15
demonstrated O 0 5.874555670474374e-14
a O 0 2.6669681071314795e-14
phenotype O 0 4.694211686029348e-10
consistent O 0 4.6438936029957745e-11
with O 0 1.7078925892890368e-13
that O 0 4.4405784930222347e-13
reported O 0 1.164969926081838e-10
for O 0 6.947846703346527e-13
haploinsufficiency O 0 1.0448056997347521e-07
of O 0 3.7832306460771487e-14
distal O 0 8.627761616253338e-08
3 O 0 1.8857303274444348e-08
p O 0 2.4807268346194178e-05
. O 0 1.41780281959214e-10

Uniparental B-Disease 1 0.99993896484375
disomy I-Disease 1 0.9999822378158569
associated O 0 1.5243805364661966e-06
with O 0 8.640445997576407e-11
unbalanced O 0 1.708759327812004e-06
segregation O 0 1.5659276542123735e-08
of O 0 1.8485373821930384e-12
non O 0 2.186843630624935e-07
- O 0 7.121736445014903e-08
Robertsonian O 0 1.0474395395476677e-07
translocations O 0 1.36811524953373e-06
has O 0 6.97613772304706e-11
been O 0 1.771550462749405e-12
reported O 0 4.288683991271469e-12
previously O 0 4.86691853485155e-10
but O 0 4.231556077760601e-11
has O 0 3.3947028521552625e-10
not O 0 3.1022903430183435e-12
, O 0 1.3528328271798697e-14
to O 0 2.8460534032574356e-14
our O 0 3.683140598065293e-12
knowledge O 0 2.502644359109185e-13
, O 0 1.5552251665857698e-14
been O 0 2.5777381531394417e-12
observed O 0 1.834722478111228e-12
in O 0 3.0712864096025215e-16
a O 0 4.9267586673751654e-14
case O 0 2.4491828010120287e-10
of O 0 1.279798628184281e-10
PWS B-Disease 1 0.9999980926513672
. O 0 1.158367735065724e-09

Furthermore O 0 2.571564152731298e-07
, O 0 7.065896479030442e-12
our O 0 1.3699824694818341e-12
findings O 0 9.64362812695685e-13
are O 0 5.2128335421017594e-14
best O 0 5.895037236136602e-11
interpreted O 0 2.9200801932721676e-12
as O 0 3.309810108279021e-13
true O 0 3.3748798027033455e-12
gamete O 0 3.4715641472615744e-09
complementation O 0 7.565205123682972e-06
resulting O 0 2.8941139262883553e-08
in O 0 1.196064136621544e-09
maternal B-Disease 0 0.019627122208476067
UPD I-Disease 1 0.999998927116394
15 I-Disease 0 8.427949978795368e-06
and O 0 7.870346507843351e-07
PWS B-Disease 1 0.9999728202819824

Schwartz B-Disease 1 0.9971854090690613
- I-Disease 1 0.9999678134918213
Jampel I-Disease 1 0.999906063079834
syndrome I-Disease 1 0.9999960660934448
type I-Disease 0 1.9438339222688228e-05
2 I-Disease 0 4.645022588789516e-09
and O 0 6.06969337013652e-08
Stuve B-Disease 1 0.9998925924301147
- I-Disease 1 0.9999986886978149
Wiedemann I-Disease 1 0.9999992847442627
syndrome I-Disease 1 0.9999991655349731
: O 0 4.640619079331401e-14
a O 0 2.3082873892870835e-15
case O 0 1.907991343044757e-12
for O 0 2.1045457856885136e-13
" O 0 5.522346035319314e-12
lumping O 0 2.1929078997118268e-08
" O 0 4.4105349927825444e-10
. O 0 4.802768426015458e-12

Recent O 0 6.072362612741244e-10
studies O 0 2.95269399208653e-11
demonstrated O 0 1.4380403985658763e-11
the O 0 6.2775445547347e-15
existence O 0 3.6312833707856373e-13
of O 0 6.846153537061776e-15
a O 0 1.4289921242832682e-12
genetically O 0 2.147312549993785e-08
distinct O 0 3.105511073991929e-12
, O 0 6.924453008596079e-14
usually O 0 5.5557040088208276e-14
lethal O 0 1.1597322494699691e-12
form O 0 8.513296404638604e-13
of O 0 2.725178752365637e-13
the O 0 1.7079091474414554e-09
Schwartz B-Disease 1 0.9999451637268066
- I-Disease 1 0.9999936819076538
Jampel I-Disease 1 0.9999257326126099
syndrome I-Disease 1 0.9999616146087646
( O 0 6.6215214734877126e-12
SJS B-Disease 0 0.03640343248844147
) O 0 5.11253745501955e-13
of O 0 1.2374157959144788e-13
myotonia B-Disease 0 0.017064789310097694
and O 0 4.480933402106757e-09
skeletal B-Disease 0 0.0013943910598754883
dysplasia I-Disease 0 0.07122183591127396
, O 0 8.243634073978878e-12
which O 0 7.026130111748019e-12
we O 0 1.644103742037828e-09
called O 0 3.530757552994146e-08
SJS B-Disease 1 0.999908447265625
type I-Disease 0 2.176796670028125e-06
2 I-Disease 0 1.6165123406519655e-10
. O 0 1.2369686872015784e-11

This O 0 2.9478408603011985e-09
disorder O 0 0.00399481225758791
is O 0 5.035572653300235e-12
reminiscent O 0 1.5928983826407617e-11
of O 0 5.1674549377987364e-14
another O 0 2.0011152457311e-11
rare O 0 9.53958467775351e-10
condition O 0 1.6067167596389709e-09
, O 0 3.186238707771072e-13
the O 0 4.558984856295467e-10
Stuve B-Disease 1 0.999985933303833
- I-Disease 1 0.9999996423721313
Wiedemann I-Disease 1 0.9999990463256836
syndrome I-Disease 1 0.9999992847442627
( O 0 2.0725601790339e-11
SWS B-Disease 0 5.096231689094566e-06
) O 0 1.5469659516050005e-13
, O 0 9.290637471520246e-16
which O 0 6.496140041498512e-15
comprises O 0 1.0149092503908275e-11
campomelia B-Disease 0 1.9940448510169517e-06
at O 0 1.9048524979581316e-09
birth O 0 6.55616005929005e-08
with O 0 1.5555405852296644e-09
skeletal B-Disease 0 0.03272675350308418
dysplasia I-Disease 0 0.014070054516196251
, O 0 4.18713197794518e-12
contractures B-Disease 0 5.770169991592411e-06
, O 0 4.901120308209439e-12
and O 0 3.4085904671715683e-12
early B-Disease 0 5.288247270640589e-12
death I-Disease 0 8.288676411893903e-09
. O 0 4.260186092786e-10

To O 0 6.4408283394212784e-12
test O 0 1.5629779415160527e-10
for O 0 1.6605941170484261e-15
possible O 0 3.0175321741104585e-14
nosologic O 0 7.491852471730454e-09
identity O 0 2.931964671049059e-10
between O 0 2.4496443068455775e-11
these O 0 1.672818411568855e-10
disorders O 0 1.1864344742207322e-05
, O 0 1.5316600323667974e-14
we O 0 4.080830725422535e-13
reviewed O 0 5.461739741030591e-11
the O 0 1.0346649752246417e-13
literature O 0 4.271342665413541e-13
and O 0 7.834892673877492e-13
obtained O 0 1.6428465575771267e-13
a O 0 1.3565698857211789e-13
follow O 0 9.686400986863575e-12
- O 0 1.1288832979516883e-08
up O 0 3.356539579613127e-08
of O 0 2.1791586140825284e-14
the O 0 4.3581942389811154e-14
only O 0 4.874675627888035e-14
two O 0 3.1250270925674284e-14
surviving O 0 8.74007949347444e-11
patients O 0 2.036787622242131e-12
, O 0 2.2075122796622135e-15
one O 0 2.372368523417129e-13
with O 0 1.3811449206535542e-10
SJS B-Disease 1 0.9999523162841797
type I-Disease 0 2.5384739274159074e-05
2 I-Disease 0 1.718672565376167e-10
at O 0 6.136259278477496e-10
age O 0 2.1896205681937175e-10
10 O 0 1.1456942165810613e-12
years O 0 3.97518281312903e-13
and O 0 2.042466402171067e-13
another O 0 5.228489624760357e-13
with O 0 4.86396513343923e-11
SWS B-Disease 0 9.180346387438476e-05
at O 0 1.5361790062229375e-08
age O 0 1.0898495439448652e-09
7 O 0 2.966213039079513e-11
years O 0 2.34704855377188e-12
. O 0 4.3958335235738666e-12

Patients O 0 3.25826903235793e-07
reported O 0 2.74650568954371e-09
as O 0 4.995901609072817e-11
having O 0 3.09814005561293e-08
either O 0 7.749733299533546e-07
neonatal O 1 0.9999687671661377
SJS B-Disease 1 0.9999959468841553
or O 0 9.366548852085543e-07
SWS B-Disease 0 0.00027046704781241715
presented O 0 8.812540107372424e-12
a O 0 2.4026679083799518e-14
combination O 0 6.175089194322692e-13
of O 0 2.756511856337289e-14
a O 0 8.737195689167976e-11
severe O 0 4.4915464059158694e-07
, O 0 7.669153506695281e-12
prenatal O 0 0.022019313648343086
- O 1 0.5897527933120728
onset O 0 0.29840579628944397
neuromuscular B-Disease 1 0.9998900890350342
disorder I-Disease 1 0.9998462200164795
( O 0 4.2779512571256006e-11
with O 0 1.059349497012363e-08
congenital B-Disease 1 0.9999972581863403
joint I-Disease 0 0.008265149779617786
contractures I-Disease 1 0.9999343156814575
, O 0 1.4015527938227024e-07
respiratory O 0 0.0014033635379746556
and O 0 7.755271425047283e-10
feeding O 0 3.35125696437899e-05
difficulties O 0 5.91186868348359e-08
, O 0 7.165219752160862e-14
tendency O 0 6.484365128178737e-12
to O 0 5.410727882447855e-14
hyperthermia B-Disease 0 2.3057610931687123e-08
, O 0 7.174225189615635e-12
and O 0 1.3966893613881481e-11
frequent O 0 8.807440332603278e-10
death O 0 6.13301196494831e-08
in O 0 1.6950503500812175e-10
infancy O 0 3.521133962181011e-08
) O 0 5.916476347473526e-14
with O 0 8.697904355580658e-15
a O 0 4.633439899121017e-13
distinct O 0 3.2827868201579236e-10
campomelic B-Disease 0 0.009951009415090084
- I-Disease 0 0.05608605965971947
metaphyseal I-Disease 1 0.5356200337409973
skeletal I-Disease 1 0.6027202010154724
dysplasia I-Disease 0 0.23770451545715332
. O 0 4.915467477495383e-10

The O 0 6.710440579940635e-13
similarity O 0 1.3469568342638905e-11
of O 0 1.1380007078007088e-14
the O 0 1.4456429217775402e-13
clinical O 0 3.732210096529798e-09
and O 0 9.36168503828938e-12
radiographic O 0 1.6794288626442722e-07
findings O 0 1.7425971776674487e-10
is O 0 9.725809567429078e-13
so O 0 2.5906790682974842e-14
extensive O 0 2.856379542615084e-11
that O 0 1.6305969907648432e-09
these O 0 1.3325339942582559e-08
disorders O 0 0.00015909747162368149
appear O 0 2.490038904234826e-11
to O 0 6.027902244194749e-13
be O 0 6.81445802563907e-11
a O 0 5.12824418347213e-12
single O 0 2.518198698453489e-07
entity O 0 3.115115760010667e-06
. O 0 3.1026561320146584e-09

The O 0 2.6158760487587918e-12
follow O 0 1.1123193512097007e-11
- O 0 2.2376225317088938e-08
up O 0 1.063605292728198e-08
observation O 0 8.834321468809136e-11
of O 0 7.387416907719694e-16
an O 0 5.1844125374027675e-15
identical O 0 2.7361410359638683e-10
and O 0 2.153895985179677e-12
unique O 0 8.251475810136868e-14
pattern O 0 1.1390204335270937e-08
of O 0 2.7660910020821383e-11
progressive O 0 7.136148951758514e-07
bone B-Disease 1 0.9997206330299377
dysplasia I-Disease 1 0.8094581365585327
in O 0 3.3658926340551787e-12
the O 0 5.342018060544573e-12
two O 0 3.015512839432688e-10
patients O 0 9.267064546292225e-12
( O 0 2.204365340504927e-15
one O 0 7.592737202855027e-13
with O 0 1.2155553230641658e-09
SJS B-Disease 1 0.9999898672103882
type I-Disease 0 0.0002079262922052294
2 I-Disease 0 4.678943898994703e-10
, O 0 1.6532164092558643e-13
one O 0 8.913693351139673e-13
with O 0 5.528545676813934e-11
SWS B-Disease 0 0.0002827795979101211
) O 0 5.54787064812462e-13
surviving O 0 1.6764660493162609e-10
beyond O 0 5.239338962681472e-10
infancy O 0 2.0407892264984184e-08
adds O 0 4.558941557597507e-10
to O 0 4.43793256538292e-15
the O 0 8.910858602915756e-16
evidence O 0 4.853675621141473e-12
in O 0 8.11145262421967e-15
favor O 0 1.88783450677521e-13
of O 0 5.8055138455370865e-15
identity O 0 7.676829727465417e-10
. O 0 1.8736881837733144e-11

The O 0 5.216837378752004e-12
hypothesis O 0 2.431138623748552e-10
that O 0 8.878507304355132e-12
SWS B-Disease 0 0.00036128266947343946
and O 0 1.5963248500838745e-09
SJS B-Disease 1 0.9996240139007568
type I-Disease 0 9.45830197451869e-06
2 I-Disease 0 5.368649969028638e-11
are O 0 1.001591604793406e-12
the O 0 1.3348665705778529e-12
same O 0 2.631835549493644e-08
disorder O 0 0.007408458273857832
should O 0 3.433544421005408e-11
be O 0 1.5734226530179918e-14
testable O 0 9.611377720184638e-14
by O 0 1.2067174150230605e-16
molecular O 0 1.253268322454204e-13
methods O 0 7.858093516166509e-12
. O 0 2.4288868984666256e-13
. O 0 6.653399185763131e-12

A O 0 1.0863292904117472e-10
mouse O 0 1.0299837782667964e-07
model O 0 1.411240759807697e-06
of O 0 1.746059119511756e-08
severe O 1 0.9998948574066162
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 0 0.12400835752487183
defects O 1 0.9999951124191284
in O 0 8.898283221370207e-10
hemostasis O 1 0.9986400008201599
and O 0 5.574387159867911e-06
thrombosis B-Disease 0 0.18795058131217957
. O 0 7.370157262265309e-10

von B-Disease 1 0.9746404886245728
Willebrand I-Disease 1 0.7606956958770752
factor I-Disease 0 2.6733083359431475e-05
( I-Disease 0 3.901040823706126e-09
vWf I-Disease 0 0.00021427986212074757
) I-Disease 0 4.322590939409565e-06
deficiency I-Disease 1 0.999966025352478
causes O 1 0.8391722440719604
severe O 1 0.999993085861206
von B-Disease 1 1.0
Willebrand I-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
in O 0 7.365063225961421e-08
humans O 0 5.905951638851548e-07
. O 0 7.723151562721853e-10

We O 0 2.1578362360830106e-11
generated O 0 3.89608050682666e-13
a O 0 4.731569072636242e-14
mouse O 0 6.865504076358775e-08
model O 0 3.390784897305821e-08
for O 0 2.1243557856830825e-13
this O 0 8.55238070711058e-15
disease O 0 3.873876913695895e-11
by O 0 2.08305601480391e-17
using O 0 5.79387950919337e-14
gene O 0 2.984750224754862e-10
targeting O 0 6.826198273301998e-09
. O 0 2.7205694294596405e-11

vWf B-Disease 0 0.003178439335897565
- I-Disease 1 0.9880297780036926
deficient I-Disease 1 0.9418768882751465
mice O 0 0.007257011253386736
appeared O 0 1.8884340136082756e-07
normal O 0 9.275893941840252e-11
at O 0 1.5060742930561588e-10
birth O 0 1.1592762305667748e-09
; O 0 1.9156334504777384e-13
they O 0 6.777172139454946e-13
were O 0 4.805407374103288e-12
viable O 0 9.428732239413762e-10
and O 0 2.0642043629948148e-11
fertile O 0 2.0879761808423325e-10
. O 0 8.342913165870769e-11

Neither O 0 1.2023301110275497e-07
vWf O 0 1.9264900402049534e-05
nor O 0 1.8626064957061317e-07
vWf O 0 1.6897321984288283e-05
propolypeptide O 0 0.00418300274759531
( O 0 9.121753130614252e-09
von B-Disease 0 0.2478392869234085
Willebrand I-Disease 0 0.03227487951517105
antigen O 0 0.00017531811317894608
II O 0 0.00011572209041332826
) O 0 5.006640067806156e-12
were O 0 1.0234953076032616e-12
detectable O 0 1.433859586619235e-09
in O 0 6.604256597435472e-15
plasma O 0 2.1065811595111228e-10
, O 0 1.266673940215901e-12
platelets O 0 1.6844294847828678e-08
, O 0 1.7389953680616715e-13
or O 0 4.427919402666403e-12
endothelial O 0 1.0451316478921058e-09
cells O 0 1.0853386765707906e-11
of O 0 4.51410285019771e-14
the O 0 6.4888437505128405e-12
homozygous O 0 0.00010836499131983146
mutant O 0 1.9454548237263225e-05
mice O 0 2.050397415587213e-05
. O 0 1.2220149891994936e-10

The O 0 9.95310014961781e-11
mutant O 0 8.173201422323473e-06
mice O 0 0.006087721325457096
exhibited O 0 5.731441706302576e-05
defects O 1 0.999160647392273
in O 0 3.9184250462398484e-12
hemostasis O 0 3.859269781969488e-05
with O 0 2.3855022124319447e-11
a O 0 1.273156857717339e-10
highly O 0 5.747799036726065e-07
prolonged O 0 0.0010489682899788022
bleeding O 1 0.9940904974937439
time O 0 4.4744279392716635e-08
and O 0 7.057919582109662e-09
spontaneous O 0 1.7679726127539652e-08
bleeding O 0 0.004823276307433844
events O 0 1.411404760426338e-11
in O 0 8.722596213026068e-14
approximately O 0 4.4529809527238395e-12
10 O 0 2.8522257472518575e-11
% O 0 4.3927027000654345e-14
of O 0 1.5411112598735788e-13
neonates O 0 1.554598952679953e-06
. O 0 2.8639625393456214e-11

As O 0 1.2348054523325658e-10
in O 0 3.4523467120012655e-14
the O 0 2.8337358501384635e-14
human O 0 3.469316500748221e-11
disease O 0 3.4384978420121115e-08
, O 0 4.2210277563818274e-15
the O 0 7.785070500851855e-15
factor O 0 5.315151097029513e-10
VIII O 0 1.8667050198928337e-06
level O 0 7.678652735876312e-08
in O 0 1.2593810543026773e-13
these O 0 2.902885722598503e-13
mice O 0 3.951803151380773e-08
was O 0 4.277645349048953e-09
reduced O 0 1.3446806168548875e-10
strongly O 0 4.969064049120675e-11
as O 0 2.798236468926074e-12
a O 0 2.279961972256189e-13
result O 0 1.8168576452343155e-12
of O 0 6.189542829009367e-14
the O 0 6.969590703176376e-12
lack O 0 5.111545301611509e-12
of O 0 1.0390463166717856e-15
protection O 0 4.441306805831602e-13
provided O 0 1.1097280185707811e-14
by O 0 3.833452245959393e-14
vWf O 0 2.1190233567836003e-08
. O 0 7.362314230485723e-11

Defective O 1 0.9536139369010925
thrombosis B-Disease 0 0.20920811593532562
in O 0 1.8111841887380464e-11
mutant O 0 1.3733807691096445e-06
mice O 0 0.0006159677868708968
was O 0 2.052093890370088e-07
also O 0 1.212966060926135e-09
evident O 0 3.8154840398263445e-11
in O 0 3.1141130306904094e-15
an O 0 9.318291614940442e-15
in O 0 3.252763387958345e-14
vivo O 0 2.367456453100658e-08
model O 0 3.0354574409585666e-09
of O 0 3.586777749808867e-11
vascular B-Disease 0 0.49924683570861816
injury I-Disease 0 7.86818127380684e-05
. O 0 2.602670023943432e-10

In O 0 8.500900179099491e-13
this O 0 3.137938585189015e-15
model O 0 8.80955308701914e-11
, O 0 4.414142798026335e-15
the O 0 1.6343510881667092e-14
exteriorized O 0 9.093387234315742e-07
mesentery O 0 4.087812612851849e-06
was O 0 3.747968158052117e-09
superfused O 0 4.384203862173308e-07
with O 0 3.820259213138666e-12
ferric O 0 8.614208901747133e-09
chloride O 0 2.3203794441428727e-10
and O 0 1.874445043625883e-12
the O 0 1.3149974747886199e-14
accumulation O 0 5.001469377541312e-11
of O 0 4.463267320835296e-13
fluorescently O 0 6.153079448267817e-05
labeled O 0 1.2433104529918637e-05
platelets O 0 2.916406856456888e-06
was O 0 8.045586419314077e-10
observed O 0 5.737383224763137e-12
by O 0 3.7741782355632525e-14
intravital O 0 5.422250204389911e-09
microscopy O 0 3.796720160487155e-10
. O 0 1.8018741013148265e-11

We O 0 1.734553278787132e-09
conclude O 0 2.1845969477851668e-11
that O 0 9.172320733074214e-15
these O 0 8.525471317409258e-16
mice O 0 2.5078711329840075e-10
very O 0 5.605304564146145e-14
closely O 0 4.122566454878296e-10
mimic O 0 3.909033694071695e-05
severe O 0 0.002469292376190424
human O 0 0.002861912129446864
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 1 0.8051325082778931
will O 0 7.0648454197908e-08
be O 0 6.4736631853745674e-12
very O 0 9.121929684250871e-16
useful O 0 7.830342717816702e-15
for O 0 2.0326387278115374e-16
investigating O 0 2.445847560941794e-12
the O 0 1.3769442129465265e-14
role O 0 1.9225754668839024e-11
of O 0 1.5797939501439439e-15
vWf O 0 4.375208181861545e-11
in O 0 1.4772151600908612e-13
normal O 0 1.1456313328550571e-11
physiology O 0 4.470055992022992e-10
and O 0 1.3688104469333773e-11
in O 0 5.651218154458654e-14
disease O 0 4.098436701127639e-09
models O 0 7.597500406575364e-10
. O 0 2.8801743975903626e-13
. O 0 1.4946039197938354e-11

Oral O 0 3.3663783938209235e-07
contraceptives O 0 0.0007528853020630777
and O 0 4.775497775000304e-10
the O 0 1.6826094337285546e-11
risk O 0 3.4084314393112436e-05
of O 0 6.620056325346013e-08
hereditary B-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.3209844357552356e-07

Hereditary B-Disease 1 0.9999978542327881
Ovarian I-Disease 1 0.9999991655349731
Cancer I-Disease 1 0.9998853206634521
Clinical O 0 0.011289999820291996
Study O 0 1.7327231205399585e-07
Group O 0 1.9368295411936742e-08
. O 0 2.2376116237676769e-10

BACKGROUND O 0 0.00027314736507833004
Women O 0 1.0262849237108185e-08
with O 0 2.24268975786146e-12
mutations O 0 2.65587960512903e-08
in O 0 4.60673871011813e-13
either O 0 4.318169433137342e-11
the O 0 4.1083959151366756e-11
BRCA1 O 0 0.23329827189445496
or O 0 1.2541515381769841e-08
the O 0 1.3459552916650352e-11
BRCA2 O 0 6.89664448145777e-05
gene O 0 1.314109283612197e-07
have O 0 1.4495873251751945e-11
a O 0 4.3973242473509255e-13
high O 0 4.735140990419495e-08
lifetime O 0 3.5027646845264826e-06
risk O 0 0.02241717278957367
of O 0 1.070474445441505e-05
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
. O 0 2.6739988001622805e-09

Oral O 0 7.786507012497168e-07
contraceptives O 1 0.8099436163902283
protect O 0 0.44275134801864624
against O 1 0.9842618703842163
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 1.7815424691036696e-09
general O 0 1.8032225712616423e-10
, O 0 1.306334164105638e-12
but O 0 1.849471097103983e-13
it O 0 2.7853592913032466e-13
is O 0 2.5786972383812223e-12
not O 0 1.4440830259018766e-13
known O 0 3.790565951400371e-12
whether O 0 5.338804398569152e-10
they O 0 4.816497201076686e-10
also O 0 7.528662693268018e-10
protect O 0 3.7122831031410897e-08
against O 0 1.8822662539719204e-08
hereditary B-Disease 0 0.0030997630674391985
forms I-Disease 0 2.9510365493479185e-05
of I-Disease 0 0.019318632781505585
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
. O 0 2.047697567064688e-09

METHODS O 0 6.865134682954022e-09
We O 0 8.264325335183287e-11
enrolled O 0 2.5493862576553283e-10
207 O 0 1.7368626004099497e-07
women O 0 3.090924849402654e-07
with O 0 2.6244476885040058e-06
hereditary B-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.892085599308757e-08
161 O 0 1.1256897636258145e-09
of O 0 3.438871149646916e-12
their O 0 2.2327217852335934e-10
sisters O 0 1.222158175551158e-06
as O 0 5.2869087580065255e-11
controls O 0 1.7251632344894574e-09
in O 0 8.512930994625158e-15
a O 0 3.366237681396572e-13
case O 0 2.662979614598271e-09
- O 0 3.4786918945428624e-07
control O 0 1.4802896686205713e-09
study O 0 4.3869741173097054e-11
. O 0 1.7963354762007278e-11

All O 0 1.300686780503213e-10
the O 0 7.499943049417424e-13
patients O 0 2.83867222262979e-12
carried O 0 6.949290860640278e-13
a O 0 1.0734217469965737e-13
pathogenic O 0 5.1860702399153524e-09
mutation O 0 8.65701732521984e-09
in O 0 5.098378316747976e-13
either O 0 2.0599026651080266e-10
BRCA1 O 0 0.00011469754099380225
( O 0 1.2620780288907785e-11
179 O 0 1.6394638535643935e-08
women O 0 1.536389127032578e-09
) O 0 1.0587313361079542e-12
or O 0 9.948815105076392e-10
BRCA2 O 0 0.1152968630194664
( O 0 1.2462151310899117e-09
28 O 0 1.7428389753604279e-07
women O 0 3.570765905180906e-10
) O 0 9.135560146908417e-13
. O 0 3.2114692849471993e-12

The O 0 9.903486364315484e-11
control O 0 5.317529527815168e-08
women O 0 1.3866457981848157e-10
were O 0 8.373448961117302e-13
enrolled O 0 8.815661959107879e-13
regardless O 0 6.724633870580643e-14
of O 0 9.868389115721748e-16
whether O 0 7.47866699124522e-11
or O 0 6.470928792801089e-10
not O 0 2.0039084280831787e-10
they O 0 4.456543467590279e-11
had O 0 1.516341358032136e-10
either O 0 5.632080739281786e-12
mutation O 0 5.687120996356043e-09
. O 0 3.130197837042381e-11

Lifetime O 0 4.214092541587888e-08
histories O 0 7.86200349267574e-09
of O 0 1.6234134262577138e-12
oral O 0 3.965603845301757e-09
- O 0 1.533653062324447e-07
contraceptive O 0 1.601923287353202e-07
use O 0 6.0720786038137575e-12
were O 0 1.527229541832889e-13
obtained O 0 7.79715579753669e-14
by O 0 4.72067995587952e-14
interview O 0 5.5688098576922584e-09
or O 0 1.075033291553229e-11
by O 0 1.948852219196568e-14
written O 0 4.996372781652936e-13
questionnaire O 0 2.15572195511049e-11
and O 0 1.0849851697419463e-14
were O 0 1.149922696533313e-14
compared O 0 3.3779240255632503e-13
between O 0 5.8512092740437e-13
patients O 0 2.3429839665634056e-11
and O 0 1.0409851453063723e-10
control O 0 1.1099753294274706e-07
women O 0 3.032215589726661e-10
, O 0 6.7872559481073954e-15
after O 0 8.378509068181564e-14
adjustment O 0 9.821994606529216e-11
for O 0 1.9996509873290713e-14
year O 0 1.4085399513419361e-12
of O 0 1.444054802764074e-14
birth O 0 9.332723482913252e-10
and O 0 2.806491983253778e-10
parity O 0 1.0803298700068353e-08
. O 0 5.7129908442865585e-11

RESULTS O 0 1.2069081289922678e-09
The O 0 4.64556344781375e-13
adjusted O 0 3.986122464993969e-06
odds O 0 1.9460430848994292e-05
ratio O 0 5.957549001323059e-05
for O 0 0.006934814155101776
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 5.754883236619435e-09
with O 0 3.826689399383243e-13
any O 0 4.8461087573392625e-12
past O 0 2.473184990137156e-10
use O 0 1.5824729027169582e-10
of O 0 1.6409621057811297e-12
oral O 0 6.795139118054294e-09
contraceptives O 0 6.545653832290554e-06
was O 0 9.293147362754439e-10
0 O 0 5.090551938313759e-11
. O 0 1.2330348547751058e-11

5 O 0 4.6107104245685093e-10
( O 0 4.119557613872088e-13
95 O 0 3.125413469695637e-11
percent O 0 3.5683160604094155e-06
confidence O 0 8.37424613564508e-06
interval O 0 3.575797435928507e-09
, O 0 3.0501697088208823e-13
0 O 0 2.6439281333398047e-14
. O 0 3.235533509613419e-16
3 O 0 1.2087395971291381e-13
to O 0 2.6753862254931537e-13
0 O 0 1.9532268597660662e-12
. O 0 1.1524169544530928e-14
8 O 0 2.7137842754237917e-12
) O 0 3.264659796295942e-14
. O 0 2.1743849396797105e-13

The O 0 1.4763978928300503e-10
risk O 0 3.9731543211019016e-07
decreased O 0 6.202865776572253e-09
with O 0 1.4542048663336582e-13
increasing O 0 2.153895985179677e-12
duration O 0 4.4081760811054416e-12
of O 0 2.037833792635285e-15
use O 0 6.900701364498385e-12
( O 0 4.428405477605382e-14
P O 0 5.384837908906093e-09
for O 0 1.0448983529549177e-13
trend O 0 1.1263512345038862e-09
, O 0 1.0187328275878746e-13
< O 0 3.1962106572525073e-12
0 O 0 8.862137776009457e-14
. O 0 1.1388811932554237e-16
001 O 0 3.569657048251018e-13
) O 0 5.2881130473645476e-17
; O 0 1.2890784733977915e-18
use O 0 5.520944338940177e-16
for O 0 4.20492667649406e-14
six O 0 6.2987831096761315e-12
or O 0 1.3897952884020515e-12
more O 0 3.9302325364467747e-14
years O 0 3.374108978326795e-11
was O 0 3.6090845867420285e-09
associated O 0 2.69961163883517e-13
with O 0 2.9115680135957667e-14
a O 0 7.469189383744329e-14
60 O 0 9.426092718867185e-13
percent O 0 4.461929437038492e-10
reduction O 0 2.7248292511217187e-10
in O 0 2.150964736186145e-12
risk O 0 4.683600351995665e-08
. O 0 2.1253183241087825e-11

Oral O 0 3.6214677834323084e-07
- O 0 4.237670964357676e-06
contraceptive O 0 5.7539495173841715e-05
use O 0 1.8457050998677005e-08
protected O 1 0.6828263998031616
against O 1 0.5622363686561584
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
both O 0 2.993482892121868e-11
for O 0 1.2337158204756005e-13
carriers O 0 1.3654447017508176e-10
of O 0 4.893527870788485e-15
the O 0 7.288110392966729e-11
BRCA1 O 0 0.05779267102479935
mutation O 0 3.480583359305456e-07
( O 0 3.013049011679758e-12
odds O 0 3.328614894826387e-08
ratio O 0 8.079422464390973e-09
, O 0 8.806889679330299e-13
0 O 0 2.855483319415264e-13
. O 0 5.33359759166647e-16
5 O 0 4.5904747288539466e-14
; O 0 1.1487426949344931e-15
95 O 0 3.63520758633884e-12
percent O 0 1.260220074073004e-06
confidence O 0 2.385052175668534e-05
interval O 0 1.5744593406807894e-09
, O 0 4.8581164725823925e-14
0 O 0 2.1794452500318792e-14
. O 0 3.5672697282408293e-16
3 O 0 5.0827824750725864e-14
to O 0 3.663652294407828e-14
0 O 0 7.523913675248906e-13
. O 0 5.146363817412104e-15
9 O 0 1.5856680118248034e-12
) O 0 2.2070650462660633e-16
and O 0 6.013309768102524e-16
for O 0 4.001665016586481e-16
carriers O 0 1.3321349232042756e-12
of O 0 8.855217538006213e-16
the O 0 8.42057239908156e-12
BRCA2 O 0 0.0002115163515554741
mutation O 0 9.953284774155691e-08
( O 0 2.390574934188483e-12
odds O 0 1.71632219547746e-08
ratio O 0 1.6580862238768646e-09
, O 0 1.1434058452657048e-13
0 O 0 1.0728117477492791e-13
. O 0 9.648543831844263e-16
4 O 0 9.769217227707794e-14
; O 0 1.1557049881235682e-15
95 O 0 5.036638640876223e-12
percent O 0 2.7077485356130637e-06
confidence O 0 3.422609734116122e-05
interval O 0 2.1803030492151265e-09
, O 0 2.6348828717839834e-13
0 O 0 5.444860599716772e-14
. O 0 4.0539666541014737e-16
2 O 0 7.502186399237568e-14
to O 0 7.216570277555207e-14
1 O 0 1.1384795016444738e-12
. O 0 4.849337738413754e-15
1 O 0 6.050015496179492e-14
) O 0 6.182298325618091e-14
. O 0 4.4024265027746423e-13

CONCLUSIONS O 0 7.849465077924833e-08
Oral O 0 4.5082998667567153e-08
- O 0 3.7553232345999277e-07
contraceptive O 0 7.679157079110155e-07
use O 0 5.2293922664370385e-11
may O 0 1.9562067243850123e-11
reduce O 0 2.0060795039023027e-11
the O 0 9.692476855838184e-13
risk O 0 2.887198206735775e-05
of O 0 5.448055162560195e-07
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 1.0555973872783397e-09
women O 0 1.0136697731200073e-10
with O 0 1.704673999614742e-13
pathogenic O 0 6.69296751354409e-09
mutations O 0 6.379242911691563e-09
in O 0 8.835453527665516e-14
the O 0 1.1129093306638804e-11
BRCA1 O 0 0.013797394931316376
or O 0 2.916441133038461e-07
BRCA2 O 0 0.4073129892349243
gene O 0 0.0005187740316614509

A O 0 4.591361957295703e-09
Japanese O 0 9.4997156807608e-09
family O 0 3.358308423018208e-11
with O 0 4.705566838958397e-11
adrenoleukodystrophy B-Disease 1 0.9999998807907104
with O 0 1.7091728032880837e-10
a O 0 2.283009068251851e-12
codon O 0 4.6187489388671565e-09
291 O 0 2.8077073999099866e-10
deletion O 0 1.044747488521125e-08
: O 0 1.1643601664432235e-12
a O 0 5.639904233738224e-13
clinical O 0 5.6996309893975194e-09
, O 0 1.082047537508124e-12
biochemical O 0 1.5810385889380996e-08
, O 0 6.052464844412409e-13
pathological O 0 3.156595198561263e-07
, O 0 6.18275309421934e-12
and O 0 3.5909857986488047e-12
genetic O 0 5.950805626042666e-09
report O 0 2.914254793040527e-08
. O 0 4.161544372993653e-11

We O 0 4.472136827526896e-10
report O 0 5.156314611398649e-12
a O 0 1.5437030451669054e-13
Japanese O 0 7.527255485584305e-10
family O 0 1.8155180483980793e-11
with O 0 2.918880137592339e-10
adrenoleukodystrophy B-Disease 1 1.0
( O 0 7.821380876293915e-09
ALD B-Disease 1 0.9999998807907104
) O 0 1.2330906695029453e-12
with O 0 1.132293484505404e-14
a O 0 6.898088599893021e-14
three O 0 6.48827727656176e-11
base O 0 1.314209097103003e-08
pair O 0 1.0236983705169678e-08
deletion O 0 1.3617416527722526e-07
( O 0 2.8946712648386663e-12
delGAG O 0 3.4254810099554334e-10
291 O 0 3.199664491693177e-11
) O 0 7.316777663347179e-14
in O 0 7.998043382911792e-15
the O 0 2.8837930307612503e-12
ALD B-Disease 1 0.9999992847442627
gene O 0 2.5750662189238938e-06
. O 0 2.0823247293133562e-10

A O 0 4.1633568814702926e-10
variety O 0 4.3924832521247126e-11
of O 0 2.5377098968222545e-13
phenotypes O 0 4.6815461729465824e-08
were O 0 2.102699264705521e-10
observed O 0 7.291099668460532e-11
within O 0 5.199110591916703e-14
this O 0 6.639675788344679e-14
family O 0 1.7248859285334817e-10
. O 0 1.2227539814002597e-10

While O 0 6.410810104995335e-09
the O 0 9.548859099262064e-12
proband O 0 6.394694992195582e-06
( O 0 1.0861794970395966e-11
patient O 0 1.716465303225334e-09
1 O 0 1.2183179812219613e-12
) O 0 3.883525445669278e-14
was O 0 5.242232429397697e-12
classified O 0 1.1037874259045566e-07
as O 0 3.830874728549816e-09
having O 0 3.165382123082594e-10
a O 0 4.2701671869706595e-14
rare O 0 3.999924035654606e-13
intermediate O 0 7.628071785337198e-12
type O 0 2.209845639811192e-08
of O 0 3.102840684041097e-12
adult O 0 2.851438694051467e-06
cerebral O 0 5.335060905053979e-06
and O 0 6.127148788337422e-10
cerebello O 0 0.001440439373254776
- O 0 0.0005733551224693656
brain O 0 0.0029954579658806324
stem O 0 5.028379632676661e-07
forms O 0 1.4920022994857618e-09
, O 0 1.069831549738165e-11
his O 0 7.252071165808616e-11
younger O 0 4.1249304416624e-08
brother O 0 1.6491681265051739e-07
( O 0 1.3382367046108068e-12
patient O 0 1.1734471172530903e-09
2 O 0 8.785585974002696e-12
) O 0 4.038722481447543e-13
and O 0 1.0574629366599808e-10
nephew O 0 2.435019496260793e-06
( O 0 5.6082864047235503e-11
patient O 0 3.3295169288294346e-08
3 O 0 2.3185156919347527e-11
) O 0 4.965951694996251e-13
had O 0 3.816454097194111e-10
a O 0 2.0770013486881567e-10
childhood O 0 5.116442480357364e-05
ALD B-Disease 1 0.9999995231628418
type O 0 0.001850839820690453
. O 0 6.666515117714766e-10

Another O 0 1.1044334335963413e-08
nephew O 0 1.357844848826062e-05
( O 0 2.1940227412642344e-10
patient O 0 5.8516704370958905e-08
4 O 0 1.0509020736959584e-10
) O 0 1.7921860555932673e-13
of O 0 1.06028474032311e-13
patient O 0 2.993567349562909e-08
1 O 0 4.475306410178792e-12
was O 0 4.677935261376831e-10
classified O 0 8.583842827647459e-07
as O 0 1.138218479468378e-07
having O 0 3.850608720767923e-07
an O 0 3.6148697923898965e-10
adolescent O 0 8.730580157134682e-05
form O 0 2.411857158435282e-09
. O 0 7.70397773353082e-11

The O 0 1.4136052354715711e-12
tau O 0 4.858068114454994e-11
level O 0 2.0361421437797844e-09
in O 0 1.1718858034578256e-13
the O 0 5.385076499303532e-12
cerebrospinal O 0 0.0005252993432804942
fluid O 0 5.418680188995495e-07
( O 0 2.073305527261482e-09
CSF O 1 0.9727873802185059
) O 0 4.5599370633586656e-12
in O 0 1.6253398095727317e-13
patient O 0 2.4979855961504427e-09
1 O 0 1.4018768784707092e-12
was O 0 2.556735712033742e-09
as O 0 8.372243870402585e-11
high O 0 1.1097520680181105e-09
as O 0 3.598081685027288e-12
that O 0 2.1837031152511371e-13
of O 0 1.715035990827729e-12
patients O 0 6.29046925659793e-10
with O 0 6.390101781050816e-10
Alzheimers B-Disease 1 0.9723564982414246
disease I-Disease 0 0.05271598696708679
( O 0 1.5853806982490948e-12
AD B-Disease 0 5.836477612319868e-08
) O 0 3.9317757383194873e-11
. O 0 1.607469192477229e-11

His O 0 2.2112349451486324e-10
brain O 0 3.8421600123683675e-08
magnetic O 0 9.034821502051926e-11
resonance O 0 4.718718193963412e-10
image O 0 2.9216904451345727e-08
( O 0 3.0201492348669312e-12
MRI O 0 1.5443703205164638e-06
) O 0 3.643314816503818e-12
showed O 0 3.9785760463928455e-08
abnormalities B-Disease 0 0.01059152465313673
in I-Disease 0 1.898827097076769e-13
the I-Disease 0 9.270376133407865e-11
bilateral I-Disease 0 0.000328042428009212
cerebellar I-Disease 0 2.1157429728191346e-05
hemispheres I-Disease 0 1.4559134342562174e-06
and O 0 1.0435207364878352e-08
brain O 0 6.96786912612879e-07
stem O 0 9.92387949594331e-09
, O 0 5.342769412650106e-13
but O 0 7.590015313301002e-13
not O 0 1.1256757678768103e-11
in O 0 5.016763480331088e-12
the O 0 2.8234383719905054e-09
cerebral O 0 1.0416501936560962e-05
white O 0 1.792175852166622e-09
matter O 0 1.0436913648863982e-13
, O 0 1.179506613941414e-15
where O 0 2.4100744915256855e-15
marked O 0 5.894783901456979e-13
reductions O 0 9.132088973906605e-10
of O 0 5.540603105437178e-14
the O 0 2.2807047916906242e-10
cerebral O 0 1.7950516848941334e-05
blood O 0 2.8034756383021886e-07
flow O 0 1.8983140392947462e-08
and O 0 3.5727840685950696e-09
oxygen O 0 6.368441191062502e-11
metabolism O 0 3.5738747516944613e-09
were O 0 2.5044699387272162e-12
clearly O 0 1.9800465520664057e-12
demonstrated O 0 2.089392899892891e-15
by O 0 9.7182009097507e-18
positron O 0 6.6625173260337345e-12
emission O 0 1.3306886148534147e-10
tomography O 0 3.869117914945264e-09
( O 0 5.047178387035389e-12
PET O 0 2.2467645521828672e-07
) O 0 8.21118260191378e-12
. O 0 1.5455422315222012e-12

In O 0 6.065243862707348e-10
patients O 0 4.439165035563519e-09
2 O 0 5.302038807997178e-10
and O 0 7.401459445333103e-10
3 O 0 3.258232225689106e-11
, O 0 2.0536207927062105e-15
the O 0 2.705308089988968e-16
autopsy O 0 5.914933876027817e-09
findings O 0 1.0418630541630947e-10
showed O 0 3.4650744495934305e-09
massive O 0 1.3954764011003817e-09
demyelination B-Disease 1 0.9999997615814209
of I-Disease 0 1.7559095843999728e-10
the I-Disease 0 7.197368256939285e-10
cerebral I-Disease 0 3.5527473301044665e-06
white I-Disease 0 9.94084467520473e-11
matter I-Disease 0 8.660623894473155e-15
with O 0 1.0538439822603183e-15
sparing O 0 1.817372207585377e-14
of O 0 1.4060932424636834e-14
the O 0 2.062118704959648e-11
U O 0 1.717739723972045e-05
- O 0 1.7745169316185638e-06
fibers O 0 3.9302408367802855e-06
, O 0 1.0923780733055818e-13
compatible O 0 1.1751610969057413e-12
with O 0 1.1181017862873371e-13
the O 0 2.4890949151530443e-14
findings O 0 8.068479911971238e-11
of O 0 1.2837145409172468e-11
childhood O 0 1.2309955309319776e-05
ALD B-Disease 1 0.9999954700469971
. O 0 1.2941864246940327e-09

Oleic O 0 0.3772297203540802
and O 0 3.164648987308283e-08
erucic O 0 0.00011025461571989581
acids O 0 5.02441501737394e-08
( O 0 1.670973472436832e-12
Lorenzos O 0 5.498687727367724e-08
Oil O 0 3.05316605331285e-10
) O 0 4.000158155561227e-14
were O 0 1.338281970051508e-13
administered O 0 1.6243582000308177e-12
to O 0 6.67925784125778e-13
patients O 0 5.911135296521319e-12
1 O 0 7.663856528561386e-13
and O 0 3.673545148630275e-11
4 O 0 1.8026097975409883e-11
, O 0 5.761194879451079e-14
but O 0 1.554976138899277e-14
sufficient O 0 3.0839161790658515e-14
effectiveness O 0 1.0962781030188218e-11
was O 0 8.286928782075265e-11
not O 0 8.19358957852151e-14
obtained O 0 1.3916395813495797e-11
. O 0 7.405508151148155e-11

The O 0 1.0051383336762143e-11
findings O 0 7.106650684596261e-11
in O 0 1.8083785811580204e-14
this O 0 9.472252982114593e-16
family O 0 2.6051196247954544e-13
suggest O 0 1.1423409961019981e-11
that O 0 1.1547152123370097e-12
delGAG291 O 0 7.84340059567512e-09
is O 0 7.62143711856289e-13
part O 0 8.631208811907265e-14
of O 0 7.86284930123348e-15
the O 0 3.116065077409663e-13
cause O 0 2.2549054637388544e-12
of O 0 2.0593417379352608e-13
Japanese O 0 1.8960108718601987e-06
ALD B-Disease 1 0.9999990463256836
with O 0 6.9403007646462456e-12
phenotypic O 0 5.105426836848892e-08
variations O 0 8.594764722147374e-08
. O 0 4.447620605141367e-10

Moreover O 0 8.905945314552355e-09
, O 0 6.087742614700742e-13
although O 0 4.994674446712373e-14
the O 0 6.570257965482105e-15
scale O 0 1.8309014748751906e-08
of O 0 1.8469752637029213e-13
the O 0 2.1910000669225077e-13
study O 0 4.613547391341122e-12
is O 0 5.2408150735816506e-11
limited O 0 3.085338581843011e-11
, O 0 4.373749829650851e-14
there O 0 1.4939491091154992e-14
is O 0 3.079425549192688e-14
a O 0 1.0887249049073688e-14
possibility O 0 1.0485364746598558e-12
that O 0 2.197935572694626e-13
PET O 0 6.113321546763473e-07
can O 0 1.0714152898216867e-09
detect O 0 2.350772234649412e-07
an O 0 2.3892178166451394e-11
insidious B-Disease 0 3.5003453376702964e-05
lesion I-Disease 1 0.9308491945266724
which O 0 9.659032462749906e-10
is O 0 6.136666175216021e-11
undetectable O 0 2.7785004519387257e-08
by O 0 5.1814864620864775e-15
computed O 0 4.739726389146881e-10
tomogram O 0 2.7262776711722836e-06
( O 0 1.5222911364624891e-13
CT O 0 3.562297479220433e-07
) O 0 1.3335221869890251e-13
or O 0 1.3436428076933626e-13
MRI O 0 7.364371334972475e-09
analysis O 0 3.5302386014457454e-12
, O 0 2.854301810097798e-13
and O 0 9.325942524739811e-14
that O 0 2.173724558912713e-14
the O 0 7.555461383488074e-14
higher O 0 4.550627374921845e-10
level O 0 6.342814468096591e-11
of O 0 3.412011765382668e-16
tau O 0 1.1425331811014666e-14
reflects O 0 1.4206531459039218e-14
the O 0 2.9788944379961866e-16
process O 0 3.717025873293395e-14
of O 0 1.923148157379189e-14
neuronal B-Disease 0 3.5292477829074187e-09
degeneration I-Disease 0 6.391691567841917e-05
in O 0 2.3707584784204982e-09
ALD B-Disease 1 0.9999983310699463
. O 0 9.553645874404992e-09

Lorenzos O 0 5.118316039443016e-05
Oil O 0 2.3766413903558714e-07
should O 0 4.385083615665586e-11
be O 0 3.0171120457686204e-14
given O 0 7.901181036107645e-16
in O 0 2.1326751717668424e-16
the O 0 1.2685657544222757e-14
early O 0 4.967147353152068e-12
stage O 0 8.71347261011124e-09
. O 0 3.207757681440021e-13
. O 0 1.7079879177650525e-12

Nonsense O 0 1.2270432307559531e-05
mutation O 0 3.9958663933248317e-07
in O 0 5.671986860224243e-13
exon O 0 4.849482149182904e-09
4 O 0 8.501589709997148e-11
of O 0 6.2100478025965e-14
human O 0 7.299003068617083e-11
complement O 0 6.949417430401894e-11
C9 O 0 1.310062103243581e-08
gene O 0 3.279986060533702e-08
is O 0 1.0155444193915564e-11
the O 0 3.3963022688264163e-14
major O 0 6.83750611685241e-10
cause O 0 2.4749060439921422e-11
of O 0 7.0978960556300486e-12
Japanese O 0 3.086930519202724e-05
complement B-Disease 0 3.532284381435602e-06
C9 I-Disease 0 0.03259635716676712
deficiency I-Disease 1 0.7169458270072937
. O 0 6.130664725878532e-11

Deficiency B-Disease 1 0.9998867511749268
of I-Disease 0 6.4205528914340615e-12
the I-Disease 0 5.23166200031705e-13
ninth I-Disease 0 2.7927395507276742e-08
component I-Disease 0 1.2035864527248918e-09
of I-Disease 0 1.6021445238198484e-13
human I-Disease 0 3.169423890003742e-10
complement I-Disease 0 7.55343065872438e-10
( O 0 5.785619243891746e-14
C9 O 0 5.808331038359427e-10
) O 0 1.0711141581977099e-14
is O 0 4.604836595991117e-15
the O 0 8.923448900643744e-15
most O 0 4.9394873607999656e-11
common O 0 1.644677649892401e-05
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.8026476145127646e-11
Japan O 0 7.316297256920734e-08
but O 0 4.217266455757568e-13
is O 0 7.445677782007623e-14
rare O 0 1.0751838465774058e-13
in O 0 1.507376105988785e-14
other O 0 6.3993046972576906e-12
countries O 0 9.851187920961735e-11
. O 0 8.380355437376252e-12

We O 0 2.7352970999316994e-09
studied O 0 1.1150851075836243e-11
the O 0 1.382153423220493e-15
molecular O 0 1.5962073676711874e-11
basis O 0 5.894860710675687e-10
of O 0 2.423485856439811e-10
C9 B-Disease 1 0.9818899631500244
deficiency I-Disease 1 0.9981887936592102
in O 0 2.142594099103362e-13
four O 0 3.7782894868332306e-11
Japanese O 0 2.566984278473683e-07
C9 B-Disease 0 8.270841499324888e-05
- I-Disease 0 0.0004321508458815515
deficient I-Disease 0 0.0005743771325796843
patients O 0 3.135184334368546e-09
who O 0 1.171718277959144e-09
had O 0 4.411818466110162e-08
suffered O 0 1.8986973373102956e-05
from O 0 7.680821312305852e-08
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 0.9999996423721313
. O 0 3.273347592980258e-09

Direct O 0 1.6510659159307828e-11
sequencing O 0 1.8034772286679157e-10
of O 0 4.746006647578238e-13
amplified O 0 1.0601312050440015e-09
C9 O 0 4.1797494354511855e-09
cDNA O 0 1.6095338603583365e-11
and O 0 4.1358545277772607e-13
DNA O 0 1.986230069306316e-09
revealed O 0 1.2163724250058294e-08
a O 0 1.0274050490574616e-12
nonsense O 0 8.412714969097124e-10
substitution O 0 1.243491529363816e-13
( O 0 1.1179327185110652e-14
CGA O 0 5.540199202180851e-11
- O 0 2.6021351740013188e-09
- O 0 1.4271367421159198e-09
> O 0 8.325454908808538e-12
TGA O 0 1.3272478227577267e-08
) O 0 4.6965839014092084e-14
at O 0 4.828463204351735e-14
codon O 0 1.951942080191671e-12
95 O 0 1.151501311837111e-13
in O 0 6.001782708481577e-16
exon O 0 2.9466065004646325e-11
4 O 0 6.289347515009425e-12
in O 0 3.5116310985510097e-15
the O 0 1.5990153808247837e-13
four O 0 6.687631004531625e-10
C9 B-Disease 0 0.0002142596204066649
- I-Disease 0 0.00023285395582206547
deficient I-Disease 0 0.0001588169252499938
individuals O 0 2.432038459510011e-10
. O 0 2.6880329559442195e-11

An O 0 5.583542742743086e-12
allele O 0 2.0849646453768855e-09
- O 0 1.2693942563757332e-09
specific O 0 1.917820503100076e-12
polymerase O 0 5.592426521872085e-10
chain O 0 2.144259347858224e-08
reaction O 0 5.5658602726715856e-12
system O 0 6.886839189201854e-13
designed O 0 1.808067411068759e-11
to O 0 6.453558424690618e-15
detect O 0 1.3165893930633388e-09
exclusively O 0 1.8989884317810457e-11
only O 0 9.396259811889074e-13
one O 0 2.0035805425779735e-13
of O 0 3.088983045453032e-15
the O 0 1.1851773089408685e-13
normal O 0 2.914788202468266e-12
and O 0 2.981354312731055e-13
mutant O 0 3.380036805999964e-10
alleles O 0 2.259780557123392e-11
indicated O 0 2.4279458998854864e-10
that O 0 1.0166539376847694e-13
all O 0 2.544102081780686e-13
the O 0 7.278528365954606e-14
four O 0 1.0178856368892042e-10
patients O 0 1.8886133976159236e-12
were O 0 2.4645202870675342e-14
homozygous O 0 1.687521233861844e-10
for O 0 5.6301419418518933e-14
the O 0 1.65472439895252e-13
mutation O 0 2.048174074786857e-09
in O 0 1.3882791400840477e-13
exon O 0 9.648467802492178e-09
4 O 0 2.0992820815024515e-09
and O 0 3.962741246255064e-11
that O 0 4.7817084493362305e-12
the O 0 3.214190198719269e-12
parents O 0 3.01734248697727e-10
of O 0 6.770709074779488e-14
patient O 0 5.583420392696326e-10
2 O 0 1.3668322116494602e-12
were O 0 4.152962695957996e-12
heterozygous O 0 5.787954648894811e-08
. O 0 2.148685916691928e-11

The O 0 1.0357125747317841e-11
common O 0 1.3427782323549575e-11
mutation O 0 9.975379411386598e-10
at O 0 3.7928892665517466e-11
codon O 0 6.598129265178443e-10
95 O 0 1.4953111665549912e-11
in O 0 3.049191216360214e-14
exon O 0 3.6544420822792745e-09
4 O 0 3.125814329596466e-10
might O 0 2.003360845270752e-11
be O 0 6.546918226730397e-14
responsible O 0 5.879826790386455e-13
for O 0 1.0598035578464338e-13
most O 0 2.4268240195191026e-11
Japanese O 0 4.257276486896444e-06
C9 B-Disease 0 0.0010174845810979605
deficiency I-Disease 0 0.00015330636233557016
. O 0 9.060762936382444e-14
. O 0 4.853564598839011e-12

BRCA1 O 0 0.007356265094131231
required O 0 4.407863407607238e-09
for O 0 3.093869995265952e-12
transcription O 0 1.549650619381282e-06
- O 0 4.2137977288803086e-05
coupled O 0 3.3225137485715095e-07
repair O 0 3.580180987228232e-07
of O 0 2.7723193546055382e-14
oxidative O 0 4.349815507787014e-10
DNA O 0 7.1549362701262e-07
damage O 0 2.3589834654558217e-06
. O 0 3.0113861404501563e-10

The O 0 3.2508077651982603e-07
breast B-Disease 1 0.9999860525131226
and I-Disease 1 0.9999796152114868
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 0 0.018698284402489662
gene O 0 0.049050915986299515
BRCA1 O 1 0.9966411590576172
encodes O 0 5.2650360885309055e-05
a O 0 3.566964892343094e-07
zinc O 1 0.9460126161575317
finger O 0 0.22165322303771973
protein O 0 4.548332412923628e-07
of O 0 4.435432056359989e-13
unknown O 0 7.838996118891828e-11
function O 0 3.468134113226995e-10
. O 0 1.2252006353907774e-10

Association O 0 2.5647569401598957e-08
of O 0 3.2486478242742256e-13
the O 0 5.08235814544733e-13
BRCA1 O 0 2.059017242572736e-05
protein O 0 5.181756690397776e-10
with O 0 3.2419674448258204e-14
the O 0 2.750019941719648e-15
DNA O 0 3.519783930983067e-08
repair O 0 1.3297330951900221e-06
protein O 0 3.4439504581484925e-09
Rad51 O 0 9.601031933925697e-07
and O 0 4.9395439127852825e-11
changes O 0 5.109349900632443e-13
in O 0 1.0461496408465786e-15
the O 0 6.205565071305569e-16
phosphorylation O 0 3.0708239770471657e-12
and O 0 5.2518028120784876e-11
cellular O 0 1.3686115352129491e-08
localization O 0 2.786128827647616e-10
of O 0 2.056240072689005e-14
the O 0 9.836672390528284e-15
protein O 0 1.0902393571265989e-11
after O 0 6.657406830673507e-13
exposure O 0 1.2135895587073176e-11
to O 0 4.990422193086391e-16
DNA O 0 4.145245480202675e-09
- O 0 5.656214607796528e-09
damaging O 0 2.1697918128893434e-08
agents O 0 1.5378374129682015e-09
are O 0 1.2578766153681364e-12
consistent O 0 1.7676217477571865e-12
with O 0 4.664434257676403e-15
a O 0 2.5591199759355046e-14
role O 0 1.4640647028052456e-10
for O 0 7.024407639756591e-14
BRCA1 O 0 1.6394762880622693e-08
in O 0 1.5739930450046728e-14
DNA O 0 7.157237291721685e-08
repair O 0 5.105232776259072e-05
. O 0 2.8333849155792734e-10

Here O 0 9.58112367221986e-10
, O 0 9.788614959826275e-14
it O 0 3.579567164327304e-15
is O 0 2.0653657515528386e-15
shown O 0 3.3455487322532965e-14
that O 0 1.8479529345416306e-15
mouse O 0 5.5355602768258905e-08
embryonic O 0 4.4202923277225636e-07
stem O 0 7.543272886323393e-07
cells O 0 4.0228108844075905e-08
deficient B-Disease 0 4.27972082661654e-07
in I-Disease 0 3.748180422719766e-14
BRCA1 I-Disease 0 4.591404831444379e-06
are O 0 5.146565140203008e-13
defective O 0 1.0075510203932936e-07
in O 0 9.123732043307686e-14
the O 0 7.508645940255965e-13
ability O 0 3.5631325667750957e-10
to O 0 8.80896782384441e-14
carry O 0 1.6355650167554359e-09
out O 0 8.119216410307217e-09
transcription O 0 8.827711894809909e-07
- O 0 3.93316213376238e-07
coupled O 0 2.5875448450563e-09
repair O 0 9.365717978937482e-09
of O 0 1.5518405923351311e-15
oxidative O 0 8.082862504310562e-12
DNA O 0 4.4047644109923567e-07
damage O 0 2.485995764800464e-06
, O 0 9.273023321432206e-12
and O 0 6.632884779617099e-12
are O 0 7.377849416470572e-14
hypersensitive O 0 8.789807104392366e-09
to O 0 8.717772868611223e-14
ionizing O 0 3.338263276919662e-10
radiation O 0 2.2869817151160987e-10
and O 0 5.761769100026681e-13
hydrogen O 0 1.0564726177220152e-11
peroxide O 0 2.917843175964663e-07
. O 0 2.986366015589326e-11

These O 0 1.3785307964586657e-11
results O 0 1.046213636557436e-11
suggest O 0 9.973281922537325e-11
that O 0 2.728270560858892e-11
BRCA1 O 0 0.0015114997513592243
participates O 0 7.105712285238042e-08
, O 0 9.077957027585348e-14
directly O 0 3.5260916365562056e-13
or O 0 3.0142477402961276e-10
indirectly O 0 7.144906533085305e-08
, O 0 1.455763287694367e-11
in O 0 4.437293631490147e-13
transcription O 0 1.670695269240241e-06
- O 0 3.274736081948504e-05
coupled O 0 1.2026374918150395e-07
repair O 0 1.494162233939278e-07
of O 0 9.795109330839463e-15
oxidative O 0 5.75478970032961e-11
DNA O 0 1.1607043148842422e-07
damage O 0 1.0544010820012772e-07
. O 0 5.018282339154523e-13
. O 0 1.2334323666596259e-11

Truncation O 0 1.3645670833284385e-06
mutations O 0 1.3067927284282632e-05
in O 0 9.99772638808627e-13
the O 0 1.8637740276886833e-13
transactivation O 0 7.968505997268949e-06
region O 0 4.6656095653574425e-11
of O 0 4.553188338515812e-14
PAX6 O 0 1.0135498996532988e-05
result O 0 1.1538841410141387e-10
in O 0 9.439280954093299e-13
dominant O 0 6.402772214642027e-07
- O 0 5.1289080147398636e-06
negative O 0 8.71143299718824e-08
mutants O 0 4.6120078422973165e-08
. O 0 2.0940813319492158e-11

PAX6 O 0 0.00019091597641818225
is O 0 2.678627597507699e-10
a O 0 1.9123769137274066e-13
transcription O 0 2.652869590669127e-10
factor O 0 1.2018881723196984e-10
with O 0 1.1946269779070269e-14
two O 0 1.4921464535971526e-14
DNA O 0 2.372337348788278e-06
- O 0 0.00011813777382485569
binding O 0 7.266424972840468e-07
domains O 0 9.669931841926882e-07
( O 0 2.835133603579232e-12
paired O 0 5.112167134058154e-09
box O 0 3.445128271550857e-08
and O 0 1.1095568214214424e-10
homeobox O 0 3.869885301099885e-09
) O 0 8.575551835483808e-13
and O 0 5.7742005621364e-13
a O 0 3.2807288244569854e-13
proline O 0 3.5626541716737847e-07
- O 0 5.578125339411599e-08
serine O 0 2.6002695108218177e-07
- O 0 3.574242679604822e-09
threonine O 0 2.8850147160142114e-08
( O 0 1.0802694323927206e-13
PST O 0 7.399031387578248e-10
) O 0 3.931897125594719e-14
- O 0 7.828562451073218e-12
rich O 0 7.958517200291892e-13
transactivation O 0 4.437404221846464e-09
domain O 0 5.24996268680411e-10
. O 0 9.753643205601126e-12

PAX6 O 0 0.009723414666950703
regulates O 0 0.006139602046459913
eye O 0 0.0166466161608696
development O 0 2.6206026237929336e-10
in O 0 3.3750952743326e-14
animals O 0 4.82762094189404e-12
ranging O 0 3.728305424804956e-12
from O 0 8.495218688665124e-15
jellyfish O 0 5.29109265082206e-12
to O 0 2.0295481163452433e-15
Drosophila O 0 3.78843142837329e-13
to O 0 1.1000719276753768e-14
humans O 0 1.8805124124554595e-11
. O 0 1.2167092854065142e-11

Heterozygous O 0 7.065692625474185e-05
mutations O 0 1.7180427676066756e-05
in O 0 1.03133376404968e-12
the O 0 4.5727178689608863e-14
human O 0 4.317047587465428e-12
PAX6 O 0 6.994773684709799e-07
gene O 0 3.207992449461017e-08
result O 0 2.0532528802186256e-11
in O 0 6.6090698621582445e-15
various O 0 6.551990260018556e-14
phenotypes O 0 1.3084408001518e-09
, O 0 3.4513345415106145e-13
including O 0 3.6139871650853195e-10
aniridia B-Disease 1 1.0
, O 0 3.0794438998782425e-07
Peters B-Disease 1 1.0
anomaly I-Disease 1 0.9999998807907104
, O 0 6.93885837677044e-08
autosomal B-Disease 1 0.9945726990699768
dominant I-Disease 0 0.005954494699835777
keratitis I-Disease 1 0.9988102912902832
, O 0 2.73652478455233e-08
and O 0 4.221993066266805e-08
familial B-Disease 1 0.9231863021850586
foveal I-Disease 1 0.9988486766815186
dysplasia I-Disease 1 0.9979509711265564
. O 0 2.1021109297691964e-09

It O 0 4.0820805069508026e-11
is O 0 5.053725992375246e-13
believed O 0 8.872340796078904e-13
that O 0 2.664536106133323e-15
the O 0 2.198486931850982e-15
mutated O 0 2.1978814324086215e-09
allele O 0 7.58302665104793e-09
of O 0 1.0188893131979349e-11
PAX6 O 0 7.786747300997376e-05
produces O 0 9.522101329650923e-09
an O 0 3.4754924632673934e-13
inactive O 0 2.6891960658304015e-08
protein O 0 3.873298837220318e-08
and O 0 5.685670600996673e-08
aniridia B-Disease 1 1.0
is O 0 6.992797008109619e-09
caused O 0 1.311468295073226e-10
due O 0 1.7084637740985564e-12
to O 0 2.4642863704488205e-13
genetic O 0 1.442900696702054e-07
haploinsufficiency O 0 7.929546700324863e-05
. O 0 1.7348568415176402e-10

However O 0 1.8277734881166907e-10
, O 0 2.6160826028251774e-14
several O 0 2.3540297095376575e-15
truncation O 0 4.8860071544254424e-09
mutations O 0 4.345999059296446e-06
have O 0 6.89991896951625e-10
been O 0 3.071528795195455e-11
found O 0 1.1735987182071028e-10
to O 0 3.436091255276663e-12
occur O 0 1.4062589634433742e-11
in O 0 1.7076507783232546e-14
the O 0 4.881016164165475e-12
C O 0 1.174007138615707e-06
- O 0 9.35368831278538e-08
terminal O 0 5.186552298752645e-10
half O 0 8.217633387999634e-13
of O 0 1.52505436122434e-14
PAX6 O 0 1.6623118881398113e-07
in O 0 5.934072271106608e-14
patients O 0 9.551477447508616e-13
with O 0 7.122275859361427e-13
Aniridia B-Disease 1 0.9999997615814209
resulting O 0 4.2935988098236066e-10
in O 0 5.743443101755702e-14
mutant O 0 4.487656024565467e-09
proteins O 0 1.950402339634394e-11
that O 0 1.0594761287903431e-13
retain O 0 4.817135405843498e-12
the O 0 2.7971235286197542e-14
DNA O 0 2.035782381426543e-05
- O 0 1.5148869351833127e-05
binding O 0 1.0361650026879943e-07
domains O 0 6.387056146195391e-07
but O 0 7.633275678209372e-10
have O 0 1.0137103656493451e-10
lost O 0 6.646987404934634e-10
most O 0 8.743146079359405e-15
of O 0 2.2223662729417386e-15
the O 0 3.994823135483605e-13
transactivation O 0 3.572912703475595e-07
domain O 0 2.241445606898651e-08
. O 0 1.7712954714088625e-10

It O 0 7.555732428610185e-11
is O 0 2.0718557078303057e-12
not O 0 2.804430161877712e-15
clear O 0 2.8864849963353145e-15
whether O 0 1.8359107094821636e-14
such O 0 9.857896495087635e-15
mutants O 0 4.594673530533555e-09
really O 0 2.933000953220244e-09
behave O 0 1.1589831525049554e-11
as O 0 3.574602026597089e-14
loss O 0 7.892788527787131e-13
- O 0 3.061750297739252e-10
of O 0 3.9142274491088536e-12
- O 0 1.76402906504336e-07
function O 0 4.7187788398961317e-11
mutants O 0 1.0450798004768558e-09
as O 0 4.594962648221679e-13
predicted O 0 1.6318047173918826e-12
by O 0 2.3191637412572907e-13
haploinsufficiency O 0 2.0511265574896242e-06
. O 0 2.6395734556428074e-11

Contrary O 0 1.2376684122017423e-09
to O 0 2.2706660228292985e-13
this O 0 4.873406179609985e-16
theory O 0 1.3784104269782237e-14
, O 0 3.370371625695647e-15
our O 0 1.3331953423856681e-15
data O 0 5.247351489955088e-13
showed O 0 1.3143224356082506e-11
that O 0 1.3428626352917999e-15
these O 0 2.8165450623640533e-15
mutants O 0 2.753989813975011e-10
are O 0 8.518136825237665e-13
dominant O 0 1.414505401697852e-09
- O 0 5.6778677759439233e-08
negative O 0 2.92116508759932e-09
in O 0 7.259751678393052e-15
transient O 0 6.13208485725214e-13
transfection O 0 4.171965550803236e-10
assays O 0 1.2903766055671895e-08
when O 0 1.5736449643366512e-10
they O 0 1.6838028367438529e-12
are O 0 1.0784453977627853e-13
coexpressed O 0 5.3587418946676735e-09
with O 0 1.6196865897100121e-12
wild O 0 3.2910756431192567e-07
- O 0 0.00016187051369342953
type O 0 2.8012973416480236e-05
PAX6 O 0 0.00040844804607331753
. O 0 3.2422892148886717e-10

We O 0 7.746383395845768e-11
found O 0 4.98306799469328e-13
that O 0 1.1530413871418087e-14
the O 0 7.946377930667659e-14
dominant O 0 5.320532636687858e-07
- O 0 1.0658192877599504e-05
negative O 0 9.120017097075106e-08
effects O 0 9.127700817401774e-10
result O 0 4.413379113121091e-14
from O 0 3.37166864489613e-16
the O 0 1.388001656325692e-16
enhanced O 0 5.976089848674926e-13
DNA O 0 2.1871912614379596e-10
binding O 0 1.3001336118811935e-10
ability O 0 3.127892693119416e-12
of O 0 1.8325161825943946e-15
these O 0 1.148881879388386e-13
mutants O 0 1.8578435456717557e-09
. O 0 1.1325025119079957e-11

Kinetic O 0 1.7142143260429066e-09
studies O 0 5.14011777585921e-10
of O 0 9.733196236830222e-13
binding O 0 8.869486123330717e-08
and O 0 9.526051475416963e-11
dissociation O 0 1.1358605028766178e-10
revealed O 0 9.927656613450964e-11
that O 0 3.0208358567146345e-15
various O 0 8.152058536678095e-15
truncation O 0 8.4351166051988e-09
mutants O 0 1.5469409220258967e-07
have O 0 5.256943491627197e-11
3 O 0 4.397904783404183e-12
- O 0 5.826152893462222e-09
5 O 0 1.7793816420308417e-10
- O 0 4.699239219974061e-09
fold O 0 3.2767064062078077e-10
higher O 0 1.677078289609446e-12
affinity O 0 4.3915720804874395e-14
to O 0 3.323564320332578e-16
various O 0 8.602766779615357e-16
DNA O 0 6.482986369960031e-10
- O 0 3.3868109705625926e-11
binding O 0 1.1466385566732962e-12
sites O 0 1.332068786871754e-12
when O 0 6.634209783092093e-13
compared O 0 3.0404406206260837e-13
with O 0 3.369548944945626e-15
the O 0 9.905543792436584e-15
wild O 0 8.149272900936921e-08
- O 0 1.2117894584662281e-05
type O 0 7.148647682697629e-07
PAX6 O 0 7.330522203119472e-05
. O 0 3.100820433754592e-10

These O 0 5.3668350145918975e-12
results O 0 2.730455835389667e-12
provide O 0 7.375682367378317e-14
a O 0 1.6548467443914215e-14
new O 0 9.191519751263269e-14
insight O 0 7.779675341434977e-13
into O 0 1.0155777653846239e-14
the O 0 1.2873610767086697e-14
role O 0 2.1705625144474716e-11
of O 0 1.152077887164307e-15
mutant O 0 2.3992212661028134e-09
PAX6 O 0 6.354441666189814e-07
in O 0 1.530805647173561e-12
causing O 0 1.0580188281039682e-08
aniridia B-Disease 1 0.999998927116394
. O 0 2.1042509748547822e-11
. O 0 1.512712351214862e-11

Reversal O 0 5.3213716455502436e-06
of O 0 1.0814745365905765e-07
severe O 1 0.9933109283447266
hypertrophic B-Disease 1 0.9999399185180664
cardiomyopathy I-Disease 1 0.9999997615814209
and O 0 1.1229497332010396e-08
excellent O 0 5.313717466037815e-08
neuropsychologic O 0 1.022038941300707e-05
outcome O 0 7.244222444136028e-10
in O 0 2.4433762305098305e-12
very B-Disease 0 3.5684100119226514e-10
- I-Disease 0 7.990964513737708e-05
long I-Disease 0 1.184813299914822e-05
- I-Disease 0 2.909889371949248e-05
chain I-Disease 0 9.02647661860101e-06
acyl I-Disease 0 4.2532082744628497e-08
- I-Disease 0 1.2467178578390303e-07
coenzyme I-Disease 0 6.432085086771622e-09
A I-Disease 0 4.793623720189544e-09
dehydrogenase I-Disease 0 9.573453280609101e-05
deficiency I-Disease 0 0.01420144084841013
. O 0 2.0711534917672303e-11

Very B-Disease 0 3.324072395116673e-08
- I-Disease 0 3.1115650926949456e-05
long I-Disease 0 2.7918347313971026e-06
- I-Disease 0 9.13906296773348e-06
chain I-Disease 0 1.7413932482668315e-06
acyl I-Disease 0 6.323192192070337e-09
- I-Disease 0 4.35504743379056e-09
coenzyme I-Disease 0 1.2601159005143359e-10
A I-Disease 0 1.0321313248518038e-11
dehydrogenase I-Disease 0 5.122483770492181e-09
( I-Disease 0 3.959286891397351e-12
VLCAD I-Disease 0 3.604015728342347e-05
) I-Disease 0 6.190898488300789e-11
deficiency I-Disease 0 2.5048173483810388e-05
is O 0 2.012566979389674e-12
a O 0 1.77578785010013e-10
disorder O 0 0.13203902542591095
of O 0 6.296596924415532e-12
fatty O 0 7.0705264079151675e-06
acid O 0 9.77505187904626e-10
beta O 0 1.7946863613282904e-13
oxidation O 0 1.9881877394434255e-11
that O 0 4.872969649322156e-12
reportedly O 0 1.2320052178438345e-07
has O 0 4.112955309665267e-09
high O 0 1.7063446478005062e-07
rates O 0 4.915978934150189e-05
of O 0 1.2235940038962667e-10
morbidity O 0 0.014551468193531036
and O 0 1.0947775130887294e-08
mortality O 0 3.7567235722235637e-07
. O 0 2.9678485363726637e-11

We O 0 3.435269013696285e-10
describe O 0 5.4758814670152756e-12
the O 0 1.3598124633685399e-14
outcome O 0 1.205617365922923e-13
of O 0 1.7243617219330452e-15
a O 0 1.3154547709361836e-13
5 O 0 1.298310959609028e-12
- O 0 9.810129375509291e-10
year O 0 1.7267687280053678e-10
- O 0 1.1462117299743113e-07
old O 0 2.9831594474671874e-06
girl O 0 0.0002444548299536109
with O 0 1.0793292659627696e-07
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 2.0917450882507183e-08
was O 0 1.9814161422715415e-10
first O 0 4.195880101698357e-11
seen O 0 2.4602819337360415e-08
at O 0 3.190529437868683e-11
5 O 0 1.2803680912807508e-13
months O 0 4.555206038758808e-13
of O 0 1.6865589803102647e-14
age O 0 2.0173173354010032e-08
with O 0 6.016959446242254e-07
severe O 1 0.6659542918205261
hypertrophic B-Disease 1 0.9997562766075134
cardiomyopathy I-Disease 1 0.9999998807907104
, O 0 1.636524416426255e-06
hepatomegaly B-Disease 1 1.0
, O 0 6.350122134790581e-07
encephalopathy B-Disease 1 0.999997615814209
, O 0 2.3127499915176486e-09
and O 0 7.3900365826773395e-09
hypotonia B-Disease 0 0.018740415573120117
. O 0 1.4058708364128591e-10

Biochemical O 0 0.0005995858227834105
studies O 0 3.332670166855678e-05
indicated O 1 0.9628103971481323
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 0 6.282908771026996e-07
by O 0 1.0103043618717167e-12
a O 0 3.2681055084360366e-10
stable O 0 2.0449436988201342e-07
yet O 0 1.8858266059851303e-09
inactive O 0 6.205211207088723e-07
enzyme O 0 2.0187884786082577e-07
. O 0 2.9299007664462806e-11

Molecular O 0 2.4854196478685253e-09
genetic O 0 8.325307554457595e-09
analysis O 0 2.737999549307091e-10
of O 0 3.2281059336031204e-12
her O 0 1.9053985056416423e-08
VLCAD O 0 0.0024008615873754025
gene O 0 2.047025446927364e-07
revealed O 0 3.422167083044769e-08
a O 0 5.284315086201419e-12
T1372C O 0 2.694513723255909e-09
( O 0 2.826439169517636e-13
F458L O 0 1.630844903566242e-10
) O 0 1.549141945365179e-13
missense O 0 7.635742917955213e-07
mutation O 0 5.608106584986672e-05
and O 0 4.4731990556101664e-08
a O 0 1.8576919558199734e-08
1668 O 0 0.001979502849280834
ACAG O 0 0.08759024739265442
1669 O 0 2.684108437733812e-07
splice O 0 3.344360811752267e-05
site O 0 6.877548486272644e-08
mutation O 0 1.0892851605603937e-05
. O 0 1.7086650982989227e-09

After O 0 8.692316311176285e-11
initial O 0 4.316769511292229e-11
treatment O 0 5.686521808989653e-10
with O 0 1.179315000689185e-12
intravenous O 0 2.6570651456836458e-08
glucose O 0 1.604819317435613e-06
and O 0 5.87615581193468e-11
carnitine O 0 1.2004900895590254e-07
, O 0 8.2645648408642e-14
the O 0 2.4273111461341895e-14
patient O 0 2.9003568435825855e-09
has O 0 2.5832128103253638e-11
thrived O 0 1.867648535824884e-10
on O 0 6.131412738641373e-11
a O 0 1.6599176200227106e-10
low O 0 3.868555722874589e-06
- O 0 2.0333468455646653e-06
fat O 0 1.7849862388175097e-07
diet O 0 5.714091005915023e-11
supplemented O 0 1.1430056554018186e-11
with O 0 5.313460717422391e-13
medium O 0 2.0944758816199283e-08
- O 0 1.5364814487384137e-07
chain O 0 5.00901897737549e-08
triglyceride O 0 1.6126807622640627e-07
oil O 0 2.1787121440297597e-08
and O 0 1.5341436888222093e-12
carnitine O 0 1.0992635246509508e-08
and O 0 4.108007879179143e-13
avoidance O 0 1.5307838330258505e-10
of O 0 1.6823765687859482e-13
fasting O 0 1.7005246988333056e-08
. O 0 1.3640955552618461e-11

Her O 0 1.1953760804317426e-05
ventricular O 0 0.0003616062458604574
hypertrophy O 0 2.304719964740798e-05
resolved O 0 4.423866162284185e-09
significantly O 0 3.0559799135687626e-10
over O 0 1.851894332327575e-11
1 O 0 9.92053401233095e-12
year O 0 7.682069563808014e-11
, O 0 1.170387463160505e-12
and O 0 6.017888878190325e-12
cognitively O 0 1.0398470529082715e-08
, O 0 1.652878409228592e-14
she O 0 1.4881987309145472e-10
is O 0 6.78301409181084e-14
in O 0 3.851977089449905e-16
the O 0 1.41049035989947e-14
superior O 0 2.4981830840098418e-11
range O 0 7.403347379586478e-11
for O 0 1.1945081208886155e-11
age O 0 1.284211226248999e-08
. O 0 1.3578559110438704e-10

Clinical O 0 4.105369225726463e-05
recognition O 0 1.0910678156506037e-06
of O 0 1.4632933016400784e-05
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 5.007691328273722e-08
important O 0 1.440217129583532e-11
because O 0 8.88436806761872e-12
it O 0 7.579396637223679e-13
is O 0 2.0480381713455786e-12
one O 0 3.9896682962545227e-13
of O 0 1.3592912839960943e-14
the O 0 3.5836080197054754e-13
few O 0 4.904610745315452e-11
directly O 0 6.506526428751158e-09
treatable O 0 0.000918462174013257
causes O 0 8.264550155345773e-10
of O 0 2.911619612078198e-09
cardiomyopathy B-Disease 1 1.0
in O 0 1.1131264660013684e-10
children O 0 8.183673183559392e-10
. O 0 2.830949721605719e-13
. O 0 6.9820447166912825e-12

Cloning O 0 1.368865270023889e-07
of O 0 2.7245044328244594e-12
a O 0 9.55504772526261e-13
novel O 0 8.805352974539105e-11
member O 0 9.910284398673141e-12
of O 0 7.237933803737676e-15
the O 0 5.469743581676401e-12
low O 0 3.2695886602596147e-06
- O 0 2.3828990833862917e-06
density O 0 1.1252389020555142e-09
lipoprotein O 0 0.0002490591141395271
receptor O 0 2.4643302509730347e-08
family O 0 4.0988254457197115e-10
. O 0 5.4687657180529925e-11

A O 0 6.381865175209e-11
gene O 0 1.8207111374124452e-09
encoding O 0 3.5383720953241493e-10
a O 0 8.154936448345751e-11
novel O 0 5.361290078553793e-08
transmembrane O 0 4.480344432522543e-05
protein O 0 1.0642124692594734e-07
was O 0 1.758912876459462e-10
identified O 0 4.3195327414750906e-13
by O 0 3.7707329316972736e-17
DNA O 0 2.6266150712772607e-12
sequence O 0 6.556094100766685e-13
analysis O 0 7.887973043838037e-13
within O 0 2.7026923993082874e-13
the O 0 2.1547857942394444e-10
insulin B-Disease 1 0.8864762783050537
- I-Disease 1 0.9999951124191284
dependent I-Disease 1 0.9999874830245972
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 5.7547328680129795e-08
IDDM B-Disease 0 0.000190236751222983
) O 0 7.761623375263094e-13
locus O 0 1.3041883129005782e-08
IDDM4 O 0 0.0002270554832648486
on O 0 8.633696535476076e-10
chromosome O 0 1.1176961379533168e-05
11q13 O 0 4.786289764524554e-07
. O 0 8.202733631224035e-11

Based O 0 1.797281420912178e-11
on O 0 2.120107735203991e-11
its O 0 4.851840500544324e-13
chromosomal O 0 0.0002526372263673693
position O 0 2.949131214791123e-07
, O 0 1.957741491164823e-14
this O 0 2.975122494402945e-17
gene O 0 7.111474169957388e-12
is O 0 1.4536891926753698e-13
a O 0 6.271464552239309e-15
candidate O 0 1.354137342621936e-13
for O 0 4.143535083729784e-14
conferring O 0 1.7057336099135512e-10
susceptibility O 0 3.0746164725314884e-08
to O 0 3.1741984596322936e-09
diabetes B-Disease 1 0.6288692355155945
. O 0 3.3416540645703208e-09

The O 0 8.346214886746639e-13
gene O 0 1.4451551066940738e-09
, O 0 7.426193991341701e-13
termed O 0 3.5165415024351887e-09
low O 0 7.07602453076106e-07
- O 0 7.236292276502354e-06
density O 0 1.1006775935129554e-08
lipoprotein O 0 0.0019170684972777963
receptor O 0 3.510277224449965e-08
related O 0 2.8659749573556326e-10
protein O 0 6.2459140082182785e-09
5 O 0 2.4953922608816903e-11
( O 0 9.826102605192677e-14
LRP5 O 0 1.4872061626647337e-07
) O 0 9.715880410052138e-15
, O 0 4.982069455609728e-17
encodes O 0 8.349236287150813e-14
a O 0 1.9007004629055524e-13
protein O 0 4.5063008879964173e-10
of O 0 3.961908058569552e-12
1615 O 0 5.209798104033325e-08
amino O 0 5.712931461232529e-09
acids O 0 8.705378640172512e-10
that O 0 9.613793458150208e-15
contains O 0 4.0371799328066393e-14
conserved O 0 1.2114064959489745e-11
modules O 0 1.953200046145298e-09
which O 0 9.052864707870256e-11
are O 0 1.1821706807912946e-12
characteristic O 0 3.815693420949895e-12
of O 0 6.011412477828146e-14
the O 0 2.6904758976264986e-10
low O 0 0.0017476893262937665
- O 0 0.023056255653500557
density O 0 4.641571536012634e-07
lipoprotein O 1 0.8537811636924744
( O 0 2.039644231288662e-09
LDL O 0 8.10147394076921e-05
) O 0 5.493728735816994e-12
receptor O 0 1.3336488857706996e-10
family O 0 4.700283565139962e-11
. O 0 2.2134447053012707e-11

These O 0 3.794696327996672e-12
modules O 0 7.17891024404338e-11
include O 0 1.2325074771543654e-12
a O 0 8.215811657299316e-14
putative O 0 2.943176258263236e-10
signal O 0 6.90332443986641e-11
peptide O 0 2.1914985017662536e-12
for O 0 6.675655651537497e-16
protein O 0 1.287432888161938e-13
export O 0 2.88440105133958e-10
, O 0 1.6935142643017013e-15
four O 0 7.901972397814441e-14
epidermal O 0 4.297196198876918e-07
growth O 0 3.299941795376071e-07
factor O 0 2.8695097409325854e-09
( O 0 2.0126745322451844e-12
EGF O 0 1.6779140423750505e-06
) O 0 1.2025795940659445e-12
repeats O 0 1.8423250480736897e-08
with O 0 1.730334300321934e-12
associated O 0 9.703741716410308e-13
spacer O 0 5.514946721518754e-08
domains O 0 5.325026904756669e-06
, O 0 7.633632441439442e-12
three O 0 3.511624671603819e-11
LDL O 0 0.008968774229288101
- O 0 8.77150523592718e-06
receptor O 0 1.6079438225347076e-08
( O 0 1.2947548849034929e-12
LDLR O 0 3.4500672541071253e-07
) O 0 1.0470729914623805e-13
repeats O 0 1.0438965247772103e-09
, O 0 2.8174651942546557e-14
a O 0 3.3774652725190174e-14
single O 0 9.377228771256796e-09
transmembrane O 0 9.786175425574584e-09
spanning O 0 4.3665342452925415e-09
domain O 0 7.94902973666467e-07
, O 0 4.915373663649802e-10
and O 0 3.603424850173731e-12
a O 0 1.662484576002085e-13
cytoplasmic O 0 1.029046714506876e-08
domain O 0 1.326645957533401e-07
. O 0 5.866169217050299e-10

The O 0 4.382695920589208e-13
encoded O 0 1.4934754821727125e-11
protein O 0 1.0301026698300575e-09
has O 0 3.360594138038242e-12
a O 0 2.740124055796876e-15
unique O 0 3.6404215687964314e-14
organization O 0 7.789356724734187e-13
of O 0 5.686133530170834e-13
EGF O 0 0.033496107906103134
and O 0 2.395842990665642e-08
LDLR O 0 0.00019785754557233304
repeats O 0 3.5318325330990774e-07
; O 0 2.59437924702427e-13
therefore O 0 1.7296998252105955e-13
, O 0 3.659762041487678e-14
LRP5 O 0 4.968124471815827e-07
likely O 0 1.4420202011644623e-11
represents O 0 8.951785710267779e-14
a O 0 8.484729032646326e-14
new O 0 3.393445247024118e-11
category O 0 1.8433716775234643e-09
of O 0 1.6411615718758127e-13
the O 0 1.9442737350661154e-11
LDLR O 0 9.361038246424869e-05
family O 0 4.247253659883654e-10
. O 0 3.1499504393739386e-11

Both O 0 3.5889555216606084e-10
human O 0 1.2016865280628508e-10
and O 0 4.6030176198419426e-12
mouse O 0 1.2500388493208447e-06
LRP5 O 0 0.00026259885635226965
cDNAs O 0 5.157702531732866e-08
have O 0 3.5614185212029525e-11
been O 0 2.3330974305291186e-11
isolated O 0 2.195835457907691e-10
and O 0 4.724492823869608e-13
the O 0 4.248050489679404e-16
encoded O 0 5.5728178148528595e-12
mature O 0 1.349485384549709e-10
proteins O 0 6.909838369886789e-13
are O 0 5.91306924214649e-14
95 O 0 8.639019404357851e-13
% O 0 7.814322783685282e-14
identical O 0 2.5283025673061843e-10
, O 0 1.8443991993410958e-12
indicating O 0 2.441836455258084e-10
a O 0 5.151343240861195e-11
high O 0 1.1198268339285278e-06
degree O 0 3.2339729852393084e-12
of O 0 5.347351183268394e-15
evolutionary O 0 3.119075527371895e-12
conservation O 0 2.721067642041941e-11
. O 0 1.3407448708115804e-13
. O 0 5.206807207613906e-12

The O 0 5.078971618277528e-11
APC B-Disease 0 1.6591057416803778e-08
variants O 0 4.704133194088911e-10
I1307K O 0 5.02263730606245e-10
and O 0 1.1248161148162683e-13
E1317Q O 0 5.344466535994741e-11
are O 0 2.038263492449427e-13
associated O 0 5.993255336456116e-10
with O 1 0.7520868182182312
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 5.3069329624122474e-06
but O 0 1.1488535678338962e-09
not O 0 1.6220386145349153e-09
always O 0 1.1028442159499718e-08
with O 0 7.566281043543122e-13
a O 0 2.820339231254798e-12
family O 0 1.231618140806745e-10
history O 0 1.4689045535476453e-09
. O 0 4.4755585348887905e-10

Classical O 1 0.9856196641921997
familial B-Disease 1 0.9999994039535522
adenomatous I-Disease 1 0.9999662637710571
polyposis I-Disease 1 0.9999992847442627
( O 0 5.2840537279053024e-08
FAP B-Disease 0 2.719194469591457e-07
) O 0 1.5894046061920575e-12
is O 0 1.7426744726087295e-13
a O 0 1.509190515613934e-11
high O 0 0.056015413254499435
- O 1 0.9999970197677612
penetrance O 1 0.9999983310699463
autosomal B-Disease 1 0.9999998807907104
dominant I-Disease 1 0.9998698234558105
disease I-Disease 1 0.9621404409408569
that O 0 2.7494036236065666e-13
predisposes O 0 3.9228394838053404e-11
to O 0 7.525997850637602e-16
hundreds O 0 1.0092671158176952e-14
or O 0 9.96250540288672e-14
thousands O 0 1.3953413077749666e-12
of O 0 8.45127274828883e-08
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9908479452133179
carcinoma I-Disease 1 1.0
and O 0 1.637192639236673e-07
that O 0 4.730265658337007e-12
results O 0 1.2108983087066871e-11
from O 0 1.4386891200937613e-13
truncating O 0 7.366650578433109e-08
mutations O 0 1.5543646725291183e-07
in O 0 2.592903715630153e-14
the O 0 5.106453319003376e-14
APC B-Disease 0 9.305496817546555e-09
gene O 0 2.335530657759932e-09
. O 0 3.3072641847375905e-11

A O 0 9.234150666337371e-10
variant O 0 4.2978232528412263e-08
of O 0 5.618058102063728e-12
FAP B-Disease 0 6.4179357650573365e-06
is O 0 2.4375113483188215e-08
attenuated B-Disease 1 0.764617383480072
adenomatous I-Disease 1 0.9999994039535522
polyposis I-Disease 1 0.9999896287918091
coli I-Disease 1 1.0
, O 0 2.1101359548580945e-10
which O 0 6.040606654201391e-14
results O 0 6.978207074681553e-13
from O 0 1.1024676180651505e-12
germ O 0 0.0011668129591271281
- O 0 1.1870230082422495e-05
line O 0 4.004270408586308e-07
mutations O 0 2.0042934067987517e-07
in O 0 2.5111651039827487e-13
the O 0 2.388869267330729e-13
5 O 0 4.7974513250892414e-11
and O 0 9.949640937534365e-12
3 O 0 4.78800376083055e-13
regions O 0 1.7377378968294957e-14
of O 0 7.753296495055333e-16
the O 0 8.606697711292799e-14
APC B-Disease 0 3.13483150549132e-09
gene O 0 1.2198195786794486e-09
. O 0 1.7871561869275965e-11

Attenuated B-Disease 1 0.9969502091407776
adenomatous I-Disease 1 0.999984860420227
polyposis I-Disease 1 0.9999507665634155
coli I-Disease 1 0.9999998807907104
patients O 1 0.9779415726661682
have O 0 4.518268070796694e-08
" O 0 7.889699449314946e-10
multiple O 0 1.2249773135408759e-05
" O 1 0.995163083076477
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 1.028312324180547e-09
typically O 0 8.9040467707302e-12
fewer O 0 1.2688259731080676e-12
than O 0 6.078330113540309e-14
100 O 0 1.8874889173327303e-13
) O 0 1.3584151978187492e-14
without O 0 8.808732687498252e-14
the O 0 1.5765626380347814e-13
florid O 0 3.163846429288242e-07
phenotype O 0 9.032396497410389e-10
of O 0 7.189917200023724e-14
classical O 0 3.307556173393067e-10
FAP B-Disease 0 6.451955982811342e-07
. O 0 5.6956259153473354e-11

Another O 0 8.617934699195473e-10
group O 0 8.648607524586183e-11
of O 0 7.061752983587855e-14
patients O 0 1.7396207738218372e-11
with O 0 6.880274345047455e-13
multiple O 0 4.292219912827022e-08
adenomas B-Disease 1 0.9939232468605042
has O 0 7.244532298500417e-07
no O 0 1.2984904818047482e-10
mutations O 0 2.394169751340769e-09
in O 0 1.5397530933646333e-14
the O 0 6.739015134772305e-14
APC B-Disease 0 6.89631352024378e-10
gene O 0 6.376405514707528e-10
, O 0 2.7598591272569306e-13
and O 0 1.4931614972235607e-12
their O 0 5.668288104512809e-13
phenotype O 0 4.546645282488271e-10
probably O 0 1.38777558889025e-10
results O 0 2.7091141829860277e-12
from O 0 1.0492567101630379e-12
variation O 0 1.1757098627995788e-09
at O 0 3.2868483490489098e-09
a O 0 7.619027804495193e-12
locus O 0 1.1286017098655066e-07
, O 0 1.67399219486164e-11
or O 0 3.211108028783327e-12
loci O 0 6.734707930222683e-11
, O 0 4.0806751424107834e-13
elsewhere O 0 8.074953466302714e-13
in O 0 4.151386030947559e-16
the O 0 1.3603468564549626e-14
genome O 0 3.556670069571055e-09
. O 0 1.0991995508247143e-10

Recently O 0 8.679066922923084e-06
, O 0 1.494095971076026e-12
however O 0 4.482640319591717e-14
, O 0 1.6166532241184252e-15
a O 0 2.151881612082098e-14
missense O 0 1.0572627218152775e-07
variant O 0 7.151245426939568e-07
of O 0 1.1773895226829811e-11
APC B-Disease 0 5.130886506776733e-07
( O 0 4.3012810110529265e-13
I1307K O 0 4.285660715197537e-11
) O 0 2.994363451310801e-14
was O 0 2.249883222435467e-12
described O 0 1.998108926579145e-12
that O 0 1.7294054643207657e-14
confers O 0 2.7645917239499385e-12
an O 0 2.4586525849100427e-13
increased O 0 1.5641968786894722e-07
risk O 1 0.7923381924629211
of O 1 0.7847861051559448
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 1.1206602756885786e-08
including O 0 2.852403643144319e-12
multiple O 0 1.3758825190279822e-08
adenomas B-Disease 0 0.004685890860855579
, O 0 2.3903676260594864e-10
in O 0 6.0904749125956226e-12
Ashkenazim O 0 0.0019802951719611883
. O 0 8.082223224015195e-10

We O 0 7.519427072111284e-07
have O 0 2.951697566921929e-11
studied O 0 1.3157872361113654e-11
a O 0 1.9485289914238958e-14
set O 0 3.9090025704194287e-13
of O 0 6.726756619849757e-16
164 O 0 3.9728084710866085e-10
patients O 0 4.474726145176078e-12
with O 0 5.1132028298928045e-12
multiple O 1 0.9373043775558472
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 0.0038744176272302866
/ I-Disease 1 0.8536052703857422
or I-Disease 0 0.028897341340780258
carcinoma I-Disease 1 1.0
and O 0 2.3232276191720302e-07
analyzed O 0 2.4223202217399376e-06
codons O 0 3.2089592423290014e-05
1263 O 0 4.5014778038421355e-07
- O 0 4.426637190135807e-07
1377 O 0 2.6665032848427472e-08
( O 0 1.1483983252194574e-12
exon O 0 3.00462899005538e-09
15G O 0 1.4265877368302426e-08
) O 0 2.688244219513792e-14
of O 0 2.560084026484422e-16
the O 0 8.63100262291208e-16
APC B-Disease 0 4.108638776423312e-11
gene O 0 8.634379669580916e-12
for O 0 2.0758259477657304e-13
germ O 0 4.332169737608638e-06
- O 0 8.328867693307984e-07
line O 0 8.097228487713437e-08
variants O 0 4.092562289059742e-09
. O 0 1.7316096473374287e-11

Three O 0 1.3940770760001442e-09
patients O 0 4.710059009482848e-10
with O 0 2.9765459438587175e-14
the O 0 4.868821613782971e-14
I1307K O 0 3.8068792562739873e-10
allele O 0 3.1313460158166606e-10
were O 0 4.9410957096707175e-12
detected O 0 2.109895591573263e-09
, O 0 8.392499003151595e-15
each O 0 6.340651473920461e-14
of O 0 2.524759221134154e-11
Ashkenazi O 0 5.105337550048716e-06
descent O 0 1.788410770586779e-07
. O 0 4.4033571233725866e-10

Four O 0 2.6725826884899107e-08
patients O 0 1.472563226911916e-08
had O 0 1.578954467174043e-10
a O 0 3.0439817333416386e-12
germ O 0 0.009641697630286217
- O 0 0.0006166591192595661
line O 0 1.0153077028007829e-06
E1317Q O 0 1.9310888443868635e-09
missense O 0 3.4897611467243905e-09
variant O 0 7.929981116205909e-10
of O 0 7.041816030295151e-15
APC O 0 2.7561758431104977e-10
that O 0 2.2345546365955954e-13
was O 0 5.30342436633191e-10
not O 0 5.012870327170127e-12
present O 0 2.1331471745239527e-12
in O 0 2.3000099546276187e-13
controls O 0 7.547846792022028e-09
; O 0 1.6155874449125425e-14
one O 0 6.129462443247441e-14
of O 0 1.2810514435812777e-14
these O 0 2.1770087902522883e-12
individuals O 0 8.239142701427227e-11
had O 0 5.592354579420089e-09
an O 0 1.1491520625697693e-12
unusually O 0 3.1518614107550746e-11
large O 0 9.32068831838162e-12
number O 0 7.223098785757998e-10
of O 0 1.6863363136443432e-11
metaplastic B-Disease 0 0.0003267926222179085
polyps I-Disease 0 9.53337803366594e-05
of I-Disease 0 7.022843678122781e-13
the I-Disease 0 1.7445584907238576e-11
colorectum I-Disease 0 1.618059104657732e-05
. O 0 3.9003373447643597e-11

There O 0 1.7265570917412987e-11
is O 0 8.614580538713126e-14
increasing O 0 3.361231716678299e-14
evidence O 0 3.989693124484273e-12
that O 0 2.523101736220945e-12
there O 0 5.069464813212132e-12
exist O 0 9.134227402229911e-11
germ O 0 1.818854252633173e-05
- O 0 1.220669560098031e-06
line O 0 1.3686167754656253e-08
variants O 0 7.219969067051579e-11
of O 0 2.5770068977376158e-15
the O 0 5.473638289989853e-15
APC B-Disease 0 1.1626385618135338e-11
gene O 0 8.02356824643885e-13
that O 0 9.348265358086693e-16
predispose O 0 1.6693159983656447e-13
to O 0 5.99101194340341e-15
the O 0 8.53611682749035e-15
development O 0 1.5598484418184733e-13
of O 0 5.850877074498051e-12
multiple O 1 0.9985001087188721
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9885966181755066
carcinoma I-Disease 1 1.0
, O 0 4.160961353250059e-09
but O 0 1.3554486526234921e-11
without O 0 8.585376333469785e-12
the O 0 9.691312422704934e-13
florid O 0 5.61939771159814e-07
phenotype O 0 7.648593425280126e-10
of O 0 4.492712303664223e-15
classical O 0 7.705486422537877e-12
FAP B-Disease 0 1.902046076196484e-09
, O 0 4.5823042490447316e-14
and O 0 1.1001768750575416e-14
possibly O 0 1.234838918401024e-13
with O 0 2.95555897464328e-13
importance O 0 3.34716565575377e-09
for O 0 0.022817149758338928
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 0 0.034723468124866486
in O 0 1.6056288785516737e-13
the O 0 1.145765746819391e-13
general O 0 1.375475579788732e-12
population O 0 2.9685689263746554e-14
. O 0 3.977546780440863e-14
. O 0 5.407844311244858e-12

Genomic O 0 2.344659399966531e-08
structure O 0 1.727240683813136e-09
of O 0 2.9566995553287345e-12
the O 0 1.300082153044002e-09
human O 0 0.0004701474099420011
congenital B-Disease 1 0.9999996423721313
chloride I-Disease 1 0.9999414682388306
diarrhea I-Disease 1 1.0
( O 0 9.854392857278071e-09
CLD B-Disease 0 0.00124455988407135
) O 0 1.0756608277706636e-11
gene O 0 1.176661612589669e-08
. O 0 9.775476261797422e-11

Congenital B-Disease 1 0.9999973773956299
chloride I-Disease 1 0.9999614953994751
diarrhea I-Disease 1 1.0
( O 0 3.901824641161511e-07
CLD B-Disease 0 0.2699574828147888
) O 0 4.932202979368583e-10
is O 0 1.538223194652577e-11
caused O 0 1.6185447079819504e-11
by O 0 9.874674862520028e-13
mutations O 0 1.454656171517854e-06
in O 0 4.3030696735869844e-13
a O 0 5.762846796986132e-13
gene O 0 3.772330892104492e-09
which O 0 1.6758952081988299e-12
encodes O 0 2.2874149241403074e-09
an O 0 9.94202387083476e-10
intestinal O 0 0.0007046980317682028
anion O 0 7.40879642080472e-08
transporter O 0 0.00018755100609268993
. O 0 6.253635387309942e-10

We O 0 5.636904276684618e-09
report O 0 1.957610289149425e-11
here O 0 2.2514178089666666e-14
the O 0 5.047976493665544e-16
complete O 0 5.143069198060464e-14
genomic O 0 3.576953663819715e-11
organization O 0 4.493884864925635e-12
of O 0 6.243131723670126e-15
the O 0 1.4640402063413605e-13
human O 0 1.0465908521772871e-11
CLD B-Disease 0 4.0623273633855206e-08
gene O 0 1.1317328185711517e-09
which O 0 9.834182621883125e-14
spans O 0 1.089616244454028e-10
approximately O 0 1.3821359334809102e-10
39kb O 0 7.423477654810995e-05
, O 0 1.776227255556595e-11
and O 0 6.48139744999221e-12
comprises O 0 4.489312394051481e-11
21 O 0 1.7118774453539487e-10
exons O 0 2.791238387089834e-07
. O 0 6.156068016460736e-11

All O 0 7.455537576195326e-11
exon O 0 3.520758582453709e-07
/ O 0 1.617922634977731e-06
intron O 0 1.4848629689367954e-05
boundaries O 0 1.0472713363185449e-08
conform O 0 2.6336960390338504e-10
to O 0 2.6007294530298354e-14
the O 0 2.2677174333772705e-14
GT O 0 1.888003566818952e-07
/ O 0 2.662681879428419e-07
AG O 1 0.9304167628288269
rule O 0 1.7772380789260467e-10
. O 0 8.289517509918465e-12

An O 0 1.1237267626834635e-13
analysis O 0 6.452013402713508e-13
of O 0 5.2857384302015895e-15
the O 0 1.2348734942859308e-14
putative O 0 1.1212940992377796e-10
promoter O 0 1.8873629326066066e-09
region O 0 3.204376054864039e-13
sequence O 0 3.8119906536904224e-12
shows O 0 5.639019251546529e-10
a O 0 1.4952190961065037e-12
putative O 0 6.837300503548249e-09
TATA O 0 0.00028738105902448297
box O 0 6.708076512040861e-07
and O 0 5.641889386232002e-11
predicts O 0 1.1696349444534349e-09
multiple O 0 8.517268140773027e-11
transcription O 0 1.6713656236788665e-08
factor O 0 1.4081008581356969e-10
binding O 0 2.764784234887685e-10
sites O 0 1.256814297079245e-08
. O 0 1.733061055775309e-10

The O 0 7.914380088791528e-12
genomic O 0 6.621316384070042e-09
structure O 0 1.9533266115701053e-09
was O 0 1.3928477295144237e-11
determined O 0 6.5378801310733096e-15
using O 0 2.674505895680743e-15
DNA O 0 1.3774566209878714e-10
from O 0 3.6155084663451985e-15
several O 0 2.3389102243687274e-16
sources O 0 5.398898008548265e-16
including O 0 2.395072733348512e-14
multiple O 0 1.4090197064664522e-10
large O 0 1.91814164551829e-09
- O 0 0.00010312021186109632
insert O 0 8.446697393083014e-06
libaries O 0 2.4921962449298007e-06
and O 0 2.2174007963983444e-14
genomic O 0 2.0440342127225897e-12
DNA O 0 3.01728206864027e-08
from O 0 3.815207524904274e-11
Finnish O 0 2.2773635919293156e-06
CLD B-Disease 0 0.0009481541928835213
patients O 0 1.446662167836621e-07
and O 0 3.585642199821493e-11
controls O 0 1.2732691345718194e-07
. O 0 2.8371324733988956e-10

Exon O 0 1.6015290782434022e-07
- O 0 4.765102801229659e-08
specific O 0 3.0725363225903024e-11
primers O 0 2.518455914923834e-07
developed O 0 7.894310094513912e-09
in O 0 8.53377224029235e-15
this O 0 1.6945668350875628e-16
study O 0 3.302474735193163e-14
will O 0 3.0929951525329735e-13
facilitate O 0 1.5237843539045448e-13
mutation O 0 2.843171184596649e-11
screening O 0 1.9330670397721406e-10
studies O 0 2.301898255341328e-12
of O 0 3.274756767840392e-14
patients O 0 1.1554201605895598e-12
with O 0 1.7929270061342074e-14
the O 0 1.7515735389883602e-11
disease O 0 2.7811049221782014e-05
. O 0 1.0113310189296953e-10

Genomic O 0 6.609124358902818e-10
sequencing O 0 3.7343014791524354e-10
of O 0 1.4128451013284415e-12
a O 0 3.3109170786971287e-12
BAC O 0 8.096440495819479e-08
clone O 0 7.159889355534688e-05
H O 1 0.9999998807907104
_ O 0 9.094122677133498e-11
RG364P16 O 0 7.856449518728326e-11
revealed O 0 2.4469695714124384e-10
the O 0 5.050639946416538e-14
presence O 0 2.602086731848252e-12
of O 0 6.648032318940758e-16
another O 0 7.273341000660349e-13
, O 0 6.748349183741164e-15
highly O 0 5.158451401085897e-15
homologous O 0 2.387074641684722e-13
gene O 0 2.378647556700031e-10
3 O 0 7.209960493220757e-12
of O 0 1.3585059150474001e-14
the O 0 1.5954336376328149e-12
CLD B-Disease 0 4.151992015977157e-06
gene O 0 9.053792382474057e-08
, O 0 1.5827390667608882e-13
with O 0 1.1185213217061122e-14
a O 0 2.86821110753125e-14
similar O 0 1.1845919752929979e-13
genomic O 0 6.038870736801982e-09
structure O 0 3.8116350964401136e-08
, O 0 7.787663200940764e-13
recently O 0 8.483128643987925e-10
identified O 0 5.5802718001984886e-09
as O 0 5.383739232200924e-09
the O 0 7.513609034504043e-06
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 3.3588307815080043e-06
( O 0 3.917812688852829e-12
PDS B-Disease 0 3.115573576906172e-08
) O 0 3.0397098683618284e-13
. O 0 3.4877757284926605e-14
. O 0 3.922867239380956e-12

The O 0 7.398731627361599e-11
APCI1307K O 0 2.3721138859400526e-05
allele O 0 3.77082642444293e-06
and O 0 4.5722782004986584e-08
cancer B-Disease 0 1.8467071640770882e-05
risk O 0 2.256890866192407e-06
in O 0 7.035674126631974e-13
a O 0 3.17115778081245e-11
community O 0 5.126992580484213e-12
- O 0 7.486967490422103e-09
based O 0 4.568660120357615e-12
study O 0 2.7371195587821973e-12
of O 0 2.516632735538593e-12
Ashkenazi O 0 2.363950457606734e-08
Jews O 0 3.23851778727402e-11
. O 0 6.584230556605508e-12

Mutations O 0 1.862126555352006e-05
in O 0 7.050562824545414e-12
APC O 0 2.1225248758582893e-07
are O 0 1.652723270739731e-11
classically O 0 2.6883431928581558e-05
associated O 0 8.40435063764744e-08
with O 0 0.00037054342101328075
familial B-Disease 1 1.0
adenomatous I-Disease 1 0.9999991655349731
polyposis I-Disease 1 0.9999997615814209
( O 0 1.881831934724687e-08
FAP B-Disease 0 2.994458370153552e-08
) O 0 1.6937098696202108e-13
, O 0 4.294997026083177e-15
a O 0 4.1442270622138455e-12
highly O 0 1.9578579667722806e-05
penetrant O 1 0.9999963045120239
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 1.310809125243395e-06
by O 0 1.6153004281371786e-11
multiple O 0 1.0216530426987447e-05
intestinal O 1 0.9320493340492249
polyps B-Disease 1 0.9987568855285645
and O 0 1.2478498234713697e-08
, O 0 1.0879226122403884e-12
without O 0 1.003839286001229e-11
surgical O 0 9.326224699179875e-07
intervention O 0 1.1202872657323226e-10
, O 0 1.081093307459197e-14
the O 0 1.8517007588716994e-14
development O 0 4.631953154365931e-10
of O 0 4.898804036201909e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 2.3488162526064116e-09
CRC B-Disease 0 4.4838438952865545e-06
) O 0 1.6835659602532083e-11
. O 0 1.5365340944040184e-11

APC B-Disease 0 2.8893377930216957e-06
is O 0 1.1879061623254472e-10
a O 0 3.757577582419458e-11
tumour O 1 0.9999996423721313
- O 0 4.5209151267044945e-07
suppressor O 0 7.055795947508159e-08
gene O 0 7.605937639709737e-07
, O 0 5.8849461762044974e-12
and O 0 4.5025566391618255e-13
somatic O 0 3.418056948589765e-08
loss O 0 5.240243794446542e-08
occurs O 0 2.6559098031953e-08
in O 0 7.541827717894023e-10
tumours B-Disease 1 1.0
. O 0 4.1720809917933366e-08

The O 0 1.1306382913245372e-10
germline O 0 5.83380096941255e-06
T O 0 0.0004605670692399144
- O 0 1.4252386826285601e-08
to O 0 1.4421956467600139e-12
- O 0 1.1507329533699817e-09
A O 0 1.5974432063595168e-12
transversion O 0 1.937937366136566e-09
responsible O 0 8.10784165500289e-13
for O 0 8.41143738930278e-16
the O 0 3.759778082536866e-15
APC O 0 1.4901585521087668e-10
I1307K O 0 3.0274162083482326e-12
allele O 0 1.6246051270756012e-13
converts O 0 3.274625647140157e-14
the O 0 4.214720749056572e-15
wild O 0 6.963379317603824e-10
- O 0 2.549577216015564e-09
type O 0 1.2088042788960252e-09
sequence O 0 2.4833890152620164e-11
to O 0 1.8274301342990906e-12
a O 0 1.6997966922893681e-10
homopolymer O 0 0.00226040743291378
tract O 0 0.00040814134990796447
( O 0 2.7221044428954455e-12
A8 O 0 8.481015356665011e-07
) O 0 5.570474230541869e-14
that O 0 3.1185351779497873e-15
is O 0 1.9423739418093777e-13
genetically O 0 1.1356931395312131e-07
unstable O 0 3.781622808674001e-06
and O 0 4.0597977757350634e-10
prone O 0 7.895380349509651e-07
to O 0 1.2919525475482696e-12
somatic O 0 4.830522470911092e-07
mutation O 0 1.130578993979725e-06
. O 0 3.0937905015626654e-10

The O 0 5.224138482917695e-11
I1307K O 0 1.1167681890356107e-08
allele O 0 6.7545640192179235e-09
was O 0 5.79725156768518e-10
found O 0 1.4150572207050072e-11
in O 0 7.804699811778115e-14
6 O 0 3.218726951637052e-10
. O 0 8.35134652404923e-12

1 O 0 3.4201290688429253e-09
% O 0 2.870010479272267e-11
of O 0 2.9886875851752037e-13
unselected O 0 0.00039312339504249394
Ashkenazi O 0 1.4192311027727555e-05
Jews O 0 1.4589746077930954e-10
and O 0 3.75537066721332e-11
higher O 0 6.535524899042855e-11
proportions O 0 1.2025383355762642e-08
of O 0 5.705626509450168e-12
Ashkenazim O 0 4.2272800783393905e-05
with O 0 5.913664002932251e-11
family O 0 4.685630702883081e-11
or O 0 1.069560690014626e-10
personal O 0 1.937478844027396e-09
histories O 0 7.283368574917404e-08
of O 0 4.363732292178568e-11
CRC B-Disease 0 5.1117895054630935e-05
( O 0 6.390388652272039e-12
ref O 0 1.5113943163669319e-06
. O 0 1.1273978712394994e-13
2 O 0 1.949791239921894e-12
) O 0 3.088420361466171e-13
. O 0 6.350458353621136e-13

To O 0 2.182946315029688e-12
evaluate O 0 9.383481491820334e-11
the O 0 3.205768305978782e-14
role O 0 2.2243089314866182e-11
of O 0 2.7360400864416892e-15
I1307K O 0 1.5231067795884456e-10
in O 0 2.3673271527216606e-14
cancer B-Disease 0 1.4235481682334239e-09
, O 0 2.9249392079384873e-13
we O 0 6.106879585354719e-11
genotyped O 0 1.760865728783756e-07
5 O 0 2.4258197880988597e-11
, O 0 5.713267857941629e-13
081 O 0 2.1196788679844758e-07
Ashkenazi O 0 1.9441245058260392e-08
volunteers O 0 5.511654934536869e-12
in O 0 4.641130263715069e-15
a O 0 1.9012370074556612e-13
community O 0 8.562182538494889e-13
survey O 0 2.4915296492622474e-08
. O 0 3.564898029551067e-11

Risk O 0 2.2079761038185097e-05
of O 0 3.9070535001739515e-11
developing O 0 0.00045746134128421545
colorectal B-Disease 1 1.0
, I-Disease 0 2.7156025339536427e-07
breast I-Disease 0 0.39733654260635376
and I-Disease 0 7.691757986094672e-08
other I-Disease 0 8.862692524314042e-11
cancers I-Disease 0 1.9390090528759174e-05
were O 0 1.2728406002804338e-11
compared O 0 5.2277943259071424e-12
between O 0 9.047297416450717e-13
genotyped O 0 1.5488911913053016e-06
I1307K O 0 4.776465445388567e-09
carriers O 0 2.526510334277532e-09
and O 0 1.759803782731828e-12
non O 0 1.2311091035499544e-09
- O 0 4.641660211746057e-08
carriers O 0 4.6219064131491905e-08
and O 0 1.829843785175478e-12
their O 0 1.979172271763304e-14
first O 0 2.8526065190548344e-11
- O 0 1.8954304792373478e-08
degree O 0 4.651896489543672e-12
relatives O 0 2.818646878399722e-11
. O 0 1.96910565110342e-12

Sperm O 0 2.2129365007117485e-09
DNA O 0 2.8651785388689177e-09
analysis O 0 9.510620069264064e-11
in O 0 1.678409581457041e-12
a O 0 4.2603462424573024e-11
Friedreich B-Disease 0 0.003361252136528492
ataxia I-Disease 1 0.9929046034812927
premutation O 0 0.07025451958179474
carrier O 0 5.881462357137934e-07
suggests O 0 3.364843403907969e-10
both O 0 2.6460536778176447e-13
meiotic O 0 1.2064508503328852e-08
and O 0 2.7803607940274366e-12
mitotic O 0 1.0127618743638322e-09
expansion O 0 2.8045549216315635e-10
in O 0 2.906441092572626e-14
the O 0 3.518124105841153e-13
FRDA B-Disease 0 2.47012189902307e-06
gene O 0 3.876726495377625e-09
. O 0 3.963754324765034e-11

Friedreich B-Disease 1 0.9813995957374573
ataxia I-Disease 1 0.9999263286590576
is O 0 1.3975707588542718e-05
usually O 0 6.859322887464714e-09
caused O 0 8.680085296364215e-12
by O 0 2.154813066057603e-15
an O 0 1.9580215202571853e-14
expansion O 0 5.045817097482086e-10
of O 0 2.4184868517573843e-12
a O 0 5.953958992499508e-10
GAA O 0 4.975837782694725e-06
trinucleotide O 0 1.1231766620767303e-05
repeat O 0 2.1570191677255934e-07
in O 0 2.673325157163259e-13
intron O 0 5.232231092833217e-09
1 O 0 7.915674409345042e-13
of O 0 1.8208305160540743e-15
the O 0 5.208539762685538e-14
FRDA B-Disease 0 7.742921752651455e-07
gene O 0 2.266802079375907e-09
. O 0 8.179919415429726e-12

Occasionally O 0 1.341479446637095e-06
, O 0 7.535834478135384e-13
a O 0 2.9107030913126664e-13
fully O 0 1.1614932626802243e-10
expanded O 0 3.3398665777450987e-11
allele O 0 6.186982037803546e-10
has O 0 6.037332439534637e-11
been O 0 9.536987085473347e-13
found O 0 3.29107791366412e-12
to O 0 6.027153060493562e-14
arise O 0 2.1102063239158975e-12
from O 0 1.1638720798009942e-15
a O 0 3.0913660032435425e-14
premutation O 0 5.9267915020200235e-09
of O 0 5.295708431507246e-15
100 O 0 8.83437542413025e-14
or O 0 4.569426868133997e-12
less O 0 3.381877677205436e-12
triplet O 0 8.691869879839942e-05
repeats O 0 1.7724939880281454e-06
. O 0 7.309005484179565e-11

We O 0 9.906484876864852e-08
have O 0 2.332767009075032e-12
examined O 0 8.857803379669349e-12
the O 0 4.384169213698762e-16
sperm O 0 8.643996976531731e-13
DNA O 0 1.1214379425084076e-09
of O 0 2.0804873394810602e-13
a O 0 9.400243604351655e-12
premutation O 0 1.772819996403996e-05
carrier O 0 1.544414516274628e-07
. O 0 3.2827851548233866e-11

This O 0 1.4214350183006097e-12
mans O 0 5.057137486552676e-10
leucocyte O 0 2.427022138817847e-08
DNA O 0 5.239034521764552e-07
showed O 0 1.386893728749783e-07
one O 0 1.0772371493092403e-12
normal O 0 9.693830807511183e-12
allele O 0 2.3350228417484686e-09
and O 0 2.4700581857661774e-11
one O 0 3.37148589753776e-14
allele O 0 1.813879883967584e-12
of O 0 8.971365342711683e-16
approximately O 0 5.907164948165677e-13
100 O 0 3.1819286788747903e-12
repeats O 0 9.947648749175642e-08
. O 0 2.9116389854699776e-11

His O 0 4.390029312295596e-11
sperm O 0 3.513102253549505e-09
showed O 0 2.64635136026925e-09
an O 0 3.488481137531134e-14
expanded O 0 3.748273635917343e-10
allele O 0 3.4218647915196243e-09
in O 0 3.800984266916219e-12
a O 0 1.3875611770686191e-10
tight O 0 1.4890838428982534e-07
range O 0 3.6327000435543155e-11
centering O 0 9.277521806350109e-11
on O 0 5.4607785307525525e-12
a O 0 6.906959067729847e-15
size O 0 8.774122921273442e-14
of O 0 5.205356274056577e-16
approximately O 0 1.4581106504499286e-12
320 O 0 2.64258226412295e-10
trinucleotide O 0 7.142794515857531e-07
repeats O 0 8.951527661338332e-07
. O 0 5.5610134552797064e-11

His O 0 9.373223086583948e-09
affected O 0 3.685621763338531e-08
son O 0 7.313184937629558e-07
has O 0 8.080712765590192e-10
repeat O 0 1.6305689021223202e-09
sizes O 0 3.587381502967446e-10
of O 0 5.743914052074375e-14
1040 O 0 5.212684728306272e-10
and O 0 7.422120210098804e-12
540 O 0 6.599639723603445e-10
. O 0 1.1922024131805209e-11

These O 0 1.231736067308642e-13
data O 0 2.985151188739099e-12
suggest O 0 1.879156118905767e-12
that O 0 1.486034433256355e-14
expansion O 0 1.1387449143362982e-11
occurs O 0 6.416451571455983e-12
in O 0 1.667367754824324e-14
two O 0 2.575718284492101e-12
stages O 0 9.131950196028527e-10
, O 0 2.2457705725446864e-13
the O 0 6.947684073020655e-14
first O 0 7.637047660935536e-10
during O 0 4.637471504899404e-13
meiosis O 0 5.870271282959472e-12
followed O 0 6.095073447690003e-13
by O 0 6.426237271097812e-16
a O 0 1.2752297861347989e-14
second O 0 3.9670424063775744e-12
mitotic O 0 2.750207883650546e-08
expansion O 0 2.6411992593011746e-08
. O 0 9.562642344640437e-11

We O 0 1.1101379371325493e-08
also O 0 1.2020846991422918e-11
show O 0 6.162106241935916e-11
that O 0 7.106016214905933e-14
in O 0 9.881498009371693e-16
all O 0 5.5345484292269095e-15
informative O 0 7.7648741603209e-11
carrier O 0 3.611327348274074e-10
father O 0 1.8289651043668087e-11
to O 0 2.0625100477338065e-13
affected O 0 2.5605201986467208e-11
child O 0 1.6496888299855073e-09
transmissions O 0 3.991679875525733e-08
, O 0 2.6296800227274507e-14
with O 0 1.6691107156957129e-15
the O 0 2.4369588937550634e-15
notable O 0 3.1469460284178075e-12
exception O 0 1.5647967296916754e-11
of O 0 2.854774115669187e-14
the O 0 4.3837264547541555e-12
premutation O 0 3.484340368231642e-06
carrier O 0 1.413240635628199e-09
, O 0 8.511952142175488e-16
the O 0 1.2956959762008586e-16
expansion O 0 2.9549630971292817e-12
size O 0 6.6095372230901e-11
decreases O 0 9.770639408657189e-09
. O 0 4.070856878587298e-13
. O 0 1.436935379711679e-11

The O 0 2.615557770369037e-11
R496H O 0 4.158295485723329e-09
mutation O 0 1.780981806476234e-09
of O 0 1.0625318848508578e-13
arylsulfatase O 0 3.820216079475358e-06
A O 0 9.222761998550766e-10
does O 0 2.74505485009513e-09
not O 0 7.921183708958779e-10
cause O 0 3.3402919541458687e-08
metachromatic B-Disease 1 0.9999980926513672
leukodystrophy I-Disease 1 0.9999959468841553
. O 0 2.5024741390211602e-08

Deficiency B-Disease 1 0.9996885061264038
of I-Disease 0 2.6665144051141176e-11
arylsulfatase I-Disease 0 6.0544320149347186e-05
A I-Disease 0 3.915726409786657e-09
( O 0 2.4226894795864595e-11
ARSA O 0 0.0005407247226685286
) O 0 1.2221635162235067e-11
enzyme O 0 4.9723321353667416e-06
activity O 0 9.250424227502663e-06
causes O 0 0.00010485976963536814
metachromatic B-Disease 1 0.9999998807907104
leukodystrophy I-Disease 1 0.9999997615814209
( O 0 6.688312623737147e-07
MLD B-Disease 1 0.9999895095825195
) O 0 1.1086471324306402e-10
. O 0 1.455255360660601e-11

A O 0 1.444972475006523e-10
number O 0 1.1808725655301777e-12
of O 0 3.662962403012948e-13
ARSA O 0 0.005090121179819107
gene O 0 2.7517958187672775e-06
mutations O 0 1.7100292097893544e-06
responsible O 0 3.243838975208746e-08
for O 0 5.283826709501227e-10
MLD B-Disease 1 1.0
have O 0 4.666263819785854e-09
been O 0 1.870752858179614e-11
identified O 0 7.227660692166182e-10
. O 0 3.1451355408940174e-11

Recently O 0 1.1459869710961357e-06
, O 0 4.1496192875085935e-13
the O 0 2.019690601014982e-14
R496H O 0 1.802376720094756e-10
mutation O 0 1.1073707228970164e-10
of O 0 4.1037455416259236e-14
ARSA O 0 5.4295007430482656e-05
was O 0 7.271521162977024e-10
proposed O 0 4.832446292082904e-13
to O 0 6.874001015752182e-14
be O 0 1.2338859317964634e-12
a O 0 3.626521283793538e-13
cause O 0 3.8744975977555995e-11
of O 0 1.473511312966025e-10
MLD B-Disease 1 0.9999996423721313
( O 0 2.2950263911525326e-10
Draghia O 0 6.385234883055091e-07
et O 0 1.6780800748961155e-08
al O 0 4.9925940714956596e-08
. O 0 1.0151299939531455e-11
, O 0 3.188974691953339e-13
1997 O 0 3.2668431761834205e-12
) O 0 1.1686871359984502e-13
. O 0 2.134184972843456e-12

We O 0 8.434436482573915e-10
have O 0 1.0582441363092207e-13
investigated O 0 4.06027607369186e-11
the O 0 4.721048923431344e-14
R496H O 0 7.309733929261597e-10
mutation O 0 1.6005016201248168e-09
and O 0 7.86606782314514e-13
found O 0 4.761193067408243e-13
this O 0 3.0496066013175477e-16
mutation O 0 1.2367044888161871e-11
at O 0 6.415791075492505e-12
a O 0 4.4537917326609514e-14
relatively O 0 2.111210647493325e-14
high O 0 2.8410137090095766e-11
frequency O 0 2.1738012865452072e-12
in O 0 6.391699100332868e-14
an O 0 2.4321983229519395e-12
African O 0 1.3593841330372669e-11
American O 0 6.761423886059159e-12
population O 0 7.138343904964251e-15
( O 0 5.1992196897603093e-14
f O 0 2.6053250223867508e-08
= O 0 5.0996477873876955e-11
0 O 0 9.183639092247287e-13
. O 0 3.421151504993426e-14
09 O 0 1.8572234861125025e-09
, O 0 1.3443791435988062e-12
n O 0 3.7731318514033774e-08
= O 0 6.692278731179613e-09
61 O 0 6.591663326283026e-10
subjects O 0 1.6983262574044033e-09
) O 0 4.031074953003699e-12
. O 0 4.654150329019835e-12

The O 0 2.2480067807251203e-10
ARSA O 0 9.758178202901036e-05
enzyme O 0 2.3979839625098975e-06
activity O 0 2.0242589826580115e-08
in O 0 1.191523821882784e-13
subjects O 0 7.795729617399161e-10
with O 0 4.631571168256521e-11
and O 0 2.3066548671124565e-11
without O 0 9.223311133940704e-13
the O 0 1.301796669593569e-13
R496H O 0 8.505194881713862e-10
mutation O 0 3.2598646004800003e-09
was O 0 7.687735781303218e-09
determined O 0 4.098481554137834e-10
and O 0 2.769786830447707e-11
found O 0 1.732194249148833e-11
to O 0 4.45943818981262e-13
be O 0 9.894083469186299e-11
normal O 0 9.123848898617837e-11
. O 0 1.2978510627315032e-11

It O 0 3.970596629265799e-10
is O 0 1.0922458250350875e-11
therefore O 0 4.3232063572486504e-14
concluded O 0 6.7344727884555144e-12
that O 0 8.2177196837163e-15
the O 0 1.391358765533016e-14
R496H O 0 1.0919839338319193e-10
mutation O 0 6.347897901770594e-11
of O 0 1.0379144646608524e-13
ARSA O 0 2.5709787223604508e-05
does O 0 3.729580186351278e-11
not O 0 5.0085352938612424e-14
negatively O 0 1.916306740026852e-12
influence O 0 1.8655548297569907e-14
the O 0 4.541598386698532e-15
activity O 0 2.409042132445194e-10
of O 0 3.150367607843846e-13
ARSA O 0 0.017409637570381165
and O 0 2.408362120842611e-10
is O 0 1.4390521109811094e-12
not O 0 7.357164871898622e-14
a O 0 2.8800754641421233e-13
cause O 0 5.5066031595663034e-11
of O 0 4.65419258688371e-09
MLD B-Disease 1 0.9999948740005493

Down O 0 1.4365738934429828e-05
- O 0 1.0419793170513003e-06
regulation O 0 1.548961958697248e-09
of O 0 3.683180876176001e-13
transmembrane O 0 4.420102754920663e-07
carbonic O 0 4.998253189114621e-06
anhydrases O 0 0.00011112370702903718
in O 0 3.4738606435880115e-10
renal B-Disease 0 0.37280359864234924
cell I-Disease 1 0.9944213032722473
carcinoma I-Disease 1 1.0
cell O 0 0.4152247905731201
lines O 0 2.3237861057623377e-07
by O 0 1.41789054455832e-12
wild O 0 9.932374268828426e-06
- O 1 0.741084098815918
type O 1 0.8896840214729309
von B-Disease 1 0.9999752044677734
Hippel I-Disease 1 0.9988779425621033
- I-Disease 1 0.9483454823493958
Lindau I-Disease 1 0.848926842212677
transgenes O 0 0.00042259966721758246
. O 0 9.22867915420511e-09

To O 0 2.8621261177058654e-12
discover O 0 1.029988178080643e-10
genes O 0 1.9968089404187594e-09
involved O 0 5.882755615971291e-09
in O 0 3.556403782578599e-10
von B-Disease 1 0.9999819993972778
Hippel I-Disease 1 0.9999871253967285
- I-Disease 1 0.9999916553497314
Lindau I-Disease 1 0.9999008178710938
( O 0 9.33036048422764e-09
VHL B-Disease 0 0.00011846557754324749
) O 0 3.526564240283192e-12
- O 0 1.2792020775975743e-08
mediated O 0 3.343619425777433e-08
carcinogenesis O 0 3.814635192611604e-06
, O 0 4.3347395117798726e-11
we O 0 1.7430228094195144e-10
used O 0 3.7200285074590056e-09
renal B-Disease 0 0.08022426068782806
cell I-Disease 1 0.9881712198257446
carcinoma I-Disease 1 1.0
cell O 1 0.999349057674408
lines O 0 0.0049496362917125225
stably O 0 0.005556189455091953
transfected O 0 6.955242133699358e-05
with O 0 2.0558049707020132e-10
wild O 0 1.6834594134707004e-05
- O 0 0.3790433704853058
type O 0 0.09282395243644714
VHL O 0 0.3076142370700836
- O 0 5.555272309720749e-06
expressing O 0 2.7525943746553594e-09
transgenes O 0 1.0213365158051602e-06
. O 0 1.9632685754888968e-10

Large O 0 5.06376829356725e-10
- O 0 6.837460375663795e-08
scale O 0 1.0577020148616612e-08
RNA O 0 5.432734262456052e-10
differential O 0 2.0918705656569614e-10
display O 0 1.3668484746820475e-11
technology O 0 9.384448079741148e-11
applied O 0 3.576337576777222e-12
to O 0 1.3137489482243671e-14
these O 0 1.5364644032436238e-14
cell O 0 2.002857601990371e-10
lines O 0 8.02006128175492e-10
identified O 0 1.3664477882535664e-10
several O 0 7.55799841657169e-14
differentially O 0 2.8540951824140848e-09
expressed O 0 2.0882396560648747e-13
genes O 0 4.746651422610215e-12
, O 0 3.01463112861776e-15
including O 0 7.999752695399352e-15
an O 0 7.970817202888197e-14
alpha O 0 1.2482382315270879e-11
carbonic O 0 1.2230771950783037e-08
anhydrase O 0 8.491388925335741e-09
gene O 0 1.2369187452065944e-08
, O 0 1.6601342696376253e-12
termed O 0 1.9824795138845275e-09
CA12 O 0 3.745391950360499e-05
. O 0 5.866167274160006e-11

The O 0 3.22767485481934e-12
deduced O 0 3.526512415419347e-11
protein O 0 7.88572401821952e-11
sequence O 0 5.5496306335112155e-12
was O 0 1.5282304935415603e-11
classified O 0 8.664412520786868e-10
as O 0 3.1487353956832775e-12
a O 0 8.885210817967393e-13
one O 0 2.4689301714175826e-09
- O 0 0.0012629317352548242
pass O 0 0.00011305711814202368
transmembrane O 0 0.0034462870098650455
CA O 0 6.236597982933745e-05
possessing O 0 4.1131622197099205e-07
an O 0 1.6835330872433385e-12
apparently O 0 3.5760072680801613e-10
intact O 0 2.959369554966784e-11
catalytic O 0 1.1237119013074448e-09
domain O 0 1.9793924277422548e-09
in O 0 1.458171907872674e-12
the O 0 1.6494030533747983e-12
extracellular O 0 3.592650799078001e-08
CA O 0 9.423970368516166e-06
module O 0 4.183596047369065e-08
. O 0 2.935863704922603e-11

Reintroduced O 0 4.2867014826697414e-07
wild O 0 6.159028544061584e-06
- O 0 0.022406764328479767
type O 0 0.0006798207759857178
VHL B-Disease 0 0.0005073949578218162
strongly O 0 1.51887710742038e-10
inhibited O 0 1.9261513217738724e-10
the O 0 2.943460879290612e-15
overexpression O 0 3.490208339354539e-12
of O 0 4.084035000240021e-15
the O 0 2.6779680157977027e-14
CA12 O 0 6.58626504446147e-08
gene O 0 2.667604193096196e-10
in O 0 1.0098953601546737e-13
the O 0 1.4775153323043355e-11
parental O 0 0.0005711180856451392
renal B-Disease 0 0.2291417270898819
cell I-Disease 1 0.8873928189277649
carcinoma I-Disease 1 1.0
cell O 1 0.6194162368774414
lines O 0 0.0004925489192828536
. O 0 4.1809133932702025e-09

Similar O 0 5.906070077443815e-10
results O 0 1.6225576437989275e-10
were O 0 9.790001925455427e-13
obtained O 0 2.9172298257607032e-12
with O 0 4.562947675951223e-12
CA9 O 0 5.352408606995596e-06
, O 0 9.95948522220999e-14
encoding O 0 8.007900766104914e-12
another O 0 2.5442348672299886e-08
transmembrane O 0 0.01886112615466118
CA O 0 0.28067126870155334
with O 0 1.402134398170718e-11
an O 0 1.835806626073605e-13
intact O 0 1.0411603801330216e-09
catalytic O 0 2.5228278133226922e-08
domain O 0 3.680879956391436e-08
. O 0 1.8858975492364038e-10

Although O 0 3.181217067549369e-09
both O 0 4.027216927993127e-12
domains O 0 9.095658448643462e-09
of O 0 2.2162137305447444e-13
the O 0 8.3517725070828e-13
VHL B-Disease 0 5.752498850597476e-07
protein O 0 6.514815076297253e-11
contribute O 0 9.835670689364862e-13
to O 0 2.0181127819221545e-13
regulation O 0 1.1487587964209567e-10
of O 0 5.1970114409855e-13
CA12 O 0 4.1123435948975384e-05
expression O 0 1.9080067387156063e-11
, O 0 6.2402031072549945e-15
the O 0 3.3106591910460077e-15
elongin O 0 1.9451224630984143e-08
binding O 0 1.925437760619264e-11
domain O 0 9.149519336615342e-11
alone O 0 3.0410323148544194e-09
could O 0 3.352319810634441e-10
effectively O 0 3.74633168931382e-09
regulate O 0 1.4700212602747342e-07
CA9 O 0 0.00015905106556601822
expression O 0 4.450290091995157e-08
. O 0 1.057079770938607e-10

We O 0 3.5183864710575108e-09
mapped O 0 2.7489866170071764e-06
CA12 O 0 0.0003697506617754698
and O 0 5.5864538689442966e-11
CA9 O 0 5.419129820438684e-07
loci O 0 2.8014555120137175e-09
to O 0 5.7055393395955e-12
chromosome O 0 3.841940724669257e-06
bands O 0 4.157946431604387e-09
15q22 O 0 3.243282264975278e-08
and O 0 2.5498228528597622e-11
17q21 O 0 1.0288150775750182e-08
. O 0 1.0820811260914276e-11

2 O 0 1.3309541024852933e-08
respectively O 0 2.054301972975736e-08
, O 0 5.4027411884594034e-12
regions O 0 4.0877058682387e-11
prone O 0 2.501238896002178e-07
to O 0 2.237888998733121e-14
amplification O 0 8.518767913301417e-10
in O 0 6.834437800851828e-15
some O 0 1.2166100239871178e-14
human O 0 1.685629830161517e-10
cancers B-Disease 0 2.201387360400986e-06
. O 0 2.11449417003573e-11

Additional O 0 2.577267566028496e-11
experiments O 0 3.50909579172054e-10
are O 0 1.1592302638641083e-12
needed O 0 9.580689106641893e-13
to O 0 9.007096368800422e-16
define O 0 2.3140040231184322e-12
the O 0 2.9030410345597113e-13
role O 0 5.318814721988474e-09
of O 0 1.4093623186897664e-12
CA O 0 4.7972131142159924e-05
IX O 0 1.0135354386875406e-05
and O 0 3.662846026486477e-08
CA O 0 2.033279452007264e-05
XII O 0 2.2984064429465434e-08
enzymes O 0 2.824643574594887e-10
in O 0 7.649824538405524e-16
the O 0 1.6417735743560276e-15
regulation O 0 2.1457821630654905e-11
of O 0 1.2765908664370829e-13
pH O 0 6.703965160781422e-10
in O 0 2.0684409046678454e-15
the O 0 4.680726089383892e-15
extracellular O 0 2.2441500047154506e-11
microenvironment O 0 5.612055264947458e-10
and O 0 1.1108553177796229e-13
its O 0 2.611026705514664e-15
potential O 0 2.6316396978254275e-12
impact O 0 2.7726937065764012e-11
on O 0 9.51164147444672e-10
cancer B-Disease 0 3.456389663369919e-08
cell O 0 2.835669299372512e-08
growth O 0 6.902912446093978e-07
. O 0 2.9923754446548045e-11

A O 0 1.7015483466664705e-10
gene O 0 4.6259520658509246e-09
encoding O 0 1.1223233453705461e-10
a O 0 1.4832784306362257e-11
transmembrane O 0 1.501337720810625e-08
protein O 0 3.0948293927579584e-10
is O 0 1.8119425231055697e-13
mutated O 0 5.139218384186961e-09
in O 0 2.382637316611369e-11
patients O 0 1.3980499602439522e-07
with O 0 5.0394384743412957e-05
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.9799506664276123
optic B-Disease 1 0.9999997615814209
atrophy I-Disease 1 0.9999901056289673
( O 0 0.052712973207235336
Wolfram B-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
) O 0 1.6909373901086155e-09
. O 0 8.25937720994041e-11

Wolfram B-Disease 1 0.9999877214431763
syndrome I-Disease 1 1.0
( O 0 1.1537904356373474e-06
WFS B-Disease 0 0.004297045059502125
; O 0 2.6811627917844305e-10
OMIM O 0 0.00013723198208026588
222300 O 0 5.166258461031248e-07
) O 0 4.825724455453928e-12
is O 0 7.924863022756856e-12
an O 0 6.236339777920819e-10
autosomal B-Disease 1 0.9999997615814209
recessive I-Disease 1 0.9999998807907104
neurodegenerative I-Disease 1 0.9999986886978149
disorder I-Disease 1 0.9999933242797852
defined O 0 4.705502121282734e-08
by O 0 2.7508856303981588e-11
young O 0 3.4736569887172664e-06
- O 0 0.003545389510691166
onset O 0 0.3344968259334564
non O 0 0.34950727224349976
- O 1 0.5041107535362244
immune O 0 0.2370396852493286
insulin B-Disease 0 0.1017555445432663
- I-Disease 1 0.9580519199371338
dependent I-Disease 1 0.9951456189155579
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 4.933906438964186e-06
progressive O 0 1.8631124021339929e-06
optic B-Disease 1 0.9999871253967285
atrophy I-Disease 1 0.769761323928833
. O 0 4.016008414708949e-09

Linkage O 0 3.0580594057028065e-07
to O 0 4.9826141476638774e-12
markers O 0 8.993653750621888e-07
on O 0 1.4042053742002736e-08
chromosome O 0 0.01289692148566246
4p O 0 0.0037164222449064255
was O 0 6.12658155318968e-08
confirmed O 0 1.158842799497961e-09
in O 0 8.078199296556593e-14
five O 0 2.4108978702308548e-11
families O 0 1.0381848158935725e-11
. O 0 1.5697410385429045e-11

On O 0 2.1127365482098703e-11
the O 0 7.56638946376037e-15
basis O 0 9.083568451454319e-14
of O 0 1.8854512948748153e-14
meiotic O 0 4.208476639178116e-06
recombinants O 0 0.1643911600112915
and O 0 6.693838372484606e-08
disease O 0 6.986757216509432e-05
- O 0 1.6835514315971523e-06
associated O 0 9.567353576045434e-10
haplotypes O 0 5.852563589314741e-08
, O 0 1.073508252777411e-12
the O 0 5.6255801612111606e-14
WFS B-Disease 0 1.0999980304404744e-07
gene O 0 1.5089274274515674e-09
was O 0 4.552448001904352e-11
localized O 0 8.552626662439167e-11
to O 0 9.587726662943497e-13
a O 0 2.0031698522160468e-11
BAC O 0 1.5468303615762125e-07
/ O 0 5.476662678916e-09
P1 O 0 7.580051430977619e-08
contig O 0 2.7772736888032057e-10
of O 0 2.0315378496779028e-16
less O 0 2.7372809367698576e-16
than O 0 7.612679496690462e-16
250 O 0 8.11099302414249e-14
kb O 0 2.3649657521218614e-07
. O 0 5.339677658366959e-11

Mutations O 0 0.00011026038555428386
in O 0 2.0866164698873924e-12
a O 0 1.3723146696700134e-13
novel O 0 4.1867346395330074e-11
gene O 0 4.135328524057513e-08
( O 0 4.271214024825776e-12
WFS1 O 0 7.008635520833195e-07
) O 0 3.025791084159367e-14
encoding O 0 1.709405837366229e-12
a O 0 7.411594775408314e-12
putative O 0 2.610199523189749e-08
transmembrane O 0 2.219074524134612e-08
protein O 0 2.8960893683205313e-09
were O 0 1.6549115593525454e-12
found O 0 4.996165807458208e-12
in O 0 7.230868701924627e-15
all O 0 3.544488487439157e-12
affected O 0 6.637153326938261e-11
individuals O 0 4.910718641622236e-13
in O 0 7.572528758562069e-14
six O 0 2.8760083203849263e-09
WFS B-Disease 0 2.2383730993169593e-06
families O 0 2.7205746336300685e-11
, O 0 4.8857988645513786e-14
and O 0 2.445062652779023e-13
these O 0 3.3853979054766434e-14
mutations O 0 1.1136584099347147e-08
were O 0 6.682705777638631e-11
associated O 0 1.204259673752428e-12
with O 0 9.037609202677821e-12
the O 0 4.651903307006933e-09
disease O 0 0.0031524428632110357
phenotype O 0 1.245967951035709e-07
. O 0 6.06843464368012e-11

WFS1 O 0 0.0002523601579014212
appears O 0 1.6413034487072764e-08
to O 0 8.42024692158938e-13
function O 0 1.2066239500618803e-11
in O 0 2.072067967510624e-13
survival O 0 7.313178951307009e-10
of O 0 1.226459689016024e-12
islet O 0 5.708455864805728e-05
beta O 0 1.8081701469441214e-08
- O 0 2.8142410428699804e-06
cells O 0 1.3485141003855006e-08
and O 0 1.3488310295073358e-11
neurons O 0 1.0095695113232495e-10
. O 0 9.571861261502973e-14
. O 0 2.6847421855102915e-12

Stable O 0 8.91074165565442e-08
interaction O 0 1.658103515600473e-11
between O 0 1.6541343219201449e-13
the O 0 1.2948374130176098e-14
products O 0 8.696073194869314e-09
of O 0 4.9113125980655096e-15
the O 0 7.68520230093328e-12
BRCA1 O 0 0.066708505153656
and O 0 1.861593723617716e-08
BRCA2 O 0 8.701522165210918e-05
tumor B-Disease 0 1.5509701967175715e-08
suppressor O 0 2.012892519331899e-09
genes O 0 3.375233958990975e-08
in O 0 3.245631844880914e-13
mitotic O 0 1.188142846331175e-06
and O 0 6.230220339631387e-09
meiotic O 0 0.00021527222997974604
cells O 0 1.1950862699450227e-06
. O 0 3.011972060651402e-10

BRCA1 O 1 0.9990442395210266
and O 0 5.63763791205929e-08
BRCA2 O 0 0.00022177280334290117
account O 0 2.646686862728398e-11
for O 0 7.125533209263388e-14
most O 0 1.0630057659035286e-14
cases O 0 2.3842134863616415e-12
of O 0 1.7849980662402315e-13
familial O 0 1.71524925463018e-06
, O 0 6.367515022198678e-12
early O 0 2.3530379034131244e-11
onset O 0 1.1035323041141964e-05
breast B-Disease 1 0.9294881224632263
and I-Disease 0 5.847755528520793e-05
/ I-Disease 1 0.9826881289482117
or I-Disease 1 0.9999634027481079
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 3.339242424238442e-11
encode O 0 7.9369948113861e-12
products O 0 1.477319756304496e-06
that O 0 2.1465444574814488e-14
each O 0 1.2280251143227672e-13
interact O 0 1.5396026467606738e-11
with O 0 1.482401701391467e-11
hRAD51 O 0 1.0628547215674189e-06
. O 0 2.6738328565145686e-11

Results O 0 3.5722391711345836e-09
presented O 0 1.391945586570742e-10
here O 0 1.4555098662785704e-12
show O 0 3.911126422728728e-10
that O 0 8.569604227626204e-12
BRCA1 O 0 0.007777716964483261
and O 0 6.831319865341356e-08
BRCA2 O 0 0.001969572389498353
coexist O 0 1.4755941357691427e-08
in O 0 1.5133941056724373e-14
a O 0 9.127299746081521e-14
biochemical O 0 2.503804941156318e-09
complex O 0 1.126541308155149e-11
and O 0 2.418709503515526e-11
colocalize O 0 9.562032801113673e-07
in O 0 5.073796200891212e-13
subnuclear O 0 3.0625042768406274e-07
foci O 0 3.077407439988633e-09
in O 0 1.6169100021563854e-14
somatic O 0 1.1482883532920596e-09
cells O 0 1.5214872695068493e-09
and O 0 3.4435969700763458e-12
on O 0 1.090197268398263e-12
the O 0 3.086521355950074e-15
axial O 0 2.614399582240301e-12
elements O 0 7.811614853234228e-13
of O 0 2.0654113727473777e-13
developing O 0 4.792325647429152e-09
synaptonemal O 0 6.197907396199298e-07
complexes O 0 5.188582896664684e-09
. O 0 3.257244474141885e-11

Like O 0 9.322320693172514e-07
BRCA1 O 1 0.5719200968742371
and O 0 4.781168794210089e-09
RAD51 O 0 0.0008721560006961226
, O 0 3.78058001571091e-12
BRCA2 O 0 4.059911020704021e-07
relocates O 0 4.841272938094221e-10
to O 0 2.0308902400501677e-13
PCNA O 0 7.42847817036818e-07
+ O 0 3.1478587098066058e-12
replication O 0 5.116617199374396e-12
sites O 0 3.81810486005385e-11
following O 0 9.089431681277849e-13
exposure O 0 5.972315975100173e-10
of O 0 3.422110685102897e-14
S O 0 4.574441803129048e-08
phase O 0 1.1998489875264529e-11
cells O 0 3.2790038045904524e-12
to O 0 4.208746117459819e-14
hydroxyurea O 0 5.370119904313242e-09
or O 0 6.834891159990253e-12
UV O 0 6.29244034655585e-09
irradiation O 0 4.575870349299294e-09
. O 0 4.2043236947453266e-11

Thus O 0 2.373454988102708e-09
, O 0 1.0613340067910926e-11
BRCA1 O 0 8.425828855251893e-05
and O 0 4.9458179773864686e-09
BRCA2 O 0 0.011972475796937943
participate O 0 6.426235543699477e-09
, O 0 6.104325812189559e-12
together O 0 1.7837992194458252e-10
, O 0 1.3875168104315189e-13
in O 0 1.4717997904678624e-15
a O 0 4.922196547921254e-13
pathway O 0 3.114312363550198e-09
( O 0 2.772417495230939e-12
s O 0 8.753656288718048e-08
) O 0 9.492808692975266e-14
associated O 0 1.3359967429224517e-13
with O 0 1.2636224701420996e-14
the O 0 1.7220161182955086e-14
activation O 0 1.022974673720034e-11
of O 0 2.2322755081037593e-13
double O 0 2.967316561353073e-07
- O 0 3.5374960134504363e-06
strand O 0 0.0001279485150007531
break O 0 4.654203439713456e-05
repair O 0 0.001012273132801056
and O 0 1.9656029581760492e-10
/ O 0 2.9588462235885515e-10
or O 0 1.4465696435844722e-13
homologous O 0 4.656159485749711e-11
recombination O 0 9.469156569963388e-10
. O 0 1.998675114300852e-10

Dysfunction O 0 0.001331157167442143
of O 0 1.9349426574888362e-12
this O 0 4.949447969526677e-14
pathway O 0 1.8540248447607155e-08
may O 0 2.0389285815269886e-09
be O 0 5.251018370122651e-12
a O 0 4.470978437736556e-13
general O 0 2.751188599853238e-12
phenomenon O 0 1.269146732152393e-10
in O 0 2.99463213016167e-14
the O 0 3.8182229323809394e-14
majority O 0 1.292582848481244e-13
of O 0 1.1689897469891863e-14
cases O 0 2.2387601494866516e-10
of O 0 7.755830006006548e-11
hereditary B-Disease 1 0.9972013235092163
breast I-Disease 1 0.9999871253967285
and I-Disease 0 0.38992881774902344
/ I-Disease 1 0.9998301267623901
or I-Disease 1 0.9999594688415527
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
. O 0 6.480646574935633e-11
. O 0 2.743712028407952e-11

A O 0 4.1309572429426566e-10
novel O 0 8.183891342383731e-10
Arg362Ser O 0 1.2456534932425711e-06
mutation O 0 1.4167013340227186e-08
in O 0 3.209036768953011e-13
the O 0 5.137189501916439e-13
sterol O 0 7.884013757575303e-05
27 O 0 4.3504837066166147e-08
- O 0 1.0119769200400697e-07
hydroxylase O 0 5.158547082828591e-06
gene O 0 4.7026308180875276e-08
( O 0 7.022803562642399e-13
CYP27 O 0 5.767941146928024e-08
) O 0 6.183403618910963e-15
: O 0 2.1999706159372165e-16
its O 0 2.5928514960489547e-16
effects O 0 4.928699809392256e-12
on O 0 1.9072998388991458e-12
pre O 0 1.985052344721794e-09
- O 0 1.043378439202769e-10
mRNA O 0 2.498704910515459e-13
splicing O 0 1.5158151123184638e-10
and O 0 6.71454124939741e-12
enzyme O 0 7.329195583771764e-10
activity O 0 2.634941986823236e-10
. O 0 1.6677065544506986e-12

A O 0 3.3761710094282193e-10
novel O 0 5.191708729590516e-10
C O 0 3.1107998665902414e-07
to O 0 8.493635075866937e-14
A O 0 8.006293653224639e-13
mutation O 0 5.904647604193514e-11
in O 0 2.0687182232547764e-14
the O 0 3.354086214497898e-13
sterol O 0 3.3930104109458625e-05
27 O 0 6.252481643542751e-09
- O 0 5.231894206758625e-08
hydroxylase O 0 4.964300842402736e-06
gene O 0 1.359550054758074e-07
( O 0 9.706092266720256e-13
CYP27 O 0 7.510941912869384e-08
) O 0 7.810355281360343e-15
was O 0 2.0749896551962473e-14
identified O 0 6.640659955926094e-15
by O 0 6.171967774150523e-17
sequencing O 0 2.0603182354639316e-11
amplified O 0 1.4620625599093273e-08
CYP27 O 0 5.900153610127745e-08
gene O 0 4.0794517763842464e-10
products O 0 5.383759660304577e-09
from O 0 3.01066781910591e-14
a O 0 1.214951490108307e-11
patient O 0 1.9988760868727695e-07
with O 0 1.334207411218813e-08
cerebrotendinous B-Disease 1 0.9999998807907104
xanthomatosis I-Disease 1 0.9999995231628418
( O 0 1.7518884953826586e-10
CTX B-Disease 0 1.2557557965919841e-05
) O 0 1.7718082209738917e-11
. O 0 9.017188037918622e-12

The O 0 2.9169753418267774e-11
mutation O 0 1.569767427156421e-08
changed O 0 1.0766815217166936e-10
the O 0 1.1735454459333577e-13
adrenodoxin O 0 1.9789554883686833e-08
cofactor O 0 1.536156896131402e-10
binding O 0 4.6038273887605285e-11
residue O 0 4.007851384102423e-09
362Arg O 0 1.133353499938039e-08
to O 0 2.2192774961488082e-12
362Ser O 0 4.636758177412048e-08
( O 0 9.178578036506124e-13
CGT O 0 3.000759107862905e-08
362Arg O 0 2.6204640679594604e-09
to O 0 4.403165386555191e-13
AGT O 0 3.521665234984539e-07
362Ser O 0 1.8924898981254046e-08
) O 0 1.2208226237656744e-13
, O 0 2.700247226947801e-15
and O 0 8.8157207093131e-15
was O 0 1.2628557921612327e-11
responsible O 0 2.59152449499922e-10
for O 0 2.261709014517166e-10
deficiency O 0 9.457384066990926e-07
in O 0 1.4218885858091395e-15
the O 0 2.54719991843802e-13
sterol O 0 4.780676317750476e-05
27 O 0 1.1297125901421623e-08
- O 0 9.82406600513741e-09
hydroxylase O 0 2.479158183632535e-06
activity O 0 6.339893943163588e-09
, O 0 9.106114943850923e-15
as O 0 2.34603350675734e-15
confirmed O 0 6.249067561157895e-14
by O 0 1.2153006381056047e-16
expression O 0 2.2533337974933558e-14
of O 0 1.0521804227868006e-16
mutant O 0 1.0127917601798764e-11
cDNA O 0 1.2616224254538566e-12
into O 0 2.0400467773407094e-11
COS O 0 0.010379327461123466
- O 0 1.8111384392227592e-08
1 O 0 1.9746532967795938e-12
cells O 0 1.0286604901210694e-11
. O 0 3.668215037277989e-12

Quantitative O 0 1.1508960007233782e-08
analysis O 0 1.9987132782173234e-10
showed O 0 1.0019662433080612e-08
that O 0 1.609986558133436e-13
the O 0 3.395486067878442e-14
expression O 0 1.3658653201520377e-12
of O 0 2.4351805904339503e-14
CYP27 O 0 1.6333983410277142e-07
gene O 0 1.9768889650273458e-11
mRNA O 0 1.318972058308998e-13
in O 0 2.505564750834399e-15
the O 0 3.114910469858602e-14
patient O 0 9.507216125470563e-10
represented O 0 1.0335753086732069e-11
52 O 0 9.783301280208434e-09
. O 0 1.481105099676583e-10

5 O 0 8.300572673647366e-09
% O 0 3.8576906426224244e-12
of O 0 1.2314066731361137e-14
the O 0 2.925742601748299e-13
normal O 0 3.3928646003822394e-10
level O 0 3.6839684636191805e-09
. O 0 1.7258361406646827e-11

As O 0 1.4924909919056262e-10
the O 0 1.0268167745111981e-13
mutation O 0 1.7050960643416602e-10
occurred O 0 1.2158787865423903e-11
at O 0 3.507907506139496e-12
the O 0 1.6325243980884843e-15
penultimate O 0 3.837723194788367e-11
nucleotide O 0 1.5417949902896133e-11
of O 0 1.2292242080442183e-14
exon O 0 6.07284889042603e-10
6 O 0 2.3712501406869535e-10
( O 0 6.83094802510914e-14
- O 0 7.19964754480884e-10
2 O 0 2.3510282262662052e-11
position O 0 7.072331609236926e-11
of O 0 9.560653152138315e-15
exon O 0 2.9646225030433015e-08
6 O 0 9.091876584932379e-09
- O 0 7.935284429549938e-08
intron O 0 1.4060593684916967e-06
6 O 0 4.664944541765692e-10
splice O 0 1.330984567005089e-08
site O 0 1.0369306802093803e-10
) O 0 1.0241679500192034e-14
of O 0 5.685102500491612e-17
the O 0 1.2101801121812156e-15
gene O 0 1.466127080851365e-10
, O 0 8.030545222944066e-14
we O 0 1.3176847037544431e-13
hypothesized O 0 5.878840166409494e-13
that O 0 7.335026818789184e-14
the O 0 5.827064091662448e-13
mutation O 0 1.137496155934059e-06
may O 0 2.702116752573147e-08
partially O 0 4.0065767592523116e-08
affect O 0 1.5781107323697974e-11
the O 0 1.919339812545039e-15
normal O 0 3.5855135050236187e-14
splicing O 0 2.4729525718858447e-11
efficiency O 0 8.521200411948371e-11
in O 0 6.3963540545977984e-15
exon O 0 2.5453694707522345e-09
6 O 0 2.3870476706377985e-09
and O 0 1.5566097672989332e-12
cause O 0 2.712880850411041e-14
alternative O 0 2.6321289643845523e-14
splicing O 0 2.6229682315026537e-10
elsewhere O 0 1.439122931934378e-09
, O 0 4.1651750814662367e-14
which O 0 1.623919708014683e-14
resulted O 0 5.333059081152891e-12
in O 0 7.366520045869185e-13
decreased O 0 8.579757349025385e-09
transcript O 0 1.2467375742897246e-10
in O 0 2.6133064353998925e-13
the O 0 3.2147296977202977e-12
patient O 0 1.0925599980282641e-08
. O 0 7.959158505876918e-12

Transfection O 0 9.528396844871168e-07
of O 0 3.775235332681426e-11
constructed O 0 9.379074583648617e-08
minigenes O 0 4.4505486584967e-05
, O 0 9.436243453286863e-12
with O 0 8.397183230875183e-13
or O 0 6.939139540751427e-11
without O 0 6.689805393672588e-12
the O 0 1.2059876209648268e-13
mutation O 0 1.6053811613403468e-09
, O 0 1.8223089866525183e-13
into O 0 2.568472344532946e-12
COS O 0 0.2521277368068695
- O 0 2.0580589676910677e-08
1 O 0 6.346329169647225e-13
cells O 0 1.324630075766331e-12
confirmed O 0 3.0736600330899533e-12
that O 0 1.7402742946384013e-15
the O 0 4.682315546709415e-15
mutant O 0 3.6752254573002574e-08
minigene O 0 5.398013058766082e-07
was O 0 2.637652318782102e-10
responsible O 0 8.257466758976317e-12
for O 0 2.454555960882624e-14
a O 0 4.0263064014561464e-14
mRNA O 0 5.986471626577561e-13
species O 0 4.84792815700491e-13
alternatively O 0 1.0679008892455766e-11
spliced O 0 1.7249130905838683e-05
at O 0 6.106166665631463e-07
an O 0 3.926164671153032e-10
activated O 0 1.6140873412950896e-05
cryptic O 0 2.1445691888999363e-09
5 O 0 9.856234751970394e-13
splice O 0 1.935440963052315e-08
site O 0 5.356266541411969e-10
88 O 0 1.466949478556856e-10
bp O 0 2.6171373956884736e-09
upstream O 0 8.19338347168852e-11
from O 0 1.3906935227969014e-13
the O 0 6.693279336675425e-15
3 O 0 3.565009886689202e-13
end O 0 1.3289263895051306e-13
of O 0 1.7364282356622748e-15
exon O 0 5.363360866539324e-10
6 O 0 1.208854405465587e-10
. O 0 3.362658675815089e-12

Our O 0 5.1057016253741594e-11
data O 0 1.1600447165360794e-11
suggest O 0 3.5156304950545447e-12
that O 0 7.437615383602478e-14
the O 0 2.911008565274764e-13
C O 0 2.9183709671087854e-08
to O 0 2.4550348733110017e-13
A O 0 2.2943515143314386e-11
mutation O 0 1.4332854902932013e-09
at O 0 2.1917305470520176e-10
the O 0 8.314523691126206e-15
penultimate O 0 4.241379816805058e-12
nucleotide O 0 1.15787783007415e-12
of O 0 7.464354498505578e-16
exon O 0 5.2322157023665383e-11
6 O 0 4.295593394876285e-12
of O 0 5.1456150402867315e-16
the O 0 1.216136701976192e-14
CYP27 O 0 4.766311789694555e-08
gene O 0 5.49230938506895e-10
not O 0 1.5956405034073251e-12
only O 0 5.631175322047544e-13
causes O 0 7.360403952993977e-11
the O 0 4.238683015689304e-10
deficiency B-Disease 0 6.928245420567691e-05
in I-Disease 0 1.8396823777896976e-14
the I-Disease 0 8.303945096647947e-13
sterol I-Disease 0 5.474577847053297e-05
27 I-Disease 0 2.5298197314782556e-08
- I-Disease 0 6.618364523092168e-08
hydroxylase I-Disease 0 9.441917427466251e-06
activity I-Disease 0 9.579816406812824e-08
, O 0 4.090774756698029e-13
but O 0 6.978552935174576e-13
also O 0 3.3499852197804714e-11
partially O 0 1.4014574389875634e-08
leads O 0 1.0617238199728263e-09
to O 0 1.161922012597738e-12
alternative O 0 3.406726983845587e-11
pre O 0 1.6442299966001883e-08
- O 0 4.832137120991398e-11
mRNA O 0 1.470033133849774e-14
splicing O 0 1.2079496474262652e-12
of O 0 3.033330227961346e-15
the O 0 7.16382265601766e-15
gene O 0 1.208374927896827e-10
. O 0 7.267299175633957e-12

To O 0 8.306678261904565e-11
our O 0 1.446554594858318e-11
knowledge O 0 7.010090207967834e-13
, O 0 5.798851507890458e-15
this O 0 4.748631476685628e-17
is O 0 9.39703857398078e-15
the O 0 6.074592072440781e-16
first O 0 9.747413813598893e-12
report O 0 4.436705863808399e-11
regarding O 0 1.5626545196711916e-12
effects O 0 1.817433877004948e-11
on O 0 4.542627125153631e-12
pre O 0 3.686714822315196e-10
- O 0 3.2667434295835518e-12
mRNA O 0 4.4747187827657e-15
splicing O 0 1.1865078147418884e-12
of O 0 2.8220946104762267e-15
a O 0 1.0592896629573346e-14
mutation O 0 3.323648994912887e-11
at O 0 6.209607134044504e-11
the O 0 6.571684169065506e-12
- O 0 8.316997991641983e-06
2 O 0 9.82350290001932e-09
position O 0 1.4627739020056651e-08
of O 0 5.919772322077882e-14
a O 0 1.4470561250992664e-12
5 O 0 1.705429309058204e-12
splice O 0 9.430395664367097e-08
site O 0 7.690493575296387e-09
. O 0 1.6732204510816473e-10

ATM O 0 6.606663373531774e-05
germline O 0 0.00020347120880614966
mutations O 0 0.01822006143629551
in O 0 2.6827602361834124e-09
classical O 0 0.0007585023413412273
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9999182224273682
in O 0 1.0951084483679097e-10
the O 0 1.5390858726371803e-11
Dutch O 0 1.7059652464013197e-06
population O 0 1.2571384905291083e-11
. O 0 2.203335604245016e-11

Germline O 0 0.00018763366097118706
mutations O 0 7.689044286962599e-05
in O 0 6.439276737692234e-13
the O 0 9.622120639054665e-15
ATM O 0 3.721790520216928e-08
gene O 0 8.159607434166105e-10
are O 0 5.770212731020727e-14
responsible O 0 5.594866930858089e-11
for O 0 1.2563990958724958e-09
the O 1 0.5112516283988953
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.39198577404022217
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
) O 0 1.3032824819347866e-09
. O 0 1.051769782378642e-11

In O 0 2.38987996059592e-10
our O 0 9.537518344537865e-12
study O 0 1.8758962211287006e-13
, O 0 3.938787908027222e-14
we O 0 5.098300254191557e-13
have O 0 1.3478362645273113e-14
determined O 0 4.5221083279888e-14
the O 0 1.6258124031353228e-15
ATM O 0 4.693459629834251e-07
mutation O 0 1.2378195135553938e-09
spectrum O 0 6.637532884434805e-11
in O 0 3.6049077134850394e-13
19 O 0 4.2167071917509347e-11
classical O 0 5.282557169472568e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 6.426777332535494e-08
, O 0 3.8968476010395174e-16
including O 0 1.248094577449739e-16
some O 0 1.8229423544800365e-16
immigrant O 0 7.327682211011322e-11
populations O 0 1.412727226868249e-11
, O 0 1.138279195293107e-13
as O 0 5.457300843864088e-12
well O 0 3.0092945496607015e-11
as O 0 1.616786704516926e-10
12 O 0 4.932906166876805e-11
of O 0 2.951334109827647e-13
Dutch O 0 6.480247805029649e-08
ethnic O 0 3.628861967863717e-12
origin O 0 2.563228518326355e-10
. O 0 7.967212306558835e-11

Both O 0 4.538524417396772e-11
the O 0 1.5041944469509905e-13
protein O 0 2.7783424866312245e-11
truncation O 0 4.3674940997107115e-08
test O 0 7.825837201380637e-06
( O 0 2.1740283726902343e-13
PTT O 0 2.7890399323382553e-08
) O 0 7.554222004879652e-14
and O 0 7.676136981637268e-15
the O 0 2.388865580619826e-16
restriction O 0 2.684269907043957e-13
endonuclease O 0 3.2927340853916576e-09
fingerprinting O 0 2.6860332624778493e-08
( O 0 1.5164432209946455e-13
REF O 0 3.0693412256255215e-09
) O 0 2.0456056110939187e-16
method O 0 3.4983540688610353e-15
were O 0 2.7048259058958316e-14
used O 0 3.143866731617623e-13
and O 0 1.9339380357558111e-13
compared O 0 1.205840440519912e-13
for O 0 2.672709497618294e-16
their O 0 3.4222052775072817e-16
detection O 0 4.783275555156341e-13
efficiency O 0 6.099214015786725e-13
, O 0 2.532865416817793e-16
identifying O 0 6.567640181698309e-11
76 O 0 2.9318822925006316e-09
% O 0 3.3636190620994766e-13
and O 0 7.814737051914378e-11
60 O 0 1.0260152102925524e-11
% O 0 6.034223752724062e-15
of O 0 4.9213461268422104e-15
the O 0 5.68162617647916e-12
mutations O 0 4.735140990419495e-08
, O 0 2.5649376286102088e-12
respectively O 0 1.405728589087829e-10
. O 0 5.560674143367805e-11

Most O 0 2.1267711203254436e-10
patients O 0 1.1791908560709885e-09
were O 0 1.0865105473309433e-12
found O 0 3.656500449644717e-12
to O 0 8.212948550412325e-13
be O 0 7.24767398874171e-11
compound O 0 6.038495398152932e-11
heterozygote O 0 9.485506069495386e-08
. O 0 3.567931713965855e-11

Seventeen O 0 1.379756611186167e-07
mutations O 0 7.971678132889792e-05
were O 0 2.4382866836702988e-09
distinct O 0 4.805856667483566e-12
, O 0 1.9162984729852867e-13
of O 0 1.2227935339086636e-14
which O 0 3.058713698989024e-11
10 O 0 1.7675325092447736e-10
were O 0 1.227197926612078e-10
not O 0 3.744539834454885e-12
reported O 0 3.013023441855722e-10
previously O 0 3.088993949518226e-08
. O 0 8.144334512349971e-11

Mutations O 0 0.0036531793884932995
are O 0 9.311346832463485e-11
small O 0 4.442698813000856e-12
deletions O 0 3.3968089496738685e-07
or O 0 6.279434217049129e-08
point O 0 3.058526090171654e-07
mutations O 0 0.00019216023792978376
frequently O 0 1.1207461625417636e-07
affecting O 0 7.685405201129925e-09
splice O 0 1.1767010619223583e-05
sites O 0 3.986730916949455e-06
. O 0 2.1202228861483263e-09

Moreover O 0 1.0340347245119119e-07
, O 0 3.804625451492294e-12
a O 0 2.025146977197023e-12
16 O 0 1.2748772870718739e-10
. O 0 5.7206860776259916e-12

7 O 0 4.26440962542074e-08
- O 0 5.183788687190827e-08
kb O 0 3.7701792621192e-07
genomic O 0 1.49499901347383e-09
deletion O 0 8.663693762400726e-08
of O 0 4.589812145801286e-13
the O 0 1.8767622276139734e-13
3 O 0 2.2668158582844766e-12
end O 0 1.6401047187031281e-12
of O 0 3.1489569485855767e-16
the O 0 2.1249604221530298e-16
gene O 0 2.7466744156878775e-12
, O 0 4.157077192380601e-15
most O 0 2.4474114920824182e-15
likely O 0 8.648203138859889e-13
a O 0 1.737128202514062e-14
result O 0 3.776093546463584e-14
of O 0 1.2113625701755826e-15
recombination O 0 5.6894992189748805e-12
between O 0 6.110887490473615e-11
two O 0 5.015534099150898e-10
LINE O 0 2.5464993086643517e-05
elements O 0 1.696560947284098e-10
, O 0 7.021370789471459e-13
was O 0 5.398314434357232e-11
identified O 0 4.748775261909088e-10
. O 0 1.7861339143832033e-11

The O 0 9.44173385308833e-12
most O 0 6.20527880381555e-13
frequently O 0 1.4396157009544108e-11
found O 0 7.591322535860368e-12
mutation O 0 3.5050956581628157e-10
, O 0 1.678923317103946e-14
identified O 0 8.34311526115572e-12
in O 0 2.9873736083751165e-15
three O 0 1.39869333563164e-12
unrelated O 0 2.6903041572268194e-08
Turkish O 0 2.9232131737444433e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
individuals O 0 2.4747928364377003e-06
, O 0 2.9722147052574366e-12
was O 0 2.3180968256042433e-10
previously O 0 9.0726443024991e-10
described O 0 1.1873550753715989e-11
to O 0 3.490027006541191e-13
be O 0 5.3807566041674804e-11
a O 0 1.5309583462075338e-11
Turkish O 0 1.6836006366816036e-08
A B-Disease 1 1.0
- I-Disease 1 0.9999996423721313
T I-Disease 1 1.0
founder O 0 1.446677629246551e-06
mutation O 0 3.5190529956707906e-07
. O 0 4.821025870183071e-11

The O 0 3.502881665284896e-11
presence O 0 7.272765722987629e-11
of O 0 4.3063989365861675e-15
a O 0 9.488789691047134e-14
founder O 0 1.2004676419596905e-10
mutation O 0 1.0770688341210644e-08
among O 0 1.8402668711808845e-12
relatively O 0 2.8502529926099224e-14
small O 0 1.720362134000064e-13
ethnic O 0 5.969456564258388e-14
population O 0 2.600641598772546e-13
groups O 0 2.1887893786928098e-14
in O 0 5.474549782144393e-14
Western O 0 5.699187215907342e-12
Europe O 0 1.0022027652212273e-09
could O 0 1.372692931544961e-11
indicate O 0 6.142233531687691e-13
a O 0 9.835665268353999e-14
high O 0 5.480066400664896e-10
carrier O 0 2.14388090613582e-10
frequency O 0 2.1573908024624666e-12
in O 0 4.075586100701044e-14
such O 0 2.602022113398772e-12
communities O 0 7.500165766227695e-11
. O 0 1.560993001525901e-11

In O 0 4.7347722964552474e-11
patients O 0 6.433615307166463e-10
of O 0 5.042672551226757e-13
Dutch O 0 4.3399751348260907e-07
ethnic O 0 1.8177173091368792e-12
origin O 0 4.884886384282083e-10
, O 0 1.1982480979666477e-11
however O 0 1.207696160958338e-12
, O 0 5.653838196771101e-14
no O 0 5.478605308133211e-13
significant O 0 5.309550000186236e-13
founder O 0 8.013092411829348e-09
effect O 0 3.5992695046616063e-08
could O 0 8.586825139822452e-10
be O 0 1.1779756857455137e-11
identified O 0 3.340836496334987e-10
. O 0 2.320413652889819e-11

The O 0 1.0791291905204448e-12
observed O 0 5.980471760175243e-12
genetic O 0 1.2146317805716844e-11
heterogeneity O 0 4.345666881899746e-11
including O 0 5.296625985029557e-12
the O 0 2.4695092433642263e-13
relative O 0 6.730341978178345e-11
high O 0 4.969507827468078e-08
percentage O 0 9.588990224074223e-07
of O 0 2.288677060369171e-12
splice O 0 0.060039717704057693
- O 0 1.7671569594313041e-06
site O 0 7.966874449039096e-08
mutations O 0 8.139372221194208e-05
had O 0 1.4791812219527856e-08
no O 0 3.3716243772602406e-12
reflection O 0 1.722944053053621e-12
on O 0 1.1944739468361387e-11
the O 0 1.5664203874971028e-12
phenotype O 0 3.104331236514213e-09
. O 0 7.129727797733354e-12

All O 0 4.2740955219500165e-10
patients O 0 1.667686988504613e-09
manifested O 0 3.150132099616343e-10
classical O 0 9.286949875786377e-09
A B-Disease 1 0.9999998807907104
- I-Disease 1 1.0
T I-Disease 1 1.0
and O 0 1.3694653411278068e-08
increased O 0 5.2982527219691544e-12
cellular O 0 1.7276187425085965e-10
radioresistant O 0 6.582868694593458e-10
DNA O 0 1.4035907158760352e-10
synthesis O 0 3.214825072817007e-10
. O 0 1.5535612726824688e-11

Determination O 0 6.98269442267474e-09
of O 0 3.0917729178714035e-14
the O 0 1.9198378679180245e-15
genomic O 0 4.68920666185646e-11
structure O 0 8.110355442791928e-11
of O 0 9.08491625027999e-15
the O 0 3.983772811416361e-14
COL4A4 O 0 1.5655818685900158e-07
gene O 0 5.2617087770157056e-11
and O 0 4.2216582877077635e-14
of O 0 1.051358469955719e-15
novel O 0 2.593989911758854e-08
mutations O 0 0.03272657096385956
causing O 0 0.008996059186756611
autosomal B-Disease 1 0.9999979734420776
recessive I-Disease 1 0.9999984502792358
Alport I-Disease 1 0.999997615814209
syndrome I-Disease 1 0.9999985694885254
. O 0 7.120432599094784e-08

Autosomal B-Disease 1 0.9999881982803345
recessive I-Disease 1 0.9999966621398926
Alport I-Disease 1 0.9999964237213135
syndrome I-Disease 1 0.9999996423721313
is O 0 6.655643147723822e-09
a O 0 6.479252689928217e-10
progressive O 0 9.499539373791777e-06
hematuric B-Disease 1 0.9999548196792603
glomerulonephritis I-Disease 1 0.9999998807907104
characterized O 0 2.2888421881361865e-05
by O 0 7.668338186661572e-11
glomerular B-Disease 1 0.7316722869873047
basement I-Disease 1 0.9985924363136292
membrane I-Disease 1 0.9993137121200562
abnormalities I-Disease 1 0.9999994039535522
and O 0 3.45890049935349e-09
associated O 0 3.322223052215634e-11
with O 0 4.460291511132475e-12
mutations O 0 8.514568605733075e-08
in O 0 7.146797801997617e-13
either O 0 9.742882889351989e-11
the O 0 2.4410853546874556e-11
COL4A3 O 0 0.00029033300234004855
or O 0 1.0208817818879723e-10
the O 0 4.070585014892547e-13
COL4A4 O 0 4.259386230387463e-07
gene O 0 4.6354972638162906e-10
, O 0 3.5101043216635838e-15
which O 0 4.4897097174499947e-17
encode O 0 9.573157560725451e-14
the O 0 2.994794950222923e-12
alpha3 O 0 7.858088793000206e-05
and O 0 3.4056000242088658e-09
alpha4 O 0 4.991009700461291e-05
type O 0 0.00024229357950389385
IV O 0 0.00023564753064420074
collagen O 0 0.0023792507126927376
chains O 0 0.0001505315158283338
, O 0 4.283158029638745e-12
respectively O 0 7.982605548795263e-11
. O 0 1.3476275650958769e-11

To O 0 3.870913572318058e-12
date O 0 1.6364309213257044e-11
, O 0 3.024417874345278e-14
mutation O 0 5.045426316324653e-12
screening O 0 7.305692162340449e-10
in O 0 1.8706073812873626e-14
the O 0 2.6349202344072868e-15
two O 0 1.2538613810425536e-13
genes O 0 3.048301611130455e-10
has O 0 8.286142882951708e-10
been O 0 2.0347629137162926e-10
hampered O 0 6.684748865559698e-10
by O 0 7.232220566508445e-15
the O 0 5.934516658472055e-13
lack O 0 4.5037934427900883e-13
of O 0 1.0237371887668992e-16
genomic O 0 1.8303471585601194e-11
structure O 0 1.5867973601757512e-11
information O 0 8.044293009490389e-11
. O 0 5.6550764071516824e-11

We O 0 2.4079971794321864e-08
report O 0 1.8243880017809744e-10
here O 0 2.7570271911823985e-14
the O 0 1.1894327812920504e-16
complete O 0 1.4086836386229765e-14
characterization O 0 2.5767649732694187e-12
of O 0 3.0494103014320215e-15
the O 0 2.0664625745162382e-14
48 O 0 1.4983938569079758e-12
exons O 0 7.464102946830309e-11
of O 0 1.3127620701375211e-14
the O 0 3.9081826425264865e-13
COL4A4 O 0 1.7337359849989298e-06
gene O 0 1.8416038694013537e-09
, O 0 1.6221272168917035e-14
a O 0 3.3929207015427404e-15
comprehensive O 0 2.6281596690602704e-11
gene O 0 1.5684683773997676e-08
screen O 0 0.039146821945905685
, O 0 1.7696948073631091e-10
and O 0 6.268409727915036e-13
the O 0 4.629422044922528e-16
subsequent O 0 2.176429473926475e-14
detection O 0 9.622710267498391e-11
of O 0 1.3676738777959607e-13
10 O 0 3.6081481227280554e-13
novel O 0 3.37620599880073e-12
mutations O 0 5.108472755921412e-09
in O 0 9.420049240432479e-14
eight O 0 7.607162011424862e-09
patients O 0 3.501570589037328e-08
diagnosed O 0 0.0001628883765079081
with O 0 1.970528700212526e-07
autosomal B-Disease 1 0.9999971389770508
recessive I-Disease 1 0.9999990463256836
Alport I-Disease 1 0.9999984502792358
syndrome I-Disease 1 0.9999991655349731
. O 0 5.845445727459264e-08

Furthermore O 0 1.8525196310292813e-07
, O 0 5.5496306335112155e-12
we O 0 4.0888711687336876e-13
identified O 0 5.231991597777486e-13
a O 0 6.7985795080627645e-15
glycine O 0 1.45826517528036e-10
to O 0 4.1843573284029364e-14
alanine O 0 7.564229798084909e-10
substitution O 0 1.7716585577060018e-12
in O 0 6.91492033040109e-15
the O 0 1.328509450242339e-15
collagenous O 0 5.769751343365215e-10
domain O 0 4.053219218591586e-11
that O 0 2.535916138537986e-12
is O 0 1.9419823821947846e-12
apparently O 0 6.092545912217417e-11
silent O 0 3.6082585808117074e-09
in O 0 8.337900953437477e-15
the O 0 1.7194362253447615e-14
heterozygous O 0 3.1875597272801315e-08
carriers O 0 5.62905777545808e-10
, O 0 1.237259331988462e-14
in O 0 7.580603523648245e-15
11 O 0 6.925890416731306e-11
. O 0 1.0211091520939686e-11

5 O 0 1.4972876272167923e-09
% O 0 1.9578032771361276e-12
of O 0 1.5298583932879875e-14
all O 0 1.6854898553242403e-12
control O 0 7.530152890122821e-11
individuals O 0 2.7179228919566034e-12
, O 0 3.4518018326469557e-13
and O 0 3.2307175597962035e-12
in O 0 1.1776864036652356e-14
one O 0 1.9768135045561408e-11
control O 0 5.697052274378223e-10
individual O 0 8.455427655783276e-13
homozygous O 0 1.048871989262068e-09
for O 0 1.6067914312717802e-15
this O 0 1.3239655684665728e-16
glycine O 0 2.484897010379683e-10
substitution O 0 1.6398897864644546e-11
. O 0 1.2686911417258973e-11

There O 0 4.656676710901309e-10
has O 0 6.032348232043461e-11
been O 0 8.221870233249273e-12
no O 0 3.7578317194086885e-13
previous O 0 5.437868037805327e-13
finding O 0 1.6822491750306812e-12
of O 0 1.4015005027687285e-15
a O 0 1.11764277913322e-14
glycine O 0 1.377697608773154e-11
substitution O 0 1.1474759402212154e-13
that O 0 3.8379168549804166e-13
is O 0 1.703316307444247e-12
not O 0 5.842755749704831e-13
associated O 0 2.2145319974499478e-13
with O 0 9.985791355046278e-14
any O 0 1.0757593600640991e-11
obvious O 0 2.470997295667132e-10
phenotype O 0 1.0420504459318636e-09
in O 0 1.3024573552924273e-13
homozygous O 0 5.548447461478645e-06
individuals O 0 1.7625745307725538e-09
. O 0 9.587352439721641e-11

Founder O 0 2.3857048745412612e-06
BRCA1 O 1 0.8260651230812073
and O 0 9.20575438101423e-09
BRCA2 O 0 0.015155931003391743
mutations O 0 6.504528573714197e-05
in O 0 1.6875510988612064e-09
French O 0 0.006459408905357122
Canadian O 1 0.9948215484619141
breast B-Disease 1 0.9999994039535522
and I-Disease 1 0.9999992847442627
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
families O 0 2.4267683329526335e-07
. O 0 4.597669467365506e-10

We O 0 3.9577543020641315e-08
have O 0 3.2354290687569565e-12
identified O 0 2.0151645976906885e-11
four O 0 9.265947384373696e-13
mutations O 0 1.2689627126860614e-10
in O 0 5.148660970765058e-15
each O 0 5.745505525338312e-13
of O 0 4.400598375281506e-12
the O 0 2.2259333931629044e-08
breast B-Disease 1 0.9994069337844849
cancer I-Disease 0 0.013272588141262531
- O 0 6.068471066100756e-06
susceptibility O 0 3.3160432622025837e-07
genes O 0 3.5485382454680803e-07
, O 0 3.624864991502719e-11
BRCA1 O 0 8.652431279188022e-05
and O 0 1.298397056537226e-09
BRCA2 O 0 7.18014343874529e-05
, O 0 2.8279830734112554e-12
in O 0 1.684210713601142e-12
French O 0 5.959629561402835e-05
Canadian O 0 0.09226127713918686
breast B-Disease 1 0.9999691247940063
cancer I-Disease 1 0.9998500347137451
and O 1 0.9474545121192932
breast B-Disease 1 0.9999995231628418
/ I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 3.7052851897811934e-09
from O 0 5.62287438832243e-11
Quebec O 0 6.207199731989022e-08
. O 0 2.542068777700024e-10

To O 0 1.3326438043359534e-11
identify O 0 4.3366771285135997e-10
founder O 0 3.5705360890148086e-09
effects O 0 3.14660974254366e-06
, O 0 3.601198549432749e-12
we O 0 1.7103254576489313e-12
examined O 0 1.5419486520951153e-10
independently O 0 1.7977211386188685e-10
ascertained O 0 1.028534461511299e-05
French O 0 8.592588710598648e-05
Canadian O 0 3.8875128666404635e-05
cancer B-Disease 0 8.873003935150336e-06
families O 0 2.0059177843062548e-12
for O 0 2.1587920456789776e-14
the O 0 1.7474589339761307e-15
distribution O 0 1.1580081511752827e-12
of O 0 4.840965241246619e-15
these O 0 1.2775189434967305e-13
eight O 0 6.90929188862377e-11
mutations O 0 1.144709216305273e-08
. O 0 2.8665637571978486e-11

Mutations O 0 0.00012150886323070154
were O 0 1.0915258280563833e-10
found O 0 1.3459167808038686e-11
in O 0 4.925621610346771e-14
41 O 0 5.448182530121137e-11
of O 0 3.489239740238695e-14
97 O 0 5.666743074783653e-09
families O 0 2.347247951561826e-10
. O 0 6.084602960365615e-11

Six O 0 5.263058877602589e-09
of O 0 5.335824013533164e-13
eight O 0 3.10211023535345e-10
mutations O 0 2.0519602017543548e-08
were O 0 2.167695363486377e-11
observed O 0 2.0941052711331842e-11
at O 0 1.679557014300226e-11
least O 0 3.541202433284679e-13
twice O 0 3.53653355489314e-08
. O 0 2.48903342381368e-10

The O 0 3.7427871912854016e-10
BRCA1 O 0 0.0006905862246640027
C4446T O 0 5.5398277964968656e-08
mutation O 0 1.5907308181795088e-07
was O 0 2.8610824820418657e-09
the O 0 1.4756972770493815e-13
most O 0 1.2651237479496813e-12
common O 0 3.3892541551061584e-11
mutation O 0 1.4394716529864127e-09
found O 0 2.87072499105534e-09
, O 0 9.914130334829491e-14
followed O 0 2.9637387379335967e-13
by O 0 3.936399275115965e-14
the O 0 1.0930362170924468e-10
BRCA2 O 0 0.03996220603585243
8765delAG O 0 6.580340595974121e-06
mutation O 0 5.366543405216362e-07
. O 0 2.1409142514361434e-10

Together O 0 4.38513803047158e-09
, O 0 2.2731706653730116e-13
these O 0 3.034371866728232e-15
mutations O 0 3.976311224729301e-10
were O 0 1.2830829280996436e-11
found O 0 2.9204061391396863e-10
in O 0 1.8435973234143255e-12
28 O 0 2.9742311391522946e-10
of O 0 5.880810839383258e-14
41 O 0 1.0727996269110918e-09
families O 0 4.341644231631303e-13
identified O 0 2.0174164561126418e-09
to O 0 7.613072498802165e-12
have O 0 2.6184093782077866e-10
a O 0 7.0801693501099106e-12
mutation O 0 6.199225310865586e-08
. O 0 1.3748344129815848e-10

The O 0 8.299388953858511e-12
odds O 0 7.931902357150022e-10
of O 0 1.5494507947535715e-15
detection O 0 1.57376420922839e-11
of O 0 9.330919182118109e-15
any O 0 7.523828023277279e-13
of O 0 5.2947924500780855e-14
the O 0 1.8385687937383377e-12
four O 0 8.109895532903977e-10
BRCA1 O 0 5.453152334666811e-05
mutations O 0 3.767717089431244e-07
was O 0 2.9478254504056167e-08
18 O 0 8.260074846333509e-10
. O 0 1.3122734669746006e-11

7x O 0 6.693210161756724e-05
greater O 0 8.722980116004919e-10
if O 0 3.874023064148746e-12
one O 0 8.896427702593385e-15
or O 0 6.4330102524231755e-15
more O 0 6.148588870712917e-16
cases O 0 5.795969260091738e-10
of O 0 6.110084996180376e-06
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 3.6726858070323942e-06
also O 0 3.527836156536068e-08
present O 0 1.1669152623350332e-11
in O 0 1.0390633123878723e-13
the O 0 2.34099480252159e-12
family O 0 1.1600769234121344e-09
. O 0 1.0023149671356535e-10

The O 0 3.119479934782232e-12
odds O 0 3.815347759950072e-10
of O 0 6.159105843544263e-16
detection O 0 4.846996068397225e-12
of O 0 1.1441250948225363e-14
any O 0 8.288912091425349e-13
of O 0 9.646621744680353e-14
the O 0 7.871835128181459e-12
four O 0 6.335566293813599e-09
BRCA2 O 0 0.00012469498324207962
mutations O 0 3.194968201114534e-07
was O 0 1.054583709247936e-08
5 O 0 2.2511947861403314e-10
. O 0 5.5724591607742013e-11

3x O 0 8.392611562157981e-06
greater O 0 5.590243379316462e-09
if O 0 2.1273593997506168e-10
there O 0 6.286393389350053e-13
were O 0 2.2007460957762515e-13
at O 0 2.674263805194088e-13
least O 0 2.131918533116928e-16
five O 0 1.6763164207428405e-13
cases O 0 2.4966778644497367e-11
of O 0 9.272638906709929e-11
breast B-Disease 1 0.780371904373169
cancer I-Disease 0 1.1771590834541712e-05
in O 0 9.0565857764624e-13
the O 0 4.230384272052579e-12
family O 0 1.0759861890363709e-09
. O 0 1.4840970119500696e-10

Interestingly O 0 1.1682799616608008e-08
, O 0 8.000568523652829e-13
the O 0 1.1352604715130464e-14
presence O 0 6.917146976731514e-12
of O 0 2.209733623566388e-14
a O 0 2.3271785887235552e-10
breast B-Disease 0 0.0010149464942514896
cancer I-Disease 0 2.653571300470503e-07
case O 0 1.455145032247529e-10
< O 0 2.2681425626558394e-09
36 O 0 6.961559662066463e-10
years O 0 1.702397944836065e-11
of O 0 1.0043630830442948e-13
age O 0 3.4649620950233384e-09
was O 0 2.236583418468996e-10
strongly O 0 4.6705616940168407e-14
predictive O 0 4.182073784497753e-11
of O 0 8.552348519858585e-15
the O 0 2.4836222352808343e-14
presence O 0 1.3839810374116635e-12
of O 0 2.6374432808593613e-16
any O 0 1.1978173444435192e-13
of O 0 4.237823572692933e-15
the O 0 3.6129319615262404e-14
eight O 0 4.322322708083526e-11
mutations O 0 1.370251134780176e-09
screened O 0 2.8640468485718884e-07
. O 0 6.910134964233094e-11

Carriers O 0 1.5764786667205044e-06
of O 0 1.4874443365377188e-13
the O 0 3.329963664836996e-14
same O 0 7.848528684600842e-14
mutation O 0 2.5611356785359973e-11
, O 0 5.9801661100302925e-15
from O 0 1.4891148379756348e-15
different O 0 2.3847296140295897e-14
families O 0 1.3199114110712395e-12
, O 0 4.51082347743912e-14
shared O 0 4.219028284287857e-13
similar O 0 1.1162074818040976e-13
haplotypes O 0 8.0973133753659e-10
, O 0 9.486474241782519e-14
indicating O 0 4.059143212525873e-12
that O 0 1.2739486488020767e-14
the O 0 1.14401599697893e-14
mutant O 0 2.3198730048079597e-08
alleles O 0 2.57028814898419e-10
were O 0 2.7361304888451343e-10
likely O 0 1.1072898674358012e-11
to O 0 5.859415464761972e-14
be O 0 5.736310298293246e-12
identical O 0 6.1132860926238486e-12
by O 0 2.6828059630605583e-13
descent O 0 3.307494722548654e-09
for O 0 7.446001454303186e-11
a O 0 3.1866551064574367e-11
mutation O 0 4.2407632960816954e-09
in O 0 1.51383070033477e-13
the O 0 1.806021830566898e-13
founder O 0 2.9425604175514763e-09
population O 0 8.37669603820368e-12
. O 0 1.9498591977140656e-11

The O 0 3.8240775563497253e-13
identification O 0 9.325969684004232e-12
of O 0 6.294936360368153e-13
common O 0 4.595970715115527e-09
BRCA1 O 1 0.7596657872200012
and O 0 1.9837708009617927e-07
BRCA2 O 0 0.13727732002735138
mutations O 0 4.349415576143656e-06
will O 0 8.180419015790807e-12
facilitate O 0 2.4196586574654066e-12
carrier O 0 3.5990393998375225e-10
detection O 0 1.9780981297401468e-09
in O 0 2.5169411693726218e-11
French O 0 4.588275714922929e-06
Canadian O 0 0.0005505171720869839
breast B-Disease 1 0.9995936751365662
cancer I-Disease 1 0.9943839311599731
and O 0 0.02740517258644104
breast B-Disease 1 0.9999980926513672
/ I-Disease 1 0.9999997615814209
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
families O 0 1.1968697322117805e-07
. O 0 2.4530164011160593e-10

Are O 0 3.980281437776512e-09
Dp71 O 0 4.482032454689033e-05
and O 0 5.97557503478896e-10
Dp140 O 0 5.392775648260795e-08
brain O 0 3.8428092352660315e-07
dystrophin O 0 1.1880048056411852e-08
isoforms O 0 1.940032336167352e-11
related O 0 4.992341540166478e-10
to O 0 2.67942473763938e-10
cognitive B-Disease 0 0.0007974373875185847
impairment I-Disease 0 0.0034564428497105837
in O 0 7.526771206300964e-09
Duchenne B-Disease 1 0.9998663663864136
muscular I-Disease 1 0.996269941329956
dystrophy I-Disease 1 0.7864920496940613
? O 0 6.345978817989817e-06

Molecular O 0 1.645357059487651e-07
study O 0 1.997799703445935e-09
and O 0 1.4597789643744363e-10
neuropsychological O 0 5.462145509227412e-06
analysis O 0 1.4466621477138286e-11
were O 0 4.566578018505574e-12
performed O 0 8.423977661264903e-12
concurrently O 0 9.813380663636906e-11
on O 0 1.2551033545804557e-09
49 O 0 2.659352276168647e-07
patients O 0 1.343858246904972e-09
with O 0 2.879696925361941e-09
Duchenne B-Disease 1 0.9998711347579956
muscular I-Disease 1 0.7935314178466797
dystrophy I-Disease 0 0.004098237492144108
( O 0 8.747171875711501e-10
DMD B-Disease 1 0.9999997615814209
) O 0 1.4407185444653692e-09
in O 0 1.6751250993957134e-12
order O 0 1.782006313344464e-11
to O 0 1.578361871540021e-13
find O 0 3.0804566796688304e-12
a O 0 3.4233429486345626e-15
molecular O 0 4.072961315004092e-13
explanation O 0 2.300061386468176e-14
for O 0 8.794848801053218e-14
the O 0 6.887473230632324e-12
cognitive B-Disease 0 1.514479208708508e-06
impairment I-Disease 0 3.241717649871134e-08
observed O 0 1.2917707702120307e-11
in O 0 9.065671661718372e-14
most O 0 2.414313471366114e-10
DMD B-Disease 1 0.9999998807907104
patients O 0 3.2956249924609438e-06
. O 0 4.5875934995276424e-11

Complete O 0 4.967339387040859e-11
analysis O 0 7.673660318285869e-12
of O 0 3.2344139438153854e-14
the O 0 3.741723321156257e-14
dystrophin O 0 1.800965376830277e-09
gene O 0 1.8807519097663317e-08
was O 0 4.49653247969195e-09
performed O 0 1.3680620525313714e-10
to O 0 3.166825119195818e-14
define O 0 2.793630257680313e-11
the O 0 1.1174813515941323e-13
localization O 0 5.1074741658219125e-11
of O 0 1.054532217705786e-14
deletions O 0 5.268804059710419e-09
and O 0 6.30469981777182e-11
duplications O 0 5.991718410314206e-08
in O 0 6.410601758634338e-13
relation O 0 9.808701767477501e-11
to O 0 1.6862187102346937e-13
the O 0 2.1682803393475308e-13
different O 0 2.9839006265852674e-11
DMD B-Disease 1 0.9999967813491821
promoters O 0 9.16290673558251e-07
. O 0 1.4782208790364848e-10

Qualitative O 0 1.7849437483619113e-09
analysis O 0 1.4187976314639084e-11
of O 0 2.0671061162682441e-13
the O 0 4.890509655228192e-13
Dp71 O 0 5.531317626150667e-08
transcript O 0 4.358086669320471e-10
and O 0 1.344471517623902e-12
testing O 0 4.2326135651915564e-11
for O 0 4.0802019114558996e-16
the O 0 4.6736376279903457e-17
specific O 0 1.5319541645577315e-15
first O 0 2.62172851787576e-13
exon O 0 6.498557247880399e-11
of O 0 2.7579227421768715e-13
Dp140 O 0 1.4133809678185116e-09
were O 0 1.3556788504287542e-11
also O 0 1.0782160754507775e-11
carried O 0 1.5257556329473232e-10
out O 0 1.557896034398709e-08
. O 0 7.694035686345302e-11

Neuropsychological O 0 9.525100176688284e-05
analysis O 0 1.8490232678303187e-09
assessed O 0 3.366849554709006e-08
verbal O 0 6.95581974241577e-08
and O 0 1.7023070453259237e-11
visuospatial O 0 1.332414171884011e-06
intelligence O 0 3.1386207410832867e-07
, O 0 1.9768691891797197e-12
verbal O 0 6.6127219255918135e-09
memory O 0 2.163351950912329e-07
, O 0 5.741972522455008e-11
and O 0 6.799916185684651e-11
reading O 0 1.0102913705622996e-07
skills O 0 8.378931397601264e-07
. O 0 1.904512658690294e-11

Comparison O 0 8.080588975722947e-10
of O 0 1.655077984386022e-13
molecular O 0 7.833066972828817e-10
and O 0 2.2487560424888642e-11
psychometric O 0 4.622241362994828e-07
findings O 0 3.8553604753133186e-11
demonstrated O 0 9.825507378199982e-13
that O 0 3.0207668235294333e-15
deletions O 0 7.234060572791634e-10
and O 0 2.2164347180525512e-12
duplications O 0 3.025546035928528e-08
that O 0 1.4141406101675358e-10
were O 0 1.9479931556709573e-11
localized O 0 2.275108573757123e-10
in O 0 4.974331493587392e-13
the O 0 1.0122017969887293e-13
distal O 0 4.470518621957353e-09
part O 0 9.314757298817256e-11
of O 0 6.644058675626952e-14
the O 0 6.943404862571126e-14
gene O 0 2.56346455174139e-09
seemed O 0 4.359903063577697e-12
to O 0 3.5663187219992995e-15
be O 0 4.0739091787533876e-13
preferentially O 0 2.1352622447956549e-10
associated O 0 1.6219194390321157e-11
with O 0 4.513147910945037e-10
cognitive B-Disease 0 8.748180698603392e-05
impairment I-Disease 0 4.932329829898663e-05
. O 0 8.074807489322211e-11

Two O 0 3.4635661005921747e-10
altered O 0 4.432483180494273e-08
Dp71 O 0 2.943247636721935e-07
transcripts O 0 2.4040275548031786e-08
and O 0 1.4242692095156606e-11
two O 0 2.8150305674543626e-15
deleted O 0 4.361177738387845e-11
Dp140 O 0 3.973684228886221e-12
DNA O 0 3.675982261641675e-12
sequences O 0 1.1658512696910428e-12
were O 0 3.8740573791475053e-13
found O 0 2.412275565931432e-13
in O 0 4.304460501686376e-15
four O 0 7.90454784960204e-11
patients O 0 3.209011112392801e-10
with O 0 6.2266680700417965e-09
severe O 0 0.03286391496658325
cerebral B-Disease 0 0.15505079925060272
dysfunction I-Disease 0 0.00044516322668641806
. O 0 6.64347687973077e-10

These O 0 1.3198132907746296e-12
findings O 0 3.347619924320977e-12
suggest O 0 7.426024313701707e-13
that O 0 1.8302876389101686e-15
some O 0 3.746230518464473e-17
sequences O 0 1.30716848478242e-13
located O 0 3.462474751358968e-11
in O 0 2.2709680070156536e-14
the O 0 6.696676362310389e-15
distal O 0 4.428895861163795e-10
part O 0 1.200719038085829e-11
of O 0 1.1570200703016516e-14
the O 0 5.066956172672908e-14
gene O 0 4.876489212435331e-10
and O 0 1.0846439024714272e-10
, O 0 1.3688240468943784e-14
in O 0 1.4813802889666801e-16
particular O 0 3.182235020198626e-14
, O 0 5.6462267587070736e-15
some O 0 2.759836799468441e-14
DMD B-Disease 1 0.9999991655349731
isoforms O 0 1.9687105279331263e-09
expressed O 0 6.8901828687018e-11
in O 0 3.5458119188210013e-13
the O 0 2.8649239230960077e-11
brain O 0 7.195949001470581e-05
may O 0 5.736819908008783e-10
be O 0 8.67921525122585e-14
related O 0 1.586191247793245e-12
to O 0 3.479234912326379e-12
the O 0 4.25270874071515e-10
cognitive B-Disease 0 0.000825191440526396
impairment I-Disease 0 3.0141011393425288e-06
associated O 0 3.26004154227455e-11
with O 0 1.274649386040494e-09
DMD B-Disease 1 0.9999996423721313
. O 0 2.0337075079535083e-10
. O 0 9.583384780187387e-11

I1307K O 0 3.6293756693339674e-06
APC O 0 1.6603884205323993e-06
and O 0 1.0516901238766252e-10
hMLH1 O 0 4.366561512370026e-08
mutations O 0 5.7350096227537506e-08
in O 0 3.94993933394705e-13
a O 0 1.3714629258643196e-11
non O 0 1.7328466128674336e-06
- O 0 1.085062876882148e-06
Jewish O 0 3.613850996231349e-09
family O 0 1.5166921052411908e-09
with O 0 2.462759551846716e-09
hereditary B-Disease 1 0.9998435974121094
non I-Disease 1 0.9999920129776001
- I-Disease 1 0.9999969005584717
polyposis I-Disease 1 0.9999947547912598
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
. O 0 3.933049086413121e-08

We O 0 3.950683669096122e-10
describe O 0 2.0839248729420667e-11
a O 0 4.9653121891868324e-11
French O 0 5.357740519684739e-06
Canadian O 0 0.0005245840875431895
hereditary B-Disease 1 0.9999879598617554
non I-Disease 1 0.9999985694885254
- I-Disease 1 0.9999994039535522
polyposis I-Disease 1 0.9999992847442627
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 4.796461894329695e-07
HNPCC B-Disease 1 0.8775556683540344
) O 0 1.2267861726478202e-10
kindred O 0 2.7680163938725855e-08
which O 0 2.0806470695661217e-12
carries O 0 1.3789233643812793e-10
a O 0 3.1735868815697954e-13
novel O 0 2.8838509358308784e-10
truncating O 0 3.552127282091533e-06
mutation O 0 1.104783223127015e-06
in O 0 1.155063891755681e-11
hMLH1 O 0 1.008331310003996e-06
. O 0 5.2811137407626774e-11

Interestingly O 0 9.090681096779463e-09
, O 0 1.014531340881586e-12
the O 0 3.763510702625532e-14
I1307K O 0 3.6961073091035246e-10
APC O 0 1.6004925162960149e-09
polymorphism O 0 4.173567269560863e-09
, O 0 5.945707793296451e-14
associated O 0 1.6448587012839883e-14
with O 0 6.5467400957015896e-15
an O 0 5.384735084039416e-13
increased O 0 3.3304510793641384e-07
risk O 0 0.10437747091054916
of O 0 0.00020991370547562838
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 6.593980472757721e-09
is O 0 3.1049396387317074e-10
also O 0 8.097406634099968e-10
present O 0 2.9494562174547934e-12
in O 0 6.330911272653394e-14
this O 0 5.849758611536915e-13
family O 0 3.695331818320824e-10
. O 0 1.302590812990445e-10

The O 0 4.869346679342579e-12
I1307K O 0 4.402032516281906e-09
polymorphism O 0 2.077939313949173e-07
has O 0 1.5410231979373634e-09
previously O 0 9.95132087844297e-10
only O 0 1.7610922214885555e-13
been O 0 1.233225327412768e-11
identified O 0 2.2446519643004592e-10
in O 0 2.9214139245746507e-14
individuals O 0 2.4383852142290108e-12
of O 0 2.2710396931080457e-12
self O 0 0.00010807675425894558
- O 0 0.0010291625512763858
reported O 0 1.378090018988587e-05
Ashkenazi O 0 1.3175703372780845e-07
Jewish O 0 3.3232243346059676e-11
origins O 0 1.0234747771509234e-10
. O 0 9.243926457624951e-11

In O 0 1.1125103442644058e-11
addition O 0 9.386215762963168e-12
, O 0 6.099606225922621e-14
in O 0 2.212123315268829e-15
this O 0 2.3284867957384936e-15
family O 0 8.840958347355876e-12
, O 0 3.590018365050296e-13
there O 0 1.082505260560293e-13
appears O 0 3.477292759290762e-11
to O 0 1.083856962513785e-12
be O 0 1.7272175911742238e-09
no O 0 8.834388776080004e-11
relationship O 0 1.775939291459583e-11
between O 0 6.819826906028165e-15
the O 0 8.512703989795294e-15
I1307K O 0 8.368919272860875e-12
polymorphism O 0 4.092310657011211e-10
and O 0 2.5952826693265152e-11
the O 0 2.030232752747718e-12
presence O 0 3.854923047441616e-09
or O 0 1.0132193695167047e-10
absence O 0 7.434194926325688e-11
of O 0 7.813368685773495e-14
cancer B-Disease 0 2.5660082947354113e-09
. O 0 3.231147445957594e-13
. O 0 1.2371432003832616e-11

Identification O 0 2.2492806228679996e-10
of O 0 1.1906673021665204e-13
a O 0 1.0193353729452334e-13
novel O 0 8.652975905243387e-12
mutation O 0 3.718453989165482e-09
of O 0 4.4294103974940047e-14
the O 0 1.2546268277763284e-13
CPO O 0 1.810173841931828e-07
gene O 0 1.3759703099136544e-10
in O 0 7.012410010981797e-15
a O 0 1.8259666782066697e-12
Japanese O 0 4.00436960035222e-07
hereditary B-Disease 0 4.222529969410971e-05
coproporphyria I-Disease 0 0.0008528835605829954
family O 0 7.411662394929408e-09
. O 0 1.426259804704344e-10

Hereditary B-Disease 1 0.9987809062004089
coproporphyria I-Disease 1 0.5420373678207397
( O 0 1.1972625113543245e-09
HCP B-Disease 0 2.142924495274201e-05
) O 0 3.6074289389009806e-11
is O 0 3.381737598284751e-11
an O 0 1.1418774953364519e-10
autosomal B-Disease 1 0.9999996423721313
dominant I-Disease 1 0.9999995231628418
disease I-Disease 1 0.9999986886978149
characterized O 0 1.5424068067204644e-07
by O 0 2.072647262152394e-11
a O 0 5.851893547514919e-08
deficiency B-Disease 0 0.399543821811676
of I-Disease 0 9.147591538416489e-13
coproporphyrinogen I-Disease 0 1.1440211892477237e-05
oxidase I-Disease 0 5.6898365130564343e-08
( O 0 1.3987307406065908e-12
CPO O 0 2.1471178115461953e-06
) O 0 7.291784092765957e-14
caused O 0 6.75997276276645e-14
by O 0 4.12154770719375e-16
a O 0 7.24702687183304e-14
mutation O 0 2.0671131473193327e-10
in O 0 1.1851495262601985e-14
the O 0 4.1723630030566367e-14
CPO O 0 1.8548101934356964e-06
gene O 0 6.814123154619267e-10
. O 0 4.069267058731674e-12

Only O 0 4.652380147796009e-10
11 O 0 3.9052580613763155e-11
mutations O 0 1.6974616157128253e-09
of O 0 2.046966078356107e-14
the O 0 4.378607733009944e-14
gene O 0 2.031701029636679e-08
have O 0 1.031165638987197e-10
been O 0 6.632113261351158e-12
reported O 0 4.50877460367316e-11
in O 0 4.513915554272413e-13
HCP B-Disease 0 0.005787460599094629
patients O 0 5.898350252664386e-09
. O 0 9.728653646567942e-12

We O 0 9.05147512497706e-09
report O 0 6.358509638954013e-12
another O 0 8.570217018694093e-14
mutation O 0 1.7352540238046998e-10
in O 0 2.5487101104203387e-14
a O 0 1.1072048226173914e-12
Japanese O 0 4.563722555417371e-08
family O 0 3.338032281141601e-11
. O 0 8.034905206455445e-12

Polymerase O 0 2.6221960069960915e-07
chain O 0 7.903554433141835e-07
reaction O 0 3.8379227573770436e-10
- O 0 3.0460189925918257e-09
single O 0 4.919800677960495e-10
strand O 0 2.395993803361307e-08
conformational O 0 3.282922891867379e-11
polymorphism O 0 2.407619437150288e-09
and O 0 2.6204373686136012e-14
direct O 0 7.411159664747705e-15
sequence O 0 2.5965388693316438e-12
analyses O 0 1.4598765252227253e-10
demonstrated O 0 2.582014463348159e-12
a O 0 5.3325247185596544e-14
C O 0 6.64511168313453e-10
to O 0 3.478157974308449e-13
T O 0 7.203909024866562e-09
substitution O 0 9.44818665850073e-15
in O 0 2.8936164843556037e-16
exon O 0 3.4651418019671087e-12
1 O 0 1.9341729688140616e-14
of O 0 1.1647286683386847e-16
the O 0 2.33958059800692e-15
CPO O 0 1.2774100000001454e-08
gene O 0 3.1682059319776412e-12
at O 0 3.6873284915868443e-13
nucleotide O 0 1.6208005770845801e-10
position O 0 3.316623198301727e-09
85 O 0 3.080587174242311e-11
, O 0 2.804138757132868e-13
which O 0 4.665658050878596e-13
lies O 0 4.445873669212119e-10
in O 0 2.2778264327895717e-14
the O 0 1.6808875865086288e-14
putative O 0 3.941634518778159e-11
presequence O 0 6.299306076762434e-10
for O 0 3.603130350370498e-15
targeting O 0 6.209117855288104e-12
to O 0 9.986820669483781e-14
mitochondria O 0 3.4680677774012736e-10
. O 0 2.181790338673384e-11

This O 0 1.0680062520126987e-12
mutation O 0 4.908459749763949e-10
changes O 0 5.488478053115864e-13
the O 0 1.3340499986294477e-15
codon O 0 5.159738521859358e-12
for O 0 6.71186419245025e-16
glutamine O 0 5.602677610044848e-13
to O 0 3.560826983885776e-15
a O 0 1.4540441333615872e-13
termination O 0 8.018378183649588e-10
codon O 0 3.630577394275747e-09
at O 0 1.282132039426287e-10
amino O 0 6.879838920781367e-10
acid O 0 1.5704524347626148e-09
position O 0 1.9753230162677937e-09
29 O 0 1.1743517269735548e-09
. O 0 8.91594350432845e-12

MaeI O 0 1.854185939009767e-06
restriction O 0 9.20760620526373e-11
analysis O 0 6.7102395688578564e-12
showed O 0 2.1260736227102228e-10
two O 0 8.735678636896411e-15
other O 0 1.0177811691309754e-13
carriers O 0 5.829985383343228e-10
in O 0 5.0913570743009364e-15
the O 0 1.0244653432869844e-13
family O 0 2.1290724738776134e-10
. O 0 4.669606715190788e-11

The O 0 3.0122722094461096e-09
C O 0 0.02719004638493061
- O 1 0.7412246465682983
T O 0 0.40786823630332947
mutation O 0 9.530354105891092e-08
is O 0 1.709158856111337e-11
located O 0 1.8870434728701646e-12
within O 0 6.454247485993209e-15
a O 0 1.3219792285596582e-13
recently O 0 8.012018826164535e-10
proposed O 0 1.2332600218822876e-12
putative O 0 8.051077859949629e-11
alternative O 0 3.9147775732911727e-13
translation O 0 1.7424691247172608e-12
initiation O 0 2.1913157052799725e-11
codon O 0 1.7274391694854785e-08
( O 0 1.1242804647329518e-12
TIC O 0 1.0805136696490081e-07
- O 0 9.267127620837812e-10
1 O 0 6.676277369485617e-13
) O 0 1.7133658578491451e-15
, O 0 1.1913400612612507e-16
supporting O 0 3.857487652870681e-14
that O 0 6.864174755937674e-14
TIC O 0 1.3300654018166824e-06
- O 0 7.177545224834603e-10
1 O 0 2.788399936295982e-13
is O 0 4.157999357150277e-14
the O 0 1.5221620401709981e-15
real O 0 9.870974176928726e-11
TIC O 0 3.018692495970754e-08
rather O 0 3.3704250734746186e-14
than O 0 7.763603128430052e-14
TIC O 0 3.132006298756096e-08
- O 0 7.987722983049395e-11
2 O 0 3.624585169764022e-13
. O 0 7.872543593314806e-15
. O 0 2.884418506994557e-13

Human B-Disease 0 2.2062659255084327e-08
complement I-Disease 0 1.8596189192976453e-06
factor I-Disease 0 0.00029356981394812465
H I-Disease 1 1.0
deficiency I-Disease 1 0.99998939037323
associated O 0 4.346297828305978e-06
with O 0 0.00010563265095697716
hemolytic B-Disease 1 0.9999964237213135
uremic I-Disease 1 0.9999990463256836
syndrome I-Disease 1 0.999998927116394
. O 0 3.6604781428195565e-08

This O 0 4.3153493473925553e-13
study O 0 3.848149555084335e-13
reports O 0 1.945251902266132e-12
on O 0 9.26916421221946e-13
six O 0 6.43832253136023e-12
cases O 0 2.8497568888008473e-11
of O 0 2.1248927964401254e-11
deficiency B-Disease 0 5.094129664939828e-05
in I-Disease 0 3.2344615894186685e-15
the I-Disease 0 1.75866791154956e-14
human I-Disease 0 7.626297163221274e-12
complement I-Disease 0 9.855730814800623e-12
regulatory I-Disease 0 6.488153764250271e-11
protein I-Disease 0 1.3551141320178317e-09
Factor I-Disease 0 2.1779184677939156e-08
H I-Disease 1 0.9999997615814209
( O 0 3.388541183757532e-12
FH O 0 1.850444988349409e-07
) O 0 6.971787157864428e-15
in O 0 3.914217335111947e-17
the O 0 1.0893219572560646e-16
context O 0 6.992952901853713e-14
of O 0 8.646009255763865e-13
an O 0 9.396747913115178e-08
acute B-Disease 1 0.9868313074111938
renal I-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
. O 0 6.367927340988899e-08

Five O 0 8.991293126703326e-11
of O 0 5.601945570290513e-15
the O 0 3.965273781254917e-15
cases O 0 6.259058375757132e-12
were O 0 4.36806840697912e-12
observed O 0 1.2631858233025373e-11
in O 0 3.8169777939484756e-14
children O 0 2.0067185760308526e-11
presenting O 0 4.743038406473943e-09
with O 0 4.2933740473927173e-07
idiopathic O 1 0.9999496936798096
hemolytic B-Disease 1 0.9999986886978149
uremic I-Disease 1 0.9999998807907104
syndrome I-Disease 1 0.9999998807907104
( O 0 3.04864147437911e-06
HUS B-Disease 1 0.9998489618301392
) O 0 1.2801467441647674e-08
. O 0 5.495746080441677e-10

Two O 0 1.2759957153385404e-11
of O 0 4.753396095247449e-14
the O 0 2.650382354991293e-13
children O 0 2.6222926607921693e-10
exhibited O 0 1.226177204216583e-07
a O 0 8.166648690632883e-09
homozygous O 1 0.9999727010726929
deficiency O 1 0.9652732610702515
characterized O 0 1.9015544347467106e-11
by O 0 3.9806967265651125e-14
the O 0 2.3571155877838423e-12
absence O 0 1.5451576129699163e-10
of O 0 8.815581690030632e-16
the O 0 6.720091317587813e-15
150 O 0 3.369402874113872e-14
- O 0 1.503197913366172e-11
kD O 0 9.58224732200419e-12
form O 0 8.271992303372083e-14
of O 0 3.2258748352675254e-14
Factor O 0 1.6091457055722458e-09
H O 1 1.0
and O 0 4.303650769088563e-10
the O 0 1.2174927678434283e-13
presence O 0 1.6138366684681493e-12
, O 0 2.4510820034802264e-16
upon O 0 4.3868625137732345e-16
immunoblotting O 0 1.7676571317792877e-10
, O 0 2.44393039842744e-16
of O 0 2.3335618730513065e-17
the O 0 3.813104312280682e-15
42 O 0 4.294186881081963e-11
- O 0 1.1220006035372876e-09
kD O 0 1.69488387768979e-08
Factor O 0 1.974620289502127e-07
H O 1 0.9999998807907104
- O 0 7.544741720266757e-08
like O 0 6.392707890823246e-11
protein O 0 9.526828111117158e-12
1 O 0 1.805901213075209e-13
( O 0 4.4303880429217256e-15
FHL O 0 1.7340372471252863e-09
- O 0 1.267342203403743e-10
1 O 0 1.1999234071635723e-13
) O 0 2.0698618024368644e-15
and O 0 6.149717965631607e-15
other O 0 7.654995886306748e-15
FH O 0 9.389148090122035e-07
- O 0 1.4589801589082185e-10
related O 0 1.462213856939787e-11
protein O 0 3.371741774671477e-11
( O 0 1.663133945340768e-14
FHR O 0 5.966125815604073e-09
) O 0 1.9808565120756245e-14
bands O 0 5.362251007806629e-12
. O 0 6.080399638647149e-12

Southern O 0 7.602316998145398e-09
blot O 0 1.4205065781425219e-05
and O 0 2.056633400908392e-13
PCR O 0 7.194917838598824e-12
analysis O 0 1.609079267262314e-15
of O 0 4.6088712885428525e-18
DNA O 0 1.7389043330262588e-11
of O 0 1.126640640725313e-14
one O 0 2.655703261467135e-11
patient O 0 1.4568071193821197e-08
with O 0 2.5969032479977727e-10
homozygous O 1 0.9964610934257507
deficiency O 1 0.9062199592590332
ruled O 0 2.892379669106049e-09
out O 0 1.9535400852532803e-08
the O 0 1.6258095564269937e-11
presence O 0 1.7259917106660083e-10
of O 0 1.2568626390032419e-15
a O 0 1.17111876430211e-14
large O 0 9.597931580366745e-14
deletion O 0 2.024829637292669e-09
of O 0 1.0958172303593416e-13
the O 0 4.872103154945906e-13
FH O 0 2.4404246232734295e-06
gene O 0 1.4170520312717372e-09
as O 0 5.415820786627834e-13
the O 0 6.5318725498949085e-15
underlying O 0 8.256467731726502e-10
defect O 0 3.584594310268585e-08
for O 0 5.384942925595881e-12
the O 0 8.669243989345432e-09
deficiency O 0 0.0048091113567352295
. O 0 2.6192320881635034e-11

The O 0 2.0399912228213912e-12
other O 0 1.3112812701984722e-13
four O 0 2.5172949662255473e-12
children O 0 9.536881701022182e-12
presented O 0 1.7684792866234922e-11
with O 0 4.975012624086617e-10
heterozygous O 1 0.8063585162162781
deficiency O 1 0.5926582217216492
and O 0 2.9305100013310437e-11
exhibited O 0 3.134904957846629e-08
a O 0 3.307850868217166e-11
normal O 0 1.3634363638104219e-09
immunoblotting O 0 3.7761667499580653e-06
pattern O 0 6.098737959092659e-09
of O 0 3.703380511326307e-15
proteins O 0 1.7329865840964853e-12
of O 0 2.285865114272194e-14
the O 0 5.497239816132371e-12
FH O 0 0.00029068306321278214
family O 0 1.3135913190520654e-10
. O 0 1.6449678424956815e-11

Factor B-Disease 1 0.7615711092948914
H I-Disease 1 1.0
deficiency I-Disease 1 0.9999580383300781
is O 0 1.694429735410452e-10
the O 0 1.3672422569110942e-11
only O 0 1.5469809113710653e-06
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 0 8.326911604683573e-09
with O 0 1.0230498670438237e-09
HUS B-Disease 1 0.9990344047546387
. O 0 6.6837571033318e-09

These O 0 8.476403173113267e-13
observations O 0 2.9758678160574092e-12
suggest O 0 5.039117560723394e-12
a O 0 2.162081684476888e-13
role O 0 1.2860580655971177e-10
for O 0 4.795699427850852e-13
FH O 0 0.0005553033552132547
and O 0 6.164868615599062e-11
/ O 0 1.9026520359233245e-09
or O 0 1.5448564302800172e-11
FH O 0 5.564349066844443e-06
receptors O 0 4.0984951543698855e-11
in O 0 4.416212205395596e-16
the O 0 4.273473071860498e-15
pathogenesis O 0 8.562681119705928e-11
of O 0 4.61909210967143e-13
idiopathic O 0 2.1165872112760553e-06
HUS B-Disease 1 0.7635205388069153
. O 0 4.129017266985002e-11
. O 0 1.2684739369994702e-10

Further O 0 1.709015221007526e-11
evidence O 0 7.09613617866367e-12
for O 0 4.291297948499223e-14
a O 0 9.315258389956324e-14
major O 0 6.762610003235858e-12
ancient O 0 5.673810379858146e-11
mutation O 1 0.9321870803833008
underlying O 1 0.6968756914138794
myotonic B-Disease 1 0.9999996423721313
dystrophy I-Disease 1 0.9999991655349731
from O 0 9.306836551425945e-11
linkage O 0 9.465315429224574e-07
disequilibrium O 0 1.6240721834037686e-06
studies O 0 1.7356710513283247e-10
in O 0 2.7454824709245013e-14
the O 0 3.846900079843181e-14
Japanese O 0 2.162750201151198e-09
population O 0 7.008053805237363e-14
. O 0 1.4035303952039668e-12

The O 0 7.007246267676237e-07
myotonic B-Disease 1 0.9999942779541016
dystrophy I-Disease 1 0.9999990463256836
( O 0 1.917104100357392e-06
DM B-Disease 1 0.9999998807907104
) O 0 6.883592584827625e-10
mutation O 0 1.1727153292895309e-07
is O 0 9.273700557477227e-11
an O 0 1.9714216370481097e-11
unstable O 0 2.496509068805608e-06
( O 0 1.7031993220298358e-12
CTG O 0 7.091874465459114e-08
) O 0 8.266082588380408e-13
n O 0 3.884164989642613e-09
repeat O 0 9.286156910093268e-08
, O 0 2.0620313182645456e-12
present O 0 1.1726527409695875e-13
at O 0 1.8620552148795877e-12
a O 0 1.1069032907466301e-15
copy O 0 2.986240421609665e-11
number O 0 2.3618241043465993e-11
of O 0 7.51338417480027e-14
5 O 0 6.272016239705636e-11
- O 0 1.3071842275280687e-08
37 O 0 1.9753296220947902e-10
repeats O 0 6.777018057846362e-09
on O 0 5.105779340985883e-11
normal O 0 4.507729367726754e-13
chromosomes O 0 3.5873643465522687e-12
but O 0 9.336259724850547e-15
amplified O 0 1.7095818033788235e-12
to O 0 9.793983624052562e-16
50 O 0 2.307540179172663e-14
- O 0 3.248637253303044e-12
3000 O 0 1.6108344042323197e-13
copies O 0 1.1176215508612586e-10
on O 0 6.488880899269134e-07
DM B-Disease 1 0.9999986886978149
chromosomes O 0 1.4800907592871226e-06
. O 0 6.873618341174392e-11

Previous O 0 2.3017523442803167e-09
findings O 0 1.238813829296248e-09
in O 0 3.962754603625829e-12
Caucasian O 0 1.2247596714587416e-07
populations O 0 5.736381925025569e-10
of O 0 2.000060138123913e-13
a O 0 3.880469723327451e-09
DM B-Disease 1 1.0
founder O 0 3.554200930011575e-06
chromosome O 0 0.05771241709589958
raise O 0 1.0631184821363604e-08
a O 0 3.7699932151774584e-13
question O 0 1.1238880919667293e-12
about O 0 7.357750002258585e-15
the O 0 3.754986721556714e-17
molecular O 0 7.683641185330173e-14
events O 0 4.7990823419169146e-14
involved O 0 3.037273210715341e-11
in O 0 1.8798064979077232e-14
the O 0 1.9741212787735551e-13
expansion O 0 1.3798501230510851e-09
mutation O 0 3.160824491033054e-08
. O 0 7.423256453975569e-11

To O 0 2.8310971188910683e-12
investigate O 0 1.5029751054829177e-10
whether O 0 6.97703960578222e-12
a O 0 1.249096854595566e-13
founder O 0 2.3328304565861657e-11
chromosome O 0 1.625220562573304e-07
for O 0 3.725334277171477e-12
the O 0 1.5027744326712167e-10
DM B-Disease 1 1.0
mutation O 0 6.528557605633978e-07
exists O 0 1.2055886670914173e-11
in O 0 8.539373669172543e-15
the O 0 2.645592722487749e-14
Japanese O 0 7.893195430597189e-09
population O 0 6.440498870709851e-15
, O 0 6.926008415197122e-15
we O 0 1.8529745880041526e-12
genotyped O 0 3.815573412779827e-10
families O 0 1.045902201346862e-15
using O 0 8.43026955752238e-14
polymorphic O 0 2.9804736456640057e-09
markers O 0 7.983155683177756e-07
near O 0 9.532327149841535e-10
the O 0 1.0790694509807408e-12
( O 0 5.35871043719216e-13
CTG O 0 5.111845613470223e-09
) O 0 1.2848499120112628e-13
n O 0 1.26929988741864e-09
repeat O 0 1.5150584431466996e-07
region O 0 1.1774327346447677e-10
and O 0 4.997623842539767e-12
constructed O 0 1.4537974157846634e-09
haplotypes O 0 2.724809462506528e-07
. O 0 2.331932702492878e-10

Six O 0 6.674199526379709e-10
different O 0 2.916510349199042e-13
haplotypes O 0 1.362937096516248e-09
were O 0 2.2941062244319355e-11
found O 0 6.325227563941382e-10
and O 0 6.285593201482698e-08
DM B-Disease 1 1.0
alleles O 0 1.5268076822394505e-05
were O 0 1.6554507764610094e-09
always O 0 1.9138138296348473e-10
haplotype O 0 1.97716998329156e-09
A O 0 2.344903160533818e-10
. O 0 4.322784491472831e-11

To O 0 3.1315579469837207e-12
find O 0 2.7658101503513777e-12
an O 0 4.7618421995777e-15
origin O 0 6.363805288940247e-14
of O 0 3.263059920465168e-14
the O 0 4.715876669204866e-13
( O 0 1.1965068150675273e-13
CTG O 0 2.0094477193310922e-09
) O 0 3.0872355317795516e-14
n O 0 6.730058871307065e-11
repeat O 0 7.535213564224819e-10
mutation O 0 8.718755162284708e-10
and O 0 5.349948457335219e-13
to O 0 3.052506206854236e-15
investigate O 0 1.3077857373422486e-11
the O 0 1.0743592261219358e-14
mechanism O 0 2.1707310428331628e-12
of O 0 1.4966948299414951e-15
the O 0 6.6081372788833175e-15
expansion O 0 4.131110818011985e-12
mutation O 0 4.620638940910915e-11
in O 0 1.2505884118530451e-14
the O 0 2.058932282208558e-14
Japanese O 0 1.6075719644348396e-09
population O 0 2.8819300766614545e-15
we O 0 3.903505990665579e-12
have O 0 9.154148657630409e-14
studied O 0 4.329069654834816e-12
90 O 0 1.3011470156518157e-12
Japanese O 0 4.040755925416306e-07
DM B-Disease 1 0.9999998807907104
families O 0 2.7550850056207166e-12
comprising O 0 2.5927862829823456e-13
190 O 0 1.1480545247105622e-12
affected O 0 1.2903326844504459e-11
and O 0 5.005759261961229e-13
130 O 0 2.565524832506827e-12
unaffected O 0 3.5438583179114858e-09
members O 0 1.4410407546058823e-12
. O 0 6.467270295684724e-12

The O 0 3.8545149710911275e-11
results O 0 3.297230544152541e-11
suggest O 0 3.0754562091450666e-11
that O 0 1.390913615837916e-13
a O 0 7.229823971487484e-14
few O 0 2.0548688618726718e-13
common O 0 1.2750553651103003e-13
ancestral O 0 1.9816975751346666e-12
mutations O 0 2.2861076587332718e-08
in O 0 1.4407850997336102e-12
both O 0 1.8744612806376182e-10
Caucasian O 0 1.171089252238744e-07
and O 0 2.2794217902077918e-10
Japanese O 0 8.903787929170903e-09
populations O 0 3.3572816835608643e-12
have O 0 1.0639103970911962e-14
originated O 0 2.4652332770508855e-15
by O 0 2.1407282051639646e-16
expansion O 0 7.714394444427453e-13
of O 0 1.1895701912119187e-14
an O 0 1.4059303580279264e-13
ancestral O 0 1.54958557097018e-09
n O 0 9.216646503773518e-06
= O 0 6.929213647310917e-09
5 O 0 8.537676642050851e-12
repeat O 0 2.697907897086793e-09
to O 0 4.4930902748374635e-11
n O 0 7.206220402622421e-07
= O 0 5.399679370299282e-09
19 O 0 8.588295352662811e-11
- O 0 1.7203090341144645e-10
37 O 0 3.5814710572235064e-12
copies O 0 8.82798834034304e-11
. O 0 3.215295391045814e-11

These O 0 5.307188269041384e-14
data O 0 2.9285692794422946e-12
support O 0 4.795047076956195e-14
multistep O 0 2.343909094593144e-11
models O 0 6.965720888985061e-09
of O 0 1.5461546973294382e-13
triplet O 0 5.629045335808769e-05
repeat O 0 1.2008399608021136e-08
expansion O 0 2.0625908966898088e-11
that O 0 1.070861471328885e-13
have O 0 1.4174890543294533e-14
been O 0 2.09420188709928e-14
proposed O 0 2.117764310812821e-14
for O 0 2.092984802398029e-13
both O 0 5.175210482377679e-09
DM B-Disease 1 1.0
and O 0 9.103332843096723e-08
Friedreichs B-Disease 0 9.416172360943165e-06
ataxia I-Disease 0 6.263456270971801e-06
. O 0 3.1640328378157445e-12
. O 0 1.0496415368821399e-11

The O 0 8.912096321339602e-13
molecular O 0 4.195562230968619e-10
basis O 0 6.105895788977023e-09
of O 0 5.448439424071694e-07
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 5.182077857102119e-12
the O 0 1.6028689063963403e-13
western O 0 6.999591878331657e-12
Cape O 0 6.920291423240243e-11
, O 0 1.3048842063302646e-13
South O 0 1.3514267829806137e-11
Africa O 0 1.657477453897993e-11
. O 0 1.4054967042639865e-12

Deficiency B-Disease 1 0.9998874664306641
of I-Disease 0 4.685056162467838e-12
the I-Disease 0 2.9202343126109864e-13
sixth I-Disease 0 2.8307947985695137e-08
component I-Disease 0 6.733365864874941e-09
of I-Disease 0 2.57876944624591e-13
human I-Disease 0 4.897555694327593e-10
complement I-Disease 0 3.686904948008163e-10
( O 0 5.0899419363559587e-14
C6 O 0 1.7849846045692175e-09
) O 0 7.126172210918796e-14
has O 0 1.1701753932155667e-12
been O 0 1.7385329287300522e-11
reported O 0 6.251604789397902e-11
in O 0 1.2982544921575994e-15
a O 0 2.4539005267880387e-14
number O 0 7.424947158843342e-13
of O 0 9.67346184708659e-15
families O 0 9.296385648858551e-15
from O 0 3.5974035606141114e-15
the O 0 2.0057485403471298e-13
western O 0 1.9264884826286632e-11
Cape O 0 1.0546107737097188e-10
, O 0 4.1442882654264823e-13
South O 0 2.455487028985015e-11
Africa O 0 1.5552038823418712e-11
. O 0 1.0538777966626056e-12

Meningococcal B-Disease 1 0.9619771242141724
disease I-Disease 1 0.9950573444366455
is O 0 8.571263698797793e-10
endemic O 0 2.2333798810336702e-08
in O 0 1.641217950388782e-13
the O 0 1.5075270675887764e-12
Cape O 0 9.347794760472539e-10
and O 0 2.739228115167247e-13
almost O 0 7.815988050459584e-15
all O 0 6.907225713701642e-14
pedigrees O 0 1.2232771462450387e-09
of O 0 1.9010685387010895e-11
total O 0 0.0028592136222869158
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 7.812114150018701e-11
C6Q0 O 0 4.556761268759146e-06
) O 0 4.3060089456765926e-13
have O 0 1.124219871384037e-13
been O 0 2.4077568823270556e-13
ascertained O 0 2.5065990949535433e-10
because O 0 5.1557078051267524e-11
of O 0 2.4063407516594637e-11
recurrent O 0 0.42786651849746704
disease O 0 0.021809011697769165
. O 0 1.304095026410934e-10

We O 0 3.1136828670952355e-09
have O 0 1.5773024704922312e-13
sequenced O 0 1.1813536260341095e-10
the O 0 2.958706142499462e-13
expressed O 0 6.502316859859775e-14
exons O 0 5.817674467167855e-11
of O 0 7.473447079556998e-15
the O 0 1.6567352890506197e-14
C6 O 0 3.937310477653e-09
gene O 0 1.7313454489520375e-11
from O 0 1.752860823069774e-14
selected O 0 6.860307027317658e-12
cases O 0 5.0582156518874655e-11
and O 0 7.247535210863632e-11
have O 0 2.376182584029607e-12
found O 0 1.567162372095865e-11
three O 0 7.952557883050826e-12
molecular O 0 1.5265787567386724e-07
defects O 1 0.6604987978935242
leading O 0 1.8956004765868784e-08
to O 0 1.3042548152597533e-09
total O 0 0.00012146414519520476
deficiency O 1 0.9975312352180481
879delG O 0 2.7562186915019993e-06
, O 0 1.590584326575939e-12
which O 0 1.6960567607478272e-13
is O 0 3.013736992168309e-13
the O 0 4.0286879192906466e-14
common O 0 1.4100573486608425e-10
defect O 0 7.429159154526133e-08
in O 0 7.559324531353911e-14
the O 0 1.891814829790839e-12
Cape O 0 3.586040631109455e-10
and O 0 1.0589797268256707e-12
hitherto O 0 2.1536916347542068e-11
unreported O 0 7.163376558594337e-10
, O 0 1.95944714447005e-12
and O 0 8.263091599847172e-12
1195delC O 0 1.0208345457840551e-07
and O 0 3.8751848951967816e-11
1936delG O 0 5.293250726623455e-09
, O 0 6.347957556607003e-15
which O 0 1.7328955788766323e-14
have O 0 1.1334528151121792e-12
been O 0 2.7287182929880416e-11
previously O 0 3.976980522679696e-09
reported O 0 5.011616011074693e-09
in O 0 3.4991738239592562e-12
African O 0 3.082740174242815e-10
- O 0 4.3311430886205926e-08
Americans O 0 5.3419219048223e-10
. O 0 6.198575073362855e-12

We O 0 1.325330334367436e-08
also O 0 3.2835225424049375e-12
show O 0 1.0113015459778385e-11
that O 0 2.7258841614041102e-14
the O 0 3.038149294859807e-14
879delG O 0 3.05482984686023e-07
and O 0 1.519143699724168e-10
1195delC O 0 1.1437748526077485e-06
defects O 0 0.15965941548347473
are O 0 3.039159093658206e-13
associated O 0 3.5638337983825985e-13
with O 0 4.62436824943957e-11
characteristic O 0 1.0517031796553056e-06
C6 O 0 0.03201520815491676
/ O 0 0.0002644394990056753
C7 O 0 0.0002199737064074725
region O 0 7.60223620166478e-11
DNA O 0 1.5410512332891813e-07
marker O 0 2.945737151094363e-06
haplotypes O 0 6.379659112099034e-08
, O 0 8.61276165404351e-13
although O 0 1.1272688511809736e-13
small O 0 1.7659603163480697e-12
variations O 0 5.111669754143122e-09
were O 0 2.1858734267077295e-10
observed O 0 2.5297748340591397e-09
. O 0 5.3775761621466245e-11

The O 0 2.1220911139430143e-10
1936delG O 0 6.678700401607784e-07
defect O 0 1.5162181625782978e-05
was O 0 3.0223420988129135e-10
observed O 0 1.0521049309542008e-11
only O 0 2.587559344308793e-13
once O 0 1.2739317933885275e-10
in O 0 3.7879022021878456e-14
the O 0 2.2609002343909612e-12
Cape O 0 2.6663835028806204e-10
, O 0 4.087138274848877e-14
but O 0 8.163946644092809e-15
its O 0 7.703917968241315e-15
associated O 0 2.1945089517284855e-13
haplotype O 0 1.920897607643468e-10
could O 0 1.1033822744366262e-09
be O 0 1.2966832468874756e-11
deduced O 0 2.156764544736234e-09
. O 0 6.225949616966986e-11

The O 0 5.801092028620558e-13
data O 0 2.4625409350553795e-11
from O 0 1.3383636917902592e-13
the O 0 3.88821699175753e-14
haplotypes O 0 6.218404680069511e-10
indicate O 0 2.016203731747268e-10
that O 0 1.9935019347078198e-13
these O 0 4.577290491623344e-14
three O 0 5.8284670492736446e-12
molecular O 0 1.1697922275288875e-07
defects O 0 0.1324700266122818
account O 0 3.3772512564311796e-11
for O 0 9.868315366257097e-12
the O 0 3.27468219207816e-10
defects O 1 0.9941654205322266
in O 0 9.37044631341491e-14
all O 0 6.918357488457094e-13
the O 0 5.2146431432902735e-14
38 O 0 1.1367485078239703e-11
unrelated O 0 1.0653949944483543e-10
C6Q0 O 0 1.9554023310774937e-05
individuals O 0 1.1664624821605685e-09
we O 0 4.331206948648969e-09
have O 0 4.7543349465661855e-12
studied O 0 1.8839506777529325e-12
from O 0 1.2772404729449911e-14
the O 0 3.6602453923686995e-13
Cape O 0 1.1135898869696348e-09
. O 0 8.558594805085917e-12

We O 0 1.995264398146901e-08
have O 0 5.93968364076547e-12
also O 0 2.565415870188492e-13
observed O 0 2.1954395766632384e-12
the O 0 6.436560675724887e-14
879delG O 0 1.325469867197171e-07
defect O 0 4.6165715161805565e-07
in O 0 5.056773142581017e-13
two O 0 3.7607307490361563e-08
Dutch O 1 0.9999663829803467
C6 B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
deficient I-Disease 1 1.0
kindreds O 0 2.3120925106923096e-05
, O 0 1.3095966910729728e-13
but O 0 1.2710864397700097e-15
the O 0 2.0050616643895423e-15
879delG O 0 7.496197440559627e-09
defect O 0 5.97952265479762e-09
in O 0 5.612405580156157e-15
the O 0 1.022082334674497e-13
Cape O 0 1.5792435414940798e-10
probably O 0 4.6391770980314107e-10
did O 0 9.946268114680024e-11
not O 0 3.3021488646776953e-13
come O 0 1.3344738454459243e-13
from O 0 1.925335704668768e-14
The O 0 2.7286685281083245e-13
Netherlands O 0 1.1122955001496848e-08
. O 0 2.302283526583321e-13
. O 0 3.552041039772691e-12

Complement B-Disease 1 0.9999310970306396
C7 I-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
: O 0 1.0796839811089143e-10
seven O 0 7.708103252901388e-12
further O 0 1.615299582459484e-12
molecular O 0 4.337854534242069e-06
defects O 1 0.9999974966049194
and O 0 2.970213186515025e-09
their O 0 4.8179806498571676e-12
associated O 0 1.2866045902282242e-11
marker O 0 2.5150600322376704e-06
haplotypes O 0 6.309307082119631e-06
. O 0 4.984311297029365e-10

Seven O 0 1.5068357672731736e-10
further O 0 8.736903344894187e-13
molecular O 0 2.8998923262690823e-09
bases O 0 6.381706953106914e-06
of O 0 8.642532520752866e-07
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 9.26062448947107e-10
described O 0 4.811465115217572e-10
. O 0 1.3438389290243435e-11

All O 0 3.6430233829598535e-12
these O 0 1.8701435460454462e-14
new O 0 3.553977316432533e-13
molecular O 0 7.250083311483024e-10
defects O 0 0.0006507440120913088
involve O 0 7.031710630434063e-11
single O 0 3.4117113578702174e-09
- O 0 6.708908273367342e-08
nucleotide O 0 3.3891924822171404e-09
events O 0 5.771638375562382e-12
, O 0 4.238011783413813e-14
deletions O 0 2.2505680652429305e-10
and O 0 3.5734890740934944e-11
substitutions O 0 2.0783884335795477e-10
, O 0 1.5287558952038413e-14
some O 0 3.9085490965080395e-16
of O 0 1.6278396070879865e-14
which O 0 3.432241643674949e-11
alter O 0 1.5319070456598638e-08
splice O 0 4.893092409474775e-06
sites O 0 1.0864431487789261e-06
, O 0 1.813797723126953e-11
and O 0 1.907307428314353e-12
others O 0 1.4576574539418297e-12
codons O 0 3.143041382713818e-08
. O 0 1.1706202847350244e-11

They O 0 3.5286652072530345e-11
are O 0 2.597139176827956e-15
distributed O 0 5.721659277824805e-15
along O 0 3.981892940374543e-12
the O 0 3.693522538598254e-13
C7 O 0 4.066570909344591e-06
gene O 0 4.369683281879588e-09
, O 0 1.4959600669762346e-13
but O 0 5.102478616898385e-15
predominantly O 0 9.723704453385926e-15
towards O 0 2.2706401375024304e-13
the O 0 4.310495645316881e-13
3 O 0 6.967015853120984e-11
end O 0 3.6104201850406525e-09
. O 0 3.764227124447572e-11

All O 0 8.670360263085541e-11
were O 0 4.975453642835914e-12
found O 0 1.2667801920288047e-12
in O 0 9.635784974559771e-15
compound O 0 6.564352468714507e-13
heterozygous O 0 4.2033757807757866e-08
individuals O 0 3.7614658610074514e-10
. O 0 6.531138824206195e-11

The O 0 9.77789138545404e-09
C6 O 0 0.011157126165926456
/ O 0 0.0002716151939239353
C7 O 0 0.004044684115797281
marker O 0 1.915107532113325e-05
haplotypes O 0 2.087448137899628e-06
associated O 0 5.865814944883141e-09
with O 0 6.272961317055348e-11
most O 0 4.3595665966122965e-10
C7 B-Disease 1 0.9999200105667114
defects I-Disease 1 0.9999959468841553
are O 0 1.4673419146404854e-09
tabulated O 0 2.571179902588483e-05
. O 0 8.310568487719661e-13
. O 0 6.67297120338084e-12

A O 0 1.4066404985246805e-10
genome O 0 5.71043379249403e-10
- O 0 3.994998998280153e-09
wide O 0 9.592011213088725e-12
search O 0 2.3138537526973257e-12
for O 0 1.6365728217060393e-13
chromosomal O 0 1.2315722415223718e-06
loci O 0 2.183850256187725e-08
linked O 0 2.3477672584704123e-05
to O 0 8.572675014306697e-09
mental O 0 0.0020764977671205997
health O 0 3.966783790332329e-09
wellness O 0 1.3397448428431602e-10
in O 0 4.994900350399406e-15
relatives O 0 1.6454304824047028e-13
at O 0 1.177337827923397e-11
high O 0 6.163266874636975e-08
risk O 0 7.180666443673545e-07
for O 0 1.8012230595942924e-09
bipolar B-Disease 1 0.9993587136268616
affective I-Disease 1 0.9038353562355042
disorder I-Disease 0 0.41602587699890137
among O 0 1.0513245655985326e-11
the O 0 2.3334342270919795e-12
Old O 0 5.878131923964247e-05
Order O 0 5.529181557051288e-10
Amish O 0 7.321186330955243e-06
. O 0 9.670068912281948e-11

Bipolar B-Disease 1 0.999625563621521
affective I-Disease 1 0.9992983341217041
disorder I-Disease 1 0.999920129776001
( O 0 8.775201081334671e-07
BPAD B-Disease 1 0.9999998807907104
; O 0 0.0005455004866234958
manic B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999998807907104
depressive I-Disease 1 1.0
illness I-Disease 1 0.9999822378158569
) O 0 4.5204857218594796e-11
is O 0 2.720410973312132e-13
characterized O 0 7.332900427278397e-14
by O 0 3.443407888605596e-15
episodes O 0 2.3649562308492023e-08
of O 0 5.522461828111336e-12
mania B-Disease 0 0.0006115969736129045
and O 0 4.371709216854924e-09
/ O 0 1.8451582661782595e-07
or O 0 6.901932358971408e-10
hypomania B-Disease 0 0.0003729156160261482
interspersed O 0 3.061105644519557e-07
with O 0 2.4382319080418213e-12
periods O 0 1.655405673650634e-10
of O 0 6.8824958752988774e-12
depression B-Disease 0 1.3951737855677493e-05
. O 0 1.7317152919971157e-11

Compelling O 0 4.53350884610515e-10
evidence O 0 5.6707812057243956e-11
supports O 0 4.6655828506159125e-11
a O 0 1.3451198976281026e-13
significant O 0 9.956237359077039e-14
genetic O 0 5.865341545785441e-10
component O 0 8.420295571909264e-09
in O 0 1.683817304066592e-14
the O 0 9.43551402917027e-14
susceptibility O 0 5.651606960199729e-10
to O 0 3.115973104539371e-11
develop O 0 1.1835796840387047e-06
BPAD B-Disease 1 0.9999995231628418
. O 0 1.3443685054070897e-09

To O 0 1.1794641652240756e-11
date O 0 4.752291338228076e-10
, O 0 7.703454844507074e-13
however O 0 3.983848705568435e-14
, O 0 2.630762573185689e-15
linkage O 0 5.037950612241104e-10
studies O 0 2.9973565296437243e-11
have O 0 4.216874245621671e-12
attempted O 0 9.06406061318421e-11
only O 0 4.904054050867968e-13
to O 0 2.0718376761929246e-14
identify O 0 5.186977514171076e-10
chromosomal O 0 7.715097126492765e-06
loci O 0 7.413416103219106e-09
that O 0 3.1023929952800344e-11
cause O 0 9.281162643981489e-12
or O 0 3.5921932095561715e-11
increase O 0 7.545824382004795e-11
the O 0 5.8402184997807804e-12
risk O 0 5.254240704744007e-07
of O 0 4.930542519404613e-12
developing O 0 2.502981033103424e-06
BPAD B-Disease 1 0.9999986886978149
. O 0 1.105800895295772e-09

To O 0 9.079555141587592e-13
determine O 0 2.708866117528963e-12
whether O 0 1.389925934763836e-11
there O 0 2.2714683866470464e-12
could O 0 7.087928854954129e-11
be O 0 2.7842561155927426e-12
protective O 0 1.8907526933009677e-10
alleles O 0 8.115329697307161e-13
that O 0 1.276982941047708e-13
prevent O 0 4.9087567344230365e-11
or O 0 3.431331607739452e-11
reduce O 0 4.5938214343621553e-10
the O 0 5.081311348249795e-13
risk O 0 3.792690606019278e-09
of O 0 8.219949243840063e-14
developing O 0 1.3406746290911542e-07
BPAD B-Disease 1 1.0
, O 0 8.907876199908474e-14
similar O 0 1.1659562043677134e-15
to O 0 4.2154923960715206e-15
what O 0 2.1174140457484725e-13
is O 0 1.157775725334556e-13
observed O 0 7.792135534902267e-13
in O 0 1.2951536104168198e-14
other O 0 8.462410772125395e-10
genetic B-Disease 1 1.0
disorders I-Disease 1 1.0
, O 0 6.754836707340006e-12
we O 0 3.7951636278066303e-10
used O 0 6.364236071476626e-08
mental O 0 0.0001528292486909777
health O 0 1.7298715793145902e-09
wellness O 0 2.5707883044567836e-10
( O 0 1.4902245019585147e-13
absence O 0 6.659569163486312e-12
of O 0 3.7129254206770546e-13
any O 0 3.60585261205415e-07
psychiatric B-Disease 0 0.0044792876578867435
disorder I-Disease 0 1.1742976312234532e-05
) O 0 3.3418560074164466e-14
as O 0 2.4197592714270133e-13
the O 0 4.793264242008814e-14
phenotype O 0 1.4643475321207688e-09
in O 0 4.9443058019104855e-14
our O 0 1.0786233885229368e-11
genome O 0 6.434240917840839e-10
- O 0 7.289358450179861e-08
wide O 0 2.238658591835474e-09
linkage O 0 8.150578878485248e-08
scan O 0 5.46529065559298e-07
of O 0 3.4473145909055813e-13
several O 0 4.197300601700704e-13
large O 0 3.21226135968633e-11
multigeneration O 0 6.874176324345171e-05
Old O 0 4.207525762467412e-06
Order O 0 3.409847404434174e-11
Amish O 0 4.071868886512675e-08
pedigrees O 0 9.502905129465944e-09
exhibiting O 0 3.5100498507745215e-08
an O 0 2.610063315651445e-13
extremely O 0 1.6103422761926112e-10
high O 0 1.1164998703350193e-08
incidence O 0 5.368143320083618e-06
of O 0 1.3895277817255192e-08
BPAD B-Disease 1 0.9999998807907104
. O 0 7.4056427656898904e-09

We O 0 4.603614911502518e-08
have O 0 2.7964490532245145e-12
found O 0 6.77077697294054e-13
strong O 0 2.2040132712604008e-14
evidence O 0 8.116378120807954e-14
for O 0 1.7491836836391536e-14
a O 0 1.634108701218523e-13
locus O 0 7.126750034558427e-08
on O 0 6.49519620310457e-07
chromosome O 0 0.0002898310194723308
4p O 0 7.243796972034033e-06
at O 0 1.1562458629432726e-10
D4S2949 O 0 6.749547448725579e-11
( O 0 3.028127539841073e-15
maximum O 0 9.026092183785431e-14
GENEHUNTER O 0 1.9236242110309831e-07
- O 0 1.9386470206939066e-09
PLUS O 0 1.8914415866877476e-10
nonparametric O 0 8.347059043956051e-09
linkage O 0 5.634735700255078e-08
score O 0 2.997098391688269e-08
= O 0 5.819519310890087e-10
4 O 0 2.323556928460202e-12
. O 0 3.98397067831284e-14
05 O 0 9.035175274618723e-09
, O 0 7.930060687971752e-13
P O 0 5.985167490507592e-07
= O 0 1.475808537876322e-11
5 O 0 1.708029469813313e-13
. O 0 7.902055068230093e-16
22 O 0 1.5520078982828728e-13
x O 0 1.5714501921948454e-09
10 O 0 5.302771676624074e-12
( O 0 1.714435681637351e-14
- O 0 1.326618814800895e-10
4 O 0 8.784007050378906e-13
) O 0 1.910909293621017e-15
; O 0 5.638518335370586e-16
SIBPAL O 0 6.653558259905878e-10
Pempirical O 0 1.6426610072173276e-10
value O 0 1.8150808547140462e-12
< O 0 8.38198607744367e-12
3 O 0 7.116667281523159e-13
x O 0 1.0986744847230057e-08
10 O 0 3.227867279020913e-11
( O 0 7.439431422241391e-14
- O 0 3.4451638764032566e-10
5 O 0 2.1379252534980964e-12
) O 0 2.6733124262580616e-15
) O 0 2.2503894580291406e-16
and O 0 5.778929928245747e-16
suggestive O 0 1.5435301691305026e-12
evidence O 0 2.8111365028859504e-14
for O 0 7.149376826739594e-16
a O 0 1.9291256688879627e-14
locus O 0 7.301906634893385e-09
on O 0 1.3440029533740017e-07
chromosome O 0 0.0051070572808384895
4q O 0 0.0017185596516355872
at O 0 1.31408317560755e-09
D4S397 O 0 3.333414932971124e-10
( O 0 2.9283260522374246e-14
maximum O 0 1.64927728592279e-12
GENEHUNTER O 0 4.071298462804407e-07
- O 0 4.2043919457057655e-09
PLUS O 0 4.1001232964354983e-10
nonparametric O 0 1.0476568945705367e-08
linkage O 0 4.548540388782385e-08
score O 0 7.086949249668351e-09
= O 0 9.141338380702635e-11
3 O 0 7.015868463446095e-13
. O 0 1.8185511080413656e-14
29 O 0 3.5841447865170295e-11
, O 0 8.919301657927398e-14
P O 0 4.720343440567376e-07
= O 0 1.7030734461576102e-11
2 O 0 1.7400172286092391e-13
. O 0 1.2549844493218239e-15
57 O 0 2.4088374524222633e-12
x O 0 1.1748138462053248e-08
10 O 0 2.8629574405636404e-11
( O 0 3.7412520320244044e-14
- O 0 3.050668884174712e-10
3 O 0 1.496092095695789e-12
) O 0 2.7328376666263575e-15
; O 0 1.9995013166072915e-15
SIBPAL O 0 1.6843192396365225e-09
Pempirical O 0 1.7725933221246493e-10
value O 0 9.628061152164302e-13
< O 0 7.139648247611596e-12
1 O 0 3.8796477965993836e-13
x O 0 1.2203880572769776e-08
10 O 0 4.6535938297287416e-11
( O 0 2.0553079637525284e-13
- O 0 5.387927881628229e-10
3 O 0 1.68956786495561e-12
) O 0 5.31754843489837e-16
) O 0 2.7391283619499335e-17
that O 0 4.14513373665674e-17
are O 0 5.971457764299571e-15
linked O 0 3.384683422424928e-09
to O 0 1.86793824852316e-09
mental O 0 8.540439011994749e-05
health O 0 6.741589952952154e-09
wellness O 0 2.8926681494567674e-08
. O 0 1.556248359346757e-11

These O 0 3.9094987663856884e-11
findings O 0 4.3216902279041847e-10
are O 0 1.0720601489877524e-11
consistent O 0 3.7694649485109366e-11
with O 0 2.09627186621578e-14
the O 0 5.641659239418123e-16
hypothesis O 0 3.0744910740551634e-13
that O 0 1.0347867785624569e-14
certain O 0 3.2391058287168165e-14
alleles O 0 5.7442401529828047e-11
could O 0 1.9609856793945113e-10
prevent O 0 2.3743368382511676e-10
or O 0 6.102338773184002e-11
modify O 0 9.380627830068988e-09
the O 0 7.291235323836354e-12
clinical O 0 1.5980225143152893e-08
manifestations O 0 1.6352157405918888e-09
of O 0 3.143232852817479e-12
BPAD B-Disease 1 1.0
and O 0 6.980650085752771e-11
perhaps O 0 3.171759187757528e-13
other O 0 5.226017101706004e-13
related O 0 7.109304789310045e-08
affective B-Disease 1 0.9012724757194519
disorders I-Disease 0 0.07292431592941284
. O 0 1.4269183057358248e-10

Segregation O 0 5.5015927500789985e-05
distortion O 0 0.00030528660863637924
in O 0 7.244160116215426e-08
myotonic B-Disease 1 0.9999792575836182
dystrophy I-Disease 1 0.999987006187439
. O 0 5.555021687086992e-08

Myotonic B-Disease 1 0.9999710321426392
dystrophy I-Disease 1 0.9999971389770508
( O 0 3.221078486603801e-06
DM B-Disease 1 0.9999998807907104
) O 0 2.560893941350173e-09
is O 0 2.241468954888859e-10
an O 0 1.9399923334439961e-10
autosomal B-Disease 1 0.9999985694885254
dominant I-Disease 1 0.9999977350234985
disease I-Disease 1 0.9999991655349731
which O 0 1.8127007450630117e-08
, O 0 3.957029582474236e-12
in O 0 3.701390661526617e-14
the O 0 1.6329129888525973e-12
typical O 0 3.081495281165303e-09
pedigree O 0 1.4104241472523427e-06
, O 0 1.7430532657427417e-13
shows O 0 6.717679797846321e-12
a O 0 7.307921086850688e-14
three O 0 7.574771430755856e-13
generation O 0 1.5524484475726297e-10
anticipation O 0 1.082089903792216e-10
cascade O 0 1.6675517144904006e-07
. O 0 4.9958634451563455e-11

This O 0 1.4393102595183782e-12
results O 0 1.2363512991164782e-10
in O 0 1.6323666029993689e-10
infertility B-Disease 1 0.9992166757583618
and O 0 0.008379208855330944
congenital B-Disease 1 0.9999997615814209
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.3685722777267983e-08
CDM B-Disease 0 2.593619683466386e-05
) O 0 1.0133458742261903e-12
with O 0 9.428671866428939e-15
the O 0 2.1111853635598496e-15
disappearance O 0 2.1455605292430846e-08
of O 0 1.5320466006940592e-09
DM B-Disease 1 1.0
in O 0 1.9625001276835086e-11
that O 0 3.79925908441936e-12
pedigree O 0 3.530219601088902e-07
. O 0 1.918670430867131e-11

The O 0 4.2012254135651017e-13
concept O 0 9.299800513007384e-13
of O 0 7.728130743851758e-14
segregation O 0 3.686314309359062e-10
distortion O 0 5.540564007588955e-09
, O 0 3.930569994372961e-14
where O 0 6.3066833351531956e-15
there O 0 2.4830146161961214e-15
is O 0 8.453774213588918e-15
preferential O 0 8.843824977899928e-12
transmission O 0 3.843160512051469e-10
of O 0 1.3124458939141347e-15
the O 0 3.694519276148606e-15
larger O 0 2.088574267960358e-13
allele O 0 9.366167563751304e-12
at O 0 1.5380918760854456e-10
the O 0 5.052632617852382e-11
DM B-Disease 1 1.0
locus O 0 1.880386690800151e-07
, O 0 2.204832150187741e-11
has O 0 1.3090585906927465e-11
been O 0 2.1954322040884655e-11
put O 0 2.6965292221348136e-09
forward O 0 3.67971964010394e-09
to O 0 5.285602684701463e-13
explain O 0 3.863465103393082e-11
partially O 0 2.593533388051128e-09
the O 0 1.3421309894077853e-14
maintenance O 0 1.3604671833533644e-09
of O 0 8.553156555408947e-13
DM B-Disease 1 1.0
in O 0 7.097310478036689e-13
the O 0 1.5417579864694664e-13
population O 0 4.557552252260066e-13
. O 0 3.431964998648618e-12

In O 0 3.2649868052236908e-12
a O 0 5.491117001203694e-13
survey O 0 1.5918977247508792e-09
of O 0 7.105047886840632e-12
DM B-Disease 1 1.0
in O 0 2.1887447410051664e-09
Northern O 0 3.160260386714242e-10
Ireland O 0 3.8868279261805583e-07
, O 0 5.709085005960179e-13
59 O 0 1.0931607181963177e-11
pedigrees O 0 6.703338439884021e-10
were O 0 3.5693661568081403e-12
ascertained O 0 2.66326405373718e-09
. O 0 2.5887863033813296e-11

Sibships O 0 1.0584774827293586e-05
where O 0 4.5595305309120704e-11
the O 0 1.2828607906599076e-14
status O 0 1.2200829539385505e-12
of O 0 5.3867839550948704e-15
all O 0 2.111180587988093e-12
the O 0 5.769156311528911e-14
members O 0 5.292843596673043e-14
had O 0 4.167342859684453e-11
been O 0 7.862452551000987e-13
identified O 0 1.131043262520004e-11
were O 0 2.294322772131846e-13
examined O 0 1.5045698020799136e-10
to O 0 7.288638042993265e-15
determine O 0 3.821955230597085e-13
the O 0 2.4927900116821465e-15
transmission O 0 4.492192728910993e-10
of O 0 7.665837060998656e-15
the O 0 2.349296755396746e-12
DM B-Disease 1 0.9999998807907104
expansion O 0 6.730572349455954e-11
from O 0 3.7824100405578487e-13
affected O 0 4.759254795816403e-11
parents O 0 3.448169484318586e-13
to O 0 3.1668717483595643e-15
their O 0 1.1074682024301424e-13
offspring O 0 8.199668027897289e-11
. O 0 1.885661765621549e-12

Where O 0 1.7541823549294122e-10
the O 0 1.828559656122386e-12
transmitting O 0 3.556836236384697e-05
parent O 0 1.561732824484352e-05
was O 0 4.147271681631537e-08
male O 0 1.3089300754387523e-09
, O 0 3.2618794275872387e-13
58 O 0 4.2489203128104336e-11
. O 0 4.127337794451735e-12

3 O 0 2.4472790460805527e-09
% O 0 2.497505240811604e-12
of O 0 2.6874841344985733e-15
the O 0 1.0706321117474275e-14
offspring O 0 5.042757322826219e-10
were O 0 1.9281143348592877e-10
affected O 0 1.6745868580692047e-10
, O 0 9.683731274539101e-14
and O 0 6.315127457426351e-13
in O 0 7.900216477338959e-16
the O 0 1.9704703211313344e-15
case O 0 1.6627780749511878e-11
of O 0 1.5602584057649443e-14
a O 0 1.935054373680689e-11
female O 0 3.126520908836028e-08
transmitting O 0 3.888339506374905e-06
parent O 0 3.2623105994389334e-08
, O 0 4.877133310925152e-13
68 O 0 3.3312855252098927e-10
. O 0 1.4770335995950568e-11

7 O 0 1.242075313712121e-07
% O 0 4.9909298915906675e-11
were O 0 1.1018081412517144e-11
affected O 0 8.647832450137116e-11
. O 0 9.464470873687958e-12

Studies O 0 2.7127156077000336e-10
on O 0 3.5024053969545665e-12
meiotic O 0 2.4293933975627624e-08
drive O 0 9.769580344709539e-08
in O 0 2.028739676251945e-11
DM B-Disease 1 1.0
have O 0 1.3095836914889247e-10
shown O 0 7.089124751634424e-13
increased O 0 1.844210954738898e-14
transmission O 0 3.922480049101118e-11
of O 0 3.274209828078438e-16
the O 0 1.739690371300388e-15
larger O 0 1.6400068965621156e-13
allele O 0 1.4572607009988303e-11
at O 0 5.960273247174186e-11
the O 0 2.266695858788026e-11
DM B-Disease 1 0.9999996423721313
locus O 0 5.268862537377572e-07
in O 0 7.635470727906934e-11
non O 0 1.0384138477093074e-05
- O 0 0.0005004326812922955
DM O 1 0.9999971389770508
heterozygotes O 0 5.862875127604639e-07
for O 0 1.3628317224734232e-11
CTGn O 0 4.6017277099963394e-07
. O 0 3.042073884462759e-11

This O 0 1.7924432554536351e-12
study O 0 7.172306910711856e-13
provides O 0 8.333358146334763e-14
further O 0 7.534131060997137e-15
evidence O 0 3.868261505383941e-13
that O 0 2.6097846756931165e-13
the O 0 9.70511605108415e-12
DM B-Disease 1 1.0
expansion O 0 7.469934892867514e-09
tends O 0 1.1065556804190635e-10
to O 0 1.6113438098467985e-14
be O 0 1.906193302161907e-13
transmitted O 0 1.3018141009624173e-09
preferentially O 0 2.8169404586719793e-09
. O 0 8.41447137661655e-12

Diagnosis O 0 0.0022895310539752245
of O 0 1.2798976989358835e-08
hemochromatosis B-Disease 1 0.9999979734420776
. O 0 4.001815625542804e-07

If O 0 1.3396113729413628e-07
untreated O 0 0.002306462498381734
, O 0 4.867615199799502e-10
hemochromatosis B-Disease 1 1.0
can O 0 0.019308825954794884
cause O 0 6.582977221114561e-06
serious O 0 0.06405482441186905
illness O 0 0.0006948032532818615
and O 0 1.6236534339242326e-10
early B-Disease 0 9.770680792220432e-12
death I-Disease 0 6.994891332823272e-09
, O 0 1.015006047960787e-11
but O 0 2.9938581995458957e-12
the O 0 2.3466187760307067e-12
disease O 0 2.8309138997428818e-06
is O 0 5.5061309678361425e-11
still O 0 2.130226134378077e-10
substantially O 0 7.396618872945737e-10
under O 0 3.3204159421984514e-08
- O 1 0.9968634843826294
diagnosed O 1 0.642214298248291
. O 0 6.492833354299066e-11

The O 0 5.901964680865568e-12
cornerstone O 0 5.207917208593926e-09
of O 0 1.2844718473255853e-14
screening O 0 3.4928272080181344e-11
and O 0 3.32323657152155e-15
case O 0 3.2619941836109327e-15
detection O 0 6.697027914864817e-13
is O 0 3.216419237070736e-14
the O 0 6.998590139051751e-16
measurement O 0 4.3614795108837257e-10
of O 0 2.43554417085623e-13
serum O 0 2.8824022280105055e-08
transferrin O 0 1.1979179870280632e-09
saturation O 0 9.530885802799816e-11
and O 0 1.1408493941211795e-11
the O 0 6.701794067615063e-13
serum O 0 3.051338808290893e-07
ferritin O 0 2.992368536069989e-06
level O 0 1.8289609826638298e-08
. O 0 6.43047143311648e-11

Once O 0 1.133753855242503e-07
the O 0 5.866608197499512e-13
diagnosis O 0 7.548825564640538e-09
is O 0 7.910603053683241e-13
suspected O 0 8.182119870525639e-08
, O 0 7.01002298743314e-13
physicians O 0 2.2407997766343835e-12
must O 0 1.984936867649445e-11
use O 0 7.051161876603373e-10
serum O 0 8.850565791362897e-05
ferritin O 0 0.0650610700249672
levels O 0 4.9003458116203547e-05
and O 0 2.7575932648460366e-08
hepatic O 0 0.020707992836833
iron O 0 0.12472755461931229
stores O 0 9.769310963747557e-06
on O 0 1.626255574649349e-08
liver O 0 9.918471732817125e-08
biopsy O 0 2.26038807227269e-07
specimens O 0 1.5472700898300218e-09
to O 0 1.8254642860249942e-13
assess O 0 9.533108746850871e-10
patients O 0 1.638632046892241e-12
for O 0 3.928866611116032e-15
the O 0 3.535020854598253e-13
presence O 0 3.449135421718097e-10
of O 0 6.944137105613368e-13
iron B-Disease 0 0.000189725193195045
overload I-Disease 0 5.133131708134897e-06
. O 0 3.8417730802153827e-11

Liver O 1 0.7741033434867859
biopsy O 0 0.2297562062740326
is O 0 1.2674449934024778e-08
also O 0 2.352695729207488e-12
used O 0 4.980236058618748e-13
to O 0 3.116847803615562e-14
establish O 0 1.4819607346838737e-11
the O 0 1.2695722077793459e-11
presence O 0 1.0194273869501558e-08
or O 0 2.2124129195333353e-09
absence O 0 5.067374964085047e-09
of O 0 2.982868943166017e-12
cirrhosis B-Disease 0 6.561390819115331e-06
, O 0 1.1725370023876747e-12
which O 0 1.187993388558628e-12
can O 0 1.034517138620572e-09
affect O 0 1.1052511794673592e-08
prognosis O 0 2.317887215497194e-08
and O 0 1.7441126667905316e-11
management O 0 3.852348995359023e-10
. O 0 6.021195261135537e-12

A O 0 2.0978951215111508e-11
DNA O 0 1.5849991319427659e-09
- O 0 4.836346434444749e-09
based O 0 8.197819159616593e-12
test O 0 1.4990192420683002e-09
for O 0 2.0872738352170975e-15
the O 0 2.411564422479906e-15
HFE O 0 1.0420945883993227e-08
gene O 0 5.598720445587624e-11
is O 0 1.2803478980152883e-14
commercially O 0 9.766874808914139e-13
available O 0 6.106421791829408e-12
, O 0 5.583731177080664e-13
but O 0 2.9061101398594746e-13
its O 0 1.2597006228930174e-13
place O 0 9.918268983888368e-11
in O 0 1.7435189305758242e-13
the O 0 1.0006845612559045e-12
diagnosis O 0 1.1081370843157856e-07
of O 0 1.5843779413438064e-11
hemochromatosis B-Disease 1 1.0
is O 0 3.515360162964498e-07
still O 0 1.5109778983557476e-09
being O 0 5.700930005847482e-11
evaluated O 0 1.6492295307202198e-09
. O 0 4.898821365922901e-12

Currently O 0 1.0438401432111277e-06
, O 0 1.3196364031901886e-13
the O 0 1.0128148709656224e-15
most O 0 5.516986577494131e-16
useful O 0 8.068702498677249e-13
role O 0 1.0919880971682616e-10
for O 0 2.1995321281562466e-14
this O 0 5.7143087259085325e-15
test O 0 5.373050004919833e-09
is O 0 1.663162405647796e-14
in O 0 1.519758259928364e-17
the O 0 1.737653151183123e-16
detection O 0 2.6681016770946364e-11
of O 0 3.4246802442516877e-12
hemochromatosis B-Disease 1 1.0
in O 0 4.1933519157044685e-11
the O 0 4.179740863315129e-13
family O 0 2.4400660311729716e-11
members O 0 2.284985894072944e-13
of O 0 1.1812233591430854e-13
patients O 0 3.2767343526030057e-12
with O 0 5.538814510665756e-15
a O 0 4.363584417844263e-14
proven O 0 6.691535103797719e-10
case O 0 2.83056390826264e-11
of O 0 3.5235570429274776e-13
the O 0 7.043271521567362e-10
disease O 0 7.373125845333561e-05
. O 0 4.913515080917641e-11

It O 0 6.5052884953842316e-12
is O 0 1.859630071460172e-13
crucial O 0 1.9296069950214267e-11
to O 0 1.7490096176908665e-11
diagnose O 1 0.6359096765518188
hemochromatosis B-Disease 1 1.0
before O 0 0.26122546195983887
hepatic B-Disease 1 0.9999676942825317
cirrhosis I-Disease 1 0.9990614056587219
develops O 0 0.00018580966570880264
because O 0 1.5754296756043118e-09
phlebotomy O 0 0.00030078605050221086
therapy O 0 1.9971964775322704e-06
can O 0 6.881131042746347e-08
avert O 0 0.13228555023670197
serious O 1 0.9942094087600708
chronic O 1 0.9999641180038452
disease O 0 0.1346915066242218
and O 0 2.049697217509916e-10
can O 0 3.895001543519072e-10
even O 0 8.014632291164503e-10
lead O 0 5.958395377092529e-08
to O 0 1.9560500788551316e-11
normal O 0 3.641484336291967e-10
life O 0 1.7322843159917056e-10
expectancy O 0 4.256573760130777e-09
. O 0 5.964062658450273e-14
. O 0 2.797937662807337e-12

Prevalence O 0 0.0004030947748105973
of O 0 4.0545470626762725e-12
the O 0 6.452777223144024e-13
I1307K O 0 1.5559293853328882e-09
APC B-Disease 0 1.0876919365188087e-09
gene O 0 6.015530851222195e-10
variant O 0 1.6928284196637833e-07
in O 0 1.9468814581313776e-12
Israeli O 0 4.340204196040531e-09
Jews O 0 4.358412773481507e-13
of O 0 1.3866740380599893e-15
differing O 0 4.5638301216519364e-14
ethnic O 0 8.768601621710059e-14
origin O 0 4.512491422192788e-11
and O 0 2.3112285418847023e-09
risk O 0 2.8086371912650065e-06
for O 0 3.102782386577019e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
. O 0 8.361464409745167e-09

BACKGROUND O 0 1.6234436088780058e-06
& O 0 3.0129120887067984e-07
AIMS O 0 2.2689103218453965e-07
Israeli O 0 1.5144618714657554e-07
Jews O 0 1.2106772528941434e-10
of O 0 9.662491640138882e-11
European O 0 2.8781996661564335e-06
birth O 0 4.6931643282732693e-07
, O 0 9.671047296322399e-11
i O 0 3.197827069811865e-08
. O 0 3.5417528607047935e-15
e O 0 4.4320540293352195e-11
. O 0 6.507648254636383e-15
, O 0 3.307225954752549e-15
Ashkenazim O 0 1.4698427197590291e-10
, O 0 6.410546091629044e-15
have O 0 1.4730490048228684e-12
the O 0 3.74555081394945e-10
highest O 1 0.999980092048645
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 0 0.011399144306778908
of O 0 1.687562242724816e-11
any O 0 3.537874437853361e-09
Israeli O 0 1.2081154636689462e-06
ethnic O 0 1.9329220515840184e-11
group O 0 2.3121369263634506e-09
. O 0 6.071525920914311e-11

The O 0 5.951049375507722e-11
I1307K O 0 2.8450200417751148e-08
APC B-Disease 0 1.6956827053604684e-08
gene O 0 1.7162044230190077e-08
variant O 0 1.8861658190871822e-06
was O 0 4.68769112416112e-09
found O 0 1.4678983029092763e-10
in O 0 1.664534260209169e-13
6 O 0 3.158351802312609e-09
. O 0 1.4450957791511954e-11

1 O 0 6.694793608374994e-09
% O 0 1.6519258183578245e-11
of O 0 7.1186871501705e-14
American O 0 5.109366818523142e-10
Jews O 0 6.104861408062767e-12
, O 0 3.106321081434993e-13
28 O 0 1.8785647950408935e-12
% O 0 1.3375763026679858e-15
of O 0 9.577339870605814e-14
their O 0 2.39813402913569e-07
familial O 1 0.9999977350234985
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 6.395976015483029e-06
, O 0 5.583478991655344e-12
but O 0 5.208128199540862e-12
not O 0 1.0765269752022188e-11
in O 0 2.8466588895131872e-12
non O 0 2.464225644871476e-06
- O 0 2.1730808441589033e-07
Jews O 0 1.463356436026686e-09
. O 0 6.160719850933916e-11

We O 0 3.4293706763222076e-10
assessed O 0 2.7551824710592143e-10
the O 0 4.590320094519096e-13
I1307K O 0 2.9269164869560882e-08
prevalence O 0 4.498320322454674e-06
in O 0 1.2906642985269223e-12
Israeli O 0 1.10560693933337e-09
Jews O 0 2.0696981726121139e-13
of O 0 5.625670963143106e-16
differing O 0 2.548802606418179e-14
ethnic O 0 2.0757614716177854e-14
origin O 0 5.317295215245821e-12
and O 0 1.5306620415600491e-09
risk O 0 8.985937256511534e-07
for O 0 1.1411040645725734e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
. O 0 7.622412034891113e-09

METHODS O 0 3.3734914167693475e-11
DNA O 0 2.8291782805389687e-10
samples O 0 3.736365730699909e-11
from O 0 7.284413042652361e-15
500 O 0 1.737804134805971e-14
unrelated O 0 1.917491556160944e-12
Jews O 0 2.467038726083892e-12
of O 0 5.8446979894766216e-12
European O 0 4.638756934127741e-07
or O 0 2.2254537768162663e-08
non O 0 4.482772055780515e-05
- O 0 8.15969815448625e-06
European O 0 1.7782401329213826e-08
origin O 0 2.8086955504436073e-12
, O 0 1.2648481437574355e-13
with O 0 3.575188173396589e-14
or O 0 1.343397615372055e-12
without O 0 4.645704936197259e-13
a O 0 6.624041593017438e-14
personal O 0 7.456778527981101e-10
and O 0 2.387043007701095e-09
/ O 0 4.072024140100439e-08
or O 0 3.960824168647292e-10
family O 0 7.035776128372362e-11
history O 0 3.645597018708813e-11
of O 0 1.1616273264472565e-12
neoplasia B-Disease 0 3.199834850420302e-07
, O 0 1.192467213298118e-13
were O 0 4.37777289733713e-14
examined O 0 1.1095990792853172e-10
for O 0 9.460815242117934e-14
the O 0 1.3490303438137147e-13
I1307K O 0 1.627367823830994e-10
variant O 0 8.375278942596154e-11
by O 0 1.003676952475701e-14
the O 0 6.703247982728366e-14
allele O 0 2.2232876650818412e-10
- O 0 3.924998548399117e-09
specific O 0 1.203456605203268e-11
oligonucleotide O 0 2.409847184026148e-07
( O 0 4.740871931141477e-11
ASO O 0 6.717680662404746e-06
) O 0 2.5434217449174512e-14
method O 0 2.3017666331975883e-12
. O 0 1.2553270055393195e-11

RESULTS O 0 2.006469124182786e-08
In O 0 1.7775945917054142e-13
persons O 0 2.3226963429857916e-13
at O 0 4.648809549118171e-12
average O 0 1.0204510658695654e-07
risk O 0 9.030164801515639e-05
for O 0 5.2331157348817214e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 2.166209434051325e-09
I1307K O 0 4.869446623700924e-09
was O 0 2.749061811524456e-10
found O 0 4.586193924627224e-11
in O 0 2.7219890295741844e-13
5 O 0 1.4029269412851875e-10
. O 0 1.7300480492643544e-11

0 O 0 3.0255735694595387e-09
% O 0 3.5136865205592782e-12
of O 0 1.2144869528454838e-13
120 O 0 6.578321221084593e-11
European O 0 4.409496412449698e-08
and O 0 1.1504208002888205e-10
1 O 0 2.1974599223595348e-11
. O 0 4.784682632735793e-12

6 O 0 5.131111535661148e-08
% O 0 1.8933101614271308e-11
of O 0 1.229084244320014e-13
188 O 0 2.187525938168733e-09
non O 0 3.2700158953957725e-06
- O 0 0.00011806074326159433
European O 0 1.2193943348393077e-06
Jews O 0 4.5778758561709765e-10
( O 0 6.18004085406465e-12
P O 0 1.582040022185538e-05
= O 0 4.0504546938713304e-10
0 O 0 2.1870389613903862e-12
. O 0 2.7203059412266722e-14
08 O 0 2.973259832783626e-11
) O 0 2.2425601143866852e-13
. O 0 6.704363626763854e-13

It O 0 4.1594814398360214e-11
occurred O 0 1.0175323778005563e-10
in O 0 3.227931973364545e-13
15 O 0 1.8728378223253905e-11
. O 0 2.1153885934599437e-12

4 O 0 3.4334037835037634e-09
% O 0 5.7393092015023406e-12
of O 0 3.0941809986591295e-13
52 O 0 1.8155276393372333e-08
Ashkenazi O 0 2.336504394406802e-06
Israelis O 0 1.0172232123295544e-07
with O 0 1.94596760927368e-09
familial O 1 0.8228567838668823
cancer B-Disease 1 0.5710996985435486
( O 0 4.578489587458989e-09
P O 1 0.6200441122055054
= O 0 8.870837291397038e-07
0 O 0 5.328163465989633e-10
. O 0 9.492126052182415e-13
02 O 0 9.187051674963698e-10
) O 0 3.470840151745258e-14
and O 0 6.328618185058588e-14
was O 0 1.7310812505666462e-11
not O 0 1.3829089511984555e-13
detected O 0 7.017315173385441e-09
in O 0 2.825280428445792e-13
51 O 0 2.39068924656749e-08
non O 0 7.800405796842824e-07
- O 0 4.554261749944999e-07
European O 0 3.518587643469573e-09
Jews O 0 7.779230818544258e-13
at O 0 5.653533891036844e-11
increased O 0 1.4123803515619926e-10
cancer B-Disease 0 6.811777808479746e-08
risk O 0 1.4158909600325842e-08
. O 0 7.732754540856757e-12

Colorectal B-Disease 1 0.9902656674385071
neoplasia I-Disease 0 0.029191290959715843
occurred O 0 4.3566041085796314e-07
personally O 0 2.0557841651225317e-07
or O 0 3.504821155519977e-10
in O 0 1.0931617481883815e-13
the O 0 1.5745672994615934e-13
families O 0 2.259067092462777e-13
of O 0 1.2238388572688701e-14
13 O 0 9.638961503966037e-12
of O 0 1.600613596470981e-14
20 O 0 2.871625680300749e-11
Ashkenazi O 0 5.18660170367724e-10
I1307K O 0 3.350515698219425e-11
carriers O 0 1.513526109997443e-11
, O 0 1.5530723899986757e-15
8 O 0 4.741470548976466e-14
of O 0 5.619732415149906e-15
whom O 0 2.2246219089083752e-08
also O 0 4.4122053566297836e-08
had O 0 4.8055635915034145e-08
a O 0 1.251807511815084e-11
personal O 0 1.9587934829701226e-08
or O 0 1.643120306482615e-08
family O 0 2.2008335431866755e-10
history O 0 3.575507598330141e-11
of O 0 4.1250183824281805e-11
noncolonic O 0 0.00021846441086381674
neoplasia B-Disease 0 4.5022432459518313e-05
. O 0 2.6693652843690074e-10

CONCLUSIONS O 0 1.7216434500255673e-08
The O 0 9.310951315510962e-12
I1307K O 0 7.603666141164922e-09
APC O 0 2.9734968265415773e-08
variant O 0 2.755341199645045e-07
may O 0 3.9063682844009406e-11
represent O 0 8.598931943825782e-15
a O 0 3.9374733128930833e-14
susceptibility O 0 1.5137868736303517e-10
gene O 0 1.1381126263643182e-08
for O 0 3.4572249507647257e-09
colorectal B-Disease 1 1.0
, I-Disease 0 9.338509965317598e-10
or I-Disease 0 3.699492656661363e-10
other I-Disease 0 6.016712683631908e-10
, I-Disease 0 1.2607896948679809e-09
cancers I-Disease 0 0.008183195255696774
in O 0 2.0360750585535214e-10
Ashkenazi O 0 2.9709226510021836e-06
Jews O 0 1.2579096653198008e-09
, O 0 1.8458791439801558e-10
and O 0 1.5197000602373834e-10
partially O 0 2.7465070218113397e-08
explains O 0 7.896053255684876e-10
the O 0 6.379960036835552e-13
higher O 0 6.8237998585019e-10
incidence O 0 0.0006569898687303066
of O 0 0.00038644729647785425
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 2.1776527248107413e-08
European O 0 6.934610610187519e-07
Israelis O 0 2.2325790993704686e-08
. O 0 5.3800998378594755e-11

Systematic O 0 1.3036777213315531e-09
analysis O 0 4.7320730667266275e-11
of O 0 8.456975896485586e-13
coproporphyrinogen O 0 1.1518972087287693e-06
oxidase O 0 1.3669480267708423e-06
gene O 0 0.0007342061726376414
defects O 1 0.9999432563781738
in O 0 7.446512850783904e-11
hereditary B-Disease 0 0.4177754521369934
coproporphyria I-Disease 1 0.9988749623298645
and O 0 1.9537971240879415e-08
mutation O 0 2.644368066739844e-07
update O 0 9.492996468907222e-07
. O 0 1.2449030695194097e-10

Hereditary B-Disease 1 0.9979479908943176
coproporphyria I-Disease 1 0.8356471657752991
( O 0 8.708488152819882e-09
HC B-Disease 0 0.0018603048520162702
) O 0 5.2120561339075167e-11
is O 0 3.218357177980913e-11
an O 0 1.7742652902441591e-09
acute O 1 0.9925133585929871
hepatic B-Disease 1 0.9999954700469971
porphyria I-Disease 1 0.9999986886978149
with O 0 0.01136664766818285
autosomal O 1 0.9999972581863403
dominant O 1 0.7988463640213013
inheritance O 0 0.0001259230775758624
caused O 0 1.349226408819959e-06
by O 0 1.056414070804701e-11
deficient B-Disease 0 4.145429193158634e-05
activity I-Disease 0 3.160786743450217e-09
of I-Disease 0 4.883400107902336e-12
coproporphyrinogen I-Disease 0 0.00022264975996222347
III I-Disease 0 1.3680389201908838e-05
oxidase I-Disease 0 4.533954154339881e-07
( O 0 3.219522088163118e-12
CPO O 0 1.852604469831931e-07
) O 0 3.7558324506026253e-13
. O 0 6.869168320093599e-13

Clinical O 0 0.0002529430785216391
manifestations O 0 1.944334144354798e-06
of O 0 3.369060933011703e-11
the O 0 7.952489777807159e-10
disease O 0 0.023467442020773888
are O 0 6.26659618294112e-12
characterized O 0 4.49812973327135e-12
by O 0 1.2748128290843153e-12
acute O 0 1.8835701212083222e-06
attacks O 0 2.2074451067055634e-07
of O 0 1.0682757789481911e-07
neurological B-Disease 1 0.9999432563781738
dysfunction I-Disease 0 1.907472324091941e-05
often O 0 5.6260040029454395e-12
precipitated O 0 2.9373985882541476e-11
by O 0 6.8488437137022556e-15
drugs O 0 4.080434212738737e-09
, O 0 6.562246134943911e-14
fasting O 0 1.1561135382365251e-10
, O 0 3.1641095993295565e-13
cyclical O 0 1.8492009985493496e-05
hormonal O 0 1.7681398958302452e-06
changes O 0 3.938074588649698e-10
, O 0 4.12704679458864e-12
or O 0 1.3570908841131768e-08
infectious B-Disease 0 0.00025916218874044716
diseases I-Disease 0 2.295632384630153e-06
. O 0 1.4570216561038407e-11

Skin O 1 0.9999575614929199
photosensitivity O 1 0.9996734857559204
may O 0 0.0014182220911607146
also O 0 5.1746282814235656e-09
be O 0 7.492669679143305e-12
present O 0 1.3608056521896561e-11
. O 0 5.535805494560897e-11

The O 0 1.4697017908238408e-11
seven O 0 1.041411575031237e-11
exons O 0 3.0304247999879408e-09
, O 0 1.878433796313403e-14
the O 0 8.896932322471711e-16
exon O 0 5.994321927715873e-09
/ O 0 1.0884877355010758e-07
intron O 0 1.8768120071399608e-06
boundaries O 0 6.766009050807043e-07
and O 0 8.508824894670752e-11
part O 0 1.340535213216476e-13
of O 0 1.7058920626390468e-15
3 O 0 8.123378001084064e-14
noncoding O 0 1.513884330395232e-11
sequence O 0 3.79854703464258e-13
of O 0 3.3311057193597792e-15
the O 0 1.8599483186791145e-14
CPO O 0 6.103697103299055e-08
gene O 0 1.1976632359467221e-11
were O 0 6.155726817359429e-15
systematically O 0 4.799380077386006e-12
analyzed O 0 1.2363854514849115e-12
by O 0 4.1527484305036583e-16
an O 0 3.241413771151936e-16
exon O 0 7.233669913064844e-11
- O 0 6.062152863028913e-11
by O 0 4.5121252654350963e-13
- O 0 1.173474561966259e-08
exon O 0 6.336952083074721e-07
denaturing O 0 2.3576280000270344e-05
gradient O 0 2.40092134617953e-07
gel O 0 6.601574114029063e-06
electrophoresis O 0 2.0495036778811482e-08
( O 0 2.52878685873259e-12
DGGE O 0 6.824795661941607e-08
) O 0 2.1859021821887988e-14
strategy O 0 6.533247114961713e-14
followed O 0 4.3192810371644845e-15
by O 0 2.5867942840338004e-17
direct O 0 1.2696955057914998e-15
sequencing O 0 1.6388704629499706e-11
in O 0 3.686939263006922e-14
seven O 0 7.035110883603368e-13
unrelated O 0 2.1082251222548365e-10
heterozygous O 0 9.617876912670908e-07
HC B-Disease 0 0.0012785145081579685
patients O 0 7.248817723848333e-08
from O 0 6.40882277802568e-11
France O 0 4.704461844085017e-06
, O 0 3.531553868785231e-11
Holland O 0 2.341382469239761e-06
, O 0 1.179026043462983e-10
and O 0 1.6180279338584569e-09
Czech O 0 1.7848475181381218e-05
Republic O 0 4.020973554119678e-10
. O 0 5.275938366744448e-11

Seven O 0 6.627011717164066e-10
novel O 0 4.5570724971355503e-10
mutations O 0 6.177460818435065e-07
and O 0 1.174227295258623e-11
two O 0 6.793864922678347e-14
new O 0 2.384081864217902e-12
polymorphisms O 0 8.596879297328996e-08
were O 0 3.228747824657319e-11
detected O 0 5.370900879597684e-08
. O 0 5.3011765116517395e-11

Among O 0 1.16961218488143e-10
these O 0 2.20962937075124e-13
mutations O 0 3.041092000444223e-08
two O 0 3.146353663718848e-11
are O 0 1.337711625498672e-11
missense O 0 3.2930785209828173e-07
( O 0 9.260293270044184e-13
G197W O 0 3.330783704402762e-10
, O 0 4.6747236751064694e-14
W427R O 0 2.071931862190901e-11
) O 0 1.4882638239735284e-14
, O 0 2.6976320127231534e-15
two O 0 1.7992690128608435e-13
are O 0 2.5733182945630872e-11
nonsense O 0 2.021578069388852e-07
( O 0 2.14887938850385e-14
Q306X O 0 6.793534484961228e-12
, O 0 1.3080176056658893e-15
Q385X O 0 7.675530133352537e-13
) O 0 3.14548903688084e-15
, O 0 7.699536372684287e-16
two O 0 1.1509409148392075e-14
are O 0 1.0502912423234964e-13
small O 0 1.7005334315180198e-13
deletions O 0 1.694567153265325e-08
( O 0 2.769637600860686e-12
662de14bp O 0 1.969017587866162e-10
; O 0 1.6498546710134836e-14
1168del3bp O 0 1.7220499470838035e-09
removing O 0 2.679874377964353e-10
a O 0 9.40233202168135e-14
glycine O 0 6.571302391122913e-10
at O 0 1.4917027335581423e-10
position O 0 2.8904685936415042e-11
390 O 0 1.4819513888611469e-12
) O 0 3.046365514448174e-14
, O 0 1.4393334411160787e-14
and O 0 1.6443106370857968e-13
one O 0 2.5816141216959687e-13
is O 0 2.1823873003895544e-13
a O 0 2.921664985140217e-14
splicing O 0 1.962547990785879e-08
mutation O 0 1.623355530000481e-07
( O 0 2.5806258172056395e-12
IVS1 O 0 2.651362819960923e-06
- O 0 2.6223354154808476e-08
15c O 0 8.423412189983992e-09
- O 0 2.1675251815622687e-08
- O 0 2.5117653734696432e-08
> O 0 1.1853938663985986e-10
g O 0 1.8497862797062226e-08
) O 0 1.9952086383339014e-14
which O 0 7.4193304621942755e-16
creates O 0 3.288326235655406e-14
a O 0 1.1463094233869157e-14
new O 0 1.2015156664740845e-12
acceptor O 0 8.051857791624428e-12
splice O 0 2.4502647022472956e-08
site O 0 5.4975419772063105e-09
. O 0 6.225878146359776e-11

The O 0 5.0026502038114096e-12
pathological O 0 1.1201217731127144e-08
significance O 0 1.849027441575002e-12
of O 0 1.1346672943400842e-14
the O 0 4.3570392248542394e-14
point O 0 9.846341103569856e-11
mutations O 0 6.131018470689753e-10
G197W O 0 1.0701994151984806e-10
, O 0 1.5543830464296096e-14
W427R O 0 6.743830320565802e-12
, O 0 1.2362214625181913e-14
and O 0 3.3077954573546356e-14
the O 0 2.2441465393342568e-14
in O 0 1.6229150185190222e-12
- O 0 7.430950859088625e-07
frame O 0 2.2216063371161e-06
deletion O 0 1.1964592658841866e-06
390delGly O 0 4.2482302120561144e-08
were O 0 3.011875145987608e-13
assessed O 0 1.1841904410184179e-12
by O 0 8.331986969399748e-15
their O 0 1.9070162116108236e-12
respective O 0 2.0222348795506662e-10
expression O 0 3.2274656038000504e-12
in O 0 2.0135082769395622e-15
a O 0 9.649762712255362e-15
prokaryotic O 0 2.9320846965663616e-12
system O 0 6.306394496918182e-15
using O 0 1.3982544607566132e-14
site O 0 5.6181254093345956e-11
- O 0 3.126644720907734e-09
directed O 0 9.53401801950804e-10
mutagenesis O 0 1.6002703162598664e-08
. O 0 3.390858982488254e-10

These O 0 8.324120906455512e-12
mutations O 0 1.1027516677586391e-08
resulted O 0 1.3296154455222364e-10
in O 0 2.602508486493349e-12
the O 0 1.2462043549876789e-11
absence O 0 5.83992354474816e-10
or O 0 2.470815435931528e-12
a O 0 3.3870532789061214e-13
dramatic O 0 6.850451456097417e-11
decrease O 0 2.4864819092584867e-09
of O 0 3.514274646027743e-13
CPO O 0 0.0003631484287325293
activity O 0 6.472774316534924e-08
. O 0 3.1075451240036855e-11

The O 0 1.0631892501805629e-12
two O 0 2.1430436364291289e-13
polymorphisms O 0 2.88619812494062e-08
were O 0 1.48080419454244e-12
localized O 0 6.941892893852497e-11
in O 0 4.48990752346598e-13
noncoding O 0 2.6254639351463993e-07
part O 0 4.6837717732062245e-11
of O 0 3.757973140029562e-14
the O 0 3.823039839345385e-14
gene O 0 4.877044948448095e-11
1 O 0 8.796648305609001e-13
) O 0 4.815143865366045e-15
a O 0 1.2754689882391035e-13
C O 0 8.226243686237922e-09
/ O 0 1.294043205923856e-09
G O 0 3.6077216769569986e-09
polymorphism O 0 2.589508607542257e-10
in O 0 1.2942751525472224e-13
the O 0 1.3470018015489943e-13
promotor O 0 6.24963405471135e-08
region O 0 3.0360204367890775e-12
, O 0 3.5518461053042757e-15
142 O 0 1.0093374703742941e-12
bp O 0 1.0435296377009351e-10
upstream O 0 1.1585986510465052e-11
from O 0 7.20276076060294e-15
the O 0 8.526381348431965e-16
transcriptional O 0 2.53954003008941e-13
initiation O 0 1.2317924458216112e-13
site O 0 1.4147063728819909e-11
( O 0 1.6952418472899328e-13
- O 0 1.5814984044570934e-10
142C O 0 2.2625071260939933e-10
/ O 0 1.9104366699718156e-10
G O 0 1.2596167442424644e-09
) O 0 3.0499221210904e-15
, O 0 7.98148928862801e-16
and O 0 1.1129245515071294e-14
2 O 0 1.8737961215205962e-14
) O 0 2.415540765711232e-16
a O 0 1.8478966068506382e-15
6 O 0 1.442833916578956e-12
bp O 0 2.0973760228581995e-10
deletion O 0 1.2491987999574405e-10
polymorphism O 0 1.286024398083896e-09
in O 0 1.9106523546467968e-13
the O 0 4.619618422063536e-14
3 O 0 1.0478986385217826e-12
noncoding O 0 2.584189806587034e-10
part O 0 1.0982736936690149e-13
of O 0 1.6501243663038893e-15
the O 0 1.670965442564492e-14
CPO O 0 1.234013637940734e-07
gene O 0 5.235437951223165e-12
, O 0 7.820785962710187e-16
574 O 0 8.624433090430317e-13
bp O 0 1.6689358228738627e-11
downstream O 0 3.955128325544566e-12
of O 0 7.686740351829234e-16
the O 0 1.7988254047657075e-14
last O 0 1.4409754639510552e-11
base O 0 5.53652089452239e-12
of O 0 1.961994697702871e-15
the O 0 3.808151710638086e-13
normal O 0 2.828367401397358e-11
termination O 0 8.034146681268339e-10
codon O 0 4.141688769720986e-09
( O 0 1.3466016496321842e-12
+ O 0 5.178987447229666e-11
574 O 0 1.8340393648230702e-09
delATTCTT O 0 5.314890305641029e-09
) O 0 1.8772500914865375e-12
. O 0 4.440817939072028e-12

Five O 0 4.011071030873836e-09
intragenic O 0 2.6771649572765455e-06
dimorphisms O 0 1.3353398571780417e-05
are O 0 1.1656522969083483e-10
now O 0 5.7348254617339833e-11
well O 0 7.756857764613934e-13
characterized O 0 9.9339399553533e-12
and O 0 3.640383567510286e-12
the O 0 4.450760032336139e-14
high O 0 1.7562521437142209e-09
degree O 0 3.5326415729307337e-13
of O 0 1.6227956952936766e-14
allelic O 0 1.0164447061811188e-09
heterogeneity O 0 1.3984953195489425e-09
in O 0 5.615722730584194e-12
HC B-Disease 0 0.0001556164352223277
is O 0 1.392872484018426e-10
demonstrated O 0 7.401451847244278e-12
with O 0 1.8514996732500212e-14
seven O 0 2.2337843380570988e-12
new O 0 1.122636922659681e-12
different O 0 1.9928610018172914e-15
mutations O 0 1.951206037020814e-11
making O 0 3.525030961570863e-12
a O 0 1.1165998681228473e-12
total O 0 1.255916204367935e-11
of O 0 9.263026272670477e-14
nineteen O 0 1.003621079576078e-07
CPO O 0 0.013764610514044762
gene B-Disease 0 2.9077032195345964e-06
defects I-Disease 0 0.018775202333927155
reported O 0 2.7980723640852467e-11
so O 0 1.1576607999042726e-13
far O 0 5.190513275264708e-13
. O 0 1.4823605125509343e-13
. O 0 1.097747066858279e-11

Coincidence O 0 5.873648789567198e-10
of O 0 3.85810063367395e-13
two O 0 5.5217505237235495e-14
novel O 0 1.8599016424203363e-11
arylsulfatase O 0 1.4971618611525628e-06
A O 0 5.4740045829504425e-11
alleles O 0 3.0166418252264293e-09
and O 0 4.5213843780089746e-10
mutation O 0 2.109985075549048e-08
459 O 0 3.713366680813124e-08
+ O 0 1.6749071019006578e-09
1G O 0 2.9957807328173658e-06
> O 0 7.176915173268128e-10
A O 0 1.429312501688429e-10
within O 0 3.9618758577650293e-13
a O 0 1.3246711887127116e-11
family O 0 6.822527875982587e-09
with O 0 8.254881322500296e-06
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 0.9999997615814209
: O 0 5.391414853624099e-13
molecular O 0 2.1209385159606797e-13
basis O 0 4.2168238302206507e-13
of O 0 4.089938226959321e-14
phenotypic O 0 8.28953332643323e-08
heterogeneity O 0 9.017753086482116e-07
. O 0 1.5923594665068208e-09

In O 0 1.471303114064515e-11
a O 0 2.62404117531978e-12
family O 0 1.011758819086106e-11
with O 0 1.952900167967453e-11
three O 0 2.211918148642411e-10
siblings O 0 5.92381077524351e-08
, O 0 1.3195022501120025e-14
one O 0 1.662058891124113e-14
developed O 0 3.1521740079254457e-11
classical O 0 8.342296298202712e-10
late O 0 2.617558720885427e-07
infantile O 1 0.9999706745147705
metachromatic B-Disease 1 0.9999998807907104
leukodystrophy I-Disease 1 0.9999994039535522
( O 0 7.847160077290027e-08
MLD B-Disease 1 0.999994158744812
) O 0 1.1937679143814162e-11
, O 0 2.2471748515272803e-14
fatal O 0 3.721343233564767e-08
at O 0 2.3821366212928297e-08
age O 0 5.2865235744548045e-08
5 O 0 1.1267460575670185e-10
years O 0 4.0668482470529455e-11
, O 0 9.472677769137641e-14
with O 0 2.479175718883564e-12
deficient O 0 9.124260031967424e-07
arylsulfatase O 0 1.9459980293845547e-08
A O 0 3.613199670016165e-11
( O 0 3.526427739229676e-13
ARSA O 0 2.5037975319719408e-06
) O 0 1.3843974252560065e-13
activity O 0 5.831161248304184e-11
and O 0 5.439032904619445e-12
increased O 0 1.017150044746451e-10
galactosylsulfatide O 0 3.4807867450581398e-06
( O 0 2.643362438659036e-11
GS O 1 0.9999969005584717
) O 0 7.0991415870858e-12
excretion O 0 2.293277345799538e-09
. O 0 2.559763338794152e-11

The O 0 4.35751738511736e-12
two O 0 8.173053163071375e-13
other O 0 8.820977260258489e-13
siblings O 0 3.0342437895569674e-08
, O 0 7.01447688995771e-13
apparently O 0 3.258930070249022e-10
healthy O 0 8.86680506795301e-10
at O 0 1.086999268373745e-09
12 O 0 4.930112568191092e-11
( O 0 6.337456465643418e-15
1 O 0 1.7151791055144971e-13
/ O 0 3.510955068342092e-11
2 O 0 3.2369457591760464e-13
) O 0 2.7081697378617074e-15
and O 0 7.64603969873566e-14
15 O 0 1.2706900961133305e-13
years O 0 6.453991936153022e-14
, O 0 3.7955300726910494e-15
respectively O 0 1.45954374888152e-12
, O 0 7.465415004931364e-14
and O 0 7.510482687156372e-12
their O 0 3.982014371017861e-12
father O 0 2.4710326229637758e-08
, O 0 1.4244992989007055e-12
apparently O 0 9.232191400254663e-11
healthy O 0 1.0171767074462768e-11
as O 0 2.412119169768051e-13
well O 0 6.170285636597495e-13
, O 0 1.992688376502641e-13
presented O 0 6.898586563108822e-11
ARSA O 0 0.04596021771430969
and O 0 1.0453574077473604e-06
GS O 1 1.0
values O 0 4.27736568386905e-10
within O 0 1.0117302876283107e-14
the O 0 1.5201173449879736e-14
range O 0 2.2513192698969675e-10
of O 0 1.4757859864711342e-11
MLD B-Disease 1 0.9999979734420776
patients O 0 8.631975845219131e-08
. O 0 1.0509676462433504e-11

Mutation O 0 7.929789944682852e-07
screening O 0 1.546813344077691e-08
and O 0 3.9395614185146546e-14
sequence O 0 1.2542719887340646e-14
analysis O 0 3.4028383138606094e-14
disclosed O 0 4.8257453588718136e-11
the O 0 9.343813564674161e-15
involvement O 0 7.098901327884377e-11
of O 0 3.297389149377848e-14
three O 0 5.727061620081075e-12
different O 0 1.9552807723616228e-12
ARSA O 0 0.0016044756630435586
mutations O 0 1.595108756191621e-07
being O 0 2.7242147773720582e-11
the O 0 2.1797216315886124e-16
molecular O 0 7.592070418518948e-13
basis O 0 4.081728444821353e-12
of O 0 3.7188007122497535e-13
intrafamilial O 0 2.612257048895117e-06
phenotypic O 0 2.5655674562585773e-07
heterogeneity O 0 3.537836334999156e-07
. O 0 1.6997910856630938e-09

The O 0 7.729601680939169e-11
late O 0 1.2507204161238406e-09
infantile O 0 0.0035916329361498356
patient O 0 4.567439464153722e-05
inherited O 0 0.00023491262982133776
from O 0 2.86437928931349e-10
his O 0 1.506799129913361e-09
mother O 0 5.631984549836488e-07
the O 0 1.8330213106924897e-13
frequent O 0 7.747081309794623e-10
0 O 0 1.0960571339424519e-10
- O 0 5.324573066900484e-07
type O 0 6.85451277604443e-06
mutation O 0 1.2255576109510002e-07
459 O 0 3.38341843431067e-09
+ O 0 1.3413421415253701e-11
1G O 0 2.6735245128861607e-09
> O 0 4.992021986754969e-12
A O 0 3.7571116356938106e-11
, O 0 5.287062088588264e-14
and O 0 2.2507019306009651e-13
from O 0 1.9848514921493726e-13
his O 0 7.17091871993425e-11
father O 0 6.641085459335727e-09
a O 0 1.9774904370245538e-13
novel O 0 2.9851243005252215e-11
, O 0 7.449342385350624e-14
single O 0 2.0975670853018435e-11
basepair O 0 3.3774689711663086e-08
microdeletion O 0 1.9328836309284725e-09
of O 0 4.126347684087163e-15
guanine O 0 4.7987600004795183e-11
at O 0 3.7490401950425467e-13
nucleotide O 0 2.317971856125034e-11
7 O 0 8.043506832811076e-12
in O 0 1.923415989197111e-14
exon O 0 3.418133776023069e-09
1 O 0 1.764706158979834e-10
( O 0 8.049902433006351e-13
7delG O 0 1.0512700043818768e-08
) O 0 8.039913136290155e-13
. O 0 1.7633787225551645e-12

The O 0 3.809099910490055e-11
two O 0 1.073797994965986e-10
clinically O 0 2.265339753648732e-05
unaffected O 0 6.721319323332864e-07
siblings O 0 3.7021581533736025e-07
carried O 0 6.224649240493818e-09
the O 0 3.690709543535675e-11
maternal O 0 9.214820693159709e-07
mutation O 0 7.301965609940453e-08
459 O 0 1.0037221720438083e-08
+ O 0 1.9885870727875954e-10
1G O 0 7.367381016365471e-08
> O 0 1.595575199742072e-10
A O 0 6.076046887848463e-10
and O 0 3.938974146855401e-11
, O 0 3.46073945325584e-14
on O 0 1.2901037876877908e-11
their O 0 6.400244483700801e-12
paternal O 0 1.5066612402137025e-09
allele O 0 2.985306446490199e-11
, O 0 2.130781259036341e-15
a O 0 2.520739610782256e-16
novel O 0 1.475702969110787e-13
cytosine O 0 2.39547048863642e-10
to O 0 3.103358634523948e-14
thymidine O 0 7.593559669949457e-10
transition O 0 6.321265125924791e-12
at O 0 4.1914948074872616e-12
nucleotide O 0 1.4542460291533388e-10
2435 O 0 2.3021564654612803e-09
in O 0 3.6826590361178566e-14
exon O 0 1.1010340417172415e-09
8 O 0 1.5647377837879617e-10
, O 0 4.291213753424266e-15
resulting O 0 1.1538685995180972e-14
in O 0 1.2027427393878493e-15
substitution O 0 7.797735845698969e-14
of O 0 3.34230222437306e-14
alanine O 0 5.1603787909471066e-08
464 O 0 2.6484911486157614e-10
by O 0 7.040534062870141e-13
valine O 0 7.4178838076477405e-06
( O 0 5.204552934456874e-12
A464V O 0 1.3883375560297395e-09
) O 0 6.460264181246123e-13
. O 0 2.0652195231729564e-12

The O 0 8.930040040766585e-11
fathers O 0 5.277172032691624e-09
genotype O 0 1.4365869382970686e-08
thus O 0 3.55375069649444e-11
was O 0 1.928839754583578e-09
7delG O 0 1.16385274395725e-06
/ O 0 1.1371464836429368e-07
A464V O 0 8.68863310188317e-08
. O 0 4.257324701106846e-11

Mutation O 0 2.4522982130292803e-05
A464V O 0 3.6235991274224943e-07
was O 0 3.4284630689995765e-09
not O 0 1.882727406323035e-14
found O 0 1.9681934033954906e-12
in O 0 4.4075745657401466e-14
18 O 0 1.0739106826029854e-10
unrelated O 0 9.70541194078578e-08
MLD B-Disease 1 0.9999996423721313
patients O 0 1.2420611028574058e-07
and O 0 3.763569859406568e-13
50 O 0 7.354362344808019e-13
controls O 0 4.304542144950574e-08
. O 0 8.881238106051015e-11

A464V O 0 1.0345929979393986e-07
, O 0 8.628480417140205e-13
although O 0 1.4220472943724666e-13
clearly O 0 6.083067643353202e-12
modifying O 0 1.4778305690299476e-08
ARSA O 0 0.07537880539894104
and O 0 9.404527077094826e-07
GS O 1 1.0
levels O 0 3.172716333210701e-06
, O 0 5.534342515517432e-13
apparently O 0 1.564599838577152e-11
bears O 0 1.4161757877495518e-10
little O 0 6.277287175303348e-13
significance O 0 4.631743122721077e-13
for O 0 4.0346878941131814e-13
clinical O 0 5.725145357793338e-10
manifestation O 0 2.5379606749531547e-10
of O 0 9.193493188952573e-12
MLD B-Disease 1 0.9999992847442627
, O 0 5.3451470680143665e-12
mimicking O 0 3.186609864869183e-09
the O 0 1.2790653952654552e-12
frequent O 0 1.1015282019855022e-08
ARSA O 0 0.0038876403123140335
pseudodeficiency O 0 3.9519578422186896e-05
allele O 0 3.643750119408651e-07
. O 0 4.2357981011598156e-10

Our O 0 2.8281599284696313e-09
results O 0 1.2046922487352063e-11
demonstrate O 0 4.191143092302507e-12
that O 0 9.814147243361951e-15
in O 0 1.4962552198418701e-15
certain O 0 1.2009674938556758e-13
genetic O 0 1.844166064302044e-07
conditions O 0 2.0224265995238966e-07
MLD B-Disease 1 0.9999978542327881
- O 0 2.1206049495958723e-05
like O 0 1.441192694073834e-07
ARSA O 1 0.5205491781234741
and O 0 4.707638723289165e-08
GS O 1 0.9999998807907104
values O 0 1.0542231532184587e-09
need O 0 3.198875843032911e-12
not O 0 1.60364406859802e-15
be O 0 6.599769969792984e-16
paralleled O 0 9.334494115165182e-12
by O 0 2.7356910139997304e-11
clinical O 0 4.048638857057085e-06
disease O 0 9.099233466258738e-06
, O 0 1.545490555736155e-14
a O 0 8.822886608046872e-15
finding O 0 1.1180922507292301e-11
with O 0 4.43151314255541e-11
serious O 0 2.8808852192696577e-08
diagnostic O 0 1.5355117000126484e-07
and O 0 7.490287556866093e-11
prognostic O 0 5.792576303065289e-06
implications O 0 4.4335401128137164e-08
. O 0 1.8202343798900955e-10

Moreover O 0 2.2262263144057215e-08
, O 0 7.487554846974387e-12
further O 0 8.858106956277645e-12
ARSA O 0 0.00027053203666582704
alleles O 0 4.1197250055802215e-08
functionally O 0 1.943111671565134e-09
similar O 0 3.81222126349251e-13
to O 0 1.1803450198581006e-13
A464V O 0 2.0432262548553126e-09
might O 0 1.0593362992361577e-10
exist O 0 7.494470322111368e-12
which O 0 5.070915475718918e-12
, O 0 1.0528686619380376e-13
together O 0 9.070662623789083e-12
with O 0 5.771366023976654e-11
0 O 0 6.633157356716879e-10
- O 0 4.637329311663052e-06
type O 0 0.0002660077589098364
mutations O 0 2.9256885682116263e-05
, O 0 6.770822097434959e-11
may O 0 3.6910632883468963e-10
cause O 0 3.496680028858279e-11
pathological O 0 2.3725838218524586e-06
ARSA O 1 0.9951404333114624
and O 0 6.9708539740531705e-06
GS O 1 1.0
levels O 0 3.0063447411521338e-05
, O 0 6.109483036663421e-13
but O 0 7.946680829649597e-14
not O 0 8.262847058047168e-14
clinical O 0 5.900267774361367e-11
outbreak O 0 4.724727720173405e-09
of O 0 6.15227880034104e-14
the O 0 1.3219661476604472e-10
disease O 0 6.1220189309096895e-06
. O 0 4.294960383437879e-13
. O 0 9.358239010104352e-12

Human O 0 6.872399535495788e-05
MLH1 O 1 0.9924928545951843
deficiency O 1 0.9992189407348633
predisposes O 0 7.41969925002195e-05
to O 0 4.735987602089153e-09
hematological B-Disease 1 0.9993927478790283
malignancy I-Disease 1 0.9998112320899963
and O 0 2.833661483236938e-07
neurofibromatosis B-Disease 1 0.9940398931503296
type I-Disease 0 0.007699744775891304
1 I-Disease 0 2.714446978302476e-08
. O 0 1.639505892159221e-10

Heterozygous O 0 0.00019541366782505065
germ O 0 0.08739791810512543
- O 0 0.004792712163180113
line O 0 8.717563559912378e-07
mutations O 0 1.4124976743801199e-08
in O 0 2.8223961542054492e-15
the O 0 1.2164608614851063e-15
DNA O 0 1.4802856185269775e-07
mismatch O 0 2.301425593032036e-05
repair O 0 6.254344384615251e-07
genes O 0 1.9992496902432322e-07
lead O 0 5.104847673464974e-07
to O 0 1.2340107602426542e-08
hereditary B-Disease 1 0.9999967813491821
nonpolyposis I-Disease 1 0.9999995231628418
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.757071430574797e-07

The O 0 2.946904525957805e-11
disease O 0 6.407017849596741e-07
susceptibility O 0 2.6277515718931e-09
of O 0 2.0081649017289482e-12
individuals O 0 3.348201360608982e-08
who O 0 3.6897326936013997e-05
constitutionally O 0 0.007387605961412191
lack O 0 8.54314230469555e-10
both O 0 2.3619849565809092e-12
wild O 0 7.410845341837557e-07
- O 0 5.407225762610324e-05
type O 0 3.1887843761069234e-06
alleles O 0 3.174695173413511e-09
is O 0 2.0555805321786913e-11
unknown O 0 4.175904760872484e-11
. O 0 2.3353680100868246e-11

We O 0 1.0963969288013686e-08
have O 0 4.24344099355517e-13
identified O 0 3.2271394757865668e-12
three O 0 1.0620719798418166e-13
offspring O 0 1.3531452347503858e-10
in O 0 5.535670324365548e-14
a O 0 4.397213426710067e-10
hereditary B-Disease 1 0.9999862909317017
nonpolyposis I-Disease 1 0.9999998807907104
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 4.376224387669936e-05
who O 0 2.1332834876375273e-06
developed O 0 1.5508746287196118e-07
hematological B-Disease 0 0.004276440013200045
malignancy I-Disease 0 0.0001188593523693271
at O 0 3.291281969186599e-10
a O 0 2.592921103522494e-12
very O 0 4.410514054670189e-12
early O 0 1.6736089944457966e-11
age O 0 9.350727481205467e-08
, O 0 3.802550288534157e-12
and O 0 9.988273229344369e-13
at O 0 2.9024554027562433e-12
least O 0 1.549498016840381e-15
two O 0 2.506914286077612e-14
of O 0 6.3496041886564655e-15
them O 0 1.3469021904743972e-12
displayed O 0 1.7464395796196186e-07
signs O 0 9.502008992967603e-07
of O 0 1.4241054082514415e-12
neurofibromatosis B-Disease 0 0.059316642582416534
type I-Disease 0 0.00016529964341316372
1 I-Disease 0 4.332958436492618e-09
( O 0 1.7523487869097742e-11
NF1 B-Disease 0 3.045694711545366e-06
) O 0 1.4216093580099454e-11
. O 0 5.780661539722676e-12

DNA O 0 2.8192612133715045e-10
sequence O 0 1.4377907718576832e-11
analysis O 0 1.4032473967529047e-11
and O 0 3.0709514250125414e-13
allele O 0 9.743621708080408e-12
- O 0 2.569288393150515e-10
specific O 0 4.9298091650551434e-12
amplification O 0 1.3305327506429876e-08
in O 0 5.241397187149069e-14
two O 0 8.342267848737706e-13
siblings O 0 1.1733223281851224e-08
revealed O 0 6.041866118522421e-09
a O 0 1.4902089978674482e-11
homozygous O 0 0.0002772870648186654
MLH1 O 0 0.0032511220779269934
mutation O 0 1.5016491943242727e-06
( O 0 1.4108287454961399e-11
C676T O 0 8.003549112345354e-08
- O 0 3.6138505947747035e-06
- O 0 1.2421336577972397e-05
> O 0 6.3992655618960725e-09
Arg226Stop O 0 1.2004320524283685e-06
) O 0 3.737019808186526e-12
. O 0 1.179240841260587e-12

Thus O 0 2.2318542569621513e-09
, O 0 6.8052025603213e-13
a O 0 8.694695354319326e-13
homozygous O 0 1.8111570170731284e-05
germ O 0 0.13141991198062897
- O 0 0.0031163902021944523
line O 0 1.2682724445767235e-05
MLH1 O 0 0.03270561248064041
mutation O 0 2.8888534870930016e-05
and O 0 8.79634365347215e-10
consequent O 0 1.3761969057668466e-06
mismatch O 1 0.7824251651763916
repair O 1 0.986417293548584
deficiency O 1 0.9996585845947266
results O 0 2.4853047397854766e-10
in O 0 3.0923343313088436e-13
a O 0 3.3733175974770546e-11
mutator O 0 6.909039075253531e-05
phenotype O 0 2.2857069836845767e-07
characterized O 0 2.7350974263207206e-10
by O 0 1.4553663829630636e-11
leukemia B-Disease 0 0.24761556088924408
and O 0 1.0573393183221924e-07
/ O 1 0.9770082831382751
or O 1 0.9999465942382812
lymphoma B-Disease 1 1.0
associated O 0 0.0002672307309694588
with O 0 5.5933281117859224e-08
neurofibromatosis B-Disease 1 0.9841859936714172
type I-Disease 0 0.009188465774059296
1 I-Disease 0 2.0049915061548518e-09
. O 0 2.912648637901083e-12
. O 0 1.6312950990027275e-11

Missense O 0 0.0021715518087148666
mutations O 0 0.0009189488482661545
in O 0 7.731973047930829e-12
the O 0 1.8898294387725834e-14
most O 0 4.909755539750219e-16
ancient O 0 7.947583089145012e-16
residues O 0 4.875022163730591e-09
of O 0 1.0289498745229275e-13
the O 0 3.246580955462708e-12
PAX6 O 0 1.6238218449871056e-05
paired O 0 2.5007551585076726e-09
domain O 0 3.456424035874761e-11
underlie O 0 8.17786838247514e-10
a O 0 1.517638147313996e-13
spectrum O 0 4.747577331265518e-11
of O 0 1.513549355292021e-11
human O 0 4.223912583256606e-06
congenital B-Disease 1 0.9999769926071167
eye I-Disease 1 0.9986787438392639
malformations I-Disease 1 0.9987744688987732
. O 0 3.4386926639484727e-09

Mutations O 0 5.045860689278925e-07
of O 0 2.9825146801061575e-13
the O 0 2.6421296791048765e-13
human O 0 4.765495290048882e-11
PAX6 O 0 0.00019049759430345148
gene O 0 0.000488430610857904
underlie O 1 0.9773157835006714
aniridia B-Disease 1 1.0
( O 0 3.1858207876211964e-06
congenital B-Disease 1 0.9999935626983643
absence I-Disease 0 2.6206851799770448e-08
of I-Disease 0 1.1142972531014497e-13
the I-Disease 0 1.6502088324293895e-12
iris I-Disease 0 5.170988970348844e-06
) O 0 4.76799285817342e-12
, O 0 1.6867261846140527e-14
a O 0 1.692399692609925e-12
rare O 0 2.0756912988417753e-07
dominant O 1 0.800889790058136
malformation B-Disease 1 0.9999903440475464
of I-Disease 0 8.344790830561166e-11
the I-Disease 0 1.869271182286525e-09
eye I-Disease 0 0.31916072964668274
. O 0 4.264464337211393e-09

The O 0 2.140422387941765e-12
spectrum O 0 7.301258903025243e-11
of O 0 3.7850804305086805e-13
PAX6 O 0 3.589421248761937e-05
mutations O 0 1.382905975333415e-05
in O 0 1.434942303868425e-10
aniridia B-Disease 1 1.0
patients O 0 3.8249339695539675e-07
is O 0 3.525688042297498e-13
highly O 0 1.7564370097256088e-12
biased O 0 9.78923697658729e-09
, O 0 2.8352686951699235e-12
with O 0 2.0811076386489935e-12
92 O 0 5.126880031625092e-10
% O 0 2.588239274596213e-14
of O 0 1.4004851220232074e-15
all O 0 6.952158466966285e-12
reported O 0 9.144499601987377e-10
mutations O 0 3.1875826422833597e-09
leading O 0 2.124080467069689e-09
to O 0 2.929541375110145e-12
premature O 0 2.244951724517108e-10
truncation O 0 2.1996877930252623e-10
of O 0 1.11651464983209e-12
the O 0 1.7302947269426383e-12
protein O 0 3.4765270662262537e-09
( O 0 3.2667046693558854e-13
nonsense O 0 1.1179184244980434e-09
, O 0 3.181424515547222e-16
splicing O 0 2.01086326409583e-12
, O 0 1.2720692520987089e-14
insertions O 0 6.043265887711868e-11
and O 0 1.7846823194625494e-12
deletions O 0 1.5019785415404385e-09
) O 0 1.4616755722451913e-11
and O 0 2.9978540483366345e-11
just O 0 6.963246645952381e-10
2 O 0 1.4207907420016319e-11
% O 0 9.930817561516758e-15
leading O 0 1.287250167569809e-11
to O 0 5.709275232619474e-15
substitution O 0 5.729309171184638e-13
of O 0 3.7887912479692837e-14
one O 0 2.6616857589506493e-12
amino O 0 1.976948335938311e-12
acid O 0 2.8117815692972614e-13
by O 0 7.709499068330773e-16
another O 0 6.825169227529793e-13
( O 0 2.508809945813567e-13
missense O 0 1.0147017448502993e-08
) O 0 2.3501127259517585e-12
. O 0 3.901749583146152e-12

The O 0 2.610333607253046e-12
extraordinary O 0 2.2542777106809853e-12
conservation O 0 3.17286046611423e-13
of O 0 9.557876366378978e-16
the O 0 1.060903260721854e-14
PAX6 O 0 1.2160110429704218e-07
protein O 0 2.4101268203402526e-10
at O 0 5.900321464052949e-12
the O 0 2.5110965959579748e-14
amino O 0 1.7518818340445108e-10
acid O 0 6.832708288051492e-10
level O 0 2.7559272572363902e-11
amongst O 0 1.199470969596994e-12
vertebrates O 0 2.3744589627838764e-10
predicts O 0 4.6836809985961736e-08
that O 0 1.5557615959393978e-11
pathological O 0 2.141741106242989e-06
missense O 0 7.470703712897375e-05
mutations O 0 0.005824066232889891
should O 0 1.017966511085433e-07
in O 0 5.2040315145270716e-14
fact O 0 4.177416225437103e-12
be O 0 1.2491838292938429e-11
common O 0 2.5917887627735503e-12
even O 0 7.68974727644034e-12
though O 0 6.043562351953913e-12
they O 0 6.499050429764619e-12
are O 0 9.327495373301353e-13
hardly O 0 8.811900861771527e-12
ever O 0 1.8370186483096518e-09
seen O 0 5.5852151348290136e-08
in O 0 7.74171560191661e-11
aniridia B-Disease 1 0.9999998807907104
patients O 0 1.2730080811707012e-07
. O 0 1.8883332397745534e-11

This O 0 4.281793669624889e-12
indicates O 0 1.210150868402593e-10
that O 0 7.592820279846493e-14
there O 0 9.031189289248828e-14
is O 0 3.967045943587162e-14
a O 0 1.8356910230169637e-13
heavy O 0 5.563607352598865e-09
ascertainment O 0 2.6785032787302043e-06
bias O 0 2.3200615828500304e-07
in O 0 3.086111010838777e-14
the O 0 1.846346324798926e-15
selection O 0 1.827254845912854e-13
of O 0 2.1858190035533784e-14
patients O 0 4.978128369595436e-13
for O 0 3.0316179508584713e-15
PAX6 O 0 6.219976000920724e-08
mutation O 0 9.666104028305256e-11
analysis O 0 3.296211914527447e-11
and O 0 3.030398501580045e-11
that O 0 1.1209268105730197e-13
the O 0 3.057759666129367e-13
missing O 0 5.4672931071308994e-08
PAX6 O 0 0.0009960827883332968
missense O 0 0.00046975500299595296
mutations O 0 0.002030464354902506
frequently O 0 8.079616122813604e-07
may O 0 4.259554486907291e-09
underlie O 0 3.663642758056085e-07
phenotypes O 0 1.9773375470322208e-07
distinct O 0 8.217092978268781e-11
from O 0 4.080741647372044e-11
textbook O 0 0.12125648558139801
aniridia B-Disease 1 0.9999991655349731
. O 0 7.884213282238761e-09

Here O 0 2.80609757652428e-09
we O 0 3.55478112223917e-11
present O 0 8.678189324920135e-14
four O 0 1.0300062262521073e-13
novel O 0 1.3380389851658236e-10
PAX6 O 0 3.32141607941594e-05
missense O 0 5.184419933357276e-06
mutations O 0 3.115228537353687e-06
, O 0 9.602110773165862e-13
two O 0 1.2596820288257593e-12
in O 0 4.1342932766488816e-13
association O 0 1.8427124409692297e-11
with O 0 1.2195671555970122e-11
atypical O 0 2.128028881998034e-06
phenotypes O 0 3.46124966199568e-06
ectopia B-Disease 0 5.921503543504514e-05
pupillae I-Disease 0 3.076682332903147e-05
( O 0 8.935793945064052e-12
displaced B-Disease 0 4.734558300967251e-10
pupils I-Disease 0 1.4078231025393961e-08
) O 0 1.2494806300722416e-09
and O 0 1.848368924584065e-07
congenital B-Disease 1 0.9999873638153076
nystagmus I-Disease 0 0.0008970504277385771
( O 0 2.0952788115646825e-12
searching B-Disease 0 3.718439778310767e-09
gaze I-Disease 0 0.0022521300707012415
) O 0 7.925799773433884e-12
, O 0 8.454971748769746e-14
and O 0 2.352440074335216e-12
two O 0 8.39041596617518e-12
in O 0 3.321226540314859e-12
association O 0 1.1059891067213834e-12
with O 0 1.805121908882417e-14
more O 0 1.2470924358291835e-13
recognizable O 0 1.336780951533001e-05
aniridia B-Disease 1 0.9999992847442627
phenotypes O 0 2.0181070794933476e-05
. O 0 1.5345609505335034e-10

Strikingly O 0 4.597024982899711e-08
, O 0 6.533054045659847e-12
all O 0 2.932676074641344e-13
four O 0 3.1142245900117604e-12
mutations O 0 4.191037294987154e-09
are O 0 2.048585259761815e-12
located O 0 3.4461086761972126e-11
within O 0 2.3890388365505055e-12
the O 0 2.4637953136008583e-11
PAX6 O 0 0.00010370062955189496
paired O 0 6.865111856768635e-08
domain O 0 1.0611594269960278e-08
and O 0 1.7851004008306859e-09
affect O 0 7.988668060399107e-11
amino O 0 2.907787552408614e-11
acids O 0 1.1536508554010894e-10
which O 0 7.801990661599617e-14
are O 0 9.35265828270939e-15
highly O 0 7.944347084473322e-14
conserved O 0 5.971208250077353e-11
in O 0 2.5129202104595683e-12
all O 0 1.504552593623032e-10
known O 0 6.706868393990817e-10
paired O 0 4.996364211251603e-09
domain O 0 3.74354408583244e-10
proteins O 0 2.45655740194195e-09
. O 0 2.943904495178451e-11

Our O 0 1.0802021499500825e-08
results O 0 4.77310933832964e-11
support O 0 1.1582285152668403e-13
the O 0 4.883045414549739e-16
hypothesis O 0 1.7048007157436512e-13
that O 0 2.0277963675070267e-14
the O 0 2.366167056397101e-14
under O 0 1.128496254776401e-11
- O 0 8.570173015698401e-09
representation O 0 9.515442253582584e-12
of O 0 3.719339831780022e-13
missense O 0 2.082344508380629e-06
mutations O 0 2.0851931026300008e-07
is O 0 3.1130961523906375e-12
caused O 0 1.5226521215758182e-12
by O 0 8.728187985730662e-14
ascertainment O 0 2.4881184799596667e-05
bias O 0 2.660345307958778e-05
and O 0 4.68399520558993e-11
suggest O 0 8.607571578243822e-13
that O 0 2.071662806240964e-15
a O 0 2.019528648315467e-14
substantial O 0 6.003996605441486e-11
burden O 0 5.922431228100322e-06
of O 0 1.3901804186977618e-11
PAX6 B-Disease 0 0.4171715974807739
- I-Disease 0 0.0003007390187121928
related I-Disease 0 2.5168950742227025e-05
disease I-Disease 0 0.11759725213050842
remains O 0 2.062050086237832e-09
to O 0 8.511554904899049e-14
be O 0 5.150493204673923e-13
uncovered O 0 1.6207096109610575e-08
. O 0 1.8793853192450305e-12
. O 0 9.531317575472986e-12

The O 0 1.3544925597797075e-11
chromosomal O 0 3.038650356756989e-05
order O 0 2.5608669698695685e-11
of O 0 1.5306407129180716e-14
genes O 0 3.2958488715983947e-10
controlling O 0 6.898450806147594e-07
the O 0 2.3245144958189412e-12
major O 0 1.2062056908845875e-10
histocompatibility O 0 1.4265816306036072e-09
complex O 0 1.3168862701695705e-12
, O 0 1.4586488416320868e-14
properdin O 0 2.7538506586211042e-08
factor O 0 3.8270787428018593e-08
B O 0 0.013806604780256748
, O 0 7.090312781343755e-10
and O 0 6.829193655022436e-09
deficiency B-Disease 0 2.3791387775418116e-06
of I-Disease 0 9.285995730969293e-16
the I-Disease 0 1.7511266078135655e-14
second I-Disease 0 2.1917516412894855e-10
component I-Disease 0 9.13400577395862e-10
of I-Disease 0 3.6333341391948937e-13
complement I-Disease 0 1.639531732600119e-09
. O 0 2.429139701887184e-11

The O 0 9.530517867950561e-12
relationship O 0 2.690496436752454e-10
of O 0 1.0545558075733671e-15
the O 0 5.8785844132814e-16
genes O 0 2.5922029822135484e-13
coding O 0 2.0888943786517844e-12
for O 0 2.1757436737007306e-15
HLA O 0 1.3337778798083733e-11
to O 0 1.2037893544733004e-15
those O 0 2.6735978763612863e-15
coding O 0 2.4558510607064488e-12
for O 0 1.1483971054920133e-14
properdin O 0 1.4879901755193714e-08
Factor O 0 6.450125156209907e-11
B O 0 8.671332096810147e-08
allotypes O 0 7.430065807056963e-08
and O 0 1.561597552657279e-11
for O 0 1.1496870079216737e-12
deficiency B-Disease 0 3.388483449384694e-08
of I-Disease 0 2.7484977705738726e-16
the I-Disease 0 1.3758861840921111e-14
second I-Disease 0 1.6886288201067856e-10
component I-Disease 0 4.123150709745005e-09
of I-Disease 0 1.827185971969847e-12
complement I-Disease 0 1.8482204211522912e-08
( O 0 6.332560344157745e-12
C2 O 0 1.8571788018562074e-07
) O 0 9.800234896609888e-14
was O 0 1.4154242881925239e-11
studied O 0 7.06631766989041e-11
in O 0 2.3954791397566046e-14
families O 0 8.047319185805132e-14
of O 0 4.707249672518399e-13
patients O 0 1.0069853839667076e-09
with O 0 9.094803798959106e-10
connective O 1 0.9934121966362
tissue O 1 0.9998898506164551
disorders O 1 0.9958217144012451
. O 0 5.082501641773263e-10

Patients O 0 8.032198479668295e-07
were O 0 1.2034749932721134e-11
selected O 0 3.292636649443459e-11
because O 0 1.9147357310789204e-12
they O 0 9.887698299015923e-13
were O 0 2.074378429445245e-12
heterozygous O 0 3.0748683599313154e-08
or O 0 9.751923712997268e-10
homozygous O 0 0.18125496804714203
for O 0 0.00015307003923226148
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999997615814209
. O 0 3.330529740885879e-10

12 O 0 1.9775104220798312e-08
families O 0 9.867542546948549e-12
with O 0 2.9160988944745836e-13
15 O 0 2.1604298211519435e-12
matings O 0 1.1121051102236379e-07
informative O 0 9.936076094163582e-05
for O 0 0.060826946049928665
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 1.0870173511312586e-10
found O 0 3.3735944593438205e-11
. O 0 1.4015674905387687e-11

Of O 0 1.6338111419322843e-11
57 O 0 5.069799025037014e-10
informative O 0 2.6823596122049764e-10
meioses O 0 1.319481555128732e-07
, O 0 4.7484192684625615e-15
two O 0 2.705824250691201e-16
crossovers O 0 5.854086659873303e-10
were O 0 1.7422972786729218e-11
noted O 0 2.785117796111347e-11
between O 0 4.447991627798409e-11
the O 0 2.3824561594665283e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999997615814209
gene O 0 6.479252689928217e-10
and O 0 8.280801446023528e-14
the O 0 1.2610895028166303e-14
HLA O 0 3.788290143802442e-07
- O 0 4.749382696900284e-06
B O 0 4.95634537855949e-07
gene O 0 5.223035337564852e-10
, O 0 1.8439742090301404e-15
with O 0 6.628703655741681e-18
a O 0 5.529538199565398e-18
recombinant O 0 3.3543981936730305e-14
fraction O 0 8.56689868241993e-14
of O 0 1.0427800251977884e-13
0 O 0 1.703145818821028e-10
. O 0 3.162303058301674e-11

035 O 0 0.008591238409280777
. O 0 1.132502518430556e-07

A O 0 4.024136135427625e-09
lod O 0 5.325402526068501e-06
score O 0 1.768367141607996e-08
of O 0 1.2552156850812596e-13
13 O 0 9.883399437402018e-13
was O 0 2.5064263950999935e-14
calculated O 0 1.4047428855985117e-13
for O 0 1.7325435790888077e-12
linkage O 0 0.0018318326910957694
between O 0 0.0005942722782492638
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 3.606850929038785e-11
HLA O 0 1.8667017798179586e-07
- O 0 7.631979315192439e-07
B O 0 1.4470265341515187e-07
at O 0 4.718215835392003e-13
a O 0 3.4719623751091634e-16
maximum O 0 1.6127480845942277e-15
likelihood O 0 1.6970623582628075e-14
value O 0 2.876676015992931e-14
of O 0 2.226301197585433e-17
the O 0 2.38770729615168e-17
recombinant O 0 1.1842688830455972e-13
fraction O 0 7.165711708896627e-14
of O 0 5.025405818478296e-14
0 O 0 9.633140812814744e-11
. O 0 1.6886088013978728e-11

04 O 0 0.001323289587162435
. O 0 2.6433763622435436e-08

18 O 0 6.308004572019854e-07
families O 0 1.11739723376858e-11
with O 0 3.764661379943718e-13
21 O 0 2.673646623107401e-13
informative O 0 1.6092690331356851e-12
matings O 0 6.577358657722243e-10
for O 0 3.043277435610392e-13
both O 0 1.662904080927674e-12
properdin O 0 1.2001562481600558e-06
Factor O 0 2.5637187928140293e-09
B O 0 5.958940505479404e-07
allotype O 0 6.974523785174824e-07
and O 0 1.0117362503336835e-10
HLA O 0 3.7144582165637985e-07
- O 0 3.2024099709815346e-06
B O 0 7.424342243211868e-07
were O 0 2.044299191733545e-12
found O 0 4.087703699834355e-12
. O 0 1.8838752172817275e-12

Of O 0 4.605575296134923e-11
72 O 0 8.568501463912526e-10
informative O 0 2.6123780916265105e-10
meioses O 0 7.492978511436377e-06
, O 0 7.800090868342879e-13
three O 0 2.7416429044559154e-13
recombinants O 0 6.280044999584788e-07
were O 0 1.7374487265575667e-11
found O 0 6.667195007886706e-12
, O 0 4.018921460002215e-16
giving O 0 1.2361258695561377e-16
a O 0 5.19565278372684e-17
recombinant O 0 1.6985916254270983e-13
fraction O 0 2.830809317424382e-13
of O 0 2.9587627920629744e-13
0 O 0 2.5522031710245585e-10
. O 0 4.0437830167716626e-11

042 O 0 0.0002777593908831477
. O 0 2.9450884397874688e-08

A O 0 1.4718548602132842e-09
lod O 0 5.084688723400177e-07
score O 0 3.98248961586134e-10
of O 0 3.3481786001479316e-14
16 O 0 8.304769090299036e-13
between O 0 3.8232150057588773e-14
HLA O 0 3.238664803006941e-08
- O 0 2.2903882381797303e-06
B O 0 1.168335529655451e-06
and O 0 1.0677297587746715e-11
Factor O 0 1.7028819326858624e-11
B O 0 5.082698262270924e-09
allotypes O 0 1.581656139393317e-09
was O 0 1.5729952063114894e-12
calculated O 0 4.3781926868657894e-13
at O 0 2.9922470209074736e-13
a O 0 7.099263181206477e-16
maximum O 0 3.200512720650953e-15
likelihood O 0 4.5103847143724424e-14
value O 0 3.983673877968122e-14
of O 0 2.3242779287282564e-17
the O 0 6.234414616442357e-17
recombinant O 0 2.8399109236118547e-13
fraction O 0 2.0574023712992273e-13
of O 0 9.520552071316454e-14
0 O 0 5.5892349776209826e-11
. O 0 9.498795847107111e-12

04 O 0 0.0008472209447063506
. O 0 1.9406680706879342e-08

A O 0 6.143072162068108e-11
crossover O 0 2.1009634310065195e-10
was O 0 6.367327221035168e-10
shown O 0 7.863131153140746e-12
to O 0 8.941917607025677e-15
have O 0 2.7605789697368252e-14
occurred O 0 5.071488222457192e-15
between O 0 6.138672100134039e-17
genes O 0 2.598816886516253e-13
for O 0 1.6453175898534927e-13
Factor O 0 6.231437588155586e-11
B O 0 5.923268631136125e-08
and O 0 3.2271352257140506e-11
HLA O 0 1.6900095545224758e-08
- O 0 1.6563618032705563e-07
D O 0 1.6601352115230839e-07
, O 0 3.193207696755595e-15
in O 0 1.9327477352951437e-16
which O 0 5.006892727569927e-14
HLA O 0 7.114646205508279e-09
- O 0 1.5774411110669462e-07
D O 0 2.2031379387499328e-07
segregared O 0 1.8159527215289017e-09
with O 0 6.486906958856967e-14
HLA O 0 4.70390004725374e-10
- O 0 4.6056478075762186e-10
A O 0 2.585282855849247e-11
and O 0 6.52565987357967e-11
B O 0 4.9091948284285536e-08
. O 0 3.5262682530901035e-12

These O 0 2.1565186702349193e-12
studies O 0 1.0581518300467607e-12
suggest O 0 9.983544346043802e-14
that O 0 6.216511913357647e-16
the O 0 6.101737493166811e-17
genes O 0 1.7174321860491393e-12
for O 0 1.2786854908242162e-11
Factor O 0 5.802340183436172e-06
B O 1 0.9999749660491943
and O 1 0.9992256164550781
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 7.09115383600023e-13
located O 0 1.0555972599930047e-13
outside O 0 1.3423774082328005e-13
those O 0 8.15955647232719e-15
for O 0 4.900346062497408e-15
HLA O 0 5.761335505893861e-11
, O 0 5.3122387029893876e-15
that O 0 9.471457829935358e-16
the O 0 3.6357703414764686e-15
order O 0 5.915801702671697e-13
of O 0 9.013460550849617e-15
genese O 0 7.758353071096735e-09
is O 0 1.38207831680906e-13
HLA O 0 6.333106955525025e-11
- O 0 5.118962892458612e-11
A O 0 6.197112267791738e-11
, O 0 6.854365707832655e-13
- O 0 4.94356378055727e-09
B O 0 2.3562842343949342e-08
, O 0 8.317779516368862e-14
- O 0 3.6883818221866704e-10
D O 0 6.898211779571284e-09
, O 0 1.5846988638316094e-14
Factor O 0 2.1626405527497283e-11
B O 0 2.0114139260840602e-06
allotype O 0 0.005499981343746185
, O 0 2.119380724252551e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 1.0877570638860123e-15
that O 0 1.1641195656228252e-17
the O 0 1.4987624638355225e-16
genes O 0 4.9154555425978685e-11
coding O 0 1.7943285683941212e-06
for O 0 2.9444923711707816e-05
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 1.019749618080823e-09
Factor O 0 3.5431959588549944e-09
B O 0 2.6433369839651277e-06
allotypes O 0 2.7498572308104485e-07
are O 0 1.1772153347619496e-13
approximately O 0 2.276459457137975e-13
3 O 0 2.93890454507173e-12
- O 0 1.705900420923001e-09
- O 0 3.111502444586023e-10
5 O 0 1.1522153944929642e-13
centimorgans O 0 1.4300944976841645e-11
from O 0 2.438008049939356e-16
the O 0 1.8306846326646348e-16
HLA O 0 3.0876802850632323e-12
- O 0 5.716319887057175e-13
A O 0 2.1536318193203507e-13
and O 0 2.609993655661863e-13
HLA O 0 8.014479080387105e-10
- O 0 5.282126291916711e-09
B O 0 3.831150119371074e-10
loci O 0 2.434825344815872e-12
, O 0 4.887166653354605e-15
and O 0 1.4765855266198492e-15
that O 0 1.2177794800257444e-15
the O 0 1.3816453305070826e-14
apparent O 0 1.5381116519330718e-11
lack O 0 2.494162103412745e-13
of O 0 5.935594495191942e-16
recombinants O 0 1.6165316862881696e-09
between O 0 1.1793453176924332e-14
the O 0 1.1276946038215815e-13
Factor O 0 1.6660496315878959e-09
B O 0 1.806278851290699e-05
gene O 0 0.02842167392373085
and O 1 0.8883417248725891
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 7.844432658998812e-09
suggests O 0 2.3597348033921328e-11
that O 0 7.977871293272931e-15
these O 0 2.6521848834546976e-15
two O 0 3.2300275735336337e-12
genes O 0 4.3233332469583274e-09
lie O 0 4.906695494355517e-07
in O 0 7.927883067908315e-13
close O 0 4.800813080407806e-10
proximity O 0 5.835978922341667e-11
to O 0 7.43643254613735e-12
one O 0 1.3922050144665743e-11
another O 0 1.1856651771502413e-10
. O 0 1.734472981906876e-10

Distribution O 0 2.3069023080690698e-10
of O 0 2.135406435010978e-12
emerin O 0 3.853363887174055e-05
and O 0 1.851178516032448e-10
lamins O 0 1.6412179775215918e-06
in O 0 2.69225830865083e-13
the O 0 3.3342108913224366e-13
heart O 0 4.098371919614152e-10
and O 0 5.854022236580214e-13
implications O 0 4.878847759820504e-12
for O 0 5.325801431810273e-12
Emery B-Disease 1 0.5047013163566589
- I-Disease 1 0.9999115467071533
Dreifuss I-Disease 1 0.9999589920043945
muscular I-Disease 1 0.9940945506095886
dystrophy I-Disease 0 0.014697922393679619
. O 0 7.922029698903543e-10

Emerin O 0 0.00018468115013092756
is O 0 5.566343497243054e-10
a O 0 4.550848847068023e-12
nuclear O 0 4.921186018691515e-07
membrane O 0 3.604815404512074e-11
protein O 0 6.197020674392206e-10
which O 0 5.949045509684447e-13
is O 0 2.265042672736431e-13
missing O 0 1.599730764523244e-11
or O 0 2.1805753383508097e-11
defective O 0 2.9910568628110923e-05
in O 0 2.10555670121515e-10
Emery B-Disease 1 0.9997647404670715
- I-Disease 1 0.9999985694885254
Dreifuss I-Disease 1 0.9999969005584717
muscular I-Disease 1 0.999876856803894
dystrophy I-Disease 1 0.9692689776420593
( O 0 5.754653198408732e-09
EDMD B-Disease 1 0.9999985694885254
) O 0 9.303304654428857e-11
. O 0 1.8249022085137234e-11

It O 0 3.351904309667475e-10
is O 0 1.9387153341043906e-11
one O 0 1.7771684731465731e-12
member O 0 3.3272182752008828e-12
of O 0 6.499635322955357e-15
a O 0 1.9810477043524788e-12
family O 0 7.085239339676974e-11
of O 0 2.021762314854958e-12
lamina O 0 4.137974428886082e-06
- O 0 7.914355251159577e-07
associated O 0 1.599761295656421e-11
proteins O 0 9.274934119340994e-12
which O 0 4.285623505378977e-13
includes O 0 8.404750853618914e-12
LAP1 O 0 6.650025170529261e-06
, O 0 2.476175080950993e-12
LAP2 O 0 4.181727945251623e-06
and O 0 2.875853166717235e-10
lamin O 0 0.014396489597856998
B O 0 0.002710690489038825
receptor O 0 2.4818255894842878e-08
( O 0 4.711420056174864e-12
LBR O 0 1.4060826288186945e-05
) O 0 5.707999177484435e-12
. O 0 7.355909284467721e-12

A O 0 1.8270492896377277e-09
panel O 0 5.2061892574784e-09
of O 0 9.807101962119869e-13
16 O 0 7.605267804411397e-11
monoclonal O 0 8.835673304119496e-10
antibodies O 0 2.0357537877657705e-09
( O 0 4.6095492331997556e-14
mAbs O 0 3.2584126369306077e-11
) O 0 4.5731278329073574e-14
has O 0 4.349526652475816e-13
been O 0 4.116612107619988e-13
mapped O 0 3.7519541251640476e-08
to O 0 2.1698040499756877e-12
six O 0 8.037142999739455e-12
specific O 0 4.405532199897727e-14
sites O 0 3.977499926643979e-11
throughout O 0 6.059392489718776e-14
the O 0 7.698864569677995e-15
emerin O 0 9.195934985717358e-11
molecule O 0 3.0579915498690075e-14
using O 0 7.760523994260193e-14
phage O 0 7.007289887228652e-11
- O 0 2.692776002177766e-10
displayed O 0 4.8858157103426336e-11
peptide O 0 2.6532413419100287e-12
libraries O 0 3.217961108085282e-13
and O 0 8.170122564599147e-13
has O 0 1.6152678424408845e-13
been O 0 1.8047673408906964e-14
used O 0 1.6464665731057843e-13
to O 0 1.4351124726520031e-13
localize O 0 6.826006426763342e-08
emerin O 0 5.299509211909026e-06
in O 0 5.062708065273203e-13
human O 0 8.400235368410947e-11
and O 0 3.907180481932393e-11
rabbit O 0 0.0012377483071759343
heart O 0 2.543653863540385e-06
. O 0 1.3815243393722199e-10

Several O 0 1.5572994283008512e-11
mAbs O 0 6.142538921949381e-09
against O 0 6.549984946785381e-12
different O 0 7.944195296169174e-14
emerin O 0 4.5742062582121434e-08
epitopes O 0 2.711094104768108e-08
did O 0 1.1584268266862097e-10
not O 0 4.327878387697798e-13
recognize O 0 1.705448933117526e-12
intercalated O 0 4.705479339506269e-10
discs O 0 5.089863861940103e-06
in O 0 6.993243484298972e-11
the O 0 3.074376864198314e-11
heart O 0 1.8646783672693346e-08
, O 0 2.2129192467183756e-13
though O 0 5.278329314427344e-13
they O 0 4.676538670200792e-12
recognized O 0 1.0249101047021814e-11
cardiomyocyte O 0 1.832292007009073e-08
nuclei O 0 2.953691111140522e-11
strongly O 0 1.4697444650213498e-10
, O 0 4.300212462049306e-14
both O 0 5.082745747723993e-13
at O 0 2.232722895456618e-09
the O 0 3.8539928193248585e-11
rim O 0 4.0779887058306485e-06
and O 0 1.9158419295450813e-09
in O 0 1.334122563942039e-13
intranuclear O 0 9.711504134202187e-08
spots O 0 3.6359479871350686e-09
or O 0 1.371243951719947e-10
channels O 0 3.230181988556069e-08
. O 0 4.0803077583362324e-10

A O 0 2.7074291697459785e-09
polyclonal O 0 6.171701443236088e-07
rabbit O 0 1.4490635749098146e-06
antiserum O 0 1.4325368056233856e-06
against O 0 1.869092658424165e-09
emerin O 0 7.2811383233784e-07
did O 0 8.542975354908222e-11
recognize O 0 5.662812666701322e-12
both O 0 5.583582099281947e-13
nuclear O 0 5.086036480861367e-08
membrane O 0 2.544619376321222e-11
and O 0 7.843893720313466e-13
intercalated O 0 1.1464429405805276e-10
discs O 0 5.424104898565929e-08
but O 0 3.3204790913371474e-12
, O 0 7.527835912133143e-16
after O 0 2.6353727617593574e-15
affinity O 0 7.916179342625559e-15
purification O 0 3.4573369557880373e-13
against O 0 6.917549351262778e-14
a O 0 7.446895984792364e-15
pure O 0 2.505387173765139e-12
- O 0 8.352223090923871e-08
emerin O 0 1.7718218714435352e-07
band O 0 3.389402300491007e-11
on O 0 1.0106551012745157e-12
a O 0 1.1226084759051805e-13
western O 0 9.183918816407788e-13
blot O 0 4.7467970034631435e-06
, O 0 9.987624876445222e-13
it O 0 1.2453008459492598e-12
stained O 0 2.723413854255341e-05
only O 0 7.731692022727721e-12
the O 0 6.814424784000461e-13
nuclear O 0 1.0825575600392767e-06
membrane O 0 3.697701034255374e-10
. O 0 1.2199765503373428e-11

These O 0 9.383905978654905e-12
results O 0 2.3046408531568474e-11
would O 0 3.718966107291166e-12
not O 0 3.1386406060956995e-14
be O 0 1.7283510777080235e-13
expected O 0 9.043708165158704e-13
if O 0 3.237293245972328e-12
immunostaining O 0 8.418882480043521e-09
at O 0 7.340474257079566e-13
intercalated O 0 5.041283362983151e-11
discs O 0 2.2133727384243684e-07
were O 0 9.140593282275233e-10
due O 0 7.394365068164044e-13
to O 0 1.5610910391520953e-15
a O 0 1.1429777886954803e-14
product O 0 1.7879174529777941e-10
of O 0 7.341793595598209e-16
the O 0 1.5970882453445086e-14
emerin O 0 6.228782378769893e-09
gene O 0 2.743641758229387e-09
and O 0 2.727980341621361e-10
, O 0 1.7822321309729494e-13
therefore O 0 5.722230008624665e-14
, O 0 3.704576183034651e-14
cast O 0 7.008884583825647e-10
some O 0 1.8885790487358466e-14
doubt O 0 7.250514750221926e-13
upon O 0 9.183973788846065e-16
the O 0 6.5068295972928614e-15
hypothesis O 0 1.4298326411754658e-11
that O 0 6.63887486651582e-11
cardiac B-Disease 0 2.556001561515586e-07
defects I-Disease 1 0.8542929887771606
in O 0 2.498789508642574e-10
EDMD B-Disease 1 1.0
are O 0 1.2093577250738008e-09
caused O 0 1.7548171249437416e-11
by O 0 1.475139997132724e-13
absence O 0 2.568592560869831e-10
of O 0 2.163843241956634e-13
emerin O 0 1.5774365920151467e-06
from O 0 5.807823297808434e-13
intercalated O 0 5.722738194435806e-08
discs O 0 1.6182519175345078e-05
. O 0 3.3327413051509325e-10

Although O 0 2.2099753138604683e-09
emerin O 0 1.1775157418014714e-06
was O 0 3.557265315645708e-10
abundant O 0 5.371276882472353e-13
in O 0 1.6897595790047598e-14
the O 0 8.059423625434575e-14
membranes O 0 7.3765455965713045e-09
of O 0 3.7575880449704224e-13
cardiomyocyte O 0 4.899943064629042e-07
nuclei O 0 2.9001438403564173e-11
, O 0 5.639148273773459e-14
it O 0 1.214505384282416e-13
was O 0 2.4859114766684343e-10
absent O 0 1.6068622127329846e-11
from O 0 2.0404640840463936e-14
many O 0 9.776784958871743e-14
non O 0 2.8352204139991954e-08
- O 0 1.2030590745837344e-08
myocyte O 0 4.1589956367715786e-08
cells O 0 2.4498930661920326e-10
in O 0 3.3712738004877674e-14
the O 0 1.9653835850452772e-12
heart O 0 1.6699061688996153e-08
. O 0 2.1076893702565158e-11

This O 0 2.898712425148699e-14
distribution O 0 1.073815407252876e-12
of O 0 1.626799789441937e-14
emerin O 0 9.414507928795501e-08
was O 0 3.204391613165214e-11
similar O 0 2.5329345029425536e-15
to O 0 3.269768040242596e-15
that O 0 4.4744996553422456e-14
of O 0 2.2127322896062576e-14
lamin O 0 6.21652475274459e-07
A O 0 1.1203556832262151e-10
, O 0 6.710971313844726e-15
a O 0 1.494578200485425e-15
candidate O 0 1.7827965937289997e-13
gene O 0 2.073897859000695e-10
for O 0 8.851284288846628e-12
an O 0 1.0932510452477118e-10
autosomal O 0 0.06823382526636124
form O 0 1.295248580390762e-06
of O 0 2.1999180717102718e-06
EDMD B-Disease 1 1.0
. O 0 7.594870510274632e-08

In O 0 2.532939656629818e-11
contrast O 0 8.930329392642378e-11
, O 0 1.0998595263711497e-11
lamin O 0 0.004518136382102966
B1 O 1 0.9984689354896545
was O 0 2.844575064386845e-08
absent O 0 3.3430166967995945e-10
from O 0 1.1687005530003347e-13
cardiomyocyte O 0 4.575722023503204e-09
nuclei O 0 8.08653231182399e-12
, O 0 2.3363445509835823e-14
showing O 0 6.530382345992791e-10
that O 0 1.1700673763215264e-10
lamin O 0 0.024536285549402237
B1 O 1 0.733465850353241
is O 0 8.307466693724397e-12
not O 0 8.625838792428262e-15
essential O 0 2.3720730783251265e-14
for O 0 7.963606305529103e-16
localization O 0 3.180181161813178e-12
of O 0 1.3243760776905037e-14
emerin O 0 6.339170965929952e-08
to O 0 1.9887319872499698e-13
the O 0 1.4085319282458597e-12
nuclear O 0 6.908569503139006e-07
lamina O 0 4.151450383460542e-08
. O 0 2.1696809279769802e-11

Lamin O 1 0.9905845522880554
B1 O 1 0.9998575448989868
is O 0 9.000743972364944e-08
also O 0 2.721276537442918e-10
almost O 0 3.339660796172761e-12
completely O 0 9.13763464893691e-09
absent O 0 2.228167694795502e-08
from O 0 2.1393947377545963e-11
skeletal O 0 0.00021295556507539004
muscle O 0 1.123871555819278e-07
nuclei O 0 2.5481527998749698e-09
. O 0 5.4459489001734696e-11

In O 0 2.2024428947275965e-09
EDMD B-Disease 1 0.9999988079071045
, O 0 5.147487796251793e-13
the O 0 1.0111972497946035e-15
additional O 0 2.1313281543290652e-13
absence O 0 5.7788092887312015e-12
of O 0 1.2032121989285355e-13
lamin O 0 0.00327424262650311
B1 O 1 0.5883843898773193
from O 0 1.4590106900413957e-10
heart O 0 1.540554563916885e-07
and O 0 1.3502583495750287e-09
skeletal O 0 5.606632839771919e-06
muscle O 0 1.8103536447711122e-09
nuclei O 0 3.620719349339829e-11
which O 0 3.9127364542812515e-11
already O 0 1.4744384202458605e-07
lack O 0 6.400967950126457e-11
emerin O 0 2.7148773824592354e-06
may O 0 3.9153810749148477e-10
offer O 0 4.009859732125899e-14
an O 0 3.1767798633205123e-16
alternative O 0 6.298656258021951e-14
explanation O 0 2.9439060374560413e-14
of O 0 1.1648542780308066e-14
why O 0 3.076467136597927e-10
these O 0 5.164658848158532e-13
tissues O 0 4.820258414639511e-09
are O 0 3.85858608519668e-13
particularly O 0 9.165755177412138e-13
affected O 0 4.241711582669838e-12
. O 0 8.093776571269778e-14
. O 0 1.3104024809695858e-11

Genetic O 0 8.505899984356802e-08
mapping O 0 9.827251901128875e-09
of O 0 4.947121705345392e-12
the O 0 2.3149795882332347e-12
copper B-Disease 0 4.428876763995504e-06
toxicosis I-Disease 0 5.0248022489540745e-06
locus O 0 2.525562514676949e-08
in O 0 2.67961607763878e-12
Bedlington O 0 1.5198949085970526e-06
terriers O 0 8.083931788860355e-06
to O 0 5.1525394194340546e-12
dog O 0 8.791997970547527e-06
chromosome O 0 1.599681309016887e-05
10 O 0 1.4525688984967644e-10
, O 0 2.0328501048835247e-14
in O 0 6.590587603249156e-16
a O 0 1.0997059382913954e-12
region O 0 5.616036455324824e-11
syntenic O 0 1.8743686496236478e-06
to O 0 2.1956822211094407e-12
human O 0 4.6364878603100124e-10
chromosome O 0 8.802250704320613e-06
region O 0 4.5773607126875504e-10
2p13 O 0 2.7758096265984022e-08
- O 0 1.7040377997545875e-08
p16 O 0 4.503538519884387e-08
. O 0 7.385633077339193e-11

Abnormal O 1 0.9921339750289917
hepatic B-Disease 1 0.9983505010604858
copper I-Disease 0 0.00030875724041834474
accumulation I-Disease 0 1.0505848280217833e-07
is O 0 3.239334633864388e-10
recognized O 0 5.145581738474903e-10
as O 0 1.6440943051421186e-09
an O 0 7.584295076412673e-07
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 1.1387163212361884e-08
man O 0 1.2390208212309517e-05
, O 0 8.03140702814592e-13
mouse O 0 2.176444979795633e-07
, O 0 1.7964717170457223e-12
rat O 0 1.7415577531210147e-06
and O 0 6.600542334922466e-11
dog O 0 1.9935236196033657e-05
. O 0 1.3178549918002602e-10

The O 0 7.01927543866887e-11
major O 0 4.597435321329613e-09
cause O 0 6.350443504388181e-10
of O 0 2.273337768032846e-11
hepatic B-Disease 1 0.8756112456321716
copper I-Disease 0 0.12695105373859406
accumulation I-Disease 0 3.0925484679755755e-06
in O 0 1.722853110175393e-11
man O 0 9.950520052370848e-07
is O 0 5.771120994285672e-12
a O 0 1.5317841396342291e-12
dysfunctional O 0 2.318263483402916e-07
ATP7B O 0 9.63074398896424e-07
gene O 0 1.931421600431804e-08
, O 0 2.3251886527297927e-12
causing O 0 1.1687792067505143e-08
Wilson B-Disease 0 0.000801261980086565
disease I-Disease 0 0.09918064624071121
( O 0 1.703412272346938e-10
WD B-Disease 0 0.003970325458794832
) O 0 4.11350016549239e-11
. O 0 1.177456829953849e-11

Mutations O 0 2.1960253434372135e-05
in O 0 4.607092918967881e-12
the O 0 1.3263739065405566e-13
ATP7B O 0 1.8317979311177623e-06
genes O 0 1.6062578822584328e-08
have O 0 3.63393377889043e-11
also O 0 6.240046240141295e-12
been O 0 1.3679700601454403e-11
demonstrated O 0 1.7890924202193514e-12
in O 0 4.419753544268948e-15
mouse O 0 6.222076081030536e-07
and O 0 2.747432947813877e-09
rat O 0 7.296523108379915e-05
. O 0 1.255040377179384e-10

The O 0 3.8007104408155357e-11
ATP7B O 0 1.7088375443563564e-06
gene O 0 4.5624344124917116e-07
has O 0 1.4094827527344478e-09
been O 0 2.6066333119745266e-11
excluded O 0 1.341534799914612e-10
in O 0 2.6102384354781253e-16
the O 0 4.1683814823364205e-16
much O 0 3.520418006587589e-14
rarer O 0 1.6735268726364438e-10
human O 0 9.149519336615342e-11
copper B-Disease 0 1.1069662832596805e-05
overload I-Disease 0 5.6074753956636414e-05
disease O 1 0.9296998381614685
non B-Disease 0 0.012846441008150578
- I-Disease 1 0.8800042271614075
Indian I-Disease 0 2.9557206289609894e-05
childhood I-Disease 0 0.0004269224882591516
cirrhosis I-Disease 0 0.0012717836070805788
, O 0 2.3721874616543237e-13
indicating O 0 1.3295362207010886e-11
genetic O 0 2.630609730047695e-09
heterogeneity O 0 2.2564852031337068e-07
. O 0 4.837829581383346e-10

By O 0 3.1665505721006904e-12
investigating O 0 1.0157396701515609e-08
the O 0 2.509464580580101e-10
common O 0 2.0679263457168418e-07
autosomal O 1 0.9908406138420105
recessive O 1 0.9987564086914062
copper B-Disease 0 0.25122344493865967
toxicosis I-Disease 0 0.0007879738113842905
( O 0 1.0095728940340276e-11
CT B-Disease 0 2.4695336833246984e-05
) O 0 5.144055320593921e-12
in O 0 7.12643038656112e-14
Bedlington O 0 1.7527545423945412e-06
terriers O 0 0.004485338926315308
, O 0 1.6135767721969785e-10
we O 0 2.890512655617794e-11
have O 0 6.8536531667767655e-15
identified O 0 8.605893368806086e-14
a O 0 3.5323884879564236e-15
new O 0 2.95861046165774e-13
locus O 0 1.5683181420200754e-09
involved O 0 2.1362419388992748e-08
in O 0 1.0581414633392683e-09
progressive O 0 0.022389624267816544
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 1.8685733849110875e-08

We O 0 1.8419402114666639e-10
examined O 0 3.086328970169916e-10
whether O 0 4.981511730894894e-12
the O 0 5.90259232550322e-13
WD B-Disease 0 0.0015328601002693176
gene O 0 6.565832677551953e-07
ATP7B O 0 0.00031169888097792864
was O 0 1.0468999001034263e-08
also O 0 1.0157066160365602e-12
causative O 0 2.2470166005650327e-10
for O 0 8.98376166989475e-16
CT B-Disease 0 1.2550752437334722e-08
by O 0 1.5147803597939137e-14
investigating O 0 1.4534806691557378e-10
the O 0 3.717517287928074e-13
chromosomal O 0 0.0002695356961339712
co O 0 2.534664872655412e-06
- O 0 7.786070677084922e-10
localization O 0 4.097543693237782e-10
of O 0 4.5236893658068267e-13
ATP7B O 0 1.0485721759323496e-05
and O 0 8.246839084020963e-13
C04107 O 0 1.3530665303462808e-12
, O 0 9.297257795009202e-18
using O 0 9.75408400472325e-17
fluorescence O 0 8.546286643868264e-14
in O 0 2.241762480400915e-15
situ O 0 1.429350041104449e-11
hybridization O 0 2.6343226211533732e-11
( O 0 8.307113677497036e-13
FISH O 0 4.162963662679431e-08
) O 0 4.6353333497950455e-12
. O 0 2.5979359722511086e-12

C04107 O 0 6.071898496884387e-06
is O 0 6.988550016462369e-11
an O 0 1.7172632470218753e-14
anonymous O 0 7.374002450322159e-12
microsatellite O 0 5.023245194024639e-06
marker O 0 1.72385716723511e-06
closely O 0 2.7808211289226392e-09
linked O 0 8.509730520245284e-08
to O 0 2.4932039072167456e-11
CT B-Disease 0 0.05550259351730347
. O 0 5.764680399700239e-10

However O 0 4.558917687802477e-09
, O 0 1.5398426891216621e-12
BAC O 0 3.871332587834786e-09
clones O 0 1.4198446862678793e-08
containing O 0 3.0687909990945172e-09
ATP7B O 0 2.7658277758746408e-05
and O 0 7.724701412380186e-13
C04107 O 0 1.5118413465575742e-11
mapped O 0 1.6617113240968706e-09
to O 0 1.3986952058803875e-13
the O 0 2.4425874192192387e-13
canine O 0 3.640857903519645e-05
chromosome O 0 0.00021386472508311272
regions O 0 8.041294741190086e-09
CFA22q11 O 0 1.4778827789996285e-05
and O 0 2.2692665802015455e-10
CFA10q26 O 0 1.8191053641203325e-07
, O 0 5.3547644156227633e-14
respectively O 0 8.274632606712629e-13
, O 0 4.607349319229147e-15
demonstrating O 0 1.4927343215676014e-12
that O 0 2.9120041881297576e-12
WD B-Disease 0 0.2666771113872528
cannot O 0 2.095281947944727e-09
be O 0 1.2308624714081617e-13
homologous O 0 1.788452025364151e-11
to O 0 3.6202065650803306e-12
CT B-Disease 0 8.83136090124026e-05
. O 0 5.036182582074389e-10

The O 0 1.93649419416575e-11
copper O 0 1.351504153035421e-07
transport O 0 2.0921339660695537e-10
genes O 0 4.366657035959065e-10
CTR1 O 0 2.707371641008649e-05
and O 0 3.204599433037636e-11
CTR2 O 0 1.4787385225645266e-05
were O 0 8.852036326167934e-10
also O 0 1.4886757104815018e-10
excluded O 0 4.813080489718402e-10
as O 0 7.731643558890611e-13
candidate O 0 9.401986940458639e-15
genes O 0 2.5219171369272875e-13
for O 0 2.5760594490344645e-14
CT B-Disease 0 3.7208064895821735e-05
since O 0 5.280713089028666e-10
they O 0 6.8073875529595096e-12
both O 0 3.7135412475110263e-13
mapped O 0 2.301996573805809e-06
to O 0 1.0274040646018889e-10
canine O 0 0.00033226137747988105
chromosome O 0 0.00044812055421061814
region O 0 1.0895258917287265e-08
CFA11q22 O 0 1.8386783267487772e-05
. O 0 2.432525569862065e-10

2 O 0 1.2164471741016314e-07
- O 0 2.6117362722288817e-05
22 O 0 1.2481996769508896e-08
. O 0 3.109395033118467e-11

5 O 0 1.179113198190862e-07
. O 0 2.1200410316168927e-09

A O 0 8.850005450700138e-11
transcribed O 0 1.487143186373885e-10
sequence O 0 1.2387583146755698e-11
identified O 0 1.1781291220369638e-10
from O 0 5.5660984583363535e-14
the O 0 6.463490902436711e-14
C04107 O 0 2.792668762907624e-09
- O 0 3.972505657756642e-10
containing O 0 9.437328002404044e-11
BAC O 0 4.239695705621216e-09
was O 0 4.2131784172561026e-11
found O 0 3.957842625683383e-13
to O 0 1.017186196248165e-15
be O 0 4.631367361965016e-15
homologous O 0 1.21320664560505e-13
to O 0 1.2269192619881499e-14
a O 0 4.2011431497252644e-14
gene O 0 1.2351593081660894e-09
expressed O 0 2.438644446968452e-13
from O 0 3.6494295947838915e-15
human O 0 5.0329510524471655e-12
chromosome O 0 6.217935606400715e-07
2p13 O 0 1.6663237900615968e-08
- O 0 4.7053383411821414e-09
p16 O 0 7.341088292811548e-10
, O 0 1.4933429384571262e-13
a O 0 1.7298055349224128e-13
region O 0 6.913766976458791e-13
devoid O 0 4.076631827248933e-12
of O 0 5.510889528460676e-15
any O 0 1.42458896242037e-12
positional O 0 5.784787049378792e-08
candidate O 0 2.7114846479214805e-10
genes O 0 9.089641039849994e-09
. O 0 6.57623885902403e-11

Molecular O 0 8.311595856014264e-10
analysis O 0 1.5688490437315572e-11
of O 0 3.7017860565063954e-14
the O 0 5.307967539352858e-14
APC B-Disease 0 1.2282430628118846e-09
gene O 0 1.4345838406093492e-10
in O 0 1.76616737185796e-14
205 O 0 1.4408161295997868e-11
families O 0 3.208302493031695e-13
: O 0 4.655992388510888e-14
extended O 0 3.122964387092253e-11
genotype O 0 3.734818676548457e-07
- O 0 3.613409262470668e-06
phenotype O 0 4.700084588193931e-08
correlations O 0 5.039528794270609e-09
in O 0 3.4366579677522213e-14
FAP B-Disease 0 5.5535936960282584e-11
and O 0 6.1388191926992856e-15
evidence O 0 3.481249170227477e-14
for O 0 1.801897635617046e-15
the O 0 1.4708940581373633e-14
role O 0 1.778920205586232e-10
of O 0 4.940495000680788e-15
APC B-Disease 0 1.4382961488479395e-10
amino O 0 5.6328114915460414e-12
acid O 0 5.5879776500455947e-11
changes O 0 9.10543862531199e-11
in O 0 1.6895389975957187e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 0.5407600402832031
. O 0 1.9305734788588325e-09

BACKGROUND O 0 6.815364628209863e-08
/ O 0 2.823854572397977e-08
AIMS O 0 1.011620898161425e-09
The O 0 8.02987166234441e-14
development O 0 1.0905659188209516e-11
of O 0 2.322206071880828e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.2959723294514447e-09
a O 0 1.7500623617373173e-13
variable O 0 2.3312970998112803e-10
range O 0 5.190619600803359e-10
of O 0 1.5041384804348468e-11
extracolonic O 1 0.7266758680343628
manifestations O 0 0.07218277454376221
in O 0 1.7782793975129607e-06
familial B-Disease 1 1.0
adenomatous I-Disease 1 0.9999940395355225
polyposis I-Disease 1 0.9999995231628418
( O 0 4.990544422156518e-09
FAP B-Disease 0 2.391701947601632e-08
) O 0 1.8340997123833525e-12
is O 0 1.6074367856742933e-13
the O 0 4.900832259409132e-15
result O 0 8.409813644083552e-13
of O 0 7.540229698217368e-14
the O 0 3.206556201118538e-11
dominant O 0 5.169075393496314e-06
inheritance O 0 8.06230164016597e-05
of O 0 8.241035538958386e-05
adenomatous B-Disease 1 0.9999998807907104
polyposis I-Disease 1 0.9999799728393555
coli I-Disease 1 0.9999998807907104
( O 0 1.1205869565600324e-09
APC B-Disease 0 1.1947469680251288e-08
) O 0 3.9094796193753223e-13
gene O 0 1.7992417555845464e-09
mutations O 0 1.2166876786068315e-06
. O 0 4.3460338106093843e-10

In O 0 2.6078963641373853e-11
this O 0 1.98808593828044e-14
study O 0 3.5174581346567035e-14
, O 0 3.9469207478098434e-16
direct O 0 2.1281169169007526e-15
mutation O 0 1.994903547908322e-11
analysis O 0 2.237682044867184e-12
of O 0 3.728422532192112e-14
the O 0 8.450458079600418e-14
APC B-Disease 0 3.229451706054931e-10
gene O 0 8.227270947847032e-11
was O 0 1.8116747685370527e-11
performed O 0 3.011796541330103e-12
to O 0 3.9990576903561545e-15
determine O 0 1.6199036903530306e-11
genotype O 0 2.7677314662355457e-08
- O 0 2.7105357958134846e-08
phenotype O 0 1.1334502225679444e-09
correlations O 0 4.6429660116587e-10
for O 0 5.990963367757951e-12
nine O 0 5.867056618313882e-09
extracolonic O 0 6.011377990944311e-06
manifestations O 0 1.2030705320853485e-08
and O 0 8.319005206924857e-13
to O 0 2.0653894684753617e-15
investigate O 0 2.204579921394334e-11
the O 0 1.2704090167001136e-13
incidence O 0 2.8960355891172185e-08
of O 0 1.007177739646703e-12
APC B-Disease 0 2.426631624530273e-07
mutations O 0 1.220623602193882e-07
in O 0 1.2243030374226027e-11
non O 0 0.001189053407870233
- O 1 0.9981196522712708
FAP O 1 0.9984219074249268
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
. O 0 4.350193094637689e-08

METHODS O 0 3.396038783520794e-09
The O 0 5.348091219013751e-13
APC B-Disease 0 2.1944339678725555e-09
gene O 0 3.328687880888026e-10
was O 0 1.8238443741380728e-11
analysed O 0 1.000017776919826e-10
in O 0 6.01932571373128e-15
190 O 0 2.4873923450477453e-13
unrelated O 0 5.505749935824644e-12
FAP B-Disease 0 3.746524424030895e-09
and O 0 1.1709753826305569e-11
15 O 0 1.9504738102416042e-10
non O 0 3.316058428026736e-05
- O 1 0.8660401701927185
FAP O 1 0.9982581734657288
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
patients O 0 1.9696543063218996e-08
using O 0 6.79339570708315e-11
denaturing O 0 0.00014032550097908825
gradient O 0 1.0378871593275107e-05
gel O 0 0.00012943727779202163
electrophoresis O 0 1.819351780341094e-07
, O 0 1.085915862439335e-12
the O 0 1.0096252413477943e-14
protein O 0 6.782274741823358e-11
truncation O 0 3.9487446201746934e-07
test O 0 0.00013116605987306684
, O 0 3.3142179999738966e-14
and O 0 1.11949411787021e-15
direct O 0 4.353990245057303e-14
sequencing O 0 1.979287667097651e-08
. O 0 3.005647952747381e-10

RESULTS O 0 2.2756975681659242e-07
Chain O 0 1.6628318633138406e-07
terminating O 0 1.2252537828771892e-07
signals O 0 6.543417185866929e-08
were O 0 9.44890433257628e-12
only O 0 6.268358905938201e-14
identified O 0 3.622358246690993e-10
in O 0 9.258522767896515e-14
patients O 0 1.1681128070026303e-12
belonging O 0 4.851868147699723e-13
to O 0 2.0255758875764585e-12
the O 0 2.7728630155876566e-11
FAP B-Disease 0 1.6961297433226719e-07
group O 0 7.692036244066891e-12
( O 0 3.413317127857682e-14
105 O 0 6.823754235274482e-12
patients O 0 1.0860199892159805e-11
) O 0 7.794732605681184e-14
. O 0 1.863046392505674e-12

Amino O 0 4.1546030615791096e-08
acid O 0 3.854945251902109e-09
changes O 0 3.396085496154555e-12
were O 0 8.866601300828308e-14
identified O 0 1.2682822674026095e-11
in O 0 5.6568583774478307e-14
four O 0 8.904311177282409e-10
patients O 0 4.2317257337165515e-11
, O 0 9.828833947634393e-15
three O 0 7.668023117510248e-13
of O 0 4.997068297346585e-13
whom O 0 9.447224336156523e-09
belonged O 0 1.246039271762811e-09
to O 0 8.758235803263403e-11
the O 0 2.2884655281885102e-10
non O 0 4.205350705888122e-05
- O 0 2.408144723631267e-07
FAP O 0 4.1768345226955716e-08
group O 0 2.415312949644033e-10
of O 0 9.1558485237897e-09
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 1.0315915233150008e-06
. O 0 2.8288260622844064e-11

Genotype O 0 0.023560572415590286
- O 0 0.002532409271225333
phenotype O 0 8.657640137244016e-06
correlations O 0 1.7455437273383723e-07
identified O 0 3.3813174127317325e-07
significant O 0 3.0065880340934825e-10
differences O 0 5.77663605838552e-09
in O 0 3.498050915769213e-13
the O 0 1.2682736805214034e-13
nature O 0 3.147836158401418e-11
of O 0 5.930848124896179e-14
certain O 0 2.1621414728056898e-11
extracolonic O 0 1.3936404684500303e-05
manifestations O 0 3.2546722650295123e-08
in O 0 3.2137655167283063e-13
FAP B-Disease 0 8.401493722942632e-09
patients O 0 1.1541389371982902e-11
belonging O 0 1.0016547053598446e-12
to O 0 4.4851139946108787e-13
three O 0 1.4233736411739528e-10
mutation O 0 4.058505851389782e-07
subgroups O 0 7.832520765305162e-08
. O 0 5.2478972556446735e-11

CONCLUSIONS O 0 7.989685002485203e-08
Extended O 0 1.0473552691792065e-08
genotype O 0 2.0741076696140226e-06
- O 0 1.7702739569358528e-05
phenotype O 0 3.447458993832697e-07
correlations O 0 2.5718654228512605e-07
made O 0 7.697885662238946e-10
in O 0 3.940373214891303e-14
this O 0 3.499742355861585e-15
study O 0 9.972586992312849e-13
may O 0 2.196673398735527e-10
have O 0 1.6437524084922384e-13
the O 0 6.289166164408385e-16
potential O 0 1.7992003015481622e-13
to O 0 6.061397416704927e-16
determine O 0 1.6359237911805352e-13
the O 0 6.378104306232731e-15
most O 0 5.042013169958637e-15
appropriate O 0 5.2433467181804694e-14
surveillance O 0 4.160048749923817e-09
and O 0 9.118495346814581e-14
prophylactic O 0 8.062265438590899e-11
treatment O 0 6.45549491141463e-14
regimens O 0 4.066159979250819e-14
for O 0 4.671786397779452e-16
those O 0 1.1017481550560163e-13
patients O 0 8.000065453844796e-13
with O 0 1.4845618495368945e-13
mutations O 0 3.5835828526842306e-08
associated O 0 1.3623230321613278e-10
with O 0 3.5260566688677386e-10
life O 0 3.1732744787404954e-07
threatening O 0 0.16387906670570374
conditions O 0 2.9929051237331805e-08
. O 0 2.2338110527986288e-11

This O 0 2.270710529328479e-12
study O 0 8.082488129300403e-13
also O 0 4.04419553401425e-13
provided O 0 1.3428216600729764e-15
evidence O 0 1.443130283242805e-13
for O 0 2.965242797397377e-13
the O 0 2.010832689594566e-12
pathological O 0 3.261912979724002e-07
nature O 0 5.955318876926796e-11
of O 0 2.5006677569047904e-14
amino O 0 1.592692783214389e-10
acid O 0 1.1086873780152828e-10
changes O 0 4.73408150788307e-13
in O 0 1.3105253949370014e-14
APC O 0 9.93470750110248e-10
associated O 0 9.239281431941415e-13
with O 0 4.896340358986548e-14
both O 0 1.522443087396963e-12
FAP B-Disease 0 3.107781054723091e-08
and O 0 6.58014476240254e-10
non O 0 0.0005756187019869685
- O 1 0.9988484382629395
FAP O 1 0.9997915625572205
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 1.8649008097781916e-06
. O 0 7.775002972172651e-13
. O 0 6.377749457026072e-12

Inherited B-Disease 1 0.9999221563339233
colorectal I-Disease 1 1.0
polyposis I-Disease 1 0.9999890327453613
and O 0 0.0008003088878467679
cancer B-Disease 1 0.836927592754364
risk O 0 4.4233926018932834e-05
of O 0 2.0657305347619032e-13
the O 0 2.566900251382842e-12
APC O 0 9.032211778503552e-07
I1307K O 0 1.0839232622572581e-08
polymorphism O 0 4.628213545743165e-08
. O 0 8.541280877016888e-11

Germ O 0 0.008274110034108162
- O 0 0.0023362471256405115
line O 0 1.4645601140728104e-06
and O 0 1.2698234391067542e-12
somatic O 0 2.2554755285675299e-10
truncating O 0 7.933525836278932e-09
mutations O 0 1.6774976074884762e-08
of O 0 2.3183352752722403e-14
the O 0 2.8097590579071255e-14
APC B-Disease 0 5.330583197071803e-10
gene O 0 6.827025056388436e-11
are O 0 2.144972872551113e-14
thought O 0 6.060955773726229e-13
to O 0 1.4303774093990529e-12
initiate O 0 7.374357210210292e-06
colorectal B-Disease 1 1.0
tumor I-Disease 1 0.9585912227630615
formation O 0 2.5922277927747928e-05
in O 0 1.6954310240180348e-06
familial B-Disease 1 1.0
adenomatous I-Disease 1 0.9999992847442627
polyposis I-Disease 1 1.0
syndrome I-Disease 1 0.9999998807907104
and O 0 3.829481443062832e-07
sporadic O 0 0.004656387027353048
colorectal O 1 0.9999998807907104
carcinogenesis O 1 0.9973793029785156
, O 0 2.1666570759748538e-08
respectively O 0 3.338744036796015e-08
. O 0 2.0800540456722416e-10

Recently O 0 2.222286639153026e-06
, O 0 2.0439132157601403e-12
an O 0 2.6898765875284225e-13
isoleucine O 0 0.00041926559060811996
- O 0 2.6663725293474272e-05
- O 0 3.2465385402247193e-07
> O 0 1.2333506438366726e-10
lysine O 0 2.2902564467131015e-07
polymorphism O 0 3.893416078426526e-08
at O 0 3.785237956410725e-10
codon O 0 2.0554180579779313e-09
1307 O 0 4.238141504409043e-10
( O 0 9.672341053090783e-14
I1307K O 0 5.658051284440635e-12
) O 0 3.7402208858781526e-16
of O 0 1.7172049486557915e-17
the O 0 7.857747304154813e-16
APC B-Disease 0 7.71449085168463e-11
gene O 0 1.1124345195012708e-10
has O 0 7.855575565041129e-12
been O 0 2.593524787292134e-12
identified O 0 7.40171313129423e-10
in O 0 5.826774609682395e-13
6 O 0 3.5061937797564724e-09
% O 0 1.0874891482118287e-12
- O 0 6.412989961290805e-08
7 O 0 1.500644053464839e-09
% O 0 1.4194341807895281e-14
of O 0 3.3938914013002938e-15
the O 0 8.467892186059256e-12
Ashkenazi O 0 1.7066856372593975e-08
Jewish O 0 1.5413569726119292e-11
population O 0 2.600036342909756e-13
. O 0 2.4577629428174097e-12

To O 0 1.3408638782630433e-11
assess O 0 7.470801199893629e-10
the O 0 1.9257665395070594e-13
risk O 0 8.703269771537236e-10
of O 0 5.853298891619083e-16
this O 0 2.0733071089498213e-15
common O 0 2.500236346084095e-12
APC B-Disease 0 1.562114437803075e-09
allelic O 0 2.177090951960281e-09
variant O 0 3.952349288738333e-06
in O 0 1.5814659581891988e-09
colorectal O 1 1.0
carcinogenesis O 1 0.5190613865852356
, O 0 5.3304027858303016e-09
we O 0 7.380397959444451e-10
have O 0 7.43886424897991e-14
analyzed O 0 1.1674806954520278e-11
a O 0 1.6705265100912248e-13
large O 0 1.6773768138356182e-11
cohort O 0 3.850978913533254e-08
of O 0 8.15628467543128e-12
unselected O 0 0.02655915915966034
Ashkenazi O 0 3.3903891107911477e-06
Jewish O 0 2.443145685759873e-10
subjects O 0 6.8838064137821675e-09
with O 0 3.036927098687414e-10
adenomatous B-Disease 0 0.0010658289538696408
polyps I-Disease 1 0.5861477851867676
and O 0 3.608905618790459e-09
. O 0 7.261677370529185e-11
or O 0 0.3250521421432495
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 4.2979883541072184e-11
for O 0 2.2848800149545372e-14
the O 0 1.734619257042977e-13
APC O 0 3.635298284621058e-08
I1307K O 0 4.395588781846982e-09
polymorphism O 0 1.492845669304188e-08
. O 0 1.2575611385567953e-10

The O 0 4.5404468379528495e-11
APC O 0 1.9219550395632723e-08
I1307K O 0 1.2759873158074697e-09
allele O 0 4.692233268599466e-10
was O 0 1.0310063219831633e-10
identified O 0 2.6904758976264986e-10
in O 0 2.3031137543969016e-13
48 O 0 5.204498498834198e-10
( O 0 1.0759593899439118e-13
10 O 0 9.118987032499803e-13
. O 0 3.3653868368010553e-15
1 O 0 2.698993643596853e-13
% O 0 1.630029039025873e-15
) O 0 3.2259207444532666e-16
of O 0 9.432372553375493e-16
476 O 0 8.620942848480695e-10
patients O 0 1.477727523679917e-10
. O 0 3.576337576777222e-12

Compared O 0 3.3634783846991922e-09
with O 0 2.2831516950476416e-13
the O 0 5.674837837599429e-15
frequency O 0 7.937430010138136e-13
in O 0 2.4254125641345664e-15
two O 0 5.795910185981117e-15
separate O 0 6.688896398571176e-13
population O 0 5.3107017617065946e-14
control O 0 1.8854973138360265e-11
groups O 0 2.220706427178299e-14
, O 0 1.608454241650535e-14
the O 0 4.705451658740603e-14
APC O 0 1.9863032107991785e-08
I1307K O 0 3.7873537639399046e-10
allele O 0 1.686324413441298e-10
is O 0 4.654647760976571e-12
associated O 0 3.4801889560280574e-13
with O 0 5.339768967841047e-15
an O 0 4.878579433335341e-15
estimated O 0 1.0820032370073562e-10
relative O 0 5.598053132160885e-09
risk O 0 2.4162109184544533e-06
of O 0 6.48139744999221e-12
1 O 0 1.5393047947398486e-09
. O 0 7.299504056756945e-11

5 O 0 6.07255401519069e-08
- O 0 3.334466100568534e-06
1 O 0 1.5215453341710372e-09
. O 0 5.691890014869472e-11

7 O 0 2.577281499327455e-08
for O 0 2.0207784334758117e-09
colorectal B-Disease 1 0.9999998807907104
neoplasia I-Disease 1 0.9979228377342224
( O 0 3.203993159672791e-08
both O 0 4.2275530631741276e-08
P O 1 0.9995543360710144
= O 0 4.171678483544383e-06
. O 0 1.1103078526031318e-11
01 O 0 3.167777435919561e-07
) O 0 3.104900885009254e-12
. O 0 4.399490754342095e-12

Furthermore O 0 2.0982773296651658e-09
, O 0 6.020548642959866e-13
compared O 0 9.292393243764963e-12
with O 0 9.976201722355915e-13
noncarriers O 0 2.4477224087604554e-06
, O 0 1.7963817824755146e-13
APC O 0 2.526851228257243e-10
I1307K O 0 1.2377010527586663e-10
carriers O 0 5.1157515723598834e-11
had O 0 6.03581746215498e-13
increased O 0 5.856856747634906e-14
numbers O 0 7.867987945192612e-13
of O 0 5.408512721884196e-13
adenomas B-Disease 1 0.7623860836029053
and O 0 0.0002642869658302516
colorectal B-Disease 1 1.0
cancers I-Disease 1 0.9938706159591675
per O 0 1.5325090529927365e-08
patient O 0 7.429466222674819e-06
( O 0 1.604694571666343e-10
P O 1 0.917556881904602
= O 0 3.1107636004890082e-06
. O 0 1.2535899401866502e-11
03 O 0 2.0436795367118066e-08
) O 0 1.7068635459020765e-13
, O 0 5.225752403909987e-15
as O 0 9.382894309607759e-14
well O 0 3.009107719942339e-13
as O 0 1.2357464227244486e-12
a O 0 1.4274367278466205e-12
younger O 0 1.3916967578353479e-09
age O 0 2.537254017997981e-10
at O 0 1.6250724377275816e-10
diagnosis O 0 2.153645617397615e-08
. O 0 8.980320827245425e-12

We O 0 4.1196265843090885e-10
conclude O 0 7.480845803931047e-12
that O 0 1.013982802344944e-14
the O 0 4.355582751701436e-15
APC O 0 1.333718246954163e-09
I1307K O 0 9.051794730430274e-11
variant O 0 3.6998454300274375e-10
leads O 0 2.338141347202338e-10
to O 0 3.3394717546819663e-11
increased O 0 1.6830505273901508e-06
adenoma B-Disease 1 1.0
formation O 0 1.975273704601932e-07
and O 0 2.7675474759125684e-11
directly O 0 3.594144513258124e-12
contributes O 0 5.914750356161846e-10
to O 0 1.930511523209888e-12
3 O 0 2.5379992552032604e-10
% O 0 1.7887435781703542e-13
- O 0 4.350846349865378e-09
4 O 0 1.0237866977791388e-11
% O 0 8.68583106558785e-16
of O 0 1.773359825074628e-15
all O 0 2.404728194349559e-09
Ashkenazi O 0 1.7945090803550556e-05
Jewish O 0 5.041202894062735e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999991655349731
. O 0 3.7887284420889955e-09

The O 0 6.5927596498358e-13
estimated O 0 2.7431089084234417e-12
relative O 0 3.26776730674716e-11
risk O 0 2.2815424216560132e-08
for O 0 2.8318532414861597e-12
carriers O 0 1.0178286657946956e-07
may O 0 4.87734028511988e-12
justify O 0 1.4166760212847018e-13
specific O 0 1.5723516645594834e-14
clinical O 0 5.440544932969194e-13
screening O 0 7.30583453976974e-13
for O 0 3.403068420948643e-16
the O 0 8.340564025023645e-17
360 O 0 7.499839779160494e-14
, O 0 6.30078904463149e-16
000 O 0 6.725425507573147e-15
Americans O 0 8.295708548268846e-14
expected O 0 8.30793292776362e-14
to O 0 1.9093472801629853e-14
harbor O 0 1.04461099492692e-10
this O 0 1.3568945830960146e-15
allele O 0 5.162081265913665e-12
, O 0 3.21264824638956e-14
and O 0 2.7606567697130305e-15
genetic O 0 4.485644440523767e-13
testing O 0 7.907823840191952e-10
in O 0 2.4371073362790697e-15
the O 0 8.006285013488577e-15
setting O 0 7.742793906029277e-11
of O 0 1.136253634584361e-12
long O 0 1.484585432365293e-08
- O 0 2.995552677020896e-07
term O 0 1.8517832822695368e-09
- O 0 1.1904532914996935e-10
outcome O 0 3.31736916582559e-13
studies O 0 1.3765876459570503e-13
may O 0 3.6102612327622297e-13
impact O 0 2.0179483084525884e-12
significantly O 0 8.740867474266167e-10
on O 0 0.03925587236881256
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 0 6.247191208785807e-07
in O 0 2.2516541311589505e-14
this O 0 3.247541895706643e-15
population O 0 1.063533484370327e-13
. O 0 3.4231259320172125e-12

Localization O 0 1.3024631151381527e-08
of O 0 9.993684482387244e-13
human O 0 8.599785467078291e-11
BRCA1 O 0 0.00020791795395780355
and O 0 2.9914182242407605e-10
its O 0 6.944600602042106e-13
loss O 0 1.022103957026843e-09
in O 0 1.2186318577508959e-12
high O 0 3.0437784062087303e-06
- O 0 0.00017544101865496486
grade O 0 0.32594534754753113
, O 0 1.546635708393751e-09
non B-Disease 0 3.349129474372603e-05
- I-Disease 0 0.0167950838804245
inherited I-Disease 1 0.9776135683059692
breast I-Disease 1 0.9998325109481812
carcinomas I-Disease 1 0.9999986886978149
. O 0 1.990903975013225e-08

Although O 0 3.805933693201702e-11
the O 0 7.777535126346491e-14
link O 0 6.360262316817966e-10
between O 0 6.492384321127309e-12
the O 0 3.913975393787794e-11
BRCA1 O 1 0.992665708065033
tumour B-Disease 1 0.9999998807907104
- O 0 2.15158095784318e-07
suppressor O 0 3.6029652505931153e-07
gene O 0 0.0009862928418442607
and O 0 1.63289507781883e-06
hereditary B-Disease 1 0.9999971389770508
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 2.2267387578267517e-07
established O 0 3.4699074169530775e-10
, O 0 6.610564417912357e-13
the O 0 2.826751961844398e-13
role O 0 1.9913862558951223e-08
, O 0 1.7699004154630993e-14
if O 0 7.229493289824876e-14
any O 0 2.0740767230856966e-13
, O 0 1.699310214298231e-14
of O 0 2.833044332440325e-14
BRCA1 O 0 0.003014107933267951
in O 0 1.5375354323055035e-09
non B-Disease 1 0.9530325531959534
- I-Disease 1 0.9779079556465149
familial I-Disease 1 0.9335031509399414
cancers I-Disease 1 0.9589037299156189
is O 0 2.2802437715796486e-10
unclear O 0 1.7490429243816052e-11
. O 0 2.0005160722424975e-11

BRCA1 O 1 0.9647220969200134
mutations O 0 0.00032233321690000594
are O 0 3.964238312614832e-11
rare O 0 1.8129339696137947e-10
in O 0 1.2271668924090928e-11
sporadic B-Disease 0 2.4228645997936837e-05
cancers I-Disease 1 0.9998199343681335
, O 0 3.170457785195424e-10
but O 0 7.529516940496528e-12
loss O 0 7.923057210312834e-10
of O 0 1.4216492566498928e-12
BRCA1 O 0 0.09048070758581161
resulting O 0 2.6278417220026995e-09
from O 0 6.314426759246317e-10
reduced O 0 2.2638438679223327e-07
expression O 0 3.592135255914286e-09
or O 0 6.606100111383739e-10
incorrect O 0 4.705223588530316e-08
subcellular O 0 9.890796093259269e-08
localization O 0 2.8069232271832334e-08
is O 0 3.7894743766531125e-12
postulated O 0 2.345848992488242e-12
to O 0 1.2220947994898146e-13
be O 0 5.073982466824445e-12
important O 0 1.2219281142478167e-11
in O 0 1.3704901796751656e-11
non B-Disease 0 0.001711818971671164
- I-Disease 1 0.5643318891525269
familial I-Disease 1 0.9998624324798584
breast I-Disease 1 0.999998927116394
and I-Disease 1 0.9999943971633911
ovarian I-Disease 1 1.0
cancers I-Disease 1 0.9999998807907104
. O 0 1.279185024571916e-08

Epigenetic O 0 2.8919016585859936e-06
loss O 0 5.056778900325298e-05
, O 0 2.0305822995281275e-11
however O 0 4.018682359541864e-13
, O 0 6.669045469944596e-14
has O 0 6.812972928871286e-12
not O 0 8.105981977226534e-14
received O 0 5.441582514448262e-13
general O 0 9.002696049580095e-13
acceptance O 0 7.256883028522454e-12
due O 0 1.436501064584414e-13
to O 0 6.70518533766115e-16
controversy O 0 1.2599992663814286e-12
regarding O 0 2.6233308060563676e-12
the O 0 3.203482672273911e-14
subcellular O 0 9.190499056233037e-11
localization O 0 1.3151028877000925e-10
of O 0 8.987987898433428e-14
BRCA1 O 0 3.07431650981016e-06
proteins O 0 1.5588366708563228e-10
, O 0 1.831245252008687e-14
reports O 0 6.092632908599738e-13
of O 0 3.600506242299904e-15
which O 0 5.883105634596486e-12
have O 0 1.0253833372664278e-11
ranged O 0 3.008341839527695e-11
from O 0 3.1981162103332864e-14
exclusively O 0 4.584007479158103e-11
nuclear O 0 2.5932311586984724e-07
, O 0 1.0068516531378338e-15
to O 0 8.210786004358975e-17
conditionally O 0 3.19663434611428e-10
nuclear O 0 1.3768057804952605e-09
, O 0 5.866711128943262e-16
to O 0 1.5245212386873382e-15
the O 0 3.504207828856215e-13
ER O 0 1.2255943602212938e-06
/ O 0 1.3147191668672065e-10
golgi O 0 2.564314038888682e-10
, O 0 6.409201426825278e-15
to O 0 7.413021654924007e-16
cytoplasmic O 0 1.1855340320554575e-10
invaginations O 0 9.778376330871197e-09
into O 0 6.806445733637326e-14
the O 0 4.259958068263993e-14
nucleus O 0 4.88073019500046e-11
. O 0 5.529840040735534e-12

In O 0 9.088708084747932e-12
an O 0 2.4972647173359015e-14
attempt O 0 2.3142113225738115e-12
to O 0 1.5656378103690027e-12
resolve O 0 1.9054628985770705e-09
this O 0 7.511890516901081e-15
issue O 0 3.582497493104242e-11
, O 0 2.8478670702040965e-14
we O 0 3.293508044413529e-12
have O 0 4.847142110429858e-13
comprehensively O 0 7.673922937101452e-07
characterized O 0 1.0651958481933121e-10
19 O 0 2.6481325465788075e-10
anti O 0 4.0529749867346254e-07
- O 0 3.6559645195666235e-06
BRCA1 O 0 0.0002872241020668298
antibodies O 0 5.99235789877639e-08
. O 0 5.096582010588602e-12

These O 0 3.3336020575924774e-12
reagents O 0 1.7836358778833272e-10
detect O 0 1.2888483613693325e-09
a O 0 1.498341517048099e-13
220 O 0 2.101354030017988e-12
- O 0 2.8443567501312828e-09
kD O 0 2.8653532879729937e-09
protein O 0 1.4299198977663075e-11
localized O 0 1.5963870850232986e-11
in O 0 2.5660789021686144e-15
discrete O 0 3.5725469891417783e-12
nuclear O 0 8.654351972836594e-07
foci O 0 4.215706450594325e-09
in O 0 6.185084454150835e-13
all O 0 1.5903757477619962e-11
epithelial O 0 2.568789847501307e-09
cell O 0 1.1367770866854698e-06
lines O 0 7.347873633989366e-07
, O 0 1.8774855259882928e-13
including O 0 3.0678821841875065e-14
those O 0 8.678900832595829e-14
derived O 0 8.799971385267669e-13
from O 0 5.2353205104438416e-11
breast B-Disease 0 0.0076675727032125
malignancies I-Disease 0 0.0002783529635053128
. O 0 2.7394846391359806e-09

Immunohistochemical O 0 5.1350361900404096e-05
staining O 0 1.0767671483336017e-05
of O 0 4.068120840194922e-11
human O 0 2.6827755572611522e-09
breast O 0 0.00021283050591591746
specimens O 0 3.062347605009563e-05
also O 0 5.118130985692915e-08
revealed O 0 2.8163567549199797e-06
BRCA1 O 1 0.9311027526855469
nuclear O 0 0.0034618405625224113
foci O 0 2.6144277853745734e-06
in O 0 5.276683603949728e-11
benign O 0 0.006783175747841597
breast O 0 0.10535051673650742
, O 0 1.2202756582979646e-09
invasive B-Disease 1 0.9073484539985657
lobular I-Disease 1 0.9999067783355713
cancers I-Disease 1 0.9999960660934448
and O 0 1.2435546523192897e-05
low B-Disease 1 0.9097362756729126
- I-Disease 1 0.999883770942688
grade I-Disease 1 0.9999276399612427
ductal I-Disease 1 0.9998446702957153
carcinomas I-Disease 1 0.999998927116394
. O 0 8.224161263115093e-08

Conversely O 0 1.5892386784344126e-07
, O 0 8.163729414700782e-11
BRCA1 O 0 0.0005892382469028234
expression O 0 7.708320204358188e-09
was O 0 3.1248696075181215e-08
reduced O 0 3.562228845233051e-10
or O 0 2.287806333267639e-10
undetectable O 0 1.2518004041339736e-05
in O 0 5.714944170025563e-14
the O 0 3.970414424211803e-14
majority O 0 1.3430593442942396e-12
of O 0 3.4064522036469924e-12
high O 0 4.941043516737409e-05
- O 0 0.0006394342635758221
grade O 0 0.03294353932142258
, O 0 4.457861163542631e-11
ductal B-Disease 0 1.6532463632756844e-05
carcinomas I-Disease 1 0.9999995231628418
, O 0 3.617997394733674e-12
suggesting O 0 1.7598894563874978e-10
that O 0 4.621914396346627e-12
absence O 0 9.128705430461181e-11
of O 0 1.2838314395954842e-12
BRCA1 O 0 0.2605708837509155
may O 0 1.533041249501821e-08
contribute O 0 6.071983194022579e-13
to O 0 9.916205396143674e-15
the O 0 8.604805270282043e-15
pathogenesis O 0 1.3783381987847454e-12
of O 0 1.0607403524632954e-16
a O 0 1.8229711800700227e-15
significant O 0 1.0587650954531e-13
percentage O 0 4.4785775088485025e-08
of O 0 4.358633245993282e-11
sporadic B-Disease 0 0.00950885470956564
breast I-Disease 1 0.9999003410339355
cancers I-Disease 1 0.9802660346031189
. O 0 4.5316563002106847e-11
. O 0 3.962136521651338e-11

